Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [nTPM]"	"Tissue RNA - adrenal gland [nTPM]"	"Tissue RNA - amygdala [nTPM]"	"Tissue RNA - appendix [nTPM]"	"Tissue RNA - basal ganglia [nTPM]"	"Tissue RNA - bone marrow [nTPM]"	"Tissue RNA - breast [nTPM]"	"Tissue RNA - cerebellum [nTPM]"	"Tissue RNA - cerebral cortex [nTPM]"	"Tissue RNA - cervix [nTPM]"	"Tissue RNA - choroid plexus [nTPM]"	"Tissue RNA - colon [nTPM]"	"Tissue RNA - duodenum [nTPM]"	"Tissue RNA - endometrium 1 [nTPM]"	"Tissue RNA - epididymis [nTPM]"	"Tissue RNA - esophagus [nTPM]"	"Tissue RNA - fallopian tube [nTPM]"	"Tissue RNA - gallbladder [nTPM]"	"Tissue RNA - heart muscle [nTPM]"	"Tissue RNA - hippocampal formation [nTPM]"	"Tissue RNA - hypothalamus [nTPM]"	"Tissue RNA - kidney [nTPM]"	"Tissue RNA - liver [nTPM]"	"Tissue RNA - lung [nTPM]"	"Tissue RNA - lymph node [nTPM]"	"Tissue RNA - medulla oblongata [nTPM]"	"Tissue RNA - midbrain [nTPM]"	"Tissue RNA - olfactory bulb [nTPM]"	"Tissue RNA - ovary [nTPM]"	"Tissue RNA - pancreas [nTPM]"	"Tissue RNA - parathyroid gland [nTPM]"	"Tissue RNA - pituitary gland [nTPM]"	"Tissue RNA - placenta [nTPM]"	"Tissue RNA - pons [nTPM]"	"Tissue RNA - prostate [nTPM]"	"Tissue RNA - rectum [nTPM]"	"Tissue RNA - retina [nTPM]"	"Tissue RNA - salivary gland [nTPM]"	"Tissue RNA - seminal vesicle [nTPM]"	"Tissue RNA - skeletal muscle [nTPM]"	"Tissue RNA - skin 1 [nTPM]"	"Tissue RNA - small intestine [nTPM]"	"Tissue RNA - smooth muscle [nTPM]"	"Tissue RNA - spinal cord [nTPM]"	"Tissue RNA - spleen [nTPM]"	"Tissue RNA - stomach 1 [nTPM]"	"Tissue RNA - testis [nTPM]"	"Tissue RNA - thalamus [nTPM]"	"Tissue RNA - thymus [nTPM]"	"Tissue RNA - thyroid gland [nTPM]"	"Tissue RNA - tongue [nTPM]"	"Tissue RNA - tonsil [nTPM]"	"Tissue RNA - urinary bladder [nTPM]"	"Tissue RNA - vagina [nTPM]"	"Tissue RNA - white matter [nTPM]"	"Cell RNA - A-431 [nTPM]"	"Cell RNA - A549 [nTPM]"	"Cell RNA - AF22 [nTPM]"	"Cell RNA - AN3-CA [nTPM]"	"Cell RNA - ASC diff [nTPM]"	"Cell RNA - ASC TERT1 [nTPM]"	"Cell RNA - BEWO [nTPM]"	"Cell RNA - BJ [nTPM]"	"Cell RNA - BJ hTERT+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]"	"Cell RNA - CACO-2 [nTPM]"	"Cell RNA - CAPAN-2 [nTPM]"	"Cell RNA - Daudi [nTPM]"	"Cell RNA - EFO-21 [nTPM]"	"Cell RNA - fHDF/TERT166 [nTPM]"	"Cell RNA - GAMG [nTPM]"	"Cell RNA - HaCaT [nTPM]"	"Cell RNA - HAP1 [nTPM]"	"Cell RNA - HBEC3-KT [nTPM]"	"Cell RNA - HBF TERT88 [nTPM]"	"Cell RNA - HDLM-2 [nTPM]"	"Cell RNA - HEK 293 [nTPM]"	"Cell RNA - HEL [nTPM]"	"Cell RNA - HeLa [nTPM]"	"Cell RNA - Hep G2 [nTPM]"	"Cell RNA - HHSteC [nTPM]"	"Cell RNA - HL-60 [nTPM]"	"Cell RNA - HMC-1 [nTPM]"	"Cell RNA - HSkMC [nTPM]"	"Cell RNA - hTCEpi [nTPM]"	"Cell RNA - hTEC/SVTERT24-B [nTPM]"	"Cell RNA - hTERT-HME1 [nTPM]"	"Cell RNA - hTERT-RPE1 [nTPM]"	"Cell RNA - HUVEC TERT2 [nTPM]"	"Cell RNA - JURKAT [nTPM]"	"Cell RNA - K-562 [nTPM]"	"Cell RNA - Karpas-707 [nTPM]"	"Cell RNA - LHCN-M2 [nTPM]"	"Cell RNA - MCF7 [nTPM]"	"Cell RNA - MOLT-4 [nTPM]"	"Cell RNA - NB-4 [nTPM]"	"Cell RNA - NTERA-2 [nTPM]"	"Cell RNA - OE19 [nTPM]"	"Cell RNA - PC-3 [nTPM]"	"Cell RNA - REH [nTPM]"	"Cell RNA - RH-30 [nTPM]"	"Cell RNA - RPMI-8226 [nTPM]"	"Cell RNA - RPTEC TERT1 [nTPM]"	"Cell RNA - RT4 [nTPM]"	"Cell RNA - SCLC-21H [nTPM]"	"Cell RNA - SH-SY5Y [nTPM]"	"Cell RNA - SiHa [nTPM]"	"Cell RNA - SK-BR-3 [nTPM]"	"Cell RNA - SK-MEL-30 [nTPM]"	"Cell RNA - SuSa [nTPM]"	"Cell RNA - T-47d [nTPM]"	"Cell RNA - THP-1 [nTPM]"	"Cell RNA - TIME [nTPM]"	"Cell RNA - U-138 MG [nTPM]"	"Cell RNA - U-2 OS [nTPM]"	"Cell RNA - U-2197 [nTPM]"	"Cell RNA - U-251 MG [nTPM]"	"Cell RNA - U-266/70 [nTPM]"	"Cell RNA - U-266/84 [nTPM]"	"Cell RNA - U-698 [nTPM]"	"Cell RNA - U-87 MG [nTPM]"	"Cell RNA - U-937 [nTPM]"	"Cell RNA - WM-115 [nTPM]"	"Blood RNA - basophil [nTPM]"	"Blood RNA - classical monocyte [nTPM]"	"Blood RNA - eosinophil [nTPM]"	"Blood RNA - gdT-cell [nTPM]"	"Blood RNA - intermediate monocyte [nTPM]"	"Blood RNA - MAIT T-cell [nTPM]"	"Blood RNA - memory B-cell [nTPM]"	"Blood RNA - memory CD4 T-cell [nTPM]"	"Blood RNA - memory CD8 T-cell [nTPM]"	"Blood RNA - myeloid DC [nTPM]"	"Blood RNA - naive B-cell [nTPM]"	"Blood RNA - naive CD4 T-cell [nTPM]"	"Blood RNA - naive CD8 T-cell [nTPM]"	"Blood RNA - neutrophil [nTPM]"	"Blood RNA - NK-cell [nTPM]"	"Blood RNA - non-classical monocyte [nTPM]"	"Blood RNA - plasmacytoid DC [nTPM]"	"Blood RNA - T-reg [nTPM]"	"Blood RNA - total PBMC [nTPM]"	"Brain RNA - amygdala [nTPM]"	"Brain RNA - basal ganglia [nTPM]"	"Brain RNA - cerebellum [nTPM]"	"Brain RNA - cerebral cortex [nTPM]"	"Brain RNA - hippocampal formation [nTPM]"	"Brain RNA - hypothalamus [nTPM]"	"Brain RNA - medulla oblongata [nTPM]"	"Brain RNA - midbrain [nTPM]"	"Brain RNA - olfactory bulb [nTPM]"	"Brain RNA - pons [nTPM]"	"Brain RNA - spinal cord [nTPM]"	"Brain RNA - thalamus [nTPM]"	"Brain RNA - white matter [nTPM]"	"Single Cell Type RNA - Adipocytes [nTPM]"	"Single Cell Type RNA - Alveolar cells type 1 [nTPM]"	"Single Cell Type RNA - Alveolar cells type 2 [nTPM]"	"Single Cell Type RNA - Astrocytes [nTPM]"	"Single Cell Type RNA - B-cells [nTPM]"	"Single Cell Type RNA - Basal keratinocytes [nTPM]"	"Single Cell Type RNA - Basal prostatic cells [nTPM]"	"Single Cell Type RNA - Basal respiratory cells [nTPM]"	"Single Cell Type RNA - Basal squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Bipolar cells [nTPM]"	"Single Cell Type RNA - Breast glandular cells [nTPM]"	"Single Cell Type RNA - Breast myoepithelial cells [nTPM]"	"Single Cell Type RNA - Cardiomyocytes [nTPM]"	"Single Cell Type RNA - Cholangiocytes [nTPM]"	"Single Cell Type RNA - Club cells [nTPM]"	"Single Cell Type RNA - Collecting duct cells [nTPM]"	"Single Cell Type RNA - Cone photoreceptor cells [nTPM]"	"Single Cell Type RNA - Cytotrophoblasts [nTPM]"	"Single Cell Type RNA - dendritic cells [nTPM]"	"Single Cell Type RNA - Distal enterocytes [nTPM]"	"Single Cell Type RNA - Distal tubular cells [nTPM]"	"Single Cell Type RNA - Ductal cells [nTPM]"	"Single Cell Type RNA - Early spermatids [nTPM]"	"Single Cell Type RNA - Endometrial ciliated cells [nTPM]"	"Single Cell Type RNA - Endometrial stromal cells [nTPM]"	"Single Cell Type RNA - Endothelial cells [nTPM]"	"Single Cell Type RNA - Enteroendocrine cells [nTPM]"	"Single Cell Type RNA - Erythroid cells [nTPM]"	"Single Cell Type RNA - Excitatory neurons [nTPM]"	"Single Cell Type RNA - Exocrine glandular cells [nTPM]"	"Single Cell Type RNA - Extravillous trophoblasts [nTPM]"	"Single Cell Type RNA - Fibroblasts [nTPM]"	"Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]"	"Single Cell Type RNA - Glandular and luminal cells [nTPM]"	"Single Cell Type RNA - granulocytes [nTPM]"	"Single Cell Type RNA - Granulosa cells [nTPM]"	"Single Cell Type RNA - Hepatic stellate cells [nTPM]"	"Single Cell Type RNA - Hepatocytes [nTPM]"	"Single Cell Type RNA - Hofbauer cells [nTPM]"	"Single Cell Type RNA - Horizontal cells [nTPM]"	"Single Cell Type RNA - Inhibitory neurons [nTPM]"	"Single Cell Type RNA - Intestinal goblet cells [nTPM]"	"Single Cell Type RNA - Ionocytes [nTPM]"	"Single Cell Type RNA - Kupffer cells [nTPM]"	"Single Cell Type RNA - Langerhans cells [nTPM]"	"Single Cell Type RNA - Late spermatids [nTPM]"	"Single Cell Type RNA - Leydig cells [nTPM]"	"Single Cell Type RNA - Macrophages [nTPM]"	"Single Cell Type RNA - Melanocytes [nTPM]"	"Single Cell Type RNA - Microglial cells [nTPM]"	"Single Cell Type RNA - monocytes [nTPM]"	"Single Cell Type RNA - Muller glia cells [nTPM]"	"Single Cell Type RNA - NK-cells [nTPM]"	"Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]"	"Single Cell Type RNA - Oligodendrocytes [nTPM]"	"Single Cell Type RNA - Pancreatic endocrine cells [nTPM]"	"Single Cell Type RNA - Paneth cells [nTPM]"	"Single Cell Type RNA - Peritubular cells [nTPM]"	"Single Cell Type RNA - Plasma cells [nTPM]"	"Single Cell Type RNA - Prostatic glandular cells [nTPM]"	"Single Cell Type RNA - Proximal enterocytes [nTPM]"	"Single Cell Type RNA - Proximal tubular cells [nTPM]"	"Single Cell Type RNA - Respiratory ciliated cells [nTPM]"	"Single Cell Type RNA - Rod photoreceptor cells [nTPM]"	"Single Cell Type RNA - Sertoli cells [nTPM]"	"Single Cell Type RNA - Skeletal myocytes [nTPM]"	"Single Cell Type RNA - Smooth muscle cells [nTPM]"	"Single Cell Type RNA - Spermatocytes [nTPM]"	"Single Cell Type RNA - Spermatogonia [nTPM]"	"Single Cell Type RNA - Squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Suprabasal keratinocytes [nTPM]"	"Single Cell Type RNA - Syncytiotrophoblasts [nTPM]"	"Single Cell Type RNA - T-cells [nTPM]"	"Single Cell Type RNA - Theca cells [nTPM]"	"Single Cell Type RNA - Undifferentiated cells [nTPM]"	"Single Cell Type RNA - Urothelial cells [nTPM]"
KHDC3L	"C6orf221, ECAT1"	ENSG00000203908	"KH domain containing 3 like, subcortical maternal complex member"	Q587J8	6	73362658-73364171	"Disease related genes, Human disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"testis: 1.1"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	3156	"testis cancer: 254.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA043699	Uncertain					NA	NA					"HPA043699: AB_10960564"					"unprognostic (1.39e-2)"					"unprognostic (1.37e-1)"					"unprognostic (1.67e-1)"	"unprognostic (4.36e-1)"		0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.2	0.4	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.6	0.0	0.2	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.4	0.4	0.1	0.2	0.1	0.2	0.2	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DPPA5	Esg1	ENSG00000203909	"Developmental pluripotency associated 5"	A6NC42	6	73353063-73354276	"Predicted intracellular proteins"		"Developmental protein, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"testis: 2.1"	"Group enriched"	"Detected in some"	4	"Spermatocytes: 2.4;Spermatogonia: 1.4"	"Cancer enriched"	"Detected in single"	2209	"testis cancer: 347.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	43	"SuSa: 6.9"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA055016, HPA064505"	Uncertain		Uncertain	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA055016: , HPA064505: AB_2685275"															"unprognostic (1.85e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1
NANOG	"FLJ12581, FLJ40451"	ENSG00000111704	"Nanog homeobox"	Q9H9S0	12	7787794-7799146	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"brain: 1.8"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 8.4;Spermatocytes: 5.5"	"Cancer enriched"	"Detected in single"	1164	"testis cancer: 58.1"	"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 1.7"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.7;granulocytes: 1.5"	"Cell line enriched"	"Detected in some"	5	"NTERA-2: 125.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB019380, HPA072117"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"CAB019380: , HPA072117: "	"unprognostic (1.76e-1)"	"unprognostic (1.86e-1)"		"unprognostic (1.01e-1)"	"unprognostic (1.78e-1)"	"unprognostic (8.59e-3)"	"unprognostic (3.50e-1)"	"unprognostic (3.46e-2)"		"unprognostic (6.35e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.87e-1)"	"unprognostic (4.51e-7)"	"unprognostic (3.46e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.51e-1)"	"unprognostic (3.85e-2)"	0.0	0.1	0.3	0.1	0.6	0.4	0.1	1.8	0.5	0.0	0.3	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.3	0.2	0.0	0.2	0.4	0.1	0.2	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.8	0.1	0.0	0.1	0.0	0.0	0.3	0.3	0.0	0.1	0.1	0.2	0.2	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	125.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.3	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	1.5	0.2	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.3	0.2	0.2	0.7	0.3	0.2	1.7	0.1	0.0	0.3	0.6	1.8	0.5	0.3	0.2	0.2	0.1	0.3	0.8	0.1	0.3	0.7	0.4	0.0	0.0	0.0	0.2	1.7	1.8	0.8	0.0	2.2	0.3	0.1	0.8	0.0	0.3	0.0	8.4	1.6	1.4	0.1	0.0	0.4	1.0	0.3	0.5	0.6	0.0	0.0	0.0	0.4	0.2	0.4	0.0	0.3	0.0	2.1	0.7	0.6	0.5	0.0	0.0	0.3	2.0	0.3	0.0	0.3	1.5	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.1	0.2	0.4	1.5	0.0	0.9	0.0	0.3	0.9	1.0	0.0	1.7	0.4	5.5	0.6	0.0	0.6	0.7	0.7	0.7	0.4	1.8
DPPA3	"Pgc7, Stella"	ENSG00000187569	"Developmental pluripotency associated 3"	Q6W0C5	12	7711433-7717559	"Predicted intracellular proteins"		"Chromatin regulator, Developmental protein"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	14	"Cytotrophoblasts: 1.1;Extravillous trophoblasts: 1.0;Spermatocytes: 1.4;Spermatogonia: 2.5;Syncytiotrophoblasts: 1.4"	"Cancer enriched"	"Detected in single"	779	"testis cancer: 339.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"BEWO: 338.4;NTERA-2: 143.2"	"Not detected"	"Not detected"													NA	NA																			"unprognostic (2.52e-1)"	"unprognostic (9.49e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	338.4	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	143.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	45.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	2.5	0.0	0.0	1.4	0.0	0.0	0.0	0.0
PRDM14		ENSG00000147596	"PR/SET domain 14"	Q9GZV8	8	70051651-70071693	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Methyltransferase, Transferase"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	658	"testis cancer: 34.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	93	"NTERA-2: 49.4;SuSa: 13.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA019094, HPA057070"	Uncertain		Uncertain	Nucleoplasm		NA	NA			Nucleoplasm		"HPA019094: AB_1855686, HPA057070: AB_2683327"					"unprognostic (5.86e-2)"					"unprognostic (9.32e-2)"			"unprognostic (6.14e-3)"	"unprognostic (1.37e-2)"	"unprognostic (8.62e-2)"			0.0	0.0	0.2	0.0	0.3	0.3	0.0	0.6	0.5	0.0	0.3	0.0	0.2	0.1	0.2	0.0	0.0	0.1	0.3	0.1	0.2	0.1	0.0	0.1	0.1	0.3	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.3	0.1	0.1	0.1	0.2	0.0	0.0	0.1	0.1	0.0	0.8	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	49.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	13.3	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.2	0.4	0.3	0.2	0.0	0.2	0.1	0.0	0.0	0.2	0.3	0.6	0.5	0.1	0.2	0.3	0.1	0.3	0.4	0.1	0.2	0.7	0.1	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2
GDF3		ENSG00000184344	"Growth differentiation factor 3"	Q9NR23	12	7689784-7695775	"Disease related genes, Human disease related genes, Predicted secreted proteins"		"Cytokine, Developmental protein, Growth factor"	"Disease variant, Microphthalmia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"kidney: 1.0"	"Cell type enriched"	"Detected in some"	25	"Granulosa cells: 30.2"	"Cancer enriched"	"Detected in some"	422	"testis cancer: 383.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"NTERA-2: 452.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA018468	Uncertain				"Secreted to blood"	NA	NA					"HPA018468: AB_1849586"	"unprognostic (9.48e-2)"	"unprognostic (3.90e-2)"	"unprognostic (3.30e-2)"	"unprognostic (1.86e-2)"	"unprognostic (3.51e-1)"	"unprognostic (5.40e-2)"		"unprognostic (3.09e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.07e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.25e-3)"	"unprognostic (8.00e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.03e-1)"	0.3	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.2	0.0	0.0	1.0	0.1	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.9	0.0	0.4	0.0	0.0	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	36.8	0.0	0.0	0.0	0.6	2.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	1.2	0.0	0.0	0.0	0.1	0.0	452.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	77.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	30.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NANOGP8		ENSG00000255192	"Nanog homeobox retrogene P8"	Q6NSW7	15	35083410-35085295	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	4	"brain: 3.2"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	415	"testis cancer: 20.7"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	69	"NTERA-2: 33.2;SuSa: 11.6"									HPA072117			Supported	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA072117: "										"unprognostic (1.58e-1)"			"unprognostic (9.05e-3)"	"unprognostic (1.48e-1)"	"unprognostic (2.37e-1)"			0.1	0.1	0.4	0.0	3.2	0.2	0.1	2.0	1.4	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.0	0.1	0.2	0.9	0.1	0.1	0.1	0.0	0.7	0.3	0.7	0.2	0.2	0.0	0.2	0.0	1.3	0.2	0.0	0.2	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.7	0.7	0.0	0.1	0.0	0.0	0.1	0.1	0.5	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	33.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.4	3.2	2.0	1.4	0.2	0.9	0.7	0.3	0.7	1.3	0.1	0.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LIN28A	"CSDD1, FLJ12457, LIN-28, LIN28, ZCCHC1"	ENSG00000131914	"Lin-28 homolog A"	Q9H9Z2	1	26410817-26429728	"Predicted intracellular proteins"	"RNA-mediated gene silencing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"testis: 5.2"	"Group enriched"	"Detected in some"	43	"Early spermatids: 35.2;Late spermatids: 69.5"	"Cancer enriched"	"Detected in single"	261	"testis cancer: 101.9"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"NTERA-2: 861.2;SuSa: 300.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB020785, HPA063074, HPA068814"	Enhanced		Supported	"Nucleoli,Cytosol,Rods & Rings"		NA	NA			Cytosol	"Nucleoli, Rods & Rings"	"CAB020785: , HPA063074: , HPA068814: "	"unprognostic (9.64e-3)"	"unprognostic (1.69e-1)"		"unprognostic (1.35e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.55e-1)"		"unprognostic (1.17e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.21e-1)"			"unprognostic (2.49e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.13e-1)"		"unprognostic (6.82e-2)"	0.0	0.0	0.3	0.0	0.3	0.2	0.0	1.0	0.3	0.0	0.3	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.1	5.2	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	84.3	0.5	0.0	0.0	62.7	0.1	0.0	0.0	0.0	2.0	0.5	0.0	0.1	0.0	0.0	0.2	11.6	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.1	861.2	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.2	0.0	300.9	27.2	0.2	0.1	0.4	0.1	0.1	0.0	0.2	0.0	0.1	0.0	0.1	0.2	0.4	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.1	0.1	0.3	0.1	0.0	0.1	0.0	0.0	0.3	0.3	1.0	0.3	0.1	0.1	0.2	0.2	0.1	0.4	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.2	0.1	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	69.5	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.9	0.0	1.1	0.4	1.2	0.4	0.0	0.1	0.0	0.2	0.0	0.0	0.2
UTF1		ENSG00000171794	"Undifferentiated embryonic cell transcription factor 1"	Q5T230	10	133230217-133231558	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	10	"testis: 6.0"	"Group enriched"	"Detected in some"	5	"Langerhans cells: 42.1;Spermatogonia: 40.0"	"Cancer enriched"	"Detected in single"	243	"testis cancer: 49.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	18	"NTERA-2: 5.5;RPMI-8226: 2.0"									CAB022384	Enhanced					NA	NA					"CAB022384: "					"unprognostic (9.19e-2)"					"unprognostic (1.95e-1)"	"unprognostic (8.57e-2)"		"unprognostic (1.78e-1)"	"unprognostic (2.99e-3)"	"unprognostic (2.88e-1)"	"unprognostic (3.82e-1)"		0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	1.1	0.9	0.0	0.0	0.0	0.0	0.1	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.2	0.0	0.4	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.1	0.0	0.0	2.0	42.1	1.1	0.3	7.0	0.0	0.0	4.4	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	40.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0
DPPA4	FLJ10713	ENSG00000121570	"Developmental pluripotency associated 4"	Q7L190	3	109326141-109337572	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 4.7;lymphoid tissue: 12.3;testis: 4.1"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 22.3;Erythroid cells: 16.4;Extravillous trophoblasts: 17.2;Spermatogonia: 11.7;Syncytiotrophoblasts: 6.2"	"Cancer enriched"	"Detected in single"	218	"testis cancer: 59.0"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	12	"plasmacytoid DC: 7.3"	"Lineage enriched"	"Detected in single"	12	"dendritic cells: 7.3"	"Group enriched"	"Detected in some"	4	"HAP1: 89.7;NTERA-2: 327.5;SuSa: 120.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB020678, HPA035249, HPA035250"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome,Cytosol"		Yes	NA			"Nucleoli, Nucleoli rim"	"Nucleoplasm, Mitotic chromosome, Cytosol"	"CAB020678: , HPA035249: AB_2674535, HPA035250: AB_2674536"	"unprognostic (2.07e-2)"	"unprognostic (2.53e-2)"	"unprognostic (3.80e-1)"	"unprognostic (2.53e-1)"	"unprognostic (8.57e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.52e-1)"	"unprognostic (9.83e-2)"	"unprognostic (2.02e-2)"	"unprognostic (6.60e-2)"	"unprognostic (2.48e-2)"	"unprognostic (3.03e-8)"	"unprognostic (5.28e-2)"	"unprognostic (5.04e-2)"	"unprognostic (5.56e-2)"	"unprognostic (3.85e-2)"	0.0	0.0	0.0	0.1	0.1	4.7	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	4.1	0.0	12.3	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	43.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	89.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	327.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	120.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.1	0.1	0.0	0.5	0.0	7.3	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.6	0.0	0.0	22.3	4.3	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	16.4	0.1	0.0	17.2	0.5	0.0	0.0	1.3	0.0	0.4	1.6	1.7	0.0	0.1	0.0	0.0	0.3	0.0	0.6	0.3	0.4	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.1	0.7	0.0	0.0	0.9	0.3	0.3	11.7	0.0	0.0	6.2	0.5	0.2	0.0	0.3
ZSCAN10	ZNF206	ENSG00000130182	"Zinc finger and SCAN domain containing 10"	Q96SZ4	16	3088890-3099295	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	4	"brain: 1.8"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 1.4;Cytotrophoblasts: 1.9"	"Cancer enriched"	"Detected in single"	207	"testis cancer: 19.5"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	10	"NTERA-2: 56.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA076826			Approved	Nucleoplasm,Centrosome		NA	NA			Nucleoplasm	Centrosome	"HPA076826: "	"unprognostic (4.37e-2)"	"unprognostic (5.13e-2)"		"unprognostic (9.15e-2)"	"unprognostic (6.65e-3)"	"unprognostic (6.24e-2)"	"unprognostic (7.60e-2)"	"unprognostic (3.24e-2)"		"unprognostic (1.15e-1)"		"unprognostic (1.72e-1)"	"unprognostic (1.85e-11)"	"unprognostic (5.98e-2)"	"unprognostic (2.92e-2)"		"unprognostic (1.79e-2)"	0.0	0.0	0.4	0.0	0.5	0.2	0.0	0.9	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.4	0.2	0.6	0.1	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.2	0.4	0.0	0.0	0.1	0.1	0.1	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.3	0.0	0.1	0.3	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	56.8	0.3	0.4	0.0	0.1	0.2	0.0	0.0	0.1	0.2	0.0	0.1	0.0	5.8	0.1	0.6	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.5	0.3	0.0	0.1	0.6	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.4	0.5	0.9	0.9	0.4	0.4	0.4	0.2	0.6	0.5	0.1	0.5	1.8	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	1.4	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.7	0.0	0.0	0.1	0.0	0.1	0.0	0.0
PRM2	CT94.2	ENSG00000122304	"Protamine 2"	P04554	16	11275639-11276480	"Predicted intracellular proteins"	"Differentiation, DNA condensation, Spermatogenesis"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	1082	"testis: 11788.4"	"Cell type enriched"	"Detected in some"	7	"Late spermatids: 506606.3"	"Cancer enriched"	"Detected in single"	187	"testis cancer: 11.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"BEWO: 1.1;NB-4: 1.3;U-2197: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB032738, HPA056386"	Enhanced					NA	NA					"CAB032738: AB_2171312, HPA056386: AB_2683111"															"unprognostic (3.88e-2)"			1.8	1.9	0.0	0.3	0.0	0.0	8.6	0.0	0.0	1.5	0.0	1.8	0.6	1.0	0.0	1.6	1.1	0.0	1.5	0.0	0.0	2.1	3.6	1.1	0.5	0.0	0.0	0.0	1.4	2.6	0.0	1.7	0.0	0.0	10.8	0.0	0.0	1.7	0.8	4.7	3.1	3.2	0.0	0.0	1.1	2.1	11788.4	0.0	0.2	3.6	0.0	0.0	1.3	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	70432.4	0.2	0.0	77.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	506606.3	1538.1	115.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1673.0	0.0	0.0	0.0	0.0	0.0	0.0	913.8	0.0	0.0	1879.2	957.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRM1	CT94.1	ENSG00000175646	"Protamine 1"	P04553	16	11280841-11281330	"Predicted intracellular proteins"	"Differentiation, DNA condensation, Spermatogenesis"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	1098	"testis: 14225.7"	"Cell type enriched"	"Detected in some"	6	"Late spermatids: 776887.9"	"Cancer enriched"	"Detected in single"	161	"testis cancer: 11.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NB-4: 2.4;U-2197: 1.7"					"Not detected"	"Not detected"			"HPA055150, HPA059371"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA055150: AB_2682718, HPA059371: "															"unprognostic (2.10e-2)"			2.2	2.2	0.0	0.5	0.0	0.0	10.0	0.0	0.0	1.8	0.0	2.1	1.5	1.0	0.0	2.0	1.2	0.0	1.7	0.0	0.0	2.6	4.4	1.4	0.4	0.0	0.0	0.0	1.6	3.1	0.0	1.9	0.0	0.1	12.9	0.0	0.0	2.1	1.3	5.8	3.6	4.1	0.0	0.0	1.4	2.4	14225.7	0.0	0.0	4.4	0.0	0.1	1.5	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	126844.3	0.0	0.0	80.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	776887.9	1855.9	161.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1689.6	0.0	0.0	0.0	0.0	0.0	0.0	1157.0	0.0	0.0	2054.0	1211.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ERVW-1	"envW, ERVWE1, HERV-7q, HERV-W, HERV-W-ENV, HERVW"	ENSG00000242950	"Endogenous retrovirus group W member 1, envelope"	Q9UQF0	7	92468380-92477986	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"placenta: 55.0"	"Group enriched"	"Detected in some"	6	"Cytotrophoblasts: 272.2;Syncytiotrophoblasts: 853.9"	"Cancer enriched"	"Detected in single"	143	"testis cancer: 31.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	36	"BEWO: 85.2;SuSa: 26.2"	"Not detected"	"Not detected"													NA	NA		54000				"unprognostic (2.85e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.48e-4)"	"unprognostic (4.80e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.11e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.33e-1)"	"unprognostic (3.96e-2)"	"unprognostic (8.02e-2)"	0.5	0.7	1.0	0.8	1.3	0.8	0.7	2.1	1.7	0.2	0.6	0.4	0.5	0.5	3.5	0.1	0.2	0.3	0.2	0.9	0.8	0.3	0.3	0.6	0.7	1.6	0.9	0.2	0.5	0.7	0.3	0.0	55.0	1.7	0.5	0.5	6.9	1.0	0.2	0.7	1.0	0.6	0.4	0.4	0.9	1.2	6.1	1.1	0.4	0.7	0.0	0.4	0.2	0.0	4.3	0.2	0.4	0.7	0.5	0.0	0.6	85.2	0.2	0.0	0.0	0.0	0.4	0.4	0.2	0.5	0.0	1.2	0.6	0.3	0.2	0.1	0.2	0.4	0.4	1.4	0.3	0.1	0.4	0.6	0.2	0.2	0.1	0.0	0.3	0.0	0.6	0.7	1.3	0.1	0.5	0.4	0.7	0.3	0.1	0.2	0.5	0.2	0.1	0.2	0.4	0.3	0.6	0.1	1.2	0.0	26.2	0.3	0.5	0.2	0.1	1.5	0.4	0.2	1.5	0.7	0.2	0.1	0.4	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	1.3	2.1	1.7	0.9	0.8	1.6	0.9	0.2	1.7	0.4	1.1	4.3	0.7	3.2	3.1	0.0	0.1	0.8	0.8	0.2	0.0	2.1	0.1	0.1	0.2	0.0	1.4	0.0	0.0	272.2	0.0	0.1	0.0	0.0	47.9	0.4	0.2	1.4	0.0	0.0	0.1	0.0	86.2	2.4	0.0	0.2	2.5	0.1	0.0	0.0	27.4	0.0	0.1	0.0	0.0	1.9	0.7	10.4	1.2	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	3.4	0.1	0.4	0.0	0.1	5.3	1.8	0.0	2.6	0.4	1.0	0.3	0.0	2.0	853.9	0.3	0.1	0.1	1.0
RBMXL2	"HNRNPG-T, HNRPGT"	ENSG00000170748	"RBMX like 2"	O75526	11	7088998-7091148	"Predicted intracellular proteins"		"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	168	"testis: 36.1"	"Group enriched"	"Detected in some"	8	"Early spermatids: 157.6;Late spermatids: 160.6;Spermatocytes: 205.3"	"Cancer enriched"	"Detected in single"	133	"testis cancer: 6.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"HPA038912, HPA051842"	Enhanced					NA	NA					"HPA038912: AB_10670913, HPA051842: AB_2681634"		"unprognostic (3.73e-1)"			"unprognostic (2.24e-1)"							"unprognostic (5.47e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.24e-1)"	"unprognostic (8.28e-2)"	"unprognostic (3.77e-2)"		0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	36.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	157.6	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	160.6	3.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.2	205.3	20.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0
ARGFX		ENSG00000186103	"Arginine-fifty homeobox"	A6NJG6	3	121567949-121590622	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 2.0"	"Cell type enhanced"	"Detected in some"		"Inhibitory neurons: 1.0;Oligodendrocyte precursor cells: 1.5"	"Cancer enriched"	"Detected in single"	119	"testis cancer: 6.4"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in single"		"SK-BR-3: 1.7"									HPA043049	Uncertain					NA	NA					"HPA043049: AB_2678288"															"unprognostic (6.00e-2)"			0.1	0.2	0.7	0.3	0.7	1.2	0.3	2.0	1.1	0.0	0.6	0.1	0.2	0.3	0.2	0.2	0.1	0.2	0.2	0.8	0.3	0.1	0.1	0.1	0.4	0.7	0.3	1.1	0.2	0.4	0.1	0.0	0.2	1.2	0.2	0.2	0.6	0.4	0.1	0.5	0.8	0.3	0.1	0.2	0.3	0.4	0.3	0.6	0.1	0.3	0.1	0.3	0.1	0.0	1.9	0.1	0.2	0.3	0.3	0.1	0.1	0.4	0.1	0.0	0.1	0.1	0.3	0.4	0.6	0.1	0.1	0.1	0.4	0.1	0.1	0.0	0.2	0.3	0.3	0.6	0.3	0.1	0.5	0.9	0.1	0.5	0.1	0.1	0.2	0.0	0.4	0.3	0.8	0.0	0.3	0.2	0.5	0.4	0.1	0.1	0.3	0.2	0.2	0.2	0.5	0.3	0.3	0.2	1.7	0.1	0.3	0.2	0.2	0.4	0.4	0.3	0.4	0.1	0.5	0.2	0.4	0.3	0.3	0.2	1.3	0.4	0.3	0.3	0.3	0.2	0.4	0.3	0.2	0.1	0.6	0.3	0.3	1.8	0.6	0.3	0.4	0.2	0.1	0.7	0.7	2.0	1.1	0.8	0.3	0.7	0.3	1.1	1.2	0.2	0.6	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TRIM60	"FLJ35882, RNF129, RNF33"	ENSG00000176979	"Tripartite motif containing 60"	Q495X7	4	165016458-165041749	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"placenta: 1.5;testis: 1.5"	"Group enriched"	"Detected in some"	4	"Cytotrophoblasts: 5.1;Early spermatids: 3.0;Extravillous trophoblasts: 10.6;Spermatocytes: 9.6;Spermatogonia: 8.2;Syncytiotrophoblasts: 5.6"	"Cancer enriched"	"Detected in single"	103	"testis cancer: 5.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"BEWO: 14.2"	"Not detected"	"Not detected"							"HPA035809, HPA035810, HPA061496"	Uncertain		Uncertain	Nucleoplasm,Nucleoli,Cytosol		NA	NA			Nucleoli	"Nucleoplasm, Cytosol"	"HPA035809: AB_2674794, HPA035810: AB_10601827, HPA061496: AB_2684540"															"unprognostic (1.10e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	14.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.3	0.2	0.3	0.2	0.3	0.0	0.4	0.5	0.9	0.7	0.0	0.1	0.0	0.0	5.1	0.6	0.0	0.0	0.0	3.0	0.8	0.9	0.7	0.0	0.0	0.2	0.0	10.6	0.3	0.0	1.5	0.0	0.2	0.0	1.1	0.5	0.0	0.3	0.0	0.0	1.3	0.0	0.5	0.9	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.4	0.7	0.3	0.0	0.1	0.8	0.5	0.0	0.0	0.3	9.6	8.2	0.0	0.3	5.6	0.7	0.2	0.0	0.1
DNMT3L	MGC1090	ENSG00000142182	"DNA methyltransferase 3 like"	Q9UJW3	21	44246339-44262216	"Metabolic proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"liver: 1.9"	"Group enriched"	"Detected in some"	6	"Hepatocytes: 20.8;Proximal tubular cells: 29.1"	"Cancer enriched"	"Detected in some"	90	"testis cancer: 46.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"BEWO: 24.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA055234, HPA066780"	Approved		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA055234: AB_2682750, HPA066780: AB_2685719"							"unprognostic (1.05e-4)"			"unprognostic (1.91e-1)"			"unprognostic (2.73e-9)"	"unprognostic (2.77e-1)"	"unprognostic (5.28e-2)"			0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.5	1.9	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	24.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.8	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	3.7	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	20.8	0.0	0.0	0.4	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	29.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.1
CER1	DAND4	ENSG00000147869	"Cerberus 1, DAN family BMP antagonist"	O95813	9	14719724-14722733	"Predicted secreted proteins"		Cytokine		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"epididymis: 1.0"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	82	"testis cancer: 17.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HEL: 4.0;NTERA-2: 7.0;SCLC-21H: 2.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA019917	Uncertain				"Secreted - unknown location"	NA	NA					"HPA019917: AB_1846539"					"unprognostic (2.98e-2)"						"unprognostic (5.36e-2)"				"unprognostic (5.99e-2)"			0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.1	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.2	0.0	0.2	0.2	0.1	0.0	0.4	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0
KCNV2	Kv8.2	ENSG00000168263	"Potassium voltage-gated channel modifier subfamily V member 2"	Q8TDN2	9	2717510-2730037	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Cone-rod dystrophy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	59	"retina: 291.7"	"Group enriched"	"Detected in some"	6	"Cone photoreceptor cells: 515.0;Rod photoreceptor cells: 530.1"	"Cancer enriched"	"Detected in single"	78	"testis cancer: 6.2"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA031131	Enhanced					NA	NA					"HPA031131: AB_10609996"	"unprognostic (5.06e-2)"	"unprognostic (1.47e-3)"	"unprognostic (3.45e-3)"	"unprognostic (6.41e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.12e-3)"	"unprognostic (5.38e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.69e-1)"	"unprognostic (5.21e-2)"	"unprognostic (2.35e-1)"	"unprognostic (7.96e-8)"	"unprognostic (3.01e-1)"	"unprognostic (4.90e-2)"	"unprognostic (9.90e-2)"	"unprognostic (1.06e-2)"	0.0	0.1	1.1	0.0	1.0	0.0	0.0	0.1	0.7	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.8	0.6	0.1	0.0	0.1	0.0	0.1	0.0	1.2	0.2	0.1	0.0	0.1	0.0	0.4	0.0	0.0	291.7	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	4.9	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.1	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.0	0.1	0.7	0.8	0.6	0.1	0.0	1.2	0.4	0.0	0.3	0.3	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	49.6	0.0	0.0	0.2	0.0	0.0	0.0	515.0	0.0	0.0	0.0	0.0	0.0	81.5	0.0	0.0	2.3	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.2	1.3	0.0	0.0	0.0	0.0	25.3	0.6	0.0	0.0	0.0	0.0	69.1	0.0	0.5	1.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	530.1	13.1	0.0	0.0	7.4	14.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TCL1B	TML1	ENSG00000213231	"TCL1 family AKT coactivator B"	O95988	14	95686426-95692628	"Predicted intracellular proteins"			Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 1.2;lymphoid tissue: 2.5;testis: 2.6"	"Cell type enriched"	"Detected in some"	8	"Syncytiotrophoblasts: 72.7"	"Cancer enriched"	"Detected in single"	72	"testis cancer: 8.3"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	24	"naive B-cell: 11.7;plasmacytoid DC: 6.2"	"Group enriched"	"Detected in many"	24	"B-cells: 11.7;dendritic cells: 6.2"	"Cell line enriched"	"Detected in some"	7	"U-698: 511.8"					"Not detected"	"Not detected"			HPA053163	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA053163: AB_2682064"															"unprognostic (1.55e-1)"			0.1	0.0	0.2	0.5	0.6	1.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.1	0.4	0.5	0.0	0.0	2.2	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.8	0.0	2.6	0.3	0.2	0.0	0.0	2.5	0.0	0.0	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	5.1	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	73.5	0.1	0.0	0.0	0.0	0.2	0.0	0.4	0.5	0.0	2.5	0.6	0.4	0.0	0.0	1.3	0.0	0.2	0.2	0.4	511.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.7	0.0	0.0	0.3	0.3	0.0	6.2	0.0	0.3	0.2	0.6	0.1	0.2	0.1	0.4	0.5	0.3	0.0	0.5	0.2	0.3	1.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.1	9.0	0.0	0.0	72.7	0.0	0.1	0.0	0.1
DEFB119	"DEFB-19, DEFB-20, DEFB120"	ENSG00000180483	"Defensin beta 119"	Q8N690	20	31377164-31390590	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"epididymis: 1942.3"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 42.6;Cone photoreceptor cells: 39.6;Early spermatids: 61.9;Late spermatids: 99.8;Rod photoreceptor cells: 150.2"	"Cancer enriched"	"Detected in single"	67	"testis cancer: 3.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"NB-4: 1.5"									HPA043059	Supported				"Secreted in male reproductive system"	NA	NA					"HPA043059: AB_10797025"															"unprognostic (2.03e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.1	1942.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	157.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	334.1	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.6	0.0	0.0	0.0	0.0	0.0	0.0	39.6	0.0	0.0	0.0	0.0	0.0	61.9	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	0.1	0.0	0.0	0.0	0.0	99.8	12.5	0.8	0.0	0.0	0.0	22.0	0.0	0.0	0.1	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	150.2	13.1	0.0	0.0	17.4	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GIP		ENSG00000159224	"Gastric inhibitory polypeptide"	P09681	17	48958554-48968596	"Plasma proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	209	"intestine: 261.9"	"Cell type enriched"	"Detected in single"	4	"Intestinal goblet cells: 1.9"	"Cancer enriched"	"Detected in some"	63	"testis cancer: 74.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"A549: 6.6;BEWO: 5.9;Hep G2: 9.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA021612, HPA064596"	Enhanced				"Secreted to blood"	NA	NA	33900	540000			"HPA021612: AB_1849506, HPA064596: "										"unprognostic (2.95e-1)"	"unprognostic (2.70e-3)"			"unprognostic (4.42e-2)"	"unprognostic (1.82e-1)"			0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	261.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	94.5	0.0	0.0	0.0	1.2	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.1	0.0	0.3	0.5	5.9	0.3	0.0	0.0	0.0	1.7	0.7	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.0	9.8	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	1.6	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	1.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0
NLRP9	"CLR19.1, NALP9, NOD6, PAN12"	ENSG00000185792	"NLR family pyrin domain containing 9"	Q7RTR0	19	55708438-55738402	"Predicted intracellular proteins"	"Immunity, Inflammatory response, Innate immunity"			"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	40	"Extravillous trophoblasts: 61.2"	"Cancer enriched"	"Detected in single"	59	"testis cancer: 14.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA042623	Uncertain					NA	NA					"HPA042623: AB_10965692"	"unprognostic (2.50e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.85e-1)"	"unprognostic (8.82e-2)"	"unprognostic (6.53e-2)"	"unprognostic (9.92e-3)"	"unprognostic (1.63e-1)"	"unprognostic (9.55e-2)"	"unprognostic (3.68e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.56e-3)"	"unprognostic (2.73e-1)"	"unprognostic (3.46e-1)"	"unprognostic (9.56e-2)"	"unprognostic (8.09e-3)"	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.5	0.0	61.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0
TNP1		ENSG00000118245	"Transition protein 1"	P09430	2	216859458-216860064	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	1159	"testis: 5999.9"	"Group enriched"	"Detected in some"	205	"Early spermatids: 41424.6;Late spermatids: 136509.6"	"Group enriched"	"Detected in some"	58	"liver cancer: 6.0;testis cancer: 4.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 2.5;U-2197: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA044387	Enhanced					NA	NA					"HPA044387: AB_2678923"															"unprognostic (1.67e-1)"			0.9	0.9	0.9	0.5	4.0	0.0	4.0	1.6	1.7	0.8	0.0	0.9	0.8	0.6	0.0	0.8	0.6	0.0	0.7	1.8	0.7	1.1	2.0	0.6	0.1	0.5	0.2	1.7	0.8	1.3	0.0	0.8	0.0	1.3	5.1	0.0	0.0	0.8	0.0	2.4	1.4	1.6	0.0	0.0	0.6	1.0	5999.9	0.9	0.0	2.4	0.0	0.0	0.6	0.5	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	4.0	1.6	1.7	1.8	0.7	0.5	0.2	1.7	1.3	0.0	0.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41424.6	0.0	0.0	15.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	136509.6	410.1	26.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	246.7	0.0	0.0	0.0	0.0	0.0	0.0	249.8	0.0	0.1	433.2	234.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0
OTUD6A	"DUBA2, FLJ25831, HSHIN6"	ENSG00000189401	"OTU deubiquitinase 6A"	Q7L8S5	X	70062457-70064179	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	8	"testis: 4.8"	"Group enriched"	"Detected in some"	17	"Spermatocytes: 64.1;Spermatogonia: 25.1"	"Cancer enriched"	"Detected in single"	57	"testis cancer: 2.8"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.2"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA053304	Enhanced		Approved	Vesicles,Cytosol		NA	NA			Cytosol	Vesicles	"HPA053304: AB_2682107"															"unprognostic (1.58e-1)"			0.0	0.0	0.2	0.0	0.2	0.5	0.0	0.5	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.1	4.8	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.6	0.1	0.0	0.1	0.0	0.0	0.2	0.2	0.5	0.3	0.3	0.3	0.2	0.1	0.3	0.3	0.1	0.2	0.4	0.1	0.0	0.5	0.0	0.0	0.4	0.1	0.0	0.0	0.5	0.4	0.4	1.2	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.6	0.4	0.3	0.6	0.0	0.0	0.1	0.0	0.1	2.6	0.0	0.3	1.3	0.7	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.6	0.9	0.7	0.3	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	1.5	0.1	0.3	0.0	0.3	0.0	1.8	0.0	0.4	0.4	64.1	25.1	0.0	0.6	0.3	1.0	0.2	0.0	0.2
ANHX		ENSG00000227059	"Anomalous homeobox"	E9PGG2	12	133218312-133235877	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	39	"testis: 5.0"	"Cell type enriched"	"Detected in some"	7	"Spermatogonia: 27.8"	"Cancer enriched"	"Detected in single"	55	"testis cancer: 3.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"									NA	NA																				"unprognostic (2.28e-1)"			0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	27.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DAZL	"DAZH, DAZL1, DAZLA, MGC26406, SPGYLA"	ENSG00000092345	"Deleted in azoospermia like"	Q92904	3	16586792-16670306	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Translation regulation"	"Developmental protein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	79	"testis: 80.3"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 64.1;Late spermatids: 41.2;Spermatocytes: 257.9;Spermatogonia: 143.1"	"Cancer enriched"	"Detected in single"	51	"testis cancer: 13.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"HAP1: 18.8"									"HPA019777, HPA047113"	Enhanced					NA	NA					"HPA019777: AB_1847495, HPA047113: AB_2679936"	"unprognostic (5.61e-2)"	"unprognostic (5.27e-3)"	"unprognostic (2.80e-1)"			"unprognostic (5.85e-2)"		"unprognostic (2.32e-3)"	"unprognostic (2.60e-2)"	"unprognostic (6.34e-2)"	"unprognostic (4.91e-2)"	"unprognostic (9.69e-2)"		"unprognostic (7.79e-2)"	"unprognostic (2.04e-1)"		"unprognostic (3.47e-1)"	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.4	80.3	0.0	0.0	0.0	0.1	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	64.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	41.2	3.4	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	257.9	143.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0
CLEC4D	"CD368, CLECSF8, Dectin-3, MCL, Mpcl"	ENSG00000166527	"C-type lectin domain family 4 member D"	Q8WXI8	12	8509475-8522366	"CD markers, Predicted intracellular proteins"	"Adaptive immunity, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"bone marrow: 65.3"	"Group enriched"	"Detected in some"	5	"Kupffer cells: 10.6;Macrophages: 11.9;monocytes: 15.1"	"Cancer enriched"	"Detected in single"	50	"testis cancer: 11.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	17	"classical monocyte: 57.1;neutrophil: 98.7"	"Group enriched"	"Detected in many"	32	"granulocytes: 98.7;monocytes: 57.1"	"Group enriched"	"Detected in some"	5	"NB-4: 2.4;NTERA-2: 9.0;SuSa: 9.1;U-937: 5.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA004906	Approved					NA	NA					"HPA004906: AB_1078535"	"unprognostic (1.10e-1)"	"unprognostic (4.94e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.39e-1)"	"unprognostic (3.84e-2)"	"unprognostic (7.61e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.81e-1)"	"unprognostic (7.91e-5)"	"unprognostic (1.12e-2)"	"unprognostic (8.57e-2)"	"unprognostic (7.89e-2)"	"unprognostic (2.18e-1)"	2.3	0.2	0.0	7.4	0.1	65.3	0.2	0.1	0.2	3.2	0.3	0.1	0.1	0.1	0.5	0.4	0.7	0.4	0.2	0.0	0.1	0.2	0.5	3.1	0.6	0.1	0.1	0.0	0.0	0.5	0.0	0.0	0.7	0.1	0.1	0.1	0.6	0.4	0.0	0.1	0.0	0.2	0.8	0.0	7.1	0.2	0.2	0.3	0.3	0.1	0.7	0.3	2.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.4	9.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.9	57.1	0.0	0.0	4.5	0.0	0.3	0.0	0.1	2.4	0.0	0.0	0.1	98.7	0.0	1.2	0.7	0.0	12.4	0.0	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	10.6	0.8	0.0	0.0	11.9	0.0	0.0	15.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0
DCAF4L1	WDR21B	ENSG00000182308	"DDB1 and CUL4 associated factor 4 like 1"	Q3SXM0	4	41981756-41986465	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	22	"testis: 24.9"	"Group enriched"	"Detected in some"	9	"Early spermatids: 35.4;Spermatocytes: 89.6;Spermatogonia: 128.4"	"Cancer enriched"	"Detected in single"	49	"testis cancer: 8.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"REH: 1.1"									CAB073535	Enhanced					NA	NA					"CAB073535: "	"unprognostic (6.24e-2)"	"unprognostic (7.52e-3)"	"unprognostic (8.11e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.33e-1)"	"unprognostic (9.63e-3)"	"unprognostic (4.64e-4)"	"unprognostic (1.62e-1)"	"unprognostic (1.42e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.83e-2)"	"unprognostic (4.03e-1)"	"unprognostic (3.76e-3)"	"unprognostic (4.17e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.36e-4)"	0.2	0.2	0.5	0.2	0.6	0.1	0.1	0.8	0.7	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.4	0.5	0.3	0.4	0.4	0.3	0.1	0.5	0.4	0.5	0.1	0.1	0.0	0.8	0.0	0.5	0.2	0.0	0.8	0.2	0.0	1.1	0.3	0.2	0.0	0.4	0.6	0.1	24.9	0.5	0.0	0.2	0.0	0.1	0.2	0.1	0.7	0.0	0.0	0.0	0.7	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.2	0.6	0.0	0.1	0.0	0.2	0.6	0.7	0.1	0.0	0.7	0.3	0.0	0.7	0.1	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.2	0.9	0.0	0.1	0.2	1.1	0.1	0.1	0.0	0.1	0.2	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.6	0.2	0.6	0.2	0.9	0.1	0.0	0.6	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.8	0.7	0.5	0.3	0.5	0.4	0.5	0.5	0.4	0.5	0.7	0.8	0.0	0.0	0.7	0.5	0.4	0.3	0.2	0.0	1.2	0.9	0.5	1.2	1.5	0.3	0.0	0.0	0.2	0.6	0.3	0.0	0.3	35.4	0.9	0.9	0.9	0.0	0.4	1.4	0.6	0.3	0.5	0.0	1.2	0.0	0.1	0.0	0.6	0.3	0.0	0.8	0.4	2.0	2.2	0.3	8.6	1.2	0.8	3.6	0.0	0.7	0.7	2.1	0.5	0.6	0.9	0.1	0.4	0.9	1.2	0.2	0.1	0.5	1.6	0.0	2.9	0.7	89.6	128.4	0.6	0.9	0.5	0.6	0.2	0.7	0.6
HYAL4		ENSG00000106302	"Hyaluronidase 4"	Q2M3T9	7	123828983-123877481	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"placenta: 4.0;skeletal muscle: 4.0"	"Cell type enhanced"	"Detected in some"		"Basal respiratory cells: 2.8;Cytotrophoblasts: 4.3;Extravillous trophoblasts: 8.1;Spermatogonia: 4.4;Syncytiotrophoblasts: 2.2"	"Cancer enriched"	"Detected in single"	48	"testis cancer: 8.4"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 3.6;CAPAN-2: 5.9;RT4: 13.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA029453	Uncertain					NA	NA					"HPA029453: AB_10601432"	"unprognostic (5.19e-5)"	"unprognostic (4.18e-2)"	"unprognostic (4.82e-2)"	"unprognostic (2.20e-1)"		"unprognostic (4.14e-2)"		"unprognostic (2.60e-1)"	"unprognostic (8.24e-2)"	"unprognostic (5.26e-2)"	"unprognostic (8.15e-3)"	"unprognostic (3.30e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.57e-1)"	"unprognostic (5.55e-3)"	0.1	0.1	0.7	0.0	0.8	0.5	0.1	1.1	1.1	0.1	0.5	0.2	0.0	0.1	0.4	0.4	0.0	0.1	0.2	0.8	0.5	0.4	0.1	0.4	0.2	0.7	0.3	0.4	0.3	0.5	0.0	0.0	4.0	0.8	0.2	0.1	1.0	0.6	0.2	4.0	0.9	0.3	0.0	0.2	0.8	0.2	2.1	0.4	0.1	0.4	0.0	1.0	0.2	0.0	1.4	0.2	0.4	0.0	0.3	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	5.9	0.2	0.3	0.0	0.6	0.8	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.1	0.0	0.1	0.0	13.9	0.2	0.0	0.0	0.8	0.0	1.1	0.2	0.0	2.0	0.1	0.2	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.2	0.1	0.1	0.6	0.2	0.1	0.1	0.0	0.0	0.7	0.8	1.1	1.1	0.8	0.5	0.7	0.3	0.4	0.8	0.2	0.4	1.4	0.1	0.0	0.0	0.0	0.1	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	4.3	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.2	8.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	1.3	4.4	0.0	0.0	2.2	0.0	0.0	0.0	0.2
C13orf42	LINC00371	ENSG00000226792	"Chromosome 13 open reading frame 42"	A0A1B0GVH6	13	51082119-51200252	"Predicted intracellular proteins"				"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"Alveolar cells type 1: 3.2;Alveolar cells type 2: 1.1"	"Cancer enriched"	"Detected in single"	46	"testis cancer: 2.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 8.6;NTERA-2: 10.7;SuSa: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA										"unprognostic (9.77e-2)"									"unprognostic (5.61e-2)"	"unprognostic (1.73e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
BEND4	"CCDC4, FLJ35632, FLJ43965"	ENSG00000188848	"BEN domain containing 4"	Q6ZU67	4	42110853-42152878	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.2;prostate: 3.3;testis: 9.5"	"Cell type enhanced"	"Detected in some"		"B-cells: 8.1;Inhibitory neurons: 6.2;Muller glia cells: 10.7;Spermatogonia: 38.3"	"Group enriched"	"Detected in some"	43	"prostate cancer: 6.3;testis cancer: 5.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 33.2;HEK 293: 7.9;HEL: 21.1;MOLT-4: 13.1;SuSa: 15.4;U-698: 13.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA036850	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			"Nucleoli fibrillar center"	"Nucleoplasm, Cytosol"	"HPA036850: AB_10600787"	"unprognostic (3.62e-4)"	"unprognostic (3.82e-1)"	"unprognostic (4.82e-2)"	"unprognostic (5.96e-3)"	"unprognostic (2.97e-3)"	"unprognostic (1.10e-1)"	"unprognostic (3.81e-2)"	"unprognostic (4.00e-1)"	"unprognostic (2.97e-1)"	"unprognostic (5.58e-2)"	"unprognostic (6.71e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.54e-5)"	"unprognostic (3.48e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.58e-3)"	"unprognostic (4.24e-1)"	0.0	0.0	0.8	1.1	0.8	0.8	0.0	0.0	1.5	0.0	0.1	0.2	0.2	0.1	0.0	0.0	0.0	0.1	0.0	1.4	0.9	0.0	0.1	0.2	2.1	1.2	3.2	0.7	0.1	0.0	0.0	1.0	0.3	2.1	3.3	0.2	1.1	0.0	0.0	0.0	0.0	1.2	0.1	0.2	1.2	0.2	9.5	1.1	1.1	0.0	0.0	1.6	0.2	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.6	0.0	33.2	0.0	0.0	0.0	7.9	21.1	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.4	0.0	7.0	0.0	0.1	0.0	0.0	13.1	0.0	6.2	0.0	1.9	0.0	0.0	0.0	0.0	0.0	4.7	0.8	0.0	0.0	0.0	15.4	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.2	13.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.8	0.0	1.5	1.4	0.9	1.2	3.2	0.7	2.1	0.2	1.1	1.6	0.4	0.0	0.0	0.0	8.1	0.0	0.1	0.0	0.0	1.2	0.1	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.6	0.0	3.4	4.4	0.0	0.0	0.3	0.0	0.0	0.0	4.8	2.5	0.0	0.0	3.3	6.2	0.0	0.0	0.0	0.0	1.5	0.0	0.3	0.0	0.0	0.1	10.7	0.0	3.5	0.2	0.0	0.0	0.0	3.9	1.7	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.6	38.3	0.0	0.0	0.0	1.5	2.2	0.0	0.0
DPPA2	"CT100, PESCRG1"	ENSG00000163530	"Developmental pluripotency associated 2"	Q7Z7J5	3	109293788-109316517	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	9	"testis: 3.4"	"Group enriched"	"Detected in some"	4	"Extravillous trophoblasts: 12.0;Spermatogonia: 14.5"	"Cancer enriched"	"Detected in some"	41	"testis cancer: 35.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"BEWO: 6.0;EFO-21: 11.4;SuSa: 6.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA036134	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA036134: AB_10601547"				"unprognostic (2.23e-1)"						"unprognostic (2.79e-1)"				"unprognostic (1.81e-2)"	"unprognostic (3.50e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	11.4	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.1	0.0	6.5	0.4	0.0	0.1	0.0	1.6	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	12.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	14.5	0.0	0.0	1.6	0.0	0.1	0.0	0.0
HDGFL1	"dJ309H15.1, Hdgfrp1, HRP-1, PWWP1"	ENSG00000112273	"HDGF like 1"	Q5TGJ6	6	22569566-22571666	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	215	"testis: 91.8"	"Group enriched"	"Detected in some"	5	"Early spermatids: 130.5;Late spermatids: 120.2;Spermatocytes: 165.6"	"Cancer enriched"	"Detected in some"	41	"testis cancer: 21.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	8	"K-562: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA045679, HPA063707"	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoplasm, Nucleoli fibrillar center"		"HPA045679: AB_2679415, HPA063707: AB_2685099"						"unprognostic (1.55e-1)"									"unprognostic (6.18e-2)"		"unprognostic (4.03e-2)"	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	91.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	130.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	120.2	5.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.0	0.0	6.6	0.0	0.0	165.6	24.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RNF17	"FLJ11045, Mmip-2, SPATA23, TDRD4"	ENSG00000132972	"Ring finger protein 17"	Q9BXT8	13	24764169-24879921	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"testis: 24.5"	"Group enriched"	"Detected in some"	7	"Early spermatids: 22.2;Late spermatids: 27.6;Spermatocytes: 67.0;Spermatogonia: 24.3"	"Cancer enriched"	"Detected in single"	41	"testis cancer: 4.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	13	"olfactory bulb: 1.4"	"HPA039699, HPA040111"	Approved					NA	NA					"HPA039699: AB_10795254, HPA040111: AB_10795414"	"unprognostic (2.57e-1)"	"unprognostic (1.87e-2)"		"unprognostic (1.37e-1)"	"unprognostic (4.44e-1)"	"unprognostic (4.26e-1)"		"unprognostic (3.21e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.69e-1)"	"unprognostic (8.61e-2)"			"unprognostic (5.04e-1)"	"unprognostic (3.12e-1)"	"unprognostic (8.32e-2)"	"unprognostic (1.22e-1)"	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	24.5	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	1.3	0.0	0.0	0.1	3.8	0.0	0.0	0.1	0.8	1.2	0.0	0.2	0.0	0.0	1.9	0.0	0.0	0.0	0.0	22.2	0.0	0.1	0.2	0.0	0.0	2.1	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.9	0.0	0.0	0.0	0.0	27.6	0.9	0.0	0.0	1.0	0.0	0.0	0.0	1.5	1.5	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	67.0	24.3	0.0	0.0	1.0	0.0	0.0	0.0	0.1
ZFP42	"REX1, ZNF754"	ENSG00000179059	"ZFP42 zinc finger protein"	Q96MM3	4	187995771-188005046	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"testis: 2.1"	"Group enriched"	"Detected in some"	4	"Early spermatids: 44.8;Extravillous trophoblasts: 59.3"	"Cancer enriched"	"Detected in some"	41	"testis cancer: 40.5"	"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	13	"BEWO: 115.5;SuSa: 77.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB025557	Uncertain					NA	NA					"CAB025557: "	"unprognostic (2.30e-1)"					"unprognostic (1.07e-4)"		"unprognostic (4.88e-3)"	"unprognostic (3.75e-1)"	"unprognostic (1.77e-1)"				"unprognostic (3.86e-1)"	"unprognostic (2.27e-1)"		"unprognostic (4.66e-3)"	0.0	0.1	0.3	0.2	0.5	0.4	0.1	0.5	0.5	0.0	0.3	0.1	0.2	0.1	0.3	0.1	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.4	0.4	0.6	0.2	0.3	0.1	0.0	0.0	0.0	0.7	0.4	0.1	0.2	0.1	0.1	0.1	0.7	0.5	0.1	0.1	0.1	0.5	0.2	2.1	0.5	0.2	0.1	0.0	0.2	0.1	0.0	0.9	0.3	0.0	0.1	0.2	0.0	0.0	115.5	0.0	0.1	0.2	0.2	0.2	0.0	0.2	0.1	0.1	0.2	7.5	0.2	0.0	0.4	0.2	0.1	0.2	0.3	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.0	0.1	0.1	0.3	0.1	0.4	0.1	0.1	0.5	0.3	0.0	0.4	0.2	0.3	0.3	0.1	0.2	0.2	0.1	0.2	0.0	0.1	0.1	77.1	0.1	0.2	0.0	0.2	0.2	0.3	0.1	0.1	0.2	0.2	0.4	0.2	0.2	1.6	0.2	0.3	0.5	0.2	0.4	0.5	0.4	0.3	0.1	0.5	0.4	0.4	1.3	0.7	0.2	0.3	0.4	0.1	0.3	0.5	0.5	0.5	0.3	0.1	0.6	0.2	0.3	0.4	0.1	0.5	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	12.6	0.0	0.0	0.0	0.0	44.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	59.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.1	0.0	0.0	0.0	0.0	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.3	0.0	0.0	9.4	0.1	0.0	0.0	0.2
ZNF729		ENSG00000196350	"Zinc finger protein 729"	A6NN14	19	22286441-22317176	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	13	"testis: 2.0"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 1.9;Distal tubular cells: 1.9;Early spermatids: 1.1;Late spermatids: 1.9;Oligodendrocyte precursor cells: 1.0;Spermatocytes: 4.4;Spermatogonia: 4.3"	"Cancer enriched"	"Detected in single"	41	"testis cancer: 5.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 2.7;SuSa: 1.4"															NA	NA						"unprognostic (1.84e-1)"				"unprognostic (2.14e-3)"					"unprognostic (3.05e-4)"				"unprognostic (1.30e-1)"	"unprognostic (1.74e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.9	0.0	1.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.3	0.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	4.4	4.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0
LIM2	"MP17, MP19"	ENSG00000105370	"Lens intrinsic membrane protein 2"	P55344	19	51379909-51387974	"Disease related genes, Human disease related genes, Predicted membrane proteins"		"Eye lens protein"	"Cataract, Disease variant"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	4	"NK-cells: 20.6"	"Cancer enriched"	"Detected in single"	40	"testis cancer: 18.3"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	7	"gdT-cell: 11.3"	"Lineage enriched"	"Detected in many"	7	"T-cells: 11.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA											"unprognostic (5.25e-2)"							"unprognostic (1.09e-3)"		"unprognostic (1.21e-1)"			0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.3	0.2	1.4	0.0	0.0	0.3	0.0	0.0	0.0	1.3	0.0	1.5	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	20.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0
TBPL2	"TBP2, TRF3"	ENSG00000182521	"TATA-box binding protein like 2"	Q6SJ96	14	55413541-55456726	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skeletal muscle: 1.7"	"Cell type enhanced"	"Detected in some"		"Microglial cells: 1.0;Smooth muscle cells: 2.0"	"Cancer enriched"	"Detected in single"	40	"testis cancer: 2.0"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 5.7;HMC-1: 2.7;U-2 OS: 2.5;U-937: 4.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA056241	Uncertain					NA	NA					"HPA056241: AB_2683076"					"unprognostic (3.42e-1)"	"unprognostic (1.16e-1)"				"unprognostic (1.50e-1)"			"unprognostic (3.06e-4)"	"unprognostic (1.43e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.76e-1)"		0.2	0.5	0.5	0.8	0.5	0.5	0.0	1.5	1.2	0.4	0.3	0.2	0.9	0.7	0.0	0.2	0.2	0.1	0.0	0.5	0.3	0.2	0.2	0.4	0.4	1.4	0.6	0.1	0.1	0.2	0.1	0.0	0.2	0.8	0.3	0.2	0.1	0.6	0.1	1.7	1.3	0.6	0.0	0.2	0.5	0.5	0.8	0.5	0.0	0.0	0.0	0.1	0.0	0.0	1.4	2.0	0.5	0.0	0.6	0.0	0.6	1.2	0.0	0.0	0.0	0.2	0.2	0.3	0.4	1.6	0.0	0.2	0.5	0.1	0.0	0.0	5.7	0.0	0.4	0.6	0.0	0.0	0.0	2.7	0.0	1.0	0.0	0.2	0.0	0.0	0.1	0.3	1.9	0.0	1.4	0.3	1.0	0.4	0.0	0.5	0.5	0.0	0.4	0.0	0.8	0.7	0.5	0.0	0.1	0.2	0.0	0.8	0.7	0.0	0.2	2.5	0.2	0.4	1.7	0.9	0.2	0.3	4.0	0.1	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.5	0.5	1.5	1.2	0.5	0.3	1.4	0.6	0.1	0.8	0.2	0.5	1.4	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.3	2.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2
VRTN	"C14orf115, FLJ10811, vertnin"	ENSG00000133980	"Vertebrae development associated"	Q9H8Y1	14	74303069-74360008	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 1.5;testis: 1.7"	"Cell type enhanced"	"Detected in single"		"Spermatocytes: 2.7"	"Cancer enriched"	"Detected in single"	40	"testis cancer: 15.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"NTERA-2: 50.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA001460	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA001460: AB_1078318"			"unprognostic (1.20e-1)"	"unprognostic (4.31e-2)"				"unprognostic (1.37e-1)"		"unprognostic (5.98e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.78e-2)"		"unprognostic (1.66e-1)"	"unprognostic (1.77e-1)"			0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.0	0.1	0.1	0.2	0.0	1.5	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.1	1.7	0.1	0.0	0.0	0.1	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	50.5	2.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	2.7	0.9	0.0	0.0	0.0	0.0	0.0	0.4	0.0
PPP1R2C	"I-4, PPP1R2P9"	ENSG00000102055	"PPP1R2C family member C"	O14990	X	42777366-42778163	"Predicted intracellular proteins"		"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	181	"testis: 71.6"	"Cell type enhanced"	"Detected in some"		"B-cells: 4.5;dendritic cells: 8.2;T-cells: 22.0"	"Cancer enriched"	"Detected in single"	38	"testis cancer: 1.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"									NA	NA																				"unprognostic (1.74e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	71.6	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.8	1.8	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	22.0	0.0	0.0	0.0
DDX4	VASA	ENSG00000152670	"DEAD-box helicase 4"	Q9NQI0	5	55738017-55817157	"Enzymes, Predicted intracellular proteins"	"Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis"	"Developmental protein, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	106	"testis: 151.1"	"Group enriched"	"Detected in some"	4	"Early spermatids: 565.1;Late spermatids: 184.1;Spermatocytes: 320.9"	"Cancer enriched"	"Detected in single"	37	"testis cancer: 3.0"	"Region enhanced"	"Detected in single"		"white matter: 1.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.8;PC-3: 1.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB026170, HPA037763, HPA037764"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Plasma membrane, Cytosol"		"CAB026170: , HPA037763: AB_2675652, HPA037764: AB_2675653"	"unprognostic (1.49e-1)"	"unprognostic (1.15e-2)"		"unprognostic (1.54e-1)"	"unprognostic (2.58e-1)"	"unprognostic (3.80e-2)"	"unprognostic (3.03e-1)"	"unprognostic (5.35e-2)"	"unprognostic (3.91e-1)"	"unprognostic (3.77e-2)"	"unprognostic (3.28e-1)"	"unprognostic (5.73e-2)"	"unprognostic (5.43e-7)"	"unprognostic (4.84e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.60e-2)"	"unprognostic (1.55e-1)"	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.6	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.3	0.3	0.0	0.1	0.4	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	151.1	0.4	0.3	0.0	0.0	0.5	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.6	0.2	0.1	0.3	0.3	0.0	0.1	0.0	0.4	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	565.1	0.0	0.0	0.4	0.0	0.0	3.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	12.2	0.0	0.0	184.1	5.6	0.5	0.0	1.0	0.0	0.0	0.0	1.5	8.7	0.1	0.0	3.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	320.9	83.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC2A14	"GLUT14, SLC2A3P3"	ENSG00000173262	"Solute carrier family 2 member 14"	Q8TDB8	12	7812512-7891148	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Differentiation, Spermatogenesis, Sugar transport, Transport"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"testis: 82.0"	"Cell type enriched"	"Detected in many"	5	"Spermatocytes: 65.7"	"Cancer enriched"	"Detected in single"	35	"testis cancer: 7.1"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"basophil: 3.7;neutrophil: 3.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 18.4;CACO-2: 31.0;SuSa: 35.5"									HPA006539	Supported		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA006539: AB_1078984"	"unprognostic (2.52e-1)"	"unprognostic (4.74e-3)"	"unprognostic (1.79e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.82e-3)"	"unprognostic (8.62e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.89e-1)"	"unprognostic (9.91e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.27e-1)"	"unprognostic (8.46e-4)"	"unprognostic (3.92e-2)"	"unprognostic (3.41e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.22e-2)"	0.6	5.7	0.8	0.3	1.1	6.3	0.9	4.2	1.2	0.2	1.5	0.9	0.2	0.3	0.2	1.5	0.4	0.9	0.7	1.7	0.7	0.6	3.0	0.5	0.6	0.3	0.4	1.0	2.7	6.7	0.0	0.4	1.1	1.8	1.3	0.5	1.4	0.1	0.1	0.5	0.7	0.5	0.5	0.0	0.3	0.2	82.0	1.1	0.2	0.2	0.1	0.2	1.0	0.3	1.0	0.4	1.5	0.7	0.4	0.3	0.8	18.4	0.2	0.0	0.0	0.5	31.0	0.2	0.1	0.8	0.0	0.3	0.2	0.1	0.0	0.0	0.7	0.2	3.3	1.2	8.1	0.1	2.0	4.5	0.0	0.2	0.2	0.0	0.1	0.0	1.1	3.6	0.8	0.0	0.7	0.4	1.6	3.6	0.1	0.0	0.2	0.1	1.1	0.0	0.5	0.6	0.2	0.5	0.7	0.1	35.5	0.1	2.7	0.5	0.1	3.0	0.5	0.5	3.0	1.3	0.6	0.9	0.1	0.6	3.7	0.4	1.0	0.6	0.1	0.6	0.3	0.5	0.4	0.2	0.3	0.3	0.4	3.4	0.6	0.1	0.2	1.0	0.2	0.8	1.1	4.2	1.2	1.7	0.7	0.3	0.4	1.0	1.8	0.0	1.1	1.0	2.1	0.0	1.1	0.0	0.9	0.6	0.0	0.0	0.0	0.1	0.1	0.3	2.4	0.0	0.0	0.0	4.2	0.4	0.5	0.1	0.0	0.0	8.9	0.1	1.3	3.2	0.0	6.9	1.9	1.5	1.5	1.9	0.0	0.2	9.5	6.4	5.3	0.5	0.2	0.0	2.2	0.0	0.0	2.5	12.2	5.4	0.3	1.4	1.8	1.9	0.0	0.1	0.0	0.5	0.4	0.3	5.7	2.6	0.1	0.0	0.1	0.0	0.0	0.5	0.0	0.2	2.7	65.7	3.1	0.0	0.1	0.4	3.6	4.2	0.1	0.0
FOXR1	"DLNB13, FOXN5"	ENSG00000176302	"Forkhead box R1"	Q6PIV2	11	118971712-118981287	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	20	"testis: 4.2"	"Group enriched"	"Detected in some"	19	"Spermatocytes: 13.1;Spermatogonia: 33.5"	"Cancer enriched"	"Detected in single"	34	"testis cancer: 2.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA038124			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA038124: "					"unprognostic (1.84e-2)"					"unprognostic (4.80e-2)"				"unprognostic (1.16e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.47e-1)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	13.1	33.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0
NANOS3	"NANOS1L, NOS3, ZC2HC12C"	ENSG00000187556	"Nanos C2HC-type zinc finger 3"	P60323	19	13862063-13880757	"Predicted intracellular proteins"	"Differentiation, Oogenesis, Spermatogenesis, Translation regulation"	"Developmental protein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 1.6;testis: 4.2"	"Cell type enhanced"	"Detected in many"		"Spermatogonia: 20.2"	"Cancer enriched"	"Detected in many"	34	"testis cancer: 132.0"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA062989	Enhanced					NA	NA					"HPA062989: AB_2684916"	"unprognostic (9.42e-3)"	"unprognostic (3.17e-2)"	"unprognostic (1.58e-1)"	"unprognostic (8.58e-2)"	"unprognostic (2.69e-1)"	"unprognostic (6.89e-3)"	"unprognostic (3.23e-3)"	"unprognostic (4.97e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.39e-1)"	"unprognostic (5.29e-3)"	"unprognostic (5.17e-2)"	"unprognostic (4.60e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.06e-1)"	0.0	0.0	0.5	0.0	0.8	0.0	0.0	0.8	1.6	0.0	0.1	0.0	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.7	0.4	0.0	0.0	0.2	0.0	0.6	0.5	0.6	0.2	0.1	0.0	0.3	0.0	1.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.4	0.1	0.1	4.2	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.2	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.8	0.8	1.6	0.7	0.4	0.6	0.5	0.6	1.0	0.4	0.3	0.7	0.8	0.0	2.4	0.7	0.4	1.8	1.0	1.9	0.0	1.0	5.6	5.5	0.5	0.0	1.1	1.8	0.0	0.0	0.1	0.2	0.0	2.0	1.1	1.7	0.2	1.1	1.2	0.4	5.1	1.2	0.2	0.8	0.0	2.0	1.3	0.7	0.4	0.2	0.4	0.0	4.5	0.7	0.0	0.8	5.5	3.0	0.0	0.6	3.6	1.9	2.7	4.9	0.0	2.5	0.5	3.2	0.2	0.7	0.2	1.8	0.4	0.0	0.9	0.8	0.0	2.8	1.4	0.2	20.2	0.0	1.3	0.1	0.7	0.0	0.4	1.2
POU5F1	"MGC22487, OCT3, Oct4, OTF3"	ENSG00000204531	"POU class 5 homeobox 1"	Q01860	6	31164337-31180731	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 16.4"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 27.9;Glandular and luminal cells: 67.8"	"Cancer enriched"	"Detected in many"	34	"testis cancer: 355.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	51	"SuSa: 287.4"	"Not detected"	"Not detected"							"CAB025600, CAB026380, HPA058267, CAB079773"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB025600: , CAB026380: , CAB079773: AB_2687916, HPA058267: AB_2683659"	"unprognostic (3.25e-2)"	"unprognostic (3.12e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.06e-2)"	"unprognostic (3.02e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.62e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.59e-1)"	"unprognostic (9.27e-2)"	"unprognostic (2.27e-2)"	"unprognostic (4.79e-2)"	"unprognostic (1.19e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.86e-2)"	"prognostic favorable (2.04e-5)"	1.0	0.3	1.4	1.0	1.3	1.5	1.2	1.7	1.4	3.9	0.6	3.3	4.4	2.3	2.4	1.8	7.2	2.1	2.7	1.1	0.8	16.4	8.1	3.7	1.0	1.1	1.0	0.9	0.5	13.1	0.0	0.3	0.3	1.6	7.7	1.1	0.7	0.8	2.5	1.0	2.2	8.0	0.3	0.6	2.0	10.1	1.3	1.3	0.2	0.9	0.3	0.3	10.3	2.1	1.9	3.6	1.8	0.4	0.7	0.0	0.0	0.8	0.5	0.0	0.0	0.0	0.0	1.3	0.3	5.6	0.1	0.4	2.9	0.7	3.1	0.0	0.6	1.4	0.6	3.3	2.5	0.2	0.9	0.8	0.3	0.6	0.3	0.9	0.2	0.0	0.7	0.1	1.0	1.0	0.2	0.3	1.0	2.9	0.6	0.1	0.8	0.6	0.7	4.8	3.8	0.6	0.1	1.0	0.2	0.3	287.4	0.6	0.4	0.0	0.7	0.5	1.8	0.3	1.3	1.3	1.6	0.5	1.3	0.5	0.4	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.0	0.3	0.2	0.1	0.3	0.0	0.1	1.4	1.3	1.7	1.4	1.1	0.8	1.1	1.0	0.9	1.6	0.6	1.3	1.9	1.0	0.0	1.1	0.0	0.9	5.2	2.7	5.3	2.8	0.5	0.7	0.8	0.4	10.0	2.3	9.2	2.1	0.0	0.1	9.2	0.0	6.7	0.0	27.9	5.9	1.2	1.2	0.0	0.2	6.6	0.1	0.7	11.2	67.8	0.0	0.1	0.4	2.4	0.1	0.0	0.1	6.4	2.0	0.0	1.5	0.2	0.0	0.7	1.8	1.0	0.7	0.1	1.0	0.5	0.1	12.6	12.5	0.7	0.2	5.6	10.1	2.0	1.6	1.0	0.0	1.4	1.2	0.1	0.8	0.8	3.8	0.1	0.8	0.0	4.1	4.3
VSX2	"CHX10, HOX10, RET1"	ENSG00000119614	"Visual system homeobox 2"	P58304	14	74239449-74262738	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Sensory transduction, Transcription, Transcription regulation, Vision"	"Activator, Developmental protein, DNA-binding, Repressor"	"Cataract, Disease variant, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	42	"retina: 74.3"	"Group enriched"	"Detected in some"	10	"Bipolar cells: 152.4;Muller glia cells: 86.0"	"Cancer enriched"	"Detected in single"	34	"testis cancer: 2.5"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"midbrain: 1.3;pons and medulla: 1.7"	"Region enhanced"	"Detected in single"		"pons: 1.7"	HPA003436	Enhanced					NA	NA					"HPA003436: AB_1078523"	"unprognostic (2.87e-1)"	"unprognostic (1.22e-1)"			"unprognostic (2.79e-1)"	"unprognostic (3.29e-1)"		"unprognostic (3.21e-4)"		"unprognostic (7.77e-2)"				"unprognostic (8.39e-4)"	"unprognostic (3.13e-1)"			0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	1.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	74.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.8	1.2	0.4	0.0	1.7	0.4	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	152.4	0.0	0.0	0.4	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.6	86.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.8	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TRIML2	"FLJ25801, SPRYD6"	ENSG00000179046	"Tripartite motif family like 2"	Q8N7C3	4	188091273-188109603	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"placenta: 4.1;testis: 2.6"	"Group enriched"	"Detected in some"	6	"Cytotrophoblasts: 16.5;Early spermatids: 17.3;Extravillous trophoblasts: 6.7;Late spermatids: 5.2;Spermatocytes: 6.4;Spermatogonia: 6.4;Syncytiotrophoblasts: 8.9"	"Cancer enriched"	"Detected in some"	33	"testis cancer: 24.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"SuSa: 145.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA043838	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA043838: AB_10963835"	"unprognostic (3.32e-1)"	"unprognostic (1.99e-1)"		"unprognostic (1.30e-1)"	"unprognostic (9.82e-2)"	"unprognostic (1.21e-5)"		"unprognostic (3.06e-2)"	"unprognostic (1.65e-3)"		"unprognostic (2.65e-1)"		"unprognostic (0.00e+0)"	"unprognostic (2.26e-2)"	"unprognostic (1.20e-1)"		"unprognostic (1.28e-3)"	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	3.7	33.8	0.0	0.0	0.0	0.1	18.3	0.2	1.4	0.0	0.0	0.2	0.5	0.0	0.0	0.0	7.5	0.9	6.4	0.1	0.0	2.4	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	21.4	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	145.3	0.0	0.0	0.2	0.1	7.6	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.5	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	16.5	0.0	0.0	0.0	0.0	17.3	0.0	0.0	0.1	0.0	0.0	1.6	0.0	6.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.3	0.0	0.0	0.0	0.5	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	6.4	6.4	0.0	0.0	8.9	0.1	0.0	0.0	0.3
IQCF1	MGC39725	ENSG00000173389	"IQ motif containing F1"	Q8N6M8	3	51894876-51903353	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	242	"testis: 71.3"	"Group enriched"	"Detected in some"	170	"Early spermatids: 1222.4;Late spermatids: 3277.3"	"Cancer enriched"	"Detected in single"	30	"testis cancer: 1.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"									NA	NA										"unprognostic (1.47e-1)"						"unprognostic (1.67e-1)"			"unprognostic (2.76e-1)"	"unprognostic (1.96e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	71.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1222.4	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3277.3	10.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	13.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NLRP7	"CLR19.4, NALP7, NOD12, PAN7, PYPAF3"	ENSG00000167634	"NLR family pyrin domain containing 7"	Q8WX94	19	54923509-54966312	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	6	"testis: 3.9"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 8.2;Early spermatids: 8.3;Extravillous trophoblasts: 5.7;Late spermatids: 14.8;Plasma cells: 5.2;Spermatocytes: 6.4;Spermatogonia: 5.6"	"Cancer enriched"	"Detected in many"	30	"testis cancer: 146.9"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	6	"plasmacytoid DC: 3.9"	"Lineage enriched"	"Detected in single"	6	"dendritic cells: 3.9"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.9;RT4: 1.0;SuSa: 1.5;U-266/84: 5.0"									HPA051382	Uncertain		Uncertain	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA051382: AB_2681461"	"unprognostic (2.15e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.68e-3)"	"unprognostic (1.24e-2)"	"unprognostic (5.29e-3)"	"unprognostic (5.46e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.15e-1)"	"unprognostic (5.01e-1)"	"unprognostic (5.81e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.25e-8)"	"unprognostic (1.84e-1)"	"unprognostic (1.18e-1)"	"unprognostic (7.31e-3)"	"unprognostic (4.45e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	2.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.8	8.2	0.0	0.0	0.0	8.3	0.3	0.0	0.0	0.0	0.0	0.9	0.0	5.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.0	14.8	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.5	0.0	0.0	0.4	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	5.6	0.0	0.0	1.9	0.3	0.0	0.0	0.6
HES3	bHLHb43	ENSG00000173673	"Hes family bHLH transcription factor 3"	Q5TGS1	1	6244179-6245578	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	28	"testis cancer: 1.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"NTERA-2: 11.0"	"Region enriched"	"Detected in some"	30	"cerebellum: 34.8"	"Low region specificity"	"Detected in some"			"HPA047927, HPA072697"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA047927: AB_2680213, HPA072697: "															"unprognostic (7.42e-2)"			0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.4	0.2	0.2	0.1	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TRIM71	"LIN-41, LIN41"	ENSG00000206557	"Tripartite motif containing 71"	Q2Q1W2	3	32817997-32897824	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"RNA-mediated gene silencing, Ubl conjugation pathway"	"Developmental protein, RNA-binding, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"testis: 4.9"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 9.6;Extravillous trophoblasts: 15.6;Inhibitory neurons: 4.5;Oligodendrocyte precursor cells: 4.5;Spermatogonia: 13.7"	"Cancer enriched"	"Detected in some"	28	"testis cancer: 28.6"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 31.4;BEWO: 94.5;Hep G2: 63.8;NTERA-2: 84.3;SuSa: 76.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA038141, HPA038142"	Uncertain		Approved	"Plasma membrane,Actin filaments,Focal adhesion sites"		NA	NA			"Plasma membrane, Actin filaments, Focal adhesion sites"		"HPA038141: AB_2675857, HPA038142: AB_10697240"	"unprognostic (2.93e-2)"	"unprognostic (4.29e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.58e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.16e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.11e-2)"	"unprognostic (3.11e-1)"	"unprognostic (4.36e-6)"	"unprognostic (3.92e-2)"	"unprognostic (9.27e-2)"	"unprognostic (8.17e-2)"	"unprognostic (4.65e-2)"	0.0	0.0	1.0	0.0	0.9	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.5	0.9	0.0	0.7	0.0	0.3	0.1	0.7	0.0	0.0	0.0	0.2	0.2	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	31.4	0.0	0.0	0.0	94.5	0.0	0.0	0.0	0.0	23.1	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	1.6	0.0	63.8	0.0	1.8	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.3	0.4	0.0	0.0	0.6	6.9	84.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	76.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.9	0.0	0.8	0.9	0.5	0.3	0.1	0.7	0.2	0.0	0.6	0.2	0.0	9.6	4.1	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.1	0.0	2.7	0.0	1.8	0.0	0.0	3.9	0.0	0.0	0.0	0.0	1.0	0.2	0.0	0.2	0.0	0.0	3.1	0.0	15.6	0.3	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	4.5	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	1.0	0.1	0.0	0.0	4.5	0.1	0.0	0.0	0.4	0.0	0.0	0.0	3.6	0.7	0.5	0.0	0.0	0.1	0.3	13.7	0.0	0.0	4.0	0.1	0.0	0.0	0.0
OTX2		ENSG00000165588	"Orthodenticle homeobox 2"	P32243	14	56799905-56816693	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"	"Disease variant, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	15	"choroid plexus: 89.6;retina: 282.3"	"Group enriched"	"Detected in some"	11	"Bipolar cells: 170.6;Cone photoreceptor cells: 168.9;Rod photoreceptor cells: 202.5"	"Cancer enriched"	"Detected in single"	27	"testis cancer: 11.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 249.6;hTERT-RPE1: 57.0;NTERA-2: 199.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA000633, HPA001123"	Uncertain		Supported	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA000633: AB_1079538, HPA001123: "					"unprognostic (3.82e-1)"			"unprognostic (2.56e-2)"							"unprognostic (9.28e-2)"			0.0	0.0	3.6	0.0	1.2	0.0	0.0	7.7	0.7	0.0	89.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.1	2.3	0.0	0.0	0.0	0.0	2.3	11.9	0.1	0.0	0.0	0.0	2.5	0.0	1.1	0.0	0.0	282.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	12.0	0.0	0.0	0.8	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	249.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	57.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	199.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	1.2	7.7	0.7	6.1	2.3	2.3	11.9	0.1	1.1	0.1	12.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	170.6	0.0	0.0	0.3	0.0	0.0	0.0	168.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	202.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TSPYL6		ENSG00000178021	"TSPY like 6"	Q8N831	2	54253178-54256229	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	32	"testis: 21.7"	"Group enriched"	"Detected in some"	6	"Spermatocytes: 33.9;Spermatogonia: 22.5"	"Cancer enriched"	"Detected in single"	27	"testis cancer: 1.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	69	"K-562: 8.3"									"HPA034699, HPA034700"	Enhanced		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			Nucleoplasm	"Nucleoli, Cytosol"	"HPA034699: AB_2674288, HPA034700: AB_10670159"	"unprognostic (8.21e-2)"				"unprognostic (4.25e-1)"			"unprognostic (1.06e-2)"		"unprognostic (1.00e-1)"			"unprognostic (5.54e-6)"	"unprognostic (4.50e-2)"	"unprognostic (1.77e-1)"	"unprognostic (5.73e-1)"		0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	21.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.4	0.6	0.1	0.1	0.3	0.1	0.0	0.5	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.4	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	33.9	22.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FOXH1	FAST1	ENSG00000160973	"Forkhead box H1"	O75593	8	144473412-144475849	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"retina: 2.1;skin 1: 1.4"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 3.4;Spermatogonia: 1.7"	"Cancer enriched"	"Detected in some"	26	"testis cancer: 23.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"NTERA-2: 26.6;SuSa: 6.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (1.62e-1)"	"unprognostic (8.26e-2)"	"unprognostic (4.70e-2)"	"unprognostic (2.23e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.09e-2)"	"unprognostic (3.43e-1)"	"unprognostic (4.57e-2)"	"unprognostic (6.20e-2)"	"unprognostic (3.99e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.65e-8)"	"unprognostic (1.03e-1)"	"unprognostic (3.39e-2)"	"unprognostic (3.99e-1)"	"unprognostic (9.35e-3)"	0.1	0.1	0.0	0.2	0.1	0.0	0.2	0.4	0.2	0.0	0.0	0.6	0.4	0.0	0.0	0.4	0.0	0.2	0.1	0.1	0.1	0.5	0.4	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.5	0.0	0.1	0.4	0.2	2.1	0.2	0.0	0.0	1.4	0.8	0.0	0.0	0.2	0.5	1.1	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.2	0.4	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.3	0.1	0.1	1.4	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.3	0.4	0.0	0.0	0.7	0.0	0.3	26.6	0.6	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.1	6.9	0.3	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.4	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.4	0.2	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.7	0.2	0.4	0.1	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.4	0.2	0.1	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.7	0.4	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.1	0.3	1.7	0.0	0.1	0.0	0.1	0.4	0.7	0.1
OOEP	"C6orf156, Em:AC019205.2, KHDC2"	ENSG00000203907	"Oocyte expressed protein"	A6NGQ2	6	73368555-73395133	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"testis: 14.3"	"Group enriched"	"Detected in some"	6	"Early spermatids: 29.4;Spermatocytes: 74.1;Spermatogonia: 56.8"	"Cancer enriched"	"Detected in single"	26	"testis cancer: 10.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.8;CAPAN-2: 8.3;MCF7: 2.9;U-2 OS: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA055165	Approved					NA	NA					"HPA055165: AB_2682722"	"unprognostic (7.95e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.63e-1)"	"unprognostic (4.50e-1)"	"unprognostic (4.68e-1)"	"unprognostic (2.20e-3)"	"unprognostic (6.86e-2)"	"unprognostic (3.99e-2)"	"unprognostic (7.22e-2)"	"unprognostic (2.52e-1)"	"unprognostic (6.04e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.86e-2)"	"unprognostic (8.66e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.16e-1)"	"unprognostic (4.98e-2)"	0.2	0.2	0.1	0.1	0.1	0.0	0.3	0.1	0.6	0.1	0.3	0.1	0.1	0.1	0.0	0.3	0.0	0.1	0.1	0.2	0.2	0.1	0.3	0.2	0.1	0.3	0.2	0.0	0.2	0.9	0.0	0.1	1.4	0.2	0.2	0.0	0.0	1.8	0.4	0.0	0.9	0.1	0.0	0.1	0.2	0.5	14.3	0.2	0.0	0.4	0.2	0.1	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.1	0.0	0.1	0.2	0.0	8.3	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.0	0.3	0.5	0.2	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.1	0.6	0.2	0.2	0.3	0.2	0.0	0.2	0.1	0.2	0.3	0.3	0.0	0.0	0.0	0.3	1.1	0.3	3.8	0.0	0.0	0.4	0.6	0.0	1.5	0.5	0.0	0.0	8.6	0.2	0.2	0.0	0.1	29.4	1.8	0.1	0.7	0.0	2.7	0.0	0.6	2.4	0.5	0.0	0.8	0.0	0.0	0.0	0.7	1.2	0.0	0.0	0.5	2.0	0.3	0.7	7.2	0.6	0.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.7	0.0	1.2	0.4	0.3	0.2	1.2	0.5	0.6	0.0	0.5	0.2	74.1	56.8	0.0	1.0	4.5	0.4	0.0	0.0	0.3
TLE7		ENSG00000260734	"TLE family member 7"	A0A1W2PR48	16	71429980-71442054	"Predicted intracellular proteins"				"Evidence at protein level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	26	"testis cancer: 1.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA																				"unprognostic (2.29e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DNMT3B		ENSG00000088305	"DNA methyltransferase 3 beta"	Q9UBC3	20	32762385-32809356	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors"		"Activator, DNA-binding, Methyltransferase, Repressor, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 5.3;Extravillous trophoblasts: 5.2;Horizontal cells: 5.0;Inhibitory neurons: 6.8;Sertoli cells: 6.6"	"Cancer enriched"	"Detected in all"	25	"testis cancer: 111.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 245.7;CACO-2: 95.8;HEL: 100.7;K-562: 98.6;NTERA-2: 333.9;SuSa: 174.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA001595, HPA001803, CAB069896"	Enhanced		Supported	Nucleoplasm		NA	Yes			Nucleoplasm		"CAB069896: AB_2094115, HPA001595: AB_1847814, HPA001803: "	"unprognostic (7.65e-3)"	"unprognostic (3.52e-3)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (5.04e-4)"	"unprognostic (3.42e-1)"	"unprognostic (7.27e-2)"	"unprognostic (4.39e-4)"	"unprognostic (4.18e-3)"	"unprognostic (8.60e-3)"	"unprognostic (8.48e-2)"	"unprognostic (6.79e-2)"	"unprognostic (4.65e-2)"	"prognostic unfavorable (1.87e-7)"	"unprognostic (6.62e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.50e-1)"	"unprognostic (6.55e-2)"	0.7	0.6	1.3	0.8	1.5	3.7	1.4	2.4	1.6	1.1	1.0	0.7	0.8	1.0	3.1	0.8	0.8	0.8	0.9	1.2	1.4	1.7	1.3	0.7	0.9	1.4	1.3	1.2	0.8	6.0	1.1	0.6	2.1	1.8	0.8	0.8	3.0	1.2	0.6	0.5	3.8	0.8	0.9	0.9	1.0	0.9	5.9	1.3	3.7	1.7	0.2	0.9	1.3	1.1	1.6	3.9	5.3	27.0	6.2	0.5	2.1	245.7	3.5	2.4	3.6	3.8	95.8	4.3	10.0	9.7	1.7	4.3	2.2	17.6	1.7	3.0	1.2	14.0	100.7	3.3	18.5	0.9	4.6	9.7	2.3	1.9	5.5	1.1	1.8	6.6	6.2	98.6	2.7	1.4	15.7	15.6	86.1	333.9	8.8	3.2	15.4	4.5	2.3	9.1	4.2	8.6	5.7	5.9	8.5	2.5	174.4	5.8	5.5	1.6	5.5	12.3	2.8	2.6	5.9	2.8	3.8	2.6	27.4	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.3	1.5	2.4	1.6	1.2	1.4	1.4	1.3	1.2	1.8	0.9	1.3	1.6	1.6	0.0	1.5	3.9	0.1	0.9	0.2	0.3	0.6	2.1	1.5	1.3	1.3	0.0	0.8	0.0	2.1	5.3	0.3	0.2	0.0	1.3	0.1	0.8	0.9	1.6	0.0	4.6	1.1	0.6	5.2	1.2	0.5	2.2	0.0	1.3	0.7	0.6	0.8	5.0	6.8	0.3	0.0	0.3	0.3	1.0	0.0	0.7	0.0	1.9	0.1	0.8	0.0	1.5	1.3	1.0	0.1	0.4	1.3	0.3	0.1	1.3	0.1	2.5	6.6	0.3	0.9	0.1	2.6	0.9	1.3	4.8	0.3	0.8	0.6	0.1
KLF17	"FLJ40160, Zfp393, ZNF393"	ENSG00000171872	"Kruppel like factor 17"	Q5JT82	1	44118821-44135140	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"testis: 8.4"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 160.6;Late spermatids: 45.3;Oligodendrocyte precursor cells: 29.1"	"Cancer enriched"	"Detected in single"	25	"testis cancer: 4.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 1.5;BJ hTERT+ SV40 Large T+ RasG12V: 1.2;HBF TERT88: 1.5;U-138 MG: 2.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA024629	Enhanced					NA	NA					"HPA024629: AB_1668927"	"unprognostic (1.73e-2)"	"unprognostic (1.18e-4)"	"unprognostic (4.02e-4)"	"unprognostic (2.38e-1)"	"unprognostic (4.64e-2)"	"unprognostic (5.17e-2)"		"unprognostic (1.58e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.70e-3)"	"unprognostic (5.30e-3)"	"unprognostic (8.35e-2)"		"unprognostic (5.54e-2)"	"unprognostic (6.60e-2)"		"unprognostic (8.04e-3)"	0.0	0.6	0.2	0.2	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.2	0.0	0.7	0.1	0.6	0.3	0.2	0.0	0.1	0.2	0.0	0.0	0.5	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.1	0.1	0.0	1.1	0.1	0.0	0.1	8.4	0.2	0.0	0.0	0.0	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.8	1.5	1.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.0	2.6	0.3	0.1	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.2	0.2	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.0	0.0	0.0	1.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	160.6	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	45.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	29.1	4.9	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.1	1.3	1.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2
LIN28B	"CSDD2, FLJ16517"	ENSG00000187772	"Lin-28 homolog B"	Q6ZN17	6	104936616-105083332	"Predicted intracellular proteins"	"RNA-mediated gene silencing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"placenta: 66.0"	"Group enriched"	"Detected in some"	5	"Cytotrophoblasts: 75.4;Early spermatids: 27.5;Excitatory neurons: 40.2;Extravillous trophoblasts: 83.0;Late spermatids: 25.2;Syncytiotrophoblasts: 55.8"	"Cancer enriched"	"Detected in single"	25	"testis cancer: 12.6"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 49.1;BEWO: 252.1;Hep G2: 44.0;K-562: 86.9;NTERA-2: 44.8;SuSa: 44.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"HPA036630, HPA061745"	Enhanced		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Nucleoplasm, Nucleoli"	Cytosol	"HPA036630: AB_10669911, HPA061745: AB_2684601"				"unprognostic (2.00e-4)"	"unprognostic (6.75e-2)"					"unprognostic (2.02e-1)"				"unprognostic (2.57e-2)"	"unprognostic (1.59e-2)"		"unprognostic (4.10e-2)"	0.1	0.1	0.5	0.0	0.7	0.5	0.0	0.1	1.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.0	0.0	0.0	0.1	0.4	0.4	0.5	0.0	0.0	0.0	0.3	66.0	0.5	0.0	0.0	1.5	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.1	4.2	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.1	3.2	49.1	10.0	0.0	0.0	252.1	0.1	0.0	0.0	0.0	16.6	0.1	0.1	0.0	0.1	3.0	0.1	31.2	0.0	0.0	0.0	24.1	36.6	0.0	44.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	86.9	1.2	0.0	0.0	5.6	6.2	44.8	0.0	0.0	0.0	0.0	2.2	0.0	0.1	0.1	11.6	0.1	0.3	4.0	44.5	0.0	10.6	1.0	0.1	5.3	0.2	0.1	14.8	22.6	0.1	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.5	0.7	0.1	1.4	0.6	0.6	0.4	0.4	0.5	0.5	0.0	0.5	0.9	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.0	6.2	75.4	0.0	0.0	0.0	0.0	27.5	0.0	0.0	8.3	0.0	0.0	40.2	0.0	83.0	3.7	0.0	0.1	0.0	0.0	0.0	0.0	9.7	1.7	5.7	0.0	0.0	0.0	0.0	25.2	0.3	0.0	0.0	1.0	0.0	0.5	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	6.6	0.0	0.0	6.3	9.9	0.0	0.0	55.8	0.0	0.0	0.0	0.0
RBMXL3	"CXorf55, FLJ40249"	ENSG00000175718	"RBMX like 3"	Q8N7X1	X	115189410-115192868	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	8	"testis: 2.7"	"Group enriched"	"Detected in some"	9	"Spermatocytes: 17.9;Spermatogonia: 16.7"	"Cancer enriched"	"Detected in single"	25	"testis cancer: 1.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA051842	Supported					NA	NA					"HPA051842: AB_2681634"															"unprognostic (1.05e-1)"			0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.2	0.2	0.1	0.2	0.2	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.9	16.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ZNF723	ZNF723P	ENSG00000268696	"Zinc finger protein 723"	P0DPD5	19	22832291-22858667	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	9	"testis: 3.4"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	25	"testis cancer: 3.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA															"unprognostic (4.37e-2)"				"unprognostic (5.02e-2)"	"unprognostic (7.20e-2)"			0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2		0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.3	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.1	0.1	0.5	0.1	0.0	0.1	0.0	0.2	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FAM71F1	"FAM137A, NYD-SP18"	ENSG00000135248	"Family with sequence similarity 71 member F1"	Q96KD3	7	128709061-128731743	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	88	"testis: 94.6"	"Group enriched"	"Detected in some"	93	"Early spermatids: 1122.8;Late spermatids: 2008.1"	"Cancer enriched"	"Detected in single"	23	"testis cancer: 4.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	11	"NTERA-2: 16.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA020636			Uncertain	Cytosol		No	NA			Cytosol		"HPA020636: AB_1854739"	"unprognostic (3.09e-2)"	"unprognostic (3.39e-3)"		"unprognostic (6.03e-2)"	"unprognostic (5.25e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.67e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.00e-5)"	"unprognostic (1.48e-1)"	"unprognostic (2.18e-6)"	"unprognostic (6.97e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.19e-3)"	"unprognostic (1.99e-1)"	0.0	0.0	0.8	0.0	0.7	0.0	0.1	0.4	0.9	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.7	0.6	0.2	0.0	0.1	0.0	0.7	0.9	0.7	0.0	0.1	0.0	0.5	0.0	0.6	0.2	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.1	0.1	94.6	0.5	0.0	0.1	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	16.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.2	1.4	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.7	0.4	0.9	0.7	0.6	0.7	0.9	0.7	0.6	0.4	0.5	0.6	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.1	0.3	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.1	1122.8	0.2	0.1	0.6	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	1.0	0.0	2008.1	12.8	0.7	0.0	0.0	0.0	0.3	0.0	0.5	0.4	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.8	0.1	16.7	6.8	0.0	0.1	1.2	0.0	0.5	0.0	0.0
TRPC5	PPP1R159	ENSG00000072315	"Transient receptor potential cation channel subfamily C member 5"	Q9UL62	X	111768011-112082776	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	5	"brain: 3.7"	"Group enriched"	"Detected in some"	11	"Excitatory neurons: 46.3;Inhibitory neurons: 78.5;Oligodendrocytes: 38.3"	"Group enriched"	"Detected in some"	23	"testis cancer: 0.8;thyroid cancer: 2.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	6	"NTERA-2: 1.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"									NA	NA										"unprognostic (3.29e-2)"		"unprognostic (6.15e-2)"	"unprognostic (7.32e-2)"			"unprognostic (2.60e-3)"		"unprognostic (3.68e-2)"	"unprognostic (5.69e-2)"	"unprognostic (5.09e-2)"	"unprognostic (2.78e-2)"		0.0	0.1	1.1	0.0	2.1	0.1	0.0	0.9	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.8	0.1	0.8	0.0	0.0	1.9	3.7	1.4	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	2.1	0.9	1.3	1.2	1.8	1.9	3.7	1.4	1.9	0.3	1.8	3.3	0.0	0.0	0.0	4.9	0.2	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	46.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	78.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.5	38.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
ZNF716	FLJ46189	ENSG00000182111	"Zinc finger protein 716"	A6NP11	7	57450177-57473559	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"Early spermatids: 3.9;Late spermatids: 4.0;Spermatocytes: 3.3;Spermatogonia: 6.0"	"Cancer enriched"	"Detected in single"	23	"testis cancer: 2.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"RPMI-8226: 1.2"															NA	NA															"unprognostic (1.57e-1)"				"unprognostic (1.95e-2)"	"unprognostic (1.21e-1)"			0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.5	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.2	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.4	4.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.5	0.2	3.3	6.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3
FAM9C	TEX39C	ENSG00000187268	"Family with sequence similarity 9 member C"	Q8IZT9	X	13035617-13044682	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"lymphoid tissue: 38.5"	"Group enriched"	"Detected in some"	14	"Spermatocytes: 89.4;Spermatogonia: 47.9"	"Cancer enriched"	"Detected in single"	22	"testis cancer: 4.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	60	"AN3-CA: 182.5"															NA	NA						"unprognostic (2.28e-1)"				"unprognostic (7.35e-2)"			"unprognostic (1.90e-1)"		"unprognostic (1.66e-1)"	"unprognostic (3.35e-2)"		"unprognostic (2.06e-4)"	"unprognostic (3.96e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.89e-1)"		0.1	0.0	0.4	0.0	0.3	0.4	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.3	0.0	0.0	0.1	0.2	0.1	0.1	0.2	0.8	0.3	0.0	0.0	0.6	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	38.5	0.0	4.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	182.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.2	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.2	0.3	0.3	0.1	0.1	0.2	0.2	0.1	0.1	0.2	0.1	0.0	1.5	0.0	0.1	0.5	0.3	0.0	0.0	1.2	0.1	0.0	0.8	1.5	0.6	0.0	2.1	0.1	0.1	0.0	0.0	0.1	1.7	0.1	0.1	4.9	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.1	1.3	0.0	0.4	0.1	0.5	0.0	0.1	0.0	0.0	0.3	0.8	3.4	0.9	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.4	0.1	0.7	1.7	0.0	0.4	0.3	89.4	47.9	0.0	0.6	0.1	0.2	0.1	0.1	0.1
TBXT	T	ENSG00000164458	"T-box transcription factor T"	O15178	6	166157656-166168700	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"parathyroid gland: 2.6;pituitary gland: 1.3"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	22	"testis cancer: 6.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"HeLa: 16.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA003322	Uncertain		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA003322: AB_1080176"						"unprognostic (5.68e-2)"		"unprognostic (4.59e-2)"						"unprognostic (6.21e-3)"	"unprognostic (8.64e-3)"	"unprognostic (9.34e-3)"		0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	2.6	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	16.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	1.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
INSL3	"MGC119818, MGC119819, RLF, RLNL"	ENSG00000248099	"Insulin like 3"	P51460	19	17816512-17821574	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted secreted proteins"		Hormone	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"testis: 413.0"	"Cell type enriched"	"Detected in some"	19	"Theca cells: 24080.8"	"Cancer enriched"	"Detected in many"	21	"testis cancer: 39.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 5.7;PC-3: 2.6;SCLC-21H: 5.2;SH-SY5Y: 4.7"									HPA028615	Enhanced				"Secreted to blood"	NA	NA	566000				"HPA028615: AB_10600717"	"unprognostic (3.25e-1)"	"unprognostic (2.25e-4)"	"unprognostic (3.50e-5)"	"unprognostic (7.04e-2)"	"unprognostic (1.74e-4)"	"unprognostic (4.60e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.46e-1)"	"unprognostic (4.93e-2)"	"unprognostic (9.51e-10)"	"unprognostic (6.80e-3)"	"unprognostic (1.41e-1)"	"unprognostic (8.85e-2)"	"unprognostic (1.09e-5)"	0.4	1.7	1.1	4.8	1.4	1.8	0.5	2.1	1.5	0.1	1.6	0.4	1.5	0.3	0.8	0.6	0.8	0.4	0.2	1.3	1.2	0.4	0.4	0.9	2.9	1.3	1.2	1.0	29.8	0.2	0.0	0.2	0.3	1.6	0.6	0.0	0.1	0.6	0.0	0.2	0.3	1.7	0.0	1.2	5.3	0.8	413.0	1.3	0.5	0.3	0.4	1.3	0.4	0.3	1.3	0.2	0.6	0.1	0.5	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.1	1.1	0.1	1.4	0.0	0.2	0.0	0.0	0.0	0.0	1.2	0.1	0.5	0.0	0.2	0.0	0.0	1.2	0.8	0.6	0.0	0.0	0.0	0.0	0.1	0.0	5.7	0.0	1.0	0.2	1.1	0.0	1.1	2.6	0.9	0.0	0.1	0.1	0.3	5.2	4.7	0.0	1.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.4	0.0	0.4	2.1	0.1	0.1	1.3	0.0	0.4	0.2	0.0	0.7	0.4	0.7	0.0	0.9	0.9	0.1	1.1	0.7	1.0	2.2	0.5	0.1	0.1	0.8	0.5	1.1	1.4	2.1	1.5	1.3	1.2	1.3	1.2	1.0	1.6	1.2	1.3	1.3	0.4	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.7	2.3	0.0	0.0	0.1	6.8	0.0	0.1	3.4	0.0	0.0	0.3	0.0	0.4	42.3	0.0	0.0	0.0	0.9	0.4	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	257.1	1240.2	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	998.6	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	2.9	5.7	0.0	0.0	0.5	0.8	24080.8	0.0	0.0
B3GAT2	GlcAT-S	ENSG00000112309	"Beta-1,3-glucuronyltransferase 2"	Q9NPZ5	6	70856679-70957060	"Enzymes, Metabolic proteins, Predicted membrane proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.2;retina: 18.5"	"Cell type enriched"	"Detected in many"	8	"Horizontal cells: 319.7"	"Group enriched"	"Detected in some"	20	"glioma: 4.7;testis cancer: 1.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	19	"SCLC-21H: 21.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012059	Uncertain					NA	NA					"HPA012059: AB_2061050"	"unprognostic (7.10e-3)"	"unprognostic (7.81e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.10e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.96e-2)"	"unprognostic (4.88e-2)"	"unprognostic (4.22e-2)"	"unprognostic (9.16e-4)"	"unprognostic (8.09e-2)"	"unprognostic (7.43e-3)"	"unprognostic (6.88e-7)"	"unprognostic (2.72e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.53e-2)"	"unprognostic (3.45e-3)"	1.2	0.4	15.9	0.5	18.3	0.4	1.1	13.4	14.7	1.2	6.2	0.8	0.7	0.7	0.1	1.0	0.7	0.2	0.8	26.1	14.1	0.6	0.9	1.0	0.5	19.8	18.4	11.5	0.8	1.5	0.0	0.8	0.1	23.8	0.9	0.0	18.5	1.2	0.0	0.8	1.5	1.0	0.1	22.3	0.7	1.1	1.0	15.3	0.6	1.0	0.0	0.0	1.1	1.4	30.2	0.3	0.0	0.6	0.3	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.2	1.1	0.1	0.3	0.2	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.1	0.5	0.0	0.2	0.0	0.5	0.7	0.1	0.1	0.1	0.2	0.2	0.0	0.2	21.8	0.2	0.0	0.1	0.0	0.3	0.1	0.0	0.1	0.1	0.2	0.1	0.3	0.5	0.0	0.1	0.1	0.1	0.1	0.2	0.1	0.2	0.1	0.1	0.1	0.1	0.2	0.3	0.0	0.1	0.2	0.2	0.3	0.1	0.1	0.1	0.3	0.0	15.9	18.3	13.4	14.7	26.1	14.1	19.8	18.4	11.5	23.8	22.3	15.3	30.2	4.5	0.0	2.2	23.8	9.7	25.5	11.9	19.4	0.0	16.5	7.2	1.7	1.0	11.5	9.0	16.5	22.9	6.0	10.0	13.0	0.0	5.6	9.7	3.6	5.4	7.7	0.0	3.2	2.5	3.9	3.9	6.9	2.0	6.0	0.0	2.5	9.3	10.7	7.5	319.7	8.2	4.9	16.2	10.0	27.0	6.0	19.9	5.1	14.2	0.0	11.6	15.2	30.9	32.2	0.2	9.1	15.5	13.5	3.7	16.9	23.3	1.4	3.4	22.5	13.1	5.8	5.8	18.7	36.7	1.2	19.9	7.1	15.1	2.1	6.2	12.2
IL12B	"CLMF, CLMF2, IL-12B, NKSF, NKSF2"	ENSG00000113302	"Interleukin 12B"	P29460	5	159314780-159330487	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"		Cytokine	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"lymphoid tissue: 1.4"	"Cell type enriched"	"Detected in some"	4	"monocytes: 6.7"	"Cancer enriched"	"Detected in single"	20	"testis cancer: 3.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SCLC-21H: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA040970	Supported				"Secreted to blood"	NA	NA	140000				"HPA040970: AB_10796234"	"unprognostic (5.96e-5)"	"unprognostic (4.59e-5)"	"unprognostic (1.05e-1)"	"unprognostic (3.40e-1)"		"unprognostic (9.13e-4)"	"unprognostic (6.89e-2)"	"unprognostic (2.58e-4)"	"unprognostic (6.69e-3)"	"unprognostic (3.83e-2)"	"unprognostic (4.50e-2)"	"unprognostic (2.53e-1)"	"unprognostic (7.15e-3)"	"unprognostic (9.25e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.02e-2)"	0.1	0.0	0.0	0.2	0.1	0.3	0.0	0.4	0.2	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.2	0.1	0.1	0.0	0.1	0.3	0.1	0.0	0.0	0.4	0.2	0.1	0.0	1.4	0.1	0.0	0.2	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.1	0.4	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.3	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPZ1	"FLJ25709, NYD-TSP1, PPP1R148"	ENSG00000164299	"Spermatogenic leucine zipper 1"	Q9BXG8	5	80319625-80321842	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"testis: 28.2"	"Group enriched"	"Detected in some"	40	"Early spermatids: 309.3;Late spermatids: 740.0"	"Group enriched"	"Detected in some"	20	"prostate cancer: 1.0;testis cancer: 0.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA															"unprognostic (1.67e-1)"		"unprognostic (1.25e-1)"		"unprognostic (2.22e-1)"	"unprognostic (2.73e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	309.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	740.0	3.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.0	0.0	3.8	2.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0
ZNF722P	ZNF722	ENSG00000241149	"Zinc finger protein 722, pseudogene"		7	63998874-64016130	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in single"	21	"testis: 2.0"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	19	"testis cancer: 1.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA																				"unprognostic (6.95e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ERVH48-1	"C21orf105, NDUFV3-AS1, SUPYN"	ENSG00000233056	"Endogenous retrovirus group 48 member 1"	M5A8F1	21	42916803-42925646	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	60	"placenta: 153.5"	"Group enriched"	"Detected in some"	8	"Cytotrophoblasts: 130.7;Extravillous trophoblasts: 258.3;Syncytiotrophoblasts: 88.8"	"Cancer enriched"	"Detected in some"	18	"testis cancer: 74.5"	"Low region specificity"	"Detected in some"			"Immune cell enriched"	"Detected in some"	6	"neutrophil: 7.7"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 7.7"	"Cell line enriched"	"Detected in some"	7	"BEWO: 296.4"														"Secreted in female reproductive system"	NA	NA		57000				"unprognostic (1.48e-1)"	"unprognostic (1.08e-1)"	"unprognostic (5.28e-2)"	"unprognostic (5.92e-2)"	"unprognostic (5.66e-2)"	"unprognostic (9.72e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.92e-2)"	"unprognostic (3.48e-1)"	"unprognostic (1.52e-2)"	"unprognostic (7.74e-2)"	"unprognostic (3.12e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.08e-2)"	0.1	0.4	0.7	0.2	0.9	0.7	0.1	2.4	1.7	0.0	0.6	0.1	0.3	0.2	0.2	0.1	0.1	0.3	0.1	0.7	0.1	0.1	0.1	0.4	0.4	0.7	0.2	0.9	0.2	0.7	0.0		153.5	2.5	0.7	0.0	1.5	0.4	0.0	0.4	0.8	0.6	0.0	0.0	0.4	0.3	1.4	0.8	1.3	0.4	0.0	0.0	0.0		1.2	0.0	0.3	0.7	0.1	0.0	0.0	296.4	0.1	0.0	0.0	0.0	11.9	0.2	0.3	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.4	2.8	1.4	0.4	0.1	1.2	0.2	0.0	0.0	0.2	0.0	0.1	11.1	1.0	0.7	0.6	0.0	0.2	8.2	5.0	0.9	0.0	0.3	6.4	0.3	0.1	0.0	0.2	0.4	0.3	0.1	0.0	0.0	44.6	0.3	0.2	0.3	0.2	0.6	0.4	0.1	0.9	2.9	0.5	0.4	3.0	0.2	0.1	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.6	7.7	0.0	0.0	0.0	0.0	0.0	0.7	0.9	2.4	1.7	0.7	0.1	0.7	0.2	0.9	2.5	0.0	0.8	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	130.7	0.0	0.0	0.0	0.0	1.4	0.1	0.1	0.4	0.0	0.0	0.0	0.0	258.3	1.4	0.0	0.1	0.0	0.0	0.0	0.0	19.2	3.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.4	0.0	0.0	88.8	0.0	0.0	0.0	0.0
FAM162B	"bA86F4.2, C6orf189"	ENSG00000183807	"Family with sequence similarity 162 member B"	Q5T6X4	6	116752197-116765719	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 65.7"	"Group enriched"	"Detected in some"	4	"Adipocytes: 34.6;Sertoli cells: 65.7;Smooth muscle cells: 105.1"	"Cancer enriched"	"Detected in many"	18	"testis cancer: 32.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 8.7;BJ hTERT+: 23.5;BJ hTERT+ SV40 Large T+ RasG12V: 22.1;HHSteC: 6.3;HSkMC: 7.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA036112, HPA060342"	Enhanced					NA	NA					"HPA036112: AB_10696649, HPA060342: AB_2684258"	"unprognostic (1.81e-1)"	"unprognostic (5.65e-3)"	"unprognostic (1.54e-1)"	"unprognostic (3.38e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.86e-5)"	"unprognostic (8.29e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.19e-2)"	"unprognostic (2.44e-2)"	"unprognostic (7.32e-2)"	"unprognostic (6.27e-3)"	"prognostic unfavorable (2.48e-4)"	"unprognostic (1.22e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.73e-3)"	"unprognostic (4.34e-2)"	14.4	15.0	3.6	0.8	4.9	0.0	11.0	2.3	7.1	13.0	2.9	2.9	0.9	5.9	7.5	4.4	10.2	5.2	6.4	4.7	3.2	4.4	0.9	18.1	1.6	3.4	3.2	3.4	5.8	1.7	3.7	6.6	65.7	3.8	6.2	2.2	0.2	8.3	13.5	5.4	2.7	2.3	3.7	3.0	0.1	3.6	2.6	3.4	1.9	9.8	10.7	1.2	8.0	10.0	5.0	0.0	0.0	0.0	0.0	2.3	0.1	0.0	8.7	23.5	3.7	22.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.3	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	4.9	2.3	7.1	4.7	3.2	3.4	3.2	3.4	3.8	3.0	3.4	5.0	34.6	0.0	0.0	1.3	0.0	1.3	0.1	0.0	1.2	0.0	0.9	0.8	0.9	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	16.9	0.7	15.7	13.7	0.0	0.0	14.8	0.0	0.2	14.1	0.0	0.4	0.0	0.1	3.6	0.0	0.5	0.0	6.9	0.0	0.0	0.0	2.1	2.2	2.1	0.7	1.8	3.7	0.0	0.0	0.0	6.6	0.5	0.2	0.0	5.3	0.0	0.2	0.0	0.1	0.0	0.1	65.7	2.2	105.1	10.3	5.9	0.6	0.9	0.5	2.3	0.1	0.0	0.0
NANOGNB		ENSG00000205857	"NANOG neighbor homeobox"	Q7Z5D8	12	7765216-7774121	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"Microglial cells: 1.0"	"Cancer enriched"	"Detected in single"	18	"testis cancer: 1.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA060371	Uncertain					NA	NA					"HPA060371: AB_2684266"															"unprognostic (2.76e-1)"			0.0	0.0	0.2	0.1	0.1	0.3	0.0	0.2	0.3	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.6	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.3	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.4	0.0	0.1	0.0	0.0	0.0
TCL1A	TCL1	ENSG00000100721	"TCL1 family AKT coactivator A"	P56279	14	95709947-95714196	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"lymphoid tissue: 269.7"	"Group enriched"	"Detected in some"	4	"B-cells: 282.5;dendritic cells: 210.3"	"Cancer enriched"	"Detected in many"	18	"testis cancer: 64.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	296	"memory B-cell: 874.7;naive B-cell: 2160.3;plasmacytoid DC: 1099.9"	"Group enriched"	"Detected in all"	350	"B-cells: 2160.3;dendritic cells: 1099.9"	"Group enriched"	"Detected in some"	142	"Daudi: 459.4;REH: 599.4;U-698: 616.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB004045, HPA016604"	Enhanced		Enhanced	"Nucleoplasm,Endoplasmic reticulum,Cytosol"		NA	NA			"Endoplasmic reticulum, Cytosol"	Nucleoplasm	"CAB004045: AB_2179419, HPA016604: AB_1857859"	"unprognostic (1.27e-3)"	"unprognostic (3.12e-4)"	"unprognostic (2.61e-4)"	"unprognostic (2.01e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.75e-4)"	"unprognostic (7.70e-2)"	"unprognostic (9.67e-3)"	"unprognostic (1.03e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.14e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.94e-1)"	"unprognostic (2.06e-1)"	"unprognostic (4.55e-1)"	1.0	0.1	0.1	34.7	0.2	20.5	0.2	0.1	0.1	0.1	0.0	2.4	0.8	0.8	0.6	0.5	0.1	3.6	0.6	0.1	0.2	0.3	0.4	1.0	269.7	0.1	0.1	0.1	0.1	0.3	0.0	0.0	0.8	0.1	0.4	2.0	0.0	4.0	0.0	0.1	0.4	14.3	0.3	0.1	57.2	3.5	7.8	0.1	19.2	1.1	0.0	217.8	2.7	0.1	0.3	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	459.4	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.6	0.3	0.0	0.0	0.4	0.3	0.0	0.0	0.0	599.4	0.3	0.8	0.0	0.0	0.2	0.2	0.4	0.7	0.1	0.3	0.1	1.0	1.0	0.2	2.8	0.6	0.2	0.5	3.9	616.2	0.2	0.1	0.1	4.6	1.4	1.8	0.5	0.5	1.3	874.7	0.9	0.4	2.2	2160.3	1.5	0.5	3.3	1.3	1.6	1099.9	1.2	92.4	0.1	0.2	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.0	0.0	1.3	0.0	282.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	210.3	0.6	0.0	0.0	0.9	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.3	0.2	0.5	0.0	0.0	0.0	0.4	0.2	0.3	0.0	0.0	0.2	0.0	0.3	0.0	0.9	0.6	2.8	0.0	0.0	2.7	0.0	3.1	0.0	0.0	0.0	0.2	0.4	0.3	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	28.7	60.2	0.0	0.0	0.0	2.7	0.0	0.3	0.0
DEFB123	DEFB-23	ENSG00000180424	"Defensin beta 123"	Q8N688	20	31440632-31450257	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	370	"epididymis: 160.2;testis: 149.5"	"Group enriched"	"Detected in some"	4	"Early spermatids: 14.0;Late spermatids: 50.4"	"Cancer enriched"	"Detected in single"	17	"testis cancer: 3.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted in other tissues"	NA	NA																				"unprognostic (9.16e-2)"			0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	160.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	149.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	50.4	5.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	5.2	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRR23A		ENSG00000206260	"Proline rich 23A"	A6NEV1	3	139003962-139006268	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in single"		"testis: 1.6"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	17	"testis cancer: 0.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA047473	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Microtubules,Cytokinetic bridge,Mitotic spindle,Cytosol"		Yes	NA			"Nucleoplasm, Microtubules"	"Nuclear bodies, Cytokinetic bridge, Mitotic spindle, Cytosol"	"HPA047473: AB_2680062"															"unprognostic (1.48e-1)"			0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.5	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.2	0.1	0.0	0.2	0.1	0.1	0.4	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TEX37	"C2orf51, FLJ25369, TSC21"	ENSG00000172073	"Testis expressed 37"	Q96LM6	2	88524649-88529585	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	621	"testis: 85.7"	"Group enriched"	"Detected in some"	229	"Early spermatids: 846.6;Late spermatids: 3191.0"	"Cancer enriched"	"Detected in single"	17	"testis cancer: 2.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	31	"BEWO: 50.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA043987, HPA070239"	Enhanced		Supported	Cytosol		NA	NA			Cytosol		"HPA043987: AB_10961125, HPA070239: "										"unprognostic (1.08e-3)"					"unprognostic (2.24e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	85.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.1	50.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	846.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3191.0	8.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	8.4	8.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0
IGF2BP1	IMP-1	ENSG00000159217	"Insulin like growth factor 2 mRNA binding protein 1"	Q9NZI8	17	48997385-49056145	"Predicted intracellular proteins"	"mRNA transport, Translation regulation, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"placenta: 5.5;testis: 4.8"	"Group enriched"	"Detected in some"	4	"Extravillous trophoblasts: 37.3;Spermatocytes: 30.4;Spermatogonia: 21.7"	"Cancer enriched"	"Detected in many"	16	"testis cancer: 28.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 146.7;CACO-2: 238.7;Hep G2: 112.0;K-562: 124.4;NTERA-2: 117.6;REH: 140.0;SuSa: 111.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA021367, HPA062273"	Enhanced		Supported	Cytosol		NA	NA		13000	Cytosol		"HPA021367: AB_1851480, HPA062273: AB_2684733"	"unprognostic (6.79e-4)"	"unprognostic (2.76e-1)"	"unprognostic (4.86e-3)"	"unprognostic (2.30e-6)"	"unprognostic (1.95e-2)"	"unprognostic (9.11e-3)"	"unprognostic (1.80e-2)"	"unprognostic (1.01e-2)"	"unprognostic (9.55e-3)"	"unprognostic (2.58e-1)"	"unprognostic (2.86e-2)"	"unprognostic (5.91e-2)"	"unprognostic (2.80e-6)"	"unprognostic (2.58e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.32e-3)"	"unprognostic (1.47e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	59.5	146.7	0.1	5.2	7.6	105.0	8.5	0.2	12.1	20.1	238.7	4.0	12.4	0.9	1.0	3.6	0.0	91.4	0.0	21.1	0.0	52.9	91.3	33.6	112.0	6.9	48.8	23.6	10.4	0.0	2.9	0.2	4.1	24.9	16.6	124.4	0.0	16.6	0.9	0.1	42.9	117.6	0.2	0.2	140.0	48.3	0.0	0.0	0.1	0.0	0.0	5.1	0.1	3.6	111.4	0.2	13.5	0.5	0.0	1.4	12.5	0.0	0.1	0.1	80.7	0.1	0.0	11.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.4	1.1	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.1	0.1	5.5	0.0	0.6	0.0	0.0	3.5	0.2	0.0	0.0	0.0	5.3	0.1	0.1	3.9	0.0	2.7	0.2	0.0	37.3	3.7	0.0	0.1	1.3	0.0	0.0	0.0	6.9	0.0	0.2	0.0	0.0	0.0	0.8	4.4	0.3	0.3	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	1.1	0.0	0.0	0.1	0.0	5.3	0.7	0.0	0.0	1.1	1.1	30.4	21.7	0.0	0.1	2.9	0.3	0.1	0.0	0.3
NNAT	Peg5	ENSG00000053438	Neuronatin	Q16517	20	37521206-37523690	"Predicted membrane proteins"		"Developmental protein"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in many"	10	"pituitary gland: 1599.2"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 42.0;Excitatory neurons: 33.9;Late spermatids: 65.5;Muller glia cells: 177.1"	"Group enriched"	"Detected in many"	16	"glioma: 87.5;testis cancer: 55.0;urothelial cancer: 37.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	22	"SH-SY5Y: 720.8"					"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.18e-2)"	"unprognostic (7.41e-3)"	"unprognostic (1.85e-2)"	"unprognostic (1.04e-2)"	"prognostic unfavorable (9.66e-4)"	"unprognostic (7.08e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.36e-1)"	"unprognostic (4.05e-2)"	"unprognostic (7.52e-2)"	"unprognostic (4.94e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.77e-1)"	"unprognostic (5.91e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.15e-3)"	"unprognostic (5.90e-2)"	27.6	15.3	118.3	2.5	153.1	2.5	32.8	21.5	66.4	6.0	55.6	51.3	4.0	5.0	0.2	3.4	3.6	4.7	2.4	105.9	89.6	1.4	2.0	2.2	1.4	49.4	47.2	71.0	1.6	1.4	0.0	1599.2	107.3	49.6	4.4	4.0	31.6	6.6	0.6	13.6	4.5	14.7	5.2	30.8	1.4	17.0	5.0	71.4	11.2	2.0	0.3	0.1	14.6	5.6	50.1	2.2	1.7	12.6	1.7	0.0	0.0	4.5	0.5	0.0	0.1	0.0	4.2	2.2	1.0	0.7	0.0	0.2	10.2	0.0	0.0	0.0	0.1	0.3	0.3	12.9	2.4	3.2	1.3	1.1	2.9	0.0	0.0	0.0	0.2	32.5	0.3	0.2	2.4	0.1	1.0	5.7	1.3	0.9	0.3	1.6	0.5	4.0	0.5	0.0	20.6	1.9	720.8	1.1	5.0	0.0	0.6	1.3	0.2	0.8	5.7	0.8	1.6	1.1	0.9	0.2	0.1	1.7	0.6	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	118.3	153.1	21.5	66.4	105.9	89.6	49.4	47.2	71.0	49.6	30.8	71.4	50.1	0.3	0.0	0.0	1.6	0.2	4.0	0.8	0.1	19.9	4.5	0.3	5.8	0.1	0.0	0.7	0.0	0.0	0.6	0.3	0.1	0.0	0.2	42.0	0.1	3.0	21.6	0.0	0.0	33.9	0.0	1.1	3.1	0.0	0.1	1.3	2.2	0.0	0.0	1.6	0.0	9.6	0.2	0.0	0.3	1.1	65.5	0.6	0.1	1.8	4.7	0.0	177.1	0.0	2.0	1.8	0.0	0.0	1.2	0.0	2.5	0.0	0.0	1.1	6.5	0.0	1.4	1.9	1.5	5.6	3.6	1.0	0.3	0.1	0.1	0.0	4.8
NR6A1	"CT150, GCNF, GCNF1, RTR"	ENSG00000148200	"Nuclear receptor subfamily 6 group A member 1"	Q15406	9	124517275-124771311	"Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"testis: 23.1"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 105.5;Extravillous trophoblasts: 160.0;Inhibitory neurons: 114.7;Oligodendrocyte precursor cells: 112.6;Spermatogonia: 111.1"	"Cancer enriched"	"Detected in many"	16	"testis cancer: 27.8"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"eosinophil: 1.2;neutrophil: 4.9"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 4.9"	"Cell line enhanced"	"Detected in many"		"BEWO: 110.7;CACO-2: 26.5;Hep G2: 25.8;K-562: 34.1;NTERA-2: 39.2;U-266/84: 25.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA031461, HPA045145"			Enhanced	Nucleoplasm,Centrosome,Cytosol		NA	NA			Nucleoplasm	"Centrosome, Cytosol"	"HPA031461: AB_2673894, HPA045145: AB_2679233"	"unprognostic (1.73e-1)"	"unprognostic (6.66e-2)"	"unprognostic (4.53e-1)"	"unprognostic (1.34e-6)"	"unprognostic (4.40e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.52e-5)"	"unprognostic (6.31e-2)"	"unprognostic (8.01e-3)"	"unprognostic (2.71e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.63e-1)"	"unprognostic (7.26e-2)"	"unprognostic (7.20e-3)"	"unprognostic (1.71e-1)"	"unprognostic (6.77e-3)"	"unprognostic (1.09e-1)"	0.3	0.8	1.7	0.9	1.9	4.4	0.9	2.2	1.9	0.7	3.7	1.8	1.7	0.5	0.5	1.9	0.5	0.4	0.9	1.8	1.4	1.7	2.7	1.5	0.3	1.9	1.3	1.6	0.3	2.9	0.8	1.5	2.3	1.5	1.4	1.5	3.2	1.2	0.5	1.4	2.1	2.5	0.4	1.4	0.8	0.4	23.1	2.7	0.1	5.4	0.8	0.7	0.7	1.3	1.9	1.2	3.0	14.7	2.0	0.3	0.2	110.7	0.2	1.1	0.8	1.3	26.5	2.9	5.0	1.0	0.1	3.8	2.8	1.6	1.3	1.7	1.1	4.6	4.1	4.8	25.8	0.1	2.3	7.2	0.1	1.3	1.2	1.6	0.3	0.2	1.2	34.1	0.7	0.6	0.6	0.1	3.2	39.2	1.3	1.1	1.2	1.5	2.2	0.5	2.0	2.2	0.8	0.2	0.7	0.9	21.7	2.6	1.3	0.0	1.4	3.1	0.9	0.7	3.3	25.0	4.3	0.9	2.3	0.8	0.0	0.6	1.2	0.0	0.5	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	4.9	0.0	0.3	0.1	0.0	0.1	1.7	1.9	2.2	1.9	1.8	1.4	1.9	1.3	1.6	1.5	1.4	2.7	1.9	0.8	0.0	7.7	47.0	0.6	37.3	17.4	4.2	13.6	3.8	6.8	3.7	2.0	7.2	5.9	5.5	29.2	36.7	1.6	8.9	1.9	10.1	53.5	4.1	0.9	3.2	4.8	6.1	105.5	3.5	160.0	2.0	2.0	3.7	1.3	16.1	1.4	6.0	8.2	1.7	114.7	6.9	8.2	2.2	30.6	30.3	1.2	3.2	8.8	54.4	5.2	7.0	0.0	112.6	73.0	1.9	6.0	1.9	0.5	19.4	24.5	3.3	8.6	10.7	0.0	1.5	3.5	72.7	111.1	8.6	39.8	30.6	0.3	8.1	11.9	15.5
SYCP3		ENSG00000139351	"Synaptonemal complex protein 3"	Q8IZU3	12	101728648-101739472	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Meiosis"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	146	"testis: 83.7"	"Group enriched"	"Detected in many"	8	"Spermatocytes: 825.7;Spermatogonia: 346.9"	"Cancer enriched"	"Detected in single"	16	"testis cancer: 5.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"Karpas-707: 1.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB032978, HPA039635, HPA043938"	Enhanced					NA	NA					"CAB032978: AB_656732, HPA039635: AB_2676607, HPA043938: AB_2678740"	"unprognostic (2.86e-3)"	"unprognostic (3.91e-1)"	"unprognostic (3.18e-1)"	"unprognostic (9.61e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.22e-2)"	"unprognostic (7.49e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.86e-2)"	"unprognostic (7.15e-3)"	"unprognostic (7.81e-3)"	"unprognostic (4.85e-2)"	"unprognostic (1.93e-2)"	"unprognostic (2.24e-1)"	"unprognostic (4.07e-2)"	"unprognostic (5.86e-4)"	0.0	0.1	0.3	0.3	0.5	0.2	0.0	0.5	0.4	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.3	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.1	83.7	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	1.3	0.2	0.0	0.3	0.2	0.0	0.1	0.0	0.0	0.2	0.6	0.4	0.2	0.0	0.1	0.0	0.0	0.5	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.5	0.4	0.2	0.0	0.1	0.0	0.1	0.3	0.0	0.1	0.2	0.4	0.0	2.0	9.1	4.5	0.0	0.7	0.4	1.2	2.2	0.9	0.6	1.3	1.5	0.3	1.8	0.0	0.4	3.1	0.6	0.0	0.1	24.1	0.3	1.3	0.9	1.2	0.4	10.1	0.4	0.2	0.7	0.0	0.7	3.8	0.3	0.7	0.2	0.6	0.0	10.7	0.7	0.0	1.0	0.3	31.2	9.0	1.7	0.0	0.0	0.4	0.3	1.0	9.5	1.8	0.3	1.9	1.9	2.0	0.9	1.0	0.3	0.8	1.7	65.7	2.0	0.4	825.7	346.9	0.7	0.3	0.1	2.0	0.2	1.3	0.5
C3orf56	FLJ40141	ENSG00000214324	"Chromosome 3 open reading frame 56"	Q8N813	3	127193131-127198185	"Predicted intracellular proteins"				"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	15	"testis cancer: 0.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA055395			Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			Nucleoplasm	"Centrosome, Cytosol"	"HPA055395: "															"unprognostic (1.12e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DDX43	"CT13, DKFZp434H2114, HAGE"	ENSG00000080007	"DEAD-box helicase 43"	Q9NXZ2	6	73394828-73417566	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"placenta: 4.9;testis: 19.7"	"Group enriched"	"Detected in many"	6	"Spermatocytes: 50.6;Spermatogonia: 41.5"	"Cancer enriched"	"Detected in many"	15	"testis cancer: 13.0"	"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 8.0;CAPAN-2: 13.8;HHSteC: 3.7;MCF7: 2.6;U-2 OS: 8.7"									HPA031381	Enhanced					NA	NA					"HPA031381: AB_10601885"	"unprognostic (4.03e-3)"	"unprognostic (8.20e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.19e-1)"	"unprognostic (3.59e-4)"	"unprognostic (1.64e-2)"	"unprognostic (3.11e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.15e-1)"	"unprognostic (3.12e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.58e-1)"	"unprognostic (8.78e-2)"	1.0	0.4	0.4	0.5	0.4	0.7	0.9	0.4	0.7	0.5	0.6	0.8	1.2	0.8	0.0	0.9	0.4	1.2	0.5	0.3	0.6	0.4	0.3	1.0	0.8	0.7	0.7	0.1	1.1	1.3	0.0	0.4	4.9	0.8	1.4	0.5	0.4	1.8	1.8	0.2	1.2	0.8	0.8	0.5	0.9	1.7	19.7	0.7	0.2	1.4	0.3	0.6	1.0	0.4	0.9	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.5	0.0	0.0	0.0	0.1	13.8	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.7	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.9	1.0	0.3	0.7	0.8	0.7	0.9	0.2	1.0	0.4	0.1	0.2	0.6	0.2	0.0	0.4	0.2	0.4	0.4	0.4	0.7	0.3	0.6	0.7	0.7	0.1	0.8	0.5	0.7	0.9	2.1	3.2	5.4	0.3	1.0	2.7	0.9	3.4	0.0	0.3	0.8	0.9	0.8	1.5	2.5	0.0	0.0	7.2	2.6	0.5	0.0	0.4	5.1	2.1	0.5	2.4	0.0	0.0	0.3	1.0	3.2	1.7	0.0	2.4	0.0	0.1	0.4	0.1	2.7	0.0	0.3	0.3	4.1	0.8	1.5	5.0	2.1	1.5	3.6	0.0	0.6	0.5	6.2	0.0	2.0	1.5	0.0	1.2	0.7	0.3	0.3	1.5	1.4	1.1	0.0	1.7	1.3	50.6	41.5	0.0	1.4	6.0	2.1	0.2	0.3	0.8
DPYSL5	"CRAM, CRMP-5, CRMP5, CV2, Ulip6"	ENSG00000157851	"Dihydropyrimidinase like 5"	Q9BPU6	2	26847747-26950351	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 118.8"	"Group enriched"	"Detected in some"	4	"Cone photoreceptor cells: 85.5;Late spermatids: 134.3;Oligodendrocytes: 331.2"	"Group enriched"	"Detected in some"	15	"glioma: 17.7;testis cancer: 8.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"AF22: 141.0;HAP1: 118.7;SCLC-21H: 167.3;SH-SY5Y: 99.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034544, HPA072387"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA034544: AB_10671228, HPA072387: AB_2686516"	"unprognostic (1.07e-4)"	"unprognostic (1.10e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.64e-6)"	"unprognostic (3.94e-1)"	"unprognostic (6.21e-2)"		"unprognostic (6.12e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.54e-1)"	"unprognostic (3.54e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.77e-2)"	"unprognostic (5.67e-3)"	"unprognostic (3.62e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.43e-1)"	0.0	1.9	29.9	0.3	49.4	0.0	0.0	56.1	39.9	0.1	4.6	0.5	0.3	0.0	0.0	0.1	0.0	0.0	0.0	17.7	43.6	0.0	0.0	0.0	0.0	68.7	51.1	17.8	0.1	0.0	0.0	7.9	0.0	66.5	0.1	0.2	15.9	0.0	0.0	0.1	0.0	0.3	0.3	71.6	0.0	0.1	7.8	58.0	0.0	0.0	0.0	0.0	0.0	0.1	118.8	0.0	3.0	141.0	0.1	0.6	0.0	3.3	0.0	0.0	0.0	0.0	13.2	0.0	0.0	1.0	0.0	3.9	0.0	118.7	0.0	0.0	0.0	26.2	0.0	0.1	0.4	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.3	0.0	31.5	0.1	0.0	0.0	0.0	0.1	0.0	0.0	167.3	99.0	3.8	0.2	0.0	3.3	0.0	0.0	0.0	0.0	4.1	0.1	3.8	0.0	5.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.9	49.4	56.1	39.9	17.7	43.6	68.7	51.1	17.8	66.5	71.6	58.0	118.8	0.1	0.0	0.0	13.4	0.1	0.0	0.3	0.0	0.0	12.1	0.1	0.0	6.0	0.0	0.0	0.0	85.5	0.1	0.0	0.0	0.0	0.0	45.6	0.1	0.1	0.4	0.0	0.0	18.3	0.0	0.0	0.3	0.0	0.2	2.5	0.2	0.0	0.2	0.1	8.4	40.5	0.0	0.0	0.0	0.7	134.3	1.5	0.2	1.8	2.8	0.1	17.2	0.0	18.1	331.2	0.0	0.0	1.2	0.1	0.2	0.0	0.1	0.0	12.1	0.0	0.7	0.3	2.9	4.6	0.0	0.3	0.0	0.2	0.7	0.0	0.1
HOXB1	"HOX2, HOX2I"	ENSG00000120094	"Homeobox B1"	P14653	17	48528526-48531011	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"Early spermatids: 2.2"	"Cancer enriched"	"Detected in single"	15	"testis cancer: 3.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA044576	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA044576: AB_10794501"	"unprognostic (1.80e-2)"	"unprognostic (9.50e-3)"		"unprognostic (8.22e-2)"		"unprognostic (1.22e-1)"		"unprognostic (6.26e-2)"		"unprognostic (2.40e-2)"	"unprognostic (1.03e-1)"			"unprognostic (1.96e-1)"	"unprognostic (6.74e-2)"		"unprognostic (1.45e-2)"	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.3	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.2
RBM46	"CT68, MGC27016"	ENSG00000151962	"RNA binding motif protein 46"	Q8TBY0	4	154781213-154828813	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	55	"testis: 27.9"	"Group enriched"	"Detected in some"	5	"Spermatocytes: 135.7;Spermatogonia: 82.1"	"Cancer enriched"	"Detected in single"	15	"testis cancer: 1.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SuSa: 1.4"	"Low region specificity"	"Detected in single"			"Region enriched"	"Detected in many"	8	"spinal cord: 12.9"	HPA037746			Approved	Cytosol		NA	NA			Cytosol		"HPA037746: "	"unprognostic (4.79e-1)"				"unprognostic (1.14e-2)"	"unprognostic (3.23e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.33e-3)"	"unprognostic (1.13e-1)"	"unprognostic (8.11e-2)"	"unprognostic (2.24e-2)"		"unprognostic (2.99e-7)"	"unprognostic (4.86e-2)"	"unprognostic (7.31e-2)"	"unprognostic (4.27e-2)"		0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	27.9	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.3	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.6	0.6	0.6	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.2	0.3	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.3	0.0	4.3	0.4	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	9.7	2.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.6	135.7	82.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RPL10L		ENSG00000165496	"Ribosomal protein L10 like"	Q96L21	14	46651010-46651781	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	33	"testis: 92.7"	"Group enriched"	"Detected in some"	17	"Early spermatids: 581.2;Late spermatids: 224.4;Spermatocytes: 310.1"	"Cancer enriched"	"Detected in single"	15	"testis cancer: 6.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	43	"U-2 OS: 41.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA011311	Uncertain		Approved	"Endoplasmic reticulum,Cytosol"		NA	NA			"Endoplasmic reticulum, Cytosol"		"HPA011311: AB_1856431"	"unprognostic (7.36e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.92e-2)"	"unprognostic (4.18e-2)"	"unprognostic (6.67e-2)"	"unprognostic (2.92e-1)"	"unprognostic (8.70e-4)"	"unprognostic (4.69e-2)"	"unprognostic (5.27e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.83e-1)"	"unprognostic (4.40e-2)"	"unprognostic (1.44e-2)"		0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	92.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	41.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	10.4	0.3	0.0	0.0	0.0	0.1	1.3	0.0	0.2	0.0	0.0	0.2	0.0	2.2	0.0	0.0	581.2	0.0	0.1	2.1	0.0	0.0	0.0	0.0	0.3	2.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	1.5	0.0	0.3	19.2	224.4	6.2	0.9	10.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	2.2	0.0	6.6	0.1	0.1	0.1	0.0	6.6	2.9	20.8	310.1	14.7	0.0	18.8	0.3	2.4	0.2	2.0	4.3
TET1	"bA119F7.1, CXXC6, KIAA1676, LCX"	ENSG00000138336	"Tet methylcytosine dioxygenase 1"	Q8NFU7	10	68560337-68694487	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Dioxygenase, DNA-binding, Oxidoreductase, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 4.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 54.5;Extravillous trophoblasts: 79.9;Oligodendrocyte precursor cells: 44.7;Oligodendrocytes: 45.3;Theca cells: 43.7"	"Cancer enriched"	"Detected in some"	15	"testis cancer: 10.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 17.7;HAP1: 20.4;K-562: 12.0;NTERA-2: 11.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019032, HPA057273"			Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			Nucleoplasm	"Nuclear membrane"	"HPA019032: AB_1847363, HPA057273: AB_2683391"	"unprognostic (1.60e-1)"	"unprognostic (8.30e-2)"	"unprognostic (9.85e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.27e-1)"	"unprognostic (8.15e-2)"	"unprognostic (3.60e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.00e-1)"	"unprognostic (7.90e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.18e-3)"	"unprognostic (2.88e-4)"	"unprognostic (4.02e-2)"	"unprognostic (2.54e-1)"	"unprognostic (9.52e-3)"	0.4	0.2	0.5	0.2	1.0	0.3	0.4	4.8	0.8	0.6	0.6	0.3	0.1	0.9	0.6	0.2	0.5	0.3	0.4	0.3	0.6	0.3	0.2	0.2	0.3	1.1	1.2	0.0	0.8	0.2	0.7	0.3	1.2	1.6	0.6	0.3	1.6	1.0	0.3	0.9	0.3	0.2	0.5	0.8	0.3	0.4	0.2	1.1	2.0	0.5	0.3	0.3	0.2	0.4	2.1	0.7	0.8	8.0	9.0	0.8	0.7	17.7	0.4	1.0	0.7	1.2	5.5	0.3	0.0	0.3	0.8	0.1	0.0	20.4	0.0	0.8	0.3	3.3	2.1	0.0	4.9	1.2	1.9	1.0	1.0	0.1	0.5	0.1	1.6	0.1	3.5	12.0	1.4	0.7	0.6	3.3	1.4	11.9	0.0	1.1	3.2	2.5	0.2	0.4	0.8	2.2	3.5	0.4	0.5	1.6	7.9	1.0	1.5	0.3	0.7	1.6	0.0	0.6	0.5	0.6	3.2	0.2	0.0	0.2	0.0	0.0	0.2	0.3	0.0	0.4	0.3	0.1	0.2	0.0	0.1	0.2	0.2	0.0	0.1	0.0	0.2	0.5	0.0	0.5	1.0	4.8	0.8	0.3	0.6	1.1	1.2	0.0	1.6	0.8	1.1	2.1	6.3	3.2	6.2	54.5	2.5	1.1	1.8	0.4	5.2	2.5	7.0	9.5	7.2	1.5	2.6	0.0	10.4	21.0	3.0	0.2	0.0	2.7	0.8	3.6	34.2	4.8	13.8	2.5	15.6	0.4	79.9	15.4	1.5	2.9	0.0	13.6	5.7	2.5	3.9	35.3	20.6	0.3	4.1	0.0	0.3	1.7	25.7	0.8	1.8	12.2	0.4	16.1	5.2	44.7	45.3	0.6	0.0	20.7	7.3	1.4	0.0	0.9	0.8	12.5	6.6	21.9	10.7	0.5	1.5	0.8	1.1	27.9	2.6	43.7	0.6	0.4
VENTX	"HPX42B, VENTX2"	ENSG00000151650	"VENT homeobox"	O95231	10	133237855-133241928	"Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Kupffer cells: 6.2;Langerhans cells: 7.9;Macrophages: 7.8;monocytes: 5.0"	"Cancer enriched"	"Detected in some"	15	"testis cancer: 30.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Group enriched"	"Detected in many"	7	"dendritic cells: 1.8;granulocytes: 1.9;monocytes: 3.2"	"Group enriched"	"Detected in some"	10	"NB-4: 18.2;NTERA-2: 10.9"									HPA050955	Uncertain		Uncertain	"Nucleoli fibrillar center,Cytosol"		NA	NA			"Nucleoli fibrillar center"	Cytosol	"HPA050955: AB_2681288"	"unprognostic (9.41e-2)"	"unprognostic (8.89e-2)"	"unprognostic (2.34e-1)"	"unprognostic (4.26e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.54e-1)"	"unprognostic (9.62e-3)"	"unprognostic (2.22e-1)"	"unprognostic (3.00e-3)"	"unprognostic (3.70e-4)"	"unprognostic (4.22e-1)"	"unprognostic (2.51e-3)"	"unprognostic (3.43e-2)"	"unprognostic (3.48e-1)"	"unprognostic (7.54e-2)"	"unprognostic (3.14e-1)"	4.0	2.3	1.5	3.7	1.2	2.8	1.9	1.6	1.8	1.2	2.2	1.5	0.4	1.6	0.6	0.5	1.8	1.5	1.3	1.4	1.8	1.4	0.5	3.8	0.5	1.9	1.7	1.2	1.5	1.3	0.5	1.4	0.5	1.6	1.3	0.4	0.2	1.4	0.8	0.9	1.2	1.0	1.3	1.1	5.8	0.9	1.0	1.9	0.2	0.8	0.1	0.4	1.4	1.0	2.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	18.2	10.9	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	1.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.0	1.9	2.6	0.3	0.1	3.2	0.0	0.3	0.1	0.0	1.8	0.2	0.1	0.1	0.9	0.3	2.4	0.1	0.0	0.7	1.5	1.2	1.6	1.8	1.4	1.8	1.9	1.7	1.2	1.6	1.1	1.9	2.0	0.0	0.0	1.1	0.0	0.1	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	1.8	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	6.2	7.9	0.2	0.0	7.8	0.0	0.0	5.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.1	0.1	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0
AIRE	"APECED, APS1, PGA1"	ENSG00000160224	"Autoimmune regulator"	O43918	21	44285838-44298648	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 1.2;lymphoid tissue: 1.3"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 3.1;Excitatory neurons: 1.1;Microglial cells: 1.9"	"Cancer enriched"	"Detected in single"	14	"testis cancer: 6.7"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (3.24e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.86e-2)"	"unprognostic (2.47e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.43e-1)"	"unprognostic (8.53e-3)"	"unprognostic (3.69e-3)"	"unprognostic (1.79e-1)"	"unprognostic (6.29e-7)"	"unprognostic (5.04e-2)"	"unprognostic (3.18e-1)"	"unprognostic (2.27e-1)"	"unprognostic (3.57e-2)"	0.0	0.0	0.8	0.1	0.6	0.1	0.1	0.4	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.1	0.0	0.0	0.0	0.2	0.7	0.8	0.6	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.0	0.1	0.0	0.3	0.1	0.0	0.4	0.0	0.0	0.0	1.2	1.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.6	0.4	0.9	0.6	1.1	0.7	0.8	0.6	0.7	0.4	1.2	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.5	0.1	0.0	0.0	1.1	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.4	0.1	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	1.9	0.7	0.2	0.0	0.5	0.1	0.0	0.0	0.4	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.2	0.0
CCDC172	"C10orf96, MGC35062"	ENSG00000182645	"Coiled-coil domain containing 172"	P0C7W6	10	116324448-116380029	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"retina: 3.1;testis: 12.3"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 32.9;Late spermatids: 9.6;Spermatocytes: 107.9;Spermatogonia: 22.9"	"Cancer enriched"	"Detected in single"	14	"testis cancer: 1.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	21	"NTERA-2: 31.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA																				"unprognostic (9.85e-2)"			0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.2	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	12.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	31.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.3	0.1	0.1	0.2	0.0	0.1	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.9	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	9.6	0.9	0.1	0.0	0.0	0.0	1.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	107.9	22.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0
L1TD1	"ECAT11, FLJ10884"	ENSG00000240563	"LINE1 type transposase domain containing 1"	Q5T7N2	1	62194849-62212328	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 5.6;intestine: 5.4;lymphoid tissue: 4.8;placenta: 11.7;testis: 5.8"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 110.2;Extravillous trophoblasts: 26.2;Intestinal goblet cells: 37.5;Spermatogonia: 53.1;Syncytiotrophoblasts: 28.2"	"Cancer enriched"	"Detected in some"	14	"testis cancer: 120.2"	"Region enhanced"	"Detected in some"		"cerebellum: 5.6"	"Immune cell enriched"	"Detected in single"	13	"non-classical monocyte: 5.0"	"Lineage enriched"	"Detected in single"	21	"monocytes: 5.0"	"Group enriched"	"Detected in some"	22	"NTERA-2: 255.7;SuSa: 191.2"	"Not detected"	"Not detected"							"HPA028501, HPA030064"			Enhanced	Vesicles		NA	NA			Vesicles		"HPA028501: AB_10599287, HPA030064: AB_10600538"	"unprognostic (2.03e-2)"	"unprognostic (7.88e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.51e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.46e-1)"	"unprognostic (4.03e-1)"	"unprognostic (1.09e-1)"	"unprognostic (9.23e-2)"	"unprognostic (4.04e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.52e-5)"	"unprognostic (3.49e-2)"	"unprognostic (2.43e-1)"	"unprognostic (5.75e-2)"	"unprognostic (1.95e-1)"	0.2	0.3	0.3	4.8	0.6	0.0	0.2	5.6	1.5	0.3	0.0	5.4	0.1	0.1	0.3	0.0	0.1	0.3	0.0	0.6	0.1	0.1	0.0	1.5	0.2	0.4	0.2	0.4	0.2	0.0	0.0	0.1	11.7	1.6	0.1	1.2	0.0	0.4	0.1	0.0	0.1	0.3	0.4	0.0	0.9	0.1	5.8	0.1	0.2	0.5	0.0	0.1	0.1	0.2	0.7	0.0	0.0	0.2	0.1	0.0	0.0	10.1	0.1	0.0	1.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	255.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	191.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	5.0	0.0	0.0	0.0	0.3	0.6	5.6	1.5	0.6	0.1	0.4	0.2	0.4	1.6	0.0	0.1	0.7	0.5	6.4	13.0	0.0	1.8	0.4	0.7	0.1	0.0	2.5	1.0	2.2	0.3	0.0	7.5	0.0	6.2	110.2	2.1	3.6	0.0	0.0	0.5	0.8	0.5	2.3	10.7	0.0	0.6	0.4	26.2	3.6	0.0	1.7	1.3	2.2	0.0	0.1	7.6	3.3	0.4	37.5	0.0	1.4	1.2	1.0	1.8	4.3	0.0	0.0	0.5	0.4	1.0	0.0	0.1	0.3	1.6	18.4	1.1	0.6	0.1	0.1	6.0	3.7	0.0	1.1	2.7	0.7	53.1	0.0	0.1	28.2	1.9	2.3	9.2	0.3
OR7E24	"HSHT2, OR19-8, OR7E24P, OR7E24Q"	ENSG00000237521	"Olfactory receptor family 7 subfamily E member 24"	Q6IFN5	19	9247344-9252625	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	19	"testis: 1.8"	"Group enriched"	"Detected in some"	20	"Early spermatids: 15.9;Late spermatids: 5.0"	"Cancer enriched"	"Detected in single"	14	"testis cancer: 2.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"									NA	NA																				"unprognostic (1.09e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP6	"HRP1, Tre-2, TRE17, Tre2, TRESMCR"	ENSG00000129204	"Ubiquitin specific peptidase 6"	P35125	17	5116032-5175034	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Calmodulin-binding, Hydrolase, Protease, Thiol protease"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"skeletal muscle: 19.8;testis: 13.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 24.4;Spermatocytes: 26.9"	"Cancer enriched"	"Detected in single"	14	"testis cancer: 2.8"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA046969			Uncertain	Vesicles		NA	NA			Vesicles		"HPA046969: "	"unprognostic (3.89e-2)"	"unprognostic (3.79e-3)"	"unprognostic (2.50e-1)"	"unprognostic (1.85e-1)"	"unprognostic (9.32e-2)"	"unprognostic (3.50e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.67e-2)"	"unprognostic (3.45e-2)"	"unprognostic (2.46e-2)"	"unprognostic (7.91e-4)"	"unprognostic (6.28e-3)"	"unprognostic (3.24e-4)"	"unprognostic (3.75e-2)"	"unprognostic (3.13e-1)"	"unprognostic (2.71e-1)"	"unprognostic (7.09e-4)"	0.4	0.3	0.9	0.2	0.5	0.1	0.7	0.3	0.5	0.8	1.3	0.6	0.0	0.9	0.7	0.2	0.6	0.5	0.4	0.4	0.3	0.6	0.1	0.4	0.3	0.9	0.3	0.3	2.6	0.3	0.0	0.6	0.5	1.0	0.6	0.3	2.5	0.5	0.5	19.8	0.6	0.3	0.9	0.2	0.4	0.2	13.5	0.4	0.0	0.9	0.6	0.2	0.3	0.5	0.9	0.1	0.1	0.3	0.2	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.1	0.2	0.2	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.3	0.2	0.1	0.3	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.0	0.2	0.4	0.3	0.1	0.1	0.0	0.3	0.2	0.0	0.3	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.5	0.3	0.5	0.4	0.3	0.9	0.3	0.3	1.0	0.2	0.4	0.9	2.0	6.4	10.8	0.0	0.4	10.8	1.0	1.1	0.0	8.5	4.0	3.8	1.6	5.7	3.5	3.7	12.5	0.6	1.0	0.1	3.9	0.0	24.4	1.1	2.1	3.0	0.0	5.3	1.2	0.0	0.8	1.8	0.0	1.4	0.0	1.2	3.6	3.2	2.7	1.7	1.0	0.0	0.0	5.4	6.4	13.5	1.8	3.1	3.6	2.8	3.2	5.1	0.0	0.0	2.9	0.1	0.1	2.6	0.1	2.1	0.0	3.2	4.0	12.3	6.6	5.9	1.7	26.9	11.5	0.0	10.4	0.7	1.1	0.9	0.2	1.1
ZIC3	"HTX, HTX1, ZNF203"	ENSG00000156925	"Zic family member 3"	O60481	X	137566127-137577691	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease variant, Heterotaxy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 13.5;choroid plexus: 3.5;retina: 2.7"	"Cell type enhanced"	"Detected in some"		"Microglial cells: 4.7;Muller glia cells: 9.6;Rod photoreceptor cells: 1.3;Spermatocytes: 2.0;Spermatogonia: 3.7"	"Cancer enriched"	"Detected in single"	14	"testis cancer: 5.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	35	"AF22: 38.8;NTERA-2: 42.8;SuSa: 24.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052936, HPA069523"	Uncertain		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA052936: AB_2681993, HPA069523: AB_2732136"					"unprognostic (3.55e-5)"					"unprognostic (3.82e-1)"		"unprognostic (1.95e-1)"			"unprognostic (3.31e-1)"			0.0	0.0	3.1	0.0	3.8	0.1	0.0	13.5	2.8	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	3.8	0.0	0.0	0.0	0.0	3.4	3.6	1.5	0.0	0.0	0.0	0.7	0.0	5.8	0.0	0.0	2.7	0.0	0.0	0.0	0.1	0.0	0.0	2.2	0.0	0.0	0.7	4.1	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	38.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.1	42.8	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	24.8	0.6	0.0	0.3	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	3.8	13.5	2.8	2.0	3.8	3.4	3.6	1.5	5.8	2.2	4.1	3.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	4.7	0.0	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	2.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ZNF534	"FLJ25344, KRBO3"	ENSG00000198633	"Zinc finger protein 534"	Q76KX8	19	52429187-52452315	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 1.3;retina: 1.1;testis: 1.8"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 4.6;Excitatory neurons: 6.4;Inhibitory neurons: 4.4;Oligodendrocyte precursor cells: 3.5;Oligodendrocytes: 3.7;Spermatocytes: 5.4;Spermatogonia: 12.1"	"Cancer enriched"	"Detected in single"	14	"testis cancer: 2.0"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SuSa: 1.1"															NA	NA						"unprognostic (2.66e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.35e-1)"	"unprognostic (7.65e-4)"	"unprognostic (7.25e-2)"	"unprognostic (9.42e-2)"	"unprognostic (2.02e-1)"	"unprognostic (9.36e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.22e-1)"	"unprognostic (9.57e-4)"	"unprognostic (3.04e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.59e-1)"	"unprognostic (5.80e-2)"	0.1	0.1	0.9	0.0	1.2	0.0	0.2	0.6	1.3	0.2	0.0	0.1	0.0	0.2	0.1	0.1	0.3	0.0	0.3	1.3	0.3	0.1	0.0	0.1	0.0	0.5	0.1	0.9	0.3	0.0	0.0	0.2	0.2	0.7	0.2	0.0	1.1	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.1	1.8	0.2	0.1	0.2	0.1	0.0	0.2	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	1.2	0.6	1.3	1.3	0.3	0.5	0.1	0.9	0.7	0.0	0.2	1.0	0.1	0.0	0.0	4.6	0.1	0.4	0.8	0.1	0.0	1.2	0.1	0.0	1.8	0.0	0.0	0.0	2.1	0.1	0.1	0.1	0.0	0.0	1.0	0.1	0.0	0.3	0.0	0.0	6.4	0.0	0.2	0.5	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	4.4	0.0	0.0	0.0	0.7	0.8	0.3	0.0	0.0	1.9	0.1	1.0	1.0	3.5	3.7	0.0	0.0	0.4	0.3	0.5	0.0	0.2	0.3	0.7	0.0	0.5	0.3	5.4	12.1	0.0	0.4	0.0	0.1	0.0	0.0	0.3
RGS8	"MGC119067, MGC119068, MGC119069"	ENSG00000135824	"Regulator of G protein signaling 8"	P57771	1	182641816-182684576	"Predicted intracellular proteins"		"GTPase activation, Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"brain: 58.5;retina: 34.7"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 65.6;Early spermatids: 11.7;Inhibitory neurons: 18.0;Late spermatids: 22.1;Theca cells: 14.0"	"Group enriched"	"Detected in some"	13	"glioma: 0.6;testis cancer: 0.8;thyroid cancer: 0.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 5.7;Daudi: 2.1;SCLC-21H: 15.9;U-698: 3.3"	"Region enhanced"	"Detected in all"		"cerebellum: 425.5"	"Low region specificity"	"Detected in many"			HPA076764	Enhanced					NA	NA					"HPA076764: AB_2732321"	"unprognostic (6.75e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.03e-1)"	"unprognostic (9.29e-5)"	"unprognostic (2.60e-1)"	"unprognostic (2.37e-1)"		"unprognostic (9.29e-3)"		"unprognostic (1.16e-1)"	"unprognostic (3.78e-1)"	"unprognostic (2.40e-1)"	"unprognostic (3.23e-2)"	"unprognostic (7.08e-2)"	"unprognostic (2.98e-2)"	"unprognostic (6.37e-2)"	"unprognostic (1.02e-1)"	0.0	1.1	15.7	0.0	40.6	0.0	0.0	13.4	12.8	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.6	19.1	0.0	0.0	0.0	0.1	23.6	30.3	7.1	0.4	0.0	0.0	1.4	0.0	27.7	0.0	0.0	34.7	0.1	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	3.0	58.5	0.0	6.7	0.0	0.3	0.0	0.0	36.9	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.9	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.2	0.0	3.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.7	40.6	13.4	12.8	3.6	19.1	23.6	30.3	7.1	27.7	1.0	58.5	36.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	65.6	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.7	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.7	18.0	0.0	0.0	0.0	0.0	22.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.5	0.3	0.2	0.0	0.0	0.0	0.0	14.0	0.0	0.0
TSPY10		ENSG00000236424	"Testis specific protein Y-linked 10"	P0CW01	Y	9527880-9530682	"Predicted intracellular proteins"	"Differentiation, Gonadal differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	11	"testis: 1.7"	"Cell type enriched"	"Detected in some"	10	"Spermatogonia: 10.3"	"Cancer enriched"	"Detected in single"	13	"testis cancer: 1.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"U-266/84: 63.8"									"HPA049384, HPA067289"	Supported		Approved	Cytosol		NA	NA			Cytosol		"HPA049384: AB_2680738, HPA067289: "															"unprognostic (5.36e-1)"			0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	11.8	63.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	10.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AIPL1	LCA4	ENSG00000129221	"Aryl hydrocarbon receptor interacting protein like 1"	Q9NZN9	17	6393693-6435199	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Sensory transduction, Vision"		"Disease variant, Leber congenital amaurosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	134	"retina: 843.2"	"Cell type enriched"	"Detected in some"	4	"Rod photoreceptor cells: 1926.4"	"Cancer enriched"	"Detected in single"	12	"testis cancer: 0.5"	"Region enriched"	"Detected in single"	12	"midbrain: 6.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 1.5;OE19: 2.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA026578	Enhanced		Uncertain	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA026578: AB_2671905"		"unprognostic (2.42e-2)"		"unprognostic (1.17e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.68e-3)"		"unprognostic (3.24e-1)"		"unprognostic (1.13e-3)"				"unprognostic (3.76e-1)"	"unprognostic (5.35e-2)"			0.0	0.0	0.3	0.1	0.3	0.7	0.0	0.1	0.3	0.0	0.5	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.2	6.2	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	843.2	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.6	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.3	2.8	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.3	0.3	0.1	0.3	0.1	0.5	0.2	6.2	0.1	0.3	0.0	0.3	0.4	0.0	3.2	1.1	0.0	0.0	0.8	1.0	0.0	0.0	139.2	0.1	0.0	0.6	0.0	1.4	0.0	412.8	0.1	0.1	0.2	0.0	0.0	7.8	0.4	0.2	8.5	0.0	0.0	0.3	0.0	0.1	0.3	0.0	0.4	0.0	0.1	1.4	0.0	0.1	65.6	0.2	0.2	0.0	0.3	1.1	1.3	0.0	0.3	1.8	0.0	0.0	256.1	0.0	0.5	0.1	0.1	0.0	0.4	0.0	0.7	0.0	0.0	0.0	1926.4	0.0	1.8	0.3	0.4	0.2	0.0	0.4	0.3	0.4	0.1	0.0	1.7
C12orf40	FLJ40126	ENSG00000180116	"Chromosome 12 open reading frame 40"	Q86WS4	12	39626167-39908300	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	40	"testis: 8.8"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 11.5;Late spermatids: 5.2;Spermatocytes: 33.2;Spermatogonia: 7.6"	"Cancer enriched"	"Detected in single"	12	"testis cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	8	"K-562: 2.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA039032			Approved	"Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus"	Cytosol	"HPA039032: AB_2676316"					"unprognostic (1.75e-1)"								"unprognostic (2.76e-6)"	"unprognostic (3.45e-1)"	"unprognostic (1.96e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.2	7.6	0.0	0.0	0.0	0.3	0.1	0.0	0.0
CCDC63	"FLJ35843, ODA5"	ENSG00000173093	"Coiled-coil domain containing 63"	Q8NA47	12	110846769-110907535	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"testis: 17.5"	"Group enriched"	"Detected in some"	32	"Early spermatids: 305.6;Late spermatids: 241.7"	"Cancer enriched"	"Detected in single"	12	"testis cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	19	"MCF7: 4.4"									HPA061568			Approved	"Nucleoplasm,Nuclear bodies,Vesicles"		No	NA			"Nucleoplasm, Nuclear bodies"	Vesicles	"HPA061568: AB_2684561"					"unprognostic (1.98e-2)"	"unprognostic (1.05e-1)"		"unprognostic (1.17e-1)"	"unprognostic (2.65e-1)"					"unprognostic (5.59e-2)"	"unprognostic (1.09e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.1	0.0	0.0	0.0	0.0	0.0	17.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	305.6	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	241.7	1.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	8.4	4.3	0.0	0.0	0.1	0.0	0.9	0.0	0.0
KCNK12	"K2p12.1, THIK-2, THIK2"	ENSG00000184261	"Potassium two pore domain channel subfamily K member 12"	Q9HB15	2	47509290-47570985	"Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	14	"brain: 6.8;pituitary gland: 3.6"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 10.2;Cone photoreceptor cells: 14.6;Excitatory neurons: 19.0;Extravillous trophoblasts: 33.7;Inhibitory neurons: 30.4;NK-cells: 11.3"	"Cancer enriched"	"Detected in single"	12	"testis cancer: 2.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"REH: 10.5;SCLC-21H: 4.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (6.10e-2)"	"unprognostic (1.24e-1)"	"unprognostic (6.02e-3)"	"unprognostic (3.29e-2)"	"unprognostic (2.50e-1)"	"unprognostic (3.77e-2)"	"unprognostic (3.76e-2)"	"unprognostic (2.16e-2)"	"unprognostic (2.54e-2)"	"unprognostic (2.14e-1)"	"unprognostic (6.55e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.12e-6)"	"unprognostic (1.36e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.25e-1)"	0.0	0.1	1.6	0.1	1.3	0.1	0.0	6.8	5.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.5	0.6	0.0	0.0	0.0	0.1	3.1	1.3	1.7	0.0	0.0	0.0	3.6	0.1	4.2	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.1	0.0	1.3	0.0	0.0	0.3	1.5	0.0	0.0	0.0	0.1	0.0	0.0	2.6	0.0	0.0	0.4	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.6	0.0	0.3	10.5	0.0	0.8	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.6	1.3	6.8	5.6	1.5	0.6	3.1	1.3	1.7	4.2	1.3	1.5	2.6	0.2	0.0	0.0	0.3	3.2	0.1	0.1	0.0	0.0	10.2	0.2	0.3	1.3	0.0	0.0	0.0	14.6	0.2	2.6	0.0	0.0	0.0	8.3	0.2	0.4	0.1	0.0	0.4	19.0	0.0	33.7	0.3	0.5	0.1	0.0	1.0	0.0	0.0	0.4	1.7	30.4	0.0	0.0	0.3	0.4	5.2	0.3	0.0	0.0	0.0	0.1	0.6	11.3	1.0	8.2	0.0	0.0	0.4	4.7	0.6	0.0	0.1	0.0	5.3	0.0	0.2	0.4	3.9	2.5	0.0	0.0	0.8	3.0	1.3	0.0	0.1
NEUROG1	"AKA, bHLHa6, Math4C, NEUROD3, ngn1"	ENSG00000181965	"Neurogenin 1"	Q92886	5	135534282-135535964	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	5	"brain: 4.2"	"Cell type enriched"	"Detected in single"	15	"Bipolar cells: 9.1"	"Cancer enriched"	"Detected in single"	12	"testis cancer: 1.1"	"Region enriched"	"Detected in single"	10	"midbrain: 4.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA072232			Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA072232: "															"unprognostic (3.04e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC7A3	"ATRC3, CAT-3, FLJ14541"	ENSG00000165349	"Solute carrier family 7 member 3"	Q8WY07	X	70925579-70931125	"FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 19.9"	"Cell type enhanced"	"Detected in some"		"Breast myoepithelial cells: 1.5;Early spermatids: 6.9;Granulosa cells: 1.5;Inhibitory neurons: 1.6;Late spermatids: 2.3"	"Cancer enriched"	"Detected in some"	12	"testis cancer: 43.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HAP1: 64.2;NTERA-2: 130.9;SuSa: 154.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (1.42e-4)"	"unprognostic (4.30e-4)"	"unprognostic (3.59e-3)"	"unprognostic (1.81e-2)"	"unprognostic (6.45e-2)"			"unprognostic (1.45e-2)"		"unprognostic (3.66e-1)"	"unprognostic (9.18e-3)"	"unprognostic (1.89e-1)"		"unprognostic (7.99e-5)"	"unprognostic (1.31e-2)"	"unprognostic (5.42e-4)"	"unprognostic (3.57e-2)"	0.0	0.0	3.5	0.1	0.7	0.9	0.7	0.1	1.1	1.5	0.2	0.1	0.1	5.3	1.3	0.4	1.6	0.1	0.0	0.8	2.7	0.0	0.0	0.0	0.3	0.9	1.9	0.7	1.0	0.0	0.0	0.3	0.0	1.6	5.9	0.0	0.1	0.2	5.4	0.0	0.0	0.2	2.7	0.3	0.0	3.1	0.8	4.1	19.9	0.0	0.0	0.3	1.0	0.8	0.8	0.0	0.0	4.3	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	23.7	0.5	0.0	0.2	0.0	64.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.4	0.0	130.9	0.0	0.0	28.4	9.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	154.2	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.2	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.7	0.1	1.1	0.8	2.7	0.9	1.9	0.7	1.6	0.3	4.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.5	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.9	0.0	0.3	0.1	0.0	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	2.3	0.6	0.0	0.0	1.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.1
TNFRSF8	"CD30, D1S166E, KI-1"	ENSG00000120949	"TNF receptor superfamily member 8"	P28908	1	12063303-12144207	"Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adipose tissue: 4.9"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 7.1;Early spermatids: 3.5;Kupffer cells: 5.3;Langerhans cells: 3.3;Late spermatids: 9.8;Macrophages: 5.8;monocytes: 5.1"	"Cancer enriched"	"Detected in some"	12	"testis cancer: 9.3"	"Region enhanced"	"Detected in single"		"basal ganglia: 2.0"	"Group enriched"	"Detected in many"	4	"intermediate monocyte: 59.4;non-classical monocyte: 96.6"	"Lineage enriched"	"Detected in many"	5	"monocytes: 96.6"	"Cell line enriched"	"Detected in some"	21	"HDLM-2: 552.9"	"Region enhanced"	"Detected in many"		"hypothalamus: 5.5"					"CAB000016, HPA014823, HPA032081, HPA032082"	Approved		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"CAB000016: AB_563546, HPA014823: , HPA032081: AB_2674141, HPA032082: AB_2674142"	"unprognostic (1.07e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.52e-2)"	"unprognostic (5.98e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.46e-3)"	"unprognostic (2.19e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.18e-1)"	"unprognostic (9.18e-3)"	"unprognostic (1.86e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.17e-8)"	"unprognostic (3.31e-1)"	"unprognostic (8.56e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.31e-2)"	4.9	0.1	0.1	3.1	2.0	0.6	3.5	0.0	0.4	0.2	0.3	0.4	0.0	0.8	0.0	0.2	0.9	0.6	1.4	0.0	0.5	0.3	0.0	0.9	1.2	0.6	0.1	0.1	0.2	0.1	0.0	0.0	0.7	0.4	0.2	0.2	0.0	0.3	0.1	0.9	0.7	0.7	0.5	0.1	1.4	2.6	1.4	0.5	1.0	0.1	1.2	1.2	0.9	0.4	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.4	0.0	0.1	0.8	11.7	0.0	0.0	0.0	0.0	0.0	0.1	552.9	0.1	0.0	0.1	0.0	0.0	10.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	3.7	26.3	1.5	0.0	0.0	1.5	0.2	21.7	0.0	0.4	0.0	0.0	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.2	0.1	0.0	1.4	1.4	0.2	0.0	0.1	0.1	0.3	0.0	0.0	0.0	17.6	1.0	0.1	59.4	0.3	0.1	0.1	0.0	8.7	0.0	0.0	0.0	18.3	0.0	96.6	2.3	0.8	8.5	0.1	2.0	0.0	0.4	0.0	0.5	0.6	0.1	0.1	0.4	0.1	0.5	0.2	7.1	0.0	0.0	0.3	0.4	0.3	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	3.5	0.1	0.5	2.2	0.0	0.0	0.6	0.0	0.2	1.1	2.6	0.1	0.0	0.1	2.2	0.1	1.5	0.0	0.5	0.0	0.0	5.3	3.3	9.8	0.3	5.8	0.0	1.0	5.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.3	1.3	1.0	0.0	0.1	0.3	0.4	0.2	0.0	0.1
WNT8A	WNT8D	ENSG00000061492	"Wnt family member 8A"	Q9H1J5	5	138083990-138092365	"Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 2.8;Inhibitory neurons: 1.5;Microglial cells: 1.0"	"Cancer enriched"	"Detected in single"	12	"testis cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SuSa: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA038539	Uncertain				"Secreted to extracellular matrix"	NA	NA					"HPA038539: AB_10669646"					"unprognostic (1.11e-5)"					"unprognostic (4.11e-2)"					"unprognostic (4.11e-2)"	"unprognostic (5.32e-2)"		0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.7	0.4	0.0	0.7	0.0	0.1	0.5	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
BHLHE23	"bA305P22.3, Beta4, BHLHB4"	ENSG00000125533	"Basic helix-loop-helix family member e23"	Q8NDY6	20	63005927-63007035	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	4	"brain: 1.0"	"Cell type enriched"	"Detected in single"	32	"Cardiomyocytes: 3.3"	"Cancer enriched"	"Detected in single"	11	"testis cancer: 0.5"	"Region enriched"	"Detected in single"	5	"medulla oblongata: 1.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	21	"MOLT-4: 13.9"	"Not detected"	"Not detected"							HPA030575	Uncertain					NA	NA					"HPA030575: AB_10601459"															"unprognostic (1.74e-1)"			0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	13.9	0.5	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	1.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CAMKV	"MGC8407, VACAMKL"	ENSG00000164076	"CaM kinase like vesicle associated"	Q8NCB2	3	49857988-49869935	"Enzymes, Predicted intracellular proteins"		Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"brain: 97.5"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 12.2;Early spermatids: 6.3;Excitatory neurons: 32.7;Inhibitory neurons: 27.0;Late spermatids: 7.8"	"Group enriched"	"Detected in some"	11	"glioma: 4.0;testis cancer: 5.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 7.6;CACO-2: 6.1;HAP1: 10.3;NTERA-2: 34.1;RPMI-8226: 6.9;SCLC-21H: 17.7;SH-SY5Y: 8.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007656, CAB034931"	Enhanced	Supported	Approved	"Nucleoplasm,Cytokinetic bridge"		Yes	NA			Nucleoplasm	"Cytokinetic bridge"	"CAB034931: AB_2068550, HPA007656: AB_1078391"	"unprognostic (9.47e-4)"	"unprognostic (5.65e-3)"	"unprognostic (1.42e-1)"	"unprognostic (2.70e-7)"	"unprognostic (2.76e-1)"	"unprognostic (7.95e-4)"		"unprognostic (3.09e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.30e-3)"	"unprognostic (1.72e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.00e-3)"	"unprognostic (7.61e-2)"	"unprognostic (9.51e-2)"	"unprognostic (1.67e-3)"	0.0	0.9	49.6	0.0	97.5	0.0	0.0	0.0	90.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	78.5	42.9	0.0	0.0	0.0	0.0	18.5	11.1	92.0	0.0	0.0	0.0	8.6	0.0	24.4	0.0	0.0	7.5	0.0	0.0	0.0	0.1	0.1	0.0	5.4	0.0	0.1	2.0	27.8	0.0	0.0	0.0	0.0	0.0	0.0	46.7	0.0	0.2	7.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	10.3	0.0	0.0	0.1	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.8	0.0	0.0	0.1	0.9	0.2	34.1	0.0	0.2	1.3	0.0	6.9	0.0	0.0	17.7	8.3	0.0	0.0	0.0	1.3	0.0	2.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	49.6	97.5	0.0	90.2	78.5	42.9	18.5	11.1	92.0	24.4	5.4	27.8	46.7	0.0	0.0	0.0	3.9	0.0	0.3	0.0	0.0	0.0	12.2	0.1	0.1	0.7	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	1.2	0.0	32.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.3	27.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	4.7	0.0	0.2	0.0	2.5	3.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.0	0.0	0.0	0.0	0.2	0.5	0.0	0.1	0.3	0.0	0.0	0.1	0.0
CDX4		ENSG00000131264	"Caudal type homeobox 4"	O14627	X	73447254-73455245	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	9	"skin 1: 1.1"	"Cell type enhanced"	"Detected in some"		"Spermatogonia: 1.2;Suprabasal keratinocytes: 1.1"	"Cancer enriched"	"Detected in single"	11	"testis cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA043714, HPA056528"	Uncertain		Approved	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	NA			"Nucleoplasm, Nuclear speckles"	Cytosol	"HPA043714: , HPA056528: AB_2683166"															"unprognostic (1.97e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.2	0.0	1.1	0.0	0.0	0.0	0.0	0.0
CHRNB3		ENSG00000147432	"Cholinergic receptor nicotinic beta 3 subunit"	Q05901	8	42697366-42737407	"Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 11.0;retina: 3.8"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 1.0;Bipolar cells: 1.5;Excitatory neurons: 2.2;Inhibitory neurons: 2.9;Microglial cells: 1.0;Rod photoreceptor cells: 1.1"	"Cancer enriched"	"Detected in single"	11	"testis cancer: 0.6"	"Group enriched"	"Detected in some"	6	"cerebellum: 11.0;midbrain: 9.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"NTERA-2: 1.1;U-266/84: 2.7"	"Region enhanced"	"Detected in many"		"midbrain: 6.9"	"Low region specificity"	"Detected in all"			HPA045555	Enhanced					NA	NA					"HPA045555: AB_10960891"					"unprognostic (8.63e-2)"						"unprognostic (4.12e-1)"			"unprognostic (7.29e-2)"	"unprognostic (1.62e-1)"			0.0	0.0	0.1	0.0	1.3	0.0	0.0	11.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.8	0.0	0.0	0.0	0.1	0.4	9.8	0.3	0.0	1.8	0.0	0.1	0.0	0.9	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	1.3	11.0	0.3	0.5	1.8	0.4	9.8	0.3	0.9	0.0	0.7	0.5	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.0	0.0	0.5	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0
DLL3	SCDO1	ENSG00000090932	"Delta like canonical Notch ligand 3"	Q9NYJ7	19	39498895-39508481	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Notch signaling pathway"	"Developmental protein"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 5.7;choroid plexus: 2.1;pituitary gland: 3.5;testis: 1.5"	"Group enriched"	"Detected in some"	4	"Oligodendrocyte precursor cells: 24.6;Spermatogonia: 39.5"	"Group enriched"	"Detected in many"	11	"glioma: 29.2;melanoma: 15.5;testis cancer: 8.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 2.6;naive CD8 T-cell: 1.4"	"Group enriched"	"Detected in many"	13	"B-cells: 2.6;T-cells: 1.4"	"Cell line enriched"	"Detected in some"	6	"SK-MEL-30: 83.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA024559, HPA056533"			Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA			Nucleoplasm	"Golgi apparatus, Plasma membrane"	"HPA024559: , HPA056533: "	"unprognostic (2.52e-1)"	"unprognostic (3.81e-1)"	"unprognostic (3.13e-2)"	"prognostic unfavorable (2.94e-4)"	"unprognostic (9.85e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.65e-3)"	"unprognostic (1.85e-1)"	"unprognostic (4.82e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.06e-2)"	"unprognostic (4.20e-2)"	"unprognostic (3.82e-4)"	"unprognostic (4.94e-2)"	"unprognostic (5.13e-2)"	"unprognostic (4.15e-2)"	"unprognostic (2.97e-1)"	0.0	0.0	4.6	0.1	5.4	0.0	0.0	2.9	5.7	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	4.1	0.0	0.0	0.0	0.1	4.7	4.0	4.8	0.2	0.0	0.5	3.5	0.0	4.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	4.1	0.1	0.0	1.5	4.1	0.0	0.1	0.0	0.1	0.0	0.0	5.3	0.1	3.9	0.9	2.0	0.0	0.0	0.6	1.1	0.0	0.7	0.2	0.5	0.9	0.1	3.7	0.0	1.5	0.1	2.3	1.0	0.2	1.2	6.0	0.2	0.1	0.3	0.3	1.0	4.6	0.0	0.0	0.1	0.1	0.1	0.1	4.3	1.1	0.1	0.3	0.0	0.2	0.0	0.7	0.0	6.2	0.6	0.2	0.2	0.2	0.2	13.6	14.1	2.9	0.1	83.7	0.3	0.0	0.2	0.0	0.0	2.6	0.1	1.0	1.4	0.0	0.9	0.1	0.5	2.3	0.0	0.0	0.0	0.3	0.0	0.1	2.6	0.1	0.5	0.1	0.4	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.2	4.6	5.4	2.9	5.7	4.5	4.1	4.7	4.0	4.8	4.2	4.1	4.1	5.3	0.3	0.0	0.0	0.3	1.1	0.3	0.3	0.4	0.0	0.5	1.3	4.7	0.5	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.7	0.6	0.1	0.7	0.2	3.0	0.0	1.7	0.6	0.6	1.0	0.5	0.3	0.0	1.7	0.0	0.0	0.3	0.0	3.4	0.3	0.0	0.0	0.0	2.2	1.2	0.1	1.8	0.0	0.0	0.9	0.0	24.6	0.5	0.1	0.0	1.5	0.2	0.6	0.0	0.0	0.0	0.7	6.6	0.0	0.6	6.5	39.5	0.2	0.1	0.3	0.5	1.7	0.0	0.1
KLRG2	"CLEC15B, FLJ44186"	ENSG00000188883	"Killer cell lectin like receptor G2"	A4D1S0	7	139452690-139483673	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 4.0;salivary gland: 4.4;thyroid gland: 4.1"	"Group enriched"	"Detected in some"	4	"Basal squamous epithelial cells: 5.2;Collecting duct cells: 7.3;Squamous epithelial cells: 14.2;Syncytiotrophoblasts: 7.7"	"Cancer enriched"	"Detected in many"	11	"testis cancer: 42.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 14.7;HAP1: 15.7;NTERA-2: 8.2;SCLC-21H: 7.4;SK-BR-3: 31.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA018199	Uncertain		Uncertain	Nucleoplasm		NA	NA			Nucleoplasm		"HPA018199: AB_2133260"	"unprognostic (2.50e-2)"	"unprognostic (3.05e-2)"	"unprognostic (9.82e-2)"	"unprognostic (5.38e-8)"	"unprognostic (2.41e-1)"	"unprognostic (1.97e-2)"	"unprognostic (3.13e-2)"	"prognostic favorable (8.61e-4)"	"unprognostic (2.14e-2)"	"unprognostic (2.92e-1)"	"unprognostic (5.19e-2)"	"unprognostic (8.83e-2)"	"unprognostic (1.10e-3)"	"unprognostic (5.66e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.14e-2)"	"unprognostic (2.34e-2)"	0.1	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	4.0	0.2	0.0	0.0	0.0	0.6	2.3	0.0	3.0	0.0	0.1	0.0	0.0	0.0	0.1	2.8	0.3	0.4	0.1	0.1	0.1	0.0	4.4	0.2	0.0	2.7	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.9	4.1	0.1	0.7	0.1	1.1	0.2	0.0	1.0	0.0	0.0	0.0	0.0	14.7	0.0	0.0	0.1	0.0	2.0	0.0	0.0	4.3	0.0	0.0	2.2	15.7	0.0	0.0	0.0	3.9	0.0	0.6	0.0	0.1	0.0	0.3	0.0	6.6	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	2.8	2.5	0.0	8.2	0.0	0.1	0.0	0.0	0.0	0.5	0.1	7.4	0.4	2.3	31.9	0.0	6.1	7.1	1.5	0.0	0.0	0.1	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.1	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.0	1.3	0.0	0.5	0.8	0.3	5.2	0.0	1.3	1.4	0.5	0.0	0.1	7.3	0.0	1.5	0.0	0.1	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	1.8	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	1.6	0.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.5	1.6	0.0	0.1	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.2	14.2	1.0	7.7	0.0	0.0	0.3	0.5
LGALS16		ENSG00000249861	"Galectin 16"	A8MUM7	19	39655913-39660647	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	16	"placenta: 5.6"	"Cell type enriched"	"Detected in some"	66	"Syncytiotrophoblasts: 1019.7"	"Cancer enriched"	"Detected in single"	11	"testis cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	81	"BEWO: 4.2;SuSa: 11.8"															NA	NA																							0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	5.6	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.2	0.2	0.2	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.9	1.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1019.7	0.0	0.0	0.0	0.0
REC114	"C15orf60, CT147, FLJ27520, FLJ36860, FLJ44083, LOC283677"	ENSG00000183324	"REC114 meiotic recombination protein"	Q7Z4M0	15	73443164-73560013	"Predicted intracellular proteins"	"DNA recombination, Meiosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"testis: 39.5"	"Group enriched"	"Detected in some"	5	"Early spermatids: 184.0;Spermatocytes: 143.4"	"Cancer enriched"	"Detected in single"	11	"testis cancer: 1.3"	"Region enhanced"	"Detected in single"		"cerebellum: 1.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-266/84: 1.0"	"Region enhanced"	"Detected in many"		"olfactory bulb: 6.1"	"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (1.64e-1)"	"unprognostic (1.14e-1)"				"unprognostic (1.12e-1)"	"unprognostic (2.01e-1)"	"unprognostic (4.58e-2)"	"unprognostic (2.97e-1)"	"unprognostic (8.06e-2)"	"unprognostic (2.63e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.53e-7)"	"unprognostic (1.33e-1)"	"unprognostic (7.62e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.74e-1)"	0.0	0.0	0.2	0.0	0.1	0.0	0.0	1.1	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	1.1	0.4	0.1	0.0	0.0	0.1	0.0	0.4	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	184.0	0.1	0.0	0.2	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	25.1	3.1	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.7	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	143.4	29.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SALL4	"dJ1112F19.1, ZNF797"	ENSG00000101115	"Spalt like transcription factor 4"	Q9UJQ4	20	51782331-51802521	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Disease variant, Oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 4.0;thyroid gland: 5.9"	"Cell type enriched"	"Detected in some"	4	"Horizontal cells: 26.9"	"Cancer enriched"	"Detected in many"	11	"testis cancer: 22.7"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	9	"NK-cell: 2.5"	"Lineage enriched"	"Detected in single"	9	"NK-cells: 2.5"	"Cell line enhanced"	"Detected in some"		"AF22: 25.0;AN3-CA: 17.5;BEWO: 33.2;NTERA-2: 60.2;SiHa: 15.6;SuSa: 39.7"	"Not detected"	"Not detected"							"HPA015291, HPA015791"	Enhanced		Enhanced	Nucleoplasm		Yes	No			Nucleoplasm		"HPA015291: AB_1856548, HPA015791: AB_1856547"	"unprognostic (1.30e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.09e-3)"	"unprognostic (3.55e-2)"	"unprognostic (7.43e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.20e-1)"	"unprognostic (9.23e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.39e-2)"	"unprognostic (2.42e-8)"	"unprognostic (5.90e-3)"	"unprognostic (1.82e-1)"	"unprognostic (5.00e-5)"	"unprognostic (7.41e-2)"	0.2	0.3	0.2	0.2	0.2	0.8	0.2	0.3	0.2	0.1	0.2	0.1	0.1	0.2	0.4	0.2	0.2	0.0	0.1	0.2	0.3	0.4	1.6	0.2	0.1	0.2	0.2	0.2	0.1	2.1	2.0	0.5	0.2	0.2	2.5	0.2	0.5	0.9	0.2	0.1	0.2	0.4	0.1	0.1	0.6	0.2	4.0	0.2	0.0	5.9	0.0	0.1	0.4	0.1	0.4	0.0	1.7	25.0	17.5	0.0	0.1	33.2	0.0	0.2	0.1	0.3	9.0	0.2	0.0	0.3	0.3	0.3	4.3	0.2	0.1	0.3	0.4	0.0	0.0	7.0	0.4	0.1	0.0	1.9	0.7	0.5	0.1	0.1	0.0	0.4	0.0	0.0	0.1	0.0	1.8	0.0	0.1	60.2	0.2	0.4	2.3	0.0	0.0	0.0	0.5	5.7	3.1	15.6	0.1	1.5	39.7	0.1	1.0	0.0	0.9	3.3	0.4	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.5	0.0	0.0	0.0	0.0	0.2	0.2	0.3	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.1	0.2	0.4	0.1	0.0	2.0	1.6	0.0	0.0	1.1	0.1	0.0	0.4	0.3	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	3.6	0.0	0.2	0.1	0.2	1.2	0.0	4.1	0.2	0.0	0.4	0.0	0.4	0.0	0.2	0.0	0.6	0.2	26.9	3.5	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	4.7	0.0	0.2	1.0	2.0	2.0	0.2	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.4	0.0	0.2	0.2	0.7	5.5	0.0	0.0	0.0	0.0	0.1	0.0	1.2
TMEM202	FLJ27523	ENSG00000187806	"Transmembrane protein 202"	A6NGA9	15	72398302-72408367	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	124	"testis: 12.4"	"Group enriched"	"Detected in some"	34	"Early spermatids: 67.6;Late spermatids: 58.5;Spermatocytes: 61.2"	"Cancer enriched"	"Detected in single"	11	"testis cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"									NA	NA																				"unprognostic (1.31e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	67.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	58.5	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	61.2	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CETN1	"CEN1, CETN"	ENSG00000177143	"Centrin 1"	Q12798	18	580380-582114	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	1083	"testis: 135.4"	"Group enriched"	"Detected in some"	34	"Early spermatids: 930.9;Late spermatids: 435.6;Spermatocytes: 675.9"	"Cancer enriched"	"Detected in single"	10	"testis cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA001470, HPA028956, CAB037244, HPA069157"	Enhanced		Approved	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA			"Nucleoplasm, Centriolar satellite, Cytosol"		"CAB037244: AB_476871, HPA001470: , HPA028956: AB_10601798, HPA069157: "															"unprognostic (1.51e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	135.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	930.9	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	435.6	12.8	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	19.7	0.0	0.0	675.9	15.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FAM124B	FLJ22746	ENSG00000124019	"Family with sequence similarity 124 member B"	Q9H5Z6	2	224378698-224402107	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 8.6"	"Group enriched"	"Detected in some"	4	"Adipocytes: 13.8;Endothelial cells: 10.8;Erythroid cells: 9.4;granulocytes: 4.5"	"Cancer enriched"	"Detected in many"	10	"testis cancer: 7.3"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"basophil: 29.5;eosinophil: 17.2"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	7	"HUVEC TERT2: 103.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA070240	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			Nucleoplasm	Mitochondria	"HPA070240: AB_2686238"	"unprognostic (2.01e-1)"	"unprognostic (1.83e-1)"	"unprognostic (6.87e-3)"	"unprognostic (2.49e-1)"	"unprognostic (7.10e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.28e-2)"	"unprognostic (5.78e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.36e-1)"	"unprognostic (7.61e-3)"	"unprognostic (1.36e-2)"	"unprognostic (4.30e-1)"	"unprognostic (2.25e-1)"	"unprognostic (5.80e-3)"	4.2	0.5	1.6	1.1	1.2	4.8	4.4	1.3	1.7	1.5	1.0	0.9	1.0	1.6	0.3	1.4	1.2	1.2	1.5	1.2	1.5	0.4	1.9	2.3	0.7	1.5	1.8	0.9	0.4	0.4	2.5	0.2	8.6	1.3	0.5	1.1	0.2	0.9	0.5	1.2	1.8	1.0	2.4	1.4	0.6	0.6	0.3	1.5	1.1	1.0	4.6	0.7	1.5	1.4	2.2	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	5.5	0.1	0.0	0.0	0.0	15.0	0.0	0.1	0.0	0.0	0.0	103.4	0.0	4.8	0.2	0.0	0.1	0.0	0.1	6.1	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.7	7.5	0.2	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	29.5	3.0	17.2	0.2	2.3	0.0	0.0	0.7	0.0	7.9	0.0	0.0	0.0	0.1	5.4	0.8	0.0	2.5	1.1	1.6	1.2	1.3	1.7	1.2	1.5	1.5	1.8	0.9	1.3	1.4	1.5	2.2	13.8	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.3	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.4	0.7	0.0	0.0	0.0	1.2	0.3	0.2	10.8	0.0	9.4	0.2	0.0	0.1	0.4	0.0	0.8	4.5	0.0	2.2	0.4	0.4	0.0	0.2	0.0	0.0	0.9	0.6	0.0	0.0	0.7	0.0	1.0	0.5	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.3	0.0	0.1	0.1	0.0	0.1	1.1	0.1	0.0	0.0
GDPD4	GDE6	ENSG00000178795	"Glycerophosphodiester phosphodiesterase domain containing 4"	Q6W3E5	11	77216558-77301687	"Predicted membrane proteins"		Hydrolase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"retina: 1.5;testis: 3.7"	"Group enriched"	"Detected in some"	9	"Early spermatids: 10.9;Late spermatids: 18.0;Spermatocytes: 17.7;Spermatogonia: 5.3;Theca cells: 5.6"	"Cancer enriched"	"Detected in single"	10	"testis cancer: 1.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	23	"olfactory bulb: 2.3"											NA	NA						"unprognostic (6.73e-6)"	"unprognostic (3.30e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.12e-1)"	"unprognostic (3.55e-4)"	"unprognostic (4.13e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.63e-2)"	"unprognostic (3.10e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.05e-4)"	"unprognostic (1.68e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.64e-2)"	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.1	0.2	0.2	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	3.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.2	0.1	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.0	0.8	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.5	0.0	0.0	0.0	0.0	18.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	17.7	5.3	0.0	0.0	0.3	0.0	5.6	0.0	0.0
LELP1		ENSG00000203784	"Late cornified envelope like proline rich 1"	Q5T871	1	153203430-153205120	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	1197	"testis: 1126.4"	"Cell type enriched"	"Detected in some"	5	"Late spermatids: 21424.4"	"Cancer enriched"	"Detected in single"	10	"testis cancer: 0.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA070231	Enhanced					NA	NA					"HPA070231: AB_2686237"															"unprognostic (1.77e-1)"			0.1	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.1	0.1	0.4	0.3	0.3	0.0	0.0	0.1	0.1	1126.4	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3645.9	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21424.4	88.9	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	89.1	0.0	0.0	0.0	0.0	0.0	0.0	46.0	0.0	0.0	105.5	54.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NODAL		ENSG00000156574	"Nodal growth differentiation factor"	Q96S42	10	70431936-70447951	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"		"Cytokine, Developmental protein, Growth factor"	"Disease variant, Heterotaxy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 2.3;skeletal muscle: 2.3;testis: 1.9"	"Group enriched"	"Detected in some"	26	"Early spermatids: 15.4;Late spermatids: 38.5"	"Cancer enriched"	"Detected in some"	10	"testis cancer: 20.8"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 1.9;SH-SY5Y: 1.4;SuSa: 3.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA045201	Uncertain				"Secreted to blood"	NA	NA					"HPA045201: AB_2679252"	"unprognostic (3.07e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.51e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.70e-1)"	"unprognostic (4.57e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.65e-1)"	"unprognostic (5.66e-3)"	"unprognostic (3.12e-2)"	"unprognostic (8.77e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.63e-5)"	"unprognostic (4.37e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.02e-1)"	0.5	0.0	0.6	0.0	0.5	0.6	0.5	2.3	0.5	0.4	0.0	0.3	0.2	0.3	0.0	0.3	0.3	0.2	0.2	0.4	0.5	0.1	0.1	0.4	0.2	0.6	0.8	0.3	0.3	0.1	0.0	0.1	0.2	1.1	0.2	0.0	1.3	0.2	0.0	2.3	1.0	0.2	0.0	0.5	0.2	0.2	1.9	0.5	0.2	0.1	0.0	0.0	0.4	0.4	0.5	0.3	0.2	0.8	0.9	0.0	0.0	0.1	0.0	0.0	0.1	0.0	1.9	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.5	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.0	0.2	0.1	0.2	0.5	0.2	0.0	0.2	0.2	0.5	0.0	0.1	0.1	1.4	0.4	0.1	0.0	3.5	0.4	0.1	0.0	0.0	0.2	0.1	0.1	0.5	1.1	1.2	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.5	2.3	0.5	0.4	0.5	0.6	0.8	0.3	1.1	0.5	0.5	0.5	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	15.4	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	38.5	0.9	0.0	0.0	1.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0
SPATA22	NYD-SP20	ENSG00000141255	"Spermatogenesis associated 22"	Q8NHS9	17	3440019-3513852	"Predicted intracellular proteins"	Meiosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	53	"testis: 232.3"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 293.3;Late spermatids: 207.8;Spermatocytes: 1047.6"	"Cancer enriched"	"Detected in single"	10	"testis cancer: 3.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"K-562: 7.7;TIME: 10.9"	"Not detected"	"Not detected"													NA	NA						"unprognostic (4.09e-2)"				"unprognostic (9.31e-2)"	"unprognostic (2.54e-2)"		"unprognostic (7.07e-2)"	"unprognostic (9.05e-2)"		"unprognostic (1.98e-2)"		"unprognostic (6.79e-4)"	"unprognostic (4.33e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.27e-1)"		1.1	0.6	0.7	0.2	1.3	0.1	1.1	0.7	1.1	0.5	0.0	0.2	0.2	0.4	0.2	0.3	0.5	0.1	0.4	0.7	0.7	0.4	0.2	0.3	0.3	1.4	1.2	0.6	0.2	0.2	2.8	0.2	3.6	1.1	0.3	0.0	0.2	0.2	0.1	0.6	0.1	0.3	0.2	0.6	0.6	0.2	232.3	2.2	0.2	0.2	0.3	0.0	0.3	0.2	4.3	0.0	0.0	0.1	0.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	10.9	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.2	0.1	0.2	0.0	0.1	0.7	1.3	0.7	1.1	0.7	0.7	1.4	1.2	0.6	1.1	0.6	2.2	4.3	0.3	0.0	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	1.6	0.0	0.0	0.0	0.0	3.7	0.2	0.0	0.0	0.0	293.3	0.1	0.2	0.7	0.0	0.0	4.5	0.0	17.3	0.7	0.0	0.1	0.0	0.1	0.0	0.1	1.1	0.0	1.2	0.1	0.0	0.6	0.3	207.8	14.3	0.9	0.0	0.0	0.0	0.0	0.0	1.5	45.8	0.0	0.0	8.6	0.0	0.0	0.0	0.2	0.0	0.0	13.1	0.9	0.4	1047.6	58.8	0.0	0.1	1.2	0.1	0.2	0.0	0.0
ZFP57	"bA145L22, bA145L22.2, C6orf40, ZNF698"	ENSG00000204644	"ZFP57 zinc finger protein"	Q9NU63	6	29672483-29681155	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"heart muscle: 9.0"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 4.8;Erythroid cells: 4.6;Extravillous trophoblasts: 4.4;Ionocytes: 8.2;Late spermatids: 5.9;Pancreatic endocrine cells: 4.0;Spermatogonia: 3.6"	"Cancer enriched"	"Detected in many"	10	"testis cancer: 18.1"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in many"	5	"basophil: 11.1"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 11.1"	"Group enriched"	"Detected in some"	13	"BEWO: 40.3;SuSa: 12.8"	"Low region specificity"	"Detected in all"													NA	NA						"unprognostic (1.35e-1)"	"unprognostic (1.74e-1)"	"unprognostic (5.02e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.58e-1)"	"unprognostic (4.72e-3)"	"unprognostic (4.65e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.19e-4)"	"prognostic favorable (1.95e-4)"	"unprognostic (1.33e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.29e-2)"	"unprognostic (8.56e-2)"	"unprognostic (7.45e-2)"	"unprognostic (6.11e-2)"	0.3	0.3	0.1	0.0	0.3	1.9	1.6	0.2	0.3	0.1	0.0	0.1	0.0	0.2	0.0	0.3	0.4	0.2	9.0	0.0	0.1	0.2	0.0	0.6	0.9	0.5	0.2	0.0	0.0	0.0	0.0	0.1	1.5	0.3	0.5	0.2	0.0	0.7	2.2	0.0	0.7	0.4	0.2	0.2	1.0	0.0	0.7	0.2	0.3	0.1	0.0	0.0	0.1	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	40.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	11.1	1.4	0.0	1.7	0.9	0.7	0.8	1.0	1.1	2.1	0.2	0.3	1.0	0.0	1.3	0.3	0.1	1.5	1.2	0.1	0.3	0.2	0.3	0.0	0.1	0.5	0.2	0.0	0.3	0.2	0.2	0.8	1.1	0.0	0.6	0.0	0.7	0.3	0.2	0.4	2.8	0.0	0.6	1.8	4.8	0.0	0.2	0.0	0.0	0.2	0.7	0.0	0.0	0.9	2.1	0.0	0.0	0.1	0.0	4.6	0.0	1.1	4.4	0.6	1.1	0.0	2.5	2.0	0.0	0.0	1.2	0.0	0.1	0.0	8.2	0.0	1.3	5.9	0.0	1.3	0.0	0.0	0.6	0.0	0.0	0.0	2.1	4.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.8	3.6	0.3	0.1	0.3	1.7	0.2	0.1	0.1
DMRT1	"CT154, DMT1"	ENSG00000137090	"Doublesex and mab-3 related transcription factor 1"	Q9Y5R6	9	841690-969090	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Sexual differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	95	"testis: 27.1"	"Group enriched"	"Detected in some"	5	"Early spermatids: 44.0;Spermatogonia: 153.2"	"Cancer enriched"	"Detected in some"	9	"testis cancer: 5.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SCLC-21H: 3.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA027850	Enhanced					NA	NA					"HPA027850: AB_10600868"	"unprognostic (3.23e-1)"	"unprognostic (1.91e-1)"		"unprognostic (9.75e-4)"	"unprognostic (1.34e-1)"	"unprognostic (2.50e-1)"		"unprognostic (3.08e-1)"		"unprognostic (1.45e-1)"			"unprognostic (1.78e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.60e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.02e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.0	0.1	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	2.0	0.0	0.0	17.0	3.4	0.1	0.0	0.0	0.0	0.0	0.0	2.0	0.7	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	4.9	153.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FKBP6	"FKBP36, PPIase"	ENSG00000077800	"FKBP prolyl isomerase 6"	O75344	7	73328161-73358637	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis"		"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	221	"testis: 58.9"	"Group enriched"	"Detected in some"	6	"Early spermatids: 68.5;Late spermatids: 92.4;Spermatocytes: 142.0;Spermatogonia: 37.2"	"Cancer enriched"	"Detected in single"	9	"testis cancer: 0.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA061109, HPA077010"	Enhanced		Approved	Cytosol		NA	NA			Cytosol		"HPA061109: AB_2684430, HPA077010: "	"unprognostic (5.07e-2)"	"unprognostic (3.34e-2)"		"unprognostic (1.56e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.98e-2)"	"unprognostic (8.72e-3)"	"unprognostic (4.34e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.60e-1)"	"unprognostic (4.29e-2)"	"unprognostic (1.48e-1)"	"unprognostic (6.20e-2)"	"unprognostic (9.15e-2)"	"unprognostic (2.47e-1)"	"unprognostic (6.86e-2)"	0.0	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	58.9	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.2	0.0	0.5	0.0	0.0	0.1	0.2	0.6	0.0	0.6	0.0	0.3	0.5	1.5	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.2	68.5	5.2	0.3	0.2	0.0	0.0	0.3	0.2	0.0	0.2	0.0	1.0	0.0	0.2	0.4	0.2	0.3	0.0	0.3	0.0	2.0	1.3	0.0	92.4	3.1	0.3	0.0	0.0	0.0	0.5	0.0	0.0	1.1	0.2	0.0	1.2	0.0	0.0	0.0	0.1	12.6	0.5	0.0	0.3	0.1	142.0	37.2	0.0	0.0	0.1	0.1	0.0	0.0	0.2
GUCA1A	"C6orf131, COD3, CORD14, dJ139D8.6, GCAP, GCAP1, GUCA, GUCA1"	ENSG00000048545	"Guanylate cyclase activator 1A"	P43080	6	42155406-42181338	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Sensory transduction, Vision"		"Cone-rod dystrophy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	91	"retina: 811.8"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 667.2;Late spermatids: 432.4;Muller glia cells: 219.9;Rod photoreceptor cells: 1191.6"	"Cancer enriched"	"Detected in single"	9	"testis cancer: 3.5"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	10	"plasmacytoid DC: 4.9"	"Lineage enriched"	"Detected in single"	10	"dendritic cells: 4.9"	"Group enriched"	"Detected in some"	8	"NTERA-2: 3.8;SH-SY5Y: 4.5"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA005561, HPA075056"	Enhanced		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA005561: AB_2667361, HPA075056: "	"unprognostic (1.91e-2)"	"unprognostic (3.92e-3)"	"unprognostic (2.49e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.04e-4)"	"unprognostic (9.70e-2)"		"unprognostic (6.71e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.08e-3)"	"unprognostic (2.79e-1)"		"unprognostic (1.51e-1)"	"unprognostic (1.54e-1)"		"unprognostic (1.16e-1)"	0.0	0.0	1.5	0.1	3.3	0.1	0.0	0.7	1.6	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	3.9	0.0	0.0	0.0	0.1	1.3	1.6	1.4	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	811.8	0.0	0.0	0.1	0.1	0.1	0.1	0.6	0.0	0.0	8.9	4.4	0.0	0.0	0.0	0.2	0.0	0.1	1.1	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.5	0.0	0.0	4.9	0.0	0.0	1.5	3.3	0.7	1.6	1.2	3.9	1.3	1.6	1.4	1.0	0.6	4.4	1.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	140.7	0.0	0.0	0.3	0.0	0.0	0.0	667.2	0.6	1.3	0.0	0.0	0.0	106.5	0.0	0.0	8.2	0.0	0.0	0.3	0.0	0.3	0.9	0.0	0.0	0.0	0.5	0.0	0.0	0.2	65.6	1.0	0.0	4.1	0.0	0.0	432.4	1.8	0.1	0.0	0.0	5.2	219.9	0.0	0.0	0.1	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.1	1191.6	0.0	0.0	1.2	3.2	3.9	0.0	0.0	0.3	0.0	0.1	0.0	0.1
KHDC1L	RP11-257K9.7	ENSG00000256980	"KH domain containing 1 like"	Q5JSQ8	6	73223544-73225770	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"brain: 2.0;testis: 5.6"	"Group enriched"	"Detected in some"	10	"Early spermatids: 31.8;Late spermatids: 96.9"	"Cancer enriched"	"Detected in some"	9	"testis cancer: 33.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"BEWO: 51.5"															NA	NA						"unprognostic (1.18e-1)"	"unprognostic (6.11e-5)"		"unprognostic (3.06e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.07e-2)"		"unprognostic (9.32e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.01e-2)"		"unprognostic (1.31e-2)"	"unprognostic (4.13e-1)"	"unprognostic (6.63e-2)"	"unprognostic (3.17e-3)"	0.0	0.0	1.4	0.0	2.0	0.2	0.0	1.6	1.7	0.1	1.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	1.1	1.2	0.0	0.0	0.6	0.0	1.2	1.1	1.1	0.2	0.1	0.1	1.5	0.5	1.2	0.2	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.1	5.6	1.2	0.4	0.1	0.0	0.4	0.1	0.1	1.3	10.7	0.2	0.0	0.4	0.0	0.0	51.5	0.2	0.3	0.3	0.2	0.4	0.2	0.4	0.4	0.0	0.0	0.1	0.2	0.1	0.1	0.2	0.0	0.1	0.1	0.0	0.1	0.3	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.3	0.2	0.2	0.5	0.0	0.1	0.1	0.0	3.4	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.8	0.0	0.3	0.0	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	2.0	1.6	1.7	1.1	1.2	1.2	1.1	1.1	1.2	1.1	1.2	1.3	0.0	0.0	0.0	1.0	0.4	0.0	0.0	0.2	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	31.8	0.1	0.0	0.0	0.0	0.0	0.3	0.4	1.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	96.9	0.3	0.2	0.0	0.0	0.6	0.1	0.0	1.0	0.2	0.3	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.3	5.9	0.0	0.0	0.1	0.0	0.2	0.1	0.1
LRRC4B	"DKFZp761A179, HSM, LRIG4"	ENSG00000131409	"Leucine rich repeat containing 4B"	Q9NT99	19	50516892-50568435	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 56.2;cervix: 36.9;pituitary gland: 32.2"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 34.9;Bipolar cells: 19.6;Excitatory neurons: 32.1;Inhibitory neurons: 38.5;Oligodendrocyte precursor cells: 29.7;Oligodendrocytes: 48.9"	"Group enriched"	"Detected in many"	9	"glioma: 36.5;testis cancer: 9.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 8.7;HMC-1: 32.1;REH: 8.7;SH-SY5Y: 27.5;U-2 OS: 25.3;WM-115: 10.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058986	Uncertain					NA	NA		2700000			"HPA058986: AB_2683871"	"unprognostic (1.52e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.46e-2)"	"unprognostic (4.48e-2)"	"unprognostic (3.56e-1)"	"unprognostic (5.39e-4)"	"unprognostic (2.70e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.28e-2)"	"unprognostic (4.61e-3)"	"unprognostic (1.11e-3)"	"unprognostic (3.41e-1)"	"unprognostic (3.15e-5)"	"unprognostic (4.29e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.64e-1)"	"unprognostic (2.17e-1)"	2.6	5.3	48.8	0.9	28.8	0.0	2.1	15.0	56.2	36.9	0.0	2.8	0.8	16.3	0.1	1.9	10.1	1.2	1.7	42.8	20.6	1.2	1.3	5.9	1.3	45.6	43.4	39.1	5.1	0.8	0.2	32.2	4.2	38.8	3.4	0.1	1.6	0.8	1.0	0.7	1.2	3.3	1.3	10.6	0.8	2.9	2.4	31.0	0.0	2.6	0.1	0.5	5.9	13.1	32.6	0.0	0.5	2.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	4.9	0.0	0.7	0.1	0.1	0.0	0.0	0.3	8.7	0.0	0.0	0.0	0.0	0.1	32.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.1	0.5	0.0	1.0	0.1	0.0	8.2	0.0	0.0	8.7	0.0	0.1	0.0	0.0	0.0	27.5	0.0	0.0	5.7	0.2	0.0	0.3	0.0	0.0	25.3	0.0	0.0	0.6	0.1	0.1	0.1	0.3	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	48.8	28.8	15.0	56.2	42.8	20.6	45.6	43.4	39.1	38.8	10.6	31.0	32.6	0.7	0.0	0.0	34.9	0.0	0.0	0.0	0.0	0.0	19.6	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	2.5	0.9	0.0	0.0	32.1	0.0	0.0	1.3	0.0	0.1	0.0	0.2	0.7	0.0	0.1	10.1	38.5	0.0	0.0	0.0	0.3	2.2	2.8	0.0	0.0	2.8	0.0	1.6	0.0	29.7	48.9	0.0	0.0	4.5	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.1	5.8	4.8	8.1	0.2	0.0	0.1	0.1	0.1	0.0	0.0
LUZP4	"CT-8, CT28, HOM-TES-85"	ENSG00000102021	"Leucine zipper protein 4"	Q9P127	X	115289715-115307563	"Predicted intracellular proteins"	"mRNA transport, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	83	"testis: 8.2"	"Cell type enriched"	"Detected in some"	4	"Spermatogonia: 35.2"	"Cancer enriched"	"Detected in some"	9	"testis cancer: 13.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA046436, HPA051999"	Enhanced					NA	NA					"HPA046436: AB_10964168, HPA051999: AB_2681688"															"unprognostic (1.84e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	35.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MAGEB1	"CT3.1, DAM10, MAGE-Xp, MAGEL1, MGC9322"	ENSG00000214107	"MAGE family member B1"	P43366	X	30243730-30252040	"Predicted intracellular proteins"		"Tumor antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	29	"testis: 15.6"	"Group enriched"	"Detected in some"	9	"Spermatocytes: 14.2;Spermatogonia: 14.6"	"Cancer enriched"	"Detected in some"	9	"testis cancer: 7.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	70	"K-562: 25.1;U-266/70: 53.8;U-266/84: 40.5"									"HPA001193, HPA002820"	Enhanced					NA	NA					"HPA001193: AB_1079296, HPA002820: AB_1079295"															"unprognostic (1.26e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	53.8	40.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.2	14.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MIXL1	"MILD1, MIXL"	ENSG00000185155	"Mix paired-like homeobox"	Q9H2W2	1	226223618-226227060	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 3.4"	"Cell type enriched"	"Detected in some"	5	"Plasma cells: 18.5"	"Cancer enriched"	"Detected in some"	9	"testis cancer: 6.3"	"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HAP1: 1.7;Hep G2: 9.0;SuSa: 1.9;U-698: 2.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA005662			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA005662: AB_2667382"	"unprognostic (4.09e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.00e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.18e-2)"	"unprognostic (5.66e-2)"	"unprognostic (5.05e-2)"	"unprognostic (7.40e-3)"	"unprognostic (2.78e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.71e-13)"	"unprognostic (1.54e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.67e-1)"	"unprognostic (8.47e-2)"	0.0	0.1	0.2	1.0	0.2	0.2	0.2	1.1	0.3	0.1	0.2	0.7	1.3	0.2	0.1	0.0	0.0	0.2	0.2	0.2	0.2	0.0	0.1	0.2	2.4	0.2	0.2	0.2	0.2	0.1	0.6	0.0	0.2	0.5	0.1	0.6	0.1	0.2	0.2	0.1	0.2	0.7	0.1	0.1	1.0	0.8	0.4	0.2	0.2	0.1	0.0	3.4	0.6	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.0	0.0	1.7	0.0	0.1	0.0	0.1	0.1	0.2	9.0	0.4	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.1	1.2	0.0	0.1	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	1.9	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.2	0.0	2.4	0.0	0.0	0.0	49.7	6.5	13.0	6.4	10.0	12.6	11.3	7.3	7.3	7.2	10.4	9.6	9.7	18.2	19.6	19.5	11.0	10.3	6.2	0.2	0.2	1.1	0.3	0.2	0.2	0.2	0.2	0.2	0.5	0.1	0.2	0.6	0.6	0.0	0.0	0.0	3.2	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.0	0.3	0.2	0.1	1.1	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.3	0.0	1.8	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	18.5	0.1	0.1	0.1	0.0	0.5	0.0	0.3	0.1	0.1	1.5	0.0	0.0	0.3	0.1	0.1	0.0	0.1
MPC1L	SLC54A3	ENSG00000238205	"Mitochondrial pyruvate carrier 1 like"	P0DKB6	X	40623566-40624136	"Metabolic proteins, Predicted membrane proteins"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	68	"testis: 18.5"	"Cell type enriched"	"Detected in single"	5	"Endometrial ciliated cells: 1.2"	"Cancer enriched"	"Detected in single"	9	"testis cancer: 3.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"									NA	NA																		"unprognostic (8.47e-4)"		"unprognostic (1.00e-1)"			0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	18.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TDRD12	"ECAT8, FLJ13072"	ENSG00000173809	"Tudor domain containing 12"	Q587J7	19	32719753-32829580	"Enzymes, Predicted intracellular proteins"	"Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis"	"Developmental protein, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"epididymis: 7.4;testis: 16.9"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 24.0;Late spermatids: 12.0;Spermatocytes: 65.0;Spermatogonia: 43.5"	"Cancer enriched"	"Detected in many"	9	"testis cancer: 10.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	30	"HDLM-2: 25.5;NTERA-2: 81.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (5.43e-2)"	"unprognostic (3.97e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.87e-7)"	"unprognostic (5.44e-2)"	"unprognostic (1.78e-1)"	"unprognostic (6.79e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.40e-1)"	"unprognostic (9.69e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.43e-4)"	"unprognostic (2.09e-1)"	"unprognostic (4.75e-2)"	"unprognostic (3.08e-2)"	"unprognostic (2.69e-2)"	0.2	0.8	0.2	0.1	0.2	0.1	0.2	0.2	0.3	0.7	0.0	0.1	0.0	1.1	7.4	0.3	0.8	0.1	0.1	0.2	0.5	0.1	0.0	0.1	0.2	0.5	0.2	0.0	1.6	0.0	0.0	0.1	0.0	0.2	0.2	0.1	0.4	0.1	0.3	0.1	1.7	1.3	0.1	0.1	0.3	0.1	16.9	0.6	0.5	0.5	0.0	0.2	0.2	0.2	0.2	0.0	1.1	0.2	1.3	0.1	0.1	1.7	0.2	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.3	0.0	25.5	0.2	0.0	0.0	0.3	0.0	0.0	0.1	0.5	0.5	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.1	0.3	0.1	0.0	81.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.3	0.1	0.0	0.0	0.4	0.1	0.3	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.3	0.2	0.5	0.5	0.2	0.0	0.2	0.1	0.6	0.2	0.3	0.0	0.0	1.3	0.0	0.0	0.4	0.0	0.0	0.4	0.6	0.3	0.9	0.0	0.0	1.8	0.0	0.4	0.2	0.1	0.0	0.0	24.0	0.3	1.2	0.4	0.0	0.0	2.2	0.0	1.3	0.2	0.0	1.1	0.0	0.2	0.4	0.0	0.1	0.0	2.1	0.1	0.0	0.0	0.3	12.0	2.1	0.1	0.0	1.0	0.0	0.2	0.0	0.0	1.4	0.1	0.2	1.5	0.1	0.1	0.1	0.2	0.0	0.2	0.0	0.4	0.3	65.0	43.5	0.0	0.1	0.3	0.2	2.9	0.4	0.2
TSPY1	"CT78, TSPY"	ENSG00000258992	"Testis specific protein Y-linked 1"	Q01534	Y	9466955-9469749	"Disease related genes, Predicted intracellular proteins"	"Differentiation, Gonadal differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	75	"testis: 7.4"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	9	"testis cancer: 1.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	366	"U-266/70: 248.7;U-266/84: 249.2"									"HPA049384, HPA067289"	Supported		Approved	Cytosol		NA	NA			Cytosol		"HPA049384: AB_2680738, HPA067289: "															"unprognostic (2.91e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	248.7	249.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TUBB4A	"beta-5, DYT4, TUBB4"	ENSG00000104833	"Tubulin beta 4A class IVa"	P04350	19	6494319-6502848	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, Dystonia, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"adrenal gland: 205.0;brain: 805.8"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 22.2;Muller glia cells: 33.0;Oligodendrocytes: 94.1;Theca cells: 81.7"	"Group enriched"	"Detected in many"	9	"glioma: 50.1;melanoma: 83.2;testis cancer: 49.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	13	"B-cells: 3.8;T-cells: 5.4"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 100.7;HAP1: 58.3;HEL: 91.7;PC-3: 49.6;REH: 43.4;SH-SY5Y: 36.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010768, HPA043640, HPA046280"	Approved		Supported	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	NA		110000000	Microtubules	"Cytokinetic bridge, Mitotic spindle"	"CAB010768: AB_261775, HPA043640: AB_2678594, HPA046280: AB_2679612"	"unprognostic (4.05e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.72e-1)"	"prognostic unfavorable (8.42e-7)"	"unprognostic (3.07e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.11e-1)"	"unprognostic (8.08e-2)"	"unprognostic (6.69e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.12e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.30e-1)"	0.9	205.0	165.6	1.7	350.9	0.2	0.7	442.1	461.6	0.6	0.0	5.2	1.2	0.6	0.3	0.7	0.9	0.6	2.4	248.6	342.6	2.2	1.2	0.6	1.1	415.2	353.9	232.6	1.5	3.0	0.6	4.0	0.7	495.6	0.8	0.8	22.8	1.2	0.4	4.4	5.3	3.0	0.8	261.5	9.6	2.2	76.6	361.0	0.3	0.6	1.0	0.7	0.6	1.8	805.8	0.2	28.3	0.1	100.7	0.2	0.0	0.2	0.7	0.0	0.1	0.0	1.4	0.4	0.1	30.3	0.0	3.5	0.7	58.3	0.0	0.6	0.0	10.7	91.7	1.9	0.9	0.0	0.0	5.5	0.0	0.0	2.3	0.0	1.0	0.0	17.1	8.6	0.8	0.0	3.0	18.1	4.1	7.5	0.0	49.6	43.4	0.1	20.3	10.9	0.1	0.2	36.6	0.3	0.2	30.9	2.7	0.8	1.9	0.0	0.2	12.2	0.1	0.4	2.4	1.7	11.7	1.1	0.1	0.5	0.0	0.0	0.0	5.4	0.0	3.3	3.8	0.7	5.0	0.0	1.1	1.6	3.8	0.1	0.3	0.0	0.0	0.0	1.4	165.6	350.9	442.1	461.6	248.6	342.6	415.2	353.9	232.6	495.6	261.5	361.0	805.8	0.1	0.0	0.0	6.8	3.2	1.9	0.7	0.3	0.0	2.8	0.1	0.1	9.8	1.5	0.0	0.0	0.0	0.2	1.6	0.1	5.9	1.6	2.9	0.1	0.2	1.2	0.0	2.1	22.2	0.0	0.2	1.8	0.0	0.1	0.0	16.3	1.4	0.3	0.4	10.1	15.0	0.0	0.0	0.0	1.2	9.4	5.3	0.3	14.2	13.1	0.0	33.0	1.0	8.5	94.1	0.1	0.0	0.4	0.9	0.2	0.0	1.8	0.5	2.3	6.6	0.4	4.6	1.9	1.1	0.0	1.6	0.1	3.8	81.7	0.0	0.2
ZNF99	"C19orf9, MGC24986"	ENSG00000213973	"Zinc finger protein 99"	A8MXY4	19	22752183-22784151	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"testis: 1.6"	"Cell type enhanced"	"Detected in some"		"Oligodendrocyte precursor cells: 5.0;Sertoli cells: 19.7;Spermatocytes: 19.5;Spermatogonia: 8.5"	"Cancer enriched"	"Detected in single"	9	"testis cancer: 1.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA						"unprognostic (8.31e-2)"	"unprognostic (2.77e-1)"	"unprognostic (4.19e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.96e-2)"	"unprognostic (2.28e-1)"	"unprognostic (9.83e-2)"	"unprognostic (4.22e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.92e-3)"	"unprognostic (2.61e-1)"	"unprognostic (8.92e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.39e-2)"	"unprognostic (3.49e-1)"	"unprognostic (4.05e-3)"	"unprognostic (8.55e-2)"	0.1	0.0	0.2	0.0	0.2	0.1	0.2	0.1	0.3	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.2	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	1.6	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.5	0.1	0.1	0.2	0.0	0.0	0.2	0.2	0.1	0.3	0.2	0.1	0.2	0.2	0.1	0.2	0.0	0.2	0.4	0.4	0.0	0.0	2.0	0.0	0.0	0.1	0.0	0.0	0.9	0.4	0.4	1.6	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.9	0.0	1.1	0.1	1.1	0.4	0.0	0.0	1.2	0.0	0.3	0.7	0.0	0.0	0.0	4.0	0.7	0.2	0.2	0.0	0.4	0.0	0.0	0.0	0.0	1.2	0.3	0.0	0.0	0.0	0.0	0.2	0.0	5.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	19.7	0.4	0.6	19.5	8.5	0.0	0.0	0.3	0.1	0.4	0.0	0.2
C4orf51		ENSG00000237136	"Chromosome 4 open reading frame 51"	C9J302	4	145680146-145771032	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	14	"testis: 5.8"	"Cell type enriched"	"Detected in some"	9	"Early spermatids: 82.7"	"Cancer enriched"	"Detected in single"	8	"testis cancer: 1.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.37e-2)"	"unprognostic (1.44e-1)"		"unprognostic (1.03e-1)"	"unprognostic (1.93e-2)"	"unprognostic (4.37e-1)"		"unprognostic (1.32e-1)"		"unprognostic (2.19e-3)"	"unprognostic (8.13e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.97e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.98e-1)"	"unprognostic (6.07e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	82.7	0.9	0.0	0.1	0.0	0.0	2.5	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	9.1	1.5	0.0	0.0	1.9	0.0	0.0	0.0	2.5	2.6	0.0	0.0	0.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	3.8	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CCKBR		ENSG00000110148	"Cholecystokinin B receptor"	P32239	11	6259806-6272127	"Cancer-related genes, FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	21	"brain: 14.3;pancreas: 27.3;stomach 1: 42.3"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 14.6;Gastric mucus-secreting cells: 14.3;Granulosa cells: 23.3"	"Cancer enriched"	"Detected in some"	8	"testis cancer: 9.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"NTERA-2: 73.4"	"Low region specificity"	"Detected in many"													NA	NA						"unprognostic (2.82e-1)"			"unprognostic (4.62e-2)"	"unprognostic (1.79e-3)"	"unprognostic (2.19e-1)"		"unprognostic (1.95e-1)"	"unprognostic (6.34e-4)"	"unprognostic (8.01e-2)"	"unprognostic (3.01e-2)"	"unprognostic (9.00e-2)"	"unprognostic (3.30e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.30e-2)"		0.0	0.2	8.2	0.0	13.0	0.0	0.0	6.9	14.3	0.0	1.3	0.2	0.3	0.3	0.0	0.0	0.3	0.0	0.0	11.4	5.4	0.0	0.0	0.0	0.0	4.9	3.2	12.7	0.1	27.3	0.0	0.9	0.0	6.0	0.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.9	0.0	42.3	0.5	3.2	0.0	0.2	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	73.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	13.0	6.9	14.3	11.4	5.4	4.9	3.2	12.7	6.0	1.9	3.2	8.1	0.0	0.0	0.0	0.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	14.6	1.3	0.0	0.2	14.3	0.1	0.0	23.3	0.0	0.0	0.1	0.0	4.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.5	0.7	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.7	1.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0
COX8C	COX8-3	ENSG00000187581	"Cytochrome c oxidase subunit 8C"	Q7Z4L0	14	93347182-93348356	"Metabolic proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	49	"testis: 76.8"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 865.6;Late spermatids: 1864.6;Spermatocytes: 424.3"	"Group enriched"	"Detected in some"	8	"ovarian cancer: 2.9;testis cancer: 6.7"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	14	"U-937: 27.4"	"Low region specificity"	"Detected in many"							HPA003127	Approved					NA	NA					"HPA003127: AB_1078560"	"unprognostic (1.29e-1)"	"unprognostic (1.19e-1)"		"unprognostic (1.47e-1)"	"unprognostic (3.76e-3)"			"unprognostic (2.11e-1)"		"unprognostic (2.77e-2)"	"unprognostic (7.71e-2)"	"unprognostic (3.83e-1)"	"unprognostic (1.99e-2)"	"unprognostic (8.28e-2)"	"unprognostic (6.33e-2)"	"unprognostic (2.64e-2)"	"unprognostic (9.15e-2)"	0.0	0.0	0.4	0.0	0.5	0.0	0.0	0.6	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.2	0.4	0.1	0.1	0.0	0.0	0.6	0.4	0.3	0.1	0.1	0.0	0.2	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	76.8	0.4	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.6	0.7	0.2	0.4	0.6	0.4	0.3	0.7	0.1	0.4	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.1	1.6	0.0	0.1	0.0	0.0	5.2	0.0	0.0	0.0	0.0	865.6	1.2	0.0	0.8	0.0	0.0	0.0	0.0	14.3	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1864.6	11.8	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.1	0.0	0.3	1.2	0.0	19.7	0.0	0.1	424.3	124.5	0.0	0.1	3.4	0.0	0.1	0.0	0.1
CSH1	"CSA, CSMT, FLJ75407, hCS-A, PL"	ENSG00000136488	"Chorionic somatomammotropin hormone 1"	P0DML2	17	63894909-63896661	"Predicted intracellular proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	247	"placenta: 9877.3"	"Group enriched"	"Detected in some"	24	"Extravillous trophoblasts: 542.0;Syncytiotrophoblasts: 1092.3"	"Cancer enriched"	"Detected in single"	8	"testis cancer: 2.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"BEWO: 11.8;SuSa: 17.0"									"CAB026374, HPA043715"	Enhanced				"Secreted to blood"	NA	NA					"CAB026374: , HPA043715: AB_2678632"															"unprognostic (6.99e-2)"			0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	6.7	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	10.8	0.0	0.0	0.0	0.0	0.7	4.0	0.0	0.2	9877.3	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	39.9	0.0	26.3	20.1	0.1	0.0	0.8	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	1.5	0.0	0.0	0.0	17.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	10.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	542.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	32.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1092.3	0.0	0.0	0.0	0.0
FMN2		ENSG00000155816	"Formin 2"	Q9NZ56	1	240014348-240475187	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, Protein transport, Stress response, Transport"	"Actin-binding, Developmental protein"	"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 47.6;parathyroid gland: 19.8;retina: 16.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 758.1;Excitatory neurons: 537.5;Horizontal cells: 124.5;Inhibitory neurons: 366.7;Oligodendrocyte precursor cells: 154.3"	"Group enriched"	"Detected in some"	8	"glioma: 5.9;testis cancer: 3.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 70.8;BJ hTERT+: 39.4;fHDF/TERT166: 73.8;LHCN-M2: 87.9;U-138 MG: 48.9;WM-115: 69.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050649			Approved	"Plasma membrane,Actin filaments"		NA	NA			"Plasma membrane, Actin filaments"		"HPA050649: AB_2681202"	"unprognostic (1.55e-2)"	"unprognostic (8.21e-2)"	"unprognostic (4.01e-2)"	"unprognostic (8.06e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.76e-1)"	"unprognostic (7.97e-3)"	"unprognostic (2.11e-2)"	"unprognostic (2.93e-1)"	"unprognostic (3.92e-2)"	"unprognostic (3.35e-3)"	"unprognostic (4.08e-1)"	"unprognostic (1.11e-2)"	"unprognostic (8.03e-3)"	"unprognostic (9.78e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.40e-3)"	0.8	5.1	27.2	0.2	28.9	0.0	0.5	12.0	47.6	0.3	0.0	5.0	0.2	1.4	0.9	0.7	1.9	1.2	0.1	28.4	19.3	3.5	0.0	0.3	0.0	21.8	28.0	20.5	2.4	1.0	19.8	9.1	0.2	19.2	1.6	1.6	16.8	0.3	2.6	0.1	0.2	0.9	1.8	12.8	0.2	0.7	2.3	36.1	0.0	0.5	0.2	0.1	0.3	0.3	32.1	0.0	2.1	6.6	0.0	20.2	15.3	0.0	70.8	39.4	31.0	16.3	0.0	0.0	0.0	0.0	73.8	1.2	0.0	1.3	0.0	28.8	0.0	5.8	0.0	0.7	0.0	0.1	0.0	0.0	1.7	0.0	8.5	1.9	17.0	0.0	0.0	0.0	0.0	87.9	0.0	0.0	0.1	2.3	0.0	2.2	0.0	0.2	0.0	0.0	0.0	12.0	10.6	0.0	0.1	0.3	0.2	2.1	0.1	0.3	48.9	0.2	16.0	18.2	0.0	0.0	0.0	10.4	0.0	69.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.2	28.9	12.0	47.6	28.4	19.3	21.8	28.0	20.5	19.2	12.8	36.1	32.1	0.0	0.0	0.0	758.1	0.0	0.1	0.0	0.0	0.0	30.6	0.2	0.3	1.6	0.0	0.0	1.8	50.1	0.1	0.0	4.7	0.0	0.0	15.2	4.3	0.7	0.5	12.1	0.0	537.5	0.0	0.1	1.4	0.0	1.1	0.0	0.8	2.9	0.1	0.1	124.5	366.7	0.5	0.0	0.6	0.6	3.0	0.3	0.1	1.8	31.9	0.0	2.3	0.0	154.3	17.7	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.3	1.8	4.4	0.0	0.0	0.5	0.0	3.1	1.6	0.0
KCNE5	KCNE1L	ENSG00000176076	"Potassium voltage-gated channel subfamily E regulatory subunit 5"	Q9UJ90	X	109623700-109625172	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Alport syndrome, Deafness, Elliptocytosis, Hereditary hemolytic anemia, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 11.8;skeletal muscle: 4.0;tongue: 4.9"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 4.6;Erythroid cells: 3.8;monocytes: 9.4;Muller glia cells: 5.3;Peritubular cells: 3.8"	"Group enriched"	"Detected in some"	8	"glioma: 7.9;testis cancer: 2.2"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"myeloid DC: 2.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HMC-1: 1.5;hTEC/SVTERT24-B: 2.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042316			Uncertain	Cytosol		NA	NA			Cytosol		"HPA042316: AB_10795397"	"unprognostic (5.33e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.14e-3)"	"unprognostic (3.27e-2)"	"unprognostic (9.46e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.62e-3)"	"unprognostic (7.83e-2)"	"unprognostic (5.64e-6)"	"unprognostic (5.10e-2)"	"unprognostic (9.06e-2)"	"unprognostic (1.36e-1)"	"unprognostic (5.37e-3)"	1.1	0.8	4.1	0.1	4.7	1.6	0.5	9.1	2.9	0.2	0.7	0.1	0.0	0.0	0.1	0.1	0.0	0.4	0.6	2.4	5.1	0.5	0.2	0.4	0.0	7.1	9.5	1.1	0.5	0.1	0.0	0.3	0.2	5.9	0.3	0.0	0.2	0.2	0.3	4.0	0.1	0.1	0.1	3.7	0.9	0.1	0.3	7.9	2.3	0.1	4.9	0.0	0.3	0.2	11.8	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.7	0.1	0.2	0.2	0.0	0.1	0.1	0.0	0.1	0.3	0.3	0.0	0.8	0.3	0.0	0.1	1.0	1.1	0.7	0.0	0.0	1.5	0.2	0.5	2.0	0.5	0.1	0.1	0.1	0.0	0.0	0.2	0.0	0.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.5	0.0	0.4	0.5	0.0	0.9	0.4	0.7	0.3	0.3	0.9	0.2	0.2	0.1	0.4	0.4	0.1	0.0	0.3	0.0	0.3	0.8	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	4.1	4.7	9.1	2.9	2.4	5.1	7.1	9.5	1.1	5.9	3.7	7.9	11.8	0.1	0.0	1.1	4.6	0.1	0.0	0.0	0.0	1.2	0.0	0.3	1.1	0.6	0.0	0.0	0.0	0.0	0.4	2.2	0.0	0.0	0.3	0.0	0.5	0.1	0.2	0.0	3.8	0.1	0.4	1.2	1.4	0.0	0.5	1.3	0.7	1.1	0.0	0.6	0.0	0.1	0.0	0.0	2.0	0.0	0.0	1.2	2.1	0.0	1.0	9.4	5.3	0.0	0.0	0.0	0.3	0.0	3.8	0.0	0.1	0.0	0.0	0.0	0.2	0.0	1.2	0.4	0.0	0.0	0.1	0.0	0.8	0.2	0.1	0.0	0.1
LEFTY2	"EBAF, LEFTA, LEFTYA, TGFB4"	ENSG00000143768	"Left-right determination factor 2"	O00292	1	225936598-225941383	"Disease related genes, Predicted secreted proteins"		"Cytokine, Developmental protein, Growth factor"	"Disease variant, Heterotaxy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 44.3;endometrium 1: 171.6"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 17.4;Endometrial stromal cells: 30.8;Granulosa cells: 43.6;Late spermatids: 34.6;Leydig cells: 18.0;Peritubular cells: 12.0"	"Cancer enriched"	"Detected in many"	8	"testis cancer: 41.7"	"Region enriched"	"Detected in single"	12	"hypothalamus: 9.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 10.6;NTERA-2: 44.4;RPMI-8226: 50.9;SuSa: 25.5"									"CAB025801, HPA047883, HPA056210"	Approved				"Secreted in other tissues"	NA	NA					"CAB025801: , HPA047883: AB_2680200, HPA056210: AB_2683067"	"unprognostic (3.78e-2)"	"unprognostic (4.10e-3)"	"unprognostic (5.79e-3)"	"unprognostic (5.12e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.87e-2)"	"unprognostic (9.75e-4)"	"unprognostic (2.91e-1)"	"unprognostic (3.84e-1)"	"unprognostic (7.98e-2)"	"unprognostic (9.14e-3)"	"unprognostic (1.15e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.90e-4)"	"unprognostic (1.64e-3)"	1.8	1.4	0.2	1.2	0.3	0.0	0.7	0.2	0.4	44.3	13.1	1.1	0.3	171.6	12.2	0.1	3.6	0.4	2.6	0.7	9.0	0.4	0.0	2.5	0.2	0.2	0.4	0.2	38.1	0.3	0.0	16.2	3.5	0.2	1.5	0.2	0.9	0.1	12.5	0.7	0.2	0.4	37.3	0.2	0.7	0.3	4.5	0.7	0.2	0.1	0.8	0.0	0.5	1.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	10.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	44.4	0.0	0.0	0.0	0.0	50.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	25.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.2	2.6	1.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.2	0.4	0.7	9.0	0.2	0.4	0.2	0.2	0.2	0.7	0.4	0.6	0.0	0.0	0.0	0.3	0.3	0.1	0.0	0.0	0.0	0.3	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	1.4	17.4	2.2	30.8	0.6	0.0	0.0	0.0	0.0	0.6	1.4	0.0	0.7	0.0	43.6	0.4	0.0	0.5	0.0	0.1	0.2	0.0	0.0	0.2	34.6	18.0	0.3	1.8	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.4	12.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	5.3	1.7	6.7	0.4	0.0	0.0	0.0	0.2	0.7	0.0	0.1
NRK	DKFZp686A17109	ENSG00000123572	"Nik related kinase"	Q7Z2Y5	X	105822539-105958610	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 16.3;ovary: 32.8;placenta: 24.4"	"Group enriched"	"Detected in some"	4	"Cytotrophoblasts: 79.4;Leydig cells: 113.4;Syncytiotrophoblasts: 67.9;Theca cells: 70.2"	"Cancer enriched"	"Detected in some"	8	"testis cancer: 6.1"	"Group enriched"	"Detected in some"	11	"cerebellum: 7.1;pons: 2.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 58.1;HSkMC: 10.6;RH-30: 12.8;RPTEC TERT1: 34.8;SuSa: 40.5"	"Region enriched"	"Detected in single"	28	"cerebellum: 14.2"	"Region enhanced"	"Detected in all"		"cerebellum: 41.6"	HPA017238	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA017238: AB_1854645"	"unprognostic (2.64e-4)"	"unprognostic (9.82e-2)"	"unprognostic (5.98e-3)"	"unprognostic (5.52e-2)"		"unprognostic (3.87e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.86e-2)"	"unprognostic (1.35e-2)"	"unprognostic (6.08e-2)"	"unprognostic (3.24e-2)"	"unprognostic (5.28e-3)"	"unprognostic (1.47e-3)"	"unprognostic (1.14e-1)"	"unprognostic (4.28e-2)"	"unprognostic (6.80e-3)"	0.8	16.3	0.1	0.9	0.0	0.0	0.7	7.1	0.3	1.8	0.0	0.9	0.1	1.8	4.6	0.6	0.9	10.1	3.5	0.0	0.1	6.3	0.1	0.2	0.0	0.1	0.4	0.0	32.8	0.4	0.1	0.3	24.4	2.8	4.9	0.3	0.1	1.2	0.9	0.2	0.1	0.3	1.7	0.1	0.0	0.5	3.3	0.1	0.1	0.2	3.3	0.0	1.0	0.6	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	58.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	10.6	0.0	0.1	0.0	3.5	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	12.8	0.0	34.8	0.7	0.0	0.2	0.0	1.8	0.0	40.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	7.1	0.3	0.0	0.1	0.1	0.4	0.0	2.8	0.1	0.1	0.4	3.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.6	0.0	1.2	1.0	4.8	0.0	0.0	0.0	0.0	79.4	0.0	0.2	19.6	0.2	1.3	0.0	3.2	0.7	0.0	0.0	0.9	0.0	10.1	8.9	0.0	0.0	0.0	2.1	0.0	0.0	7.1	0.0	0.9	0.0	0.0	0.0	0.0	2.6	113.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	13.5	0.0	0.2	0.2	0.2	0.0	0.0	0.0	0.1	0.7	1.6	1.7	0.1	0.0	67.9	0.0	70.2	0.2	0.1
PYY	PYY1	ENSG00000131096	"Peptide YY"	P10082	17	43952738-44004469	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	30	"intestine: 53.0"	"Cell type enriched"	"Detected in some"	96	"Enteroendocrine cells: 19377.2"	"Group enriched"	"Detected in many"	8	"endometrial cancer: 7.9;ovarian cancer: 15.2;testis cancer: 18.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 2.9"	"Region enriched"	"Detected in single"	14	"pons and medulla: 1.4"	"Low region specificity"	"Detected in single"			"HPA010973, CAB016734"	Enhanced				"Secreted to blood"	NA	NA	87100				"CAB016734: AB_876471, HPA010973: AB_1855194"	"unprognostic (8.17e-3)"	"unprognostic (5.41e-2)"	"unprognostic (9.93e-2)"	"unprognostic (1.81e-3)"	"unprognostic (2.48e-4)"	"unprognostic (5.26e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.69e-3)"	"unprognostic (3.77e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.20e-1)"	0.1	1.7	0.3	1.5	0.3	0.1	0.4	0.2	0.7	0.3	0.1	53.0	2.5	0.4	0.4	0.0	0.4	0.0	0.0	0.3	0.3	1.3	0.2	0.2	0.3	0.4	0.3	0.3	0.0	0.7	0.2	0.0	0.0	0.5	0.3	37.0	0.8	0.1	0.8	0.1	0.1	42.0	0.1	0.2	0.1	0.5	1.1	0.4	0.3	0.5	0.1	0.1	0.0	0.0	0.5	0.1	0.2	0.2	0.4	0.3	0.6	0.0	0.4	0.1	0.5	0.3	0.5	0.3	0.2	0.6	0.5	0.4	0.2	0.4	0.1	0.3	1.2	0.2	0.7	0.2	0.0	0.4	0.2	2.9	0.8	0.1	0.5	0.2	0.6	0.1	0.3	0.2	0.5	0.4	0.6	0.2	0.4	0.6	0.4	0.2	0.1	0.1	0.0	0.8	0.0	0.4	0.1	0.3	0.0	0.7	0.3	0.5	0.0	0.5	0.6	0.5	0.1	0.4	0.0	0.5	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.2	0.7	0.3	0.3	0.4	0.3	0.3	0.5	0.2	0.4	0.5	0.1	0.0	0.0	0.3	1.4	0.0	0.0	0.0	0.0	0.0	1.5	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	65.0	1.9	0.0	1.0	7.9	1.3	0.1	19377.2	0.0	3.5	0.0	0.1	0.0	0.0	18.9	8.9	0.1	0.0	0.0	0.0	0.0	3.3	199.9	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	35.5	0.0	0.0	0.0	20.7	0.1	0.0	0.0	0.0	0.0	0.1	2.3	4.3	0.0	0.1	0.0	1.0	0.0	36.8	0.0
RTL4	"FLJ46608, Mar4, Mart4, SIRH11, ZCCHC16"	ENSG00000187823	"Retrotransposon Gag like 4"	Q6ZR62	X	112454500-112457112	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"liver: 1.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"testis cancer: 1.4;thyroid cancer: 3.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA003272	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			Nucleoplasm	"Plasma membrane, Cytosol"	"HPA003272: AB_2257414"							"unprognostic (9.86e-2)"						"unprognostic (2.04e-4)"		"unprognostic (6.35e-2)"	"unprognostic (5.33e-3)"		0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.8	1.1	0.0	0.0	0.3	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.1	0.1	0.1	0.3	0.6	0.1	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SOAT2	ACAT2	ENSG00000167780	"Sterol O-acyltransferase 2"	O75908	12	53103486-53124535	"Enzymes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"intestine: 19.6"	"Cell type enriched"	"Detected in some"	5	"Proximal enterocytes: 14.3"	"Group enriched"	"Detected in some"	8	"liver cancer: 5.2;testis cancer: 5.5"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"MAIT T-cell: 1.1"	"Lineage enriched"	"Detected in single"	5	"T-cells: 1.1"	"Group enriched"	"Detected in some"	5	"CACO-2: 9.5;Hep G2: 22.6;U-266/70: 7.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (2.53e-1)"	"unprognostic (2.72e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.30e-4)"	"unprognostic (3.88e-3)"	"unprognostic (9.26e-2)"	"unprognostic (4.20e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.83e-2)"	"unprognostic (9.05e-2)"	"unprognostic (2.37e-1)"	"unprognostic (7.58e-3)"	"unprognostic (3.28e-1)"	0.3	0.0	0.0	0.1	0.0	0.2	0.3	0.0	0.1	0.7	0.0	0.2	11.7	0.4	0.3	0.1	0.6	0.4	0.1	0.0	0.0	0.4	2.9	0.2	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.4	0.1	0.0	0.4	0.1	0.0	0.2	19.6	0.0	0.0	2.1	0.2	0.2	0.0	0.1	0.3	0.1	0.2	0.3	0.6	0.0	0.2	0.2	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.3	0.4	9.5	0.1	0.0	0.0	0.5	0.0	0.8	0.0	0.0	0.7	0.0	0.0	1.0	0.0	22.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.4	2.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	7.2	1.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.4	0.7	0.0	0.0	0.1	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	1.5	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	1.3	0.0	0.0	0.0	0.2	0.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	2.5	0.0	0.0	0.0	14.3	0.8	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.6	0.0	0.3	0.0
TKTL1	"TKR, TKT2"	ENSG00000007350	"Transketolase like 1"	P51854	X	154295795-154330350	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	33	"testis: 128.2"	"Group enriched"	"Detected in some"	7	"Spermatocytes: 166.9;Spermatogonia: 491.5"	"Cancer enriched"	"Detected in many"	8	"testis cancer: 44.2"	"Group enriched"	"Detected in some"	5	"cerebral cortex: 3.8;medulla oblongata: 1.8"	"Group enriched"	"Detected in many"	5	"eosinophil: 60.9;gdT-cell: 24.4"	"Group enriched"	"Detected in many"	5	"granulocytes: 60.9;T-cells: 24.4"	"Cell line enriched"	"Detected in some"	163	"THP-1: 495.2"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"white matter: 1.2"	"HPA000505, HPA029155, CAB032191"	Enhanced		Enhanced	Cytosol		NA	NA			Cytosol		"CAB032191: , HPA000505: AB_1858022, HPA029155: AB_10603134"	"unprognostic (2.69e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.98e-1)"	"unprognostic (5.80e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.34e-2)"	"unprognostic (3.90e-2)"	"unprognostic (5.04e-2)"	"unprognostic (2.38e-1)"	0.2	0.1	0.2	0.4	0.4	0.9	0.2	0.2	3.8	0.1	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.1	3.1	0.3	0.3	0.1	0.2	1.0	0.4	1.8	0.2	0.2	0.1	0.0	0.0	0.9	0.3	0.5	0.1	0.0	2.2	0.0	0.0	0.3	0.2	0.1	0.1	0.5	0.7	0.0	128.2	0.4	0.4	0.1	0.5	0.1	0.1	0.1	0.5	0.3	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.6	0.0	0.0	495.2	0.0	0.0	0.0	0.1	0.2	0.0	3.0	2.7	0.0	0.0	0.4	1.6	0.1	60.9	24.4	0.4	3.5	0.1	2.9	2.2	0.0	0.1	6.0	5.4	1.0	7.8	0.3	0.2	3.5	5.8	0.2	0.4	0.2	3.8	0.3	0.3	1.8	0.2	0.2	0.5	0.5	0.4	0.5	0.2	0.0	0.0	0.7	0.5	0.3	0.0	0.0	0.6	0.3	0.0	0.0	20.4	0.0	0.0	0.0	0.0	0.0	16.4	0.0	0.0	0.0	44.8	0.0	0.1	0.7	0.0	0.4	0.4	0.0	0.0	0.7	0.0	0.1	0.0	0.1	0.0	0.1	0.2	25.2	0.4	0.0	0.0	0.3	3.7	22.5	4.1	1.9	0.0	1.0	0.6	6.0	20.6	1.0	0.1	0.0	0.0	1.9	1.3	0.0	0.0	0.1	0.0	1.0	26.3	1.4	1.6	166.9	491.5	0.1	0.1	0.0	4.1	0.1	0.0	0.0
TRIM75P	TRIM75	ENSG00000250374	"Tripartite motif containing 75, pseudogene"	A6NK02	4	165053864-165060554	"Predicted intracellular proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	8	"testis cancer: 0.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	16	"BEWO: 1.7"															NA	NA										"unprognostic (8.51e-2)"					"unprognostic (2.81e-2)"			"unprognostic (1.94e-3)"	"unprognostic (3.29e-2)"	"unprognostic (3.78e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TULP2	"CT65, TUBL2"	ENSG00000104804	"TUB like protein 2"	O00295	19	48880967-48898744	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"testis: 37.9"	"Group enriched"	"Detected in some"	16	"Early spermatids: 281.1;Late spermatids: 233.0"	"Cancer enriched"	"Detected in single"	8	"testis cancer: 1.5"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	10	"plasmacytoid DC: 3.0"	"Lineage enriched"	"Detected in single"	10	"dendritic cells: 3.0"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.6;U-266/70: 3.0;U-266/84: 3.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA075828			Approved	Cytosol	"Secreted in male reproductive system"	NA	NA			Cytosol		"HPA075828: "	"unprognostic (9.97e-2)"	"unprognostic (5.55e-3)"	"unprognostic (1.15e-1)"	"unprognostic (9.39e-2)"	"unprognostic (1.69e-4)"	"unprognostic (6.79e-4)"	"unprognostic (1.07e-2)"	"unprognostic (2.57e-1)"	"unprognostic (5.94e-3)"	"unprognostic (1.08e-2)"	"unprognostic (9.82e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.59e-4)"	"unprognostic (6.37e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.97e-1)"	0.3	0.5	2.3	0.1	2.6	5.3	0.5	3.8	8.6	0.3	1.9	0.3	0.0	1.0	0.1	0.8	0.8	0.8	0.5	2.5	2.1	0.2	0.1	0.5	0.2	2.0	2.3	2.4	1.5	0.1	0.1	0.1	0.1	2.5	0.7	0.2	0.5	0.1	0.2	0.5	0.1	0.5	0.4	1.8	1.4	0.4	37.9	2.2	0.1	0.3	0.1	0.3	0.3	0.2	3.3	0.0	0.0	0.0	0.0	0.0	0.1	2.6	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.7	0.9	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.4	0.4	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.4	0.0	0.3	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	3.0	3.4	0.1	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	3.0	0.0	0.0	2.3	2.6	3.8	8.6	2.5	2.1	2.0	2.3	2.4	2.5	1.8	2.2	3.3	0.2	0.0	0.5	0.3	0.8	0.3	0.1	0.0	0.0	0.0	0.1	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	281.1	0.8	2.7	1.0	0.0	0.0	0.9	0.0	0.1	0.6	0.0	2.2	2.5	0.1	0.0	0.2	0.2	0.0	0.6	0.2	0.0	0.3	0.7	233.0	4.4	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.2	0.1	0.1	0.0	0.1	0.0	0.0	0.0	6.4	1.4	15.4	1.4	0.4	0.4	0.0	0.6	0.1	0.0	0.0
ZAN		ENSG00000146839	Zonadhesin	Q9Y493	7	100733595-100797797	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"Early spermatids: 15.0;Late spermatids: 16.2"	"Cancer enriched"	"Detected in single"	8	"testis cancer: 1.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (1.10e-1)"	"unprognostic (1.40e-1)"		"unprognostic (3.69e-1)"	"unprognostic (4.60e-2)"	"unprognostic (5.83e-6)"	"unprognostic (9.44e-2)"	"unprognostic (4.56e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.97e-1)"	"unprognostic (5.70e-2)"	"unprognostic (4.10e-9)"	"unprognostic (5.70e-2)"	"unprognostic (2.58e-1)"	"unprognostic (8.43e-2)"	"unprognostic (3.06e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.0	0.0	0.1	0.1	0.0	0.0	1.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	16.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	2.3	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0
ZNF728		ENSG00000269067	"Zinc finger protein 728"	P0DKX0	19	22974883-23003176	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"testis: 10.5"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 3.3;Distal tubular cells: 3.9;Early spermatids: 2.7;Horizontal cells: 8.4;Oligodendrocyte precursor cells: 2.5;Oligodendrocytes: 3.6;Spermatocytes: 4.4"	"Cancer enriched"	"Detected in single"	8	"testis cancer: 3.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"GAMG: 1.7;SuSa: 1.8;U-266/84: 2.9"															NA	NA						"unprognostic (4.12e-2)"				"unprognostic (4.25e-2)"			"unprognostic (5.00e-2)"		"unprognostic (1.78e-2)"	"unprognostic (3.56e-1)"	"unprognostic (4.03e-1)"	"unprognostic (1.13e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.60e-2)"		1.0	0.1	1.4	0.3	2.3	0.0	0.9	1.0	1.4	0.7	0.3	0.3	0.2	1.1	0.7	0.5	1.4	0.4	1.4	1.4	2.3	0.7	0.1	0.2	0.0	1.8	2.4	0.5	2.7	0.1	1.7	0.3	0.2	1.8	0.9	0.2	0.8	0.3	1.0	0.0	0.1	0.1	1.0	0.9	0.5	0.1	10.5	2.3	0.0	2.1	1.0	0.0	0.3	0.2	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.2	0.0	0.0	0.1	0.0	0.0	0.0	1.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	2.3	1.0	1.4	1.4	2.3	1.8	2.4	0.5	1.8	0.9	2.3	2.2	1.3	0.0	0.0	3.3	0.0	0.0	0.1	0.0	0.0	1.4	0.1	0.8	2.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.9	0.0	2.7	0.0	0.6	0.4	0.0	0.0	0.2	0.0	0.1	1.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	8.4	0.1	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	1.9	0.0	0.4	0.0	2.5	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.6	0.5	4.4	2.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0
AWAT2	"DGAT2L4, MFAT"	ENSG00000147160	"Acyl-CoA wax alcohol acyltransferase 2"	Q6E213	X	70040542-70049938	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"skin 1: 7.1"	"Cell type enriched"	"Detected in some"	6	"Spermatocytes: 8.3"	"Cancer enriched"	"Detected in single"	7	"testis cancer: 0.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA062748	Approved					NA	NA					"HPA062748: AB_2684862"	"unprognostic (3.41e-2)"			"unprognostic (1.06e-1)"	"unprognostic (2.99e-2)"			"unprognostic (4.11e-2)"		"unprognostic (1.11e-1)"					"unprognostic (8.60e-2)"	"unprognostic (4.55e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	8.3	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1
BFSP2	"CP47, CP49, LIFL-L, phakinin"	ENSG00000170819	"Beaded filament structural protein 2"	Q13515	3	133400056-133475222	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Sensory transduction, Vision"	"Eye lens protein"	"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"B-cells: 6.3;Melanocytes: 5.4;Plasma cells: 10.6"	"Cancer enriched"	"Detected in single"	7	"testis cancer: 1.7"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	8	"T-reg: 13.4"	"Lineage enriched"	"Detected in single"	43	"T-cells: 13.4"	"Group enriched"	"Detected in some"	6	"Daudi: 2.4;U-698: 2.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA038464, HPA062959"	Enhanced		Uncertain	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA038464: AB_10672746, HPA062959: AB_2684912"	"unprognostic (1.58e-3)"	"unprognostic (7.47e-4)"	"unprognostic (1.04e-2)"	"unprognostic (2.32e-1)"	"unprognostic (9.59e-2)"	"unprognostic (4.04e-5)"	"unprognostic (8.13e-2)"	"unprognostic (5.57e-2)"	"unprognostic (6.71e-2)"	"unprognostic (1.91e-3)"	"unprognostic (1.74e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.68e-5)"	"unprognostic (2.11e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.23e-2)"	"unprognostic (2.21e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	2.6	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	1.6	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	13.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	1.0	0.0	0.0	0.0	0.0	0.1	0.3	0.2	0.0	0.0	1.8	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.4	0.9	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.9	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.3	0.1	5.4	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.3	0.0	0.6	0.0	1.0	0.1	0.1	0.0
FNDC5	FRCP2	ENSG00000160097	"Fibronectin type III domain containing 5"	Q8NAU1	1	32862268-32872482	"Predicted membrane proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"skeletal muscle: 326.1;tongue: 482.6"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 71.3;Cardiomyocytes: 64.9;Early spermatids: 28.1;Granulosa cells: 38.6;Muller glia cells: 44.1"	"Group enriched"	"Detected in many"	7	"glioma: 4.2;liver cancer: 10.0;testis cancer: 14.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"RH-30: 48.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051290	Enhanced				"Intracellular and membrane"	NA	NA					"HPA051290: AB_2681422"	"unprognostic (4.36e-2)"	"unprognostic (9.08e-3)"	"unprognostic (7.62e-4)"	"unprognostic (1.03e-2)"	"unprognostic (3.77e-2)"	"unprognostic (6.26e-2)"	"unprognostic (5.68e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.15e-3)"	"unprognostic (1.63e-1)"	"unprognostic (9.07e-2)"	"unprognostic (7.07e-3)"	"unprognostic (1.13e-1)"	"unprognostic (3.37e-3)"	"unprognostic (1.33e-2)"	1.3	12.9	9.5	0.1	4.4	0.2	0.8	20.5	9.7	1.2	36.9	1.1	0.8	3.3	2.4	11.7	4.2	1.8	42.6	6.2	13.6	0.7	18.5	1.1	0.2	8.0	14.5	2.5	4.7	0.5	10.5	5.3	0.5	8.1	3.7	0.5	8.1	25.8	1.1	326.1	0.4	1.3	2.0	3.7	0.2	5.2	2.8	30.8	0.6	1.2	482.6	0.1	1.2	0.8	6.6	0.0	0.1	1.1	0.4	0.0	1.2	0.2	0.5	0.1	0.7	0.1	0.9	0.3	0.2	0.8	0.4	0.2	0.1	4.7	0.1	0.1	0.1	0.3	0.1	0.4	0.2	0.0	0.2	0.0	1.8	0.0	0.3	0.0	0.6	0.0	0.2	0.9	0.1	0.8	0.1	0.1	0.1	1.4	0.0	0.1	0.6	48.2	0.3	0.0	0.1	6.9	1.1	0.5	0.0	0.0	0.5	0.2	0.1	0.2	0.1	0.8	2.2	0.4	0.2	0.1	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	4.4	20.5	9.7	6.2	13.6	8.0	14.5	2.5	8.1	3.7	30.8	6.6	1.1	0.0	0.0	7.5	0.0	0.1	0.2	0.0	0.0	71.3	0.6	0.5	64.9	0.0	0.0	1.8	4.2	0.0	0.0	0.0	1.9	0.0	28.1	0.3	4.6	1.4	0.0	0.0	10.3	0.0	0.0	14.5	0.0	0.5	0.0	38.6	0.7	2.0	0.9	0.0	15.8	0.1	0.0	0.0	0.5	5.9	5.3	0.8	0.0	5.6	0.0	44.1	0.0	3.0	0.7	0.1	0.0	5.7	0.0	0.2	0.1	0.2	0.0	7.4	0.0	12.9	1.7	0.5	1.0	0.0	0.0	0.3	0.2	0.5	0.5	0.1
GABRA3		ENSG00000011677	"Gamma-aminobutyric acid type A receptor subunit alpha3"	P34903	X	152166234-152451315	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 14.6;choroid plexus: 13.6;retina: 9.1"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 70.3;Hofbauer cells: 16.2;Inhibitory neurons: 22.2;Oligodendrocyte precursor cells: 58.3"	"Cancer enriched"	"Detected in many"	7	"testis cancer: 16.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 9.9;HMC-1: 8.4;Karpas-707: 14.4;PC-3: 8.4;U-266/70: 7.7;U-266/84: 13.6;U-87 MG: 8.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000839, HPA029363"	Approved	Supported	Uncertain	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA000839: AB_1078929, HPA029363: "	"unprognostic (9.63e-3)"	"unprognostic (2.04e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.18e-2)"	"unprognostic (7.07e-2)"	"unprognostic (5.42e-2)"	"unprognostic (2.34e-6)"	"unprognostic (1.24e-1)"	"unprognostic (2.70e-1)"	"unprognostic (2.39e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.73e-1)"	"unprognostic (7.29e-6)"	"unprognostic (7.42e-3)"	"unprognostic (6.20e-2)"		"unprognostic (8.13e-2)"	0.0	0.0	6.7	0.0	14.6	0.0	0.0	0.0	13.2	0.9	13.6	0.1	0.1	0.3	0.0	0.4	0.0	0.0	0.0	8.6	10.2	0.0	0.0	0.0	0.0	1.2	3.7	10.1	0.0	0.0	0.0	0.6	2.9	2.1	0.1	0.0	9.1	0.1	0.7	0.0	0.2	0.1	0.0	0.2	0.0	0.0	0.7	7.3	0.0	0.0	0.0	0.1	0.4	0.2	4.2	0.0	0.8	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	9.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.0	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	14.4	0.0	0.0	0.0	0.0	2.6	6.4	8.4	0.0	0.0	0.0	0.0	0.0	0.2	5.2	0.0	5.3	0.4	0.3	0.1	1.3	0.1	5.3	7.0	0.3	1.6	7.7	13.6	0.0	8.4	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	14.6	0.0	13.2	8.6	10.2	1.2	3.7	10.1	2.1	0.2	7.3	4.2	0.0	0.0	0.0	3.6	0.0	0.0	0.1	0.0	0.6	1.2	0.0	0.0	0.3	0.0	0.0	0.0	2.1	3.2	0.0	0.0	0.0	0.0	0.2	0.0	1.1	0.1	0.0	0.0	70.3	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	16.2	1.7	22.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.7	0.0	3.0	0.0	58.3	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.5	1.2	0.9	0.0	1.9	0.0	0.0	0.0	0.5
GJA10	CX62	ENSG00000135355	"Gap junction protein alpha 10"	Q969M2	6	89894469-89921760	"Predicted membrane proteins"				"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	92	"Horizontal cells: 18.5"	"Cancer enriched"	"Detected in single"	7	"testis cancer: 1.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA021145	Uncertain					NA	NA					"HPA021145: AB_2670600"															"unprognostic (1.09e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GPHA2	"A2, GPA2, MGC126572, ZSIG51"	ENSG00000149735	"Glycoprotein hormone subunit alpha 2"	Q96T91	11	64934471-64935893	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"pancreas: 363.5"	"Cell type enhanced"	"Detected in some"		"Basal respiratory cells: 2.5;Exocrine glandular cells: 17.4;Pancreatic endocrine cells: 2.4;Spermatocytes: 7.7;Spermatogonia: 3.2"	"Cancer enriched"	"Detected in some"	7	"testis cancer: 15.8"	"Region enhanced"	"Detected in some"		"cerebellum: 3.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	11	"Hep G2: 21.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA067068			Approved	Vesicles	"Secreted to blood"	NA	NA			Vesicles		"HPA067068: "	"unprognostic (1.13e-1)"	"unprognostic (8.31e-3)"		"unprognostic (1.51e-2)"		"unprognostic (9.22e-4)"		"unprognostic (7.88e-3)"		"unprognostic (2.62e-1)"	"unprognostic (1.45e-1)"	"unprognostic (3.20e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.75e-1)"	"unprognostic (5.03e-2)"	"unprognostic (9.86e-3)"	"unprognostic (1.70e-1)"	0.0	0.1	0.4	0.2	0.5	0.1	0.1	3.0	0.6	0.0	0.0	0.1	0.1	0.2	0.2	0.0	0.4	17.1	0.0	0.3	0.2	0.8	0.7	0.3	0.6	0.4	0.5	0.2	2.7	363.5	0.0	28.2	0.0	1.5	0.7	0.0	0.1	0.3	0.5	0.0	0.5	0.5	0.0	0.2	0.6	1.1	10.9	0.2	0.1	0.3	0.0	0.5	0.1	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	21.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	3.0	0.6	0.3	0.2	0.4	0.5	0.2	1.5	0.2	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.3	0.1	2.5	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	17.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.4	0.0	0.5	0.2	0.0	0.0	0.0	0.0	7.7	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2
LGI1	"EPITEMPIN, EPT, ETL1, IB1099"	ENSG00000108231	"Leucine rich glioma inactivated 1"	O95970	10	93757840-93806272	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes, Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 40.0;choroid plexus: 39.0"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 242.9;Excitatory neurons: 57.1;Inhibitory neurons: 74.7;Oligodendrocyte precursor cells: 28.6"	"Group enriched"	"Detected in some"	7	"glioma: 1.8;testis cancer: 0.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 9.4;CACO-2: 2.0;NTERA-2: 6.1;SuSa: 3.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted in brain"	NA	NA						"unprognostic (1.26e-1)"			"unprognostic (4.68e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.01e-1)"	"unprognostic (8.20e-2)"		"unprognostic (1.28e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.24e-3)"	"unprognostic (1.85e-1)"	"unprognostic (4.07e-3)"	"unprognostic (8.71e-2)"	"unprognostic (2.21e-1)"	"unprognostic (5.93e-2)"	"unprognostic (4.65e-1)"	0.4	1.9	25.9	0.1	28.0	0.0	0.2	23.2	40.0	0.1	39.0	3.2	0.5	0.1	0.0	4.3	0.1	1.0	0.3	28.7	23.3	0.0	2.7	0.0	0.0	28.6	24.5	24.8	0.0	0.2	0.0	7.7	0.0	32.9	0.7	2.7	0.4	0.1	0.5	5.9	0.2	1.5	0.7	21.6	0.0	1.8	0.4	26.6	0.0	0.2	3.6	0.1	1.0	0.3	29.3	0.0	0.0	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	3.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.9	28.0	23.2	40.0	28.7	23.3	28.6	24.5	24.8	32.9	21.6	26.6	29.3	0.2	0.0	0.0	242.9	0.0	0.3	0.4	0.0	0.0	0.5	0.4	0.1	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.4	0.0	0.0	57.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.4	6.0	0.0	0.0	74.7	0.0	0.0	0.0	0.4	1.6	1.5	0.0	0.0	10.3	0.0	0.1	0.0	28.6	3.9	0.0	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.5	0.6	0.0	0.8	0.1	0.1	0.0	0.0	0.0	0.0	0.2
MAGEB2	"CT3.2, DAM6, MAGE-XP-2, MGC26438"	ENSG00000099399	"MAGE family member B2"	O15479	X	30215563-30220089	"Predicted intracellular proteins"	"Ubl conjugation pathway"	"Tumor antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	60	"testis: 29.3"	"Group enriched"	"Detected in some"	4	"Spermatocytes: 24.7;Spermatogonia: 95.8"	"Cancer enriched"	"Detected in many"	7	"testis cancer: 33.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HL-60: 92.4;K-562: 66.9;Karpas-707: 77.0;U-2 OS: 89.9;U-266/70: 149.7;U-266/84: 168.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA065224, HPA074544, HPA075519"	Enhanced		Approved	Cytosol		NA	Yes			Cytosol		"HPA065224: AB_2685437, HPA074544: AB_2732258, HPA075519: AB_2732294"					"unprognostic (4.52e-1)"	"unprognostic (2.55e-2)"		"unprognostic (6.39e-2)"	"unprognostic (5.02e-1)"					"unprognostic (6.57e-2)"	"unprognostic (1.79e-2)"		"unprognostic (1.00e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	6.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	92.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	66.9	77.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.2	0.0	0.5	0.0	14.8	0.2	0.0	89.9	0.3	0.3	149.7	168.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	3.1	2.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.0	0.0	24.7	95.8	0.0	0.0	0.0	0.1	0.0	0.3	0.0
MAGEC3	"CT7.2, HCA2, MAGE-C3"	ENSG00000165509	"MAGE family member C3"	Q8TD91	X	141838316-141897832	"Cancer-related genes, Predicted intracellular proteins"		"Tumor antigen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 5.9"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 9.8;Inhibitory neurons: 10.9;Oligodendrocytes: 36.7"	"Cancer enriched"	"Detected in single"	7	"testis cancer: 0.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-266/84: 2.1"									HPA052067	Approved					NA	NA					"HPA052067: AB_2681717"	"unprognostic (3.45e-1)"				"unprognostic (2.39e-1)"			"unprognostic (4.01e-1)"		"unprognostic (2.95e-1)"	"unprognostic (2.10e-2)"	"unprognostic (3.45e-2)"	"unprognostic (2.35e-11)"		"unprognostic (3.21e-2)"	"unprognostic (4.29e-2)"		0.0	0.0	2.1	0.0	2.5	0.0	0.1	1.6	3.0	0.1	1.2	0.0	0.0	0.1	0.4	0.0	0.2	0.0	0.1	2.2	2.4	0.1	0.0	0.0	0.0	2.9	3.1	2.2	0.1	0.0	0.1	0.8	0.0	2.7	0.1	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.0	1.8	1.0	0.0	1.1	2.2	0.0	0.2	0.0	0.0	0.1	0.1	5.9	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.1	0.9	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	2.5	1.6	3.0	2.2	2.4	2.9	3.1	2.2	2.7	1.8	2.2	5.9	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	36.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MLNR	GPR38	ENSG00000102539	"Motilin receptor"	O43193	13	49220338-49222377	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 1.3;thyroid gland: 1.7"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	7	"testis cancer: 2.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 1.3;THP-1: 4.0"					"Not detected"	"Not detected"			HPA070324			Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA070324: "	"unprognostic (9.75e-2)"	"unprognostic (2.13e-2)"		"unprognostic (2.90e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.03e-2)"		"unprognostic (7.80e-2)"	"unprognostic (1.54e-2)"	"unprognostic (7.79e-2)"	"unprognostic (1.88e-2)"	"unprognostic (3.74e-1)"	"unprognostic (2.61e-4)"	"unprognostic (3.53e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.38e-1)"		0.0	0.0	0.2	0.0	0.2	1.3	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.4	0.1	0.4	0.1	1.7	0.0	0.0	0.0	0.0	0.4	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.2	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.3	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.1	0.1	0.2	0.3	0.4	0.0	0.2	0.2	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
MYL7	"MYL2A, MYLC2A"	ENSG00000106631	"Myosin light chain 7"	Q01449	7	44138864-44141332	"Predicted intracellular proteins"		"Motor protein, Muscle protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	588	"heart muscle: 12944.8"	"Cell type enriched"	"Detected in some"	15	"Cardiomyocytes: 10772.7"	"Cancer enriched"	"Detected in some"	7	"testis cancer: 3.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	18	"BEWO: 35.6;CACO-2: 124.6;SuSa: 47.6"	"Not detected"	"Not detected"							"HPA013331, CAB033884, HPA039262"	Enhanced					NA	NA					"CAB033884: AB_2266773, HPA013331: AB_1854245, HPA039262: AB_2676418"	"unprognostic (1.00e-2)"	"unprognostic (7.99e-2)"		"unprognostic (4.36e-3)"	"unprognostic (2.31e-1)"	"unprognostic (2.51e-1)"				"unprognostic (1.28e-1)"	"unprognostic (7.85e-2)"				"unprognostic (1.67e-1)"		"unprognostic (7.28e-2)"	2.7	1.1	3.5	0.0	3.1	0.0	6.5	3.1	4.2	1.2	2.7	1.5	0.0	1.4	0.2	1.1	0.8	0.6	12944.8	2.9	3.7	1.0	2.3	22.0	0.8	3.1	3.3	3.0	4.4	18.5	0.4	9.8	2.2	3.3	2.0	0.0	0.2	11.7	0.3	3.1	2.3	2.0	0.0	2.9	0.9	1.4	1.0	3.7	0.0	3.6	0.0	0.0	0.4	1.9	3.2	0.0	0.0	0.0	0.0	0.0	0.0	35.6	0.0	0.0	0.4	0.0	124.6	0.0	0.0	1.6	0.0	0.0	0.6	0.0	0.1	0.5	0.0	0.0	0.0	0.4	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.4	0.9	0.4	0.0	47.6	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	3.1	3.1	4.2	2.9	3.7	3.1	3.3	3.0	3.3	2.9	3.7	3.2	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.4	30.5	10772.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.0	0.0	0.0	0.0	78.5	0.0	2.7	0.3	0.0	0.2	695.9	0.0	0.0	0.0	24.9	0.0	0.4	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	160.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NACAD	KIAA0363	ENSG00000136274	"NAC alpha domain containing"	O15069	7	45080437-45088969	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 79.8;pituitary gland: 24.5"	"Cell type enhanced"	"Detected in many"		"Horizontal cells: 32.0;Oligodendrocytes: 23.1;Peritubular cells: 12.0"	"Group enriched"	"Detected in many"	7	"glioma: 12.1;testis cancer: 16.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"GAMG: 33.4;SCLC-21H: 25.6;SH-SY5Y: 17.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020981, HPA079208"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA020981: AB_2670549, HPA079208: "	"unprognostic (5.54e-6)"	"unprognostic (1.89e-1)"	"unprognostic (8.55e-4)"	"unprognostic (7.06e-3)"	"prognostic unfavorable (1.38e-4)"	"unprognostic (1.61e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.17e-2)"	"unprognostic (3.17e-2)"	"unprognostic (8.17e-3)"	"unprognostic (2.76e-2)"	"unprognostic (7.72e-3)"	"unprognostic (2.72e-3)"	"unprognostic (9.22e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.87e-2)"	3.2	5.2	25.1	1.2	42.3	0.1	3.2	45.5	34.3	5.9	0.0	6.5	0.7	8.0	0.8	2.0	5.5	1.8	4.4	22.0	31.4	2.2	0.2	2.5	0.7	52.9	44.7	16.7	8.9	1.0	0.9	24.5	1.9	73.6	4.3	0.8	3.7	1.7	3.0	1.2	1.6	3.0	4.4	36.2	1.6	4.0	3.7	44.0	0.3	1.3	1.0	0.3	5.1	4.7	79.8	0.0	0.0	2.5	0.1	1.6	0.7	0.1	2.9	3.5	7.7	4.8	0.2	0.1	0.0	2.2	5.1	33.4	0.2	2.2	1.9	2.7	0.0	0.8	0.0	1.7	0.0	1.8	0.0	0.0	1.6	0.0	3.3	0.3	4.1	2.4	0.0	0.0	3.5	2.0	0.0	0.0	0.0	2.3	0.0	2.2	0.0	0.9	0.0	0.3	0.0	25.6	17.7	0.0	0.1	0.1	6.7	0.0	0.1	0.9	0.0	0.0	0.2	0.5	1.8	1.0	0.0	1.5	0.0	5.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	25.1	42.3	45.5	34.3	22.0	31.4	52.9	44.7	16.7	73.6	36.2	44.0	79.8	0.3	0.0	0.0	6.8	0.0	0.6	3.5	0.9	1.2	5.5	0.4	1.8	6.0	0.0	0.2	1.8	0.0	0.1	0.4	0.1	0.0	0.6	2.9	0.5	3.1	0.9	1.2	0.0	4.4	0.2	0.1	3.9	1.1	1.2	1.3	3.9	0.7	0.0	0.1	32.0	5.2	0.0	0.0	0.0	0.0	4.9	6.8	0.7	1.8	1.9	1.0	2.7	0.0	3.0	23.1	0.1	0.0	12.0	0.1	2.3	0.0	0.4	0.8	2.8	6.6	5.3	4.2	1.5	1.4	0.2	0.1	0.1	0.3	9.6	0.1	0.9
NLRP2	"CLR19.9, FLJ20510, NALP2, NBS1, PAN1, PYPAF2"	ENSG00000022556	"NLR family pyrin domain containing 2"	Q9NX02	19	54953130-55001142	"Predicted intracellular proteins"	"Apoptosis, Immunity, Inflammatory response, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 45.2;Extravillous trophoblasts: 216.1;Syncytiotrophoblasts: 97.3"	"Cancer enriched"	"Detected in many"	7	"testis cancer: 78.1"	"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 42.2;BEWO: 177.9;OE19: 79.7;SuSa: 80.3;T-47d: 46.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA021183			Supported	"Golgi apparatus,Vesicles,Cytosol"		NA	NA			"Golgi apparatus, Vesicles, Cytosol"		"HPA021183: AB_2670615"	"unprognostic (1.66e-2)"	"unprognostic (9.28e-2)"	"unprognostic (6.60e-2)"	"unprognostic (6.50e-3)"	"unprognostic (1.09e-2)"	"unprognostic (4.57e-3)"	"unprognostic (4.27e-1)"	"unprognostic (1.79e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (2.91e-4)"	"unprognostic (3.63e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.30e-1)"	"unprognostic (8.86e-2)"	"unprognostic (7.57e-2)"	0.4	0.3	1.0	2.7	0.8	1.1	1.0	0.0	0.9	2.6	0.2	1.7	1.8	1.1	1.8	8.0	1.9	0.9	0.4	0.8	0.3	1.2	0.4	1.6	2.1	0.6	0.2	0.2	0.3	1.6	0.4	1.2	7.1	0.6	1.5	1.9	3.2	2.4	1.1	0.6	2.5	1.7	0.8	0.0	2.1	2.5	7.2	0.3	3.4	4.5	0.0	2.0	7.2	4.4	0.4	20.4	42.2	15.8	0.4	0.2	0.1	177.9	0.1	0.0	0.6	0.2	35.9	0.7	14.7	0.1	0.1	0.1	8.1	0.0	24.4	0.3	1.7	0.2	9.8	0.5	0.1	0.4	0.1	0.4	0.2	0.3	0.0	0.1	0.1	0.9	0.0	32.7	0.2	0.0	0.3	0.1	1.3	5.0	79.7	0.0	8.8	0.0	24.0	26.4	0.7	5.3	0.7	0.0	8.1	0.0	80.3	46.7	0.2	0.0	0.3	0.7	0.4	0.3	5.2	16.6	0.7	0.4	1.0	0.0	0.1	0.2	0.0	1.8	0.3	1.3	0.6	0.4	0.7	0.2	0.6	0.3	0.8	0.2	3.0	0.1	1.0	1.3	0.4	1.0	0.8	0.0	0.9	0.8	0.3	0.6	0.2	0.2	0.6	0.0	0.3	0.4	0.0	9.6	7.3	0.3	1.5	0.5	1.9	8.1	0.0	2.7	1.9	1.5	0.8	4.3	10.1	1.8	4.2	45.2	3.5	2.9	0.0	5.3	23.1	8.6	1.3	0.7	2.4	0.8	3.0	1.9	216.1	1.1	2.0	13.1	4.5	0.7	0.0	0.0	11.6	0.0	1.9	3.0	6.1	0.3	0.5	7.2	0.9	1.1	0.0	0.0	3.0	0.7	8.2	0.5	0.5	6.7	1.0	0.0	1.5	2.5	0.8	0.4	8.4	2.7	0.0	0.3	0.8	16.8	11.7	0.0	1.3	97.3	2.4	0.3	3.0	4.7
NLRP4	"CLR19.5, CT58, FLJ32126, NALP4, PAN2, PYPAF4, RNH2"	ENSG00000160505	"NLR family pyrin domain containing 4"	Q96MN2	19	55836540-55881855	"Predicted intracellular proteins"	"Inflammatory response"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"lymphoid tissue: 5.1;testis: 7.1"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 17.6;Late spermatids: 5.1;Spermatogonia: 3.3"	"Cancer enriched"	"Detected in single"	7	"testis cancer: 1.3"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"Daudi: 82.3"					"Not detected"	"Not detected"			HPA062128			Approved	Mitochondria		NA	NA			Mitochondria		"HPA062128: "	"unprognostic (2.48e-1)"			"unprognostic (7.01e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.34e-2)"		"unprognostic (3.11e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.36e-3)"	"unprognostic (3.72e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.89e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.71e-2)"		0.1	0.0	0.6	0.6	0.6	0.0	0.0	0.6	1.3	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.5	0.0	0.0	0.0	1.6	0.7	0.5	0.4	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	7.1	0.6	0.1	0.0	0.0	5.1	0.0	0.0	1.3	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	82.3	9.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.6	0.4	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.6	1.3	1.2	0.5	0.7	0.5	0.4	1.0	0.5	0.6	1.3	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.1	5.1	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR51B5		ENSG00000167355	"Olfactory receptor family 51 subfamily B member 5"	Q9H339	11	5303444-5505652	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"Astrocytes: 10.1;Excitatory neurons: 5.7;Microglial cells: 21.5;Oligodendrocyte precursor cells: 6.6"	"Cancer enriched"	"Detected in single"	7	"testis cancer: 1.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"K-562: 4.1;U-2197: 1.1"					"Low region specificity"	"Detected in many"			HPA063124	Uncertain					NA	NA					"HPA063124: AB_2684943"	"unprognostic (9.22e-3)"				"unprognostic (1.80e-1)"		"unprognostic (2.01e-1)"	"unprognostic (3.76e-2)"		"unprognostic (4.75e-1)"		"unprognostic (1.36e-1)"	"unprognostic (7.37e-5)"	"unprognostic (2.94e-1)"	"unprognostic (2.43e-1)"	"unprognostic (4.20e-2)"	"unprognostic (2.71e-2)"	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0		0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	5.7	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	21.5	0.0	0.0	0.0	6.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0
PHC1	"EDR1, HPH1, RAE28"	ENSG00000111752	"Polyhomeotic homolog 1"	P78364	12	8913896-8941467	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Developmental protein, DNA-binding"	"Disease variant, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 48.3"	"Cancer enriched"	"Detected in many"	7	"testis cancer: 32.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"BEWO: 141.8;NTERA-2: 492.6;SuSa: 178.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006973	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA006973: AB_1855278"	"unprognostic (4.00e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.21e-3)"	"unprognostic (7.46e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.47e-1)"	"unprognostic (4.79e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.34e-2)"	"unprognostic (7.55e-2)"	"unprognostic (2.47e-1)"	"unprognostic (9.27e-2)"	"unprognostic (3.63e-2)"	20.0	18.3	22.9	17.9	20.8	7.6	23.3	24.8	22.0	45.4	28.5	25.8	6.9	42.3	13.4	20.9	45.0	15.9	20.0	21.6	26.8	25.1	7.0	21.6	16.2	19.6	20.8	18.7	47.6	25.7	26.6	76.3	14.3	21.7	32.0	9.5	40.3	23.8	20.4	16.3	10.5	21.2	22.6	18.8	22.4	22.5	43.7	18.7	28.3	44.6	10.4	14.7	28.2	27.1	19.5	6.6	11.1	46.5	43.0	13.8	14.5	141.8	6.6	13.7	11.3	14.7	7.4	10.5	17.4	5.7	11.3	17.4	5.8	12.9	15.4	15.2	60.8	7.5	22.8	14.5	7.5	15.0	12.4	38.5	18.0	8.0	18.1	18.1	36.2	13.7	19.8	4.6	6.4	11.5	8.2	15.8	22.1	492.6	2.5	3.7	25.1	31.3	0.9	12.3	29.0	9.0	32.1	10.4	23.4	17.4	178.3	3.4	12.4	7.8	20.8	34.5	13.2	9.6	12.8	8.9	24.9	9.3	6.7	14.4	0.6	0.2	0.0	0.8	1.1	0.5	1.1	1.2	1.5	0.1	0.9	1.2	0.9	0.0	0.8	2.8	1.2	0.8	0.8	22.9	20.8	24.8	22.0	21.6	26.8	19.6	20.8	18.7	21.7	18.8	18.7	19.5	11.9	16.0	19.8	48.3	7.7	2.4	5.5	4.6	9.1	24.2	10.8	11.2	0.5	11.5	13.1	9.2	27.1	5.9	10.1	0.8	1.9	5.4	26.4	20.0	17.4	11.0	11.4	9.5	36.4	5.2	11.5	11.8	5.1	10.6	19.0	15.5	8.6	2.0	4.4	16.8	44.0	2.7	4.1	5.4	3.9	17.6	14.3	6.0	7.2	12.2	3.2	17.7	7.2	23.1	13.0	4.6	1.9	12.0	3.0	4.5	0.7	5.3	19.2	36.8	0.0	15.8	12.2	17.7	25.1	10.2	2.4	5.1	11.2	8.7	2.0	4.9
RFPL4B	RNF211	ENSG00000251258	"Ret finger protein like 4B"	Q6ZWI9	6	112347330-112351294	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	4	"testis: 1.7"	"Cell type enriched"	"Detected in some"	5	"Extravillous trophoblasts: 15.7"	"Group enriched"	"Detected in some"	7	"liver cancer: 0.6;testis cancer: 1.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"K-562: 1.9;RPTEC TERT1: 2.3;U-266/70: 1.0;U-266/84: 8.0"									"HPA059324, HPA066464"	Uncertain					NA	NA					"HPA059324: , HPA066464: "	"unprognostic (4.26e-1)"				"unprognostic (1.45e-1)"						"unprognostic (6.66e-2)"	"unprognostic (3.78e-1)"	"unprognostic (2.80e-3)"		"unprognostic (3.73e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	1.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	15.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	3.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0
SLC2A3	GLUT3	ENSG00000059804	"Solute carrier family 2 member 3"	P11169	12	7919230-7936187	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 432.0"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 362.1;Endothelial cells: 356.2;Extravillous trophoblasts: 382.4;granulocytes: 485.1;Langerhans cells: 710.4;Macrophages: 305.2;T-cells: 328.9"	"Cancer enriched"	"Detected in all"	7	"testis cancer: 107.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"basophil: 166.1;neutrophil: 223.4"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 223.4"	"Group enriched"	"Detected in many"	5	"BEWO: 1473.1;CACO-2: 1646.2;SuSa: 1119.9"									"CAB002763, HPA006539"	Approved		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"CAB002763: , HPA006539: AB_1078984"	"unprognostic (9.20e-2)"	"unprognostic (9.63e-3)"	"prognostic unfavorable (8.58e-4)"	"unprognostic (2.65e-1)"	"unprognostic (5.29e-3)"	"unprognostic (2.16e-3)"	"unprognostic (1.12e-1)"	"unprognostic (8.27e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.83e-2)"	"unprognostic (8.47e-3)"	"unprognostic (5.40e-2)"	"prognostic unfavorable (6.36e-8)"	"prognostic unfavorable (2.89e-5)"	"unprognostic (1.70e-1)"	"unprognostic (1.14e-2)"	"unprognostic (2.91e-3)"	112.7	19.5	27.2	58.7	27.9	432.0	77.6	24.5	40.3	16.5	25.7	23.8	6.8	21.0	2.0	12.8	27.6	56.6	50.0	32.1	30.3	37.2	28.3	93.6	29.7	29.5	21.9	26.2	26.6	11.3	7.9	28.3	103.7	29.2	19.9	12.8	88.1	12.4	5.7	24.3	19.3	15.8	41.8	22.9	46.1	20.0	4.9	31.2	18.6	43.6	10.1	21.0	99.6	26.4	39.0	0.3	7.9	68.5	27.4	25.2	85.9	1473.1	24.7	26.7	23.9	55.9	1646.2	11.0	1.6	0.0	17.1	33.1	0.6	2.4	3.9	43.0	48.4	2.0	96.3	6.5	219.3	67.3	35.0	135.4	36.2	2.8	63.6	28.5	55.8	22.6	7.5	44.8	22.8	21.9	0.1	2.6	38.4	300.9	1.2	0.0	2.1	8.0	1.4	0.1	0.1	0.3	0.6	0.0	2.4	32.8	1119.9	0.0	4.9	23.1	29.7	15.6	57.4	2.5	0.2	68.8	5.2	86.9	15.9	16.6	166.1	19.3	29.7	25.3	2.3	20.2	7.4	16.9	19.5	10.0	7.0	10.8	14.8	223.4	15.6	1.0	0.8	24.9	17.4	27.2	27.9	24.5	40.3	32.1	30.3	29.5	21.9	26.2	29.2	22.9	31.2	39.0	362.1	144.2	98.8	5.5	301.0	129.5	3.5	1.7	8.6	33.0	5.1	7.6	21.0	7.2	26.8	3.7	62.6	69.6	112.1	0.2	0.0	0.2	3.1	5.0	84.3	356.2	1.2	13.7	24.4	0.0	382.4	188.9	12.2	4.3	485.1	6.5	96.4	2.4	113.4	5.0	20.8	0.3	0.0	76.4	710.4	3.1	10.2	305.2	183.2	34.7	43.4	28.5	41.2	6.6	5.0	0.7	1.3	7.9	93.2	5.3	0.1	1.4	10.3	70.2	118.3	21.5	187.1	2.4	1.2	4.9	82.0	111.4	328.9	41.7	0.1	4.0
SYT2		ENSG00000143858	"Synaptotagmin 2"	Q8N9I0	1	202590596-202710454	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins"	Differentiation		"Congenital myasthenic syndrome, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"brain: 64.8"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 23.2;Inhibitory neurons: 22.7;Oligodendrocytes: 7.4"	"Cancer enriched"	"Detected in some"	7	"testis cancer: 3.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"AF22: 8.5;NTERA-2: 5.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA063655	Enhanced	Supported				NA	NA					"HPA063655: AB_2685077"	"unprognostic (1.32e-2)"	"unprognostic (4.99e-2)"	"unprognostic (4.89e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.24e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.35e-3)"	"unprognostic (8.81e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.53e-2)"	"unprognostic (6.33e-2)"	"unprognostic (1.56e-2)"	"unprognostic (6.23e-2)"	"unprognostic (3.26e-1)"	"unprognostic (2.54e-1)"	"unprognostic (5.17e-3)"	0.2	1.3	11.6	0.2	9.2	0.0	0.1	42.6	64.8	0.2	0.1	0.2	0.2	0.4	0.8	0.0	0.2	0.2	0.3	4.3	15.2	0.0	0.0	0.1	0.1	52.0	26.6	0.0	0.6	0.0	0.0	0.0	0.0	62.5	0.1	0.1	5.2	0.2	0.0	0.2	0.1	0.2	0.0	12.3	0.2	0.1	0.5	20.0	0.0	0.0	0.0	0.0	0.2	0.1	52.9	0.0	0.1	8.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.6	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	11.6	9.2	42.6	64.8	4.3	15.2	52.0	26.6	0.0	62.5	12.3	20.0	52.9	0.2	0.0	0.0	2.6	0.1	0.5	1.6	1.1	0.0	3.6	0.2	0.1	2.9	0.0	0.5	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.2	0.6	1.7	0.3	0.0	0.0	23.2	0.0	0.1	0.3	0.0	2.0	0.0	0.9	0.0	0.0	0.0	3.3	22.7	0.1	0.0	0.0	0.0	0.5	3.4	0.2	0.0	1.0	0.1	1.2	0.0	1.0	7.4	0.0	0.0	1.9	0.0	0.4	0.0	0.1	0.7	5.1	0.0	0.3	0.6	0.3	0.9	0.0	0.6	0.1	0.1	0.1	0.4	2.2
TPTE	"CT44, PTEN2"	ENSG00000274391	"Transmembrane phosphatase with tensin homology"	P56180	21	10521553-10606140	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	201	"testis: 108.2"	"Cell type enriched"	"Detected in some"	6	"Spermatocytes: 464.7"	"Cancer enriched"	"Detected in single"	7	"testis cancer: 0.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 6.7;K-562: 8.2;Karpas-707: 6.4;MCF7: 4.9;PC-3: 4.8;RPMI-8226: 9.0;SuSa: 7.6;U-266/70: 7.7"									"HPA049690, HPA068342"	Enhanced		Approved	"Endoplasmic reticulum,Cytosol"		NA	NA			Cytosol	"Endoplasmic reticulum"	"HPA049690: AB_2680850, HPA068342: AB_2685976"															"unprognostic (3.63e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	108.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	6.4	0.0	4.9	0.0	0.0	1.0	0.0	4.8	0.0	0.0	9.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	7.6	0.0	0.0	0.0	1.8	4.1	2.1	0.0	7.7	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	20.6	0.1	0.0	0.1	0.0	0.0	0.7	0.0	1.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.3	13.9	5.0	0.1	0.0	1.9	0.0	0.0	0.0	0.5	0.3	0.0	0.0	2.6	0.0	0.0	0.0	0.4	0.0	0.0	13.1	0.0	0.0	464.7	69.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1
TSGA10IP	"FAM161C, FLJ32880"	ENSG00000175513	"Testis specific 10 interacting protein"	Q3SY00	11	65945445-65959963	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	28	"testis: 10.0"	"Group enriched"	"Detected in some"	5	"Early spermatids: 54.6;Late spermatids: 59.8"	"Group enriched"	"Detected in some"	7	"testis cancer: 1.5;thyroid cancer: 1.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"NTERA-2: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (1.69e-1)"	"unprognostic (8.39e-3)"	"unprognostic (3.84e-1)"	"unprognostic (6.76e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.57e-4)"	"unprognostic (8.66e-2)"	"unprognostic (8.53e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.11e-1)"	"unprognostic (5.47e-2)"	"unprognostic (5.61e-1)"	"unprognostic (1.62e-4)"	"unprognostic (8.96e-2)"	"unprognostic (2.31e-1)"	"unprognostic (7.35e-2)"	"unprognostic (6.66e-4)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	10.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.6	0.0	59.8	0.9	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	10.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1
TSPY2	TSPYQ1	ENSG00000168757	"Testis specific protein Y-linked 2"	A6NKD2	Y	6246223-6249019	"Predicted intracellular proteins"	"Differentiation, Gonadal differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	27	"testis: 7.6"	"Group enriched"	"Detected in some"	34	"Spermatocytes: 7.7;Spermatogonia: 27.0"	"Cancer enriched"	"Detected in single"	7	"testis cancer: 0.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	656	"U-266/70: 107.3;U-266/84: 119.3"									"HPA049384, HPA067289"	Supported		Approved	Cytosol		NA	NA			Cytosol		"HPA049384: AB_2680738, HPA067289: "															"unprognostic (3.69e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	107.3	119.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	27.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ZNF560	FLJ31986	ENSG00000198028	"Zinc finger protein 560"	Q96MR9	19	9466355-9498616	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"retina: 2.0;testis: 6.2"	"Group enriched"	"Detected in some"	5	"Early spermatids: 79.2;Late spermatids: 20.1"	"Cancer enriched"	"Detected in some"	7	"testis cancer: 7.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 20.5;HMC-1: 4.8;NTERA-2: 19.7;SuSa: 9.2"									"HPA045439, HPA074438"			Enhanced	"Nucleoplasm,Nuclear speckles"		NA	NA			Nucleoplasm	"Nuclear speckles"	"HPA045439: AB_2732520, HPA074438: "	"unprognostic (4.43e-3)"			"unprognostic (8.91e-2)"	"unprognostic (9.85e-3)"	"unprognostic (2.43e-2)"		"unprognostic (1.17e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.39e-1)"	"unprognostic (6.57e-3)"	"unprognostic (6.33e-5)"	"unprognostic (5.60e-2)"	"unprognostic (2.32e-1)"	"unprognostic (9.15e-3)"	"unprognostic (1.65e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.1	0.0	0.8	2.5	0.0	1.5	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.4	0.2	0.0	0.0	0.0	0.1	0.0	1.1	20.5	0.0	0.0	1.4	0.0	4.8	2.1	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	2.3	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	79.2	0.0	0.0	0.3	0.0	0.0	1.3	0.0	0.1	0.1	0.0	0.0	4.5	0.1	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	20.1	0.3	0.2	0.0	0.0	0.0	0.2	0.0	3.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	9.5	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ZNF676		ENSG00000196109	"Zinc finger protein 676"	Q8N7Q3	19	22179089-22215801	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 19.6;Early spermatids: 23.9;Oligodendrocyte precursor cells: 17.6;Oligodendrocytes: 37.1;Spermatocytes: 18.9"	"Cancer enriched"	"Detected in some"	7	"testis cancer: 9.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"NTERA-2: 12.5"															NA	NA						"unprognostic (7.77e-2)"	"unprognostic (2.54e-3)"	"unprognostic (1.20e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.64e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.18e-1)"	"unprognostic (8.33e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.64e-1)"	"unprognostic (5.45e-1)"	"unprognostic (6.76e-3)"	"unprognostic (9.98e-3)"	"unprognostic (5.14e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.70e-3)"	1.0	0.2	0.7	0.1	1.3	0.0	1.4	0.7	1.1	0.7	0.6	0.7	0.1	1.6	1.0	0.2	1.5	0.4	1.4	1.0	2.3	1.0	0.1	0.3	0.1	1.8	1.6	0.1	2.0	1.0	3.8	1.1	0.0	2.2	0.5	0.3	0.3	0.3	0.4	0.1	0.3	0.3	1.0	0.7	0.6	0.2	3.8	1.5	0.0	3.3	0.3	0.0	0.4	0.6	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.3	0.7	1.1	1.0	2.3	1.8	1.6	0.1	2.2	0.7	1.5	1.6	3.7	0.0	0.0	8.1	0.0	0.0	0.6	0.0	0.0	1.5	1.4	1.3	3.5	0.0	0.0	5.5	0.0	1.3	0.0	0.0	19.6	8.6	23.9	0.0	1.0	2.8	0.0	0.0	0.8	2.7	0.6	4.6	0.0	0.0	0.0	1.2	3.6	0.0	0.2	1.7	0.5	0.0	0.0	0.0	0.3	5.0	0.9	0.0	0.0	7.5	0.0	1.4	0.0	17.6	37.1	1.0	0.0	0.4	0.0	0.2	0.0	1.2	0.0	0.0	6.6	2.1	1.3	18.9	10.3	0.4	0.3	0.8	0.1	0.0	0.0	0.4
ZYG11A	ZYG11	ENSG00000203995	"Zyg-11 family member A, cell cycle regulator"	Q6WRX3	1	52842511-52894998	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 3.0;testis: 3.8;thyroid gland: 2.3"	"Cell type enhanced"	"Detected in some"		"Prostatic glandular cells: 2.5;Spermatocytes: 3.5;Spermatogonia: 7.9"	"Cancer enriched"	"Detected in many"	7	"testis cancer: 11.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 12.5;hTEC/SVTERT24-B: 10.4;K-562: 10.7;SiHa: 10.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA030378, HPA030379"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA030378: AB_10604159, HPA030379: AB_2673451"	"unprognostic (7.94e-2)"	"unprognostic (6.71e-3)"	"unprognostic (1.04e-2)"	"unprognostic (4.06e-3)"	"unprognostic (1.59e-2)"	"unprognostic (1.00e-4)"	"unprognostic (1.87e-1)"	"unprognostic (2.34e-1)"	"unprognostic (4.56e-2)"	"unprognostic (2.06e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.15e-3)"	"unprognostic (2.95e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.02e-1)"	0.0	0.0	0.1	0.3	0.1	0.1	0.5	0.7	0.1	0.1	0.3	0.0	0.2	0.0	0.1	0.6	0.0	0.0	0.0	0.1	0.1	3.0	1.2	0.0	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.2	0.7	0.1	0.2	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	3.8	0.1	0.3	2.3	0.0	0.7	0.1	0.4	0.4	0.0	2.0	0.3	0.0	0.0	0.0	4.5	1.2	1.4	5.8	4.7	0.1	0.0	0.0	3.0	1.8	0.0	0.1	3.8	0.1	6.8	0.3	7.5	0.0	12.5	0.0	2.7	0.0	0.9	0.0	0.3	10.4	0.0	0.3	1.3	0.0	10.7	5.6	0.2	5.6	0.0	5.6	1.4	0.0	1.0	0.0	1.2	4.9	3.5	0.2	1.4	2.1	10.8	0.4	0.0	4.3	6.0	3.0	0.0	0.0	0.1	0.0	0.0	2.7	4.9	0.0	0.0	0.0	0.9	0.4	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.5	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.7	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.6	0.5	1.6	0.5	0.7	0.0	0.1	0.0	0.0	1.1	0.3	0.4	0.0	0.0	0.3	0.5	0.1	0.1	0.0	0.0	0.4	0.0	0.4	0.2	0.0	0.5	0.0	0.1	0.4	0.9	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.4	0.0	0.0	0.0	0.9	2.5	0.0	1.3	0.2	1.3	0.0	0.6	0.3	3.5	7.9	1.5	0.1	0.3	0.1	0.0	0.1	0.3
ACOXL	FLJ11042	ENSG00000153093	"Acyl-CoA oxidase like"	Q9NUZ1	2	110732539-111120610	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"epididymis: 7.3;lung: 9.3"	"Cell type enriched"	"Detected in some"	5	"Alveolar cells type 2: 41.9"	"Group enriched"	"Detected in some"	6	"lung cancer: 0.6;prostate cancer: 1.1;testis cancer: 2.1;urothelial cancer: 2.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"A-431: 12.1;RPMI-8226: 22.0;RT4: 29.3;U-266/70: 18.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA035392, HPA035393"			Supported	Nucleoli,Cytosol		NA	NA			Cytosol	Nucleoli	"HPA035392: AB_2674604, HPA035393: AB_2674605"	"unprognostic (1.62e-1)"	"unprognostic (7.30e-2)"	"unprognostic (6.77e-4)"	"unprognostic (2.93e-7)"	"unprognostic (1.32e-2)"	"unprognostic (7.84e-5)"	"unprognostic (1.28e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.29e-1)"	"unprognostic (7.31e-2)"	"unprognostic (7.24e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.72e-1)"	"prognostic favorable (6.48e-4)"	1.1	0.6	0.6	0.5	0.7	1.5	0.1	0.2	0.5	0.4	0.1	0.5	0.5	0.5	7.3	0.4	0.3	0.6	1.2	0.4	0.1	0.5	0.3	9.3	0.9	0.4	0.3	0.5	0.2	1.0	2.9	0.3	0.7	0.5	3.2	0.3	0.7	0.6	0.0	1.3	0.7	0.6	0.1	0.0	0.6	0.5	3.2	0.3	0.3	0.8	0.0	1.2	4.7	0.1	0.6	12.1	0.2	0.3	0.2	0.1	0.0	0.8	0.1	0.0	0.0	0.0	0.9	0.7	0.3	0.5	0.1	0.3	1.3	0.0	0.1	0.0	0.3	3.5	0.2	0.5	0.5	0.0	0.0	0.3	0.1	1.2	0.0	0.1	0.3	0.0	0.6	1.8	1.8	0.1	4.4	0.9	0.4	4.2	0.0	0.3	0.6	0.2	22.0	0.0	29.3	2.5	1.0	0.3	0.5	0.1	0.6	0.4	1.2	0.3	0.2	1.0	0.2	0.1	18.7	4.8	0.7	0.0	0.1	0.1	0.7	0.3	0.3	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.0	0.9	0.2	0.2	0.2	0.1	0.1	0.6	0.7	0.2	0.5	0.4	0.1	0.4	0.3	0.5	0.5	0.0	0.3	0.6	0.3	0.0	41.9	0.0	1.0	0.3	0.3	0.0	0.0	0.6	0.1	0.3	0.5	0.0	0.7	0.0	0.0	0.0	0.1	1.3	0.0	0.2	5.4	0.2	0.1	0.2	1.2	0.0	2.2	0.0	0.0	0.4	0.0	0.8	0.0	5.9	0.0	0.0	0.1	0.0	2.0	0.3	0.0	0.0	0.8	8.1	0.0	0.2	0.0	0.0	0.0	0.1	1.0	1.0	1.3	0.1	2.3	0.0	7.5	0.8	0.0	0.1	0.1	0.3	0.0	0.2	0.3	1.6	2.7	0.0	0.3	0.0	1.1	0.0	0.2	0.8
AKAP3	"AKAP110, CT82, FSP95, SOB1"	ENSG00000111254	"A-kinase anchoring protein 3"	O75969	12	4615508-4649051	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	32	"testis: 100.9"	"Group enriched"	"Detected in some"	19	"Early spermatids: 818.1;Late spermatids: 356.6"	"Cancer enriched"	"Detected in many"	6	"testis cancer: 6.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"JURKAT: 3.3;NTERA-2: 4.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA039765, HPA073296"	Enhanced					NA	NA					"HPA039765: AB_10795113, HPA073296: "	"unprognostic (2.89e-2)"	"unprognostic (2.89e-1)"	"unprognostic (5.85e-2)"	"unprognostic (2.36e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.66e-1)"	"unprognostic (6.88e-2)"	"unprognostic (7.03e-3)"	"unprognostic (8.73e-3)"	"unprognostic (5.81e-3)"	"unprognostic (3.08e-1)"	"unprognostic (2.90e-2)"	"unprognostic (8.07e-6)"	"unprognostic (3.22e-3)"	"unprognostic (3.21e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.92e-1)"	0.4	0.8	1.7	0.7	2.5	0.0	0.9	2.5	1.9	0.5	1.3	0.6	0.9	0.6	2.7	0.5	2.4	0.3	2.6	1.6	2.5	2.2	1.1	0.8	0.5	2.4	2.1	1.2	0.9	2.0	0.8	1.0	0.7	2.3	0.9	0.5	0.5	1.5	0.6	0.7	0.7	0.6	0.7	2.2	0.6	0.7	100.9	2.3	0.9	1.6	0.5	0.6	0.5	0.3	3.1	0.0	0.3	1.0	0.2	2.7	0.2	0.6	0.3	0.3	0.3	0.9	0.1	2.0	0.2	0.0	0.6	2.0	0.0	1.5	0.0	0.4	1.5	1.8	0.2	0.0	0.3	0.1	0.2	0.5	0.5	0.4	0.6	0.7	0.2	0.3	3.3	0.8	2.1	0.7	0.3	0.3	0.0	4.0	0.3	0.1	0.5	0.1	0.3	1.1	0.1	0.3	0.1	0.2	0.2	0.9	2.7	0.0	0.0	0.1	0.1	0.3	0.7	0.1	0.9	1.3	0.4	1.0	0.2	0.5	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.4	0.0	0.4	0.5	0.7	0.0	0.5	0.0	0.0	0.0	0.1	1.7	2.5	2.5	1.9	1.6	2.5	2.4	2.1	1.2	2.3	2.2	2.3	3.1	0.1	0.0	0.5	3.9	0.4	0.0	0.2	0.2	0.0	0.2	0.5	0.6	23.7	0.0	0.0	0.0	0.0	1.1	0.0	0.4	0.0	0.3	818.1	1.4	0.1	0.5	0.0	0.0	0.7	0.4	0.3	1.7	1.5	0.3	0.0	0.2	0.4	0.1	0.2	0.0	0.7	0.7	2.0	0.0	0.0	356.6	3.7	0.4	0.0	1.9	0.0	0.7	0.0	1.5	6.3	0.1	0.0	2.2	0.5	0.2	0.5	1.5	2.4	0.3	6.6	0.4	0.4	29.6	5.8	0.5	0.0	0.3	0.2	0.1	0.4	0.2
ANKRD55	FLJ11795	ENSG00000164512	"Ankyrin repeat domain 55"	Q3KP44	5	56099680-56233330	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 6.6;liver: 3.1;lymphoid tissue: 3.7;testis: 9.9"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 161.3;Hepatic stellate cells: 41.7;Inhibitory neurons: 103.5;Late spermatids: 29.1;Spermatocytes: 59.3"	"Cancer enriched"	"Detected in single"	6	"testis cancer: 1.2"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basophil: 22.9;eosinophil: 20.7;naive CD4 T-cell: 19.8"	"Group enriched"	"Detected in many"	74	"granulocytes: 22.9;T-cells: 19.8"	"Group enriched"	"Detected in some"	6	"HEL: 34.4;HMC-1: 17.1;NB-4: 22.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA051049, HPA061649"	Uncertain		Approved	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	NA			"Nucleoplasm, Nuclear speckles"	Cytosol	"HPA051049: AB_2681326, HPA061649: "	"unprognostic (1.00e-4)"	"unprognostic (1.58e-4)"	"unprognostic (2.63e-1)"	"unprognostic (1.93e-1)"	"unprognostic (7.78e-4)"	"unprognostic (1.46e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.40e-1)"	"unprognostic (7.19e-6)"	"unprognostic (2.56e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.01e-1)"	0.4	0.1	3.3	0.7	3.2	0.7	0.1	0.0	2.1	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.2	0.3	0.1	1.1	5.8	0.5	3.1	0.3	3.7	4.2	3.1	1.4	0.1	0.0	0.0	0.2	0.6	4.2	0.0	0.2	0.4	1.0	0.0	0.0	0.4	1.3	0.1	2.6	1.6	0.3	9.9	6.6	3.2	0.2	0.0	2.1	0.3	0.1	5.6	0.2	0.3	0.1	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.7	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	34.4	0.2	1.3	0.0	1.6	17.1	0.0	0.1	0.0	0.0	0.1	4.2	0.1	2.9	1.1	0.0	0.0	0.0	22.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.9	1.7	0.0	2.3	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	2.0	0.4	22.9	0.2	20.7	0.1	0.1	0.0	0.0	4.3	0.0	0.1	0.0	19.8	0.8	2.0	0.0	0.1	0.0	1.0	2.8	3.3	3.2	0.0	2.1	1.1	5.8	4.2	3.1	1.4	4.2	2.6	6.6	5.6	0.3	0.0	0.0	0.3	0.3	0.0	0.1	0.0	0.0	0.5	0.1	0.0	0.5	1.5	0.0	0.0	0.0	0.4	1.4	0.0	0.0	0.0	161.3	0.4	0.8	2.2	0.0	0.0	1.3	0.2	0.3	0.6	0.5	7.5	2.5	0.1	41.7	0.6	0.7	0.0	103.5	0.0	0.0	3.2	1.9	29.1	0.6	1.4	1.8	1.0	0.9	0.9	3.1	18.6	1.0	0.0	0.0	0.7	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.2	59.3	0.6	0.0	0.0	1.2	3.9	0.5	0.0	0.2
C9orf135		ENSG00000204711	"Chromosome 9 open reading frame 135"	Q5VTT2	9	69820817-69906227	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 37.2;testis: 15.6"	"Group enriched"	"Detected in some"	4	"Cone photoreceptor cells: 77.2;Early spermatids: 192.0;Endometrial ciliated cells: 198.0;Respiratory ciliated cells: 277.3"	"Cancer enriched"	"Detected in some"	6	"testis cancer: 7.8"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"naive CD4 T-cell: 1.2;naive CD8 T-cell: 1.7;T-reg: 1.5"	"Lineage enriched"	"Detected in single"	17	"T-cells: 1.7"	"Group enriched"	"Detected in some"	5	"HAP1: 11.7;NTERA-2: 31.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021261, HPA021325"	Uncertain					NA	NA					"HPA021261: AB_1845811, HPA021325: AB_1845812"	"unprognostic (1.05e-2)"			"unprognostic (4.39e-1)"	"unprognostic (1.97e-1)"			"unprognostic (1.39e-1)"		"unprognostic (1.90e-1)"	"unprognostic (5.22e-3)"	"unprognostic (5.72e-1)"	"unprognostic (3.25e-3)"	"unprognostic (4.11e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.60e-2)"		0.0	0.4	1.3	0.0	0.4	0.0	0.0	0.4	0.2	0.8	5.5	0.0	0.0	0.5	0.0	0.0	37.2	1.4	0.0	0.4	1.2	1.3	0.0	2.2	0.0	1.4	1.7	0.1	0.0	0.5	3.0	7.6	0.0	1.0	0.0	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.0	2.5	0.0	0.0	15.6	0.7	0.1	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.2	0.1	0.0	0.0	0.0	0.0	3.1	0.0	0.1	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	1.2	1.7	0.0	0.0	0.0	0.0	1.5	0.0	1.3	0.4	0.4	0.2	0.4	1.2	1.4	1.7	0.1	1.0	2.5	0.7	0.8	0.0	0.0	2.0	0.0	0.0	0.4	0.0	14.7	0.0	0.1	0.3	0.5	2.5	0.0	30.8	1.8	77.2	0.1	0.0	0.7	17.6	0.7	192.0	198.0	2.1	0.5	1.8	0.0	0.5	0.0	0.0	0.5	0.0	2.4	1.3	0.3	0.0	0.0	0.1	0.0	0.4	0.3	12.2	0.0	1.1	22.0	2.5	0.6	0.0	0.0	0.0	0.6	0.0	0.5	0.3	0.2	0.1	0.7	0.0	0.1	0.0	2.2	277.3	1.5	0.0	0.0	5.7	41.8	1.3	0.0	0.1	0.0	0.5	0.1	0.0	0.3
CECR2	KIAA1740	ENSG00000099954	"CECR2 histone acetyl-lysine reader"	Q9BXF3	22	17359949-17558149	"Predicted intracellular proteins"		"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.0;retina: 15.7;skeletal muscle: 22.0"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 109.4;Cone photoreceptor cells: 168.9;Oligodendrocyte precursor cells: 120.1;Oligodendrocytes: 137.7;Rod photoreceptor cells: 94.1"	"Cancer enriched"	"Detected in many"	6	"testis cancer: 8.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 15.5;HAP1: 14.4;K-562: 8.3;NTERA-2: 22.8;SCLC-21H: 10.1;SuSa: 9.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA002943	Approved		Approved	Nucleoplasm,Vesicles		No	No			Nucleoplasm	Vesicles	"HPA002943: AB_1078496"	"unprognostic (2.46e-2)"	"unprognostic (4.10e-2)"	"unprognostic (7.99e-2)"	"unprognostic (1.92e-3)"	"unprognostic (7.48e-3)"	"unprognostic (2.46e-3)"	"unprognostic (2.49e-1)"	"unprognostic (6.67e-2)"	"unprognostic (8.18e-2)"	"unprognostic (3.94e-1)"	"unprognostic (5.36e-2)"	"unprognostic (1.25e-1)"	"unprognostic (8.13e-6)"	"unprognostic (1.13e-1)"	"unprognostic (1.59e-1)"	"unprognostic (6.56e-2)"	"unprognostic (1.94e-2)"	0.7	0.4	5.3	0.2	10.7	0.5	1.0	19.0	5.6	1.3	0.7	0.9	0.2	2.3	0.6	0.4	1.7	0.2	3.1	4.6	5.5	1.2	7.7	2.6	0.1	9.7	8.5	1.7	2.9	2.7	0.0	6.4	1.0	12.0	1.0	0.3	15.7	0.9	0.2	22.0	0.7	0.5	0.9	4.6	0.4	0.6	3.5	8.2	0.2	2.2	10.7	0.2	1.3	1.0	12.4	0.2	0.1	15.5	5.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.6	0.0	0.7	0.1	14.4	0.0	0.0	0.0	7.2	0.0	0.1	0.0	0.4	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.5	8.3	0.0	0.0	0.1	0.0	0.5	22.8	0.0	0.0	1.8	1.0	0.1	0.0	5.1	10.1	0.0	0.0	0.2	0.9	9.0	1.6	2.5	0.1	0.1	3.4	0.0	0.0	5.8	1.4	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	10.7	19.0	5.6	4.6	5.5	9.7	8.5	1.7	12.0	4.6	8.2	12.4	1.9	6.4	10.6	109.4	0.3	0.0	1.1	0.2	0.0	22.1	0.7	0.6	11.8	0.0	0.8	1.8	168.9	10.1	0.0	0.0	0.0	0.1	6.3	6.3	6.2	2.0	0.0	0.0	2.3	0.2	2.5	3.1	0.0	17.2	0.0	3.5	4.2	10.7	0.7	5.0	4.3	0.0	0.0	0.3	0.3	4.0	1.2	1.4	0.0	34.7	0.2	18.3	0.0	120.1	137.7	0.1	0.0	1.2	0.8	1.8	0.0	1.4	0.9	94.1	6.6	33.9	3.2	1.9	15.9	0.1	0.1	33.0	0.2	0.4	0.0	3.6
CLEC6A	"CLECSF10, dectin-2"	ENSG00000205846	"C-type lectin domain containing 6A"	Q6EIG7	12	8455962-8478330	"Predicted membrane proteins"	"Adaptive immunity, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lung: 1.0;lymphoid tissue: 1.1"	"Cell type enhanced"	"Detected in single"		"monocytes: 1.5"	"Cancer enriched"	"Detected in single"	6	"testis cancer: 1.3"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"classical monocyte: 5.4;myeloid DC: 2.2"	"Group enriched"	"Detected in many"	12	"dendritic cells: 2.2;monocytes: 5.4"	"Cell line enriched"	"Detected in single"	4	"NTERA-2: 3.4"	"Not detected"	"Not detected"													NA	NA						"unprognostic (1.44e-1)"	"unprognostic (9.07e-3)"	"unprognostic (5.32e-3)"	"unprognostic (1.27e-2)"	"unprognostic (2.54e-1)"	"unprognostic (4.27e-4)"		"unprognostic (6.06e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.64e-2)"		"unprognostic (7.30e-4)"	"unprognostic (8.89e-2)"	"unprognostic (3.29e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.60e-2)"	0.0	0.0	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.1	0.1	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.7	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CNR2	CB2	ENSG00000188822	"Cannabinoid receptor 2"	P34972	1	23870515-23913362	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Inflammatory response"	"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 3.4;lymphoid tissue: 8.8"	"Cell type enriched"	"Detected in some"	5	"B-cells: 27.8"	"Cancer enriched"	"Detected in single"	6	"testis cancer: 2.5"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	8	"basophil: 49.3;eosinophil: 35.1;memory B-cell: 29.6;naive B-cell: 27.9;NK-cell: 19.4"	"Group enriched"	"Detected in many"	9	"B-cells: 29.6;granulocytes: 49.3;NK-cells: 19.4"	"Cell line enhanced"	"Detected in some"		"Daudi: 5.3;HEL: 4.4;HMC-1: 19.7;U-698: 13.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB009719	Uncertain					NA	NA					"CAB009719: AB_2082784"	"unprognostic (9.45e-4)"	"unprognostic (5.40e-3)"	"unprognostic (8.50e-3)"	"unprognostic (8.19e-3)"	"unprognostic (3.55e-3)"	"unprognostic (9.34e-6)"	"unprognostic (5.58e-3)"	"unprognostic (6.96e-3)"	"unprognostic (1.74e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.53e-1)"	"unprognostic (4.93e-2)"	"unprognostic (1.04e-3)"	"unprognostic (3.67e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.75e-2)"	"unprognostic (4.91e-2)"	0.1	0.0	0.2	2.4	0.1	1.5	0.0	0.4	0.3	0.0	0.2	0.3	0.2	0.1	0.1	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.2	7.4	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.3	0.2	0.1	0.0	1.6	0.2	3.4	0.1	0.0	8.8	0.4	0.1	0.1	1.0	0.2	0.0	7.5	0.4	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.4	0.2	0.0	0.0	0.0	19.7	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.1	0.0	2.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	13.4	0.0	0.1	0.0	49.3	0.1	35.1	3.2	0.1	3.8	29.6	0.1	3.0	0.4	27.9	0.2	1.8	1.2	19.4	0.2	1.7	0.2	2.0	0.2	0.1	0.4	0.3	0.2	0.0	0.1	0.0	0.2	0.2	0.0	0.1	0.3	0.1	3.2	3.9	0.3	27.8	0.6	0.8	0.0	0.0	0.8	0.2	0.0	0.3	0.0	1.8	0.0	0.0	0.1	2.1	0.5	0.0	0.0	0.2	0.1	0.3	0.3	0.0	3.2	0.4	0.0	0.0	0.9	0.0	0.2	3.8	0.1	0.4	0.3	0.2	0.0	0.4	0.0	0.0	0.6	0.9	0.0	0.0	0.8	0.0	0.0	0.5	0.2	5.2	0.0	0.5	0.1	2.0	0.0	0.5	0.5	0.0	0.1	0.7	0.7	0.0	0.9	0.4	0.3	0.2	0.0	0.3	0.3	2.4	0.2	0.0	0.8
COL26A1	"EMI6, EMID2, Emu2"	ENSG00000160963	"Collagen type XXVI alpha 1 chain"	Q96A83	7	101362875-101559024	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 13.3;liver: 5.6"	"Group enriched"	"Detected in some"	7	"Excitatory neurons: 68.4;Inhibitory neurons: 18.5"	"Group enriched"	"Detected in many"	6	"endometrial cancer: 12.6;ovarian cancer: 5.7;prostate cancer: 4.6;testis cancer: 14.7"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	45	"plasmacytoid DC: 9.2"	"Lineage enriched"	"Detected in single"	45	"dendritic cells: 9.2"	"Cell line enhanced"	"Detected in some"		"AF22: 30.0;BEWO: 23.9;HAP1: 10.7;NTERA-2: 25.4;SuSa: 19.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA027059	Approved		Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA			Vesicles		"HPA027059: AB_1848142"	"unprognostic (5.94e-3)"	"unprognostic (2.16e-2)"	"unprognostic (2.19e-2)"	"unprognostic (4.67e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.35e-1)"	"prognostic favorable (2.32e-5)"	"unprognostic (1.48e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.26e-3)"	"unprognostic (1.78e-1)"	"unprognostic (4.24e-3)"	"unprognostic (3.60e-1)"	"unprognostic (1.50e-1)"	"unprognostic (7.48e-4)"	"unprognostic (2.83e-3)"	0.0	4.5	5.4	0.1	8.1	0.2	0.1	0.5	13.3	0.2	0.6	0.0	0.0	0.3	0.1	0.0	0.3	0.1	0.0	9.9	3.8	2.1	5.6	0.4	0.5	1.5	1.3	7.3	0.5	2.2	3.9	0.9	0.3	4.5	2.2	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.3	0.2	0.3	1.0	1.9	1.2	0.1	0.0	0.1	0.2	0.1	5.8	0.0	0.8	30.0	1.9	0.0	0.0	23.9	0.0	0.0	0.0	0.0	1.3	0.0	0.1	4.7	0.0	0.1	0.0	10.7	0.0	0.0	1.0	1.3	0.0	0.0	7.9	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	25.4	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	1.6	0.0	0.0	0.2	19.2	0.3	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	5.4	8.1	0.5	13.3	9.9	3.8	1.5	1.3	7.3	4.5	0.3	1.9	5.8	0.0	0.0	0.0	3.3	0.7	0.0	0.3	0.0	0.0	0.0	0.1	0.3	1.2	0.0	0.0	5.5	0.0	0.3	0.0	0.0	0.0	0.2	1.5	0.1	1.7	0.1	0.0	0.0	68.4	0.6	0.4	0.5	0.0	0.2	0.0	1.0	0.0	3.6	0.1	0.0	18.5	0.0	0.0	0.0	0.0	3.5	0.0	0.5	0.0	5.6	0.0	0.0	0.0	3.5	2.1	0.2	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	2.0	0.0	0.0	0.4	0.0	0.9	0.0	0.4
CPEB1	"CPEB, FLJ13203"	ENSG00000214575	"Cytoplasmic polyadenylation element binding protein 1"	Q9BZB8	15	82543201-82648861	"Predicted intracellular proteins"	"mRNA processing, Translation regulation"	"Activator, Repressor, Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 34.9;testis: 32.7"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 70.0;Inhibitory neurons: 44.3;Oligodendrocytes: 196.5;Spermatocytes: 34.1;Spermatogonia: 62.3"	"Cancer enriched"	"Detected in some"	6	"testis cancer: 14.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive CD8 T-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 37.9;U-2197: 106.0;U-87 MG: 39.1"									HPA040396			Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA040396: AB_2676960"	"unprognostic (3.97e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.77e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.98e-1)"	"unprognostic (7.74e-2)"	"unprognostic (3.90e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.35e-2)"	"unprognostic (7.51e-3)"	"unprognostic (1.97e-3)"	"unprognostic (9.50e-3)"	"unprognostic (8.17e-2)"	"unprognostic (2.05e-2)"	"unprognostic (5.37e-4)"	2.8	5.0	12.8	1.3	17.9	0.2	2.5	20.3	17.9	8.8	4.4	5.3	1.2	4.2	7.9	3.6	8.4	4.0	2.9	13.9	17.2	1.2	0.2	1.6	0.5	22.4	17.8	11.9	14.4	1.3	0.8	21.9	0.3	23.7	2.3	2.4	4.5	1.5	3.8	2.4	1.7	2.5	3.4	22.5	0.6	2.5	32.7	18.1	0.4	2.3	10.6	0.5	7.8	6.2	34.9	0.1	3.6	0.3	0.4	2.6	0.2	0.1	2.8	0.3	1.8	1.4	0.2	0.1	0.0	6.3	1.1	19.5	0.1	5.1	0.0	0.4	0.0	4.2	0.1	0.1	0.1	1.8	0.1	2.3	1.4	0.0	3.5	0.0	0.2	0.0	7.6	8.9	0.2	1.3	0.2	0.6	0.1	8.2	0.1	1.0	0.0	0.2	0.1	0.0	0.1	10.5	2.4	9.2	0.5	37.9	11.2	0.1	1.1	0.1	18.9	7.5	106.0	6.0	5.3	14.3	1.4	39.1	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.1	0.5	0.0	0.1	0.3	1.0	0.0	0.0	0.0	0.0	0.0	0.1	12.8	17.9	20.3	17.9	13.9	17.2	22.4	17.8	11.9	23.7	22.5	18.1	34.9	0.3	0.0	0.0	19.6	0.1	0.8	0.3	0.0	0.0	11.5	0.6	0.3	1.9	0.0	0.0	0.0	10.4	0.0	0.1	0.1	0.0	0.1	12.6	0.5	1.4	0.2	0.0	0.0	70.0	0.0	0.0	5.9	0.5	0.1	1.3	0.3	0.4	0.0	0.3	11.8	44.3	0.0	0.0	0.0	0.8	20.0	4.1	0.4	5.4	10.3	0.1	5.2	0.0	10.1	196.5	0.1	0.0	2.2	0.2	0.5	0.0	0.4	2.2	4.3	6.6	1.9	1.8	34.1	62.3	0.0	0.6	0.1	0.4	0.0	0.0	0.1
CRYGB	CRYG2	ENSG00000182187	"Crystallin gamma B"	P07316	2	208142573-208146158	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Eye lens protein"	Cataract	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"Early spermatids: 1.1"	"Group enriched"	"Detected in some"	6	"ovarian cancer: 1.1;testis cancer: 1.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"hippocampal formation: 3.3;hypothalamus: 2.2;thalamus: 2.0"					HPA043386	Supported		Approved	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"HPA043386: "										"unprognostic (6.73e-2)"					"unprognostic (1.31e-1)"			0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.3	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.4	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.6	0.3	0.3	0.4	0.3	0.3	0.3	0.3	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DCAF4L2	WDR21C	ENSG00000176566	"DDB1 and CUL4 associated factor 4 like 2"	Q8NA75	8	87870747-87874015	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	215	"testis: 21.5"	"Group enriched"	"Detected in some"	4	"Spermatocytes: 68.6;Spermatogonia: 75.3"	"Cancer enriched"	"Detected in some"	6	"testis cancer: 20.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	26	"U-266/84: 7.5"									HPA067584	Uncertain					NA	NA					"HPA067584: AB_2685868"					"unprognostic (4.25e-1)"		"unprognostic (4.81e-2)"		"unprognostic (1.90e-1)"						"unprognostic (1.37e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.6	0.1	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	68.6	75.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DRAXIN	"C1orf187, FLJ34999, Neucrin"	ENSG00000162490	"Dorsal inhibitory axon guidance protein"	Q8NBI3	1	11691710-11725857	"Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	6	"brain: 4.0"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 5.5;NK-cells: 3.1;T-cells: 4.6"	"Group enriched"	"Detected in some"	6	"glioma: 5.1;testis cancer: 2.8"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"basophil: 2.5"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 2.5"	"Cell line enriched"	"Detected in some"	4	"NTERA-2: 27.9"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA014302	Uncertain				"Secreted in brain"	NA	NA					"HPA014302: AB_1853084"	"unprognostic (5.28e-2)"	"unprognostic (2.73e-1)"	"unprognostic (6.58e-2)"	"unprognostic (4.95e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.51e-2)"	"unprognostic (7.47e-2)"	"unprognostic (5.16e-6)"	"unprognostic (4.65e-2)"	"unprognostic (1.15e-1)"	"unprognostic (8.52e-2)"	"unprognostic (5.08e-1)"	0.0	0.0	1.7	0.2	1.5	0.5	0.0	1.1	1.3	0.0	0.6	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.0	1.3	4.0	0.0	0.0	0.1	0.2	2.7	0.7	1.5	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.7	0.0	0.1	0.2	0.1	0.0	0.6	0.1	0.0	0.3	3.0	0.0	0.1	0.0	0.1	0.0	0.0	1.2	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	2.6	0.0	0.9	0.0	0.9	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.4	0.0	5.7	0.0	0.2	0.0	0.1	0.0	0.2	2.1	0.3	27.9	0.0	0.1	6.4	0.2	0.0	0.0	0.0	1.8	0.7	0.1	0.0	0.1	4.6	0.0	0.2	0.2	0.1	1.2	0.0	0.0	0.1	0.1	0.0	0.0	0.5	0.4	2.5	0.3	0.1	0.5	0.1	0.2	0.1	0.1	0.3	0.0	0.2	0.2	0.2	0.8	0.2	0.2	0.1	0.2	0.1	1.7	1.5	1.1	1.3	1.3	4.0	2.7	0.7	1.5	0.8	0.6	3.0	1.2	0.1	0.0	0.5	0.0	1.2	0.5	2.9	0.6	0.0	0.7	0.4	0.4	1.1	1.5	0.1	0.0	2.1	0.1	5.5	0.1	0.0	0.1	0.7	0.4	0.4	0.6	0.0	0.0	0.4	0.2	0.2	0.6	0.0	0.4	1.3	0.1	1.1	0.2	0.4	0.0	0.5	0.7	0.0	0.8	1.9	2.1	0.6	1.2	1.8	0.0	0.3	0.2	3.1	1.5	0.4	0.2	0.2	0.0	1.5	2.1	0.0	0.1	0.0	0.7	0.0	2.3	0.7	0.6	1.7	0.0	0.3	0.0	4.6	0.1	0.1	2.2
EZHIP	"CATACOMB, CXorf67"	ENSG00000187690	"EZH inhibitory protein"	Q86X51	X	51406948-51408843	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"testis: 6.0"	"Group enriched"	"Detected in some"	4	"Cytotrophoblasts: 2.3;Extravillous trophoblasts: 2.5;Syncytiotrophoblasts: 1.9"	"Cancer enriched"	"Detected in some"	6	"testis cancer: 11.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	45	"U-2 OS: 32.8"									"HPA004003, HPA006128"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA004003: AB_2667113, HPA006128: AB_2667517"					"unprognostic (4.21e-2)"			"unprognostic (6.36e-2)"		"unprognostic (3.37e-2)"	"unprognostic (8.58e-3)"	"unprognostic (3.57e-4)"	"unprognostic (1.47e-6)"	"unprognostic (4.55e-2)"	"unprognostic (3.06e-2)"	"unprognostic (4.26e-1)"		0.0	0.2	0.7	0.0	0.7	0.0	0.0	0.6	0.6	0.2	0.4	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.3	0.9	0.2	0.0	0.1	0.0	0.5	0.3	0.4	0.4	0.1	0.0	1.0	0.9	0.4	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.6	0.0	6.0	0.6	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.8	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.7	0.6	0.6	0.3	0.9	0.5	0.3	0.4	0.4	0.1	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0
FOXD3	"Genesis, HFH2"	ENSG00000187140	"Forkhead box D3"	Q9UJU5	1	63322567-63325128	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 3.7"	"Cell type enriched"	"Detected in some"	5	"Melanocytes: 5.4"	"Group enriched"	"Detected in some"	6	"melanoma: 9.9;testis cancer: 3.5"	"Region enriched"	"Detected in single"	5	"medulla oblongata: 1.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"NTERA-2: 13.1;SK-MEL-30: 11.2;WM-115: 15.7"	"Region enriched"	"Detected in single"	13	"olfactory bulb: 3.4"	"Group enriched"	"Detected in some"	13	"olfactory bulb: 8.6;spinal cord: 2.2"	CAB022455	Uncertain					NA	NA					"CAB022455: "	"unprognostic (1.39e-1)"	"unprognostic (3.23e-3)"	"unprognostic (2.33e-3)"		"unprognostic (4.63e-2)"	"unprognostic (7.79e-2)"		"unprognostic (8.22e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.29e-1)"	"unprognostic (9.92e-2)"	"unprognostic (3.28e-1)"		"unprognostic (3.00e-2)"	"unprognostic (8.56e-2)"		"unprognostic (5.83e-2)"	0.3	0.3	0.3	0.2	0.1	0.0	0.3	0.0	0.0	1.4	0.0	3.7	0.2	0.2	0.0	0.4	0.4	0.1	1.0	0.0	0.0	0.1	0.1	0.0	0.0	1.6	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.3	1.4	0.2	0.0	0.4	0.5	1.4	0.5	1.3	0.1	0.2	0.0	1.1	1.5	0.2	0.0	0.2	0.2	0.0	1.5	1.5	0.3	0.1	0.2	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	1.2	0.0	0.0	0.4	3.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.0	2.1	0.0	0.0	0.3	0.0	0.0	13.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	2.7	0.0	11.2	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	15.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.3	0.2	0.2	0.3	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.6	0.0	0.7	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.3	1.0	0.3	0.2	0.3	0.0	0.0	0.0	0.2	0.0
FSD1	"MGC3213, MIR1"	ENSG00000105255	"Fibronectin type III and SPRY domain containing 1"	Q9BTV5	19	4304598-4323843	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 17.8;testis: 7.7"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 12.6;Distal tubular cells: 15.6;Excitatory neurons: 26.6;Horizontal cells: 16.8;Inhibitory neurons: 19.7;NK-cells: 16.5;Spermatogonia: 30.4"	"Group enriched"	"Detected in many"	6	"glioma: 9.2;testis cancer: 11.1"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"MAIT T-cell: 3.6;NK-cell: 5.4;plasmacytoid DC: 1.4"	"Group enriched"	"Detected in many"	35	"dendritic cells: 1.4;NK-cells: 5.4;T-cells: 3.6"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 55.3;SH-SY5Y: 57.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043141	Supported					NA	NA					"HPA043141: AB_10797137"	"unprognostic (8.31e-3)"	"unprognostic (2.38e-1)"	"unprognostic (6.85e-2)"	"prognostic unfavorable (1.61e-4)"	"unprognostic (3.29e-2)"	"unprognostic (9.72e-4)"	"unprognostic (1.33e-1)"	"unprognostic (9.87e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.15e-1)"	"unprognostic (8.16e-3)"	"unprognostic (1.69e-2)"	"unprognostic (3.96e-4)"	"unprognostic (1.82e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.06e-1)"	0.4	0.7	10.6	0.7	12.7	0.7	0.0	9.1	15.7	0.6	2.6	0.6	1.0	0.5	0.1	0.2	0.1	0.3	0.1	14.2	11.0	0.1	0.4	0.2	1.2	14.1	10.6	14.5	0.2	0.1	0.0	2.0	0.8	16.3	0.3	0.1	1.9	0.1	0.1	0.0	0.2	0.9	0.4	7.1	0.9	0.3	7.7	14.7	0.9	0.1	0.0	0.4	0.1	0.3	17.8	0.1	6.7	18.6	9.7	0.1	1.8	7.9	7.9	3.2	25.0	19.3	15.6	0.5	24.3	6.7	5.5	13.1	1.6	17.0	12.8	8.0	15.6	24.9	6.8	5.6	0.5	9.9	0.0	1.6	4.2	0.1	14.6	0.9	10.1	13.5	21.5	1.1	0.0	1.2	18.4	11.2	0.0	23.9	0.1	12.7	0.0	8.8	0.0	0.1	0.6	55.3	57.6	2.1	0.9	1.7	3.0	0.2	0.2	15.3	3.9	17.6	7.3	7.3	13.7	18.4	6.1	9.4	0.0	9.7	0.0	0.0	0.0	0.5	0.0	3.6	0.0	0.1	0.0	0.0	0.0	0.7	0.2	0.0	5.4	0.0	1.4	0.4	0.7	10.6	12.7	9.1	15.7	14.2	11.0	14.1	10.6	14.5	16.3	7.1	14.7	17.8	0.2	0.0	1.1	2.0	0.4	0.1	0.7	0.0	0.0	12.6	0.1	0.0	0.5	0.0	0.6	3.7	2.1	3.2	6.1	0.3	15.6	0.1	4.0	0.1	1.1	0.5	2.4	2.7	26.6	0.0	1.3	1.4	0.5	0.2	2.5	3.5	0.7	0.4	0.8	16.8	19.7	0.4	0.0	0.0	0.0	5.3	0.9	0.3	0.0	3.7	0.1	1.7	16.5	8.5	9.5	0.0	0.1	0.4	0.5	0.3	0.0	0.3	0.0	7.1	0.0	0.9	1.6	3.7	30.4	0.0	0.0	2.7	5.6	0.1	0.3	0.4
GBX2		ENSG00000168505	"Gastrulation brain homeobox 2"	P52951	2	236165236-236168386	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	44	"brain: 11.0"	"Cell type enriched"	"Detected in single"	4	"Early spermatids: 2.8"	"Group enriched"	"Detected in some"	6	"glioma: 1.7;testis cancer: 6.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 47.5;BEWO: 8.3;PC-3: 14.2;TIME: 7.7"	"Region enhanced"	"Detected in single"		"thalamus: 1.3"	"Group enriched"	"Detected in some"	4	"midbrain: 2.5;pons: 2.7;thalamus: 6.4"	HPA067809			Approved	Nucleoplasm		Yes	NA			Nucleoplasm		"HPA067809: AB_2685900"	"unprognostic (5.30e-2)"	"unprognostic (1.15e-1)"	"unprognostic (7.09e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.91e-2)"	"unprognostic (4.49e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.72e-2)"	"unprognostic (2.91e-1)"	"unprognostic (8.13e-2)"	"unprognostic (6.99e-2)"	"unprognostic (3.55e-4)"	"unprognostic (8.69e-7)"	"unprognostic (2.08e-1)"	"unprognostic (1.01e-2)"	"unprognostic (5.47e-2)"	"unprognostic (9.39e-4)"	0.0	0.0	1.4	0.0	1.4	0.0	0.0	2.5	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	7.5	0.0	0.0	0.0	0.0	4.8	5.1	0.1	0.0	0.0	0.0	0.1	0.1	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.2	11.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	2.6	0.9	47.5	1.8	0.0	0.0	8.3	0.7	0.0	1.3	0.0	1.1	0.0	0.0	0.9	0.0	1.4	0.0	0.4	0.1	0.3	0.0	4.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	3.9	0.0	3.4	0.0	0.6	1.2	0.0	0.4	1.2	0.0	14.2	0.0	5.1	0.0	0.4	0.0	0.6	0.3	1.6	0.0	0.5	1.5	0.0	0.0	7.7	0.4	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.4	2.5	0.8	0.4	7.5	4.8	5.1	0.1	3.3	2.7	11.0	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0
GLT1D1	FLJ31978	ENSG00000151948	"Glycosyltransferase 1 domain containing 1"	Q96MS3	12	128853427-128984968	"Predicted intracellular proteins, Predicted secreted proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 28.3;liver: 27.8"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 14.6;Excitatory neurons: 37.6;Inhibitory neurons: 30.2;Late spermatids: 41.7;Oligodendrocyte precursor cells: 34.7"	"Group enriched"	"Detected in some"	6	"liver cancer: 6.2;testis cancer: 2.6;thyroid cancer: 4.2"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	6	"neutrophil: 36.4"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 36.4"	"Group enriched"	"Detected in some"	7	"MOLT-4: 13.0;NTERA-2: 17.9;SCLC-21H: 8.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039051, HPA039052"			Enhanced	Cytosol	"Secreted to blood"	NA	NA			Cytosol		"HPA039051: AB_10673299, HPA039052: AB_10672839"	"unprognostic (1.49e-1)"	"unprognostic (9.85e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.60e-2)"	"unprognostic (3.47e-3)"	"unprognostic (2.88e-1)"	"unprognostic (2.53e-1)"	"unprognostic (4.04e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.93e-5)"	"unprognostic (2.39e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.55e-3)"	"unprognostic (2.41e-1)"	2.5	0.2	5.0	6.8	8.0	28.3	0.2	2.0	10.4	1.8	5.4	0.4	0.1	3.7	1.0	0.5	3.0	1.7	0.5	6.7	8.5	0.8	27.8	2.9	0.3	3.2	3.3	6.9	0.2	0.9	0.6	1.4	0.7	5.4	0.8	0.3	5.7	0.2	1.5	9.1	1.0	0.3	3.1	0.8	12.8	0.3	15.7	3.9	0.9	1.7	9.7	0.4	1.4	0.5	7.4	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.0	0.0	17.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.3	0.0	0.0	0.0	1.9	0.0	0.3	0.0	0.0	1.6	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.5	3.6	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	36.4	0.0	2.0	2.3	0.0	1.6	5.0	8.0	2.0	10.4	6.7	8.5	3.2	3.3	6.9	5.4	0.8	3.9	7.4	0.0	0.0	0.0	1.6	0.4	0.9	0.0	0.0	0.0	0.8	0.0	0.5	0.4	0.0	0.0	0.0	2.1	0.0	4.7	0.0	0.0	0.1	14.6	0.6	2.3	0.1	0.0	0.0	37.6	0.0	0.0	0.4	0.0	4.8	0.0	0.1	1.1	10.4	1.4	0.0	30.2	0.0	0.0	8.5	0.0	41.7	0.3	9.4	1.8	6.5	12.4	10.4	1.0	34.7	1.7	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	1.3	0.0	0.2	0.2	4.0	0.6	0.0	0.3	0.1	0.2	0.0	0.0	0.0
HCN2	"BCNG-2, BCNG2, HAC-1"	ENSG00000099822	"Hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2"	Q9UL51	19	589881-617159	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Sodium transport, Transport"	"Ion channel, Ligand-gated ion channel, Potassium channel, Sodium channel, Voltage-gated channel"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"brain: 129.3"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 60.4;Horizontal cells: 40.4;Inhibitory neurons: 18.7;Oligodendrocytes: 62.1;Rod photoreceptor cells: 14.9"	"Group enriched"	"Detected in many"	6	"glioma: 8.7;melanoma: 5.7;renal cancer: 2.8;testis cancer: 4.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 29.9;HeLa: 15.8;MCF7: 28.4;U-138 MG: 20.2;U-87 MG: 41.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (8.69e-2)"	"unprognostic (3.97e-3)"	"unprognostic (3.31e-4)"	"unprognostic (1.44e-1)"	"unprognostic (2.44e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.55e-1)"	"unprognostic (5.32e-2)"	"unprognostic (1.19e-3)"	"unprognostic (8.00e-2)"	"prognostic unfavorable (6.99e-5)"	"unprognostic (1.07e-1)"	"unprognostic (1.41e-1)"	"unprognostic (5.53e-4)"	"unprognostic (9.72e-3)"	0.1	4.2	46.5	0.2	41.1	0.4	0.1	74.5	100.5	0.1	0.0	0.5	0.1	0.1	0.2	1.6	0.0	0.1	11.8	27.8	42.9	1.3	0.2	0.2	0.3	78.2	72.5	11.0	0.1	0.3	3.4	12.9	0.1	95.2	0.3	0.0	7.5	0.3	0.1	0.1	0.9	0.4	0.1	41.6	0.4	0.4	3.2	129.3	0.1	0.1	0.0	0.3	0.1	0.5	98.2	0.1	29.9	0.3	1.0	3.1	2.1	1.0	2.1	2.4	0.8	0.2	4.3	0.3	0.0	6.5	2.9	2.1	0.2	0.6	0.1	0.1	5.1	12.6	0.0	15.8	0.4	2.2	0.3	5.6	5.6	0.5	0.2	0.1	0.9	0.1	0.7	1.8	0.2	2.1	28.4	0.1	0.0	1.4	0.7	0.8	0.2	0.1	0.7	0.5	0.9	11.3	5.8	7.3	0.1	2.3	0.5	5.9	1.0	2.8	20.2	3.0	0.4	8.4	0.5	0.4	0.2	41.7	1.4	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	46.5	41.1	74.5	100.5	27.8	42.9	78.2	72.5	11.0	95.2	41.6	129.3	98.2	0.5	0.0	0.0	2.0	0.6	0.6	0.0	0.0	1.2	60.4	0.7	0.9	4.1	0.0	0.0	0.0	2.1	0.0	1.6	0.3	0.0	0.1	0.1	0.6	0.4	0.9	1.2	2.7	12.8	0.0	0.3	0.2	0.0	1.2	0.0	0.2	0.7	0.1	0.1	40.4	18.7	0.0	0.0	1.3	0.3	0.4	0.0	1.1	0.0	2.8	0.0	2.7	0.0	5.5	62.1	0.1	0.0	0.7	1.4	0.1	0.0	0.3	0.0	14.9	0.0	0.1	0.5	0.1	1.7	4.5	0.6	0.3	1.2	0.1	0.1	0.1
IRX1	IRX-5	ENSG00000170549	"Iroquois homeobox 1"	P78414	5	3595832-3601403	"Plasma proteins, Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 18.0;breast: 16.3;kidney: 12.5;salivary gland: 18.0"	"Group enriched"	"Detected in some"	4	"Breast glandular cells: 51.4;Breast myoepithelial cells: 87.6"	"Group enriched"	"Detected in many"	6	"breast cancer: 5.6;glioma: 6.6;testis cancer: 15.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 8.8;REH: 37.8;U-251 MG: 15.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA043160	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA043160: AB_10794771"	"unprognostic (1.52e-2)"				"unprognostic (1.26e-2)"	"unprognostic (2.27e-1)"		"unprognostic (3.73e-2)"	"unprognostic (4.30e-3)"	"unprognostic (2.70e-1)"	"unprognostic (2.02e-2)"	"unprognostic (2.03e-2)"	"unprognostic (9.78e-4)"	"unprognostic (5.11e-2)"	"unprognostic (2.78e-2)"	"unprognostic (3.58e-2)"		4.2	0.0	4.1	0.0	3.9	0.6	16.3	7.7	3.8	0.1	0.9	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.3	1.9	5.1	12.5	0.0	3.1	0.1	12.9	8.3	0.6	0.0	0.2	0.2	1.0	0.0	18.0	0.1	0.0	0.1	18.0	0.5	0.1	7.8	0.0	0.0	7.2	0.0	0.0	0.1	6.8	0.3	0.3	0.0	0.0	0.0	0.5	14.2	0.0	0.0	8.8	0.0	0.5	0.6	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	1.8	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.2	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	37.8	0.0	0.0	2.8	0.0	2.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.3	0.0	0.0	15.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	3.9	7.7	3.8	1.9	5.1	12.9	8.3	0.6	18.0	7.2	6.8	14.2	2.5	6.4	3.7	0.0	0.4	3.6	0.0	1.6	1.2	0.8	51.4	87.6	3.5	0.0	1.5	5.5	0.0	0.3	1.0	0.0	15.6	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.3	3.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.8	1.0	0.0	0.5	3.7	0.0	0.2	1.1	3.0	0.3	0.6	0.0	0.0	0.0
MLN		ENSG00000096395	Motilin	P12872	6	33794673-33804003	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	316	"intestine: 257.1"	"Cell type enriched"	"Detected in single"	11	"Enteroendocrine cells: 3.5"	"Cancer enriched"	"Detected in some"	6	"testis cancer: 5.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 3.0;SuSa: 1.1;TIME: 1.3"					"Low region specificity"	"Detected in many"			"HPA069392, HPA077622"	Enhanced				"Secreted to blood"	NA	NA	450000	200000			"HPA069392: AB_2686136, HPA077622: "					"unprognostic (7.70e-2)"					"unprognostic (6.70e-2)"				"unprognostic (4.44e-2)"	"unprognostic (3.14e-1)"			0.0	0.2	0.0	0.6	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.3	257.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.1	0.3	43.7	0.0	0.3	0.0	0.1	0.3	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.6	0.6	0.0	0.0	0.7	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.3	0.0	0.0	0.0	1.1	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.2	0.8	0.3	0.0	0.7	0.3	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MYOG	"bHLHc3, MYF4"	ENSG00000122180	Myogenin	P15173	1	203083129-203086012	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Cell cycle, Differentiation, Myogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	18	"skeletal muscle: 101.8;tongue: 47.1"	"Cell type enriched"	"Detected in single"	36	"Skeletal myocytes: 11.0"	"Group enriched"	"Detected in some"	6	"head and neck cancer: 3.9;testis cancer: 1.7"	"Region enhanced"	"Detected in single"		"cerebellum: 2.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	222	"HSkMC: 29.6;RH-30: 57.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA028336			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA028336: AB_2672562"	"unprognostic (1.71e-1)"				"unprognostic (1.64e-1)"	"unprognostic (1.05e-3)"				"unprognostic (2.22e-1)"			"unprognostic (2.79e-9)"	"unprognostic (3.96e-1)"	"unprognostic (2.56e-1)"			0.0	0.0	0.6	0.0	0.3	0.0	0.0	2.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.3	0.2	0.5	0.0	0.0	0.0	0.0	0.1	0.8	2.2	0.0	0.2	4.1	0.0	101.8	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	1.6	0.0	47.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	29.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	57.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.5	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.2	0.2	0.1	0.1	0.0	0.6	0.3	2.5	0.4	0.6	0.1	0.3	0.2	0.5	0.8	0.0	0.3	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
NUDT10	"DIPP3a, hDIPP3alpha"	ENSG00000122824	"Nudix hydrolase 10"	Q8NFP7	X	51332231-51337525	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 26.5"	"Group enriched"	"Detected in many"	5	"Hepatic stellate cells: 60.3;Peritubular cells: 29.0"	"Group enriched"	"Detected in many"	6	"glioma: 5.0;prostate cancer: 5.4;testis cancer: 7.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 7.5;HAP1: 14.2;HEK 293: 10.5;NTERA-2: 25.8;SH-SY5Y: 5.6;U-2 OS: 12.7"									"HPA047027, HPA057684"	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA047027: AB_2679907, HPA057684: AB_2683501"	"unprognostic (2.61e-2)"	"unprognostic (1.12e-2)"	"unprognostic (7.40e-3)"	"unprognostic (7.84e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.51e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.49e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.80e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.12e-2)"	"unprognostic (5.04e-5)"	0.5	1.7	9.5	0.8	10.7	1.6	0.8	4.5	9.5	5.8	3.0	2.3	0.5	5.3	16.3	1.1	3.6	1.4	0.7	9.2	10.3	3.8	1.3	0.3	0.4	5.8	6.5	9.3	17.0	0.3	0.0	2.1	0.0	6.6	15.1	0.7	1.5	0.5	14.7	0.1	0.4	1.0	4.1	4.4	3.4	1.2	26.5	10.3	0.4	0.6	0.2	0.3	3.9	3.6	10.0	0.0	0.0	7.5	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	1.2	0.0	14.2	0.6	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	25.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	12.7	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	9.5	10.7	4.5	9.5	9.2	10.3	5.8	6.5	9.3	6.6	4.4	10.3	10.0	0.2	0.0	1.3	0.7	0.2	1.0	4.9	0.6	1.8	0.5	0.1	1.5	0.2	0.0	0.6	0.0	0.0	0.7	0.4	0.0	0.0	0.0	1.5	0.7	3.5	2.5	0.0	0.8	5.0	0.0	1.0	3.1	0.0	0.1	0.0	5.0	60.3	0.3	0.2	0.0	1.9	0.0	0.0	1.9	0.4	6.2	5.9	0.1	1.8	1.0	0.0	1.7	0.0	3.5	0.6	0.0	0.0	29.0	1.4	2.8	0.0	0.1	0.0	0.5	0.0	1.5	1.9	3.8	7.8	0.4	0.1	0.4	0.2	0.9	0.0	0.2
OPTC		ENSG00000188770	Opticin	Q9UBM4	1	203494153-203508949	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"Oligodendrocyte precursor cells: 1.5;Spermatocytes: 1.5"	"Cancer enriched"	"Detected in single"	6	"testis cancer: 1.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA034951, HPA034952"	Enhanced				"Secreted in other tissues"	NA	NA					"HPA034951: AB_10669852, HPA034952: AB_2674379"				"unprognostic (3.29e-1)"	"unprognostic (1.56e-1)"					"unprognostic (7.69e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.70e-3)"		"unprognostic (8.24e-2)"	"unprognostic (3.65e-2)"			0.0	0.0	0.5	0.0	0.5	0.0	0.0	0.3	0.3	0.0	0.1	0.1	0.0	0.2	0.3	0.1	0.1	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.9	0.7	0.1	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.5	0.4	0.1	0.0	0.0	0.0	0.1	0.1	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.3	0.3	0.2	0.4	0.9	0.7	0.1	0.8	0.3	0.4	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PAGE5	"CT16.1, CT16.2, PAGE-5"	ENSG00000158639	"PAGE family member 5"	Q96GU1	X	55220346-55224108	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	25	"testis: 26.7"	"Group enriched"	"Detected in some"	7	"Spermatocytes: 131.0;Spermatogonia: 158.8"	"Group enriched"	"Detected in many"	6	"liver cancer: 5.4;melanoma: 11.8;testis cancer: 6.0"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"MAIT T-cell: 1.9"	"Lineage enriched"	"Detected in single"	13	"T-cells: 1.9"	"Group enriched"	"Detected in some"	170	"Karpas-707: 437.8;U-266/84: 992.7"									"HPA052619, HPA055869"	Supported		Approved	Mitochondria		NA	NA			Mitochondria		"HPA052619: AB_2681887, HPA055869: "					"unprognostic (4.03e-1)"		"unprognostic (4.51e-2)"	"unprognostic (7.86e-4)"	"unprognostic (1.39e-2)"		"unprognostic (7.21e-2)"		"unprognostic (1.06e-4)"	"unprognostic (2.29e-1)"	"unprognostic (1.94e-1)"		"unprognostic (3.44e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.1	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.3	26.7	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.7	0.1	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	437.8	0.0	0.0	1.2	0.0	0.1	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.4	0.0	0.0	0.5	1.3	1.6	4.2	992.7	0.5	0.1	0.0	0.7	0.0	0.0	0.0	0.3	0.0	1.9	0.1	1.6	0.7	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.1	1.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	19.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.1	0.0	0.0	0.0	0.0	0.0	0.3	11.9	2.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.5	0.1	0.0	6.6	0.0	0.1	131.0	158.8	0.0	0.1	0.0	1.4	0.0	0.0	0.1
PIM2		ENSG00000102096	"Pim-2 proto-oncogene, serine/threonine kinase"	Q9P1W9	X	48913182-48919024	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 103.2;intestine: 88.4;lymphoid tissue: 165.2"	"Cell type enriched"	"Detected in many"	4	"Plasma cells: 738.8"	"Cancer enriched"	"Detected in all"	6	"testis cancer: 171.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"HDLM-2: 567.6;Karpas-707: 675.0;RPMI-8226: 703.9;U-266/70: 1218.7;U-266/84: 1160.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000285			Approved	Cytosol		NA	NA			Cytosol		"HPA000285: AB_1079619"	"unprognostic (2.34e-3)"	"prognostic favorable (4.05e-5)"	"unprognostic (8.04e-2)"	"unprognostic (7.30e-2)"	"unprognostic (6.41e-3)"	"unprognostic (2.74e-3)"	"unprognostic (2.84e-1)"	"unprognostic (5.23e-2)"	"unprognostic (2.47e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.33e-3)"	"unprognostic (2.73e-1)"	"prognostic unfavorable (1.17e-11)"	"unprognostic (3.36e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.38e-2)"	8.0	7.1	10.6	86.2	11.7	103.2	8.9	9.9	12.7	5.4	10.9	41.2	88.4	5.2	10.1	8.3	12.0	16.9	5.2	14.6	11.6	9.8	10.5	23.7	115.2	9.7	11.2	11.4	10.4	4.7	3.8	10.2	4.9	10.8	7.4	51.4	5.7	36.7	7.3	2.5	6.1	46.8	7.0	8.9	165.2	45.5	10.1	12.0	45.9	10.2	2.8	105.6	46.0	6.5	12.1	17.5	14.8	8.0	15.4	2.8	2.0	11.7	10.5	13.1	14.8	13.2	13.3	12.9	74.5	4.8	5.3	5.6	10.6	25.1	10.0	14.1	567.6	19.6	90.8	15.0	13.9	6.2	21.7	58.7	5.9	8.4	15.3	9.2	12.1	5.5	9.8	97.8	675.0	8.4	12.6	8.4	45.2	165.2	6.1	22.7	9.9	5.4	703.9	14.9	2.6	5.4	7.8	11.5	8.0	8.3	36.9	19.3	29.8	3.6	3.5	2.5	3.1	10.6	1218.7	1160.5	144.1	14.0	19.0	3.7	279.1	8.2	77.7	60.4	9.7	102.3	124.8	165.9	85.6	13.2	73.5	172.4	113.3	195.5	92.7	17.4	15.2	331.9	79.0	10.6	11.7	9.9	12.7	14.6	11.6	9.7	11.2	11.4	10.8	8.9	12.0	12.1	2.9	12.8	36.0	1.0	161.6	20.3	9.0	7.1	45.5	2.6	16.2	4.7	3.5	2.8	9.9	3.7	2.1	5.8	46.8	5.7	3.9	3.3	1.9	15.6	1.0	5.3	13.1	49.9	2.3	3.5	9.1	5.1	10.7	3.9	23.4	1.3	4.2	6.3	7.2	11.8	2.2	7.5	18.3	7.5	123.1	1.8	1.8	19.8	94.3	0.0	99.5	2.2	38.1	0.5	1.0	2.0	3.7	4.1	738.8	4.6	4.1	6.8	16.3	2.1	0.0	3.8	6.2	2.2	1.6	15.7	13.8	2.5	97.1	8.6	11.8	3.4
PIWIL2	"CT80, FLJ10351, HILI, Mili"	ENSG00000197181	"Piwi like RNA-mediated gene silencing 2"	Q8TC59	8	22275316-22357568	"Predicted intracellular proteins"	"Biological rhythms, Differentiation, Meiosis, Oogenesis, RNA-mediated gene silencing, Spermatogenesis, Translation regulation"	"Developmental protein, Endonuclease, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"testis: 29.0"	"Group enriched"	"Detected in many"	4	"Spermatocytes: 62.4;Spermatogonia: 48.9"	"Cancer enriched"	"Detected in some"	6	"testis cancer: 6.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	24	"NTERA-2: 38.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (1.91e-2)"	"unprognostic (1.77e-2)"	"unprognostic (6.51e-2)"	"unprognostic (2.18e-1)"	"unprognostic (8.29e-2)"	"unprognostic (3.58e-3)"	"unprognostic (2.60e-1)"	"unprognostic (2.37e-1)"	"unprognostic (7.59e-2)"	"unprognostic (6.68e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.16e-7)"	"unprognostic (1.27e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.05e-3)"	"unprognostic (2.61e-2)"	0.9	0.2	0.9	0.5	0.9	0.2	1.1	0.9	0.7	1.2	0.5	0.8	6.1	0.9	0.3	0.2	1.2	0.1	0.4	1.2	1.4	0.3	1.1	0.3	0.3	0.7	1.0	0.5	1.9	2.4	0.0	1.5	0.1	0.9	0.8	0.9	0.9	0.8	0.6	2.5	0.7	1.9	0.5	0.4	0.3	1.4	29.0	1.5	0.1	0.5	1.1	0.2	0.8	0.8	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.6	0.3	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	38.1	0.3	0.0	0.0	0.1	0.2	0.0	0.0	1.5	0.0	0.0	0.0	0.1	1.2	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.9	0.9	0.7	1.2	1.4	0.7	1.0	0.5	0.9	0.4	1.5	1.2	1.0	6.4	3.0	3.9	0.2	1.0	1.0	0.3	1.8	6.6	0.6	0.6	1.2	0.0	0.0	1.8	8.4	0.1	0.4	5.9	0.0	0.1	4.5	5.8	1.8	0.8	0.0	0.0	2.5	1.6	0.4	2.3	5.1	8.9	1.3	0.7	0.7	3.6	0.1	0.0	3.4	5.1	0.0	0.3	0.7	5.9	2.8	0.7	1.8	5.6	0.8	0.6	1.0	2.5	4.2	1.3	3.2	2.2	0.1	1.5	13.2	0.4	2.3	3.0	0.0	3.5	1.6	62.4	48.9	0.1	1.6	0.3	0.6	1.0	7.1	0.9
PLA2G2D	sPLA2S	ENSG00000117215	"Phospholipase A2 group IID"	Q9UNK4	1	20111939-20119566	"Enzymes, Metabolic proteins, Predicted secreted proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	23	"lymphoid tissue: 107.3"	"Cell type enhanced"	"Detected in some"		"B-cells: 1.6;dendritic cells: 1.3;Kupffer cells: 2.4;Melanocytes: 5.4;Plasma cells: 8.1"	"Cancer enriched"	"Detected in many"	6	"testis cancer: 25.6"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"memory B-cell: 3.7;naive B-cell: 3.6;plasmacytoid DC: 2.0"	"Group enriched"	"Detected in many"	6	"B-cells: 3.7;dendritic cells: 2.0"	"Cell line enriched"	"Detected in some"	7	"RPMI-8226: 8.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted in other tissues"	NA	NA						"prognostic favorable (4.35e-4)"	"prognostic favorable (8.15e-5)"	"unprognostic (3.88e-3)"	"prognostic favorable (9.74e-4)"	"unprognostic (1.78e-1)"	"unprognostic (2.56e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.82e-5)"	"unprognostic (7.51e-4)"	"unprognostic (2.50e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.64e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.85e-1)"	"unprognostic (8.08e-2)"	"unprognostic (2.60e-1)"	0.7	0.1	0.1	15.9	0.1	0.8	1.0	0.3	0.3	0.3	0.0	2.3	1.5	0.4	0.1	0.4	0.4	1.7	0.2	0.2	0.1	0.1	0.7	2.4	107.3	0.1	0.1	0.2	1.0	0.3	0.0	0.0	0.1	0.2	0.4	3.3	0.1	1.2	0.4	0.0	0.2	4.6	0.2	0.1	11.1	2.3	0.4	0.1	3.2	0.3	0.0	59.6	4.5	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	1.2	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	3.6	0.0	0.0	0.1	0.1	0.0	2.0	0.0	0.1	0.1	0.1	0.3	0.3	0.2	0.1	0.1	0.1	0.2	0.2	0.1	0.1	0.2	0.0	0.0	0.0	0.0	1.6	0.0	0.3	0.0	0.0	0.0	0.1	0.6	0.5	0.0	0.0	0.0	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.4	0.4	0.0	0.0	0.6	5.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.3
POMC	"ACTH, CLIP, LPH, MSH, NPP, POC"	ENSG00000115138	Proopiomelanocortin	P01189	2	25160853-25168903	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted secreted proteins"		"Endorphin, Hormone"	"Cancer-related genes, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	1238	"pituitary gland: 34625.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 119.8;Late spermatids: 352.6;Spermatocytes: 83.0"	"Cancer enriched"	"Detected in many"	6	"testis cancer: 18.5"	"Group enriched"	"Detected in all"	4	"hypothalamus: 27.9;thalamus: 9.3"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HMC-1: 1.5;THP-1: 2.1"	"Region enriched"	"Detected in all"	7	"hypothalamus: 44.0"	"Region enriched"	"Detected in all"	5	"hypothalamus: 88.1"	"CAB002762, HPA046135, HPA063644, CAB079881"	Enhanced				"Secreted to blood"	NA	NA	380000				"CAB002762: , CAB079881: , HPA046135: AB_2679552, HPA063644: AB_2685071"	"unprognostic (8.02e-2)"	"unprognostic (1.47e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.96e-3)"	"unprognostic (3.15e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.09e-1)"	"unprognostic (4.30e-2)"	"unprognostic (8.74e-3)"	"unprognostic (1.38e-1)"	"prognostic favorable (5.70e-4)"	"unprognostic (8.02e-2)"	"unprognostic (4.29e-2)"	"unprognostic (2.94e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.37e-3)"	"unprognostic (3.84e-2)"	5.3	19.2	3.1	1.2	2.2	1.1	3.5	2.8	4.4	2.4	1.8	5.9	0.4	3.1	0.3	13.8	2.2	0.2	10.7	1.9	27.9	4.7	13.0	3.6	1.1	4.1	2.7	1.4	5.0	22.8	0.1	34625.3	1.2	3.5	5.0	0.0	0.2	5.9	0.3	5.7	21.4	4.8	0.1	3.4	11.1	15.6	25.9	9.3	1.3	8.5	5.3	0.4	2.5	3.7	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	1.5	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	12.6	8.6	11.5	13.2	9.1	16.8	8.8	11.3	15.9	17.4	11.6	12.6	3.8	18.2	8.0	27.9	10.5	9.7	3.1	2.2	2.8	4.4	1.9	27.9	4.1	2.7	1.4	3.5	3.4	9.3	4.1	22.3	0.0	2.2	1.0	16.1	4.5	2.2	6.9	2.2	2.6	6.1	6.7	2.5	2.8	2.5	0.0	0.0	0.5	24.4	0.2	15.6	7.8	119.8	0.6	4.9	11.6	0.0	28.8	0.3	17.3	6.0	5.2	4.6	0.6	7.0	9.7	15.4	2.0	34.5	6.7	0.6	0.0	6.1	10.9	7.9	352.6	4.7	17.2	17.8	1.9	8.5	11.5	15.5	0.0	0.3	10.1	1.1	13.2	17.8	4.1	0.1	3.9	0.7	7.5	13.1	4.6	3.8	83.0	27.3	1.6	5.5	0.4	14.9	12.9	0.6	3.8
PTPN5	"PTPSTEP, STEP, STEP61"	ENSG00000110786	"Protein tyrosine phosphatase non-receptor type 5"	P54829	11	18727928-18792721	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	18	"brain: 135.1"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 59.0;Inhibitory neurons: 51.9"	"Group enriched"	"Detected in some"	6	"glioma: 1.6;testis cancer: 2.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 1.1;NTERA-2: 1.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031014, HPA072091"	Supported		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA031014: AB_10669550, HPA072091: AB_2686487"	"unprognostic (1.23e-1)"	"unprognostic (2.91e-2)"	"unprognostic (8.93e-3)"	"unprognostic (1.09e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.13e-2)"	"unprognostic (5.83e-3)"	"unprognostic (3.59e-1)"	"unprognostic (4.91e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.58e-1)"	"unprognostic (8.44e-4)"	"unprognostic (4.21e-3)"	"unprognostic (3.90e-2)"	"unprognostic (9.39e-2)"	"unprognostic (8.49e-2)"	1.5	0.5	26.6	0.2	135.1	0.1	1.1	0.3	59.3	0.5	0.0	0.8	0.1	0.8	0.0	0.5	1.1	0.3	7.4	32.1	21.6	0.3	0.0	1.5	0.1	24.9	7.2	42.7	2.1	0.4	0.2	2.2	0.0	47.2	1.0	0.3	2.0	1.2	0.6	0.7	0.5	0.6	0.4	2.3	0.4	0.9	2.9	17.4	0.0	0.7	3.3	0.0	1.0	1.1	33.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.6	135.1	0.3	59.3	32.1	21.6	24.9	7.2	42.7	47.2	2.3	17.4	33.3	0.1	0.0	0.0	4.2	0.0	0.1	0.0	0.0	0.0	1.8	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.1	0.0	0.2	6.9	0.0	0.0	59.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	51.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	6.5	0.0	0.3	0.0	12.5	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.0	2.7	0.1	0.0	0.0	0.0	0.2	0.0	0.0
RAB3B		ENSG00000169213	"RAB3B, member RAS oncogene family"	P20337	1	51907956-51990700	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 25.2;pituitary gland: 10.7;prostate: 11.1"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 147.4;Alveolar cells type 2: 103.2;Enteroendocrine cells: 293.8;Pancreatic endocrine cells: 92.8"	"Group enriched"	"Detected in many"	6	"prostate cancer: 19.4;testis cancer: 6.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 125.8;BJ hTERT+: 48.4;fHDF/TERT166: 45.8;TIME: 97.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003159, CAB023293"	Enhanced		Approved	"Cell Junctions"		NA	NA			"Cell Junctions"		"CAB023293: , HPA003159: AB_1856005"	"unprognostic (1.10e-1)"	"unprognostic (2.20e-3)"	"unprognostic (5.43e-3)"	"unprognostic (1.65e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.20e-2)"	"unprognostic (8.77e-3)"	"unprognostic (2.79e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.02e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.15e-2)"	0.0	3.0	10.1	0.6	8.7	0.2	0.8	2.9	14.6	0.0	0.0	1.6	0.7	0.1	0.2	0.0	0.2	1.3	0.0	11.0	17.4	0.5	0.7	0.0	0.1	11.4	18.0	11.3	1.5	1.0	0.0	10.7	1.7	25.2	11.1	2.3	1.7	0.3	0.1	0.5	1.9	0.9	0.3	1.7	0.1	1.2	0.3	17.6	0.2	0.0	0.0	0.1	0.1	0.1	11.6	1.8	8.5	1.2	1.3	0.2	2.3	0.2	125.8	48.4	24.8	12.0	10.4	3.7	0.6	2.0	45.8	3.6	0.1	15.4	13.0	41.7	0.0	1.1	0.1	0.6	3.4	2.1	0.0	0.1	1.1	0.4	41.1	9.4	15.4	7.8	1.1	0.4	0.4	27.9	0.3	0.1	0.1	19.9	2.4	1.2	0.3	0.2	0.2	4.0	0.8	4.3	1.1	0.1	0.3	0.1	24.6	0.2	0.3	97.9	24.0	8.8	0.5	41.5	0.2	0.6	0.4	21.9	0.1	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	10.1	8.7	2.9	14.6	11.0	17.4	11.4	18.0	11.3	25.2	1.7	17.6	11.6	1.4	147.4	103.2	0.3	1.1	2.4	6.2	0.3	0.0	5.0	2.2	3.4	0.7	12.8	27.9	0.0	2.1	0.5	0.4	2.0	3.9	4.0	2.4	1.5	1.3	8.2	293.8	0.0	6.6	18.4	0.3	13.9	3.6	1.4	7.6	27.9	0.7	2.7	0.3	0.0	48.1	14.7	14.2	1.3	1.2	1.3	0.6	3.7	1.8	1.0	1.0	31.2	1.0	1.5	1.5	92.8	1.4	1.2	2.3	18.8	1.4	0.2	29.5	3.7	0.0	4.1	4.8	10.4	4.3	0.0	1.4	4.0	3.3	1.1	1.6	2.7
RFPL4A	"RFPL4, RNF210"	ENSG00000223638	"Ret finger protein like 4A"	A6NLU0	19	55759014-55763175	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 1.4;liver: 3.4;testis: 1.6"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 1.1;Langerhans cells: 1.4"	"Cancer enriched"	"Detected in single"	6	"testis cancer: 0.9"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 9.7"	"Group enriched"	"Detected in many"	4	"dendritic cells: 3.1;monocytes: 9.7"	"Cell line enriched"	"Detected in some"	20	"U-2 OS: 68.4"									HPA046368	Uncertain		Approved	Centrosome,Cytosol		NA	NA			"Centrosome, Cytosol"		"HPA046368: AB_2679640"							"unprognostic (3.74e-1)"						"unprognostic (2.96e-2)"		"unprognostic (9.20e-2)"			0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.4	0.0	0.0	0.1	0.0	0.0	0.0	0.2	3.4	0.0	0.4	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.6	0.2	1.6	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.3	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.3	0.0	68.4	0.0	0.2	0.4	0.4	0.2	0.0	0.0	0.0	0.0	9.7	0.0	0.0	2.2	0.0	0.0	0.0	0.0	3.1	0.0	0.1	0.0	1.4	0.0	0.7	0.0	0.0	2.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	1.4	0.2	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.0	0.1	0.3	0.0	0.0	0.0	0.0
SLC16A10	"MCT10, TAT1"	ENSG00000112394	"Solute carrier family 16 member 10"	Q8TF71	6	111087503-111231194	"Metabolic proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 44.7;pancreas: 30.0;skeletal muscle: 41.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 32.8;Excitatory neurons: 33.9;Inhibitory neurons: 47.8;Macrophages: 33.8;Melanocytes: 44.4"	"Cancer enriched"	"Detected in many"	6	"testis cancer: 4.5"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"naive CD4 T-cell: 1.7;T-reg: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HAP1: 49.4;HEK 293: 20.2;RPMI-8226: 37.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA016860	Approved		Supported	"Vesicles,Cell Junctions"		NA	NA			"Vesicles, Cell Junctions"		"HPA016860: AB_2189211"	"unprognostic (2.03e-1)"	"unprognostic (2.08e-1)"	"unprognostic (6.11e-2)"	"unprognostic (3.56e-4)"	"unprognostic (2.24e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.86e-3)"	"unprognostic (5.22e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.10e-3)"	"unprognostic (2.73e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.91e-1)"	2.9	5.5	1.4	3.0	7.6	0.8	0.8	4.4	3.2	0.6	44.7	1.2	8.5	0.5	1.4	0.8	0.8	1.5	2.2	2.1	6.1	10.1	13.6	4.6	1.0	1.7	4.4	1.4	1.0	30.0	7.9	1.1	23.9	1.9	1.3	1.8	0.7	3.2	0.2	41.5	15.4	5.0	0.3	0.2	1.8	5.3	4.3	8.3	11.0	2.7	6.0	1.3	1.9	1.3	3.0	0.9	1.0	0.4	2.2	0.1	0.1	3.1	0.0	0.2	0.8	1.2	9.0	0.4	5.2	1.4	0.3	2.5	0.1	49.4	0.1	1.0	0.1	20.2	8.2	0.7	7.4	0.1	7.6	7.4	0.0	0.0	0.1	0.0	0.2	0.0	10.9	1.4	0.2	0.1	3.6	9.8	0.8	14.6	0.2	3.2	5.4	6.8	37.2	0.0	0.5	10.7	3.3	0.2	0.7	1.8	3.6	1.8	0.9	0.1	0.1	1.8	0.5	2.5	2.6	0.1	1.5	0.3	5.8	0.8	0.4	0.0	0.0	0.1	0.0	0.1	0.1	0.4	0.1	0.0	0.2	1.7	1.5	0.3	0.1	0.0	0.1	1.6	0.1	1.4	7.6	4.4	3.2	2.1	6.1	1.7	4.4	1.4	1.9	0.2	8.3	3.0	0.4	9.6	32.8	2.0	1.5	9.7	10.7	0.0	4.6	6.9	2.0	1.3	9.1	0.0	3.1	5.5	2.1	1.9	0.7	2.1	1.9	0.2	9.0	0.4	0.8	1.4	6.6	1.7	33.9	12.5	1.8	8.9	3.6	1.3	1.3	2.5	4.2	25.4	21.4	1.7	47.8	4.8	0.0	12.4	12.4	8.2	0.0	33.8	44.4	0.0	0.7	1.6	0.0	16.6	0.3	2.0	0.9	0.0	4.8	3.9	10.9	17.7	0.7	0.7	0.0	18.5	1.0	11.6	11.2	1.2	14.8	1.2	5.8	9.2	8.5	1.2
SLC4A8	NBC3	ENSG00000050438	"Solute carrier family 4 member 8"	Q2Y0W8	12	51391317-51515763	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Anion exchange, Antiport, Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 27.6;pituitary gland: 18.0;retina: 11.2;testis: 11.7"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 92.6;Cone photoreceptor cells: 179.3;Excitatory neurons: 115.0;Horizontal cells: 116.1;Inhibitory neurons: 127.8;Oligodendrocytes: 248.9;Spermatocytes: 91.9"	"Group enriched"	"Detected in some"	6	"breast cancer: 1.7;glioma: 2.7;testis cancer: 4.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 21.0;HMC-1: 14.8;SCLC-21H: 15.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077895			Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA077895: "	"unprognostic (4.01e-1)"	"unprognostic (8.15e-2)"	"unprognostic (2.49e-2)"	"unprognostic (6.39e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.96e-2)"	"unprognostic (3.46e-2)"	"unprognostic (7.72e-4)"	"unprognostic (3.13e-2)"	"unprognostic (7.03e-3)"	"unprognostic (1.07e-4)"	"unprognostic (1.70e-1)"	"unprognostic (9.60e-6)"	"unprognostic (1.35e-1)"	"unprognostic (2.57e-1)"	"unprognostic (3.21e-2)"	"unprognostic (2.47e-1)"	0.2	3.1	4.4	0.9	6.5	0.6	1.3	8.8	16.7	1.1	0.0	0.3	0.4	0.3	2.5	0.1	1.7	0.3	0.3	9.9	8.9	1.3	0.1	1.2	1.4	20.4	9.7	4.2	3.3	1.0	2.3	18.0	0.2	23.5	0.4	0.4	11.2	0.9	0.6	0.1	0.2	0.8	0.3	2.3	1.0	1.3	11.7	12.2	0.6	0.2	0.0	1.2	0.2	0.1	27.6	0.2	1.0	11.9	0.1	0.5	0.6	21.0	3.3	5.5	5.2	3.3	7.2	0.2	4.5	0.5	4.5	2.9	0.1	4.7	0.2	4.8	0.9	0.6	2.3	0.3	0.0	0.0	0.7	14.8	0.2	0.2	2.7	0.5	3.1	6.2	1.9	0.1	7.6	2.7	2.6	6.6	1.4	5.1	1.4	3.6	0.1	0.0	0.0	0.6	0.1	15.7	10.7	1.3	1.6	0.0	3.6	2.0	0.5	5.7	3.3	1.7	0.2	4.3	3.8	1.3	0.2	4.6	0.6	0.4	0.4	0.5	0.9	0.4	0.3	0.0	0.1	0.1	0.4	0.7	0.2	0.1	0.2	0.5	0.5	0.8	0.2	0.0	0.2	4.4	6.5	8.8	16.7	9.9	8.9	20.4	9.7	4.2	23.5	2.3	12.2	27.6	1.2	0.0	8.7	33.6	3.1	0.0	0.8	0.2	0.0	92.6	5.0	1.5	1.9	0.0	5.4	1.8	179.3	1.4	4.9	0.5	7.9	0.1	61.9	1.7	0.6	2.4	6.0	0.8	115.0	1.3	5.2	2.1	13.3	0.7	7.6	11.5	1.1	0.2	2.2	116.1	127.8	0.4	0.0	4.7	2.2	32.8	2.8	4.5	1.8	18.7	3.4	11.5	7.2	20.1	248.9	0.1	5.4	3.8	3.5	1.0	1.9	1.0	25.0	19.9	0.0	0.7	1.0	91.9	8.2	0.1	0.1	0.4	4.3	0.9	0.2	1.1
SOWAHD	ANKRD58	ENSG00000187808	"Sosondowah ankyrin repeat domain family member D"	A6NJG2	X	119758588-119760202	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 4.1;lymphoid tissue: 7.2;testis: 5.0"	"Cell type enhanced"	"Detected in some"		"B-cells: 12.2;Extravillous trophoblasts: 38.3;Hofbauer cells: 17.5;Proximal enterocytes: 9.1;Rod photoreceptor cells: 8.2;Syncytiotrophoblasts: 9.4"	"Cancer enriched"	"Detected in many"	6	"testis cancer: 8.5"	"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in many"		"naive B-cell: 11.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 4.3;NB-4: 2.9;SK-BR-3: 3.2;THP-1: 8.3;U-937: 7.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA065955	Uncertain					NA	NA					"HPA065955: AB_2685586"	"unprognostic (1.78e-2)"	"unprognostic (9.37e-2)"	"unprognostic (3.10e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.03e-1)"	"unprognostic (7.20e-2)"	"unprognostic (3.45e-2)"	"unprognostic (6.07e-2)"	"unprognostic (5.80e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.04e-5)"	"unprognostic (5.82e-2)"	"unprognostic (3.14e-2)"	"unprognostic (9.22e-2)"	"unprognostic (3.74e-3)"	0.3	0.4	0.6	1.8	0.6	2.2	0.2	0.6	0.9	0.2	0.4	0.8	2.1	0.1	0.0	0.2	0.3	0.2	0.2	0.6	0.9	0.6	0.3	1.6	2.5	0.9	0.6	0.3	0.3	0.3	0.7	0.1	1.1	1.0	0.2	0.5	0.7	1.7	0.1	0.0	0.3	4.1	0.1	1.3	7.2	1.2	5.0	0.7	0.6	0.1	0.2	1.5	0.3	0.2	1.1	0.4	0.0	0.1	0.1	0.0	0.0	4.3	0.0	0.0	0.4	0.6	0.8	0.1	0.2	0.6	0.0	0.5	0.0	0.0	0.0	0.1	0.7	0.5	0.0	0.0	1.2	0.2	0.8	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.1	0.4	0.0	2.9	0.9	0.8	0.3	2.5	0.1	0.1	0.0	0.1	0.2	0.1	0.9	3.2	0.1	0.3	0.5	8.3	0.1	0.1	0.1	0.1	0.0	0.4	0.0	0.1	0.0	7.4	0.0	0.0	3.1	1.9	0.0	3.3	0.0	9.1	0.4	0.3	2.0	11.7	1.7	0.9	3.3	0.3	2.9	1.0	0.0	0.7	0.6	0.6	0.6	0.9	0.6	0.9	0.9	0.6	0.3	1.0	1.3	0.7	1.1	0.2	0.0	0.0	0.0	12.2	0.0	0.1	0.0	0.0	0.8	0.3	0.5	0.5	1.5	0.0	3.7	0.0	6.1	2.7	3.7	0.0	0.4	0.6	0.1	0.0	0.4	0.0	0.0	0.0	0.4	38.3	0.1	0.5	0.2	0.0	0.2	0.0	0.0	17.5	1.7	0.0	0.9	0.0	5.4	0.6	1.2	0.0	6.5	0.0	0.0	3.4	0.6	1.0	0.0	0.0	0.0	0.5	0.0	1.1	0.0	9.1	0.2	0.0	8.2	0.0	0.0	0.2	0.1	0.9	0.1	0.1	9.4	0.5	0.1	2.3	0.0
TEX49	LINC00935	ENSG00000257987	"Testis expressed 49"	A0A1B0GTD5	12	48727435-48765790	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	19	"testis: 21.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"stomach cancer: 0.6;testis cancer: 1.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA066635			Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA066635: "											"unprognostic (2.63e-2)"			"unprognostic (6.32e-3)"	"unprognostic (8.28e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	21.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TPTE2	TPIP	ENSG00000132958	"Transmembrane phosphoinositide 3-phosphatase and tensin homolog 2"	Q6XPS3	13	19422877-19536762	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	8	"testis: 7.6"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 4.9;Early spermatids: 9.8;Excitatory neurons: 4.6;Inhibitory neurons: 6.3;Microglial cells: 3.7;Oligodendrocyte precursor cells: 7.5;Oligodendrocytes: 3.6;Spermatocytes: 14.8;Spermatogonia: 3.9"	"Cancer enriched"	"Detected in single"	6	"testis cancer: 0.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HDLM-2: 4.8;Karpas-707: 1.3"									HPA068342			Approved	"Endoplasmic reticulum,Cytosol"		NA	NA			Cytosol	"Endoplasmic reticulum"	"HPA068342: AB_2685976"	"unprognostic (2.50e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.25e-2)"	"unprognostic (5.33e-3)"		"unprognostic (1.90e-1)"	"unprognostic (1.24e-1)"	"unprognostic (5.40e-2)"	"unprognostic (3.67e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.05e-12)"	"unprognostic (1.04e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.44e-1)"	"unprognostic (5.00e-3)"	0.0	0.1	0.4	0.1	0.5	0.0	0.1	0.7	0.9	0.0	0.4	0.1	0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.2	0.6	0.5	0.4	0.0	0.0	0.0	0.1	0.1	0.7	0.0	0.0	0.4	0.1	0.1	0.0	0.0	0.1	0.0	0.5	0.2	0.1	7.6	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.8	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.7	0.9	0.5	0.5	0.6	0.5	0.4	0.7	0.5	0.5	0.8	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	9.8	0.1	0.0	0.1	0.0	0.0	4.6	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.7	0.0	0.1	0.0	6.3	0.0	0.0	0.3	0.0	1.5	0.3	0.0	0.0	3.7	0.1	0.5	0.0	7.5	3.6	0.0	0.0	0.0	0.4	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.1	14.8	3.9	0.0	0.1	0.1	0.1	0.1	0.0	0.2
TUBB8B	TUBB8P12	ENSG00000173213	"Tubulin beta 8B"	A6NNZ2	18	47390-49557	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	9	"testis: 2.1"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	6	"testis cancer: 1.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA043640, HPA046280"	Uncertain		Approved	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	NA			Microtubules	"Cytokinetic bridge, Mitotic spindle"	"HPA043640: AB_2678594, HPA046280: AB_2679612"	"unprognostic (4.34e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.29e-1)"	"unprognostic (6.73e-2)"	"unprognostic (1.76e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.09e-1)"	"unprognostic (4.46e-2)"	"unprognostic (7.42e-4)"	"unprognostic (3.96e-2)"	"unprognostic (5.98e-2)"	"unprognostic (4.88e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.78e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
WNT3	"INT4, MGC131950, MGC138321, MGC138323"	ENSG00000108379	"Wnt family member 3"	P56703	17	46762506-46833154	"Disease related genes, Human disease related genes, Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"	Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"liver: 12.4;skin 1: 24.9"	"Group enriched"	"Detected in many"	4	"Basal keratinocytes: 44.5;Early spermatids: 27.7;Late spermatids: 63.8;Suprabasal keratinocytes: 17.6"	"Cancer enriched"	"Detected in many"	6	"testis cancer: 13.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 8.5;U-698: 14.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA049893			Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA			Vesicles		"HPA049893: "	"unprognostic (1.84e-1)"	"unprognostic (2.90e-2)"	"unprognostic (2.35e-1)"	"unprognostic (6.41e-4)"	"unprognostic (4.73e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.26e-1)"	"unprognostic (4.97e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.10e-8)"	"unprognostic (1.77e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.38e-1)"	0.6	0.4	1.3	0.4	1.1	0.1	1.0	0.8	1.0	0.8	0.5	0.6	3.5	0.5	0.0	1.3	0.5	0.1	0.8	0.9	1.2	1.7	12.4	0.9	0.2	1.4	1.9	0.9	0.5	0.8	2.6	1.7	0.2	1.3	1.3	0.2	0.2	1.2	0.0	0.2	24.9	2.7	0.2	0.8	0.7	0.4	4.4	3.0	0.1	1.4	0.0	0.1	0.4	1.1	1.5	3.9	1.7	8.5	0.0	0.1	0.1	0.7	0.8	0.9	3.0	0.0	2.7	1.7	1.6	2.3	2.1	6.1	1.3	0.4	0.0	3.9	0.0	0.4	0.0	3.0	2.3	0.0	0.1	0.1	0.2	1.8	1.1	2.3	3.5	1.1	2.5	1.5	0.0	1.0	1.7	0.0	1.4	0.0	1.0	2.4	2.9	1.9	0.2	0.6	0.0	0.1	0.7	1.6	0.0	1.2	2.1	0.0	4.0	0.2	3.2	2.1	0.4	1.5	0.6	0.2	14.0	0.4	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	1.3	1.1	0.8	1.0	0.9	1.2	1.4	1.9	0.9	1.3	0.8	3.0	1.5	0.2	0.0	1.5	3.9	0.5	44.5	0.6	0.6	3.4	1.1	3.0	1.7	1.3	1.5	0.4	0.0	0.0	2.2	0.1	0.7	1.9	0.7	27.7	0.1	0.7	0.5	0.0	0.0	5.4	2.5	0.1	1.1	0.0	0.2	0.0	0.7	0.4	4.0	0.2	8.4	4.3	0.6	0.0	0.0	1.5	63.8	0.3	0.1	1.8	1.0	0.6	0.2	0.0	4.0	1.1	2.9	1.4	0.4	0.0	1.2	3.7	0.5	0.3	0.8	0.0	1.4	1.1	0.9	2.9	0.8	17.6	0.3	0.0	0.3	0.9	0.3
ABHD12B	"BEM46L3, C14orf29"	ENSG00000131969	"Abhydrolase domain containing 12B"	Q7Z5M8	14	50872053-50904970	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"brain: 6.2;retina: 15.7;skin 1: 10.6"	"Cell type enriched"	"Detected in some"	7	"Muller glia cells: 188.1"	"Cancer enriched"	"Detected in many"	5	"testis cancer: 7.6"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 1.0;neutrophil: 2.1"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 2.1"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	5	"thalamus: 2.1"	"Low region specificity"	"Detected in many"			HPA002873	Uncertain		Uncertain	Nucleoplasm		NA	NA			Nucleoplasm		"HPA002873: AB_2220573"	"unprognostic (6.61e-2)"	"unprognostic (3.49e-2)"	"unprognostic (2.92e-3)"	"unprognostic (1.99e-3)"	"unprognostic (4.63e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.31e-2)"	"unprognostic (6.27e-2)"	"unprognostic (3.30e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.70e-3)"	"unprognostic (3.16e-2)"	"unprognostic (9.62e-2)"	"unprognostic (3.18e-3)"	"unprognostic (1.68e-1)"	0.5	0.0	2.5	0.1	4.9	1.6	1.3	0.1	2.6	0.0	0.7	0.7	0.0	0.3	0.0	0.2	1.0	0.1	0.1	1.2	1.8	0.2	0.0	0.3	0.1	0.7	4.9	1.8	0.0	0.0	0.2	0.1	0.1	1.5	0.0	1.0	15.7	0.0	0.0	0.0	10.6	0.0	0.0	0.0	0.0	0.0	0.6	6.2	0.3	0.1	0.0	0.0	0.0	0.1	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	2.5	4.9	0.1	2.6	1.2	1.8	0.7	4.9	1.8	1.5	0.0	6.2	3.5	2.4	0.0	0.0	0.3	0.1	0.4	0.1	1.5	0.0	3.4	0.1	0.1	1.9	0.0	5.0	1.8	2.1	0.1	0.0	2.2	0.0	0.0	7.7	2.5	0.2	0.7	0.0	0.0	9.9	0.0	0.0	0.7	0.0	0.6	1.3	0.0	0.0	0.0	0.1	0.0	0.7	1.0	4.1	0.0	0.0	5.8	1.2	0.1	0.0	0.0	0.0	188.1	0.0	1.0	4.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	26.4	18.1	0.0	0.1	1.2	0.3	0.2	0.0	1.4	0.3	0.1	0.0	1.8	0.2
ACTN3		ENSG00000248746	"Actinin alpha 3"	Q08043	11	66546395-66563334	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	72	"skeletal muscle: 1686.9"	"Group enriched"	"Detected in some"	6	"Early spermatids: 6.3;Late spermatids: 16.2;Skeletal myocytes: 15.2"	"Cancer enriched"	"Detected in single"	5	"testis cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	12	"HDLM-2: 13.6"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA006035	Uncertain		Uncertain	"Actin filaments"		NA	NA		11000000	"Actin filaments"		"HPA006035: AB_1078095"	"unprognostic (2.54e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.16e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.35e-4)"	"unprognostic (1.40e-3)"	"unprognostic (5.37e-3)"	"unprognostic (5.09e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.66e-2)"	"unprognostic (6.71e-9)"	"unprognostic (2.06e-1)"	"unprognostic (6.98e-2)"	"unprognostic (5.16e-2)"	"unprognostic (2.48e-1)"	0.2	0.0	0.0	0.1	0.1	0.0	0.2	0.9	0.2	0.2	0.0	0.2	0.0	0.1	0.0	1.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.2	0.3	0.1	1686.9	0.1	0.1	0.0	0.0	0.1	0.1	4.0	0.0	0.0	0.3	23.5	0.0	0.2	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.2	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	6.3	0.0	0.0	0.2	1.8	0.0	0.2	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	16.2	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.2	0.2	1.1	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0
ADD2	ADDB	ENSG00000075340	"Adducin 2"	P35612	2	70607618-70768225	"Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 67.1;brain: 50.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 31.7;Erythroid cells: 74.1;Excitatory neurons: 70.1;Horizontal cells: 139.7;Inhibitory neurons: 51.8;Late spermatids: 62.4"	"Group enriched"	"Detected in many"	5	"glioma: 5.2;testis cancer: 11.1"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 2.2;non-classical monocyte: 2.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HAP1: 33.9;JURKAT: 33.1;K-562: 46.5;NTERA-2: 86.7;RPMI-8226: 41.7;SCLC-21H: 42.8;U-251 MG: 47.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009796, HPA034509, HPA034510"	Supported		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		18000	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB009796: AB_2223572, HPA034509: AB_2674201, HPA034510: AB_2674202"	"unprognostic (3.58e-2)"	"unprognostic (2.68e-4)"	"unprognostic (3.83e-2)"	"unprognostic (3.01e-4)"	"unprognostic (1.94e-1)"	"unprognostic (2.25e-3)"	"unprognostic (1.35e-1)"	"unprognostic (3.26e-1)"	"unprognostic (3.49e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.20e-2)"	"unprognostic (8.93e-2)"	"unprognostic (4.47e-7)"	"unprognostic (2.81e-4)"	"unprognostic (1.77e-1)"	"unprognostic (1.71e-3)"	"unprognostic (1.31e-3)"	1.1	1.7	10.4	2.0	19.3	67.1	0.9	15.4	50.5	0.5	0.0	0.7	0.1	0.5	0.3	1.4	0.7	0.3	0.6	15.4	20.0	0.1	0.2	1.0	2.5	15.6	7.8	22.5	0.2	1.7	0.2	4.1	0.7	12.9	0.5	0.3	16.2	0.2	0.2	0.8	0.3	0.9	1.1	0.0	1.3	0.3	2.8	6.7	0.7	1.4	1.0	2.2	0.5	0.6	37.4	17.6	20.5	0.8	0.3	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	10.5	2.7	12.3	0.0	33.9	0.0	0.0	0.1	20.1	1.7	0.2	0.0	0.0	4.7	0.1	0.0	0.0	0.0	0.0	8.0	0.0	33.1	46.5	0.0	0.0	0.1	0.2	1.6	86.7	0.0	0.4	0.0	0.5	41.7	5.7	0.0	42.8	19.3	21.6	0.1	0.1	9.4	0.1	10.7	0.8	0.2	0.9	0.0	47.1	14.1	17.0	0.0	0.7	7.1	7.9	0.0	0.0	0.0	0.0	1.2	0.0	2.2	0.0	0.0	0.0	1.7	0.8	0.4	0.0	0.0	2.3	0.0	0.0	0.3	10.4	19.3	15.4	50.5	15.4	20.0	15.6	7.8	22.5	12.9	0.0	6.7	37.4	2.8	0.0	0.5	1.0	4.2	0.1	0.3	0.0	0.0	23.3	0.2	0.0	2.5	0.0	0.0	0.0	2.1	0.1	0.0	0.1	0.0	0.1	31.7	0.1	0.2	3.9	0.0	74.1	70.1	1.1	0.2	1.0	1.1	0.1	0.0	0.0	2.9	0.0	0.2	139.7	51.8	0.0	0.0	1.0	0.4	62.4	0.9	0.6	1.8	2.8	0.8	0.8	0.0	17.6	1.8	0.3	0.0	0.7	0.1	0.6	0.0	0.0	0.0	8.7	0.0	0.6	0.3	3.5	6.8	0.0	0.1	0.3	0.5	1.5	0.0	1.3
AL589987.1		ENSG00000230707	"Novel protein (LOC389895)"		X	140091415-140092911	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"adrenal gland: 6.4;brain: 3.8"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"endometrial cancer: 2.0;glioma: 1.0;ovarian cancer: 0.9;testis cancer: 1.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.7;HAP1: 2.1;NTERA-2: 1.7;U-251 MG: 2.2"									HPA041568	Uncertain					NA	NA					"HPA041568: AB_10796677"				"unprognostic (1.27e-1)"	"unprognostic (3.32e-2)"					"unprognostic (2.17e-1)"		"unprognostic (4.08e-2)"			"unprognostic (5.26e-1)"	"unprognostic (1.28e-2)"		0.1	6.4	2.5	0.1	3.0	0.0	0.0	2.4	3.8	0.9	1.2	0.0	0.0	0.4	0.1	0.0	0.5	0.0	0.0	2.8	2.6	0.0	0.0	0.0	0.0	2.4	2.2	2.7	0.3	0.0	0.1		0.0	2.4	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	2.3	0.2	0.0	1.4	2.3	0.0	0.1	0.0	0.0	0.0		2.4	0.0	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	3.0	2.4	3.8	2.8	2.6	2.4	2.2	2.7	2.4	2.3	2.3	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
BRDT	"BRD6, CT9"	ENSG00000137948	"Bromodomain testis associated"	Q58F21	1	91949343-92014426	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Differentiation, Meiosis, mRNA processing, mRNA splicing, Spermatogenesis, Transcription, Transcription regulation"	"Activator, Chromatin regulator"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	48	"testis: 132.6"	"Group enriched"	"Detected in some"	4	"Early spermatids: 1313.5;Spermatocytes: 561.9"	"Cancer enriched"	"Detected in some"	5	"testis cancer: 6.4"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.5"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in single"	30	"BEWO: 21.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			CAB012237	Approved					NA	NA					"CAB012237: AB_304756"	"unprognostic (5.00e-2)"	"unprognostic (2.86e-1)"		"unprognostic (2.22e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.49e-1)"		"unprognostic (5.25e-2)"		"unprognostic (2.53e-3)"	"unprognostic (6.26e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.22e-13)"	"unprognostic (2.70e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.00e-3)"	0.0	0.0	0.4	0.5	0.4	2.7	0.3	0.7	0.7	0.1	0.4	0.1	0.4	0.1	0.2	0.0	0.0	0.4	0.0	0.4	0.2	0.0	0.1	0.2	0.4	0.5	0.1	0.3	0.1	0.0	0.0	0.0	0.9	0.4	0.1	0.0	0.3	0.2	0.1	0.0	0.6	0.0	0.1	0.1	0.2	0.1	132.6	0.3	0.2	0.2	0.0	0.0	0.2	0.0	0.8	0.2	0.0	0.0	0.1	0.0	0.0	21.3	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.1	0.4	0.0	0.7	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.3	0.4	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.7	0.2	0.1	0.1	0.0	0.0	0.1	0.2	0.3	0.0	0.1	0.1	0.2	0.0	0.1	0.1	0.0	0.1	0.0	0.0	1.5	0.3	0.2	0.3	0.1	0.3	0.1	0.1	0.1	0.0	0.2	0.2	0.2	0.8	0.3	0.1	0.2	0.1	0.2	0.4	0.4	0.7	0.7	0.4	0.2	0.5	0.1	0.3	0.4	0.1	0.3	0.8	0.0	0.0	0.0	1.6	0.0	0.0	0.2	0.0	0.0	0.0	1.2	1.1	0.6	0.0	0.0	0.0	0.0	38.0	1.7	0.0	0.0	0.0	1313.5	0.0	0.0	1.8	0.0	0.0	1.2	0.0	22.2	3.2	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.9	0.0	0.0	0.0	0.0	228.7	7.8	0.8	0.0	0.0	0.0	0.0	1.0	1.0	0.3	0.0	0.0	6.8	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.2	2.3	561.9	19.9	0.0	0.0	19.4	1.1	0.1	0.0	0.1
C19orf84		ENSG00000262874	"Chromosome 19 open reading frame 84"	I3L1E1	19	51388289-51390591	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"testis: 22.2"	"Cell type enriched"	"Detected in some"	10	"Spermatogonia: 31.9"	"Group enriched"	"Detected in some"	5	"ovarian cancer: 1.3;testis cancer: 3.5"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	8	"K-562: 6.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA068082	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA068082: AB_2685949"	"unprognostic (5.94e-2)"	"unprognostic (7.72e-2)"	"unprognostic (8.51e-2)"	"unprognostic (1.43e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.13e-3)"	"unprognostic (9.28e-4)"	"unprognostic (1.31e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.84e-1)"	"unprognostic (2.61e-7)"	"unprognostic (8.30e-3)"	"unprognostic (1.86e-1)"	"unprognostic (2.92e-2)"	"unprognostic (3.99e-3)"	0.0	0.0	0.4	0.2	0.4	0.7	0.0	0.4	0.7	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.5	0.4	0.0	0.0	0.1	0.3	0.5	0.4	0.2	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.4	0.0	22.2	0.4	0.1	0.0	0.0	0.1	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.4	0.4	0.7	0.5	0.4	0.5	0.4	0.2	0.4	0.4	0.4	1.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.6	0.0	2.2	0.3	0.3	0.0	0.0	0.2	0.0	3.1	0.0	0.0	0.0	1.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	31.9	0.0	0.0	0.0	0.1	0.1	0.0	0.0
C2CD5	"CDP138, KIAA0528"	ENSG00000111731	"C2 calcium dependent domain containing 5"	Q86YS7	12	22448583-22544546	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 244.6;Inhibitory neurons: 253.4;Oligodendrocyte precursor cells: 149.3;Oligodendrocytes: 103.0"	"Cancer enriched"	"Detected in all"	5	"testis cancer: 39.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046194	Approved		Supported	"Centriolar satellite,Cytosol"		NA	NA			Cytosol	"Centriolar satellite"	"HPA046194: AB_10965327"	"unprognostic (2.59e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.97e-3)"	"unprognostic (1.08e-3)"	"unprognostic (1.17e-2)"	"unprognostic (8.47e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.69e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.81e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.87e-3)"	13.4	16.0	12.3	17.3	20.3	20.4	19.8	35.6	25.0	18.0	5.9	27.6	26.6	22.6	17.4	13.6	22.3	22.7	11.8	17.6	15.3	22.5	12.1	16.8	22.9	12.9	13.2	17.4	24.2	16.9	28.2	20.9	14.2	15.1	14.7	28.8	56.7	15.6	13.9	10.2	17.7	22.5	18.5	3.9	19.4	28.1	20.1	10.3	27.2	22.5	16.5	21.9	13.2	13.9	22.1	18.6	18.0	39.2	21.4	25.3	33.4	24.9	20.1	21.4	36.6	43.3	19.9	24.0	20.9	8.7	18.9	20.4	16.2	25.2	16.4	50.7	34.2	26.3	25.9	19.8	17.9	23.3	35.4	29.9	19.3	11.7	23.6	41.1	34.6	26.9	28.5	17.2	13.2	23.9	19.8	33.5	53.9	78.3	36.0	13.5	28.9	43.3	28.5	21.7	14.9	18.1	15.7	18.1	17.5	19.3	57.5	23.2	23.4	23.4	21.9	17.5	19.9	21.5	10.6	8.8	33.4	13.5	26.4	16.4	23.2	6.7	3.3	5.6	14.9	7.6	7.6	8.4	5.6	6.8	5.1	7.3	5.9	6.9	14.2	17.1	3.9	9.1	4.9	12.3	20.3	35.6	25.0	17.6	15.3	12.9	13.2	17.4	15.1	3.9	10.3	22.1	12.4	9.6	19.6	41.1	14.8	6.9	4.3	4.1	10.2	30.4	8.0	6.6	16.2	14.3	16.3	5.5	52.1	3.9	13.6	16.9	5.9	3.5	72.2	14.3	13.2	11.2	16.2	17.1	244.6	4.6	2.6	11.5	30.1	11.7	17.7	18.8	16.8	6.7	8.3	18.5	253.4	20.4	6.1	33.8	6.7	17.6	8.7	17.3	7.2	84.3	9.1	6.4	10.3	149.3	103.0	3.4	11.4	7.9	12.0	3.9	13.6	6.4	17.4	42.9	6.6	12.0	11.7	14.1	7.8	13.3	5.5	2.6	11.5	9.4	16.5	4.6
CCER2		ENSG00000262484	"Coiled-coil glutamate rich protein 2"	I3L3R5	19	38908980-38912158	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 4.9"	"Cell type enriched"	"Detected in some"	8	"Melanocytes: 617.2"	"Group enriched"	"Detected in many"	5	"glioma: 5.1;testis cancer: 1.9;urothelial cancer: 5.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 1.4;THP-1: 1.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA069716	Uncertain				"Secreted - unknown location"	NA	NA		8800			"HPA069716: AB_2686183"	"unprognostic (6.58e-2)"	"unprognostic (2.24e-2)"	"unprognostic (5.03e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.76e-3)"	"unprognostic (3.88e-2)"	"unprognostic (2.16e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.08e-3)"	"unprognostic (3.82e-2)"	"unprognostic (1.01e-9)"	"unprognostic (1.75e-2)"	"unprognostic (3.87e-2)"	"unprognostic (3.61e-1)"	"prognostic favorable (2.32e-4)"	0.5	0.6	2.2	0.2	2.3	0.7	0.8	2.2	3.4	0.9	1.8	0.8	0.3	0.7	0.3	1.2	1.1	0.1	0.6	2.2	2.1	1.3	3.0	0.5	0.3	2.8	2.2	2.1	0.8	0.5	0.2	2.5	0.1	2.4	1.4	0.1	1.0	0.9	0.2	2.3	3.9	0.9	0.1	2.0	1.1	0.6	4.9	2.2	0.4	1.2	0.0	0.1	0.9	0.8	2.3	0.1	1.4	0.3	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.5	1.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.4	0.4	0.0	0.3	0.0	0.0	0.6	0.5	0.1	0.2	0.1	0.0	0.0	0.0	0.9	0.2	0.9	0.0	0.9	0.2	0.4	0.3	0.0	0.2	0.7	0.1	0.2	0.1	0.6	0.4	0.2	0.1	0.1	0.0	0.1	1.0	1.4	0.0	0.0	0.7	0.0	0.0	0.6	0.5	0.2	0.1	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	2.3	2.2	3.4	2.2	2.1	2.8	2.2	2.1	2.4	2.0	2.2	2.3	0.1	3.2	0.0	3.9	0.1	76.9	0.1	0.1	0.0	2.5	0.4	0.5	0.4	1.5	0.1	1.8	4.2	0.4	0.4	0.3	0.0	0.0	1.4	0.3	0.2	0.6	1.2	0.4	2.3	0.0	0.1	0.8	0.0	0.5	0.0	0.3	0.0	0.6	0.2	0.0	3.3	0.2	0.0	0.3	7.2	4.9	0.3	0.2	617.2	0.0	0.0	1.3	0.0	3.5	2.2	0.1	0.2	0.0	0.0	0.1	0.2	0.2	0.4	3.8	0.0	0.4	0.7	1.1	2.1	0.0	3.0	0.3	0.4	0.2	0.6	0.1
CGB3	CGB	ENSG00000104827	"Chorionic gonadotropin subunit beta 3"	P0DN86	19	49022869-49024333	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"placenta: 9.9"	"Cell type enriched"	"Detected in some"	7	"Syncytiotrophoblasts: 865.9"	"Group enriched"	"Detected in some"	5	"pancreatic cancer: 2.9;testis cancer: 4.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	20	"BEWO: 65.8"									"CAB000042, CAB010884, HPA038925, HPA038934"	Enhanced		Approved	Cytosol	"Secreted to blood"	NA	NA			Cytosol		"CAB000042: , CAB010884: AB_259037, HPA038925: AB_2676272, HPA038934: AB_2676277"									"unprognostic (1.39e-1)"		"unprognostic (7.88e-2)"				"unprognostic (6.92e-2)"		"unprognostic (1.04e-2)"	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.3	0.0	2.1	9.9	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.2	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.3	0.0	0.0	65.8	0.0	0.0	0.0	0.0	0.0	1.1	0.3	0.1	0.2	0.1	0.0	0.1	0.0	0.0	1.4	0.6	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.6	0.5	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.3	0.2	0.3	0.0	0.3	0.2	0.1	0.4	0.0	0.0	2.1	0.7	0.0	0.0	0.1	0.4	0.0	3.3	1.3	0.9	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.4	0.2	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	118.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	865.9	0.0	0.0	0.0	0.0
CLEC9A	"CD370, DNGR-1, HEEE9341, UNQ9341"	ENSG00000197992	"C-type lectin domain containing 9A"	Q6UXN8	12	10030678-10066031	"CD markers, Predicted membrane proteins"	Endocytosis	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 7.6"	"Group enriched"	"Detected in some"	5	"Langerhans cells: 30.2;Macrophages: 19.5;Microglial cells: 15.9;Spermatocytes: 9.4"	"Cancer enriched"	"Detected in some"	5	"testis cancer: 2.7"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	96	"myeloid DC: 22.0;neutrophil: 7.9"	"Group enriched"	"Detected in many"	96	"dendritic cells: 22.0;granulocytes: 7.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"													NA	NA						"unprognostic (1.13e-3)"	"unprognostic (1.21e-2)"	"unprognostic (5.00e-3)"	"unprognostic (7.85e-3)"	"unprognostic (1.28e-2)"	"unprognostic (1.56e-5)"	"unprognostic (6.58e-4)"	"unprognostic (4.73e-3)"	"unprognostic (9.65e-2)"	"unprognostic (7.45e-3)"	"unprognostic (8.15e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.21e-1)"	"unprognostic (7.93e-2)"	"unprognostic (3.45e-5)"	"unprognostic (2.17e-1)"	0.3	0.2	1.1	1.6	1.5	0.5	0.6	2.0	1.9	0.3	1.1	0.7	0.9	0.5	0.2	0.2	0.2	0.9	0.2	1.4	1.7	0.3	0.8	0.6	7.6	2.3	2.0	0.9	0.7	0.3	0.2	0.3	0.2	2.0	0.6	0.6	0.1	1.1	0.4	0.1	0.3	1.5	0.7	2.4	4.8	0.4	3.0	1.9	5.0	0.2	0.2	2.2	1.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.0	0.0	0.0	0.0	7.9	0.1	0.0	0.0	0.0	0.4	1.1	1.5	2.0	1.9	1.4	1.7	2.3	2.0	0.9	2.0	2.4	1.9	2.5	0.8	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.5	0.9	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	2.7	0.0	0.0	1.4	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	3.2	30.2	1.8	0.0	19.5	0.0	15.9	2.1	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	9.4	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0
CNMD	"BRICD3, CHM-I, CHM1, LECT1, MYETS1"	ENSG00000136110	Chondromodulin	O75829	13	52703264-52739820	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Chondrogenesis, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 4.8;retina: 8.4;salivary gland: 6.8"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"glioma: 1.5;lung cancer: 6.0;testis cancer: 5.8;thyroid cancer: 4.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	35	"NTERA-2: 46.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010510	Uncertain				"Secreted to extracellular matrix"	NA	NA		9500			"HPA010510: AB_10602021"	"unprognostic (7.52e-3)"		"unprognostic (1.34e-1)"		"unprognostic (7.36e-2)"			"unprognostic (1.45e-2)"		"unprognostic (1.15e-1)"	"unprognostic (3.22e-1)"	"unprognostic (2.84e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.96e-1)"		0.0	0.0	1.7	0.0	4.8	0.0	0.0	2.1	2.5	0.0	2.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.8	2.3	0.0	0.0	1.6	0.0	2.3	2.2	1.7	0.0	0.3	0.0	1.0	0.1	2.5	0.5	0.0	8.4	6.8	0.0	0.1	0.0	0.1	0.0	2.5	0.3	0.0	1.8	2.3	0.1	3.3	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	46.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.7	4.8	2.1	2.5	1.8	2.3	2.3	2.2	1.7	2.5	2.5	2.3	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
CSH2	"CS-2, CSB, hCS-B"	ENSG00000213218	"Chorionic somatomammotropin hormone 2"	P0DML3	17	63872012-63873766	"Predicted intracellular proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	218	"placenta: 3319.6"	"Cell type enriched"	"Detected in some"	12	"Syncytiotrophoblasts: 275.5"	"Cancer enriched"	"Detected in single"	5	"testis cancer: 0.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	27	"BEWO: 9.3;SuSa: 13.1"									HPA043715	Supported				"Secreted to blood"	NA	NA					"HPA043715: AB_2678632"		"unprognostic (1.68e-1)"								"unprognostic (1.85e-1)"					"unprognostic (1.86e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.1	1.2	0.0	2.0	3319.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	15.2	0.0	8.6	5.2	0.2	0.0	1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	13.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.9	0.9	0.0	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	275.5	0.0	0.0	0.0	0.0
CTH		ENSG00000116761	"Cystathionine gamma-lyase"	P32929	1	70411218-70439851	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Cysteine biosynthesis"	"Calmodulin-binding, Lyase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"liver: 123.9;ovary: 34.7"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 38.0;Hepatocytes: 141.6"	"Group enriched"	"Detected in all"	5	"liver cancer: 30.0;testis cancer: 8.1"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HHSteC: 39.7;Karpas-707: 63.8;SK-MEL-30: 85.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021591, HPA023300"	Enhanced					NA	NA		220000			"HPA021591: AB_1847321, HPA023300: AB_1847322"	"unprognostic (3.41e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.76e-1)"	"unprognostic (7.66e-2)"	"unprognostic (2.45e-3)"	"prognostic favorable (8.69e-4)"	"unprognostic (1.71e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.43e-3)"	"unprognostic (5.05e-3)"	"unprognostic (3.25e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.97e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.26e-1)"	3.4	13.1	3.4	1.3	3.0	3.4	3.0	3.3	4.0	2.4	3.9	5.2	5.2	2.3	1.6	4.5	3.8	1.9	2.1	3.2	6.6	13.6	123.9	3.1	0.9	3.4	3.4	3.2	34.7	17.1	1.4	2.9	1.1	3.2	4.3	6.3	8.2	2.5	2.1	3.6	1.2	5.3	1.3	2.6	1.0	7.5	4.2	3.3	0.6	7.8	3.0	1.3	2.2	1.9	3.2	10.2	1.5	7.1	10.0	8.5	4.8	15.0	4.3	4.1	3.8	15.7	3.2	6.4	5.8	3.4	3.1	9.3	4.9	27.3	3.1	7.2	17.3	5.9	7.0	5.1	9.4	39.7	7.8	1.7	7.5	24.4	7.5	8.8	1.5	3.2	11.9	14.0	63.8	2.2	3.2	2.7	1.9	7.2	4.2	5.9	3.0	3.7	16.2	7.3	0.1	3.9	3.3	6.6	7.7	85.7	13.3	2.6	4.6	1.1	1.2	7.7	5.7	4.1	23.8	15.3	3.1	9.8	16.1	3.1	0.8	0.3	0.1	1.2	0.2	2.1	2.2	1.1	1.7	0.5	1.7	3.2	1.5	0.4	0.2	0.2	0.7	0.3	0.6	3.4	3.0	3.3	4.0	3.2	6.6	3.4	3.4	3.2	3.2	2.6	3.3	3.2	2.8	6.4	5.6	16.6	6.7	2.5	8.0	2.2	6.2	9.4	6.2	5.8	1.9	5.7	2.5	5.5	10.4	0.8	5.5	16.1	11.7	1.8	27.2	38.0	6.4	3.3	3.0	7.4	7.8	4.2	1.8	13.6	14.8	19.7	0.0	1.9	3.9	141.6	1.2	0.0	7.4	7.9	2.0	3.5	5.7	5.2	1.2	4.7	19.6	1.9	0.0	4.4	0.0	7.1	4.2	6.4	12.9	4.1	10.8	4.0	11.1	29.2	0.7	11.6	0.0	2.8	17.7	1.4	0.6	4.8	2.0	0.8	11.2	4.5	9.1	3.8
DCLK3	"DCAMKL3, DCDC3C, KIAA1765"	ENSG00000163673	"Doublecortin like kinase 3"	Q9C098	3	36712422-36764349	"Enzymes, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.9;testis: 2.8"	"Cell type enriched"	"Detected in some"	6	"Early spermatids: 53.8"	"Cancer enriched"	"Detected in single"	5	"testis cancer: 1.2"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA040685, HPA053234"	Approved		Approved	Vesicles,Cytosol		NA	NA			Cytosol	Vesicles	"HPA040685: AB_2732487, HPA053234: "	"unprognostic (9.09e-3)"	"unprognostic (1.41e-3)"	"unprognostic (2.75e-1)"	"unprognostic (2.66e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.05e-1)"	"unprognostic (7.07e-2)"	"unprognostic (6.11e-5)"	"unprognostic (7.94e-3)"	"unprognostic (5.80e-2)"	"unprognostic (3.25e-3)"	"unprognostic (1.36e-2)"	0.4	0.1	1.0	0.4	3.9	0.1	0.2	0.2	1.5	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.3	0.8	1.5	0.0	0.0	0.0	0.0	0.7	0.2	0.9	0.0	0.1	0.2	1.0	0.3	0.7	0.0	0.1	1.5	0.1	0.0	0.9	0.1	0.1	0.3	0.7	0.0	0.0	2.8	0.5	1.3	0.3	0.9	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	3.9	0.2	1.5	0.8	1.5	0.7	0.2	0.9	0.7	0.7	0.5	0.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	53.8	0.1	0.1	0.5	0.0	0.0	1.6	0.0	0.0	0.2	0.0	0.2	0.0	0.2	0.0	0.0	2.0	0.0	0.9	0.0	0.0	0.0	0.4	8.9	0.3	0.1	0.0	0.0	0.0	0.9	0.0	0.5	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	2.1	0.0	0.1	3.3	1.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DMRTB1		ENSG00000143006	"DMRT like family B with proline rich C-terminal 1"	Q96MA1	1	53459399-53467488	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	73	"testis: 63.1"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 54.3;Late spermatids: 120.2;Spermatocytes: 222.5;Spermatogonia: 138.5"	"Cancer enriched"	"Detected in single"	5	"testis cancer: 1.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA036490, HPA058553"	Enhanced					NA	NA					"HPA036490: AB_10671844, HPA058553: AB_2683753"										"unprognostic (2.20e-3)"					"unprognostic (1.36e-1)"	"unprognostic (1.67e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	63.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	120.2	4.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	222.5	138.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DPF1	"BAF45b, NEUD4, neuro-d4"	ENSG00000011332	"Double PHD fingers 1"	Q92782	19	38211006-38229714	"Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"brain: 23.6"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 17.9;Early spermatids: 25.4;Excitatory neurons: 24.6;Horizontal cells: 45.4;Inhibitory neurons: 16.3;Late spermatids: 23.4"	"Group enriched"	"Detected in some"	5	"glioma: 5.6;testis cancer: 3.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HAP1: 19.7;SCLC-21H: 22.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049148	Enhanced	Approved	Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Nucleoplasm, Cytosol"	Mitochondria	"HPA049148: AB_2680653"	"unprognostic (7.72e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.38e-2)"	"unprognostic (4.11e-3)"	"unprognostic (8.16e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.29e-4)"	"unprognostic (1.40e-2)"	"unprognostic (2.72e-1)"	"unprognostic (5.49e-2)"	"unprognostic (4.30e-3)"	"unprognostic (2.87e-2)"	"unprognostic (1.11e-16)"	"unprognostic (2.56e-1)"	"unprognostic (3.75e-1)"	"unprognostic (6.96e-2)"	"unprognostic (8.20e-4)"	0.1	0.3	11.0	0.4	16.0	0.1	0.1	2.3	23.6	0.1	0.1	0.1	0.0	0.2	0.0	0.1	0.2	0.0	0.4	17.3	7.5	0.0	0.0	0.3	0.1	5.0	5.7	15.2	0.3	0.1	0.0	2.5	0.1	8.3	0.1	0.0	2.5	0.2	0.0	0.2	0.3	0.1	0.2	2.1	0.1	0.1	2.5	8.0	0.2	0.0	0.0	0.1	0.1	0.1	15.4	4.6	3.8	15.8	11.7	1.1	0.8	1.6	4.8	2.7	8.0	6.7	2.7	0.4	7.5	3.2	3.7	3.2	2.8	19.7	2.6	3.6	7.2	3.9	2.5	2.0	1.1	0.4	1.9	2.1	0.9	0.1	4.7	1.5	1.0	1.5	5.5	5.6	0.4	7.7	6.4	4.1	0.5	2.9	1.3	4.4	7.5	8.0	1.6	0.8	1.4	22.9	7.8	5.4	0.5	1.0	1.9	2.4	0.4	1.8	11.5	3.7	2.8	4.4	2.9	10.3	9.9	6.1	2.6	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	16.0	2.3	23.6	17.3	7.5	5.0	5.7	15.2	8.3	2.1	8.0	15.4	0.4	0.0	0.0	3.3	0.1	2.3	0.1	1.1	0.0	17.9	0.2	0.6	1.2	0.0	0.1	0.0	8.4	0.1	0.0	0.1	0.0	0.0	25.4	1.5	2.2	0.9	0.0	0.0	24.6	0.0	2.0	1.5	0.0	0.7	0.0	4.3	0.4	0.0	0.2	45.4	16.3	0.0	0.0	0.3	0.4	23.4	0.6	0.1	0.0	1.0	0.0	3.3	0.0	12.5	4.8	0.1	0.0	2.6	0.0	0.1	0.0	0.1	1.4	3.1	0.0	0.7	1.9	6.7	12.6	0.0	1.1	0.1	0.2	1.6	0.0	0.1
ELAVL2	"HEL-N1, HuB"	ENSG00000107105	"ELAV like RNA binding protein 2"	Q12926	9	23690104-23826337	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"brain: 34.9;testis: 43.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 62.2;Excitatory neurons: 135.5;Inhibitory neurons: 390.6;Spermatogonia: 159.2"	"Cancer enriched"	"Detected in many"	5	"testis cancer: 7.1"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A-431: 25.4;AF22: 37.2;SCLC-21H: 119.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022222, HPA063001"	Enhanced	Supported	Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB022222: , HPA063001: AB_2684918"	"unprognostic (3.51e-1)"	"unprognostic (4.18e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.47e-1)"	"unprognostic (6.67e-2)"	"unprognostic (1.79e-1)"	"unprognostic (4.26e-2)"	"unprognostic (8.94e-2)"	"unprognostic (3.23e-1)"	"unprognostic (1.01e-1)"	"unprognostic (9.74e-4)"	"unprognostic (3.98e-1)"	"unprognostic (9.08e-4)"	"unprognostic (8.30e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.65e-1)"	0.1	1.3	9.6	0.1	18.2	0.5	0.2	2.5	34.9	0.1	0.0	0.4	0.1	0.5	0.5	0.2	0.1	0.2	0.1	11.1	14.1	0.5	0.0	0.2	0.2	16.4	14.3	12.9	1.1	0.0	0.1	1.0	0.1	20.9	0.3	0.5	5.0	0.2	0.1	0.1	0.5	0.2	0.2	0.3	0.1	0.1	43.5	18.3	0.0	0.3	0.0	0.1	0.4	0.2	33.7	25.4	0.3	37.2	0.2	0.1	0.3	0.1	0.3	0.0	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.0	7.8	9.9	15.9	0.2	0.0	7.1	0.0	0.1	0.3	0.0	0.2	0.6	0.5	9.6	0.0	11.0	0.0	0.3	0.1	0.9	1.2	5.3	0.0	0.1	0.1	9.8	0.0	11.8	0.1	13.3	0.2	0.0	0.0	119.6	11.5	0.3	0.3	0.3	9.4	0.6	1.9	0.0	0.2	7.9	0.2	0.2	0.1	0.1	0.1	1.3	0.1	1.4	1.1	0.3	0.5	0.1	0.2	0.2	0.3	0.1	0.1	0.1	0.5	0.3	0.4	1.5	0.4	0.2	0.3	0.2	0.0	9.6	18.2	2.5	34.9	11.1	14.1	16.4	14.3	12.9	20.9	0.3	18.3	33.7	0.9	0.0	0.0	7.8	0.0	1.0	0.4	0.4	0.6	8.8	0.9	0.6	0.9	0.0	0.1	0.0	0.0	0.0	0.0	1.4	1.9	0.1	62.2	0.5	0.2	1.8	4.2	0.0	135.5	0.0	0.0	0.8	0.0	0.2	0.0	10.6	0.0	0.0	0.1	16.8	390.6	1.2	0.0	0.0	0.7	39.5	3.1	0.2	0.0	7.5	0.0	2.8	0.0	5.5	5.5	0.0	0.2	1.5	0.0	0.4	0.0	0.1	0.0	10.6	0.0	1.4	1.0	13.9	159.2	0.5	0.9	0.0	0.1	0.7	1.3	0.6
EMILIN3	"C20orf130, dJ620E11.4, EMILIN5"	ENSG00000183798	"Elastin microfibril interfacer 3"	Q9NT22	20	41359962-41366818	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"epididymis: 54.1"	"Cell type enhanced"	"Detected in some"		"Endometrial stromal cells: 17.7;Granulosa cells: 7.6;Microglial cells: 4.7;Oligodendrocyte precursor cells: 3.5;Peritubular cells: 4.9;Skeletal myocytes: 3.2"	"Group enriched"	"Detected in many"	5	"glioma: 10.8;testis cancer: 2.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 6.3;HAP1: 11.1;NTERA-2: 7.0;SCLC-21H: 13.0"	"Region enriched"	"Detected in single"	30	"cerebellum: 3.3"	"Region enriched"	"Detected in single"	4	"spinal cord: 4.1"	"HPA044034, HPA059912, HPA078559"	Enhanced		Approved	"Golgi apparatus,Microtubules,Cytokinetic bridge"	"Secreted to extracellular matrix"	Yes	NA		1200000	"Golgi apparatus"	"Microtubules, Cytokinetic bridge"	"HPA044034: AB_2678783, HPA059912: AB_2684158, HPA078559: "	"unprognostic (1.66e-4)"	"unprognostic (1.85e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.65e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.71e-1)"	"unprognostic (7.66e-2)"	"unprognostic (2.18e-3)"	"unprognostic (2.57e-1)"	"unprognostic (6.54e-2)"	"unprognostic (7.66e-2)"	"unprognostic (3.13e-7)"	"unprognostic (2.64e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.97e-1)"	"unprognostic (9.62e-2)"	0.5	1.5	2.5	0.1	2.4	0.0	3.6	2.4	3.6	7.6	1.8	3.6	0.6	2.3	54.1	0.8	4.2	0.3	7.4	2.2	2.2	1.0	0.6	0.3	0.1	3.7	2.7	1.6	9.0	0.2	0.1	1.8	0.0	3.3	6.7	0.3	0.0	1.0	10.0	0.9	3.2	1.7	1.0	2.7	0.1	2.1	1.7	2.6	0.5	0.3	2.6	0.2	2.4	4.7	3.3	0.0	0.1	6.3	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.3	0.0	0.0	0.1	0.0	0.4	0.0	11.1	0.0	0.2	0.0	1.3	0.0	0.0	0.4	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	13.0	1.3	0.0	0.0	0.0	2.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	2.4	2.4	3.6	2.2	2.2	3.7	2.7	1.6	3.3	2.7	2.6	3.3	0.6	0.0	0.0	0.7	0.0	0.9	0.2	0.0	0.0	0.3	1.2	2.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	17.7	0.4	0.0	0.0	1.1	0.0	0.0	0.8	0.0	0.7	0.0	7.6	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.3	1.8	0.1	0.0	4.7	0.0	0.1	0.0	3.5	0.1	0.0	1.2	4.9	0.0	0.2	0.3	0.1	0.0	0.0	0.0	3.2	0.6	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.2	0.1
ESX1	"ESX1L, ESXR1"	ENSG00000123576	"ESX homeobox 1"	Q8N693	X	104250038-104254933	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	69	"testis: 9.0"	"Cell type enriched"	"Detected in some"	25	"Spermatogonia: 98.0"	"Cancer enriched"	"Detected in single"	5	"testis cancer: 0.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	11	"TIME: 24.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA051992, HPA073330"	Enhanced		Supported	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA051992: AB_2681684, HPA073330: "															"unprognostic (1.87e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	24.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	98.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
FAM151A	"C1orf179, MGC27169"	ENSG00000162391	"Family with sequence similarity 151 member A"	Q8WW52	1	54609181-54623556	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"intestine: 66.8;kidney: 176.1"	"Group enriched"	"Detected in some"	15	"Proximal enterocytes: 478.5;Proximal tubular cells: 294.8"	"Group enriched"	"Detected in many"	5	"liver cancer: 2.3;renal cancer: 3.2;testis cancer: 5.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	44	"CACO-2: 78.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA016840	Approved					NA	NA		10000			"HPA016840: AB_2669461"	"unprognostic (1.89e-1)"	"unprognostic (6.90e-3)"	"unprognostic (3.73e-2)"	"unprognostic (1.97e-6)"	"unprognostic (1.71e-2)"	"unprognostic (4.84e-3)"	"unprognostic (1.02e-1)"	"unprognostic (3.46e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.05e-2)"	"unprognostic (4.91e-3)"	"unprognostic (9.99e-2)"	"prognostic favorable (4.09e-5)"	"unprognostic (5.85e-2)"	"unprognostic (8.97e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.40e-3)"	0.6	0.3	1.7	0.7	1.2	0.2	0.1	1.8	1.2	0.0	5.0	2.1	2.4	0.1	0.0	0.3	0.0	0.1	3.1	0.7	0.3	176.1	16.9	0.0	5.4	2.7	2.3	0.0	0.3	0.6	0.0	0.1	0.0	1.5	0.1	1.3	0.3	0.5	0.0	1.0	0.1	66.8	0.0	0.5	0.8	0.7	0.6	2.8	0.2	0.4	0.0	1.9	0.1	0.0	0.8	0.7	0.1	0.1	0.0	0.1	0.0	0.2	0.3	0.0	0.0	0.0	78.9	0.9	0.0	0.3	0.0	0.2	1.1	0.0	0.0	0.0	0.5	0.0	1.7	0.4	0.4	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	1.5	0.0	0.0	0.8	0.0	0.0	1.6	0.4	0.5	0.1	0.0	0.0	0.3	0.0	0.5	0.5	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.2	1.8	1.2	0.7	0.3	2.7	2.3	0.0	1.5	0.5	2.8	0.8	0.0	0.0	0.0	3.6	2.4	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	7.3	0.0	0.0	0.0	9.3	13.7	0.0	5.2	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.2	0.0	0.0	0.4	16.8	0.0	0.3	0.0	14.3	0.0	1.8	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	25.0	0.0	0.0	0.0	478.5	294.8	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.0	0.1	18.1	0.0
FATE1	"CT43, FATE"	ENSG00000147378	"Fetal and adult testis expressed 1"	Q969F0	X	151716035-151723194	"Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	102	"testis: 240.9"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 23.6;Late spermatids: 73.0;Sertoli cells: 13.1;Spermatocytes: 10.3;Theca cells: 9.6"	"Cancer enriched"	"Detected in some"	5	"testis cancer: 6.1"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA034604	Enhanced					NA	NA					"HPA034604: AB_10602318"	"unprognostic (1.82e-2)"	"unprognostic (7.13e-2)"	"unprognostic (1.22e-1)"	"unprognostic (9.89e-3)"	"unprognostic (8.40e-5)"	"unprognostic (2.10e-1)"	"unprognostic (3.70e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.16e-1)"	"unprognostic (5.07e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.50e-2)"	"prognostic unfavorable (2.88e-4)"	"unprognostic (4.40e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.68e-1)"	"unprognostic (5.34e-2)"	0.4	0.3	0.5	0.1	0.5	0.0	0.2	0.3	1.1	0.0	0.4	0.1	0.3	0.1	0.0	0.0	0.0	0.1	0.6	0.4	0.4	0.5	0.1	0.2	0.1	0.5	0.4	0.4	0.1	0.1	0.1	0.5	0.0	0.4	0.2	0.1	0.0	0.1	0.0	0.5	0.1	0.3	0.0	0.4	0.1	0.2	240.9	0.4	2.3	0.6	0.3	0.1	0.1	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.3	1.1	0.4	0.4	0.5	0.4	0.4	0.4	0.4	0.4	0.7	3.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.6	0.0	0.0	3.8	1.8	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	73.0	7.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	5.3	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.3	0.0	10.3	5.9	0.0	0.0	0.0	0.0	9.6	0.0	0.1
FGF4	"HBGF-4, HST, HST-1, HSTF1, K-FGF, KFGF"	ENSG00000075388	"Fibroblast growth factor 4"	P08620	11	69771022-69775341	"Cancer-related genes, Predicted secreted proteins, RAS pathway related proteins"	Differentiation	"Developmental protein, Growth factor, Heparin-binding, Mitogen"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"Cardiomyocytes: 1.1;Early spermatids: 3.1;Late spermatids: 1.4;Spermatocytes: 1.5"	"Cancer enriched"	"Detected in some"	5	"testis cancer: 13.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	62	"NTERA-2: 16.1;SuSa: 5.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA011209	Uncertain				"Secreted in other tissues"	NA	NA	326000				"HPA011209: AB_1848527"			"unprognostic (1.47e-2)"	"unprognostic (6.22e-2)"										"unprognostic (7.77e-2)"	"unprognostic (8.56e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FOXI3		ENSG00000214336	"Forkhead box I3"	A8MTJ6	2	88446787-88452693	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"placenta: 5.2;retina: 2.0"	"Group enriched"	"Detected in some"	5	"Cytotrophoblasts: 3.3;Muller glia cells: 6.4;Syncytiotrophoblasts: 2.7"	"Cancer enriched"	"Detected in some"	5	"testis cancer: 10.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"BEWO: 43.2;SuSa: 55.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (2.72e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.92e-1)"	"unprognostic (6.72e-4)"		"unprognostic (8.11e-3)"		"unprognostic (1.36e-1)"		"unprognostic (6.58e-2)"				"unprognostic (5.29e-2)"	"unprognostic (1.15e-1)"			0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	5.2	0.1	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	43.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.1	10.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	2.5	0.0	0.0	0.0	55.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.6	0.5	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	2.7	0.0	0.0	0.0	0.0
GP5	CD42d	ENSG00000178732	"Glycoprotein V platelet"	P40197	3	194394821-194398354	"CD markers, Plasma proteins, Predicted membrane proteins"	"Blood coagulation, Cell adhesion, Hemostasis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"lymphoid tissue: 1.1"	"Cell type enhanced"	"Detected in single"		"Paneth cells: 1.1"	"Cancer enriched"	"Detected in single"	5	"testis cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"HEL: 16.3"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA072646			Approved	Cytosol		NA	NA		270000000	Cytosol		"HPA072646: "	"unprognostic (3.74e-2)"	"unprognostic (3.40e-1)"	"unprognostic (5.22e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.35e-3)"	"unprognostic (1.69e-3)"	"unprognostic (1.68e-1)"	"unprognostic (3.41e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.65e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.21e-2)"	"unprognostic (4.18e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.94e-1)"	0.1	0.0	0.2	0.6	0.0	0.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.1	0.0	0.0	0.1	0.0	0.1	0.1	1.1	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.1	0.0	0.1	0.3	0.2	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0
GTSF1	"Cue110, FAM112B, FLJ32942"	ENSG00000170627	"Gametocyte specific factor 1"	Q8WW33	12	54455950-54473602	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"testis: 187.8"	"Group enriched"	"Detected in some"	11	"Early spermatids: 1181.4;Late spermatids: 1810.3;Spermatocytes: 531.1"	"Cancer enriched"	"Detected in many"	5	"testis cancer: 23.2"	"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HL-60: 294.6;HMC-1: 207.5;K-562: 290.1;NB-4: 442.3;THP-1: 405.8;U-266/84: 337.6;U-937: 216.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA038876, HPA038877"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA038876: AB_10670911, HPA038877: AB_2676251"	"unprognostic (1.17e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.11e-2)"	"unprognostic (6.74e-3)"	"unprognostic (2.56e-2)"	"unprognostic (3.94e-2)"	"unprognostic (9.93e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.45e-1)"	"unprognostic (7.59e-2)"	"unprognostic (3.97e-5)"	"unprognostic (4.16e-3)"	"unprognostic (1.92e-1)"	"unprognostic (2.77e-1)"	"unprognostic (9.18e-2)"	0.5	0.6	0.3	2.4	0.5	6.4	0.4	0.5	0.5	0.1	0.1	0.9	1.4	0.3	0.5	0.2	0.1	1.1	0.9	0.2	0.6	0.4	1.3	1.9	5.7	0.5	0.3	0.3	0.3	0.2	0.1	0.2	14.2	0.5	0.4	2.0	0.3	0.3	0.1	0.4	0.5	1.4	0.3	0.2	3.6	0.7	187.8	0.4	6.1	0.4	0.1	11.0	1.0	0.2	1.0	1.1	0.0	0.3	0.0	0.0	0.0	146.3	0.2	0.0	0.0	0.0	0.3	0.1	114.1	52.2	0.0	0.1	0.4	151.3	0.0	0.0	59.7	0.1	0.1	0.0	0.1	0.0	294.6	207.5	0.0	0.0	0.0	0.1	0.1	0.0	85.3	290.1	113.6	0.0	0.0	0.2	442.3	0.1	0.0	0.0	0.2	0.0	158.8	0.0	0.2	0.2	0.9	0.0	5.7	0.3	2.5	0.1	405.8	1.4	0.1	10.3	0.1	0.7	113.1	337.6	0.7	0.0	216.5	0.1	28.3	9.4	18.9	23.5	9.8	28.3	33.4	26.3	33.1	16.9	33.7	24.3	25.4	4.5	32.2	11.2	33.6	31.0	16.7	0.3	0.5	0.5	0.5	0.2	0.6	0.5	0.3	0.3	0.5	0.2	0.4	1.0	0.1	0.0	0.6	0.3	4.2	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.0	0.0	0.0	0.0	48.1	6.3	0.4	0.0	0.0	1181.4	0.0	0.0	1.7	0.0	2.1	0.2	0.0	106.6	4.1	0.0	0.0	1.3	0.0	0.0	0.0	12.0	0.0	0.2	0.2	0.0	2.2	3.0	1810.3	15.8	4.0	3.6	0.0	10.3	0.0	6.2	0.0	0.1	0.0	0.0	10.1	6.5	0.0	0.0	0.0	0.0	0.0	13.1	0.1	0.1	531.1	105.5	0.0	0.3	27.0	5.0	0.2	0.5	0.0
GTSF1L	"C20orf65, dJ1028D15.4, FAM112A"	ENSG00000124196	"Gametocyte specific factor 1 like"	Q9H1H1	20	43726164-43727002	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	147	"testis: 225.5"	"Group enriched"	"Detected in some"	115	"Early spermatids: 2791.6;Late spermatids: 4158.1"	"Cancer enriched"	"Detected in single"	5	"testis cancer: 0.5"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	5	"T-reg: 4.0"	"Lineage enriched"	"Detected in single"	5	"T-cells: 4.0"	"Cell line enhanced"	"Detected in some"		"REH: 1.1;U-698: 1.2"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA054694	Enhanced		Uncertain	Nucleoli		NA	NA			Nucleoli		"HPA054694: AB_2682576"	"unprognostic (2.61e-2)"	"unprognostic (4.24e-6)"		"unprognostic (9.96e-3)"		"unprognostic (1.30e-4)"		"unprognostic (3.50e-2)"	"unprognostic (6.70e-2)"	"unprognostic (2.15e-2)"	"unprognostic (3.06e-2)"		"unprognostic (2.45e-7)"	"unprognostic (1.19e-1)"	"unprognostic (9.54e-2)"		"unprognostic (6.07e-3)"	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.0	225.5	0.0	0.4	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.5	0.0	0.6	0.3	0.3	0.0	0.0	0.0	0.0	4.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2791.6	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4158.1	19.6	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.1	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	30.2	10.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0
H2BC1	"bA317E16.3, H2BFU, HIST1H2BA, STBP, TSH2B"	ENSG00000146047	"H2B clustered histone 1"	Q96A08	6	25726777-25727345	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	20	"testis: 6.5"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	5	"testis cancer: 0.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB011603, HPA042205, HPA043013"	Enhanced					NA	NA					"CAB011603: AB_2118143, HPA042205: AB_2677900, HPA043013: AB_2678269"															"unprognostic (3.94e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HAND1	"bHLHa27, eHand, Hxt, Thing1"	ENSG00000113196	"Heart and neural crest derivatives expressed 1"	O96004	5	154474972-154478227	"Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 13.9;intestine: 46.0;smooth muscle: 12.4"	"Cell type enriched"	"Detected in some"	8	"Cardiomyocytes: 15.2"	"Cancer enriched"	"Detected in some"	5	"testis cancer: 2.8"	"Region enhanced"	"Detected in single"		"thalamus: 1.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"SH-SY5Y: 119.5;SuSa: 212.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA040925, HPA075313"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear membrane, Nuclear bodies"	"HPA040925: AB_10796563, HPA075313: "			"unprognostic (2.37e-2)"					"unprognostic (8.29e-2)"		"unprognostic (2.46e-3)"	"unprognostic (7.23e-2)"				"unprognostic (5.21e-2)"		"unprognostic (6.38e-3)"	0.1	4.8	0.0	2.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	46.0	3.7	0.0	0.0	0.0	0.0	0.5	13.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	14.5	12.4	0.0	0.0	0.0	0.3	1.3	0.1	0.0	0.0	0.0	7.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.2	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	119.5	0.0	0.0	0.0	212.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.3	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.5	15.2	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.1	0.0	0.5	0.1	0.2	0.0	0.0	0.0	0.0	0.6	1.7	0.0	0.8	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.1	1.1	0.0	0.0	0.2	0.0
HERC5	CEB1	ENSG00000138646	"HECT and RLD domain containing E3 ubiquitin protein ligase 5"	Q9UII4	4	88457119-88506163	"Predicted membrane proteins"	"Antiviral defense, Immunity, Innate immunity, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 58.4"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 90.5;Spermatocytes: 272.1;Spermatogonia: 431.3"	"Cancer enriched"	"Detected in all"	5	"testis cancer: 31.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 89.9;BJ hTERT+ SV40 Large T+ RasG12V: 123.5;SK-MEL-30: 58.1"					"Low region specificity"	"Detected in all"			HPA043929	Supported					NA	NA					"HPA043929: AB_10962492"	"unprognostic (2.87e-1)"	"unprognostic (2.10e-3)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (4.46e-5)"	"unprognostic (3.00e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.00e-2)"	"unprognostic (2.58e-1)"	"unprognostic (9.00e-2)"	"unprognostic (9.89e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.54e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.23e-2)"	"unprognostic (3.18e-2)"	"unprognostic (7.54e-2)"	"unprognostic (1.61e-1)"	5.5	6.1	3.5	6.1	4.0	18.9	5.0	2.9	5.2	7.5	4.8	3.9	4.0	15.6	3.3	2.6	6.0	5.9	4.0	2.9	5.5	6.5	9.8	6.6	7.3	4.7	3.8	2.6	14.1	7.8	9.7	4.2	10.3	3.9	5.5	2.7	3.7	12.0	5.9	1.5	2.6	4.6	13.6	3.5	12.2	4.9	58.4	3.4	14.0	5.3	3.4	4.3	4.6	4.5	6.4	7.5	3.5	2.0	0.4	0.4	0.8	27.9	0.6	10.7	89.9	123.5	1.1	19.9	0.3	4.9	0.0	40.8	1.4	13.7	2.1	7.6	46.4	8.4	12.1	13.2	0.3	0.8	14.8	5.5	0.8	0.6	22.7	0.0	4.9	0.6	24.4	0.5	28.2	1.7	0.8	45.9	18.2	7.5	0.4	2.4	45.3	35.9	1.9	1.6	1.7	0.5	11.7	15.0	0.3	58.1	23.3	1.2	8.2	0.3	1.1	0.2	0.5	5.9	38.7	36.3	0.3	8.6	10.9	1.1	14.8	7.2	11.6	7.6	8.4	8.6	7.1	8.7	6.3	2.7	4.4	5.4	4.7	25.1	8.0	7.9	8.0	27.7	5.0	3.5	4.0	2.9	5.2	2.9	5.5	4.7	3.8	2.6	3.9	3.5	3.4	6.4	26.9	0.0	0.5	5.5	14.8	4.0	5.9	0.8	8.0	7.9	6.4	7.1	2.3	2.8	1.0	1.8	18.8	25.8	19.9	1.1	23.5	2.6	90.5	5.4	2.0	20.6	0.0	3.8	0.4	5.1	12.1	10.9	3.6	3.9	2.5	57.1	14.3	7.8	15.0	0.0	1.1	0.7	0.0	8.1	2.5	19.4	9.9	16.6	7.2	7.5	8.3	9.6	16.5	18.1	1.8	2.8	2.3	9.1	34.5	7.3	2.6	9.8	1.7	2.8	19.7	10.8	7.9	272.1	431.3	2.5	1.8	11.9	19.2	20.2	0.4	1.7
HIC2	"HRG22, KIAA1020, ZBTB30, ZNF907"	ENSG00000169635	"HIC ZBTB transcriptional repressor 2"	Q96JB3	22	21417371-21451463	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 39.6;Extravillous trophoblasts: 41.4;Syncytiotrophoblasts: 39.5"	"Cancer enriched"	"Detected in all"	5	"testis cancer: 17.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 69.2;K-562: 126.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA031884, HPA059399"	Uncertain		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA031884: AB_10602234, HPA059399: AB_2684003"	"unprognostic (2.37e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (7.42e-5)"	"unprognostic (1.83e-1)"	"unprognostic (3.83e-1)"	"unprognostic (3.62e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.21e-4)"	"unprognostic (1.28e-1)"	"unprognostic (4.83e-3)"	"unprognostic (7.34e-3)"	"unprognostic (3.33e-1)"	"unprognostic (3.86e-2)"	"unprognostic (5.64e-2)"	1.9	1.2	2.7	1.5	2.8	3.7	1.5	0.7	2.8	1.7	0.0	1.9	1.3	2.0	0.5	2.6	2.2	0.8	1.4	2.9	0.9	1.7	1.8	1.8	1.5	1.2	0.7	3.0	3.4	2.2	1.1	2.6	5.9	2.1	1.2	0.8	1.5	1.4	0.7	1.2	1.5	2.1	0.7	0.2	2.5	2.4	7.5	0.9	1.7	2.4	1.1	0.9	1.1	1.6	2.3	2.2	2.7	14.4	4.3	1.1	0.9	69.2	1.4	0.5	1.4	1.2	27.2	0.8	5.1	1.4	0.9	0.9	5.9	10.2	0.9	0.8	3.4	15.0	6.8	4.0	15.0	1.2	6.0	3.1	1.1	0.5	2.1	0.9	0.7	1.1	2.1	126.9	2.1	0.7	2.1	2.7	6.2	15.3	4.8	2.0	6.7	6.4	0.8	0.7	3.6	4.0	7.0	1.8	2.1	2.6	14.9	1.2	9.0	1.9	2.2	5.4	2.1	1.6	4.2	3.6	5.4	1.8	2.5	1.5	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.2	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.2	0.3	0.0	0.0	2.7	2.8	0.7	2.8	2.9	0.9	1.2	0.7	3.0	2.1	0.2	0.9	2.3	10.3	3.2	1.1	3.6	7.7	5.5	5.4	2.6	23.9	14.8	4.7	4.2	3.9	7.2	1.7	1.8	14.6	39.6	4.4	10.0	0.0	2.6	14.2	8.3	7.6	6.5	6.1	5.7	11.8	2.6	41.4	6.6	11.2	7.6	1.3	6.4	2.9	3.0	10.3	8.4	7.5	7.4	6.1	3.8	4.3	29.9	5.6	5.6	5.4	1.9	4.5	3.0	2.1	5.0	2.3	2.8	4.6	10.1	10.4	8.1	7.0	1.6	1.5	7.3	6.6	10.7	6.0	12.2	24.5	27.1	4.5	39.5	5.8	2.6	9.3	7.5
IGDCC3	"HsT18880, PUNC"	ENSG00000174498	"Immunoglobulin superfamily DCC subclass member 3"	Q8IVU1	15	65327127-65378002	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.9;parathyroid gland: 5.2;placenta: 6.1"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 33.3;Cytotrophoblasts: 104.8;Early spermatids: 37.6;Late spermatids: 98.6;Syncytiotrophoblasts: 41.3"	"Group enriched"	"Detected in many"	5	"glioma: 2.2;testis cancer: 5.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"AF22: 105.8;CACO-2: 27.4;Hep G2: 87.8;SuSa: 41.9"	"Low region specificity"	"Detected in many"							HPA015713			Uncertain	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA015713: "	"unprognostic (7.11e-2)"	"unprognostic (1.99e-1)"	"unprognostic (4.24e-2)"	"unprognostic (7.25e-3)"	"unprognostic (6.67e-2)"	"unprognostic (7.35e-3)"	"unprognostic (3.93e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.82e-2)"	"unprognostic (4.56e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.78e-1)"	"unprognostic (5.77e-5)"	"unprognostic (4.15e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.33e-2)"	0.0	0.2	2.3	0.0	2.0	0.0	0.8	3.9	3.2	1.0	0.0	0.3	0.0	0.8	0.1	0.0	0.6	0.1	0.1	2.6	1.8	0.2	0.0	0.0	0.0	2.4	2.8	1.7	0.8	0.0	5.2	1.9	6.1	3.6	0.1	0.0	1.0	0.0	0.1	0.1	0.1	0.1	0.2	1.3	0.0	0.2	2.8	3.1	1.4	0.9	0.0	0.0	0.1	0.4	3.1	0.0	0.0	105.8	4.7	0.0	0.0	1.3	0.0	0.0	0.0	0.0	27.4	0.2	0.0	0.3	0.0	0.0	0.0	7.2	0.0	0.0	0.0	1.0	0.0	0.2	87.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	16.1	0.0	0.0	0.1	0.0	0.0	0.0	0.5	2.2	1.5	0.1	0.1	0.0	41.9	3.6	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	2.0	3.9	3.2	2.6	1.8	2.4	2.8	1.7	3.6	1.3	3.1	3.1	0.1	0.0	0.0	15.3	0.0	0.0	0.2	0.0	0.0	4.1	2.2	1.0	0.6	0.0	0.0	1.8	33.3	104.8	0.0	0.4	0.0	0.0	37.6	0.4	4.8	1.0	0.0	0.0	2.8	0.0	4.3	3.0	0.0	0.6	0.0	0.1	0.0	0.0	7.2	0.0	7.0	0.0	0.0	0.0	0.0	98.6	0.6	0.1	0.0	1.0	0.0	3.7	0.0	16.1	8.9	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	3.1	0.0	0.7	0.4	1.3	11.0	0.0	0.0	41.3	0.1	0.1	0.2	0.0
IGLON5	LOC402665	ENSG00000142549	"IgLON family member 5"	A6NGN9	19	51311848-51330354	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 49.2;retina: 14.1"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 24.4;Horizontal cells: 79.1;Inhibitory neurons: 17.6;Spermatogonia: 9.7"	"Group enriched"	"Detected in many"	5	"glioma: 9.2;ovarian cancer: 3.5;testis cancer: 12.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 35.0;NTERA-2: 16.0;SH-SY5Y: 23.0;SuSa: 9.9;U-2 OS: 6.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041994	Approved				"Secreted in brain"	NA	NA		15000			"HPA041994: AB_10794641"	"unprognostic (2.09e-1)"	"unprognostic (5.76e-2)"	"unprognostic (1.80e-2)"	"unprognostic (8.87e-3)"	"unprognostic (2.33e-1)"	"unprognostic (2.66e-1)"	"unprognostic (3.47e-4)"	"unprognostic (6.38e-5)"	"unprognostic (4.54e-2)"	"unprognostic (7.89e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (5.62e-7)"	"unprognostic (1.77e-2)"	"unprognostic (9.28e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.86e-3)"	1.2	1.7	17.0	0.2	9.7	0.7	0.9	23.1	21.5	0.3	1.5	0.4	0.2	0.1	0.7	4.2	0.1	0.2	0.3	12.2	17.2	0.1	1.9	0.2	0.0	40.3	19.8	9.4	1.2	0.2	1.8	1.3	0.4	44.3	0.2	0.0	14.1	0.7	0.7	0.0	0.6	0.3	0.1	14.9	0.1	0.2	8.0	26.7	0.0	0.2	0.0	0.0	0.4	1.2	49.2	0.0	0.3	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.6	0.0	0.4	0.1	0.4	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.0	0.1	35.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.1	16.0	0.2	0.0	0.0	0.0	3.5	0.0	0.1	0.1	23.0	0.0	0.0	0.0	9.9	0.2	2.2	0.0	0.0	6.4	0.1	0.0	0.2	0.3	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	17.0	9.7	23.1	21.5	12.2	17.2	40.3	19.8	9.4	44.3	14.9	26.7	49.2	2.1	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.0	24.4	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.1	0.9	0.0	0.0	6.2	0.0	0.0	0.2	0.0	0.0	0.0	0.4	1.8	0.1	0.3	79.1	17.6	0.0	0.0	0.0	0.0	2.8	0.0	1.1	0.0	3.7	0.0	2.5	0.0	5.5	0.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.9	0.9	9.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0
IRX4		ENSG00000113430	"Iroquois homeobox 4"	P78413	5	1877413-1887236	"Plasma proteins, Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 16.0;prostate: 10.0;salivary gland: 9.5;skin 1: 20.2;vagina: 12.3"	"Group enriched"	"Detected in some"	4	"Basal keratinocytes: 48.6;Basal squamous epithelial cells: 50.7;Breast myoepithelial cells: 15.6;Prostatic glandular cells: 13.3;Squamous epithelial cells: 26.5;Suprabasal keratinocytes: 20.2"	"Group enriched"	"Detected in many"	5	"cervical cancer: 5.4;head and neck cancer: 7.3;lung cancer: 1.8;prostate cancer: 6.9;testis cancer: 7.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 41.8;HaCaT: 16.3;HBEC3-KT: 8.1;MCF7: 8.3"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"medulla oblongata: 1.2;pons: 1.5"	HPA064094			Uncertain	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA064094: "	"unprognostic (1.00e-2)"	"unprognostic (1.00e-1)"			"unprognostic (1.90e-1)"	"unprognostic (3.01e-1)"		"unprognostic (1.35e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.52e-2)"		"unprognostic (7.54e-2)"	"unprognostic (4.26e-1)"		"unprognostic (1.70e-2)"	0.1	0.0	0.4	0.0	0.0	0.1	3.2	0.7	0.2	1.7	0.0	0.0	0.0	0.0	0.0	16.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.6	0.0	0.0	0.0	0.0	0.9	0.0	0.9	10.0	0.0	0.0	9.5	0.0	0.6	20.2	0.0	0.0	0.1	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	12.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	41.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	16.3	0.0	8.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	1.4	0.0	0.0	0.0	0.0	0.1	0.0	8.3	1.1	0.1	0.1	4.3	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.3	2.1	0.0	0.0	0.0	3.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.7	0.2	0.0	0.0	0.7	0.6	0.0	0.9	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.0	48.6	2.8	0.1	50.7	0.0	1.4	15.6	6.7	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	6.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	3.0	0.3	0.0	0.2	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.3	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.1	1.1	26.5	20.2	3.7	0.0	0.0	0.0	1.7
ISL1	"Isl-1, ISLET1"	ENSG00000016082	"ISL LIM homeobox 1"	P61371	5	51383448-51394730	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 23.1;seminal vesicle: 19.4;vagina: 16.0"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 207.5;Cytotrophoblasts: 34.4;Enteroendocrine cells: 91.6;Horizontal cells: 43.7;Syncytiotrophoblasts: 34.2"	"Group enriched"	"Detected in some"	5	"cervical cancer: 1.1;pancreatic cancer: 4.1;prostate cancer: 2.1;stomach cancer: 1.6;testis cancer: 1.4"	"Group enriched"	"Detected in many"	4	"hypothalamus: 7.8;thalamus: 3.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	16	"SH-SY5Y: 297.1"	"Group enriched"	"Detected in many"	8	"basal ganglia: 13.8;hypothalamus: 15.0;thalamus: 6.0"	"Group enriched"	"Detected in some"	9	"basal ganglia: 5.8;hypothalamus: 5.4"	"HPA048613, HPA057416"	Approved		Approved	"Nucleoplasm,Nuclear speckles,Mitochondria"		NA	NA			Nucleoplasm	"Nuclear speckles, Mitochondria"	"HPA048613: , HPA057416: AB_2683431"	"unprognostic (4.97e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.41e-3)"		"unprognostic (5.52e-2)"		"unprognostic (6.79e-2)"	"unprognostic (9.21e-2)"	"unprognostic (9.42e-2)"	"unprognostic (5.55e-3)"	"unprognostic (1.77e-1)"		"unprognostic (1.48e-1)"	"unprognostic (2.48e-1)"	"unprognostic (9.11e-3)"	"unprognostic (4.39e-3)"	1.3	1.4	0.8	0.0	1.3	0.0	0.1	0.0	1.4	4.7	0.0	1.1	2.4	0.1	0.1	0.1	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.0	0.7	0.3	0.5	0.0	4.8	0.0	2.2	7.9	1.2	12.1	2.4	23.1	1.2	19.4	0.0	1.1	0.7	0.1	0.1	0.0	10.1	1.6	3.6	4.3	0.3	0.0	0.4	0.7	16.0	0.2	0.0	0.0	0.0	3.4	0.0	0.0	0.2	3.0	3.8	0.0	0.0	0.3	2.7	0.0	2.5	0.0	0.0	2.2	4.6	3.4	0.0	0.0	7.1	0.0	12.6	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.3	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.9	3.2	0.0	3.0	0.0	0.0	0.0	19.1	297.1	0.0	0.0	0.0	11.6	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.3	0.0	1.4	0.0	7.8	0.7	0.3	0.5	1.2	0.1	3.6	0.2	0.0	0.0	0.0	0.0	0.1	1.5	5.1	11.8	0.0	207.5	0.0	0.0	0.2	0.0	2.8	0.0	4.2	34.4	0.0	0.5	0.0	0.1	17.3	0.0	0.0	1.7	91.6	0.0	0.0	0.0	10.9	6.1	11.7	0.0	0.0	0.0	0.0	0.0	2.7	43.7	0.0	1.9	8.2	0.0	0.4	3.2	0.3	0.1	0.0	0.0	0.0	4.1	0.0	0.0	0.0	4.2	0.0	0.0	0.0	1.1	0.0	0.0	0.8	11.8	0.0	0.0	4.0	2.5	7.3	0.0	1.0	34.2	0.0	0.0	0.2	5.6
KCNC1	Kv3.1	ENSG00000129159	"Potassium voltage-gated channel subfamily C member 1"	P48547	11	17734774-17856804	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Disease variant, Epilepsy, FDA approved drug targets, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 46.7"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 79.6;Excitatory neurons: 48.2;Inhibitory neurons: 120.2"	"Group enriched"	"Detected in some"	5	"glioma: 1.1;testis cancer: 0.7"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"basophil: 3.2;neutrophil: 1.4"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 3.2"	"Cell line enhanced"	"Detected in some"		"HeLa: 1.6;RH-30: 3.7;SCLC-21H: 3.5;SH-SY5Y: 2.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047634, HPA048249"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Vesicles,Cytosol"		NA	NA			"Nucleoplasm, Nuclear membrane"	"Vesicles, Cytosol"	"HPA047634: AB_2680109, HPA048249: "	"unprognostic (1.79e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.09e-3)"	"unprognostic (1.12e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.27e-1)"	"unprognostic (8.37e-2)"	"unprognostic (2.14e-1)"	"unprognostic (7.04e-5)"	"unprognostic (5.89e-2)"	"unprognostic (7.32e-4)"	"unprognostic (1.29e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.05e-2)"	"unprognostic (7.83e-2)"	0.1	0.8	0.9	0.1	2.9	0.9	0.2	40.9	46.7	0.9	0.0	0.3	0.3	0.3	0.0	0.2	0.1	0.2	0.1	4.9	6.4	0.1	0.2	0.1	0.2	7.9	4.9	4.2	0.2	0.4	0.0	2.2	0.0	15.5	0.2	0.1	7.0	0.3	0.0	0.5	0.5	0.3	0.0	0.0	0.2	0.3	1.4	13.5	0.1	0.3	1.2	0.0	0.3	0.5	19.8	0.1	0.0	1.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.4	0.9	0.0	0.1	0.2	1.1	0.3	1.6	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.7	0.0	0.2	0.2	0.4	0.7	0.0	0.0	0.4	3.7	0.4	0.0	0.2	3.5	2.1	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.1	1.0	0.1	0.0	0.2	0.3	0.4	0.2	0.2	0.4	3.2	0.3	0.4	0.3	0.2	0.2	0.2	0.3	0.2	0.0	0.5	0.2	0.2	1.4	0.2	0.3	0.3	0.1	0.1	0.9	2.9	40.9	46.7	4.9	6.4	7.9	4.9	4.2	15.5	0.0	13.5	19.8	0.2	0.0	0.0	5.5	1.1	0.0	0.2	0.0	0.0	79.6	0.3	0.4	2.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.5	9.5	0.2	0.5	0.4	7.7	0.0	48.2	0.2	0.0	0.3	0.0	0.3	0.0	2.8	0.0	0.0	0.0	1.7	120.2	0.0	0.0	0.0	0.0	10.2	0.3	0.2	0.0	7.5	0.6	1.5	0.0	16.1	5.6	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	7.7	0.0	0.2	0.5	6.1	5.0	0.0	0.0	0.0	0.6	1.8	0.0	0.0
KIF26A	"DKFZP434N178, KIAA1236"	ENSG00000066735	"Kinesin family member 26A"	Q9ULI4	14	104138723-104180894	"Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 22.4;Endothelial cells: 11.9;Enteroendocrine cells: 7.7;Hepatic stellate cells: 13.9;Horizontal cells: 18.5;Spermatogonia: 8.1"	"Group enriched"	"Detected in many"	5	"stomach cancer: 3.8;testis cancer: 14.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 30.6;MCF7: 24.9;NTERA-2: 20.8;REH: 18.8;SCLC-21H: 19.2;SH-SY5Y: 39.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA046882, HPA060346"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Plasma membrane, Cytosol"		"HPA046882: AB_2679856, HPA060346: AB_2684259"	"unprognostic (3.01e-1)"	"unprognostic (3.20e-1)"	"unprognostic (3.95e-1)"	"unprognostic (1.77e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.49e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.21e-2)"	"unprognostic (3.31e-3)"	"unprognostic (5.24e-3)"	"unprognostic (7.01e-2)"	"prognostic unfavorable (7.78e-4)"	"unprognostic (7.96e-2)"	"unprognostic (1.72e-1)"	"unprognostic (9.12e-2)"	"unprognostic (4.68e-3)"	4.5	2.3	2.1	0.7	1.3	2.0	4.7	0.5	1.5	4.0	3.0	2.6	0.4	2.4	0.2	1.5	2.6	0.4	4.6	0.8	1.4	1.9	0.7	2.2	0.3	1.0	1.1	0.8	4.1	5.7	0.3	2.9	1.8	1.2	0.9	0.4	0.1	1.0	0.8	3.0	2.6	1.9	0.4	0.7	4.2	1.8	2.9	1.8	0.2	1.5	1.0	0.1	2.0	2.1	1.1	0.0	1.7	1.0	3.9	0.0	0.0	6.7	0.3	0.0	0.0	0.0	3.1	0.0	0.0	5.3	0.0	0.7	2.5	3.1	0.0	0.0	0.0	4.9	0.0	30.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.6	6.7	0.0	0.0	0.0	24.9	0.0	0.0	20.8	0.2	2.0	18.8	7.9	2.0	0.0	0.0	19.2	39.3	4.4	0.6	0.0	2.5	0.4	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	1.3	0.5	1.5	0.8	1.4	1.0	1.1	0.8	1.2	0.7	1.8	1.1	22.4	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.1	0.3	0.1	3.2	0.0	0.0	1.8	0.0	1.0	0.0	1.3	1.9	0.7	0.4	0.2	4.4	11.9	7.7	4.8	0.5	0.2	0.8	2.1	0.0	0.2	0.0	0.4	13.9	0.2	2.6	18.5	0.7	2.6	0.0	0.3	1.1	0.1	0.0	0.1	1.8	3.7	0.0	0.2	0.0	0.0	0.1	0.2	1.0	0.7	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.7	0.7	0.2	8.1	1.2	1.7	0.4	0.1	0.3	2.8	0.0
LANCL2	"GPR69B, TASP"	ENSG00000132434	"LanC like 2"	Q9NS86	7	55365337-55433737	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 52.5;Late spermatids: 55.3;Oligodendrocyte precursor cells: 52.8;Oligodendrocytes: 67.3"	"Group enriched"	"Detected in all"	5	"glioma: 52.5;testis cancer: 19.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in all"	8	"A-431: 144.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019711, HPA029535"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA		13000	"Nucleoplasm, Cytosol"		"HPA019711: AB_1852699, HPA029535: AB_10602342"	"unprognostic (1.11e-1)"	"unprognostic (6.89e-2)"	"unprognostic (7.28e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.56e-1)"	"prognostic favorable (1.89e-4)"	"unprognostic (1.35e-3)"	"unprognostic (5.58e-2)"	"prognostic favorable (1.03e-6)"	"unprognostic (4.58e-3)"	"unprognostic (1.04e-2)"	"unprognostic (3.94e-1)"	"unprognostic (1.45e-1)"	3.9	6.2	18.0	2.6	19.6	4.0	5.9	12.3	19.3	5.8	9.3	4.8	5.2	10.5	5.1	4.1	5.4	3.8	4.2	21.7	15.5	6.0	5.0	3.1	3.5	13.5	13.6	17.7	9.2	4.7	9.3	6.1	4.0	13.7	5.8	4.7	8.5	4.7	6.5	7.1	5.5	5.0	6.7	13.3	3.7	4.5	6.2	14.3	4.7	6.6	5.2	2.9	3.9	4.1	18.1	144.8	4.9	9.7	6.6	2.9	5.0	5.4	6.4	7.6	9.7	8.2	5.0	4.1	10.1	5.9	9.3	9.7	6.4	5.2	3.5	5.9	4.4	10.4	3.6	3.8	5.1	5.1	11.2	6.4	9.0	3.7	7.2	2.3	5.1	4.8	4.7	6.4	6.4	9.1	4.4	2.9	5.2	18.8	3.9	6.1	4.3	4.5	5.0	6.3	11.3	16.9	16.0	9.3	13.6	3.9	3.6	5.6	11.8	8.1	6.1	8.3	11.6	12.5	6.1	7.8	10.6	4.8	2.5	11.8	0.1	1.5	0.3	1.0	1.9	1.7	1.1	1.3	1.5	1.9	1.0	1.2	1.0	0.2	1.5	1.4	1.5	2.6	1.1	18.0	19.6	12.3	19.3	21.7	15.5	13.5	13.6	17.7	13.7	13.3	14.3	18.1	3.0	3.2	8.9	28.7	5.9	4.0	6.3	5.5	5.7	8.9	6.8	6.7	9.4	10.0	5.1	11.0	6.2	12.5	5.1	8.8	5.9	7.1	52.5	6.7	11.2	5.4	12.6	12.6	41.7	12.2	12.1	16.3	5.1	7.7	11.4	10.2	7.1	10.0	7.7	15.2	39.6	9.1	4.1	7.3	4.8	55.3	9.0	5.4	0.0	8.4	9.5	10.8	6.2	52.8	67.3	7.8	7.6	7.5	5.1	5.5	9.8	27.7	7.7	7.6	0.0	19.4	5.9	22.7	17.8	7.5	3.8	19.0	4.3	12.8	9.7	6.0
MEIOSIN	"BHMG1, HMGDC"	ENSG00000237452	"Meiosis initiator"	C9JSJ3	19	45733439-45764541	"Predicted intracellular proteins"	"Meiosis, Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	17	"testis: 7.4"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	5	"testis cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"Daudi: 1.5;K-562: 3.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA049521	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA049521: AB_2680803"	"unprognostic (4.15e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.53e-1)"	"unprognostic (8.33e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.70e-3)"	"unprognostic (3.31e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.15e-2)"		"unprognostic (1.08e-1)"	"unprognostic (6.53e-12)"	"unprognostic (2.29e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.11e-3)"	"unprognostic (1.87e-1)"	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.1	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.4	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MGAT5B	"FLJ25132, GnT-IX, GnT-VB"	ENSG00000167889	"Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B"	Q3V5L5	17	76868404-76950393	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"brain: 12.9"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 16.0;Early spermatids: 7.3;Excitatory neurons: 26.2;Inhibitory neurons: 21.9;Late spermatids: 8.1"	"Group enriched"	"Detected in many"	5	"glioma: 2.6;melanoma: 7.1;testis cancer: 2.4"	"Region enhanced"	"Detected in many"		"cerebral cortex: 12.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 32.1;SCLC-21H: 15.9;U-138 MG: 19.2;U-2 OS: 20.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011082			Approved	"Nucleoplasm,Cytokinetic bridge,Mitotic spindle"		Yes	No			"Nucleoplasm, Mitotic spindle"	"Cytokinetic bridge"	"HPA011082: AB_2668423"	"unprognostic (6.37e-2)"	"unprognostic (9.16e-3)"	"unprognostic (8.51e-2)"	"unprognostic (1.43e-3)"	"unprognostic (5.68e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.28e-3)"	"unprognostic (1.52e-3)"	"unprognostic (5.30e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.68e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.46e-7)"	"unprognostic (1.66e-1)"	"unprognostic (8.09e-3)"	"unprognostic (1.04e-1)"	"unprognostic (3.01e-1)"	0.2	0.2	3.1	0.2	2.0	0.1	0.1	0.0	12.9	0.2	0.0	0.1	0.0	0.2	0.0	0.1	0.1	0.1	0.0	4.4	1.9	0.2	0.0	0.3	0.1	1.3	0.0	6.1	0.2	0.0	0.2	0.9	0.2	2.9	0.0	0.0	0.9	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.1	1.2	0.3	0.2	0.2	0.1	0.0	0.1	0.1	3.0	3.7	32.1	6.4	3.4	0.0	0.0	3.7	0.4	1.3	11.7	6.9	0.1	0.7	0.0	2.5	1.5	13.7	0.2	1.6	0.2	3.0	0.1	0.5	0.0	1.7	0.1	0.0	0.0	0.2	0.1	0.2	0.0	1.8	5.2	2.0	0.7	0.2	0.0	0.0	1.5	0.1	0.0	1.8	0.8	3.5	4.8	5.6	7.1	8.9	0.1	15.9	6.1	5.5	2.4	5.0	0.4	0.2	0.2	5.8	19.2	20.9	0.3	6.3	0.0	0.0	0.7	0.6	0.0	14.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	2.0	0.0	12.9	4.4	1.9	1.3	0.0	6.1	2.9	0.0	0.3	3.0	0.1	0.0	0.0	16.0	0.1	0.1	0.1	0.0	0.0	5.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.1	0.1	0.8	0.0	0.0	26.2	0.0	3.2	0.2	0.0	0.2	0.0	0.6	0.7	0.0	0.1	0.0	21.9	0.0	0.0	0.0	0.0	8.1	0.6	0.0	0.0	2.8	0.0	0.2	0.0	5.0	1.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	1.8	0.0	0.0	0.1	1.1	2.4	0.0	0.0	0.1	0.1	0.2	0.0	0.0
MKRN1	RNF61	ENSG00000133606	"Makorin ring finger protein 1"	Q9UHC7	7	140453033-140479536	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 328.0;Erythroid cells: 424.2;Late spermatids: 340.6"	"Cancer enriched"	"Detected in all"	5	"testis cancer: 129.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000567			Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA000567: AB_1079299"	"unprognostic (9.97e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.27e-1)"	"unprognostic (7.60e-3)"	"unprognostic (1.65e-2)"	"unprognostic (2.41e-1)"	"unprognostic (4.87e-3)"	"unprognostic (1.24e-2)"	"unprognostic (8.02e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.89e-3)"	"unprognostic (5.76e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.22e-2)"	39.9	37.1	52.1	48.4	52.6	204.4	48.3	54.4	56.2	43.4	51.1	98.8	69.9	47.1	43.7	49.4	51.7	37.9	65.2	52.4	55.5	48.3	43.0	47.3	50.1	57.6	52.3	51.0	57.0	58.6	67.3	42.6	43.4	60.9	49.1	80.9	59.1	57.0	44.8	84.7	51.7	66.3	43.9	52.5	53.1	54.4	124.3	55.6	47.5	47.3	59.0	56.9	46.1	39.3	63.3	96.5	72.3	55.6	83.1	86.5	75.5	78.2	64.6	83.3	49.8	57.2	30.0	98.8	69.4	98.4	63.4	99.2	45.7	63.2	71.2	62.8	138.0	55.6	72.1	43.5	55.9	69.4	62.5	107.1	75.4	105.1	56.2	52.8	81.9	50.8	46.9	58.0	84.8	49.1	82.6	73.4	114.2	143.3	80.7	53.6	52.4	47.4	107.6	80.8	109.2	76.6	79.1	80.8	108.5	120.6	81.6	53.3	53.5	71.9	34.9	27.4	85.8	59.8	200.2	159.2	60.9	99.3	96.1	73.3	58.6	22.5	100.4	15.4	21.3	18.0	33.6	29.5	23.0	18.0	32.9	39.9	25.5	42.5	31.1	26.5	6.0	35.3	15.3	52.1	52.6	54.4	56.2	52.4	55.5	57.6	52.3	51.0	60.9	52.5	55.6	63.3	28.4	51.3	37.2	13.4	76.8	82.1	66.6	57.1	57.5	61.5	60.9	36.2	57.7	67.2	71.1	42.3	35.5	75.8	54.0	172.1	103.7	69.8	328.0	58.4	30.6	34.2	97.3	424.2	28.9	67.8	96.6	43.3	38.7	65.7	37.4	79.5	45.7	45.0	59.5	119.5	28.0	107.7	89.5	95.9	93.3	340.6	66.5	86.3	69.4	22.5	119.0	61.4	92.7	15.1	22.1	57.6	140.3	62.4	41.8	101.2	112.4	54.4	70.0	46.4	46.0	34.7	53.3	303.0	60.1	62.4	95.5	138.0	62.9	39.6	103.5	145.9
MMP25	"MMP20, MMPL1, MT6-MMP"	ENSG00000008516	"Matrix metallopeptidase 25"	Q9NPA2	16	3046062-3060726	"Enzymes, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 33.4;lymphoid tissue: 82.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 6.7;Langerhans cells: 5.8;monocytes: 15.0"	"Cancer enriched"	"Detected in many"	5	"testis cancer: 7.1"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"basophil: 18.3;neutrophil: 20.3"	"Lineage enriched"	"Detected in single"	39	"granulocytes: 20.3"	"Cell line enriched"	"Detected in some"	15	"HMC-1: 102.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB025177, HPA055640"	Uncertain		Supported	"Plasma membrane"	"Secreted to blood"	NA	NA		120000	"Plasma membrane"		"CAB025177: , HPA055640: "	"unprognostic (4.51e-3)"	"unprognostic (9.28e-3)"	"unprognostic (7.57e-2)"	"unprognostic (2.95e-3)"	"unprognostic (2.26e-1)"	"prognostic favorable (1.09e-5)"	"unprognostic (1.36e-1)"	"unprognostic (7.39e-3)"	"unprognostic (7.63e-3)"	"unprognostic (2.29e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.53e-2)"	"unprognostic (2.37e-3)"	"unprognostic (1.17e-2)"	"unprognostic (8.30e-2)"	"unprognostic (4.01e-1)"	"unprognostic (2.02e-1)"	4.8	0.5	0.4	15.2	0.3	33.4	1.4	0.3	1.4	0.7	1.0	1.6	1.1	0.5	0.1	1.3	6.2	1.1	2.0	0.3	0.3	1.3	3.0	14.5	2.6	0.6	0.5	0.2	0.4	1.2	0.2	0.8	1.0	0.6	1.0	1.5	0.0	1.2	0.1	0.5	0.7	3.5	0.9	0.2	82.5	1.9	0.4	0.6	1.4	1.2	3.5	1.9	2.2	0.9	0.5	0.0	0.0	1.2	2.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.7	0.7	0.1	0.0	6.7	0.5	0.0	0.0	0.0	0.0	0.2	102.2	0.1	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	5.7	2.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.2	0.3	7.0	0.3	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.1	1.1	0.1	18.3	0.2	4.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	20.3	0.5	0.0	0.4	0.2	0.0	0.4	0.3	0.3	1.4	0.3	0.3	0.6	0.5	0.2	0.6	0.2	0.6	0.5	1.0	3.2	6.7	0.0	0.7	0.4	0.4	0.2	0.0	0.8	2.0	1.3	1.0	0.0	0.8	1.8	0.0	0.0	1.8	0.2	0.0	0.4	0.0	1.2	1.2	1.0	0.0	2.7	1.6	0.6	0.2	0.6	1.1	3.8	1.3	0.2	0.0	0.3	0.1	0.0	1.9	0.2	0.0	3.5	5.8	0.0	0.0	3.3	0.0	1.0	15.0	0.3	3.1	1.5	0.5	1.3	0.0	0.7	0.8	0.4	1.2	0.2	0.1	0.0	0.0	0.7	0.9	0.1	0.2	0.6	0.3	0.0	4.0	0.1	0.3	0.3
MYBL2	"B-MYB, BMYB"	ENSG00000101057	"MYB proto-oncogene like 2"	P10244	20	43667019-43716495	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 92.6;lymphoid tissue: 56.0"	"Cell type enhanced"	"Detected in many"		"B-cells: 33.0;dendritic cells: 32.6;Erythroid cells: 82.3;Extravillous trophoblasts: 32.3;Plasma cells: 139.6;Spermatogonia: 33.6"	"Cancer enriched"	"Detected in all"	5	"testis cancer: 295.8"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	34	"plasmacytoid DC: 91.5"	"Lineage enriched"	"Detected in many"	34	"dendritic cells: 91.5"	"Cell line enhanced"	"Detected in many"		"MCF7: 763.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB017114, HPA030530, HPA055416"	Uncertain		Supported	Nucleoplasm,Cytosol		Yes	Yes			Nucleoplasm	Cytosol	"CAB017114: , HPA030530: AB_2673515, HPA055416: AB_2682811"	"unprognostic (9.75e-3)"	"unprognostic (1.29e-2)"	"unprognostic (3.20e-1)"	"prognostic unfavorable (9.73e-4)"	"unprognostic (2.35e-1)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (2.11e-7)"	"unprognostic (2.66e-3)"	"unprognostic (9.23e-3)"	"unprognostic (1.78e-1)"	"unprognostic (2.38e-3)"	"unprognostic (1.32e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.42e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.84e-1)"	1.6	0.6	0.1	24.5	0.1	92.6	1.6	0.1	0.2	0.6	0.2	8.7	7.1	1.4	0.1	10.1	0.4	1.0	0.3	0.1	0.2	0.6	1.1	1.8	56.0	0.1	0.1	0.0	0.3	11.3	0.1	0.2	5.8	0.1	0.5	7.0	0.0	1.6	0.2	0.1	4.2	7.9	2.1	0.1	28.1	6.1	15.7	0.3	33.6	0.5	0.0	53.9	3.6	2.5	0.4	195.8	121.8	105.4	109.6	1.0	3.5	136.2	87.0	29.0	265.6	194.6	600.2	118.8	393.6	49.2	37.8	55.8	116.1	192.1	59.6	98.8	74.2	124.1	183.2	118.7	164.2	0.2	168.6	121.7	2.4	5.1	101.6	22.9	5.9	72.2	189.6	188.1	470.3	23.8	763.7	346.0	236.3	121.8	155.4	105.4	237.3	216.3	222.1	49.6	39.7	96.7	140.6	255.6	253.3	26.1	110.4	167.2	183.1	34.0	16.3	264.3	118.3	151.5	162.1	363.8	606.5	34.2	142.3	103.9	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.3	0.0	1.4	0.0	0.0	0.1	0.2	0.0	91.5	1.3	0.8	0.1	0.1	0.1	0.2	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.3	0.4	0.2	0.0	0.0	0.0	33.0	4.2	0.8	0.8	0.0	0.0	2.5	3.4	2.0	1.5	0.1	0.0	0.0	14.4	32.6	3.4	0.0	0.4	5.9	0.9	1.3	1.8	0.0	82.3	0.4	0.9	32.3	4.8	10.2	2.9	0.0	18.9	0.7	1.4	13.5	0.0	0.3	5.1	0.0	2.4	2.6	14.1	0.0	3.2	1.8	0.0	0.0	0.0	1.0	0.0	0.5	0.7	1.1	0.0	139.6	0.3	0.5	0.0	0.0	0.0	0.0	0.1	3.9	7.0	33.6	8.2	2.4	3.7	3.0	1.2	8.6	2.4
MYCN	"bHLHe37, MYCNOT, N-myc, NMYC"	ENSG00000134323	"MYCN proto-oncogene, bHLH transcription factor"	P04198	2	15940550-15947007	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 9.6"	"Group enriched"	"Detected in some"	4	"Extravillous trophoblasts: 84.2;Granulosa cells: 26.4"	"Cancer enriched"	"Detected in many"	5	"testis cancer: 45.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 44.1;BEWO: 239.1;HMC-1: 57.3;NTERA-2: 91.3;RH-30: 63.3;SuSa: 40.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA057420			Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA057420: AB_2683434"	"unprognostic (8.04e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.07e-2)"	"unprognostic (4.11e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.23e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.35e-3)"	"unprognostic (3.09e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.12e-3)"	"unprognostic (8.89e-2)"	"unprognostic (2.47e-1)"	"unprognostic (4.90e-2)"	"unprognostic (1.23e-1)"	0.3	0.8	3.3	0.6	3.5	0.9	0.4	3.1	4.0	1.5	1.2	0.5	1.6	0.9	0.1	0.8	0.5	0.3	1.2	3.6	3.3	3.3	0.8	0.7	1.6	4.3	4.0	3.1	5.2	0.2	0.1	0.3	9.6	4.1	0.1	0.5	1.0	4.8	0.2	0.4	1.1	0.9	0.3	3.5	0.3	4.7	3.7	3.7	2.9	2.9	0.7	1.2	0.5	0.4	6.0	0.0	0.0	44.1	0.0	0.0	0.0	239.1	0.0	0.0	0.0	0.0	3.5	0.0	0.0	4.2	0.0	0.0	0.1	1.9	0.0	0.0	0.0	0.2	16.8	0.0	0.0	0.0	0.0	57.3	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.1	0.0	0.8	0.4	0.2	91.3	2.1	0.0	0.0	63.3	12.8	0.0	3.1	1.0	16.0	0.0	0.1	0.0	40.9	0.1	0.0	0.0	0.0	1.2	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	3.5	3.1	4.0	3.6	3.3	4.3	4.0	3.1	4.1	3.5	3.7	6.0	0.8	0.0	0.0	0.7	0.0	0.5	0.1	0.0	0.0	2.6	0.1	0.9	0.7	0.0	0.0	0.0	0.0	5.6	0.0	0.2	0.0	0.0	1.2	0.5	0.1	2.7	0.0	4.2	2.0	0.0	84.2	1.0	2.6	0.8	0.0	26.4	0.0	0.6	2.4	0.0	4.2	0.9	0.0	0.0	0.0	0.2	0.0	0.3	0.0	1.0	0.1	1.0	0.0	10.1	7.5	0.3	1.1	0.4	0.0	0.0	0.4	3.2	0.0	0.2	0.0	4.2	0.7	1.3	3.7	0.3	0.0	11.5	0.0	9.4	0.3	0.0
MYH6		ENSG00000197616	"Myosin heavy chain 6"	P13533	14	23381982-23408273	"Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin"	"Atrial septal defect, Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	54	"heart muscle: 2909.5"	"Cell type enriched"	"Detected in some"	17	"Cardiomyocytes: 8051.1"	"Cancer enriched"	"Detected in single"	5	"testis cancer: 1.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	23	"NTERA-2: 4.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA001239, HPA001349, CAB075723, CAB075724, CAB075725"	Enhanced		Uncertain	"Focal adhesion sites"		NA	NA		25000000	"Focal adhesion sites"		"CAB075723: AB_2665728, CAB075724: AB_2665729, CAB075725: AB_2665730, HPA001239: AB_1079438, HPA001349: AB_1079437"	"unprognostic (2.09e-2)"	"unprognostic (8.53e-4)"		"unprognostic (1.80e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.66e-1)"		"unprognostic (2.09e-1)"	"unprognostic (1.66e-1)"	"unprognostic (5.73e-2)"	"unprognostic (1.44e-2)"	"unprognostic (5.34e-3)"		"unprognostic (6.90e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.22e-2)"	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	2909.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.9	5.9	0.0	0.0	0.5	0.1	0.9	0.0	0.0	1.9	0.0	53.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	51.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	8051.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	31.7	0.0	2.7	0.1	0.0	0.0	449.6	0.0	0.0	0.0	0.3	1.1	0.2	0.0	0.0	0.1	0.0	0.0	0.3	0.0	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.8	60.3	0.1	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0
NLRP12	"CLR19.3, Monarch1, NALP12, PAN6, PYPAF7, RNO2"	ENSG00000142405	"NLR family pyrin domain containing 12"	P59046	19	53793741-53824394	"Disease related genes, Human disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 6.0;lymphoid tissue: 4.3"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 6.4;Alveolar cells type 2: 7.4;granulocytes: 7.6;Kupffer cells: 11.2;Macrophages: 7.8;monocytes: 20.5"	"Cancer enriched"	"Detected in single"	5	"testis cancer: 2.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"basophil: 56.9;classical monocyte: 18.1;eosinophil: 23.2;neutrophil: 29.8"	"Group enriched"	"Detected in many"	5	"granulocytes: 56.9;monocytes: 18.1"	"Group enriched"	"Detected in some"	4	"HMC-1: 4.6;THP-1: 4.1;U-87 MG: 4.3;U-937: 3.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA042981	Approved					NA	NA					"HPA042981: AB_10795712"	"unprognostic (6.92e-2)"	"unprognostic (3.11e-1)"	"unprognostic (6.66e-3)"	"unprognostic (9.82e-2)"	"unprognostic (1.81e-4)"	"unprognostic (3.90e-2)"	"unprognostic (5.79e-2)"	"unprognostic (6.26e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.60e-5)"	"unprognostic (1.63e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.46e-2)"	"unprognostic (4.48e-1)"	0.9	0.0	0.0	2.2	0.1	6.0	0.1	0.0	0.2	0.1	0.2	0.1	0.2	0.0	0.0	0.1	0.3	0.3	0.2	0.0	0.1	0.0	0.2	1.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.8	0.0	4.3	0.1	0.1	0.3	0.1	0.0	0.4	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	4.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	4.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.3	3.8	0.0	56.9	18.1	23.2	0.0	5.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	29.8	0.0	3.0	0.1	0.0	5.1	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.3	0.1	0.3	6.4	7.4	0.0	0.5	0.4	1.0	0.1	0.0	0.7	0.2	0.1	0.5	0.0	3.7	0.0	0.0	0.2	1.4	0.2	0.0	0.0	0.2	0.1	0.1	1.9	0.0	0.0	0.7	0.0	0.2	1.5	0.0	0.3	7.6	0.2	0.7	0.0	2.4	0.0	0.8	0.0	0.0	11.2	1.6	0.2	0.3	7.8	1.8	0.0	20.5	0.2	2.1	0.0	0.5	0.1	0.0	0.0	0.3	0.8	0.0	0.1	2.2	0.7	0.0	0.7	0.2	0.1	0.1	0.0	0.1	0.1	1.1	0.1	0.0	0.7
NR5A1	"AD4BP, ELP, FTZ1, FTZF1, hSF-1, SF-1, SF1"	ENSG00000136931	"Nuclear receptor subfamily 5 group A member 1"	Q13285	9	124481236-124507420	"Disease related genes, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"	"Disease variant, Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"adrenal gland: 189.9;lymphoid tissue: 144.0"	"Group enriched"	"Detected in some"	8	"Granulosa cells: 47.9;Theca cells: 180.1"	"Group enriched"	"Detected in some"	5	"head and neck cancer: 1.7;ovarian cancer: 2.4;testis cancer: 2.6"	"Region enriched"	"Detected in some"	9	"thalamus: 12.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 82.9;Hep G2: 59.2;K-562: 20.6"	"Region enriched"	"Detected in single"	52	"hypothalamus: 5.2"	"Region enriched"	"Detected in single"	8	"hypothalamus: 1.2"	HPA079181			Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA079181: "	"unprognostic (1.66e-1)"	"unprognostic (3.08e-1)"	"unprognostic (6.13e-5)"	"unprognostic (2.32e-7)"	"unprognostic (3.95e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.60e-2)"	"unprognostic (9.74e-2)"	"unprognostic (4.14e-2)"			"unprognostic (4.75e-3)"	"unprognostic (1.14e-1)"		"unprognostic (1.49e-2)"	0.0	189.9	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	1.3	0.0	0.1	0.0	0.1	0.0	0.0	0.1	36.1	0.0	0.0	21.3	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	144.0	0.1	14.2	12.2	0.8	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	82.9	0.0	59.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.6	0.1	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.2	1.3	0.0	0.0	0.1	0.1	0.1	12.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.9	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	47.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	11.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.0	1.4	0.3	0.2	0.0	0.0	0.0	0.0	180.1	0.0	0.0
OXT	"OT, OT-NPI, OXT-NPI"	ENSG00000101405	"Oxytocin/neurophysin I prepropeptide"	P01178	20	3071620-3072517	"Plasma proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	30	"brain: 593.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 30.0;Hepatocytes: 41.2;Late spermatids: 66.3;Proximal enterocytes: 15.7;Proximal tubular cells: 36.5"	"Cancer enriched"	"Detected in some"	5	"testis cancer: 12.1"	"Region enriched"	"Detected in many"	6	"hypothalamus: 593.3"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CACO-2: 1.6;HMC-1: 1.1"	"Region enriched"	"Detected in many"	6	"hypothalamus: 179.3"	"Group enriched"	"Detected in some"	903	"basal ganglia: 794.6;hypothalamus: 1854.1"	HPA071892	Supported	Supported			"Secreted to blood"	NA	NA	1500000				"HPA071892: AB_2732190"	"unprognostic (7.45e-3)"	"unprognostic (1.99e-2)"	"unprognostic (2.66e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.62e-1)"	"unprognostic (3.82e-2)"	"unprognostic (8.22e-2)"	"unprognostic (8.36e-2)"	"unprognostic (6.02e-2)"	"unprognostic (3.05e-2)"	"unprognostic (6.65e-2)"	"unprognostic (6.18e-1)"	"unprognostic (3.81e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.10e-1)"	2.1	1.7	94.6	0.0	0.7	0.1	1.8	0.5	0.8	0.8	0.7	0.3	1.0	0.4	0.0	0.2	0.3	0.0	0.5	0.2	593.3	3.0	19.5	0.2	0.1	0.2	0.7	0.3	0.3	0.1	0.0	16.1	0.0	15.1	0.7	0.0	0.0	0.5	0.1	0.2	1.6	1.0	0.0	1.1	0.2	0.2	2.6	17.2	0.0	0.6	0.0	0.0	0.4	1.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	3.4	0.4	0.2	0.5	2.1	0.8	0.5	0.4	1.6	1.4	1.7	0.5	0.2	0.0	0.7	1.3	0.3	94.6	0.7	0.5	0.8	0.2	593.3	0.2	0.7	0.3	15.1	1.1	17.2	0.2	0.6	0.0	1.8	0.3	3.5	0.8	0.7	0.1	1.2	0.0	1.2	1.7	0.2	0.0	1.3	5.5	0.0	0.0	2.3	0.1	1.9	0.1	30.0	0.2	2.4	0.3	0.0	0.0	0.1	0.0	0.0	3.9	0.0	0.5	0.0	0.3	0.0	41.2	0.2	0.0	0.1	1.8	0.0	0.3	1.6	66.3	0.9	0.6	3.6	0.0	0.0	0.0	1.0	0.5	0.0	0.2	1.7	1.2	1.2	0.4	15.7	36.5	0.9	0.0	0.0	1.8	0.7	1.1	7.8	0.3	1.0	0.0	1.1	0.0	2.0	0.3
PPP4R3C	"FLFL3P, FLJ32867, PPP4R3CP, SMEK3P, smk1"	ENSG00000224960	"Protein phosphatase 4 regulatory subunit 3C"	Q6ZMV5	X	27460207-27463341	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	9	"testis: 1.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"liver cancer: 0.6;testis cancer: 0.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	140	"U-2197: 20.4"					"Not detected"	"Not detected"									NA	NA																				"unprognostic (8.74e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PSKH2		ENSG00000147613	"Protein serine kinase H2"	Q96QS6	8	86047109-86088621	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	10	"retina: 2.5"	"Cell type enhanced"	"Detected in single"		"Rod photoreceptor cells: 2.1"	"Cancer enriched"	"Detected in single"	5	"testis cancer: 0.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	12	"HEL: 9.4"									"HPA015095, HPA056839"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA015095: AB_1855815, HPA056839: "															"unprognostic (1.77e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
RNASE10	"RAH1, RNASE9"	ENSG00000182545	"Ribonuclease A family member 10 (inactive)"	Q5GAN6	14	20505537-20511169	"Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion, Fertilization"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 5.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"head and neck cancer: 2.0;testis cancer: 1.8"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"SiHa: 7.2;U-2 OS: 10.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA052593	Uncertain				"Secreted - unknown location"	NA	NA					"HPA052593: AB_2681878"	"unprognostic (2.48e-3)"	"unprognostic (2.22e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.74e-1)"	"unprognostic (5.91e-3)"	"unprognostic (5.03e-3)"	"unprognostic (5.58e-3)"	"unprognostic (4.20e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.98e-3)"	"unprognostic (1.11e-1)"	"unprognostic (7.88e-4)"	"unprognostic (1.58e-1)"	"unprognostic (3.62e-1)"	"unprognostic (8.76e-2)"	"unprognostic (2.58e-1)"	2.1	1.8	3.0	1.6	3.1	1.1	0.4	2.5	4.2	0.5	2.8	0.7	1.6	2.0	1.1	1.1	1.1	0.6	0.4	3.1	2.4	0.9	0.8	1.6	0.8	3.6	2.9	2.4	1.1	0.4	0.4	0.5	0.8	3.2	1.2	0.4	0.5	0.9	0.7	2.0	2.5	1.7	0.5	1.7	1.3	1.1	1.9	3.5	0.5	0.7	0.2	0.4	0.7	0.5	5.1	4.4	2.0	0.9	1.9	0.2	0.4	2.8	0.2	0.4	0.1	0.3	0.9	1.2	0.5	1.3	0.5	0.6	2.3	0.0	0.3	0.1	1.7	0.7	0.0	1.5	0.6	0.5	0.1	2.0	0.7	1.5	0.1	2.3	0.4	1.0	0.7	1.0	2.3	0.0	1.2	0.7	1.1	0.5	0.6	0.2	3.3	0.3	2.6	0.7	1.8	1.1	1.4	7.2	1.7	0.9	0.9	1.6	0.7	0.4	0.7	10.8	0.9	0.8	2.2	0.9	0.2	0.8	0.6	0.9	1.1	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.1	0.3	0.3	0.0	0.0	3.0	3.1	2.5	4.2	3.1	2.4	3.6	2.9	2.4	3.2	1.7	3.5	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1
RND2	"ARHN, Rho7, RhoN"	ENSG00000108830	"Rho family GTPase 2"	P52198	17	43025231-43032041	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 56.7;choroid plexus: 16.5;testis: 37.5"	"Cell type enriched"	"Detected in many"	4	"Late spermatids: 590.2"	"Group enriched"	"Detected in many"	5	"glioma: 44.4;testis cancer: 11.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 12.0;AN3-CA: 15.5;HAP1: 12.1;NTERA-2: 17.2;SH-SY5Y: 10.4;SuSa: 7.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077757	Approved					NA	NA					"HPA077757: AB_2732361"	"unprognostic (2.19e-2)"	"unprognostic (5.70e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.02e-1)"	"unprognostic (6.52e-2)"	"unprognostic (2.44e-3)"	"unprognostic (4.55e-2)"	"unprognostic (7.44e-2)"	"unprognostic (3.79e-1)"	"unprognostic (1.22e-4)"	"unprognostic (7.85e-2)"	"unprognostic (8.17e-2)"	"unprognostic (6.13e-3)"	"unprognostic (9.92e-2)"	"unprognostic (7.52e-2)"	"unprognostic (5.57e-2)"	0.6	3.1	31.2	0.2	36.8	0.2	1.0	47.1	26.1	2.1	16.5	3.0	0.4	3.7	2.6	1.1	2.0	0.8	1.4	22.6	41.7	0.8	4.1	0.5	0.2	56.7	53.9	18.4	3.8	0.6	5.6	7.0	0.1	51.3	2.7	0.4	3.9	0.8	3.7	0.5	2.0	1.2	2.4	47.0	0.1	1.4	37.5	44.2	0.4	6.6	0.2	0.3	2.1	1.6	40.2	0.0	0.3	12.0	15.5	0.9	0.6	0.3	0.5	0.7	2.1	1.6	1.9	0.2	0.1	2.8	1.6	0.7	0.1	12.1	0.2	1.8	0.0	6.2	0.0	0.2	0.2	0.9	0.1	0.1	0.8	0.1	2.4	0.1	0.3	0.2	1.3	3.1	0.1	0.0	0.5	4.9	0.2	17.2	0.0	0.1	0.9	0.0	0.1	0.2	0.0	3.3	10.4	0.0	0.2	0.1	7.9	2.3	0.0	0.1	0.3	0.4	0.1	0.0	1.1	3.3	0.2	1.9	0.0	0.1	0.5	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	31.2	36.8	47.1	26.1	22.6	41.7	56.7	53.9	18.4	51.3	47.0	44.2	40.2	1.5	0.0	1.5	2.0	0.1	1.3	4.8	0.6	6.8	2.8	2.0	3.3	2.1	1.5	2.0	3.7	0.0	2.1	0.0	0.1	5.9	1.2	136.3	1.9	12.6	1.2	0.0	0.0	2.2	0.8	1.9	3.2	0.0	1.0	1.3	10.5	1.4	3.3	0.6	5.0	7.2	0.0	0.0	0.6	0.7	590.2	5.0	0.8	1.8	1.0	0.0	27.2	1.0	11.6	1.6	0.3	0.1	4.5	0.1	1.6	0.0	2.3	6.5	3.7	0.0	6.2	2.9	38.3	6.1	0.8	1.8	1.6	0.6	2.6	0.1	1.6
RPGRIP1	"CORD13, LCA6, RGI1, RPGRIP"	ENSG00000092200	"RPGR interacting protein 1"	Q96KN7	14	21280083-21351301	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Sensory transduction, Vision"		"Ciliopathy, Cone-rod dystrophy, Disease variant, Glaucoma, Leber congenital amaurosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	80	"retina: 186.9;testis: 60.2"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 231.4;Early spermatids: 177.3;Late spermatids: 108.9;Rod photoreceptor cells: 117.5;Spermatocytes: 51.7"	"Cancer enriched"	"Detected in single"	5	"testis cancer: 1.0"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 8.8"	"Group enriched"	"Detected in many"	18	"dendritic cells: 3.3;granulocytes: 8.8;monocytes: 3.7"	"Cell line enhanced"	"Detected in some"		"RT4: 3.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA042955, HPA060190"	Supported	Supported				NA	NA					"HPA042955: AB_2678239, HPA060190: AB_2684218"	"unprognostic (9.02e-4)"	"unprognostic (3.64e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.86e-1)"	"unprognostic (7.35e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.94e-3)"	"unprognostic (2.33e-1)"	"unprognostic (7.31e-3)"	"unprognostic (2.86e-2)"	"unprognostic (2.87e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.83e-2)"	0.2	0.1	0.5	0.7	0.4	1.2	0.6	0.9	0.7	0.3	0.5	0.5	0.9	0.2	0.0	0.2	0.1	0.3	0.2	0.5	0.8	0.2	0.8	0.5	0.5	0.4	0.4	0.3	0.1	0.1	0.2	0.1	1.3	0.6	0.4	0.6	186.9	0.1	0.1	0.1	0.5	0.8	0.0	0.2	1.5	0.2	60.2	0.5	0.1	0.3	0.2	0.3	0.5	0.1	0.6	0.3	0.8	0.8	0.4	0.0	0.0	1.1	0.3	0.0	0.0	0.4	0.5	0.5	1.1	0.2	0.0	0.4	0.2	0.3	0.0	0.0	0.2	0.5	0.4	0.8	0.2	0.0	0.9	0.3	0.4	0.0	0.0	0.0	0.4	0.0	0.8	0.7	0.1	0.0	0.3	0.3	0.5	1.2	0.5	0.3	0.4	0.7	0.9	0.0	3.8	0.6	0.5	0.7	0.8	0.2	0.6	0.3	0.5	0.3	0.2	0.2	0.8	0.6	0.9	0.9	1.0	0.4	0.6	0.2	0.7	3.7	0.0	0.0	1.7	0.1	0.0	0.0	0.0	3.3	0.1	0.1	0.0	8.8	0.3	0.0	0.0	0.0	1.0	0.5	0.4	0.9	0.7	0.5	0.8	0.4	0.4	0.3	0.6	0.2	0.5	0.6	0.2	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.2	0.3	1.0	0.0	0.0	0.0	231.4	0.9	0.0	0.0	0.0	0.0	177.3	0.1	0.1	0.6	0.0	0.0	1.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.9	0.0	1.2	0.0	0.0	2.7	0.9	108.9	1.8	0.8	0.0	1.0	0.5	4.8	0.0	0.0	0.9	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.7	117.5	0.0	0.1	0.1	51.7	2.2	0.0	0.1	1.5	0.1	0.1	0.0	0.1
SERPINB9	"CAP3, PI9"	ENSG00000170542	"Serpin family B member 9"	P50453	6	2887270-2903309	"Predicted intracellular proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 41.4;placenta: 52.7"	"Cell type enriched"	"Detected in many"	5	"Langerhans cells: 1527.7"	"Cancer enriched"	"Detected in all"	5	"testis cancer: 46.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 225.3;SuSa: 227.6;U-698: 98.8"					"Low region specificity"	"Detected in all"			HPA030067	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA		3400000	Nucleoplasm	Cytosol	"HPA030067: AB_2673295"	"unprognostic (6.82e-3)"	"unprognostic (8.59e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.06e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.12e-2)"	"unprognostic (9.48e-2)"	"unprognostic (2.12e-2)"	"unprognostic (3.83e-3)"	"unprognostic (1.06e-1)"	"unprognostic (9.85e-2)"	"prognostic unfavorable (1.66e-6)"	"unprognostic (9.90e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.76e-2)"	9.6	11.1	6.0	35.7	7.0	19.1	5.3	7.3	8.0	6.4	5.9	5.3	4.4	4.5	3.1	9.3	8.3	11.4	7.5	6.3	11.2	5.3	16.5	26.6	41.3	8.6	7.6	4.9	3.0	2.4	6.8	8.9	52.7	9.2	5.2	6.5	4.8	4.4	2.8	2.4	2.4	10.8	5.9	8.0	28.4	5.0	8.7	7.8	13.9	7.7	1.8	41.4	17.1	7.5	8.5	0.2	9.8	0.3	0.1	0.7	0.3	225.3	1.9	0.5	2.3	3.4	2.9	18.8	38.2	22.8	2.1	0.1	0.1	27.6	0.0	2.0	12.4	2.7	3.8	3.3	5.5	12.9	0.0	0.1	10.1	0.1	4.1	0.0	0.2	50.2	3.4	17.8	0.3	1.9	0.9	0.0	0.3	31.7	0.1	0.1	3.7	0.1	0.4	1.6	0.1	1.5	0.5	22.7	0.1	0.0	227.6	0.1	0.6	52.5	0.0	0.4	0.1	0.1	0.2	49.5	98.8	0.0	0.1	0.1	4.7	48.6	0.3	43.6	100.8	36.3	22.4	31.3	41.7	16.1	24.9	28.7	41.4	7.6	51.3	62.7	17.0	35.7	37.9	6.0	7.0	7.3	8.0	6.3	11.2	8.6	7.6	4.9	9.2	8.0	7.8	8.5	26.2	19.2	17.6	12.1	105.1	35.3	2.2	4.2	1.8	1.5	13.8	6.7	5.3	1.5	12.1	5.5	0.0	83.1	100.8	4.7	0.0	15.8	1.0	68.0	10.8	44.1	15.5	11.6	21.4	0.2	143.7	35.6	3.6	82.2	46.3	2.2	66.4	7.1	17.9	8.4	23.1	2.7	2.0	59.6	1527.7	4.9	4.4	232.6	88.9	92.8	99.8	5.3	43.3	1.0	3.2	9.3	6.0	17.7	115.7	2.5	0.1	2.4	10.4	3.0	13.1	55.3	14.6	0.4	2.2	3.8	36.9	270.2	100.6	8.1	3.4	6.9
SPINK2	HUSI-II	ENSG00000128040	"Serine peptidase inhibitor Kazal type 2"	P20155	4	56809860-56821742	"Disease related genes, Human disease related genes, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	15	"epididymis: 5356.9"	"Group enriched"	"Detected in many"	10	"Early spermatids: 1217.2;Late spermatids: 1399.4;Spermatocytes: 1989.6"	"Group enriched"	"Detected in some"	5	"lung cancer: 1.3;testis cancer: 4.6;thyroid cancer: 2.4"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in many"	7	"NK-cell: 146.4"	"Lineage enriched"	"Detected in many"	7	"NK-cells: 146.4"	"Cell line enriched"	"Detected in some"	4	"U-266/70: 90.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB020824, HPA026813"	Enhanced				"Secreted to blood"	NA	NA					"CAB020824: , HPA026813: AB_1857446"	"unprognostic (5.56e-3)"	"unprognostic (3.60e-1)"	"unprognostic (7.54e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.60e-1)"		"prognostic favorable (2.82e-4)"	"unprognostic (9.83e-2)"	"unprognostic (6.62e-2)"	"unprognostic (9.40e-3)"	"unprognostic (2.06e-1)"	"unprognostic (2.49e-1)"	"unprognostic (4.10e-3)"	"unprognostic (3.18e-2)"	"unprognostic (2.19e-2)"	"unprognostic (3.87e-2)"	0.5	0.1	0.2	1.1	0.2	13.6	1.4	0.1	0.7	0.7	1.5	2.8	1.9	0.3	5356.9	0.2	0.3	0.1	3.8	0.2	0.3	0.2	0.2	0.2	4.8	0.3	0.4	0.2	0.4	0.1	0.0	4.2	0.0	0.3	3.6	2.1	0.0	2.0	242.9	1.8	0.5	3.1	0.3	0.2	1.8	3.1	348.8	0.3	3.9	0.6	2.3	4.9	0.5	4.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	21.4	0.0	0.0	0.0	0.0	1.2	0.1	0.1	0.0	2.5	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.6	0.0	0.0	0.0	0.7	2.9	18.0	0.5	0.0	0.0	0.0	0.0	4.5	0.0	6.0	0.3	3.0	0.0	0.0	0.2	0.7	0.0	0.4	0.0	0.0	0.0	0.2	0.0	90.5	0.4	0.0	0.0	0.0	0.0	4.4	0.0	1.1	0.5	0.1	0.6	9.1	5.1	5.4	1.4	10.5	11.1	21.6	0.9	146.4	0.0	0.8	0.3	5.4	0.2	0.2	0.1	0.7	0.2	0.3	0.3	0.4	0.2	0.3	0.2	0.3	0.2	0.2	0.0	0.0	0.0	7.2	2.0	14.2	1.8	1.8	0.0	0.2	0.6	3.4	0.0	0.2	0.0	0.0	0.0	2.5	1.4	0.0	0.0	1217.2	0.2	0.1	1.6	1.8	32.4	0.3	0.0	0.3	0.8	0.5	0.2	1.3	0.3	0.0	0.0	0.1	0.0	0.2	10.4	0.0	0.0	3.6	1399.4	37.9	2.5	12.4	0.0	1.6	1.5	1.0	0.0	0.1	0.0	13.1	24.5	35.2	9.5	0.4	0.3	0.3	0.0	13.1	0.4	1.9	1989.6	149.9	0.1	0.3	0.0	16.8	0.0	2.6	2.6
SPSB2	"GRCC9, SSB-2"	ENSG00000111671	"SplA/ryanodine receptor domain and SOCS box containing 2"	Q99619	12	6870935-6889358	"Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 40.2"	"Cancer enriched"	"Detected in all"	5	"testis cancer: 38.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A549: 43.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055225	Approved					NA	NA					"HPA055225: AB_2682746"	"unprognostic (1.13e-1)"	"unprognostic (3.66e-1)"	"unprognostic (1.72e-2)"	"unprognostic (3.20e-1)"	"unprognostic (1.33e-1)"	"unprognostic (8.14e-2)"	"prognostic unfavorable (2.62e-4)"	"unprognostic (3.05e-1)"	"unprognostic (1.81e-1)"	"unprognostic (6.19e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.13e-2)"	"unprognostic (4.83e-2)"	"unprognostic (1.35e-2)"	"unprognostic (2.77e-1)"	"unprognostic (9.05e-2)"	"unprognostic (2.39e-2)"	5.3	11.3	6.7	5.9	6.5	6.2	5.9	9.6	9.9	7.7	6.0	6.9	5.0	8.0	3.4	7.3	7.7	6.4	4.5	6.0	7.2	13.5	6.8	12.5	7.4	6.7	6.5	5.4	5.1	8.7	4.6	7.6	2.4	7.0	7.2	2.3	4.3	7.8	6.2	5.2	8.2	7.5	3.0	6.6	9.4	7.7	9.8	6.3	8.5	12.2	1.7	3.6	7.5	6.6	7.8	9.4	43.6	4.2	6.5	9.7	4.6	8.3	9.7	11.0	8.4	4.0	19.9	35.8	3.2	4.5	8.4	6.1	8.8	10.3	5.5	1.2	21.4	3.5	11.0	13.7	7.8	14.7	5.0	10.5	4.9	7.8	11.1	9.8	6.9	5.7	12.6	7.1	4.3	8.7	13.7	10.0	5.8	17.1	12.6	13.2	9.3	5.5	6.4	16.7	6.4	1.8	5.3	6.7	13.0	10.4	12.3	3.9	8.5	4.8	8.4	13.2	8.8	10.3	5.7	9.2	4.1	9.3	9.6	12.0	0.1	8.4	24.0	12.1	9.9	14.2	11.8	11.9	9.9	9.3	13.2	13.5	12.1	6.8	7.0	12.1	17.3	13.6	8.3	6.7	6.5	9.6	9.9	6.0	7.2	6.7	6.5	5.4	7.0	6.6	6.3	7.8	4.2	28.9	19.9	2.0	7.1	2.5	3.7	7.5	2.2	5.3	8.5	4.4	3.3	7.2	9.4	20.2	2.1	5.8	4.4	11.1	33.2	13.3	16.8	18.6	5.3	5.5	9.5	6.6	0.5	10.7	4.5	5.8	3.6	8.9	8.2	2.5	7.5	4.7	11.5	6.7	0.9	10.8	0.0	7.6	3.9	8.9	9.6	8.1	0.0	1.9	13.4	9.4	17.5	1.0	1.8	9.0	6.6	9.1	2.2	7.6	15.6	40.2	19.5	14.3	6.6	6.5	6.3	29.0	9.2	4.1	4.8	7.7	8.5	10.2	7.8	3.4
SPSB4	SSB-4	ENSG00000175093	"SplA/ryanodine receptor domain and SOCS box containing 4"	Q96A44	3	141051347-141148611	"Predicted intracellular proteins"	"Biological rhythms, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 2.8;pancreas: 7.1;pituitary gland: 3.0;testis: 2.9"	"Group enriched"	"Detected in some"	4	"Early spermatids: 23.6;Late spermatids: 11.7;Oligodendrocyte precursor cells: 41.7;Spermatocytes: 22.1"	"Group enriched"	"Detected in some"	5	"glioma: 4.6;testis cancer: 2.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 12.5;NTERA-2: 3.5;RH-30: 4.2;SH-SY5Y: 3.6;U-2 OS: 2.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA062793			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"		"HPA062793: AB_2732689"	"unprognostic (5.07e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.23e-3)"	"prognostic favorable (3.72e-4)"	"unprognostic (7.49e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.76e-1)"	"unprognostic (8.48e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.47e-3)"	"unprognostic (2.30e-2)"	"unprognostic (2.46e-4)"	"unprognostic (9.80e-3)"	0.3	0.3	1.1	0.0	0.9	0.0	0.1	0.8	1.3	0.0	2.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.3	1.9	0.3	0.0	0.4	0.0	2.8	2.0	0.2	0.0	7.1	0.2	3.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.1	0.0	1.6	1.1	0.0	2.9	1.1	0.2	0.0	0.0	0.0	0.1	0.1	1.1	0.0	0.0	12.5	0.2	0.0	0.0	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.7	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.4	0.9	0.0	3.5	0.0	0.0	0.0	4.2	0.6	0.0	0.0	1.1	3.6	0.0	0.0	0.0	2.0	0.2	0.3	0.0	0.0	2.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.9	0.8	1.3	0.3	1.9	2.8	2.0	0.2	1.6	1.6	1.1	1.1	0.4	0.0	0.0	0.7	0.0	0.4	0.0	0.0	0.0	0.9	0.0	0.1	4.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	23.6	0.0	0.1	0.1	0.0	0.0	2.8	0.5	0.0	3.2	0.0	0.0	0.0	0.4	0.4	0.1	0.2	0.0	5.6	0.0	0.0	5.0	0.0	11.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.7	0.3	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.3	0.4	22.1	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
TEAD4	"EFTR-2, RTEF-1, TCF13L1, TEF-3, TEFR-1"	ENSG00000197905	"TEA domain transcription factor 4"	Q15561	12	2959330-3040676	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 128.4"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 50.3;Exocrine glandular cells: 38.3;Hepatic stellate cells: 32.2;Proximal enterocytes: 37.9;Syncytiotrophoblasts: 34.6"	"Cancer enriched"	"Detected in all"	5	"testis cancer: 78.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 364.1"	"Region enriched"	"Detected in single"	5	"cerebellum: 3.1"	"Low region specificity"	"Detected in all"			HPA056896	Uncertain		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA056896: AB_2683268"	"unprognostic (3.68e-1)"	"unprognostic (3.98e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.55e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.68e-1)"	"unprognostic (9.20e-3)"	"unprognostic (2.21e-3)"	"unprognostic (3.01e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.50e-2)"	"unprognostic (2.03e-1)"	"prognostic unfavorable (9.78e-9)"	"unprognostic (5.05e-3)"	"unprognostic (8.43e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.23e-3)"	13.5	5.2	4.8	7.1	3.3	0.4	12.1	4.8	5.6	8.9	4.7	7.4	4.9	9.8	1.0	7.9	8.4	4.6	18.5	3.2	6.7	17.4	4.6	26.3	1.6	5.0	4.1	2.3	4.6	51.5	1.7	3.4	11.0	5.6	8.6	4.1	0.5	8.1	5.1	128.4	15.5	8.5	9.0	3.7	9.1	8.1	3.8	6.2	1.6	23.8	47.1	2.4	11.4	7.2	10.2	37.6	51.5	13.0	36.2	4.0	8.7	137.8	29.5	15.6	49.7	27.8	99.6	39.0	0.3	22.2	22.5	34.0	52.5	51.2	364.1	46.1	0.2	41.2	59.1	43.7	87.7	18.8	12.8	10.7	12.2	14.8	43.3	66.7	20.8	42.9	23.4	38.4	0.5	17.5	53.2	0.7	0.3	99.5	48.0	30.0	27.4	73.7	28.9	23.6	15.3	7.4	13.2	36.4	89.9	27.1	93.8	61.2	21.8	49.4	28.7	100.1	20.2	15.7	0.1	0.2	0.4	23.3	0.0	37.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	3.3	4.8	5.6	3.2	6.7	5.0	4.1	2.3	5.6	3.7	6.2	10.2	17.1	12.8	4.7	0.0	0.1	12.2	12.6	6.1	9.1	0.1	6.6	3.7	2.4	5.7	2.3	7.3	0.0	50.3	0.4	3.7	5.9	17.7	0.3	3.0	5.1	25.9	0.0	0.0	1.6	38.3	18.3	6.6	4.1	5.0	5.7	3.4	32.2	0.4	5.2	0.0	0.5	3.7	2.0	0.8	1.5	2.3	0.0	0.5	8.8	3.7	0.0	0.0	0.0	0.0	0.4	21.1	0.9	0.4	1.2	28.9	37.9	21.1	1.5	0.1	0.0	9.3	12.2	0.5	6.4	5.4	7.7	34.6	0.5	0.4	7.1	4.9
TGIF2LX		ENSG00000153779	"TGFB induced factor homeobox 2 like X-linked"	Q8IUE1	X	89921908-89922883	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	89	"testis: 8.8"	"Group enriched"	"Detected in some"	13	"Early spermatids: 74.1;Late spermatids: 45.0"	"Cancer enriched"	"Detected in single"	5	"testis cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"SH-SY5Y: 10.9;U-2 OS: 12.4;U-266/84: 21.4"									HPA034543	Supported		Approved	Nucleoplasm		No	No			Nucleoplasm		"HPA034543: AB_10603037"															"unprognostic (1.45e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	12.4	0.3	0.0	1.1	21.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	74.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	45.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TSKS	"PPP1R161, TSSKS"	ENSG00000126467	"Testis specific serine kinase substrate"	Q9UJT2	19	49739753-49763306	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	74	"testis: 120.9"	"Group enriched"	"Detected in some"	46	"Early spermatids: 887.3;Late spermatids: 1022.9"	"Group enriched"	"Detected in some"	5	"head and neck cancer: 1.1;testis cancer: 2.2"	"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	5	"NB-4: 11.6"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA045729	Enhanced					NA	NA					"HPA045729: AB_10963430"	"unprognostic (3.56e-1)"	"unprognostic (3.75e-3)"	"unprognostic (8.33e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.93e-1)"	"unprognostic (3.55e-1)"	"unprognostic (1.54e-1)"	"unprognostic (3.04e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.51e-8)"	"unprognostic (7.89e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.79e-2)"	"unprognostic (3.52e-2)"	1.1	0.1	0.1	0.1	0.2	0.5	0.9	0.8	0.5	0.7	0.5	0.2	0.0	1.0	0.0	0.3	1.0	0.3	1.2	0.3	0.1	0.1	0.2	0.4	0.4	0.1	0.2	0.1	0.3	0.2	0.0	0.0	0.9	0.3	0.4	0.0	0.1	0.3	0.1	0.3	1.6	0.2	0.1	0.3	0.5	0.2	120.9	0.2	0.3	0.7	0.0	0.1	0.9	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.1	0.0	0.0	0.1	0.0	1.9	0.0	0.0	0.0	0.0	11.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.0	0.8	0.0	0.8	0.0	0.4	0.0	0.0	0.0	1.0	0.7	0.7	0.2	0.1	0.2	0.8	0.5	0.3	0.1	0.1	0.2	0.1	0.3	0.3	0.2	0.2	0.3	0.0	0.0	0.0	0.1	2.0	0.0	0.0	3.4	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	887.3	1.0	0.5	0.7	0.0	0.8	0.4	0.0	8.6	1.9	0.0	0.1	0.0	0.2	0.4	0.0	2.5	0.0	0.3	0.0	0.0	1.3	0.4	1022.9	9.6	1.5	0.0	1.0	0.2	1.2	1.0	0.5	0.5	0.0	0.0	7.5	0.1	0.0	0.0	0.0	0.0	0.0	13.1	0.1	0.3	20.5	8.4	0.7	1.4	6.7	0.5	0.2	0.0	0.1
TUBB8	bA631M21.2	ENSG00000261456	"Tubulin beta 8 class VIII"	Q3ZCM7	10	46888-74163	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"testis: 2.4"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 3.4;Early spermatids: 11.7;Late spermatids: 3.4;Spermatocytes: 13.0;Spermatogonia: 15.9"	"Cancer enriched"	"Detected in single"	5	"testis cancer: 1.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"MCF7: 1.3"									"HPA043640, HPA046280"	Uncertain		Supported	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	NA			Microtubules	"Cytokinetic bridge, Mitotic spindle"	"HPA043640: AB_2678594, HPA046280: AB_2679612"	"unprognostic (4.75e-2)"	"unprognostic (6.02e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.80e-1)"	"unprognostic (7.74e-2)"	"unprognostic (8.33e-3)"	"unprognostic (1.50e-1)"	"unprognostic (4.15e-3)"	"unprognostic (7.17e-2)"	"unprognostic (3.30e-2)"	"unprognostic (1.33e-3)"	"unprognostic (4.53e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.19e-2)"	"unprognostic (6.86e-3)"	0.1	0.1	0.4	0.1	0.3	0.0	0.2	0.2	0.6	0.1	0.2	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.3	0.3	0.3	0.0	0.1	0.1	0.3	0.3	0.4	0.4	0.3	0.3	0.2	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.3	0.1	2.4	0.3	0.0	0.7	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.2	0.6	0.3	0.3	0.3	0.3	0.4	0.3	0.3	0.3	0.3	0.3	0.0	0.0	0.3	0.1	0.0	0.7	0.0	0.0	0.0	0.2	0.1	3.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	11.7	0.4	0.1	0.1	0.0	0.0	0.7	0.0	0.2	0.2	0.0	0.5	0.0	0.1	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	3.4	0.0	0.1	0.0	1.9	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.7	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.5	13.0	15.9	0.0	0.0	0.0	0.0	0.4	0.0	0.6
UGT3A2		ENSG00000168671	"UDP glycosyltransferase family 3 member A2"	Q3SY77	5	36035021-36071358	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 6.5;lymphoid tissue: 14.8;skin 1: 10.4"	"Group enriched"	"Detected in some"	4	"Collecting duct cells: 3.7;Early spermatids: 4.4;Late spermatids: 8.2;Proximal tubular cells: 3.8"	"Cancer enriched"	"Detected in some"	5	"testis cancer: 4.4"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 6.8;JURKAT: 6.3;MOLT-4: 12.4;REH: 29.9;SuSa: 11.8;T-47d: 7.2;THP-1: 18.0"	"Low region specificity"	"Detected in many"							HPA059475	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		Yes	NA			Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA059475: AB_2684031"	"unprognostic (1.83e-4)"	"unprognostic (9.94e-2)"	"unprognostic (8.87e-2)"	"unprognostic (4.82e-4)"	"unprognostic (3.18e-1)"	"unprognostic (3.52e-2)"	"unprognostic (1.56e-1)"	"unprognostic (6.08e-2)"	"unprognostic (2.04e-1)"	"unprognostic (8.13e-2)"	"unprognostic (7.49e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.36e-3)"	"unprognostic (6.65e-2)"	"unprognostic (7.52e-2)"	"unprognostic (7.38e-2)"	"unprognostic (4.52e-3)"	0.0	0.8	0.1	0.0	0.1	6.5	1.1	0.3	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	2.7	0.6	0.0	0.0	0.9	0.4	0.0	0.0	0.0	0.1	0.9	0.2	1.2	0.4	0.0	0.1	0.1	0.0	0.1	10.4	0.0	0.0	0.1	1.2	0.1	2.9	0.5	14.8	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.6	1.8	0.0	0.1	0.0	0.0	0.3	0.4	0.0	1.3	0.0	0.5	6.8	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	12.4	0.0	5.3	0.0	0.0	29.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.8	7.2	18.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.2	0.0	0.2	0.9	0.4	0.0	1.2	0.1	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	3.7	0.0	0.2	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.7	0.0	0.0	0.0	0.1	0.0	0.7	0.1	0.0	0.1	0.0	0.0	0.0	1.1	8.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.3	0.1	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.0	0.3	0.0	0.1	0.0	0.0
UNC45B	"CMYA4, UNC45"	ENSG00000141161	"Unc-45 myosin chaperone B"	Q8IWX7	17	35147817-35189345	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Differentiation, Myogenesis"	"Chaperone, Developmental protein"	"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	59	"heart muscle: 101.3;skeletal muscle: 198.4;tongue: 153.3"	"Group enriched"	"Detected in some"	5	"Cardiomyocytes: 201.8;Late spermatids: 59.4"	"Group enriched"	"Detected in some"	5	"head and neck cancer: 0.9;testis cancer: 1.0"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"gdT-cell: 1.1"	"Lineage enriched"	"Detected in single"	9	"T-cells: 1.1"	"Group enriched"	"Detected in some"	11	"BEWO: 1.7;HSkMC: 2.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA017861			Approved	Cytosol		NA	NA			Cytosol		"HPA017861: AB_1847012"	"unprognostic (7.17e-2)"	"unprognostic (6.47e-3)"	"unprognostic (9.36e-3)"	"unprognostic (2.93e-1)"	"unprognostic (1.49e-3)"	"unprognostic (5.30e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.09e-2)"	"unprognostic (5.46e-2)"	"unprognostic (2.40e-2)"	"unprognostic (8.46e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.13e-6)"	"unprognostic (6.77e-2)"	"unprognostic (5.05e-3)"	"unprognostic (2.20e-1)"	"unprognostic (2.21e-1)"	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.2	0.3	0.0	0.2	0.0	0.0	0.0	0.0	2.1	0.0	0.1	101.3	0.2	0.1	0.1	0.0	0.7	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	2.1	0.0	0.0	2.5	0.0	198.4	0.0	0.0	0.1	0.1	1.4	0.4	1.3	0.1	0.4	0.0	153.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.9	0.0	0.2	0.5	0.0	0.0	0.1	0.6	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.2	0.3	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	201.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.9	0.0	24.6	0.0	0.0	2.3	0.0	2.7	0.4	0.0	0.5	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.4	59.4	0.6	0.1	0.0	1.9	0.0	0.0	1.0	0.5	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	6.3	4.5	0.2	0.7	0.0	0.1	0.0	1.1	0.5	0.0	0.1
UTS2R	GPR14	ENSG00000181408	"Urotensin 2 receptor"	Q9UKP6	17	82371400-82375586	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 1.6;testis: 3.2;thyroid gland: 1.6"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"stomach cancer: 0.7;testis cancer: 2.2;thyroid cancer: 1.1"	"Region enhanced"	"Detected in single"		"cerebral cortex: 1.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 6.2;U-266/70: 15.2;U-266/84: 2.7"															NA	NA						"unprognostic (1.55e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.92e-1)"	"unprognostic (1.46e-2)"	"unprognostic (8.26e-2)"		"unprognostic (2.30e-2)"	"unprognostic (3.98e-1)"	"unprognostic (6.38e-2)"	"unprognostic (4.44e-2)"	"unprognostic (8.73e-2)"		"unprognostic (1.81e-1)"	"unprognostic (1.32e-1)"	"unprognostic (7.84e-2)"		0.0	0.0	0.2	0.1	0.5	0.0	0.1	0.0	1.6	0.0	0.6	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.2	0.0	0.0	0.3	0.1	3.2	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.2	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.1	0.0	1.8	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	15.2	2.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	1.6	0.1	0.0	0.2	0.0	0.3	0.6	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
WFIKKN2	"WFDC20B, WFIKKNRP"	ENSG00000173714	"WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2"	Q8TEU8	17	50834650-50842353	"Predicted intracellular proteins, Predicted secreted proteins"		"Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	34	"choroid plexus: 472.1;ovary: 147.4"	"Group enriched"	"Detected in some"	11	"Leydig cells: 9.0;Peritubular cells: 24.0"	"Group enriched"	"Detected in some"	5	"glioma: 0.7;testis cancer: 2.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-87 MG: 1.0"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"medulla oblongata: 12.6;midbrain: 5.1;thalamus: 6.1"						"Secreted in other tissues"	NA	NA		4500000				"unprognostic (7.31e-2)"	"unprognostic (7.31e-2)"	"unprognostic (1.31e-2)"	"unprognostic (4.80e-2)"	"unprognostic (3.46e-2)"	"unprognostic (5.72e-2)"	"unprognostic (5.42e-3)"	"unprognostic (2.54e-3)"		"unprognostic (1.50e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.19e-1)"	"unprognostic (4.08e-3)"	"unprognostic (1.42e-3)"	"unprognostic (2.17e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.14e-1)"	0.0	1.3	2.4	0.0	1.6	0.0	0.1	5.0	3.6	0.3	472.1	0.7	0.0	1.1	0.5	0.2	0.8	0.2	0.5	9.0	1.2	0.0	0.0	0.2	0.0	1.4	2.2	0.6	147.4	0.3	0.0	2.2	0.0	3.8	0.4	0.0	0.3	0.1	0.6	2.2	0.9	0.2	0.3	0.7	0.0	0.2	2.4	5.2	0.5	0.0	1.0	0.0	0.1	0.8	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	1.6	5.0	3.6	9.0	1.2	1.4	2.2	0.6	3.8	0.7	5.2	1.6	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	9.0	0.1	0.0	0.0	0.0	1.5	0.0	0.5	0.1	0.0	0.0	24.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0
ZNF578	FLJ31384	ENSG00000258405	"Zinc finger protein 578"	Q96N58	19	52453553-52516882	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 6.4"	"Cell type enhanced"	"Detected in many"		"Horizontal cells: 6.7;NK-cells: 8.2;Oligodendrocyte precursor cells: 10.1;Rod photoreceptor cells: 8.2"	"Cancer enriched"	"Detected in single"	5	"testis cancer: 1.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SuSa: 5.5;U-266/84: 9.4"															NA	NA						"unprognostic (6.57e-3)"	"unprognostic (1.43e-2)"	"unprognostic (1.56e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.60e-3)"	"unprognostic (2.96e-3)"	"unprognostic (5.42e-2)"	"unprognostic (5.69e-2)"	"unprognostic (2.55e-2)"	"unprognostic (8.14e-2)"	"unprognostic (9.57e-3)"	"unprognostic (7.61e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.82e-1)"	"unprognostic (3.96e-2)"	"unprognostic (2.42e-1)"	0.7	0.7	2.4	0.7	3.2	0.8	0.8	4.7	2.8	0.9	1.6	0.5	0.4	1.2	1.8	0.4	1.3	0.6	1.2	2.1	2.4	0.9	0.3	0.7	0.8	2.6	2.2	1.8	1.7	0.7	1.0	0.3	1.3	3.1	1.4	0.7	3.1	0.7	1.2	0.9	1.2	0.4	0.9	1.8	1.3	0.6	6.4	2.5	1.1	1.7	0.6	0.7	0.5	0.2	3.7	0.5	0.3	2.1	2.7	1.2	0.7	1.2	1.3	0.7	0.5	0.9	0.9	0.7	0.9	0.5	2.0	2.5	0.7	1.1	0.6	0.6	0.2	1.5	0.8	1.6	0.5	1.1	0.2	2.7	1.9	0.3	0.9	0.8	1.0	0.9	0.8	0.6	0.6	2.6	0.8	0.9	1.2	4.1	0.6	0.7	0.8	0.8	0.3	1.8	2.7	0.6	1.5	0.6	0.6	0.2	5.5	2.0	0.6	1.3	0.6	0.7	0.8	0.7	0.5	9.4	0.8	0.1	0.2	1.7	1.4	0.3	0.4	0.9	0.3	0.7	0.5	0.6	0.5	0.1	0.8	0.7	0.8	0.5	1.1	0.3	0.5	0.3	0.3	2.4	3.2	4.7	2.8	2.1	2.4	2.6	2.2	1.8	3.1	1.8	2.5	3.7	3.9	0.0	0.0	4.9	1.3	0.9	1.7	0.2	0.0	4.4	0.5	0.5	4.1	0.0	0.2	0.0	4.2	0.7	4.0	0.0	0.0	0.2	5.9	0.9	1.4	1.6	0.0	0.8	3.9	0.2	0.8	1.4	0.0	2.1	1.3	3.9	0.7	0.0	0.2	6.7	5.8	0.1	0.0	0.3	0.6	6.1	0.6	0.4	0.0	0.0	0.4	1.8	8.2	10.1	6.2	0.0	0.0	0.0	0.4	1.0	0.2	0.8	0.1	8.2	0.0	0.7	1.8	0.2	2.3	0.1	0.4	0.8	1.8	2.6	0.1	1.7
ZNF878		ENSG00000257446	"Zinc finger protein 878"	C9JN71	19	12043805-12052961	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"Breast myoepithelial cells: 1.0;Cytotrophoblasts: 1.2;Spermatogonia: 1.2;Syncytiotrophoblasts: 1.2"	"Cancer enriched"	"Detected in single"	5	"testis cancer: 1.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 3.2"									HPA052735	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA052735: AB_2681932"	"unprognostic (3.27e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.56e-2)"	"unprognostic (3.00e-4)"	"unprognostic (1.42e-1)"	"unprognostic (7.43e-3)"	"unprognostic (2.80e-1)"	"unprognostic (6.67e-2)"	"unprognostic (8.75e-2)"	"unprognostic (3.02e-1)"	"unprognostic (7.65e-3)"	"unprognostic (6.82e-2)"	"unprognostic (4.04e-1)"	"unprognostic (3.62e-2)"	0.2	0.3	0.1	0.2	0.1	1.3	0.2	0.6	0.4	0.3	0.2	0.3	0.1	0.3	0.2	0.3	0.3	0.2	0.2	0.1	0.3	0.5	0.2	0.4	0.2	0.2	0.2	0.0	0.5	0.5	0.1	0.2	0.7	0.3	0.3	0.2	0.4	0.3	0.0	0.1	0.1	0.3	0.2	0.2	0.3	0.3	1.0	0.5	0.2	0.3	0.1	0.1	0.3	0.2	0.5	1.5	0.0	0.8	3.2	0.0	0.0	2.0	0.5	0.2	0.6	0.8	1.3	0.2	0.7	0.7	0.2	0.9	0.4	0.3	0.5	0.5	0.0	0.5	0.9	0.0	1.7	0.0	0.6	1.6	0.0	0.0	0.3	0.0	0.0	0.0	2.0	0.0	0.0	0.7	0.0	1.6	0.9	1.8	0.0	0.2	1.2	1.6	0.0	1.1	1.2	0.8	0.1	0.0	0.0	0.1	1.7	1.7	2.1	0.0	0.9	0.7	0.7	0.9	0.6	2.0	0.1	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.6	0.4	0.1	0.3	0.2	0.2	0.0	0.3	0.2	0.5	0.5	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	1.0	0.8	0.0	0.0	0.0	0.0	1.2	0.3	0.1	0.0	0.3	0.1	0.2	0.2	0.4	0.0	0.0	0.2	0.2	0.9	0.1	0.0	0.4	0.0	0.7	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.6	0.3	0.4	1.2	0.0	0.0	1.2	0.1	0.0	0.0	0.0
ART5	ARTC5	ENSG00000167311	"ADP-ribosyltransferase 5"	Q96L15	11	3638512-3642316	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 13.6;testis: 29.6"	"Group enriched"	"Detected in some"	8	"Early spermatids: 18.3;Late spermatids: 18.5;Spermatocytes: 64.9"	"Cancer enriched"	"Detected in some"	4	"testis cancer: 4.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"SuSa: 13.9"	"Not detected"	"Not detected"							"HPA041637, HPA044099"	Uncertain				"Secreted in other tissues"	NA	NA					"HPA041637: AB_2677589, HPA044099: AB_2678808"	"unprognostic (6.32e-2)"	"unprognostic (3.26e-5)"	"unprognostic (4.09e-3)"	"unprognostic (2.06e-4)"	"unprognostic (1.53e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.21e-2)"	"unprognostic (5.65e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.67e-1)"	"prognostic favorable (1.85e-4)"	"unprognostic (3.10e-3)"	"unprognostic (3.46e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.18e-1)"	0.7	0.2	0.3	0.0	0.3	0.0	1.0	0.3	0.5	4.1	0.5	0.2	0.0	3.6	0.7	0.6	1.5	1.4	1.5	0.3	0.7	0.8	0.9	0.9	0.1	0.3	0.4	0.2	8.4	0.4	2.9	0.7	0.1	0.6	1.1	0.0	0.6	1.6	0.9	13.6	0.4	0.2	1.1	0.2	0.0	0.5	29.6	0.4	0.3	2.9	10.6	0.0	0.7	2.2	0.3	0.0	0.1	1.6	2.0	0.0	0.0	3.2	0.2	1.6	0.7	1.8	0.0	0.0	0.0	0.8	0.2	0.0	0.0	1.5	0.0	0.4	0.0	2.2	0.0	0.3	0.1	0.0	0.0	1.4	0.5	0.0	0.0	0.0	0.2	0.0	0.1	0.6	0.0	0.2	0.3	0.0	0.0	1.5	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.5	0.0	13.9	0.5	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.5	0.3	0.7	0.3	0.4	0.2	0.6	0.2	0.4	0.3	0.1	0.0	1.8	0.0	0.0	0.3	2.2	0.0	2.8	0.8	0.3	1.3	2.5	0.0	0.6	0.0	0.0	0.6	0.0	0.1	0.0	0.6	18.3	0.1	0.2	0.4	0.0	0.0	0.0	0.2	0.5	1.3	0.0	0.2	0.0	3.3	0.0	1.8	0.1	0.0	0.0	0.2	0.0	0.3	0.0	18.5	3.4	0.1	0.0	1.0	0.0	3.6	0.0	0.0	0.0	0.2	0.0	1.2	0.1	0.8	0.0	0.6	0.0	0.9	0.0	1.3	0.2	64.9	3.9	0.1	0.3	2.9	0.0	1.2	0.0	0.3
ASIC3	"ACCN3, DRASIC, TNaC1"	ENSG00000213199	"Acid sensing ion channel subunit 3"	Q9UHC3	7	151048292-151052756	"Predicted membrane proteins"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 20.1"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 12.5;Early spermatids: 15.6;Granulosa cells: 14.8;Late spermatids: 61.0;Spermatocytes: 10.3"	"Group enriched"	"Detected in many"	4	"glioma: 3.1;testis cancer: 7.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"U-266/70: 16.7;U-266/84: 10.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA049155, HPA054805"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA049155: AB_2680657, HPA054805: AB_2732588"	"unprognostic (8.71e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.92e-4)"	"unprognostic (2.73e-1)"	"unprognostic (7.06e-2)"	"unprognostic (2.02e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.75e-2)"	"unprognostic (2.42e-1)"	"unprognostic (4.45e-2)"	"unprognostic (8.64e-3)"	"unprognostic (1.67e-2)"	"unprognostic (1.33e-12)"	"unprognostic (1.49e-2)"	"unprognostic (7.38e-2)"	"unprognostic (1.65e-2)"	"unprognostic (5.31e-3)"	2.4	2.1	8.2	0.3	8.9	0.6	2.7	11.9	10.9	11.6	6.6	6.0	1.1	7.7	1.5	2.0	7.2	0.7	8.4	8.2	8.5	4.7	4.1	3.2	0.8	9.6	8.7	7.3	6.4	2.1	0.5	18.3	0.6	10.1	5.4	0.6	8.7	1.6	0.4	6.0	2.8	4.2	0.8	7.2	2.9	3.8	20.1	8.7	0.6	4.1	0.9	0.7	3.1	4.3	11.8	1.5	4.0	1.7	2.7	3.7	0.0	7.4	0.4	0.2	0.3	0.5	0.8	1.9	0.9	0.4	0.2	1.8	2.4	1.0	0.0	0.7	8.9	4.5	1.7	3.4	0.0	0.0	0.1	3.9	0.9	0.7	0.2	0.0	2.9	0.1	1.1	4.2	6.8	0.5	6.3	0.3	0.4	1.8	0.1	3.3	3.1	1.7	0.5	0.3	1.4	2.3	8.2	0.6	0.5	4.3	4.9	1.8	0.4	0.1	1.4	2.1	4.3	1.1	16.7	10.2	0.1	2.3	5.9	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	8.9	11.9	10.9	8.2	8.5	9.6	8.7	7.3	10.1	7.2	8.7	11.8	0.4	0.0	0.5	2.9	0.5	0.6	0.0	0.2	0.0	9.7	0.6	0.6	2.1	0.0	0.2	0.0	12.5	0.2	0.3	0.6	0.0	0.2	15.6	0.9	1.1	0.3	0.0	0.0	3.4	0.4	0.2	0.3	0.5	0.8	8.9	14.8	0.0	0.9	0.6	6.7	4.2	0.1	0.0	0.6	0.9	61.0	1.5	0.4	0.0	0.0	0.6	1.6	0.0	1.5	5.1	0.4	0.0	1.9	0.1	0.3	0.2	0.2	0.6	4.9	0.0	0.7	0.4	10.3	5.6	0.0	0.9	0.7	0.3	0.2	0.2	0.2
BCAT1	BCT1	ENSG00000060982	"Branched chain amino acid transaminase 1"	P54687	12	24810024-24949101	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Amino-acid biosynthesis, Branched-chain amino acid biosynthesis"	"Aminotransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 58.7"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 203.2;Early spermatids: 161.4;Exocrine glandular cells: 139.9;Langerhans cells: 265.8;Late spermatids: 370.3"	"Group enriched"	"Detected in all"	4	"endometrial cancer: 19.0;glioma: 10.7;lung cancer: 7.2;ovarian cancer: 24.0;testis cancer: 27.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 17.1"	"Group enriched"	"Detected in many"	10	"dendritic cells: 5.8;monocytes: 17.1"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 261.3;NTERA-2: 287.4;RH-30: 310.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048592	Uncertain					NA	NA		97000			"HPA048592: AB_2680454"	"unprognostic (1.90e-2)"	"unprognostic (1.87e-3)"	"unprognostic (1.37e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (3.55e-4)"	"unprognostic (3.05e-5)"	"unprognostic (9.49e-3)"	"unprognostic (4.22e-2)"	"unprognostic (4.77e-3)"	"unprognostic (1.97e-3)"	"unprognostic (4.06e-1)"	"prognostic unfavorable (1.38e-4)"	"prognostic unfavorable (4.95e-4)"	"unprognostic (5.44e-2)"	"unprognostic (7.55e-2)"	"prognostic unfavorable (8.54e-4)"	6.7	5.9	5.2	7.1	7.1	2.4	2.1	9.8	9.7	3.7	1.0	2.8	0.8	8.7	1.0	2.0	7.3	4.5	1.5	2.5	15.1	1.2	1.3	9.7	6.4	17.0	18.2	2.3	7.3	58.7	0.4	6.6	15.3	19.4	0.9	2.6	14.6	1.7	0.8	0.7	0.6	3.6	5.8	6.6	2.0	1.8	7.1	13.6	5.3	1.2	2.0	5.3	4.2	1.3	23.1	30.3	12.1	106.8	0.2	30.5	59.0	54.9	60.9	40.6	33.4	55.2	67.1	83.1	114.0	0.3	100.7	6.5	12.0	77.2	0.5	88.2	261.3	15.4	91.1	2.0	37.3	112.3	105.9	31.6	77.4	2.0	85.1	17.8	73.0	114.3	56.9	88.5	1.1	28.7	0.6	65.2	30.1	287.4	0.0	8.1	0.1	310.3	1.4	0.1	10.4	0.1	60.1	0.1	0.2	0.5	114.8	0.2	45.2	150.8	19.7	72.9	80.4	58.1	13.2	13.9	152.7	69.9	62.4	0.3	0.0	2.3	0.0	0.0	3.6	0.1	1.1	0.0	0.1	5.8	0.0	0.0	0.0	1.0	0.1	17.1	3.4	0.2	1.0	5.2	7.1	9.8	9.7	2.5	15.1	17.0	18.2	2.3	19.4	6.6	13.6	23.1	1.7	16.0	26.0	1.6	1.3	8.7	0.1	2.5	0.0	203.2	0.3	0.3	1.6	1.5	2.2	0.0	2.1	61.2	4.3	0.0	1.9	1.8	161.4	41.5	92.6	16.8	0.0	20.8	39.6	139.9	23.2	27.6	0.0	89.1	11.4	117.4	7.9	0.3	72.3	42.1	81.8	0.0	14.2	87.1	265.8	370.3	7.2	59.9	7.2	38.4	22.3	7.1	0.0	84.4	57.4	49.6	0.0	4.1	0.7	0.2	0.0	0.1	3.3	12.2	6.6	14.9	17.4	1.9	1.6	0.5	7.2	22.4	2.8	41.3	0.1	0.1
BEND3	KIAA1553	ENSG00000178409	"BEN domain containing 3"	Q5T5X7	6	107065182-107115515	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 6.2;Late spermatids: 6.9"	"Cancer enriched"	"Detected in all"	4	"testis cancer: 12.0"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA017891, HPA062067"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA017891: AB_2064595, HPA062067: AB_2684675"	"unprognostic (2.86e-2)"	"unprognostic (3.16e-1)"	"unprognostic (9.47e-3)"	"unprognostic (4.25e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.43e-2)"	"unprognostic (8.37e-8)"	"unprognostic (1.59e-1)"	"unprognostic (9.71e-2)"	"unprognostic (3.99e-2)"	"unprognostic (2.71e-2)"	"unprognostic (6.89e-2)"	"unprognostic (1.12e-2)"	"unprognostic (8.65e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.09e-1)"	"unprognostic (4.37e-1)"	0.8	0.7	1.0	0.9	0.7	0.9	0.7	2.1	0.8	0.6	0.4	1.5	1.2	0.8	1.0	0.9	0.9	0.6	1.0	0.7	0.7	0.7	0.7	0.9	0.8	0.6	0.8	0.5	0.7	1.6	0.6	0.8	0.5	0.9	1.1	1.5	0.8	1.5	0.4	1.2	0.6	1.1	0.7	0.7	0.6	2.0	1.9	0.9	1.0	0.8	0.6	0.9	0.7	0.5	0.7	2.9	4.0	11.3	6.4	1.3	0.9	9.3	1.1	1.4	1.4	1.6	4.7	2.1	8.6	2.8	3.0	2.6	2.8	12.2	6.3	2.3	3.4	6.1	2.2	3.1	5.2	1.0	6.1	2.9	2.4	2.6	2.2	3.1	1.0	1.9	4.0	6.7	3.4	1.9	5.8	5.3	4.7	15.9	7.4	2.5	7.3	3.2	5.7	2.4	8.6	11.3	5.5	3.6	6.0	2.2	5.7	3.6	4.9	2.2	4.1	3.7	1.8	5.5	2.3	3.4	8.7	1.3	4.7	3.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.7	2.1	0.8	0.7	0.7	0.6	0.8	0.5	0.9	0.7	0.9	0.7	1.3	3.2	2.7	1.3	0.7	2.9	1.1	0.8	1.8	1.0	1.3	0.8	3.0	4.3	1.8	0.0	6.2	1.1	0.8	0.6	0.0	1.0	5.8	1.3	1.8	1.2	1.2	0.8	1.2	1.8	1.2	1.2	2.6	1.5	0.0	1.9	0.0	0.5	0.6	0.0	2.1	2.4	0.0	1.0	1.2	6.9	0.9	1.0	0.0	1.0	0.1	0.5	0.0	3.0	1.6	1.4	0.8	0.0	1.6	1.6	0.5	0.9	1.1	1.5	0.0	2.1	2.5	0.7	2.5	1.8	3.0	0.8	1.1	0.5	3.3	0.9
C1QTNF4	"CTRP4, ZACRP4"	ENSG00000172247	"C1q and TNF related 4"	Q9BXJ3	11	47589667-47594411	"Predicted secreted proteins"		Cytokine	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.4;ovary: 12.1;pituitary gland: 17.3"	"Cell type enhanced"	"Detected in many"		"Late spermatids: 51.7;Leydig cells: 46.0;Muller glia cells: 54.5;Peritubular cells: 38.4;Spermatogonia: 44.5;Theca cells: 39.0"	"Group enriched"	"Detected in some"	4	"glioma: 1.7;ovarian cancer: 2.5;testis cancer: 2.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	6	"REH: 6.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041032	Approved		Uncertain	"Golgi apparatus,Vesicles"	"Secreted in brain"	NA	NA			"Golgi apparatus, Vesicles"		"HPA041032: AB_10671170"	"unprognostic (1.84e-3)"	"unprognostic (1.58e-1)"	"unprognostic (8.98e-4)"	"unprognostic (8.19e-2)"	"unprognostic (3.59e-2)"	"unprognostic (2.26e-3)"	"unprognostic (6.78e-2)"	"unprognostic (6.11e-2)"	"unprognostic (6.35e-2)"	"unprognostic (4.00e-1)"	"unprognostic (4.91e-4)"	"unprognostic (1.22e-1)"	"unprognostic (8.22e-6)"	"unprognostic (6.02e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.80e-2)"	"unprognostic (6.28e-2)"	1.7	1.5	6.8	0.0	28.4	1.1	2.2	13.2	14.5	4.9	0.0	2.9	0.1	5.9	0.0	0.5	4.3	0.0	0.9	5.7	3.0	1.1	0.9	0.7	0.0	17.2	5.8	12.0	12.1	0.4	0.7	17.3	0.0	11.1	2.8	0.0	0.1	1.2	0.1	0.9	1.7	1.5	0.1	0.4	1.0	1.5	5.9	8.5	0.0	1.5	0.0	0.0	1.3	2.0	4.4	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.4	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	28.4	13.2	14.5	5.7	3.0	17.2	5.8	12.0	11.1	0.4	8.5	4.4	2.4	0.0	0.0	18.9	0.0	2.4	6.5	0.2	0.0	15.8	1.3	25.8	0.7	1.5	0.3	3.7	16.7	1.3	0.1	0.2	3.9	0.1	11.3	0.8	21.2	4.5	0.0	2.5	15.5	0.2	2.7	20.7	0.5	0.6	0.0	31.3	2.5	0.2	3.3	5.0	17.8	0.1	0.0	0.3	3.0	51.7	46.0	0.7	10.6	4.7	0.0	54.5	0.0	5.0	8.0	0.1	0.1	38.4	0.0	4.3	0.1	0.6	0.6	24.7	26.3	12.8	8.5	13.5	44.5	0.3	1.8	3.6	0.6	39.0	0.2	2.4
CAMP	"CAP18, FALL-39, FALL39, LL37"	ENSG00000164047	"Cathelicidin antimicrobial peptide"	P49913	3	48223347-48225491	"Plasma proteins, Predicted secreted proteins, Transporters"		"Antibiotic, Antimicrobial"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"bone marrow: 2941.9"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 16.3;Fibroblasts: 6.9;Late spermatids: 17.4;Prostatic glandular cells: 9.4;Spermatocytes: 5.0;Spermatogonia: 7.2"	"Cancer enriched"	"Detected in many"	4	"testis cancer: 10.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	6	"eosinophil: 84.4;neutrophil: 335.4"	"Lineage enriched"	"Detected in many"	12	"granulocytes: 335.4"	"Cell line enhanced"	"Detected in some"		"Daudi: 27.3;hTCEpi: 19.0;U-698: 77.5"	"Not detected"	"Not detected"							"CAB015949, CAB016522, HPA029874"	Enhanced				"Secreted to blood"	NA	NA	617000000	28000000			"CAB015949: , CAB016522: , HPA029874: AB_10600859"	"unprognostic (2.14e-2)"	"prognostic favorable (5.73e-4)"	"unprognostic (4.59e-2)"	"unprognostic (2.62e-1)"	"unprognostic (9.41e-2)"	"unprognostic (4.57e-5)"	"unprognostic (3.09e-1)"	"unprognostic (5.71e-2)"	"unprognostic (4.89e-2)"	"unprognostic (7.65e-2)"	"unprognostic (1.32e-1)"	"unprognostic (8.08e-4)"	"unprognostic (1.23e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.03e-2)"	0.6	0.1	0.1	1.6	0.1	2941.9	0.6	0.1	0.5	0.6	0.2	0.3	0.0	0.6	342.9	0.4	0.1	0.3	1.2	0.1	0.3	0.4	3.9	7.5	6.9	0.2	0.3	0.1	0.2	0.1	0.1	0.5	2.4	0.2	0.5	0.1	0.0	15.3	0.7	0.2	3.7	1.8	0.1	0.1	23.4	0.4	1.9	0.1	10.8	5.7	0.2	2.9	0.4	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	27.3	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	19.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	3.0	0.0	0.2	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.1	0.1	1.0	1.4	0.1	0.0	3.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	77.5	0.0	3.4	0.1	37.9	5.5	84.4	0.0	9.8	0.0	2.3	0.0	0.0	7.7	2.4	0.0	0.0	335.4	2.6	28.1	4.7	0.0	86.9	0.1	0.1	0.1	0.5	0.1	0.3	0.2	0.3	0.1	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	4.2	0.0	0.9	0.8	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	16.3	0.9	0.3	0.2	0.0	2.1	0.0	0.2	0.0	6.9	0.5	1.4	0.0	0.0	0.4	0.0	3.2	0.0	0.0	0.0	0.0	1.3	1.1	17.4	0.9	3.6	1.8	0.0	1.4	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.8	9.4	0.0	0.1	0.7	0.0	0.0	0.0	0.1	5.0	7.2	0.0	0.0	0.0	1.0	0.0	0.4	0.6
CGB8		ENSG00000213030	"Chorionic gonadotropin subunit beta 8"	P0DN86	19	49047638-49049106	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"placenta: 19.0"	"Cell type enriched"	"Detected in some"	6	"Syncytiotrophoblasts: 44.3"	"Cancer enriched"	"Detected in some"	4	"testis cancer: 5.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"BEWO: 157.9;U-251 MG: 57.2"									"HPA038925, HPA038934"	Supported		Approved	Cytosol	"Secreted to blood"	NA	NA			Cytosol		"HPA038925: AB_2676272, HPA038934: AB_2676277"		"unprognostic (3.35e-2)"				"unprognostic (1.72e-1)"					"unprognostic (7.44e-3)"				"unprognostic (4.70e-1)"		"unprognostic (1.67e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	19.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.1	1.2	0.0	0.0	0.0	0.0	157.9	0.0	0.0	0.6	0.0	0.0	5.3	0.0	0.1	1.0	4.0	1.3	0.0	0.0	0.2	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	10.1	0.2	0.6	0.0	2.8	7.1	0.7	57.2	0.1	0.2	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.3	0.0	0.0	0.0	0.0
CHST8	GALNAC-4-ST1	ENSG00000124302	"Carbohydrate sulfotransferase 8"	Q9H2A9	19	33621953-33773509	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism"	Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	25	"brain: 29.8;pituitary gland: 64.4"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 15.4;Excitatory neurons: 11.8;Granulosa cells: 7.9;Late spermatids: 56.5;Oligodendrocyte precursor cells: 12.1"	"Group enriched"	"Detected in many"	4	"breast cancer: 4.1;glioma: 4.9;testis cancer: 3.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"RPMI-8226: 24.7;SCLC-21H: 13.5;SH-SY5Y: 23.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA016004	Enhanced				"Intracellular and membrane"	NA	NA					"HPA016004: AB_1846731"	"unprognostic (1.00e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.45e-2)"	"unprognostic (9.44e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.15e-2)"	"unprognostic (5.75e-2)"	"unprognostic (8.41e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.54e-1)"	"unprognostic (6.98e-8)"	"unprognostic (9.37e-3)"	"unprognostic (2.61e-1)"	"unprognostic (3.28e-1)"	"unprognostic (3.87e-2)"	0.6	0.7	6.4	0.3	6.4	0.0	1.9	9.3	10.0	0.8	0.0	0.3	0.0	0.6	0.0	0.3	1.2	0.9	0.4	10.4	8.6	0.1	0.1	0.2	0.4	24.9	9.6	3.6	1.0	0.7	0.0	64.4	0.0	29.8	0.7	0.0	0.7	0.2	0.0	0.1	0.3	0.3	0.1	3.5	1.3	0.3	1.4	11.5	0.0	0.6	0.0	0.2	0.3	0.6	21.3	0.0	0.0	0.0	0.3	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.7	0.0	0.0	0.1	0.0	0.0	0.0	1.5	0.0	4.7	0.0	0.0	0.0	1.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	3.6	0.0	0.0	0.0	0.1	24.7	0.0	0.4	13.5	23.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.4	6.4	9.3	10.0	10.4	8.6	24.9	9.6	3.6	29.8	3.5	11.5	21.3	0.2	0.0	0.0	0.7	0.0	0.8	0.4	0.0	0.0	3.1	3.8	0.6	5.1	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	0.3	0.2	0.4	0.0	0.0	11.8	0.0	1.3	0.2	0.0	0.1	0.0	7.9	0.4	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	56.5	0.0	0.0	0.0	0.0	0.0	0.7	0.0	12.1	3.6	0.4	0.0	0.0	0.0	2.0	0.0	0.0	0.0	4.7	0.0	0.3	3.2	0.5	0.7	0.3	0.1	0.0	0.0	0.0	0.0	1.1
COL23A1	DKFZp434K0621	ENSG00000050767	"Collagen type XXIII alpha 1 chain"	Q86Y22	5	178237476-178590393	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"thyroid gland: 79.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 20.2;Cardiomyocytes: 11.3;Excitatory neurons: 21.8;Muller glia cells: 62.6"	"Group enriched"	"Detected in many"	4	"renal cancer: 41.3;testis cancer: 16.0;thyroid cancer: 14.9"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"K-562: 8.4;NB-4: 9.6;THP-1: 5.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067824	Uncertain					NA	NA					"HPA067824: AB_2685907"	"unprognostic (5.24e-2)"	"unprognostic (2.65e-1)"	"unprognostic (6.65e-2)"	"prognostic unfavorable (6.46e-5)"	"unprognostic (3.04e-1)"	"unprognostic (8.67e-3)"	"unprognostic (1.14e-1)"	"unprognostic (3.62e-1)"	"unprognostic (2.12e-1)"	"unprognostic (3.52e-2)"	"unprognostic (3.96e-2)"	"unprognostic (5.93e-3)"	"unprognostic (8.20e-2)"	"unprognostic (2.30e-1)"	"unprognostic (4.90e-2)"	"unprognostic (2.11e-3)"	"unprognostic (2.37e-1)"	1.1	1.2	0.6	0.0	0.8	1.8	2.4	1.3	1.1	3.1	0.0	2.2	1.0	1.5	0.0	1.3	2.0	0.1	14.1	0.2	0.2	4.5	1.6	2.5	0.1	1.2	0.4	0.3	0.3	0.4	0.8	1.6	0.0	1.0	8.9	0.1	2.1	2.0	1.4	2.1	7.6	5.6	0.0	0.1	2.1	2.8	5.2	0.8	0.0	79.2	0.0	0.1	0.7	3.1	0.3	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	9.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.8	1.3	1.1	0.2	0.2	1.2	0.4	0.3	1.0	0.1	0.8	0.3	1.8	0.0	0.0	20.2	0.0	2.2	4.2	0.4	1.2	1.0	0.2	3.2	11.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.3	6.3	2.2	0.0	0.0	21.8	0.0	0.4	3.7	0.0	0.7	0.0	0.6	2.2	0.1	0.5	0.0	9.1	0.0	0.0	2.1	5.0	0.4	0.3	1.8	0.0	4.7	0.1	62.6	0.0	1.0	2.2	0.1	0.0	2.6	0.0	1.9	0.0	0.6	0.0	3.4	6.6	0.1	4.8	1.4	2.5	0.1	4.7	0.1	0.5	0.1	0.0	0.2
CPNE9	KIAA4217	ENSG00000144550	"Copine family member 9"	Q8IYJ1	3	9703826-9729908	"Predicted intracellular proteins"	Differentiation			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"brain: 66.4"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 12.9;Excitatory neurons: 28.2;Inhibitory neurons: 8.0;Late spermatids: 61.3"	"Cancer enriched"	"Detected in single"	4	"testis cancer: 1.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"intermediate monocyte: 1.0"	"Lineage enhanced"	"Detected in single"		"monocytes: 1.0"	"Cell line enhanced"	"Detected in some"		"Daudi: 2.3;U-937: 2.0"	"Low region specificity"	"Detected in all"							HPA060813			Approved	"Plasma membrane,Cytosol"		NA	NA			Cytosol	"Plasma membrane"	"HPA060813: "	"unprognostic (2.96e-1)"	"unprognostic (4.75e-2)"	"unprognostic (1.34e-1)"	"unprognostic (5.04e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.13e-3)"	"unprognostic (1.03e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.20e-4)"	"unprognostic (2.67e-2)"	"unprognostic (5.44e-4)"	"unprognostic (1.47e-2)"	"unprognostic (8.59e-2)"	"unprognostic (3.45e-1)"	"unprognostic (7.48e-2)"	0.1	2.1	13.2	0.2	9.6	1.2	0.1	14.0	25.2	0.1	2.9	0.3	0.3	0.1	0.0	0.1	0.1	0.1	0.1	8.6	19.3	0.1	0.0	0.3	0.2	59.4	23.7	7.8	0.1	0.1	0.1	5.3	0.1	66.4	0.1	0.1	1.1	0.1	0.2	0.0	1.7	0.3	0.2	6.3	0.2	0.3	1.3	51.8	0.1	0.1	0.0	0.1	0.1	0.1	54.0	0.0	0.3	0.1	0.0	0.3	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.1	2.3	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.7	0.2	0.0	0.0	0.2	0.3	0.3	0.0	0.3	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.0	0.0	0.0	0.2	0.0	0.2	0.6	0.5	0.0	0.0	0.2	0.4	0.7	0.9	0.0	0.0	0.0	0.3	0.0	0.1	0.7	0.4	0.3	2.0	0.1	0.0	0.3	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.4	0.0	0.1	13.2	9.6	14.0	25.2	8.6	19.3	59.4	23.7	7.8	66.4	6.3	51.8	54.0	0.1	0.0	0.0	2.0	0.0	0.3	0.0	0.0	0.6	0.8	0.2	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	12.9	0.1	0.1	0.1	0.0	0.0	28.2	0.2	0.0	0.3	0.0	0.4	0.0	0.0	0.4	0.0	1.9	0.0	8.0	0.0	0.0	0.8	0.3	61.3	0.0	0.8	0.0	3.7	0.0	0.7	0.0	2.0	2.2	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.3	0.0	0.2	0.2	0.9	0.7	0.2	0.4	0.0	0.1	0.0	0.1	0.0
DDX53	"CAGE, CT26"	ENSG00000184735	"DEAD-box helicase 53"	Q86TM3	X	22999960-23003589	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	38	"brain: 2.2;testis: 5.4"	"Cell type enriched"	"Detected in some"	5	"Early spermatids: 62.6"	"Cancer enriched"	"Detected in single"	4	"testis cancer: 0.7"	"Region enhanced"	"Detected in single"		"cerebellum: 2.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 3.2;K-562: 4.6;RPMI-8226: 2.4;U-2197: 1.4;U-266/84: 10.5"									HPA003186			Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			Nucleoplasm	"Nucleoli, Cytosol"	"HPA003186: AB_1078637"														"unprognostic (5.76e-1)"	"unprognostic (1.12e-1)"			0.0	0.0	0.3	0.0	0.2	0.0	0.0	2.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.4	0.0	0.3	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	2.2	0.3	0.1	0.3	0.1	0.3	0.0	0.5	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	62.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	10.9	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DEFB124	DEFB-24	ENSG00000180383	"Defensin beta 124"	Q8NES8	20	31465506-31476757	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 6.0;testis: 7.2"	"Cell type enhanced"	"Detected in some"		"Club cells: 1.3;Endometrial stromal cells: 6.4;Respiratory ciliated cells: 4.0;Smooth muscle cells: 2.1"	"Cancer enriched"	"Detected in some"	4	"testis cancer: 2.9"	"Region enhanced"	"Detected in single"		"cerebral cortex: 1.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 2.7;HMC-1: 1.5;U-2 OS: 1.1;WM-115: 5.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"								"Secreted in other tissues"	NA	NA						"unprognostic (1.24e-2)"	"unprognostic (9.76e-3)"		"unprognostic (1.27e-1)"	"unprognostic (3.23e-3)"	"unprognostic (6.92e-3)"		"unprognostic (3.69e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.78e-1)"	"unprognostic (9.07e-2)"	"unprognostic (4.43e-1)"	"unprognostic (3.32e-7)"	"unprognostic (1.56e-2)"	"unprognostic (1.29e-1)"	"unprognostic (4.42e-2)"	"unprognostic (4.28e-1)"	2.6	0.4	0.1	0.2	0.0	0.0	1.7	0.0	1.5	3.3	1.3	1.7	0.0	3.2	2.7	0.6	6.0	0.0	0.8	0.1	0.4	0.3	0.1	0.7	0.5	0.2	0.1	0.1	0.6	0.2	0.8	1.0	0.1	0.1	1.2	0.6	0.0	0.7	3.0	1.1	0.4	0.9	0.5	0.0	0.8	0.8	7.2	0.1	0.2	1.0	0.8	0.5	1.4	1.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.1	0.4	0.2	0.1	0.1	0.1	0.0	0.1	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	6.4	0.2	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	2.1	0.8	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0
DGAT2L6	"DC3, FLJ25989"	ENSG00000184210	"Diacylglycerol O-acyltransferase 2 like 6"	Q6ZPD8	X	70177483-70205704	"Metabolic proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	19	"breast: 2.1;skin 1: 3.4"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	4	"testis cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (1.90e-2)"				"unprognostic (3.08e-1)"							"unprognostic (1.43e-3)"	"unprognostic (3.47e-3)"	"unprognostic (8.60e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.63e-3)"		0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
ERBB4	"ALS19, HER4"	ENSG00000178568	"Erb-b2 receptor tyrosine kinase 4"	Q15303	2	211375717-212538841	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Lactation, Transcription, Transcription regulation"	"Activator, Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Amyotrophic lateral sclerosis, Cancer-related genes, Disease variant, FDA approved drug targets, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.6;fallopian tube: 11.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 2020.2;Inhibitory neurons: 6091.7;Oligodendrocyte precursor cells: 2369.0;Oligodendrocytes: 1049.9"	"Group enriched"	"Detected in many"	4	"breast cancer: 4.1;endometrial cancer: 2.1;glioma: 1.2;ovarian cancer: 2.8;testis cancer: 1.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 6.9;EFO-21: 5.1;HEK 293: 3.8;RPTEC TERT1: 5.6;SCLC-21H: 3.1;T-47d: 5.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000276, HPA012016, CAB025522"	Enhanced					NA	NA		220000			"CAB000276: , CAB025522: , HPA012016: AB_1846541"	"unprognostic (1.48e-1)"	"unprognostic (3.28e-1)"	"unprognostic (4.31e-3)"	"unprognostic (1.76e-3)"	"unprognostic (3.59e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.88e-1)"	"unprognostic (9.56e-2)"	"unprognostic (2.07e-1)"	"unprognostic (4.67e-3)"	"unprognostic (1.07e-1)"	"unprognostic (3.61e-1)"	"unprognostic (7.14e-3)"	"unprognostic (1.49e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.11e-2)"	0.2	0.4	10.3	0.0	13.4	0.0	5.6	10.5	11.3	3.0	0.0	0.0	0.0	0.2	0.0	0.1	11.3	0.0	3.0	9.6	28.6	5.2	0.0	0.9	0.0	6.8	15.4	9.9	0.1	0.6	3.1	2.4	0.1	7.6	0.3	0.0	2.0	4.8	1.2	1.5	0.3	0.0	0.0	2.2	0.0	0.4	3.3	7.1	0.0	1.6	1.7	0.0	0.1	0.1	9.0	0.0	0.0	6.9	0.2	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.0	0.0	5.1	0.7	0.0	0.3	0.2	0.0	0.0	0.1	3.8	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	2.1	0.0	0.0	0.3	0.0	5.6	0.3	3.1	0.2	0.0	0.1	0.1	0.1	5.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.3	13.4	10.5	11.3	9.6	28.6	6.8	15.4	9.9	7.6	2.2	7.1	9.0	0.4	0.0	12.6	2020.2	0.0	0.6	0.9	1.1	0.6	15.9	45.6	17.0	27.2	0.0	10.2	12.9	0.0	0.0	0.2	0.0	5.9	0.5	6.7	25.4	1.0	1.0	0.0	0.0	62.0	0.5	0.2	1.8	0.0	25.8	0.0	5.4	0.0	0.0	0.1	0.0	6091.7	0.0	2.0	0.0	0.3	2.2	1.8	0.3	3.6	96.5	0.0	9.1	0.0	2369.0	1049.9	0.0	0.0	0.4	0.0	1.6	0.0	0.2	28.1	1.9	6.6	4.1	3.0	1.8	2.6	0.2	1.3	0.0	0.2	0.0	0.0	1.2
FOXE3	"FKHL12, FREAC8"	ENSG00000186790	"Forkhead box E3"	Q13461	1	47416285-47418052	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Aortic aneurysm, Cataract, Disease variant, Peters anomaly"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"Cardiomyocytes: 6.0;Spermatogonia: 2.3"	"Group enriched"	"Detected in some"	4	"cervical cancer: 0.5;testis cancer: 1.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	18	"SuSa: 10.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (2.11e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.71e-1)"	"unprognostic (6.24e-2)"	"unprognostic (1.24e-2)"	"unprognostic (8.21e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.34e-1)"	"unprognostic (5.15e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.39e-7)"	"unprognostic (2.41e-1)"	"unprognostic (5.46e-2)"		"unprognostic (3.60e-1)"	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	10.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	2.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0
FRAT2		ENSG00000181274	"FRAT regulator of WNT signaling pathway 2"	O75474	10	97332497-97334729	"Predicted intracellular proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Cancer enriched"	"Detected in all"	4	"testis cancer: 70.3"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"eosinophil: 15.0;neutrophil: 58.2"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 58.2"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049763	Uncertain		Approved	Nucleoplasm,Mitochondria		No	No			Nucleoplasm	Mitochondria	"HPA049763: AB_2680868"	"unprognostic (4.93e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.46e-1)"	"unprognostic (4.04e-3)"	"unprognostic (1.87e-2)"	"prognostic unfavorable (3.02e-4)"	"unprognostic (3.17e-3)"	"unprognostic (2.60e-1)"	"unprognostic (8.02e-2)"	"unprognostic (4.60e-2)"	"unprognostic (3.25e-2)"	"prognostic favorable (2.55e-4)"	"unprognostic (7.87e-3)"	"unprognostic (4.83e-2)"	"unprognostic (2.34e-1)"	"unprognostic (9.08e-2)"	5.3	3.6	7.4	10.5	7.2	31.3	8.1	8.2	7.4	6.0	9.5	17.3	25.3	4.1	6.3	14.5	7.1	4.0	4.9	6.5	7.1	5.5	18.4	9.8	8.8	7.9	7.8	6.1	2.8	14.1	5.2	3.0	7.4	7.1	8.0	15.7	3.3	15.2	4.3	10.2	20.2	16.0	4.1	7.1	29.2	13.3	14.7	7.6	9.0	5.3	9.2	10.9	6.8	8.2	7.0	10.9	4.3	6.9	31.2	4.9	4.0	25.7	2.4	8.9	3.7	3.7	6.8	12.5	13.3	8.4	2.5	2.2	20.3	18.3	9.5	2.9	20.0	28.0	17.9	9.2	15.0	2.8	28.9	20.6	3.2	20.0	3.6	11.4	7.9	9.3	11.7	15.8	4.2	1.8	17.9	12.6	36.5	42.9	36.2	17.5	12.8	2.9	19.1	8.9	9.8	12.5	10.2	3.1	19.1	12.6	28.0	28.8	44.8	4.2	2.2	2.7	1.7	6.4	11.4	12.5	6.6	2.6	49.3	0.8	8.3	7.2	15.0	1.1	4.8	0.6	1.1	1.3	1.8	3.8	3.2	2.2	1.3	58.2	1.6	7.9	1.0	0.7	2.3	7.4	7.2	8.2	7.4	6.5	7.1	7.9	7.8	6.1	7.1	7.1	7.6	7.0	18.2	0.0	3.9	2.9	15.7	31.7	25.3	6.6	46.1	19.7	24.7	19.6	6.4	20.0	5.0	14.7	4.2	6.1	26.1	31.0	11.7	2.2	40.7	39.6	9.7	10.3	13.8	14.5	2.0	5.3	18.5	6.4	37.2	46.3	1.3	16.7	8.6	11.3	8.6	11.8	2.8	30.6	4.1	28.3	9.0	42.3	2.1	25.2	10.6	7.5	24.7	5.0	14.4	2.0	1.1	3.4	21.6	2.6	8.4	30.0	13.5	3.7	4.5	18.1	0.0	14.9	8.7	2.3	4.4	37.7	52.7	7.8	18.8	20.1	31.6	32.3
GALNT8	GALNAC-T8	ENSG00000130035	"Polypeptide N-acetylgalactosaminyltransferase 8"	Q9NY28	12	4720400-4851927	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"intestine: 31.6;testis: 13.6"	"Group enriched"	"Detected in some"	6	"Early spermatids: 95.2;Intestinal goblet cells: 47.0;Late spermatids: 150.2"	"Group enriched"	"Detected in some"	4	"colorectal cancer: 1.2;glioma: 1.8;pancreatic cancer: 0.8;testis cancer: 2.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"Karpas-707: 23.4;U-266/84: 7.6"					"Not detected"	"Not detected"			"HPA012638, HPA073461"	Supported		Approved	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	No			"Golgi apparatus, Vesicles"		"HPA012638: AB_2294503, HPA073461: AB_2686604"	"unprognostic (2.36e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.75e-2)"	"unprognostic (6.24e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.59e-2)"	"unprognostic (3.79e-1)"	"unprognostic (2.72e-1)"	"unprognostic (5.76e-2)"	"unprognostic (8.06e-5)"	"unprognostic (1.16e-2)"	"unprognostic (6.67e-5)"	"unprognostic (5.18e-2)"	"unprognostic (2.59e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.33e-2)"	0.3	0.6	3.4	1.9	3.4	0.0	0.6	3.0	5.1	0.3	2.3	14.1	5.7	0.3	0.1	0.1	0.6	0.0	1.9	3.8	2.9	0.4	0.2	0.3	0.2	3.7	3.4	3.1	0.7	0.2	0.0	2.8	0.1	4.3	0.4	31.6	0.2	0.4	0.3	0.1	0.2	12.7	0.9	3.1	0.5	0.5	13.6	3.5	0.0	0.2	0.0	0.0	0.4	0.3	4.2	0.0	0.0	0.5	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	23.4	0.0	0.0	0.0	0.1	3.1	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	3.4	3.4	3.0	5.1	3.8	2.9	3.7	3.4	3.1	4.3	3.1	3.5	4.2	0.1	6.4	0.5	1.3	0.5	0.0	0.0	0.1	0.6	2.1	0.1	2.3	4.5	0.0	0.0	0.0	0.0	0.0	1.5	1.8	0.0	0.0	95.2	0.5	0.1	0.5	6.6	0.0	1.1	0.4	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.7	47.0	0.0	0.0	0.0	150.2	1.5	0.1	0.0	3.7	0.2	0.5	0.0	15.1	7.4	0.2	0.6	2.6	0.0	0.1	1.0	1.0	0.0	0.6	6.6	0.7	0.1	12.3	8.3	0.0	0.0	0.0	0.8	0.3	2.2	0.0
GRM2	"GPRC1B, mGlu2, MGLUR2"	ENSG00000164082	"Glutamate metabotropic receptor 2"	Q14416	3	51707068-51718613	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	11	"brain: 6.4"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 2.6;Cone photoreceptor cells: 6.2;Excitatory neurons: 16.2;Spermatocytes: 3.5"	"Cancer enriched"	"Detected in single"	4	"testis cancer: 1.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"SCLC-21H: 6.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027868, HPA065166"	Approved	Supported				NA	NA					"HPA027868: , HPA065166: AB_2685425"	"unprognostic (1.01e-1)"	"unprognostic (8.61e-4)"	"unprognostic (7.66e-2)"	"unprognostic (7.29e-3)"	"unprognostic (1.98e-1)"	"unprognostic (3.68e-2)"	"unprognostic (7.10e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.45e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.93e-2)"	"unprognostic (1.19e-2)"	0.2	0.0	0.9	0.0	2.3	0.4	0.1	0.0	2.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	1.8	0.6	0.0	0.0	0.1	0.0	4.6	0.9	2.1	0.0	0.1	0.0	0.1	0.0	6.4	0.1	0.0	0.4	0.1	0.0	0.3	0.4	0.1	0.0	0.0	0.2	0.0	0.6	0.9	0.1	0.1	0.0	0.0	0.1	0.0	3.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	2.3	0.0	2.5	1.8	0.6	4.6	0.9	2.1	6.4	0.0	0.9	3.4	0.4	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.0	2.6	0.5	0.9	1.1	0.0	0.0	0.0	6.2	0.0	0.3	0.1	0.0	0.0	0.3	0.1	0.1	1.5	0.0	0.0	16.2	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	1.0	0.0	0.4	0.0	1.0	0.8	0.0	0.0	0.4	0.0	0.3	0.0	0.1	0.0	2.0	0.0	0.2	0.1	3.5	1.1	0.2	0.3	0.0	0.1	0.2	0.0	0.1
HCN4		ENSG00000138622	"Hyperpolarization activated cyclic nucleotide gated potassium channel 4"	Q9Y3Q4	15	73319859-73368958	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Sodium transport, Transport"	"Ion channel, Ligand-gated ion channel, Potassium channel, Sodium channel, Voltage-gated channel"	"Brugada syndrome, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	15	"brain: 8.7;heart muscle: 6.4;testis: 7.2"	"Group enriched"	"Detected in some"	5	"Early spermatids: 29.4;Late spermatids: 49.5"	"Cancer enriched"	"Detected in some"	4	"testis cancer: 3.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.3;CACO-2: 1.7;HDLM-2: 1.1;NTERA-2: 4.9;SuSa: 1.2;U-2 OS: 2.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA073174	Approved					NA	NA					"HPA073174: "	"unprognostic (2.21e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.14e-2)"	"unprognostic (5.30e-3)"	"unprognostic (1.92e-2)"	"unprognostic (2.19e-1)"	"unprognostic (3.50e-2)"	"unprognostic (2.37e-1)"	"unprognostic (6.56e-2)"	"unprognostic (1.13e-3)"	"unprognostic (1.13e-1)"	"unprognostic (6.05e-5)"	"unprognostic (5.56e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.51e-2)"	"unprognostic (7.95e-2)"	0.0	0.4	4.0	0.0	0.7	0.0	0.0	2.5	2.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	6.4	1.0	2.4	0.0	0.0	0.0	0.0	4.5	4.0	1.9	0.0	0.1	0.0	0.5	0.0	5.0	0.1	0.0	0.4	0.0	0.3	0.0	0.0	0.1	0.0	1.2	0.0	0.1	7.2	8.7	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.7	0.0	0.3	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.7	2.5	2.2	1.0	2.4	4.5	4.0	1.9	5.0	1.2	8.7	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	29.4	0.6	0.0	0.2	1.8	0.0	1.5	0.2	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	49.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.7	1.2	0.0	0.0	0.3	1.6	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HESX1	"ANF, RPX"	ENSG00000163666	"HESX homeobox 1"	Q9UBX0	3	57197838-57227606	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	4	"Spermatocytes: 36.3"	"Cancer enriched"	"Detected in many"	4	"testis cancer: 6.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 73.5;U-266/84: 23.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA024187	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA024187: AB_1850620"	"unprognostic (6.47e-2)"	"unprognostic (1.66e-3)"	"unprognostic (5.50e-2)"	"unprognostic (1.19e-3)"	"unprognostic (5.04e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.96e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.46e-3)"	"unprognostic (9.48e-2)"	"unprognostic (2.79e-3)"	"unprognostic (1.39e-3)"	"unprognostic (4.17e-2)"	"unprognostic (3.15e-2)"	"unprognostic (4.50e-3)"	"unprognostic (1.14e-1)"	1.4	1.8	1.8	1.0	1.8	6.0	2.6	2.3	2.2	1.2	1.5	1.1	1.1	0.9	3.4	1.0	1.1	1.6	1.2	1.8	2.0	2.1	3.8	1.4	1.8	2.1	1.9	1.8	1.4	1.8	1.6	1.8	1.2	1.9	1.5	0.8	2.0	1.1	2.0	0.9	4.3	1.0	0.6	1.6	2.2	2.0	6.3	1.8	1.3	2.5	0.6	1.3	0.9	1.1	1.9	1.3	1.2	2.6	4.3	0.4	1.6	0.8	0.1	0.5	0.8	1.4	0.6	3.9	3.4	0.6	0.1	1.0	0.2	1.2	1.4	1.0	2.0	2.9	5.0	1.8	0.4	2.9	1.6	0.5	4.1	1.2	0.4	2.8	2.1	0.7	7.2	0.8	4.3	0.3	0.3	2.2	9.1	73.5	1.1	0.8	0.8	1.6	1.7	3.6	0.7	1.1	3.5	1.0	1.4	2.7	1.2	1.0	7.0	0.5	3.3	1.3	1.0	1.4	12.2	23.7	10.1	1.2	3.1	1.6	0.5	0.8	0.4	0.2	1.6	0.0	0.6	0.2	0.1	0.5	0.5	0.2	0.1	1.4	0.7	0.2	1.8	0.0	0.2	1.8	1.8	2.3	2.2	1.8	2.0	2.1	1.9	1.8	1.9	1.6	1.8	1.9	1.0	0.0	0.5	6.5	0.9	0.4	0.6	1.4	0.0	0.3	1.3	1.8	0.8	1.5	0.4	1.8	0.0	1.5	1.7	0.9	0.0	0.4	0.5	1.7	0.7	1.2	0.0	0.0	1.7	0.2	1.1	0.6	0.5	0.4	0.0	1.0	1.4	1.0	2.1	1.7	1.5	0.1	2.0	1.6	0.6	0.4	0.9	2.0	0.0	6.5	1.1	1.6	0.0	3.0	5.1	0.5	0.2	0.4	0.2	0.7	0.7	1.2	0.9	2.6	0.0	0.8	0.5	36.3	7.6	0.3	1.1	0.5	0.7	2.7	0.7	0.4
HTR1B	"5-HT1B, 5-HT1DB, HTR1D2, S12"	ENSG00000135312	"5-hydroxytryptamine receptor 1B"	P28222	6	77460924-77463491	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"	Behavior	"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 6.9;placenta: 6.7;stomach 1: 5.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"pancreatic cancer: 0.7;stomach cancer: 0.8;testis cancer: 1.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	16	"HUVEC TERT2: 79.4;TIME: 35.1"	"Region enriched"	"Detected in all"	4	"basal ganglia: 38.6"	"Region enhanced"	"Detected in many"		"basal ganglia: 11.7"	HPA028808	Enhanced		Supported	"Endoplasmic reticulum,Plasma membrane"		NA	NA			"Plasma membrane"	"Endoplasmic reticulum"	"HPA028808: AB_2672782"	"unprognostic (3.86e-2)"	"unprognostic (3.56e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.18e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.11e-1)"	"unprognostic (8.96e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.10e-3)"	"unprognostic (3.08e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.02e-1)"	0.8	0.6	1.9	0.4	5.7	0.0	0.2	0.0	3.9	0.7	0.0	0.1	0.1	0.5	0.0	0.0	0.5	0.5	0.0	1.2	1.2	0.3	0.0	0.4	0.0	1.2	1.8	1.2	0.4	0.1	0.0	0.2	6.7	1.3	0.2	0.1	0.3	0.2	0.5	0.1	0.1	0.1	0.1	0.1	0.0	5.0	0.5	6.9	0.0	0.2	0.3	0.0	1.3	0.5	1.5	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.4	3.5	1.7	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.6	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.4	0.2	0.6	2.2	1.4	79.4	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	35.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	5.7	0.0	3.9	1.2	1.2	1.2	1.8	1.2	1.3	0.1	6.9	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
INA	"NEF5, NF-66"	ENSG00000148798	"Internexin neuronal intermediate filament protein alpha"	Q16352	10	103277138-103290346	"Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 304.2;retina: 98.1"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 62.4;Cone photoreceptor cells: 22.9;Early spermatids: 41.4;Excitatory neurons: 28.7;Horizontal cells: 45.4;Inhibitory neurons: 39.8;Late spermatids: 26.5;Rod photoreceptor cells: 48.2;Spermatocytes: 20.3"	"Group enriched"	"Detected in many"	4	"glioma: 4.7;testis cancer: 18.2;urothelial cancer: 14.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 53.0;SCLC-21H: 103.3;SH-SY5Y: 58.7;SiHa: 71.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002059, HPA007572, HPA008057"	Enhanced	Supported	Approved	"Intermediate filaments,Cytosol"		NA	NA			"Intermediate filaments"	Cytosol	"CAB002059: AB_442031, HPA007572: , HPA008057: AB_1851833"	"unprognostic (1.77e-1)"	"unprognostic (2.50e-2)"	"unprognostic (9.54e-2)"	"unprognostic (5.49e-3)"	"unprognostic (3.91e-1)"	"unprognostic (1.45e-3)"	"unprognostic (1.31e-1)"	"unprognostic (2.29e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.98e-1)"	"unprognostic (8.09e-3)"	"unprognostic (3.07e-2)"	"unprognostic (1.78e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.07e-1)"	0.2	12.3	42.4	1.2	44.2	0.0	0.0	70.6	166.4	0.0	0.5	2.6	0.6	0.0	0.0	0.6	0.0	0.1	0.0	36.8	83.7	0.0	0.0	0.2	0.1	106.6	80.0	48.1	0.0	2.0	0.4	41.7	0.2	112.3	0.2	1.2	98.1	0.1	0.0	0.0	0.8	1.1	0.8	31.3	0.0	1.1	2.7	115.5	1.7	0.1	0.0	0.2	1.1	0.6	304.2	0.0	25.4	11.8	0.0	0.1	0.0	19.3	13.3	3.3	3.1	0.3	0.0	0.0	0.0	5.4	0.9	1.5	1.9	11.0	0.0	0.7	24.6	4.9	0.0	6.8	0.1	0.2	0.0	0.0	0.0	0.1	1.9	0.0	0.0	0.0	2.7	0.4	0.0	0.0	0.0	13.6	0.0	53.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	103.3	58.7	71.6	0.1	0.0	2.7	0.0	0.7	0.1	0.0	0.1	0.0	0.0	3.4	3.1	0.0	0.1	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.4	44.2	70.6	166.4	36.8	83.7	106.6	80.0	48.1	112.3	31.3	115.5	304.2	0.1	0.0	0.0	6.2	0.0	0.3	0.1	0.0	0.0	62.4	0.0	0.4	0.5	0.0	0.0	0.0	22.9	0.2	0.0	0.1	0.0	0.1	41.4	0.4	0.2	0.9	7.8	0.0	28.7	0.0	0.2	0.1	0.0	0.8	0.0	0.1	0.0	0.0	0.5	45.4	39.8	0.0	0.0	0.0	0.0	26.5	0.3	0.1	0.0	2.8	0.0	8.7	0.0	1.0	5.4	0.4	0.0	0.4	0.0	0.5	0.0	0.0	0.0	48.2	0.0	0.0	0.6	20.3	4.1	1.0	0.4	0.1	0.1	0.1	0.0	0.6
ITLN2	HL-2	ENSG00000158764	"Intelectin 2"	Q8WWU7	1	160945025-160954809	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	35	"intestine: 411.7"	"Cell type enriched"	"Detected in some"	4	"Alveolar cells type 1: 76.9"	"Group enriched"	"Detected in many"	4	"colorectal cancer: 2.8;testis cancer: 4.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 11.9;HHSteC: 1.9;HMC-1: 3.4;SK-MEL-30: 4.0;SuSa: 3.8"					"Low region specificity"	"Detected in all"			"HPA006683, HPA067326"	Enhanced				"Secreted to digestive system"	NA	NA					"HPA006683: AB_2129681, HPA067326: AB_2732764"		"unprognostic (1.42e-1)"	"unprognostic (9.62e-3)"	"unprognostic (4.61e-2)"	"unprognostic (7.45e-2)"	"unprognostic (2.25e-1)"	"unprognostic (6.84e-4)"	"unprognostic (2.47e-2)"	"unprognostic (5.74e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.36e-1)"	"unprognostic (5.01e-1)"		"unprognostic (1.84e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.91e-2)"	3.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	240.9	0.1	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.1	0.4	11.8	0.2	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.1	0.0	0.2	411.7	0.0	0.0	0.0	0.1	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	11.9	0.0	0.0	1.9	0.0	3.4	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.5	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.7	0.0	0.0	4.0	3.8	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	76.9	5.3	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.4	0.3	1.4	0.0	0.2	0.0	0.4	11.0	0.3	0.1	0.0	0.0	5.0	0.0	0.3	0.0	0.2	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	5.3	0.0	0.6	14.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.3	6.3	17.5	0.4
LEFTY1	"LEFTB, LEFTYB"	ENSG00000243709	"Left-right determination factor 1"	O75610	1	225886282-225911382	"Metabolic proteins, Predicted secreted proteins"		"Cytokine, Developmental protein, Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"intestine: 58.9;pancreas: 97.7"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 201.5;Glandular and luminal cells: 175.0;Intestinal goblet cells: 86.1;Paneth cells: 228.9;Undifferentiated cells: 301.0"	"Group enriched"	"Detected in many"	4	"colorectal cancer: 44.8;endometrial cancer: 36.2;pancreatic cancer: 13.8;testis cancer: 15.8"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	51	"basophil: 17.0"	"Lineage enriched"	"Detected in single"	51	"granulocytes: 17.0"	"Cell line enriched"	"Detected in some"	6	"NTERA-2: 50.2"									"HPA047883, HPA056210"	Approved				"Secreted in other tissues"	NA	NA					"HPA047883: AB_2680200, HPA056210: AB_2683067"	"unprognostic (2.81e-1)"	"unprognostic (2.31e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.52e-2)"	"unprognostic (4.60e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.28e-1)"	"unprognostic (7.76e-2)"	"unprognostic (6.13e-2)"	"prognostic unfavorable (2.48e-6)"	"unprognostic (2.78e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.61e-2)"	0.3	0.2	2.0	7.9	2.1	0.0	0.4	1.7	2.7	1.4	1.3	58.9	0.2	0.5	7.0	0.1	0.6	0.0	0.3	2.1	1.8	1.7	0.9	0.4	0.0	1.7	1.6	2.1	4.1	97.7	0.0	1.0	0.2	1.8	0.9	32.7	0.8	1.5	3.3	0.4	0.2	2.9	0.9	1.8	0.3	1.4	0.8	1.7	0.0	0.1	0.1	0.1	1.5	0.2	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.1	0.3	0.0	0.0	0.0	4.5	0.1	0.4	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	50.2	0.0	0.0	0.0	5.4	0.6	1.2	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.5	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	17.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.1	2.0	2.1	1.7	2.7	2.1	1.8	1.7	1.6	2.1	1.8	1.8	1.7	1.9	0.2	0.0	0.0	0.7	1.0	0.4	1.6	0.0	0.0	1.8	0.2	0.3	0.1	14.3	0.0	0.0	0.0	0.0	0.0	51.7	1.9	20.1	1.8	201.5	9.9	0.3	31.5	0.0	2.3	29.6	0.1	1.6	0.0	175.0	0.0	1.6	0.0	0.2	0.0	0.0	2.3	86.1	0.0	0.0	0.0	3.9	1.5	2.1	0.0	0.0	0.0	0.9	0.0	1.5	0.2	0.5	228.9	1.9	0.0	0.8	0.7	6.0	0.0	1.4	0.0	0.0	0.6	2.5	4.2	0.0	0.0	0.0	1.0	1.3	301.0	1.3
LHFPL4	GARLH4	ENSG00000156959	"LHFPL tetraspan subfamily member 4"	Q7Z7J7	3	9498361-9553822	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 16.6;pituitary gland: 12.3;retina: 9.4"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 42.4;Cone photoreceptor cells: 18.8;Excitatory neurons: 60.0;Inhibitory neurons: 67.2;Oligodendrocyte precursor cells: 34.2;Rod photoreceptor cells: 17.4"	"Group enriched"	"Detected in some"	4	"glioma: 6.8;testis cancer: 5.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 13.5;NTERA-2: 4.4;SCLC-21H: 10.0;SH-SY5Y: 12.5;U-266/84: 11.3;WM-115: 3.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041421	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA041421: AB_10796673"	"unprognostic (6.81e-2)"	"unprognostic (3.65e-2)"	"unprognostic (4.50e-1)"	"unprognostic (6.62e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.60e-1)"	"unprognostic (5.65e-2)"	"unprognostic (6.59e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.77e-1)"	"unprognostic (1.90e-2)"	"unprognostic (6.78e-2)"	"unprognostic (2.99e-1)"	"unprognostic (3.03e-3)"	"unprognostic (8.21e-2)"	0.0	2.0	11.2	0.0	12.2	0.0	0.0	8.1	16.6	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	12.0	12.6	0.0	0.0	0.0	0.0	10.7	9.1	13.7	0.0	0.5	0.1	12.3	0.0	12.3	0.0	0.2	9.4	0.0	0.0	0.0	0.1	0.2	0.0	3.1	0.0	0.2	0.7	10.4	0.0	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.5	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	1.5	0.0	0.0	0.0	0.0	0.0	0.0	10.0	12.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	2.9	0.0	11.3	0.0	0.5	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	11.2	12.2	8.1	16.6	12.0	12.6	10.7	9.1	13.7	12.3	3.1	10.4	11.5	0.4	0.0	0.0	4.6	0.5	0.0	2.9	0.0	0.0	42.4	0.4	0.3	0.8	0.0	0.0	0.0	18.8	0.6	0.6	0.6	0.0	0.3	0.6	0.7	1.1	0.8	1.2	0.0	60.0	0.2	1.4	0.6	0.0	1.3	1.3	0.5	4.2	0.2	0.3	15.2	67.2	0.7	0.0	0.3	0.0	0.7	0.0	0.8	0.0	1.0	0.1	2.0	3.1	34.2	5.6	0.4	1.7	0.0	0.0	6.3	0.8	0.2	0.0	17.4	0.0	2.7	0.4	1.7	1.1	0.0	0.0	1.4	0.4	0.3	0.8	2.5
LHX1	"LIM-1, LIM1"	ENSG00000273706	"LIM homeobox 1"	P48742	17	36936785-36944612	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	12	"kidney: 10.7"	"Cell type enriched"	"Detected in some"	8	"Horizontal cells: 361.7"	"Group enriched"	"Detected in some"	4	"ovarian cancer: 8.1;testis cancer: 2.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 3.8;HMC-1: 1.6;WM-115: 7.0"	"Region enhanced"	"Detected in many"		"cerebellum: 19.1"	"Region enriched"	"Detected in many"	4	"cerebellum: 15.7"	"HPA044307, HPA073521, HPA074382"	Enhanced		Supported	"Nucleoplasm,Nuclear membrane,Golgi apparatus"		NA	NA			Nucleoplasm	"Nuclear membrane, Golgi apparatus"	"HPA044307: , HPA073521: AB_2732226, HPA074382: "	"unprognostic (3.86e-5)"	"unprognostic (1.64e-1)"		"prognostic unfavorable (3.63e-5)"	"unprognostic (3.85e-2)"	"unprognostic (1.06e-4)"		"unprognostic (2.67e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.20e-3)"		"unprognostic (1.74e-5)"	"unprognostic (1.33e-1)"	"unprognostic (8.62e-2)"		"unprognostic (3.05e-2)"	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.8	10.7	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.1	0.0	3.8	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.0	1.1	0.4	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	1.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.8	0.4	0.2	0.0	0.5	0.1	0.2	0.1	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.4	2.1	0.0	0.0	42.3	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.6	0.0	0.1	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	361.7	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	13.0	0.0	1.6	0.0	0.0	0.2	1.1	2.3	0.0	0.0	0.4	0.3	0.0	0.2	0.0
LRP4	"CLSS, LRP-4, MEGF7, SOST2"	ENSG00000134569	"LDL receptor related protein 4"	O75096	11	46856717-46918642	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Differentiation, Endocytosis, Wnt signaling pathway"	"Developmental protein, Receptor"	"Congenital myasthenic syndrome, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 44.0;skin 1: 31.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 123.1;Cone photoreceptor cells: 41.7;Distal enterocytes: 31.1;Oligodendrocyte precursor cells: 137.2;Oligodendrocytes: 31.3"	"Group enriched"	"Detected in all"	4	"colorectal cancer: 12.2;endometrial cancer: 8.6;glioma: 13.2;testis cancer: 15.6;thyroid cancer: 28.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 21.3;SuSa: 16.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011934, HPA012300"	Approved		Uncertain	Nucleoplasm,Nucleoli,Mitochondria		NA	NA			"Nucleoplasm, Nucleoli, Mitochondria"		"HPA011934: AB_1853286, HPA012300: AB_1853288"	"unprognostic (1.46e-1)"	"unprognostic (4.07e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.33e-2)"	"unprognostic (4.39e-2)"	"unprognostic (9.73e-3)"	"unprognostic (5.29e-4)"	"unprognostic (8.61e-2)"	"unprognostic (2.29e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.33e-1)"	"unprognostic (7.59e-2)"	"unprognostic (7.95e-2)"	"unprognostic (2.76e-2)"	"unprognostic (9.90e-3)"	"unprognostic (6.79e-2)"	0.7	1.4	20.7	1.0	28.8	0.0	1.6	20.8	21.1	2.3	0.0	4.8	3.4	1.7	0.9	1.9	1.4	2.0	7.0	22.0	15.8	0.7	0.2	2.9	0.1	44.0	21.9	13.0	4.6	2.2	5.7	2.6	2.6	24.8	2.1	3.5	7.9	1.7	2.3	4.5	31.8	4.9	1.5	19.9	3.9	7.9	1.1	29.6	1.5	2.4	7.7	0.3	0.9	1.4	25.1	0.1	9.6	21.3	6.5	13.4	3.7	4.9	1.0	1.9	2.8	3.2	2.8	0.0	0.0	1.4	11.4	3.1	3.9	12.0	7.5	2.2	0.0	10.3	1.0	3.8	6.8	2.8	0.1	1.9	4.5	4.2	4.4	1.1	2.5	2.5	2.6	0.9	0.0	1.6	0.8	0.2	0.3	11.9	0.0	0.9	1.6	7.3	0.0	0.3	2.8	0.1	14.2	1.2	0.0	3.4	16.2	0.3	0.5	0.2	5.7	3.5	6.5	2.1	0.0	0.0	0.4	4.3	0.7	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.7	28.8	20.8	21.1	22.0	15.8	44.0	21.9	13.0	24.8	19.9	29.6	25.1	0.2	0.0	1.9	123.1	0.0	8.2	2.7	2.4	10.8	0.5	0.3	1.9	6.2	0.0	1.9	1.8	41.7	2.6	0.0	31.1	1.9	0.0	0.5	1.0	4.7	1.0	0.0	0.0	19.7	0.4	0.4	5.0	3.1	4.4	5.1	1.6	1.8	0.4	0.2	0.0	18.6	2.8	0.0	0.0	0.4	0.0	1.8	0.2	1.8	15.0	0.6	9.3	0.0	137.2	31.3	0.3	3.0	1.2	0.0	1.0	8.0	0.3	1.1	2.7	0.0	12.4	0.9	0.2	0.8	2.3	10.9	1.4	0.2	8.4	3.3	0.8
LRRC38		ENSG00000162494	"Leucine rich repeat containing 38"	Q5VT99	1	13474973-13514003	"Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"adrenal gland: 19.7;skeletal muscle: 44.9;tongue: 14.8"	"Group enriched"	"Detected in some"	6	"Bipolar cells: 19.3;Inhibitory neurons: 10.6"	"Group enriched"	"Detected in some"	4	"head and neck cancer: 0.5;lung cancer: 0.8;testis cancer: 0.6;urothelial cancer: 0.6"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 4.2;MOLT-4: 16.7;PC-3: 11.5;U-138 MG: 18.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			HPA038778	Approved					NA	NA					"HPA038778: AB_10673294"	"unprognostic (5.13e-2)"	"unprognostic (3.98e-1)"	"unprognostic (3.12e-1)"	"unprognostic (3.88e-1)"	"unprognostic (5.49e-2)"	"unprognostic (1.45e-3)"		"unprognostic (1.72e-1)"		"unprognostic (2.70e-1)"	"unprognostic (9.70e-2)"	"unprognostic (4.23e-1)"		"unprognostic (7.81e-2)"	"unprognostic (4.47e-2)"		"unprognostic (1.05e-1)"	0.2	19.7	0.4	0.0	0.4	0.1	0.6	2.9	1.2	0.1	0.7	0.0	0.0	0.1	0.2	0.3	0.1	0.1	1.2	0.4	0.6	0.1	0.0	0.0	0.0	1.0	2.9	0.4	0.1	0.0	0.0	0.0	0.5	0.8	0.2	0.0	3.0	0.6	0.0	44.9	1.0	0.0	0.0	0.6	0.0	0.1	0.4	0.4	1.3	0.0	14.8	0.0	0.3	0.7	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	16.7	0.0	0.0	0.0	11.5	0.1	0.1	1.8	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.3	18.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.4	2.9	1.2	0.4	0.6	1.0	2.9	0.4	0.8	0.6	0.4	0.7	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	19.3	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.9	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	10.6	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.0	0.0	0.5	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	1.5	0.1	0.7	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1
MAGEL2	"NDNL1, nM15"	ENSG00000254585	"MAGE family member L2"	Q9UJ55	15	23643549-23647867	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation, Transport, Ubl conjugation pathway"	Repressor	"Autism spectrum disorder, Mental retardation, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 16.6;pituitary gland: 8.8"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 2.7;Granulosa cells: 5.0;Horizontal cells: 3.3;Inhibitory neurons: 5.8;Leydig cells: 2.8;Muller glia cells: 2.2;Spermatocytes: 2.7"	"Cancer enriched"	"Detected in some"	4	"testis cancer: 4.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 3.2;JURKAT: 1.2;NTERA-2: 1.9;SuSa: 2.2"	"Region enhanced"	"Detected in many"		"hypothalamus: 17.7"	"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (3.18e-1)"	"unprognostic (2.63e-1)"	"unprognostic (2.21e-1)"	"unprognostic (7.47e-3)"	"unprognostic (1.65e-2)"	"unprognostic (3.80e-1)"	"unprognostic (1.17e-1)"	"unprognostic (5.38e-3)"	"unprognostic (3.51e-3)"	"unprognostic (8.61e-2)"	"unprognostic (1.31e-2)"	"unprognostic (9.55e-2)"	"unprognostic (2.96e-9)"	"unprognostic (1.66e-4)"	"unprognostic (3.30e-2)"	"unprognostic (2.06e-4)"	"unprognostic (1.79e-2)"	0.4	0.2	5.6	0.1	3.5	0.0	0.3	0.3	3.6	2.0	0.0	0.2	0.0	1.5	0.2	0.0	0.5	0.2	0.0	1.0	16.6	0.1	0.0	0.0	0.0	3.0	3.7	1.5	2.1	0.8	0.0	8.8	1.3	3.9	0.2	0.0	0.8	0.1	0.4	0.0	0.1	0.1	0.6	1.3	0.3	0.1	1.5	7.5	0.0	0.7	0.1	0.0	0.1	0.9	5.4	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.4	0.0	0.2	0.0	1.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	3.5	0.3	3.6	1.0	16.6	3.0	3.7	1.5	3.9	1.3	7.5	5.4	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.8	0.2	0.0	0.0	2.7	0.0	0.0	0.9	0.0	0.0	0.0	5.0	1.1	0.0	0.0	3.3	5.8	0.0	0.0	0.0	0.0	0.5	2.8	0.0	0.0	1.9	0.0	2.2	0.0	2.0	0.4	0.2	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.8	0.7	2.7	0.2	0.0	0.0	0.0	0.0	1.1	0.0	0.0
MT1G	"MT1, MT1K"	ENSG00000125144	"Metallothionein 1G"	P13640	16	56666730-56668065	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 3506.9;liver: 7016.2;thyroid gland: 2912.8"	"Cell type enriched"	"Detected in many"	4	"Proximal tubular cells: 77919.3"	"Group enriched"	"Detected in all"	4	"liver cancer: 320.1;ovarian cancer: 106.9;prostate cancer: 103.9;testis cancer: 269.9;thyroid cancer: 369.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	4	"U-937: 1103.8"														"Intracellular and membrane"	NA	NA						"unprognostic (1.62e-1)"	"unprognostic (4.21e-1)"	"unprognostic (2.77e-2)"	"unprognostic (3.15e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.73e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.97e-2)"	"unprognostic (2.49e-2)"	"unprognostic (4.21e-1)"	"prognostic unfavorable (1.67e-7)"	"unprognostic (1.42e-1)"	"unprognostic (3.50e-2)"	"unprognostic (7.92e-2)"	"unprognostic (2.26e-2)"	124.7	21.7	342.2	106.7	413.9	2.9	28.3	393.5	919.5	12.4	301.5	828.7	518.4	8.4	2.4	257.4	76.2	12.1	6.8	338.0	346.5	3506.9	7016.2	50.3	5.6	403.6	361.9	358.6	3.2	1822.1	0.3	21.8	2.1	372.5	428.9	521.1	43.0	44.5	5.9	8.5	56.7	1105.7	77.0	331.0	3.9	1272.7	4.0	363.1	0.9	2912.8	1.0	2.6	14.3	26.1	402.5	0.4	0.0	0.0	0.0	0.0	0.0	4.4	8.6	1.7	1.1	0.4	0.0	0.0	0.1	16.2	0.0	0.1	1.8	0.2	1.2	0.9	0.8	0.0	4.3	0.0	3.5	4.5	1.0	0.6	1.7	0.0	11.4	0.0	0.1	0.0	0.0	0.3	1.2	0.7	0.0	3.7	251.3	0.5	0.0	0.0	0.0	0.8	70.8	40.8	0.0	21.8	3.0	0.5	1.3	1.1	10.8	0.0	107.8	0.0	0.0	0.8	1.7	0.3	0.6	1.9	0.6	2.0	1103.8	0.0	0.2	0.3	0.1	0.3	0.3	0.3	0.0	0.4	0.6	0.3	0.0	0.4	0.7	0.0	0.0	0.1	0.1	0.7	0.5	342.2	413.9	393.5	919.5	338.0	346.5	403.6	361.9	358.6	372.5	331.0	363.1	402.5	10.6	28.9	8.7	38.5	338.7	57.9	26.0	4.5	46.1	0.0	87.0	116.2	11.7	330.3	9.1	2302.6	0.0	3.9	9.8	3657.8	6849.7	74.4	0.3	2960.7	777.1	49.2	246.7	878.6	0.1	283.4	403.2	50.7	443.9	8167.8	17.2	16.8	310.2	16307.3	26.3	0.0	0.1	3688.0	0.0	379.5	4.9	0.9	23.3	765.6	30.2	2.8	10.6	0.0	2.1	2.0	0.1	339.8	10431.2	2.2	26.3	823.7	8631.3	77919.3	3.9	0.0	0.0	25.1	42.9	0.3	0.8	42.2	77.9	132.7	247.5	4.7	3786.7	21.1
MYH3	"HEMHC, MYHC-EMB, MYHSE1, SMHCE"	ENSG00000109063	"Myosin heavy chain 3"	P11055	17	10628526-10657309	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 29.3;seminal vesicle: 18.5;skeletal muscle: 20.8"	"Cell type enriched"	"Detected in many"	7	"Early spermatids: 411.9"	"Group enriched"	"Detected in many"	4	"head and neck cancer: 3.3;prostate cancer: 4.6;testis cancer: 2.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	26	"HSkMC: 59.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			HPA021808	Enhanced					NA	NA		29000000			"HPA021808: AB_1854242"	"unprognostic (1.70e-2)"	"unprognostic (1.10e-3)"	"unprognostic (4.19e-4)"	"unprognostic (3.35e-1)"	"unprognostic (7.66e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.67e-2)"	"unprognostic (3.54e-1)"	"unprognostic (7.84e-4)"	"unprognostic (1.29e-1)"	"unprognostic (3.24e-4)"	"unprognostic (1.91e-2)"	"unprognostic (6.17e-3)"	"unprognostic (3.40e-2)"	"unprognostic (3.49e-1)"	1.4	0.9	2.0	1.1	2.0	0.8	1.5	1.7	1.8	3.0	1.7	4.8	1.1	3.4	1.2	9.2	2.6	0.5	1.0	1.8	1.7	1.8	3.4	1.2	1.3	2.0	2.1	1.6	2.3	2.5	0.3	1.5	0.4	2.1	29.3	1.0	1.8	1.5	18.5	20.8	2.4	2.5	1.7	1.6	2.7	1.7	4.6	2.0	3.1	3.5	6.1	0.6	4.5	3.8	1.9	0.2	1.1	0.8	1.1	1.0	0.3	1.0	0.8	0.4	0.5	0.5	1.0	0.1	0.7	0.3	0.4	0.2	1.1	0.5	0.2	1.0	0.7	0.9	1.0	0.3	1.6	0.3	0.6	1.4	59.6	0.4	0.6	0.8	0.1	0.1	1.3	0.4	0.1	0.2	0.7	1.0	2.3	0.9	0.3	0.6	0.8	0.8	0.3	0.3	0.3	0.0	0.4	0.4	0.0	0.3	0.7	0.3	0.3	0.3	0.1	1.0	0.3	0.1	1.3	1.1	0.3	0.3	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	2.0	1.7	1.8	1.8	1.7	2.0	2.1	1.6	2.1	1.6	2.0	1.9	0.5	0.0	9.8	4.6	0.7	2.9	0.9	0.1	0.6	4.9	0.7	1.8	3.6	1.5	0.7	0.0	6.2	0.4	0.8	0.9	0.0	0.6	411.9	0.5	0.8	1.4	0.0	2.7	3.9	0.6	0.8	1.1	1.1	0.5	7.6	0.8	0.4	0.6	0.1	0.0	3.4	0.5	0.0	0.8	0.3	56.0	2.8	1.2	1.8	1.9	0.2	1.8	0.0	7.5	5.4	0.7	0.2	2.6	0.0	1.5	1.8	0.3	0.3	4.6	0.0	5.5	0.8	10.7	4.2	0.3	1.6	0.5	1.4	0.2	0.8	0.3
NAA11	"ARD1B, ARD2, hARD2"	ENSG00000156269	"N-alpha-acetyltransferase 11, NatA catalytic subunit"	Q9BSU3	4	79225694-79326061	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"brain: 2.7;placenta: 4.2;testis: 6.2"	"Group enriched"	"Detected in some"	12	"Cytotrophoblasts: 19.4;Early spermatids: 30.6;Extravillous trophoblasts: 16.4;Late spermatids: 23.9;Spermatocytes: 25.1;Spermatogonia: 15.9;Syncytiotrophoblasts: 13.3"	"Cancer enriched"	"Detected in some"	4	"testis cancer: 2.1"	"Region enriched"	"Detected in single"	5	"cerebellum: 2.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"GAMG: 19.3;K-562: 12.3;U-266/70: 32.9;U-266/84: 11.3"					"Not detected"	"Not detected"			HPA035922	Approved		Supported	"Nucleoplasm,Golgi apparatus,Centrosome,Cytosol"		NA	NA			Nucleoplasm	"Golgi apparatus, Centrosome, Cytosol"	"HPA035922: AB_10673490"					"unprognostic (7.37e-2)"							"unprognostic (7.58e-2)"		"unprognostic (1.36e-1)"	"unprognostic (1.20e-1)"		"unprognostic (4.67e-1)"	0.0	0.0	0.2	0.0	0.2	0.0	0.0	2.7	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.1	0.0	0.0	0.0	4.2	0.5	0.1	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	6.2	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.0	19.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	12.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	3.3	0.0	0.3	0.3	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.2	0.0	32.9	11.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	2.7	0.1	0.1	0.2	0.4	0.3	0.0	0.5	0.3	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	19.4	0.0	0.0	0.0	0.0	30.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	16.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	23.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.1	15.9	0.0	0.0	13.3	0.0	0.0	0.0	0.0
NLGN4X	"HLNX, KIAA1260, NLGN, NLGN4"	ENSG00000146938	"Neuroligin 4 X-linked"	Q8N0W4	X	5840637-6228867	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion"		"Asperger syndrome, Autism, Autism spectrum disorder"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.5;lymphoid tissue: 14.4"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 113.9;Excitatory neurons: 162.2;Inhibitory neurons: 236.8;Oligodendrocyte precursor cells: 702.7"	"Group enriched"	"Detected in many"	4	"endometrial cancer: 2.7;glioma: 8.5;testis cancer: 3.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"AF22: 55.6;NTERA-2: 44.1;SuSa: 42.7"									HPA001651	Approved					NA	NA					"HPA001651: AB_1079470"	"unprognostic (2.21e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.11e-1)"	"unprognostic (8.57e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.67e-1)"	"unprognostic (9.49e-2)"	"unprognostic (1.48e-2)"	"unprognostic (9.32e-2)"	"unprognostic (5.10e-3)"	"unprognostic (7.16e-4)"	"unprognostic (6.70e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.10e-2)"	3.4	1.3	8.2	1.9	11.2	0.0	2.2	11.1	13.5	5.1	0.0	2.8	1.3	2.3	0.4	0.7	2.1	2.6	3.1	15.9	19.5	0.3	1.3	1.1	0.8	7.7	5.8	10.9	11.7	0.4	5.2	1.7	3.7	6.0	1.1	1.9	9.3	0.8	1.9	0.3	0.6	2.6	3.7	1.5	2.2	1.1	2.6	8.5	14.4	0.7	0.2	0.5	2.2	1.4	5.5	0.0	0.0	55.6	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	7.4	0.0	44.1	0.0	0.1	0.0	0.0	0.1	4.1	11.5	2.7	3.5	0.0	0.1	0.0	42.7	5.7	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	11.2	11.1	13.5	15.9	19.5	7.7	5.8	10.9	6.0	1.5	8.5	5.5	12.1	0.0	0.5	113.9	0.3	0.3	0.1	0.2	0.0	15.0	5.2	3.4	2.8	0.0	0.1	0.0	25.0	3.7	0.1	0.0	0.0	0.0	0.1	19.7	69.5	2.5	0.0	0.0	162.2	0.0	2.4	9.6	0.0	33.2	0.0	2.2	1.8	0.0	0.6	0.0	236.8	0.0	0.0	0.3	0.5	0.7	18.0	0.3	14.2	4.7	0.0	12.5	0.0	702.7	68.3	0.0	0.0	29.7	0.1	0.0	0.0	0.1	0.7	3.3	13.1	18.4	5.0	2.0	5.5	0.2	0.6	3.6	0.5	8.8	0.0	0.3
NTRK3	TRKC	ENSG00000140538	"Neurotrophic receptor tyrosine kinase 3"	Q16288	15	87859751-88256768	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 239.3;Early spermatids: 119.6;Excitatory neurons: 360.0;Inhibitory neurons: 277.8;Late spermatids: 148.9;Microglial cells: 177.1;Oligodendrocyte precursor cells: 499.6"	"Group enriched"	"Detected in some"	4	"glioma: 2.5;testis cancer: 1.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"U-138 MG: 100.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009233, HPA027484, HPA048065"	Approved		Supported	"Nuclear membrane,Nucleoli,Nucleoli rim"		NA	NA		19000000	"Nucleoli, Nucleoli rim"	"Nuclear membrane"	"CAB009233: AB_632555, HPA027484: AB_2672297, HPA048065: AB_2680245"	"unprognostic (1.27e-3)"	"unprognostic (1.24e-2)"	"unprognostic (1.98e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.34e-1)"	"unprognostic (3.18e-2)"	"unprognostic (2.23e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.91e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.09e-1)"	"unprognostic (5.78e-3)"	"unprognostic (6.45e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.49e-3)"	13.0	3.7	31.1	0.8	30.0	0.1	7.9	29.4	32.5	10.9	1.5	3.3	0.5	10.5	3.2	1.3	15.1	1.6	4.3	35.2	22.5	5.1	1.0	5.3	1.2	21.7	19.9	31.0	7.3	1.0	0.1	12.3	1.0	22.5	9.0	2.1	5.2	6.8	4.3	1.8	4.1	2.2	3.8	9.9	2.5	3.3	9.9	26.7	1.2	3.1	1.9	2.0	8.8	7.4	22.5	0.0	13.1	2.7	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.0	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	2.5	0.0	0.0	0.0	2.6	0.1	0.1	0.1	0.7	0.1	0.0	0.0	0.0	0.9	0.1	0.1	0.0	100.6	1.8	0.0	1.3	0.0	0.0	0.0	3.0	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	31.1	30.0	29.4	32.5	35.2	22.5	21.7	19.9	31.0	22.5	9.9	26.7	22.5	0.5	0.0	0.0	239.3	0.0	0.5	6.4	0.0	0.0	53.8	3.7	6.0	5.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	119.6	0.4	25.0	1.2	0.0	0.0	360.0	0.0	0.0	5.7	0.0	0.5	0.0	0.0	2.2	0.0	1.0	1.7	277.8	0.0	0.0	0.0	0.6	148.9	3.4	0.6	0.0	177.1	0.0	8.6	0.0	499.6	7.4	0.0	0.0	27.4	0.0	1.3	0.0	0.1	0.0	3.7	52.6	20.3	40.9	11.0	3.7	0.0	0.1	0.1	0.2	0.0	0.0	0.7
NUDT11	"DIPP3b, FLJ10628, hDIPP3beta"	ENSG00000196368	"Nudix hydrolase 11"	Q96G61	X	51490011-51496592	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.3;testis: 36.5"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 15.3;Late spermatids: 17.1;Peritubular cells: 20.7;Spermatocytes: 14.6;Spermatogonia: 20.3"	"Group enriched"	"Detected in many"	4	"glioma: 12.1;prostate cancer: 10.6;testis cancer: 17.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"gdT-cell: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HAP1: 69.3;NTERA-2: 42.9"					"Low region specificity"	"Detected in many"			"HPA047027, HPA057684"	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA047027: AB_2679907, HPA057684: AB_2683501"	"unprognostic (2.01e-1)"	"unprognostic (2.57e-1)"	"unprognostic (8.21e-2)"	"unprognostic (1.93e-3)"	"unprognostic (6.61e-2)"	"unprognostic (1.13e-3)"	"unprognostic (5.52e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.25e-2)"	"unprognostic (2.18e-1)"	"unprognostic (8.41e-2)"	"unprognostic (1.33e-1)"	"unprognostic (7.80e-12)"	"unprognostic (4.34e-4)"	"unprognostic (1.17e-2)"	"unprognostic (2.78e-1)"	"unprognostic (3.94e-4)"	1.0	4.6	11.8	0.9	16.3	1.4	2.2	6.5	13.7	4.0	4.4	2.3	1.1	5.2	3.5	1.3	2.0	1.6	0.3	14.5	25.3	0.5	0.1	0.5	0.6	8.7	9.4	14.8	9.0	4.9	0.2	4.3	0.0	8.8	9.2	0.8	2.2	0.7	10.5	0.1	1.2	1.0	4.4	6.5	0.3	1.1	36.5	20.1	2.7	0.6	0.5	0.6	1.9	2.4	10.7	0.0	1.0	20.6	0.0	17.5	22.0	0.1	9.8	2.7	0.5	0.5	0.0	0.0	0.0	0.5	11.9	11.4	1.5	69.3	23.9	0.3	0.0	4.7	0.0	0.0	0.0	8.2	0.0	4.6	13.5	9.3	6.2	22.4	3.9	16.4	21.6	0.1	0.0	19.6	0.5	27.6	0.1	42.9	0.0	17.5	0.0	14.4	0.0	4.3	0.0	0.0	13.4	4.2	0.0	4.0	10.2	0.0	0.1	9.6	4.8	22.4	1.4	0.0	9.0	4.5	15.2	3.1	0.0	1.9	0.0	0.0	0.0	1.2	0.0	0.5	0.1	0.3	0.6	0.1	0.1	0.0	0.9	0.0	0.7	0.1	0.0	0.0	0.3	11.8	16.3	6.5	13.7	14.5	25.3	8.7	9.4	14.8	8.8	6.5	20.1	10.7	0.4	0.0	0.0	0.3	0.3	15.3	6.4	12.8	12.0	1.6	0.5	3.9	0.6	0.0	1.6	0.0	0.0	0.3	3.5	0.0	0.0	0.2	11.3	0.5	9.0	0.9	0.0	1.3	6.3	1.5	1.0	7.7	0.0	0.3	0.0	3.4	0.4	0.0	0.1	0.0	3.8	0.0	0.0	0.3	3.8	17.1	8.7	0.6	5.4	2.8	0.0	1.4	3.1	4.0	0.6	1.4	0.0	20.7	0.3	10.4	0.0	0.2	0.2	0.2	0.0	3.0	5.3	14.6	20.3	1.6	9.1	0.3	0.8	7.5	0.0	1.3
OLAH	"FLJ11106, SAST, THEDC1"	ENSG00000152463	"Oleoyl-ACP hydrolase"	Q9NV23	10	15032227-15073853	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 9.0;testis: 27.2"	"Cell type enriched"	"Detected in some"	4	"Early spermatids: 537.8"	"Cancer enriched"	"Detected in some"	4	"testis cancer: 3.6"	"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 2.6"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 2.6"	"Cell line enhanced"	"Detected in some"		"HSkMC: 3.6;hTCEpi: 4.8;LHCN-M2: 3.6;SK-BR-3: 5.3;SuSa: 2.6;U-266/70: 3.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA037947, HPA037948"	Enhanced					NA	NA					"HPA037947: AB_10795028, HPA037948: AB_10805352"	"unprognostic (2.01e-1)"	"unprognostic (6.12e-2)"	"unprognostic (8.20e-3)"	"unprognostic (4.04e-3)"	"unprognostic (1.92e-1)"	"unprognostic (8.09e-2)"	"unprognostic (7.12e-2)"	"unprognostic (5.12e-2)"	"unprognostic (4.55e-1)"	"unprognostic (3.74e-2)"	"unprognostic (4.70e-1)"	"unprognostic (1.69e-1)"	"unprognostic (5.22e-10)"	"unprognostic (4.55e-2)"	"unprognostic (2.09e-1)"	"unprognostic (5.11e-2)"	"unprognostic (9.78e-2)"	1.2	0.9	1.1	0.2	0.7	1.1	5.5	0.5	1.5	0.8	0.6	0.2	0.1	0.4	0.4	3.0	1.7	1.0	0.2	1.2	0.1	1.1	0.3	1.8	0.3	0.6	0.2	0.6	0.2	0.1	0.3	1.0	3.2	0.4	0.3	0.0	0.7	2.7	0.1	0.2	0.5	0.5	0.2	0.2	9.0	0.3	27.2	0.5	0.1	0.4	0.3	0.0	0.2	0.8	1.2	0.0	0.0	0.1	0.2	0.2	0.7	1.2	0.3	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.1	0.4	0.1	0.1	0.2	0.1	0.0	0.5	0.0	0.4	3.6	4.8	0.5	0.0	0.0	0.4	0.1	0.2	0.1	3.6	0.0	0.3	0.2	0.2	0.0	0.3	0.4	0.7	0.2	0.0	0.0	0.0	0.1	0.1	5.3	0.0	2.6	0.1	0.1	0.2	0.0	1.8	0.1	0.1	3.1	0.7	0.2	1.1	0.2	0.0	0.8	0.1	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.1	0.1	2.6	0.4	0.0	0.5	0.2	0.0	1.1	0.7	0.5	1.5	1.2	0.1	0.6	0.2	0.6	0.4	0.2	0.5	1.2	0.7	3.2	0.6	0.3	0.1	0.3	0.5	0.0	0.0	0.1	131.3	0.9	0.4	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.0	2.7	537.8	0.1	0.2	0.3	0.0	0.0	0.1	0.0	1.7	0.3	0.0	0.2	0.0	0.1	0.0	0.3	0.1	0.0	0.1	0.0	0.0	2.2	0.3	66.1	4.4	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	8.2	0.0	0.4	0.0	0.0	0.8	0.7	6.6	0.5	1.0	2.8	1.9	0.0	0.3	11.4	0.9	0.1	0.0	0.1
PDPN	"aggrus, Gp38, GP40, PA2.26, T1A-2"	ENSG00000162493	Podoplanin	Q86YL7	1	13583465-13617957	"Predicted membrane proteins"	"Cell shape"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 136.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 105.8;Basal respiratory cells: 98.5;Fibroblasts: 123.1;monocytes: 116.3;Muller glia cells: 97.7;Peritubular cells: 62.8"	"Group enriched"	"Detected in many"	4	"glioma: 83.2;head and neck cancer: 40.2;testis cancer: 102.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 149.5;EFO-21: 356.4;HAP1: 253.3;HHSteC: 216.0;NTERA-2: 116.0;SuSa: 119.0;TIME: 242.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007534, HPA007949, CAB008376"	Enhanced		Supported	"Plasma membrane,Cell Junctions,Mitochondria"		NA	NA			"Plasma membrane"	"Cell Junctions, Mitochondria"	"CAB008376: AB_592530, HPA007534: AB_1857718, HPA007949: "	"unprognostic (1.75e-1)"	"unprognostic (3.19e-2)"	"unprognostic (6.03e-2)"	"unprognostic (3.61e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.85e-2)"	"unprognostic (5.23e-2)"	"unprognostic (9.21e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.92e-2)"	"unprognostic (5.62e-3)"	"unprognostic (9.20e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.29e-2)"	"unprognostic (2.78e-2)"	38.7	3.3	8.9	56.4	9.1	0.0	21.1	14.3	9.8	36.2	21.0	16.1	3.9	26.2	11.4	16.0	33.7	42.5	17.1	6.9	43.2	3.4	0.6	32.7	9.9	25.5	14.2	5.4	29.6	6.4	1.1	3.4	136.7	17.0	14.1	10.7	22.9	9.2	14.2	30.2	19.4	16.0	34.8	18.5	0.3	24.9	4.6	18.9	10.4	6.2	11.4	18.6	97.1	25.4	28.6	0.1	0.0	149.5	0.1	0.5	0.0	0.1	2.4	0.1	0.0	0.0	0.0	0.1	0.2	356.4	9.0	0.1	0.7	253.3	44.7	0.0	1.0	46.1	0.1	0.0	0.0	216.0	0.0	0.2	29.5	82.9	18.6	21.8	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	116.0	0.0	0.6	0.3	0.2	0.1	0.0	4.0	0.1	0.1	0.2	0.0	0.3	119.0	0.1	0.6	242.2	41.8	34.6	0.6	0.1	0.1	0.3	1.0	88.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	8.9	9.1	14.3	9.8	6.9	43.2	25.5	14.2	5.4	17.0	18.5	18.9	28.6	2.4	105.8	11.2	3.9	0.2	14.5	30.4	98.5	14.8	1.4	0.5	19.9	8.4	2.8	18.8	0.0	4.2	2.0	0.1	0.0	0.0	0.5	0.7	1.6	37.6	22.4	0.0	0.0	2.6	0.0	2.1	123.1	0.0	2.8	1.3	3.4	6.4	0.0	6.5	0.0	3.5	0.0	8.2	0.0	14.0	1.8	20.2	5.3	7.2	5.6	116.3	97.7	0.0	19.6	0.2	0.4	0.0	62.8	0.0	15.8	0.0	0.0	5.4	3.4	0.0	17.0	8.4	1.0	8.2	3.9	7.0	2.9	1.3	0.9	0.0	3.4
PDZD4	"FLJ34125, KIAA1444, LNX5, LU1, PDZK4, PDZRN4L"	ENSG00000067840	"PDZ domain containing 4"	Q76G19	X	153802166-153830565	"Cancer-related genes, Metabolic proteins, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 151.2;choroid plexus: 45.0;pituitary gland: 44.4"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 12.1;Bipolar cells: 18.0;dendritic cells: 14.0;Excitatory neurons: 11.0;NK-cells: 26.8;Rod photoreceptor cells: 14.1"	"Group enriched"	"Detected in many"	4	"glioma: 20.1;testis cancer: 10.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 24.4;NTERA-2: 12.4;RH-30: 17.3;SCLC-21H: 29.5;SH-SY5Y: 28.7;U-2 OS: 14.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003878	Enhanced					NA	NA					"HPA003878: AB_2162807"	"unprognostic (9.18e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.11e-4)"	"unprognostic (1.07e-1)"	"unprognostic (6.79e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.92e-3)"	"unprognostic (2.17e-1)"	"unprognostic (2.32e-3)"	"unprognostic (5.90e-2)"	"prognostic favorable (2.96e-5)"	"unprognostic (2.27e-1)"	"unprognostic (2.54e-4)"	"unprognostic (2.27e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.83e-2)"	"unprognostic (2.87e-2)"	3.4	5.1	98.4	1.9	102.0	2.1	3.4	76.7	151.2	9.4	45.0	17.2	1.6	12.0	1.3	3.9	14.0	2.0	5.9	134.8	60.8	3.8	2.6	4.9	2.0	61.5	49.8	99.9	2.7	2.3	2.8	44.4	0.1	70.3	10.5	1.3	14.9	4.1	9.9	3.3	4.3	5.9	4.4	36.5	14.2	7.6	6.1	51.3	1.1	3.5	1.3	0.7	10.1	9.3	90.2	0.0	1.6	24.4	6.4	0.0	0.1	0.0	0.7	0.0	0.7	0.8	0.6	0.0	0.0	0.3	0.0	7.9	0.1	4.5	0.0	0.1	0.0	0.8	0.0	1.9	0.0	0.0	0.0	3.5	0.1	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.1	0.3	5.0	0.2	0.9	12.4	0.0	0.3	0.1	17.3	0.0	0.0	0.1	29.5	28.7	1.3	0.0	9.2	8.2	2.8	0.3	0.0	0.0	14.1	0.3	1.8	0.0	0.1	0.0	0.1	0.0	7.9	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.4	0.5	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.2	98.4	102.0	76.7	151.2	134.8	60.8	61.5	49.8	99.9	70.3	36.5	51.3	90.2	1.8	0.0	0.0	12.1	0.1	0.3	0.0	0.0	0.6	18.0	0.1	2.4	3.7	0.0	1.3	0.0	6.2	0.0	14.0	0.0	0.0	0.0	0.1	0.2	1.5	3.5	1.8	0.8	11.0	0.2	0.0	0.8	0.5	0.1	1.3	0.2	4.6	0.1	0.0	1.7	8.6	0.0	0.0	1.0	0.0	0.2	0.6	0.1	3.6	4.7	0.2	3.9	26.8	5.5	0.7	0.3	0.0	3.8	3.6	0.2	0.0	0.0	4.4	14.1	0.0	1.7	2.1	0.3	4.1	0.5	0.9	0.0	4.1	0.0	0.0	0.2
PIANP	"C12orf53, DKFZp547D2210, PANP"	ENSG00000139200	"PILR alpha associated neural protein"	Q8IYJ0	12	6693791-6700815	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 91.1"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 16.1;Excitatory neurons: 24.4;Horizontal cells: 18.5;Inhibitory neurons: 23.9;Oligodendrocyte precursor cells: 16.1;Peritubular cells: 13.9;Spermatogonia: 6.7"	"Group enriched"	"Detected in many"	4	"glioma: 14.7;testis cancer: 7.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 9.9;HAP1: 9.8;hTERT-RPE1: 16.2;NTERA-2: 20.8;SH-SY5Y: 19.4;U-2 OS: 10.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010631	Enhanced		Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA			Nucleoplasm		"HPA010631: AB_10603680"	"unprognostic (1.82e-1)"	"unprognostic (9.21e-3)"	"unprognostic (1.62e-2)"	"unprognostic (7.65e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.03e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.70e-1)"	"unprognostic (6.41e-3)"	"unprognostic (1.92e-2)"	"unprognostic (3.89e-1)"	"unprognostic (3.30e-3)"	"unprognostic (3.26e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.34e-2)"	0.3	5.4	67.2	0.9	55.7	0.0	0.8	13.6	91.1	16.2	0.0	4.3	0.6	21.3	2.2	0.8	7.5	1.7	0.9	60.4	36.5	0.7	0.2	1.0	1.1	20.4	19.0	57.5	3.4	0.7	5.4	15.8	0.3	25.8	5.5	0.7	8.0	0.8	5.5	0.3	0.4	3.0	5.1	1.8	0.6	2.3	4.0	27.7	0.0	0.9	0.4	0.4	3.8	10.2	53.1	0.0	0.5	7.4	1.4	0.2	0.4	0.2	2.0	9.9	5.1	4.6	0.1	0.2	0.2	0.0	3.5	0.8	0.2	9.8	0.3	2.4	0.3	1.3	0.4	0.3	0.0	0.3	0.4	0.3	1.2	0.0	2.0	0.0	16.2	0.0	3.0	0.0	0.3	0.5	0.2	0.3	0.3	20.8	0.0	0.1	1.4	0.1	0.2	0.1	0.1	2.6	19.4	0.1	0.1	0.0	1.3	0.1	0.0	0.0	5.2	10.5	5.5	1.4	0.2	0.0	0.3	7.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	67.2	55.7	13.6	91.1	60.4	36.5	20.4	19.0	57.5	25.8	1.8	27.7	53.1	0.2	0.0	0.0	3.6	0.1	0.3	0.0	0.0	0.0	16.1	0.0	1.3	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.9	0.0	0.8	0.3	3.5	0.2	0.0	0.0	24.4	0.0	0.0	1.9	0.0	0.1	0.0	0.1	0.0	0.0	0.1	18.5	23.9	0.0	0.0	0.0	0.2	1.1	2.1	0.0	0.0	3.7	0.0	3.9	0.0	16.1	3.1	0.0	0.0	13.9	0.0	0.0	0.0	0.1	0.0	4.1	0.0	0.0	1.6	0.1	6.7	0.0	0.1	0.1	0.3	0.0	0.0	0.1
PIP5K1B	"MSS4, STM7"	ENSG00000107242	"Phosphatidylinositol-4-phosphate 5-kinase type 1 beta"	O14986	9	68705240-69009176	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 77.5"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 127.4;Early spermatids: 100.0;Inhibitory neurons: 270.1;Muller glia cells: 120.2"	"Group enriched"	"Detected in many"	4	"colorectal cancer: 10.1;pancreatic cancer: 3.4;stomach cancer: 9.4;testis cancer: 3.6"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"eosinophil: 34.5"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 34.5"	"Cell line enhanced"	"Detected in some"		"AF22: 43.8;HEL: 17.0;Hep G2: 13.4;OE19: 73.1;U-266/70: 17.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009687	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA009687: AB_1855391"	"unprognostic (2.02e-3)"	"unprognostic (1.84e-2)"	"unprognostic (3.77e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.85e-3)"	"unprognostic (1.80e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.98e-2)"	"unprognostic (2.92e-2)"	"prognostic favorable (1.03e-9)"	"unprognostic (2.10e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.34e-1)"	3.6	12.0	5.4	6.1	5.2	16.3	4.9	18.0	8.0	6.3	77.5	31.5	35.1	7.5	1.7	1.2	6.1	4.0	32.5	12.2	8.7	7.9	0.3	13.0	2.7	8.1	10.9	4.0	1.0	8.7	13.8	6.7	6.5	7.7	3.1	29.4	38.4	16.5	9.7	2.9	2.1	31.1	2.9	3.8	2.6	26.4	24.9	9.1	1.0	1.2	5.1	3.6	3.3	2.5	6.8	0.0	0.0	43.8	0.0	0.1	0.0	8.5	0.0	0.0	0.0	0.0	4.6	0.0	3.6	0.1	0.0	0.1	0.1	0.4	0.1	0.0	0.0	0.8	17.0	0.3	13.4	0.0	0.9	4.4	0.0	2.0	0.0	0.0	0.0	0.1	0.5	0.9	9.3	0.3	1.1	0.1	0.2	2.3	73.1	1.4	1.4	0.1	0.3	0.3	3.4	0.9	0.1	0.0	0.1	0.5	1.0	0.2	0.1	0.1	0.0	0.4	0.1	0.0	17.0	3.5	2.3	0.0	3.1	0.0	5.6	0.5	34.5	0.0	0.0	0.0	4.7	0.3	0.1	0.1	5.4	0.7	0.1	1.7	0.0	0.2	1.4	1.6	0.3	5.4	5.2	18.0	8.0	12.2	8.7	8.1	10.9	4.0	7.7	3.8	9.1	6.8	3.6	35.3	34.4	28.7	19.2	0.6	3.2	0.5	0.6	5.1	4.7	3.3	61.6	2.8	2.8	5.5	2.1	21.3	0.0	127.4	27.4	1.6	100.0	12.8	13.6	3.3	37.0	53.6	84.7	14.0	1.3	3.1	40.2	27.5	5.7	3.8	1.4	0.0	3.9	0.0	270.1	32.6	14.2	1.0	1.3	47.6	2.5	5.6	5.4	60.0	2.6	120.2	0.0	80.9	6.4	5.2	46.6	1.5	43.2	2.5	39.2	1.4	6.5	3.3	26.3	2.5	32.2	39.0	4.5	0.7	0.3	8.8	2.1	0.9	29.7	9.8
POU3F1	"OCT6, OTF6, SCIP"	ENSG00000185668	"POU class 3 homeobox 1"	Q03052	1	38043829-38046793	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"brain: 10.3;skin 1: 32.9"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 27.3;Breast myoepithelial cells: 39.1;Cone photoreceptor cells: 22.9;Suprabasal keratinocytes: 55.8"	"Group enriched"	"Detected in many"	4	"cervical cancer: 1.8;head and neck cancer: 4.4;melanoma: 4.8;testis cancer: 1.3;urothelial cancer: 2.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 24.1;HDLM-2: 23.9;NTERA-2: 7.5;SCLC-21H: 5.7;SK-MEL-30: 28.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA055980, HPA073824"			Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA055980: AB_2682995, HPA073824: AB_2686635"	"unprognostic (9.99e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.43e-2)"	"unprognostic (7.46e-3)"	"unprognostic (1.96e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.07e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.61e-4)"	"unprognostic (2.79e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.61e-2)"	"unprognostic (2.67e-3)"	0.1	1.5	1.5	0.2	5.7	0.0	0.3	1.0	10.3	0.1	0.2	0.0	0.0	0.0	0.1	2.6	0.0	0.0	0.0	9.4	2.2	0.0	0.0	0.0	1.0	2.0	2.4	2.7	0.1	0.1	0.2	0.0	0.0	3.4	0.2	0.0	0.3	0.3	0.1	0.9	32.9	0.0	0.0	0.5	0.1	0.1	0.8	1.9	0.3	0.0	0.5	1.0	0.8	0.3	2.5	0.0	0.0	24.1	0.4	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.3	0.1	0.0	23.9	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.1	0.0	1.4	5.7	0.0	0.1	0.0	28.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	5.7	1.0	10.3	9.4	2.2	2.0	2.4	2.7	3.4	0.5	1.9	2.5	12.2	0.0	0.0	2.3	8.3	27.3	2.9	1.4	20.5	7.8	9.9	39.1	5.2	0.0	0.2	0.0	22.9	0.2	13.4	13.8	0.0	0.0	0.2	0.5	2.3	1.9	1.8	2.7	6.4	0.0	0.1	5.2	7.1	1.4	0.0	0.5	0.0	0.0	0.3	1.7	1.1	11.0	0.0	0.0	1.3	0.0	0.3	4.3	7.2	1.0	0.0	14.0	0.0	0.5	0.2	0.0	0.1	0.0	2.7	0.7	0.3	0.1	0.0	21.1	0.0	8.5	7.2	0.2	4.1	20.2	55.8	0.1	5.2	8.3	5.7	3.2
PRPH	"NEF4, PRPH1"	ENSG00000135406	Peripherin	P41219	12	49293252-49298686	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Amyotrophic lateral sclerosis, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 53.7;intestine: 17.5"	"Group enriched"	"Detected in some"	6	"Early spermatids: 327.5;Late spermatids: 920.2"	"Group enriched"	"Detected in some"	4	"endometrial cancer: 1.6;glioma: 1.7;pancreatic cancer: 1.1;testis cancer: 1.5"	"Region enhanced"	"Detected in many"		"pons: 53.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"AN3-CA: 367.0"	"Group enriched"	"Detected in many"	4	"hypothalamus: 19.4;pons and medulla: 35.1"	"Region enriched"	"Detected in many"	8	"spinal cord: 256.8"	"CAB002437, HPA039277, HPA063887"	Enhanced					NA	NA					"CAB002437: AB_563956, HPA039277: AB_2676424, HPA063887: AB_2685142"	"unprognostic (1.73e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (7.88e-4)"	"unprognostic (5.04e-3)"	"unprognostic (1.88e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.10e-1)"	"unprognostic (7.38e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.25e-3)"	"unprognostic (3.63e-2)"	"unprognostic (5.73e-2)"	"unprognostic (4.86e-3)"	"unprognostic (6.36e-5)"	3.0	14.6	2.2	7.6	4.3	0.0	1.8	0.5	7.2	3.1	0.3	17.5	4.8	0.8	0.1	0.5	3.1	0.6	0.8	0.8	4.5	0.3	0.1	0.9	0.2	37.9	5.2	0.9	0.7	1.3	0.1	2.9	0.3	53.7	2.3	2.1	1.5	0.5	1.5	0.4	0.9	9.0	2.0	9.2	1.2	5.2	13.3	1.9	0.1	0.5	0.2	0.1	1.5	8.4	18.0	0.0	0.7	0.0	367.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.8	0.7	0.0	0.8	0.0	0.1	0.0	0.4	0.0	0.0	0.7	1.6	0.4	1.3	0.2	0.2	0.4	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	3.7	0.0	0.2	2.0	0.0	2.2	0.4	0.0	1.6	86.6	1.5	0.2	0.8	0.0	0.0	1.7	0.1	0.0	1.1	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	4.3	0.5	7.2	0.8	4.5	37.9	5.2	0.9	53.7	9.2	1.9	18.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	10.8	0.3	0.8	0.4	0.0	0.0	0.0	4.2	0.1	0.0	0.1	0.0	0.0	327.5	0.5	0.1	1.4	92.3	0.0	0.1	0.0	0.2	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.1	25.2	0.1	1.0	0.0	0.0	0.9	920.2	5.9	0.7	0.0	0.0	0.0	9.3	0.0	0.0	0.0	0.1	0.0	1.9	0.0	0.0	0.0	0.8	0.1	38.1	0.0	0.1	14.1	96.1	19.4	0.3	0.4	0.0	0.1	0.0	0.5	0.2
PRSS35	"C6orf158, dJ223E3.1, MGC46520"	ENSG00000146250	"Serine protease 35"	Q8N3Z0	6	83512534-83525704	"Enzymes, Predicted secreted proteins"		"Serine protease homolog"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"retina: 50.9"	"Cell type enriched"	"Detected in some"	36	"Muller glia cells: 410.9"	"Group enriched"	"Detected in some"	4	"glioma: 2.8;testis cancer: 4.7"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	9	"MAIT T-cell: 19.5"	"Lineage enriched"	"Detected in single"	195	"T-cells: 19.5"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 10.4;CACO-2: 86.3;HAP1: 12.8;RPTEC TERT1: 24.6;SuSa: 17.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"amygdala: 2.9;cerebellum: 3.6;cerebral cortex: 5.8;hippocampal formation: 5.3;olfactory bulb: 2.7"	"HPA038787, HPA038788"	Uncertain				"Secreted in female reproductive system"	NA	NA					"HPA038787: AB_10675951, HPA038788: AB_2676208"	"unprognostic (6.17e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.03e-2)"	"unprognostic (3.70e-4)"	"unprognostic (6.08e-2)"	"unprognostic (1.18e-3)"	"unprognostic (2.33e-2)"	"unprognostic (7.01e-2)"	"unprognostic (9.07e-2)"	"unprognostic (3.88e-6)"	"unprognostic (7.15e-3)"	"unprognostic (5.81e-2)"	"unprognostic (2.82e-2)"	"unprognostic (3.54e-4)"	1.3	2.4	3.0	0.1	3.8	0.0	0.3	1.7	6.8	2.9	1.7	0.1	0.3	1.4	1.1	0.3	1.4	4.2	2.7	3.3	2.6	3.2	0.4	1.3	0.7	2.2	2.0	3.6	10.3	0.3	0.3	1.1	3.7	2.8	1.2	0.3	50.9	0.3	0.4	0.1	0.2	0.1	1.5	1.8	0.7	0.3	3.1	2.0	0.1	0.4	0.1	0.1	1.3	0.5	2.9	0.0	0.5	1.9	0.0	0.1	0.0	0.0	0.3	10.4	1.0	2.0	86.3	0.0	0.0	0.1	0.4	0.0	0.0	12.8	0.0	0.6	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	3.1	0.0	1.2	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.1	1.6	0.4	8.2	0.0	0.0	0.0	24.6	0.0	0.0	1.0	0.0	0.0	0.0	17.9	0.0	0.0	0.0	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.2	0.0	19.5	0.0	0.3	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.0	3.8	1.7	6.8	3.3	2.6	2.2	2.0	3.6	2.8	1.8	2.0	2.9	0.3	3.2	0.5	8.1	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.1	1.5	0.0	0.0	1.8	0.0	0.3	0.0	0.1	9.8	0.1	0.1	0.0	0.3	0.8	1.8	0.0	0.2	0.0	0.0	4.4	0.0	0.0	0.0	0.9	0.0	0.3	0.4	6.7	0.2	0.0	0.0	0.0	0.0	0.2	1.2	0.1	0.0	1.0	0.0	410.9	0.0	1.0	0.1	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	11.4	6.6	0.1	3.7	0.1	0.5	0.0	0.0	0.1	0.7	5.1	0.0	0.0
PTH1R	"PTHR, PTHR1"	ENSG00000160801	"Parathyroid hormone 1 receptor"	Q03431	3	46877721-46903799	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant, Dwarfism, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"kidney: 573.4"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 95.9;Extravillous trophoblasts: 60.8;Proximal tubular cells: 324.8;Sertoli cells: 138.1"	"Group enriched"	"Detected in many"	4	"renal cancer: 18.8;testis cancer: 5.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"RPTEC TERT1: 116.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA075879	Enhanced					NA	NA					"HPA075879: "	"unprognostic (1.26e-1)"	"unprognostic (7.09e-2)"	"unprognostic (2.24e-5)"	"unprognostic (7.46e-2)"	"unprognostic (3.46e-1)"	"unprognostic (5.02e-2)"	"unprognostic (3.84e-3)"	"unprognostic (5.47e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.13e-2)"	"unprognostic (7.51e-2)"	"unprognostic (8.44e-2)"	"prognostic favorable (6.79e-6)"	"unprognostic (4.22e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.35e-4)"	"unprognostic (6.62e-3)"	28.3	72.8	39.4	1.1	39.8	0.0	20.4	40.8	61.3	41.2	33.6	9.8	1.2	19.3	2.7	3.8	20.4	3.6	27.2	37.7	38.3	573.4	85.3	25.8	2.4	41.0	39.9	35.5	22.4	7.6	1.3	6.0	16.2	43.0	12.5	0.6	0.7	2.7	3.5	7.7	9.6	9.7	2.6	39.3	54.8	7.6	10.4	40.5	0.4	6.5	2.2	0.4	12.4	20.5	38.4	0.0	0.2	0.2	0.2	15.9	1.9	0.2	0.4	0.2	0.3	0.2	0.4	0.0	0.0	1.6	0.1	0.2	0.0	1.8	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.7	0.0	0.0	15.5	0.0	0.1	0.0	0.2	0.1	0.0	0.0	2.6	0.1	0.1	0.0	0.3	2.1	0.0	0.1	0.1	5.3	0.0	116.9	0.0	0.2	0.7	0.0	0.1	0.0	5.2	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.4	39.8	40.8	61.3	37.7	38.3	41.0	39.9	35.5	43.0	39.3	40.5	38.4	4.6	0.0	0.0	17.3	2.5	1.3	0.1	0.0	0.6	1.5	2.9	0.4	5.0	2.8	0.0	33.1	0.0	0.6	0.1	0.0	95.9	0.0	11.6	0.6	20.5	4.1	0.0	8.0	1.6	0.5	60.8	9.6	0.0	0.6	0.0	0.1	17.2	0.7	2.0	1.7	2.8	0.0	0.0	1.3	2.8	32.5	5.9	2.1	0.0	1.9	0.0	3.2	0.0	1.0	0.3	0.3	0.0	2.2	0.0	0.0	0.0	324.8	0.0	1.7	138.1	6.5	21.7	0.9	2.7	0.0	0.9	0.8	2.0	0.3	0.0	0.1
PXDNL	"FLJ25471, PMR1"	ENSG00000147485	"Peroxidasin like"	A1KZ92	8	51319577-51809445	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Hydrogen peroxide"	"Endonuclease, Hydrolase, Nuclease, Oxidoreductase, Peroxidase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"heart muscle: 38.9"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 42.2;Early spermatids: 43.8;Excitatory neurons: 25.2;Inhibitory neurons: 68.8;Microglial cells: 16.9;Muller glia cells: 18.6;Spermatocytes: 24.2"	"Group enriched"	"Detected in some"	4	"breast cancer: 1.7;glioma: 0.7;renal cancer: 0.8;testis cancer: 1.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"AF22: 7.7;Daudi: 5.9;SH-SY5Y: 6.1"									HPA007919			Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			"Nucleoplasm, Cytosol"		"HPA007919: AB_1855966"	"prognostic unfavorable (3.27e-5)"	"unprognostic (4.59e-4)"	"unprognostic (5.57e-3)"	"unprognostic (2.83e-3)"	"unprognostic (2.71e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.18e-1)"	"unprognostic (7.18e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.15e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.60e-4)"	"unprognostic (2.28e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.42e-2)"	"unprognostic (2.97e-4)"	1.6	0.1	0.1	0.2	0.1	0.0	0.2	0.2	0.6	0.1	0.0	0.1	0.0	0.1	9.5	0.2	0.0	0.1	38.9	0.2	0.3	1.4	0.0	0.2	0.3	0.5	0.3	0.1	0.1	0.0	0.2	0.0	0.0	0.8	0.2	0.1	2.9	0.4	0.0	1.4	0.2	0.2	0.0	0.1	0.4	0.0	5.1	0.2	0.5	0.3	2.1	0.5	0.0	0.0	0.4	0.5	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.6	0.2	0.3	0.5	0.3	0.1	0.8	0.1	0.2	0.4	0.3	0.0	0.0	10.7	0.0	0.1	0.1	0.0	0.0	1.2	3.7	0.1	42.2	0.0	0.0	0.0	0.0	0.0	1.5	0.0	1.9	0.0	43.8	0.0	0.0	0.3	0.0	0.0	25.2	0.0	0.0	5.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	68.8	0.0	0.0	0.0	0.0	6.3	0.0	0.1	0.0	16.9	0.0	18.6	0.0	14.1	14.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.2	0.8	24.2	1.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0
RASL10A	RRP22	ENSG00000100276	"RAS like family 10 member A"	Q92737	22	29312933-29319679	"Enzymes, Predicted intracellular proteins"		Hydrolase	"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 28.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 17.9;Breast glandular cells: 35.9;Breast myoepithelial cells: 58.3;Excitatory neurons: 35.1;Rod photoreceptor cells: 19.6"	"Group enriched"	"Detected in some"	4	"glioma: 2.5;testis cancer: 3.4;urothelial cancer: 1.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 1.6;NB-4: 2.5;U-2 OS: 1.1;U-266/70: 2.7;U-266/84: 1.0"	"Group enriched"	"Detected in many"	6	"amygdala: 33.7;basal ganglia: 16.7;cerebral cortex: 36.0;hippocampal formation: 26.3;white matter: 15.3"	"Group enriched"	"Detected in many"	4	"cerebral cortex: 35.6;hippocampal formation: 27.8"	HPA056169	Approved					NA	NA					"HPA056169: AB_2683053"	"unprognostic (1.94e-1)"	"unprognostic (2.51e-4)"	"unprognostic (3.78e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.94e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.16e-1)"	"unprognostic (7.99e-2)"	"unprognostic (9.42e-2)"	"unprognostic (1.61e-2)"	"unprognostic (5.00e-4)"	"unprognostic (2.44e-1)"	"unprognostic (7.00e-4)"	"unprognostic (3.12e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.61e-2)"	"unprognostic (3.61e-3)"	0.8	1.4	28.3	0.3	24.7	0.1	2.1	7.6	27.2	0.3	6.8	0.6	0.3	0.6	0.1	0.4	0.6	0.1	2.8	26.1	13.2	1.2	0.9	1.2	0.1	12.6	13.2	26.9	0.2	0.4	0.1	5.1	0.2	17.0	2.0	0.0	2.6	1.0	0.1	0.7	0.7	1.1	0.0	9.6	1.2	0.5	1.8	14.0	0.1	1.1	0.1	0.1	0.5	0.3	19.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.1	1.6	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.5	0.0	0.4	0.0	2.5	0.6	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.3	0.0	0.0	0.1	0.0	0.5	0.5	0.2	0.1	0.0	1.1	0.0	0.1	2.7	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.3	24.7	7.6	27.2	26.1	13.2	12.6	13.2	26.9	17.0	9.6	14.0	19.0	3.9	0.0	0.0	17.9	0.4	0.4	0.6	0.0	0.0	6.8	35.9	58.3	1.1	1.5	0.0	0.0	6.2	0.2	1.0	0.7	0.0	0.0	1.3	0.8	0.3	3.1	0.0	0.0	35.1	0.0	4.7	0.5	1.5	1.4	0.0	0.5	7.9	0.5	1.1	0.0	4.4	1.1	0.0	2.6	5.8	0.5	0.3	2.7	0.0	4.7	0.2	3.3	0.0	3.0	3.9	0.1	0.1	0.0	0.3	1.7	0.2	0.1	0.2	19.6	0.0	13.4	0.5	1.5	3.9	0.3	0.6	0.5	0.5	0.6	0.4	0.2
RBP2	"CRABP-II, CRBP2, CRBPII, RBPC2"	ENSG00000114113	"Retinol binding protein 2"	P50120	3	139452884-139480747	"Metabolic proteins, Predicted intracellular proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	357	"intestine: 2738.0"	"Cell type enriched"	"Detected in some"	26	"Proximal enterocytes: 6095.4"	"Group enriched"	"Detected in many"	4	"colorectal cancer: 7.1;pancreatic cancer: 4.5;stomach cancer: 8.4;testis cancer: 2.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"CACO-2: 78.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA035866	Enhanced		Approved	"Golgi apparatus"		NA	NA		140000	"Golgi apparatus"		"HPA035866: AB_10672232"	"unprognostic (1.74e-1)"	"unprognostic (2.66e-2)"	"unprognostic (3.34e-2)"	"unprognostic (6.72e-6)"	"unprognostic (2.33e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.24e-1)"	"unprognostic (8.51e-3)"	"unprognostic (3.92e-2)"	"unprognostic (7.35e-2)"	"unprognostic (1.24e-3)"	"unprognostic (5.57e-3)"	"unprognostic (1.10e-1)"	"unprognostic (9.23e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.21e-1)"	0.4	1.1	5.2	1.2	3.3	0.7	0.5	1.3	3.8	0.1	0.0	2.7	2738.0	2.1	0.0	0.2	0.3	1.8	0.2	3.2	6.5	2.6	0.0	7.6	2.2	6.9	6.5	3.5	0.3	3.1	0.0	0.1	0.1	3.6	0.4	2.4	2.2	0.1	0.0	0.2	1.1	1902.4	1.0	5.1	0.1	3.7	1.0	7.0	0.0	0.5	0.0	0.0	0.0	0.0	5.1	0.0	0.2	0.2	0.2	0.0	0.0	7.1	0.0	0.0	0.0	0.0	78.8	0.1	0.6	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	5.9	0.1	0.2	0.1	0.1	0.0	11.7	0.0	0.0	4.0	10.1	0.0	0.1	0.0	0.5	0.4	0.0	0.0	0.0	0.2	0.5	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	3.3	1.3	3.8	3.2	6.5	6.9	6.5	3.5	3.6	5.1	7.0	5.1	0.0	9.6	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.1	12.9	8.4	0.0	0.0	14.0	0.0	0.6	0.0	0.0	0.0	0.2	1.2	0.0	1.0	6.1	0.0	3.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.1	185.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	2.5	0.9	6.1	226.3	0.0	0.0	0.0	6095.4	0.0	0.7	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	142.6	0.1
RBPMS2		ENSG00000166831	"RNA binding protein, mRNA processing factor 2"	Q6ZRY4	15	64739891-64775589	"Predicted intracellular proteins"		"Developmental protein, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 268.0"	"Cell type enriched"	"Detected in many"	4	"Cardiomyocytes: 215.3"	"Cancer enriched"	"Detected in all"	4	"testis cancer: 37.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 39.0;AN3-CA: 55.4;HEL: 86.2;NTERA-2: 76.4;SuSa: 86.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.68e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.07e-2)"	"unprognostic (6.79e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.61e-1)"	"unprognostic (4.51e-2)"	"unprognostic (6.41e-2)"	"unprognostic (5.86e-2)"	"unprognostic (2.21e-2)"	"unprognostic (4.47e-2)"	"prognostic favorable (1.48e-4)"	"unprognostic (2.05e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.23e-1)"	"unprognostic (4.68e-3)"	20.1	4.9	4.8	6.7	4.7	1.6	12.6	2.4	4.7	17.3	13.2	105.3	6.0	53.6	7.5	20.5	31.0	10.0	268.0	3.3	3.7	17.7	14.0	7.7	1.0	3.6	4.6	2.2	10.6	2.7	16.7	4.1	7.7	2.8	27.7	8.2	2.0	2.5	46.3	5.6	4.1	30.4	37.9	2.2	4.4	52.4	6.4	8.8	2.5	13.9	5.0	0.6	94.8	14.5	2.9	0.0	6.3	39.0	55.4	0.0	0.0	5.9	1.2	0.2	7.0	1.6	4.9	0.5	0.0	5.2	1.1	6.5	0.0	28.8	0.0	2.6	0.0	9.0	86.2	9.5	9.9	3.7	0.0	0.7	0.1	0.0	4.4	0.0	1.5	0.7	1.9	0.5	0.0	0.5	2.9	0.0	0.3	76.4	0.0	0.0	2.2	0.0	0.0	0.1	0.0	0.1	13.5	8.5	0.1	1.6	86.5	7.9	0.3	0.0	0.0	28.4	3.7	3.7	0.4	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	4.8	4.7	2.4	4.7	3.3	3.7	3.6	4.6	2.2	2.8	2.2	8.8	2.9	3.1	0.0	0.0	0.0	1.1	0.8	0.3	0.0	0.6	0.3	0.5	0.5	215.3	0.0	0.0	3.7	0.0	0.6	2.0	0.0	9.8	0.4	4.7	0.4	3.4	6.4	0.0	7.4	0.3	1.6	1.1	11.1	5.1	0.7	0.0	0.9	2.9	8.5	0.3	0.0	0.2	0.0	0.0	1.3	1.3	1.0	3.7	10.4	1.8	1.0	0.2	3.3	9.2	0.0	0.0	1.2	0.0	6.4	0.0	1.5	0.0	31.0	0.0	1.7	46.0	1.7	51.0	0.8	14.1	0.3	1.1	3.1	0.7	1.0	0.0	0.2
RPRM	"FLJ90327, REPRIMO"	ENSG00000177519	"Reprimo, TP53 dependent G2 arrest mediator homolog"	Q9NS64	2	153477338-153478762	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 13.7;Endometrial stromal cells: 63.3;Fibroblasts: 16.3;Sertoli cells: 13.1;Theca cells: 50.4"	"Cancer enriched"	"Detected in many"	4	"testis cancer: 28.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HEK 293: 25.9;MCF7: 29.8;NTERA-2: 20.5;SCLC-21H: 7.5;SH-SY5Y: 8.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (6.66e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.72e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.11e-1)"		"unprognostic (1.62e-2)"	"unprognostic (5.19e-1)"	"unprognostic (5.51e-2)"	"unprognostic (3.09e-3)"	"unprognostic (2.58e-1)"	"unprognostic (6.19e-2)"	"unprognostic (6.38e-4)"	"unprognostic (5.21e-2)"	"unprognostic (1.25e-2)"	"unprognostic (8.61e-2)"	2.7	16.4	12.6	0.1	8.4	0.0	0.4	2.5	8.1	18.8	10.4	11.2	0.1	23.0	2.0	0.5	4.0	0.0	0.2	6.1	23.1	0.8	0.0	0.7	0.0	9.6	7.8	8.4	18.0	0.0	1.0	19.8	0.1	6.3	12.8	0.4	1.3	11.3	6.5	0.2	0.9	0.6	12.3	4.4	2.0	9.4	1.1	7.3	0.1	1.2	0.2	0.1	3.1	3.2	6.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.1	0.0	0.0	0.0	25.9	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	29.8	0.0	0.0	20.5	0.0	1.1	0.0	0.0	0.1	0.0	0.2	7.5	8.5	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	12.6	8.4	2.5	8.1	6.1	23.1	9.6	7.8	8.4	6.3	4.4	7.3	6.6	0.9	3.2	0.0	0.0	0.0	0.1	0.8	1.3	1.2	7.8	0.8	2.2	0.5	2.8	1.6	1.8	0.0	0.3	0.0	0.0	13.7	0.0	0.5	2.2	63.3	0.9	1.8	0.0	3.2	1.7	0.4	16.3	1.1	1.0	0.0	2.9	0.0	0.0	0.6	0.0	3.1	0.0	10.2	0.0	0.3	0.8	0.9	0.5	0.0	1.0	0.0	0.8	0.0	3.0	0.3	0.4	0.0	0.7	0.0	1.6	0.0	0.5	1.1	1.8	13.1	0.7	4.0	0.6	5.2	2.2	0.3	0.8	0.3	50.4	0.0	1.4
S100Z	"Gm625, S100-zeta"	ENSG00000171643	"S100 calcium binding protein Z"	Q8WXG8	5	76850001-76921650	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 2.4;lymphoid tissue: 3.2"	"Cell type enhanced"	"Detected in some"		"Hofbauer cells: 7.4;Kupffer cells: 8.7;Macrophages: 11.8;Microglial cells: 32.8;monocytes: 26.1"	"Cancer enriched"	"Detected in single"	4	"testis cancer: 1.1"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	6	"classical monocyte: 35.0;eosinophil: 31.8;intermediate monocyte: 34.0;myeloid DC: 19.5;neutrophil: 11.8;non-classical monocyte: 39.6"	"Group enriched"	"Detected in many"	6	"dendritic cells: 19.5;granulocytes: 31.8;monocytes: 39.6"	"Cell line enriched"	"Detected in some"	6	"U-698: 81.9"	"Region enriched"	"Detected in single"	5	"olfactory bulb: 1.3"	"Low region specificity"	"Detected in all"			HPA051929	Approved		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Centrosome, Cytosol"	Nucleoplasm	"HPA051929: AB_2732571"	"unprognostic (4.17e-3)"	"unprognostic (4.10e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.61e-4)"	"unprognostic (1.86e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.31e-1)"	"unprognostic (8.89e-2)"	"unprognostic (2.17e-1)"	"unprognostic (3.54e-3)"	"unprognostic (1.32e-1)"	"unprognostic (9.47e-5)"	"unprognostic (3.39e-4)"	"unprognostic (8.94e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.62e-1)"	0.3	0.2	1.0	2.0	0.7	2.4	0.2	0.4	0.9	0.0	0.2	0.3	0.4	0.1	0.1	0.3	0.1	0.7	0.1	0.5	1.0	0.1	0.3	0.7	0.9	0.5	0.5	0.5	0.0	0.9	0.1	0.1	1.2	0.7	0.2	0.5	0.0	0.2	0.1	0.2	0.0	0.8	0.6	0.7	3.2	0.4	0.2	0.9	0.8	0.1	0.0	2.5	0.5	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.1	0.0	0.0	0.0	2.7	0.1	0.2	0.1	0.0	0.0	0.0	14.5	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	1.2	0.1	0.0	0.1	1.0	0.1	81.9	3.3	0.0	0.0	2.5	35.0	31.8	0.8	34.0	0.2	4.7	0.5	0.1	19.5	2.1	0.0	0.0	11.8	0.7	39.6	0.1	0.7	10.5	1.0	0.7	0.4	0.9	0.5	1.0	0.5	0.5	0.5	0.7	0.7	0.9	0.7	0.2	0.0	0.0	0.3	2.7	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	2.1	2.1	0.0	0.2	0.2	0.5	0.2	0.0	0.5	0.4	0.0	7.4	0.0	2.0	0.0	0.0	8.7	1.1	0.0	0.0	11.8	3.6	32.8	26.1	0.0	0.0	0.5	0.7	0.0	0.0	0.0	3.3	0.0	0.0	0.1	0.7	0.0	0.0	0.2	0.0	0.0	0.9	0.0	0.0	0.1	1.4	0.0	0.0	0.0
STAR	STARD1	ENSG00000147465	"Steroidogenic acute regulatory protein"	P49675	8	38142700-38150992	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Lipid transport, Steroidogenesis, Transport"		"Congenital adrenal hyperplasia, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"adrenal gland: 5115.5"	"Cell type enriched"	"Detected in some"	44	"Theca cells: 2243.4"	"Group enriched"	"Detected in some"	4	"head and neck cancer: 1.0;lung cancer: 0.8;ovarian cancer: 1.4;testis cancer: 3.0"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	7	"basophil: 2.4"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 2.4"	"Cell line enriched"	"Detected in some"	5	"K-562: 436.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA023644, HPA027318, CAB032598"	Enhanced					NA	NA					"CAB032598: AB_2115937, HPA023644: AB_10598916, HPA027318: AB_10601574"	"unprognostic (1.60e-4)"	"unprognostic (3.20e-2)"	"unprognostic (9.17e-2)"	"unprognostic (3.28e-2)"	"unprognostic (9.22e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.96e-2)"	"unprognostic (2.12e-5)"	"unprognostic (3.30e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.77e-3)"	"unprognostic (6.65e-2)"	"unprognostic (4.75e-9)"	"unprognostic (1.58e-1)"	"unprognostic (1.33e-1)"	"unprognostic (9.48e-2)"	"unprognostic (6.16e-2)"	1.7	5115.5	2.3	3.2	1.9	2.1	0.4	1.7	3.4	0.7	0.8	0.4	0.2	0.5	0.6	2.2	6.4	0.2	0.7	1.5	3.8	0.4	1.2	0.5	1.0	3.6	2.6	2.0	501.3	0.9	0.0	2.2	0.5	4.6	0.5	0.1	0.6	1.8	0.3	0.4	4.5	0.6	0.4	1.6	1.0	0.7	89.0	3.2	3.1	0.4	0.0	1.9	0.5	3.3	3.6	0.1	0.0	0.8	0.2	0.3	3.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.7	0.1	0.1	0.0	0.1	0.1	0.5	0.0	0.1	0.0	88.9	0.8	5.3	1.3	3.8	0.1	12.4	0.3	0.1	0.1	0.8	0.0	0.3	436.1	0.2	0.0	0.0	0.4	43.7	9.6	0.1	0.1	0.0	0.0	0.0	0.0	0.2	1.2	1.2	0.2	0.0	0.2	0.0	0.1	43.0	1.5	0.1	0.0	0.2	0.1	0.2	0.2	0.0	0.3	9.3	0.2	2.4	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.3	0.1	0.0	0.0	0.2	0.0	2.3	1.9	1.7	3.4	1.5	3.8	3.6	2.6	2.0	4.6	1.6	3.2	3.6	0.0	0.0	0.0	0.7	0.1	9.4	0.7	0.8	4.0	1.1	0.1	1.1	0.6	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.1	1.9	10.7	0.6	0.0	0.0	1.4	0.0	0.0	25.7	0.0	0.3	0.0	1.4	0.0	0.0	0.2	0.0	2.8	0.0	0.0	0.0	0.7	10.2	50.1	0.2	3.6	0.0	0.0	0.6	0.0	0.5	0.3	0.1	0.0	4.1	0.0	0.2	0.0	0.0	0.4	0.6	0.0	0.2	3.0	4.8	0.8	1.7	11.2	0.1	0.1	2243.4	0.0	0.1
SUN3	"MGC33329, SUNC1"	ENSG00000164744	"Sad1 and UNC84 domain containing 3"	Q8TAQ9	7	47987148-48029119	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	126	"testis: 42.0"	"Cell type enriched"	"Detected in some"	7	"Early spermatids: 582.2"	"Cancer enriched"	"Detected in single"	4	"testis cancer: 2.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"GAMG: 7.0;U-2 OS: 20.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA008344, HPA076890"	Enhanced		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA008344: AB_1857656, HPA076890: "	"unprognostic (5.11e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.61e-4)"	"unprognostic (2.31e-2)"	"unprognostic (5.62e-2)"	"unprognostic (1.35e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.59e-5)"	"unprognostic (4.88e-1)"	"unprognostic (1.47e-1)"		"unprognostic (2.65e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.64e-1)"	"unprognostic (3.48e-1)"	"unprognostic (2.58e-1)"	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.1	0.0	3.1	0.1	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.6	0.0	0.3	0.0	1.3	20.6	0.0	0.0	0.7	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.1	0.2	0.1	0.0	0.1	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.5	0.1	0.1	1.9	0.0	582.2	0.1	0.0	0.1	0.0	0.0	3.6	0.0	25.5	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.9	0.0	3.4	0.0	0.0	0.0	0.0	79.3	2.1	0.3	0.0	1.0	0.1	0.0	0.0	1.0	0.4	0.2	0.1	1.5	0.1	0.0	0.0	0.6	0.0	0.0	6.6	0.0	0.2	19.1	7.1	0.0	0.0	0.8	0.2	0.0	0.0	0.0
TAL2	bHLHa19	ENSG00000186051	"TAL bHLH transcription factor 2"	Q16559	9	105662457-105663124	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"skeletal muscle: 13.8"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 4.2;Distal tubular cells: 7.9;Enteroendocrine cells: 3.5;Muller glia cells: 2.7;Proximal tubular cells: 2.3"	"Group enriched"	"Detected in some"	4	"renal cancer: 1.6;testis cancer: 0.6"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"memory B-cell: 6.9;naive B-cell: 7.3"	"Lineage enriched"	"Detected in many"	4	"B-cells: 7.3"	"Cell line enhanced"	"Detected in some"		"CACO-2: 2.1;HAP1: 2.9;K-562: 8.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA030886	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA030886: AB_10601596"	"unprognostic (3.89e-2)"	"unprognostic (1.45e-1)"	"unprognostic (8.51e-2)"	"unprognostic (5.54e-2)"	"unprognostic (2.24e-1)"	"unprognostic (9.06e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.70e-3)"	"unprognostic (2.63e-1)"	"unprognostic (7.00e-4)"	"unprognostic (2.84e-2)"	"prognostic favorable (2.69e-4)"	"unprognostic (2.70e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.39e-2)"	0.1	0.2	0.7	0.1	0.6	0.0	0.1	0.5	0.9	0.2	1.2	0.1	0.0	0.2	0.6	0.1	0.2	0.0	0.2	0.6	0.6	3.1	0.2	0.1	0.2	0.6	0.7	0.4	0.3	0.1	0.0	0.4	0.1	0.7	0.1	0.1	0.5	0.1	0.1	13.8	0.1	0.1	0.0	0.6	0.2	0.1	0.3	0.5	0.1	0.1	2.4	0.3	0.1	0.1	0.8	0.0	0.4	1.5	0.4	0.1	0.0	0.1	0.1	0.1	0.1	0.2	2.1	0.1	0.0	0.1	0.0	0.4	0.0	2.9	0.0	0.1	0.4	0.3	0.7	0.0	0.0	0.1	0.3	1.1	0.1	0.3	0.1	0.1	0.1	0.0	0.5	8.2	0.2	0.2	0.2	0.5	0.4	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.7	0.7	0.1	0.1	0.1	0.0	0.2	1.3	0.3	0.2	0.4	0.4	0.6	0.6	1.2	0.0	0.1	1.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.2	0.0	1.6	0.0	0.1	0.7	0.6	0.5	0.9	0.6	0.6	0.6	0.7	0.4	0.7	0.6	0.5	0.8	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	1.0	0.4	0.1	0.2	0.0	0.0	0.0	4.2	0.0	0.1	0.0	7.9	0.1	0.1	0.0	0.2	0.0	3.5	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	2.7	0.0	0.0	0.2	0.2	0.0	0.4	0.1	0.0	0.0	2.3	0.0	1.0	0.0	0.8	0.1	0.6	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0
TDGF1	"CR, CR-1, CRIPTO, Cripto-1"	ENSG00000241186	"Teratocarcinoma-derived growth factor 1"	P13385	3	46574534-46582457	"Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 8.6;lymphoid tissue: 21.1"	"Cell type enriched"	"Detected in some"	6	"Distal tubular cells: 121.3"	"Cancer enriched"	"Detected in many"	4	"testis cancer: 27.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 25.7;NTERA-2: 110.6;SuSa: 66.3"	"Group enriched"	"Detected in many"	5	"cerebellum: 11.2;pons and medulla: 8.7"	"Low region specificity"	"Detected in single"			HPA051928			Uncertain	Vesicles,Cytosol	"Secreted in other tissues"	NA	NA			Vesicles	Cytosol	"HPA051928: "	"unprognostic (7.84e-3)"	"unprognostic (2.00e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.61e-1)"	"unprognostic (1.72e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.74e-1)"	"unprognostic (8.76e-3)"	"unprognostic (2.01e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.05e-1)"	0.3	3.4	2.2	0.5	1.8	0.4	0.3	1.9	3.1	0.7	1.3	2.6	0.7	1.1	2.1	0.1	0.1	0.7	0.4	2.1	1.7	8.6	1.3	0.4	0.4	2.3	1.7	1.4	7.8	0.4	0.1	0.1	0.2	2.4	0.4	4.6	0.4	1.0	0.3	1.5	0.3	0.5	1.2	1.6	21.1	2.7	0.6	3.3	15.2	0.8	1.5	0.1	0.2	0.1	1.9	0.1	0.2	0.1	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.4	0.2	0.1	0.1	0.1	0.0	1.8	0.0	0.2	0.0	0.0	25.7	0.2	1.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.1	0.2	110.6	4.0	0.0	0.2	0.2	0.0	0.0	0.2	0.1	0.1	0.0	0.1	0.0	66.3	0.1	0.1	1.8	0.2	0.1	0.2	0.1	0.2	0.0	0.0	0.1	0.0	0.2	0.7	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.1	0.9	0.3	0.1	0.1	0.0	0.0	2.2	1.8	1.9	3.1	2.1	1.7	2.3	1.7	1.4	2.4	1.6	3.3	1.9	0.9	0.0	0.0	0.0	0.5	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	5.5	0.0	0.0	0.0	0.9	121.3	0.2	5.0	0.3	0.1	8.2	2.4	0.0	0.0	0.0	0.0	0.3	8.2	0.2	0.0	14.3	0.4	1.4	0.1	0.0	0.0	5.5	0.0	0.0	0.0	1.0	0.3	0.1	0.0	2.8	0.0	0.0	0.0	0.0	0.1	0.0	3.1	0.0	0.0	0.0	0.3	0.6	0.0	0.2	0.0	0.1	0.3	0.1	0.3	0.0	0.0	0.0	0.1	17.7	6.1	0.0
TIFAB		ENSG00000255833	"TIFA inhibitor"	Q6ZNK6	5	135444226-135452351	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 5.7"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 8.0;Early spermatids: 4.2;Hofbauer cells: 4.0;Langerhans cells: 17.6;Late spermatids: 9.2;monocytes: 4.6"	"Cancer enriched"	"Detected in single"	4	"testis cancer: 0.8"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"myeloid DC: 4.5;plasmacytoid DC: 13.9"	"Lineage enriched"	"Detected in many"	11	"dendritic cells: 13.9"	"Cell line enriched"	"Detected in some"	5	"THP-1: 9.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA049372	Uncertain					NA	NA					"HPA049372: AB_2680733"	"unprognostic (1.33e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.98e-5)"	"unprognostic (3.87e-1)"	"unprognostic (3.25e-3)"	"unprognostic (5.29e-2)"	"unprognostic (1.09e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.94e-1)"	"unprognostic (9.01e-2)"	0.1	0.0	0.0	3.7	0.0	0.5	0.2	0.0	0.0	0.1	0.0	0.9	1.0	0.1	0.0	0.5	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.5	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.2	0.0	0.0	0.9	1.1	0.2	0.1	2.7	0.7	0.3	0.0	1.9	0.0	0.0	4.9	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.5	0.0	0.0	1.2	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	13.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	17.6	9.2	0.0	2.2	0.0	0.0	4.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TMEM132C	"DKFZp761O2018, PPP1R152"	ENSG00000181234	"Transmembrane protein 132C"	Q8N3T6	12	128267403-128707915	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 31.9"	"Group enriched"	"Detected in some"	4	"Inhibitory neurons: 217.3;Microglial cells: 160.2;Oligodendrocyte precursor cells: 580.6"	"Group enriched"	"Detected in some"	4	"glioma: 1.6;ovarian cancer: 4.6;testis cancer: 4.8"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	19	"gdT-cell: 1.9"	"Lineage enriched"	"Detected in single"	19	"T-cells: 1.9"	"Group enriched"	"Detected in some"	7	"AF22: 3.7;ASC diff: 5.2;Daudi: 6.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015633, HPA015984"			Approved	Centrosome,Cytosol		NA	NA		78000000	"Centrosome, Cytosol"		"HPA015633: AB_1858089, HPA015984: AB_1858088"	"unprognostic (2.29e-2)"	"unprognostic (5.55e-3)"	"unprognostic (7.34e-2)"	"unprognostic (8.60e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.99e-3)"		"unprognostic (5.48e-2)"		"unprognostic (1.30e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.85e-2)"	"unprognostic (6.29e-2)"	"unprognostic (7.97e-3)"	"unprognostic (2.54e-1)"	"unprognostic (5.71e-2)"	"unprognostic (6.33e-3)"	31.9	2.7	9.0	0.3	7.2	0.1	14.1	6.5	7.4	16.9	13.6	1.3	0.3	5.5	3.8	3.1	11.9	1.1	2.8	6.4	7.0	0.4	0.1	1.5	1.1	9.1	13.6	6.0	8.7	2.7	0.1	0.7	2.5	8.7	2.4	0.4	3.7	1.7	4.1	0.5	1.9	1.8	1.0	6.7	0.3	1.3	1.3	9.4	1.0	0.9	3.4	0.4	4.8	9.3	8.5	0.0	0.0	3.7	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	7.2	6.5	7.4	6.4	7.0	9.1	13.6	6.0	8.7	6.7	9.4	8.5	1.9	0.0	0.0	70.2	0.0	0.4	0.0	0.0	0.0	18.6	0.0	0.0	1.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	1.1	0.2	7.6	26.1	1.0	0.0	0.0	32.2	0.0	0.0	6.3	0.0	9.8	0.0	3.7	0.0	0.0	0.1	0.0	217.3	0.1	0.0	0.0	1.1	0.2	9.0	0.1	1.8	160.2	0.0	0.4	0.0	580.6	42.3	0.1	0.0	15.1	0.0	0.0	0.1	0.1	0.0	2.3	0.0	0.8	2.5	0.1	0.4	0.1	0.0	0.0	0.3	0.0	0.1	0.0
TMEM179	"C14orf90, FLJ42486, TMEM179A"	ENSG00000258986	"Transmembrane protein 179"	Q6ZVK1	14	104474678-104605647	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 28.7;pituitary gland: 88.8"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 58.1;Horizontal cells: 65.6"	"Group enriched"	"Detected in some"	4	"glioma: 2.7;pancreatic cancer: 3.1;testis cancer: 2.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 8.8;SCLC-21H: 37.3;SH-SY5Y: 11.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002942			Uncertain	Mitochondria		NA	NA			Mitochondria		"HPA002942: AB_1078113"	"unprognostic (8.65e-2)"	"unprognostic (8.24e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.08e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.82e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.89e-4)"	"unprognostic (8.68e-3)"	"unprognostic (1.56e-1)"	"unprognostic (9.71e-6)"	"unprognostic (1.70e-2)"	0.2	11.5	15.1	0.4	17.8	0.0	0.1	10.2	28.7	0.0	3.2	3.1	0.2	0.1	0.4	0.1	0.3	0.1	0.7	16.4	20.6	0.5	0.5	0.1	0.0	25.6	22.8	17.5	0.1	4.0	0.1	88.8	0.8	25.7	0.8	0.2	6.3	0.1	0.1	0.1	0.0	1.5	0.3	9.5	0.0	1.3	5.2	19.0	0.0	0.1	0.0	0.0	0.1	0.8	26.7	0.0	0.5	0.3	0.8	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	8.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	37.3	11.6	0.0	0.3	0.0	0.1	0.8	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.1	17.8	10.2	28.7	16.4	20.6	25.6	22.8	17.5	25.7	9.5	19.0	26.7	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	58.1	0.0	0.0	1.2	0.0	0.0	0.0	4.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	12.0	0.0	0.0	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.1	65.6	12.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.0	0.0	1.5	0.0	7.5	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.1	0.7	3.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0
TMSB15A	"TMSL8, TMSNB"	ENSG00000158164	"Thymosin beta 15A"	P0CG34	X	102513682-102516739	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 13.1;prostate: 15.9"	"Cell type enhanced"	"Detected in some"		"Breast myoepithelial cells: 12.8;Granulosa cells: 25.9;Prostatic glandular cells: 13.8;Smooth muscle cells: 13.5;Spermatogonia: 19.8"	"Group enriched"	"Detected in many"	4	"glioma: 20.1;prostate cancer: 56.4;testis cancer: 14.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 571.5;HAP1: 110.2;MOLT-4: 113.4;NTERA-2: 148.0;RH-30: 259.9;SH-SY5Y: 148.1"					"Low region specificity"	"Detected in all"									NA	NA		130000				"unprognostic (5.33e-3)"	"unprognostic (3.09e-2)"	"unprognostic (1.70e-2)"	"unprognostic (5.82e-3)"	"unprognostic (1.34e-1)"	"unprognostic (4.03e-2)"	"unprognostic (5.65e-2)"	"unprognostic (1.34e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.53e-1)"	"unprognostic (3.18e-3)"	"unprognostic (2.96e-4)"	"unprognostic (2.14e-1)"	"unprognostic (7.83e-2)"	"unprognostic (2.07e-1)"	1.0	1.0	1.0	1.1	1.2	1.0	5.1	1.7	2.1	4.7	1.2	1.0	0.4	5.1	0.7	0.3	1.9	1.2	1.3	1.1	1.2	2.4	0.2	7.1	4.1	1.2	1.1	1.1	4.8	0.9	0.8	0.8	0.5	1.3	15.9	1.1	1.4	4.0	1.3	0.3	0.5	0.6	2.4	1.0	0.4	0.5	4.8	1.1	13.1	6.0	0.3	2.8	0.7	2.3	1.4	0.1	0.0	571.5	107.7	2.4	0.3	0.2	12.4	0.7	1.7	4.8	0.0	0.7	0.0	1.3	2.1	28.5	0.0	110.2	0.7	1.2	0.0	5.6	10.3	1.7	0.3	0.3	0.2	10.1	1.4	0.0	1.1	0.0	14.3	6.7	5.5	1.0	0.0	41.2	0.1	113.4	0.2	148.0	0.0	1.4	0.2	259.9	0.0	11.7	0.2	98.1	148.1	14.0	0.9	0.3	22.0	1.4	3.2	2.4	0.3	62.6	1.4	10.5	11.8	2.1	0.0	6.7	0.0	25.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.1	1.0	1.2	1.7	2.1	1.1	1.2	1.2	1.1	1.1	1.3	1.0	1.1	1.4	1.4	0.0	0.0	0.0	0.0	0.8	0.9	0.1	1.8	0.3	7.3	12.8	0.1	0.0	0.0	0.0	0.0	0.5	0.5	0.5	0.0	0.5	0.3	0.5	5.6	1.2	0.0	0.8	0.0	0.0	0.5	4.6	0.0	1.2	0.0	25.9	2.5	0.0	0.5	0.0	0.0	0.6	0.0	0.6	0.5	0.1	0.3	0.1	1.8	0.0	0.0	0.7	1.0	0.5	0.0	0.0	0.1	2.6	0.3	13.8	0.1	0.4	0.0	0.1	6.6	1.2	13.5	3.4	19.8	1.8	0.0	0.3	0.7	0.9	0.9	1.0
UMODL1		ENSG00000177398	"Uromodulin like 1"	Q5DID0	21	42062959-42143453	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 1.3;fallopian tube: 1.1"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 1.4;Early spermatids: 4.3;Endometrial ciliated cells: 3.9;Ionocytes: 2.0;Late spermatids: 2.4;Spermatocytes: 2.1"	"Cancer enriched"	"Detected in some"	4	"testis cancer: 2.9"	"Region enhanced"	"Detected in single"		"cerebral cortex: 1.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"SCLC-21H: 1.6;U-266/70: 3.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA067245	Uncertain					NA	NA					"HPA067245: AB_2685810"	"unprognostic (4.70e-3)"	"unprognostic (3.75e-5)"	"unprognostic (2.18e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.46e-1)"	"unprognostic (4.92e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.72e-7)"	"unprognostic (2.38e-1)"	"unprognostic (9.47e-2)"	"unprognostic (2.63e-2)"	"unprognostic (3.82e-1)"	"unprognostic (9.24e-3)"	"unprognostic (4.37e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.02e-4)"	"unprognostic (2.68e-1)"	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.9	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.3	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.3	3.9	0.1	0.1	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.3	2.0	0.0	0.0	2.4	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.1	2.1	0.1	0.0	0.1	0.0	0.1	0.1	0.3	0.1
ZNF208	"PMIDP, ZNF95"	ENSG00000160321	"Zinc finger protein 208"	O43345	19	21932958-22010949	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 15.4;Late spermatids: 14.1;Oligodendrocytes: 26.3"	"Group enriched"	"Detected in some"	4	"ovarian cancer: 0.6;testis cancer: 1.9;thyroid cancer: 0.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"GAMG: 9.3;NTERA-2: 33.1;SuSa: 6.9;U-266/84: 11.2"									HPA077100			Uncertain	"Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus"	Cytosol	"HPA077100: "	"unprognostic (4.06e-3)"	"unprognostic (2.90e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.75e-1)"	"unprognostic (7.46e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.87e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.66e-1)"	"unprognostic (4.94e-2)"	"unprognostic (7.21e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.73e-3)"	4.2	1.1	4.5	2.0	7.0	1.5	3.4	3.2	4.9	4.1	3.1	3.6	1.4	6.7	4.7	2.3	4.9	3.5	11.5	6.5	7.4	3.4	0.7	1.4	2.8	9.4	7.0	3.6	3.4	2.6	13.4	7.1	2.7	8.6	3.6	1.5	2.4	2.8	3.3	1.0	4.1	2.2	6.0	3.7	2.7	1.7	8.7	6.1	0.5	8.0	1.3	1.7	3.2	2.7	7.5	0.4	0.3	0.5	1.1	0.0	0.2	1.5	0.3	0.1	0.2	0.1	1.8	0.6	0.6	0.3	0.3	9.3	0.7	1.2	0.2	0.4	0.2	0.2	0.6	1.5	0.8	0.0	0.4	0.2	1.0	0.3	0.0	0.2	0.7	0.4	0.4	0.5	1.6	0.0	0.5	0.4	0.6	33.1	0.0	1.1	0.2	0.0	1.9	1.1	1.8	0.8	1.6	0.2	0.8	0.3	6.9	0.9	0.8	0.0	0.5	0.3	1.9	0.1	1.0	11.2	0.2	0.1	0.4	0.7	2.4	0.6	0.7	0.8	0.4	0.4	1.3	1.5	0.5	0.3	1.6	0.6	0.9	2.6	1.0	0.3	1.6	1.5	0.3	4.5	7.0	3.2	4.9	6.5	7.4	9.4	7.0	3.6	8.6	3.7	6.1	7.5	6.7	0.0	0.0	11.4	4.3	0.0	1.0	0.0	0.6	6.6	4.2	2.5	11.4	0.0	1.3	5.5	0.0	6.8	0.5	0.0	3.9	6.6	15.4	0.2	3.7	3.4	0.0	1.3	11.5	0.2	3.1	5.9	0.5	0.1	0.0	2.7	1.1	0.5	0.7	3.3	1.7	0.0	0.0	0.0	0.7	14.1	1.5	0.2	0.0	9.4	0.0	0.8	1.0	11.1	26.3	0.7	0.0	1.2	0.4	1.2	0.0	2.6	0.0	0.4	0.0	2.5	1.7	8.7	6.2	0.9	0.3	5.3	2.2	0.3	0.0	2.0
ZNF492	"KIAA1473, ZNF115"	ENSG00000229676	"Zinc finger protein 492"	Q9P255	19	22634324-22667671	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 2.6;testis: 1.9"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 6.9;Granulosa cells: 5.4;Spermatocytes: 8.1;Spermatogonia: 9.1"	"Cancer enriched"	"Detected in some"	4	"testis cancer: 2.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 5.6;HAP1: 3.3;NB-4: 4.3;NTERA-2: 4.1;U-2197: 3.9"															NA	NA						"unprognostic (1.12e-1)"	"unprognostic (1.98e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.24e-3)"	"unprognostic (7.94e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.47e-2)"	"unprognostic (6.75e-2)"	"unprognostic (1.08e-3)"	"unprognostic (5.63e-3)"	"unprognostic (3.31e-1)"	"unprognostic (2.80e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.65e-1)"	"unprognostic (8.93e-2)"	"unprognostic (6.04e-2)"	0.3	0.0	0.3	0.1	0.2	2.6	0.7	0.8	0.6	0.3	0.2	0.2	0.0	0.2	0.1	0.2	0.3	0.1	0.1	0.3	0.1	0.3	0.0	0.1	0.3	0.2	0.2	0.2	0.5	0.2	0.3	0.0	0.2	0.5	0.1	0.3	0.2	0.1	0.1	0.1	0.4	0.1	0.2	0.0	0.2	0.1	1.9	0.1	0.7	0.3	0.1	0.3	0.1	0.1	0.4	0.0	0.0	1.4	0.1	0.0	0.0	5.6	0.9	0.0	0.4	0.5	0.0	0.0	0.0	2.0	0.7	2.4	0.0	3.3	0.0	1.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	1.1	0.0	0.0	0.0	2.2	0.9	0.1	0.0	0.5	0.0	4.3	4.1	0.0	0.1	0.0	0.0	0.6	0.5	1.0	0.0	2.3	0.0	0.0	0.3	0.9	1.7	1.5	0.0	0.0	2.1	3.9	0.1	0.0	0.0	2.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.5	0.1	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.3	0.2	0.8	0.6	0.3	0.1	0.2	0.2	0.2	0.5	0.0	0.1	0.4	0.9	0.0	3.8	1.3	1.0	0.5	1.2	0.0	1.8	1.8	1.0	1.1	1.0	0.0	0.6	0.0	0.0	1.0	0.4	0.2	0.0	0.5	0.7	0.5	1.2	1.3	0.0	6.9	0.3	0.2	2.4	1.1	0.0	0.6	1.3	5.4	1.1	0.1	0.1	3.3	0.2	0.2	0.0	0.3	1.1	0.4	0.9	0.5	0.0	1.9	0.1	1.0	0.0	3.0	0.6	0.2	0.2	0.4	0.0	0.9	0.0	0.0	1.5	2.4	0.0	0.6	1.2	8.1	9.1	0.6	0.6	0.5	0.5	0.8	0.3	0.7
ZNF90	HTF9	ENSG00000213988	"Zinc finger protein 90"	Q03938	19	20077994-20127076	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 217.1;Langerhans cells: 329.2;Smooth muscle cells: 451.1;Suprabasal keratinocytes: 280.3"	"Cancer enriched"	"Detected in many"	4	"testis cancer: 10.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 9.5;NB-4: 7.9;NTERA-2: 17.0;SuSa: 10.5;U-2197: 7.0"									HPA003227	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA003227: AB_1859471"	"unprognostic (4.52e-2)"	"unprognostic (2.64e-3)"	"unprognostic (3.93e-1)"	"unprognostic (2.45e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.71e-3)"	"unprognostic (1.50e-2)"	"unprognostic (7.34e-3)"	"unprognostic (4.95e-1)"	"unprognostic (4.44e-3)"	"unprognostic (2.28e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.18e-4)"	"unprognostic (2.79e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.10e-2)"	"unprognostic (2.60e-2)"	0.3	0.2	0.1	0.6	0.3	0.6	0.5	0.8	0.2	0.8	0.1	0.5	0.2	0.9	0.6	0.4	0.8	0.3	0.2	0.1	0.6	0.3	0.1	0.7	1.2	0.2	0.2	0.0	1.5	0.9	1.8	0.3	1.3	0.3	0.6	0.7	0.0	0.3	1.4	0.2	1.1	0.6	0.6	0.1	0.5	0.8	0.6	0.3	0.8	1.9	0.0	0.8	1.0	0.7	0.3	0.0	0.0	3.7	9.5	0.0	0.0	0.0	0.9	0.3	3.3	4.0	3.2	2.3	1.3	1.7	0.6	2.5	1.1	0.0	0.5	5.7	0.0	0.9	0.0	0.0	0.5	0.3	0.0	0.0	0.3	0.0	3.1	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	1.8	7.9	17.0	0.0	0.0	0.0	3.1	0.4	2.3	3.3	0.0	3.9	0.0	1.4	0.2	10.5	1.8	0.0	0.0	1.0	0.0	7.0	3.7	0.0	1.5	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.8	0.2	0.1	0.6	0.2	0.2	0.0	0.3	0.1	0.3	0.3	2.2	6.4	8.4	1.0	31.7	217.1	112.5	32.7	2.8	0.6	7.8	6.6	1.9	50.1	16.7	7.3	2.1	87.5	25.1	4.8	17.6	2.3	8.2	1.9	4.9	28.8	8.5	26.7	0.5	2.0	99.1	27.6	1.5	4.5	1.3	9.3	54.3	57.1	47.8	0.0	0.7	16.9	14.2	107.1	329.2	24.2	60.9	14.9	124.5	5.6	34.6	2.2	44.3	1.5	2.9	1.2	12.3	34.6	1.8	87.8	8.4	14.0	8.6	2.5	19.7	45.2	451.1	8.6	16.7	1.9	280.3	81.5	40.1	16.0	19.0	66.4
ZNF98	"F7175, ZNF739"	ENSG00000197360	"Zinc finger protein 98"	A6NK75	19	22391019-22532485	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"ovary: 12.0;pancreas: 37.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 34.0;Distal tubular cells: 15.6;Early spermatids: 14.7;Granulosa cells: 12.9;Oligodendrocyte precursor cells: 10.6;Spermatocytes: 15.7;Spermatogonia: 21.1"	"Cancer enriched"	"Detected in some"	4	"testis cancer: 2.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.8;GAMG: 5.4;NB-4: 4.8;RPMI-8226: 1.9;SuSa: 2.1;T-47d: 3.4;U-2197: 3.6"															NA	NA						"unprognostic (1.11e-1)"			"unprognostic (1.31e-2)"	"unprognostic (6.95e-3)"	"unprognostic (1.36e-3)"	"unprognostic (3.07e-3)"	"unprognostic (1.56e-1)"		"unprognostic (7.20e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.81e-2)"	"unprognostic (1.99e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.66e-1)"	"unprognostic (7.56e-2)"	1.0	0.6	1.3	0.2	4.1	0.2	3.8	0.8	10.4	3.4	0.0	0.2	0.1	1.2	5.7	0.2	2.2	0.4	0.6	2.8	3.7	2.1	0.0	0.2	0.4	2.3	2.4	0.9	12.0	37.5	3.9	0.3	0.5	2.7	0.8	0.1	0.7	0.8	0.6	0.0	0.1	0.1	1.3	0.2	0.2	0.3	7.6	1.4	0.0	4.7	0.2	0.0	0.5	0.2	6.0	0.0	0.0	0.1	0.0	0.0	0.0	1.8	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.8	0.0	5.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.2	0.1	4.8	1.0	0.0	0.2	0.3	0.0	1.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.1	3.4	1.1	0.0	0.0	0.3	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.3	4.1	0.8	10.4	2.8	3.7	2.3	2.4	0.9	2.7	0.2	1.4	6.0	1.2	0.0	0.0	34.0	0.1	0.0	0.4	0.0	0.0	1.4	2.9	2.5	1.2	0.0	0.0	0.0	0.0	0.9	0.0	0.0	15.6	3.1	14.7	0.3	1.6	0.4	0.0	0.0	2.5	1.4	0.4	1.2	0.0	0.5	0.0	12.9	0.0	0.0	0.1	1.7	0.5	0.0	0.0	0.0	0.0	3.5	1.2	0.1	0.0	1.9	0.0	1.0	0.0	10.6	5.2	0.3	0.0	1.9	0.0	0.1	0.0	1.7	0.0	0.1	0.0	0.0	1.0	15.7	21.1	0.0	0.0	0.4	0.0	8.2	0.0	0.4
ABCC12	MRP9	ENSG00000140798	"ATP binding cassette subfamily C member 12"	Q96J65	16	48081006-48156018	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	6	"testis: 2.9"	"Group enriched"	"Detected in some"	4	"Early spermatids: 4.4;Excitatory neurons: 5.1;Late spermatids: 2.2;Spermatocytes: 6.0;Theca cells: 3.1"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA043100	Uncertain					NA	NA					"HPA043100: AB_10794922"	"unprognostic (1.53e-1)"			"unprognostic (6.87e-2)"	"unprognostic (2.37e-2)"			"unprognostic (4.62e-3)"		"unprognostic (1.88e-1)"		"unprognostic (1.59e-2)"		"unprognostic (2.65e-1)"	"unprognostic (7.53e-2)"	"unprognostic (4.23e-1)"		0.0	0.0	0.3	0.0	0.3	0.0	0.3	0.3	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.2	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	2.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.4	0.4	0.3	0.2	0.2	0.3	0.3	0.3	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.0	0.9	0.0	0.0	0.0	0.0	3.1	0.0	0.0
ACVR2B	ActR-IIB	ENSG00000114739	"Activin A receptor type 2B"	Q13705	3	38453890-38493142	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"		"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant, Heterotaxy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Cancer enhanced"	"Detected in all"		"testis cancer: 5.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 20.9;NTERA-2: 25.9;SuSa: 14.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025115, HPA040384"	Approved					NA	No					"CAB025115: , HPA040384: AB_2732484"	"unprognostic (5.11e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.47e-1)"	"unprognostic (8.73e-2)"	"unprognostic (9.24e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.53e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.08e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.83e-1)"	"unprognostic (4.75e-1)"	1.0	2.9	3.0	0.6	3.0	0.2	1.7	5.3	2.8	1.7	0.9	1.4	0.9	1.7	1.7	0.7	1.9	0.6	1.4	2.6	2.8	1.8	2.2	1.3	0.7	2.6	3.1	2.7	2.9	2.5	3.3	2.0	2.6	3.3	1.3	1.1	6.6	1.7	1.3	6.1	0.7	1.1	0.9	2.4	1.1	1.5	2.6	2.8	4.1	1.6	2.8	0.6	1.5	1.4	3.7	1.1	1.8	20.9	1.8	0.8	0.5	11.2	0.4	0.7	0.4	0.9	3.1	1.4	0.1	1.6	0.5	0.6	1.3	8.1	1.3	1.1	3.2	5.2	5.6	3.5	4.6	1.0	4.0	2.0	0.8	1.2	0.6	2.3	1.3	1.4	8.0	9.4	1.8	0.4	1.7	6.9	2.5	25.9	1.1	0.9	2.2	7.0	1.4	1.3	2.6	4.9	8.5	0.6	3.2	3.0	14.7	1.7	5.2	1.2	0.7	3.3	0.5	1.8	5.0	7.3	1.2	0.7	3.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	3.0	3.0	5.3	2.8	2.6	2.8	2.6	3.1	2.7	3.3	2.4	2.8	3.7	7.0	6.4	6.1	9.4	0.7	4.0	4.6	2.1	4.0	23.0	5.2	5.0	15.0	2.8	3.6	0.0	22.9	8.5	1.3	3.1	0.0	3.6	11.3	8.7	7.0	7.5	7.2	0.4	12.6	3.8	7.6	3.8	2.6	5.3	1.3	17.9	7.9	8.7	2.6	21.9	17.0	4.1	0.0	2.2	6.4	15.8	11.8	2.4	7.2	5.6	0.7	7.6	0.0	15.1	17.2	3.2	5.3	7.9	1.4	5.2	4.8	3.1	7.1	25.4	0.0	9.7	7.7	11.4	17.9	1.8	4.0	6.2	2.6	7.4	4.4	3.9
ADAMDEC1	M12.219	ENSG00000134028	"ADAM like decysin 1"	O15204	8	24384285-24406013	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"intestine: 428.4"	"Cell type enhanced"	"Detected in some"		"Hofbauer cells: 14.8;Kupffer cells: 12.9;Macrophages: 25.5;monocytes: 5.2"	"Cancer enhanced"	"Detected in all"		"testis cancer: 16.7"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 1.9"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	8	"U-266/70: 10.7;U-266/84: 2.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted in other tissues"	NA	NA		28000000				"unprognostic (1.17e-2)"	"unprognostic (1.80e-2)"	"unprognostic (4.15e-3)"	"unprognostic (3.60e-1)"	"unprognostic (6.21e-2)"	"unprognostic (3.84e-3)"	"unprognostic (2.12e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.61e-1)"	"unprognostic (5.99e-3)"	"unprognostic (2.79e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.35e-2)"	"unprognostic (3.66e-2)"	"unprognostic (8.23e-2)"	0.5	0.5	0.1	52.6	0.0	0.3	0.6	0.0	0.8	0.4	0.0	217.4	191.1	0.9	0.2	0.9	0.1	3.2	0.4	0.2	0.0	0.2	0.1	1.6	73.9	0.2	0.1	0.0	0.1	0.2	0.0	0.0	7.8	0.4	0.8	314.5	0.0	0.7	0.4	0.0	0.4	428.4	11.7	0.1	5.8	5.9	0.3	0.2	5.7	0.3	0.0	27.4	20.8	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.4	0.0	10.7	2.7	0.0	0.0	0.0	0.0	0.0	0.7	1.9	0.0	0.8	0.0	1.1	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.1	0.0	0.0	0.8	0.2	0.0	0.2	0.1	0.0	0.4	0.1	0.2	0.3	0.0	0.0	0.0	0.0	2.2	0.8	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	14.8	0.0	0.1	0.0	0.0	12.9	2.0	0.0	0.0	25.5	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.1	0.0	0.0	0.0	0.1
ADAMTS19		ENSG00000145808	"ADAM metallopeptidase with thrombospondin type 1 motif 19"		5	129460281-129738683	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"cervix: 10.2;endometrium 1: 9.9;smooth muscle: 6.0"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 82.6;Inhibitory neurons: 79.7;Oligodendrocytes: 31.8"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.7;testis cancer: 1.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"MCF7: 15.9;SH-SY5Y: 34.8"	"Region enriched"	"Detected in single"	5	"olfactory bulb: 2.6"	"Low region specificity"	"Detected in many"			"HPA056171, HPA058438"	Uncertain		Approved	Vesicles,Midbody	"Secreted to extracellular matrix"	Yes	NA			"Vesicles, Midbody"		"HPA056171: AB_2683054, HPA058438: AB_2683718"	"unprognostic (1.14e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.09e-1)"	"unprognostic (6.49e-2)"		"unprognostic (3.93e-2)"		"unprognostic (4.17e-2)"	"unprognostic (5.99e-3)"	"unprognostic (5.17e-1)"		"unprognostic (1.14e-1)"	"unprognostic (5.88e-2)"		"unprognostic (3.06e-2)"	0.0	0.7	0.6	0.0	2.1	0.0	0.0	0.0	1.7	10.2	0.1	0.2	0.1	9.9	0.0	0.2	0.2	0.0	0.2	0.8	0.4	0.3	0.0	0.0	0.0	0.8	0.5	1.2	0.4	0.0	0.1	0.0	3.8	1.3	0.1	0.3	0.5	0.3	0.0	0.5	0.0	0.1	6.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.3	0.1	1.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	15.9	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	34.8	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	2.1	0.0	1.7	0.8	0.4	0.8	0.5	1.2	1.3	0.0	0.3	1.1	0.1	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.6	0.1	0.1	0.0	1.4	0.0	0.0	1.8	0.0	15.6	0.0	0.3	0.0	0.0	1.5	0.5	8.9	0.2	0.0	0.0	82.6	0.2	0.7	1.0	0.0	0.7	0.0	0.0	0.0	0.0	1.7	0.0	79.7	0.1	0.0	0.0	0.3	0.7	0.0	0.1	0.0	1.0	0.0	1.1	0.0	12.5	31.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.2	0.4	0.1	0.1	0.0	5.2	0.1	0.1	0.3	0.0
AEN	"FLJ12484, FLJ12562, ISG20L1"	ENSG00000181026	"Apoptosis enhancing nuclease"	Q8WTP8	15	88621337-88632281	"Predicted intracellular proteins"	"Apoptosis, DNA damage"	"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 62.7"	"Cancer enhanced"	"Detected in all"		"testis cancer: 38.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048599			Supported	"Nucleoplasm,Nuclear membrane,Nucleoli"		NA	NA			"Nucleoplasm, Nucleoli"	"Nuclear membrane"	"HPA048599: AB_2756313"	"unprognostic (8.64e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.16e-2)"	"prognostic favorable (1.72e-4)"	"unprognostic (1.52e-2)"	"unprognostic (4.40e-2)"	"unprognostic (4.08e-2)"	"unprognostic (9.42e-2)"	"unprognostic (4.28e-2)"	"unprognostic (1.17e-2)"	"unprognostic (9.00e-2)"	"unprognostic (7.88e-2)"	"unprognostic (8.58e-3)"	"unprognostic (3.39e-2)"	"unprognostic (2.73e-1)"	"unprognostic (8.71e-2)"	"unprognostic (6.10e-2)"	7.0	12.3	6.7	10.8	6.7	17.9	6.0	6.4	6.5	6.8	6.4	8.3	5.1	7.6	9.7	9.7	7.1	12.7	6.4	6.1	10.4	7.0	13.6	10.2	12.9	8.2	7.3	6.2	8.0	21.1	4.5	22.6	7.0	7.4	12.2	8.7	1.0	8.4	8.3	15.2	6.4	9.1	10.2	7.3	15.4	13.3	9.9	8.5	10.8	10.3	3.7	12.0	11.6	6.0	8.0	14.9	64.5	39.6	34.2	17.4	20.7	83.7	51.5	46.8	39.1	47.8	53.8	28.2	63.6	16.1	28.3	35.0	20.9	148.0	42.1	32.6	15.7	58.2	34.0	26.4	89.9	42.0	28.5	32.8	25.6	36.4	48.5	39.7	14.0	33.0	20.6	54.6	35.2	48.3	34.4	35.5	24.0	96.0	30.8	36.9	45.4	28.2	46.9	16.5	31.9	31.1	28.5	20.8	23.7	40.1	90.7	19.7	32.0	29.9	39.5	55.1	16.2	70.5	67.0	48.5	54.7	36.0	31.5	79.1	0.0	2.3	0.8	6.2	3.7	12.0	10.9	10.8	8.4	5.2	10.3	11.6	10.6	0.6	3.9	4.9	3.1	19.6	9.2	6.7	6.7	6.4	6.5	6.1	10.4	8.2	7.3	6.2	7.4	7.3	8.5	8.0	6.9	6.4	8.1	4.2	21.0	18.6	25.8	6.2	12.0	1.2	21.4	15.4	3.9	8.6	12.9	1.8	0.0	4.7	8.4	5.6	3.9	11.4	23.6	22.5	5.3	7.6	9.0	11.8	20.5	7.6	16.3	9.0	11.7	17.7	2.5	12.3	2.5	6.3	4.5	1.7	16.0	9.9	26.4	4.7	26.4	62.7	4.4	7.8	14.2	3.7	14.2	3.1	9.2	9.0	2.5	11.5	6.2	2.6	26.9	27.8	2.3	5.5	5.4	0.9	13.1	12.0	11.6	10.2	18.2	10.9	28.3	6.2	14.9	6.8	9.7	25.4
AICDA	"AID, ARP2, CDA2, HIGM2"	ENSG00000111732	"Activation induced cytidine deaminase"	Q9GZX7	12	8602170-8612867	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"mRNA processing"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"lymphoid tissue: 15.5"	"Cell type enhanced"	"Detected in single"		"Proximal enterocytes: 2.6"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.8"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"memory B-cell: 1.9;naive B-cell: 3.8"	"Lineage enriched"	"Detected in single"	6	"B-cells: 3.8"	"Group enriched"	"Detected in some"	7	"Daudi: 142.5;U-698: 118.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"									NA	NA						"unprognostic (2.71e-2)"	"unprognostic (1.39e-2)"		"unprognostic (7.76e-2)"	"unprognostic (1.68e-1)"	"unprognostic (8.73e-3)"		"unprognostic (1.11e-1)"	"unprognostic (4.05e-2)"	"unprognostic (9.69e-2)"	"unprognostic (1.96e-2)"		"unprognostic (4.04e-6)"	"unprognostic (8.82e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.21e-1)"	"unprognostic (4.65e-1)"	0.1	0.1	0.4	3.7	0.3	0.6	0.0	1.1	0.6	0.0	0.1	0.2	0.2	0.2	0.2	0.2	0.0	0.5	0.3	0.3	0.1	0.0	0.1	0.2	15.5	0.3	0.2	0.4	0.0	0.1	0.0	0.0	0.3	0.6	0.0	0.1	0.2	0.3	0.0	1.4	0.3	0.8	0.0	0.1	0.7	0.2	0.2	0.2	0.4	0.2	0.0	12.1	0.1	0.1	0.5	0.1	0.0	0.1	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	142.5	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	5.3	0.2	0.1	0.0	2.0	19.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.2	0.2	0.0	0.2	0.2	0.5	0.1	0.2	0.1	0.1	0.0	0.2	0.1	0.1	1.3	0.1	0.1	0.6	0.1	0.4	0.5	0.1	0.0	0.1	118.4	0.0	0.3	0.1	0.5	0.2	0.1	0.1	0.1	0.0	1.9	0.1	0.0	0.1	3.8	0.1	0.1	0.6	0.1	0.1	0.2	0.1	0.2	0.4	0.3	1.1	0.6	0.3	0.1	0.3	0.2	0.4	0.6	0.1	0.2	0.5	0.2	0.0	0.6	0.0	0.9	0.3	0.6	0.0	0.0	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.6	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.8	0.1	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	2.6	0.2	0.0	0.7	0.0	0.8	0.1	0.0	0.4	0.0	0.1	0.0	0.3	0.0	0.1	0.3
AKAP12	"AKAP250, SSeCKS"	ENSG00000131016	"A-kinase anchoring protein 12"	Q02952	6	151239967-151358559	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		Calmodulin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 352.6;Endothelial cells: 278.4;Fibroblasts: 270.0;Muller glia cells: 583.0;Pancreatic endocrine cells: 322.1;Spermatocytes: 325.4"	"Cancer enhanced"	"Detected in all"		"testis cancer: 39.5"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	235	"basophil: 37.2"	"Lineage enriched"	"Detected in single"	235	"granulocytes: 37.2"	"Cell line enhanced"	"Detected in many"		"REH: 193.0;TIME: 188.2;U-251 MG: 202.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006344, CAB026379, HPA056230"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		No	No		10000000	"Plasma membrane, Cytosol"		"CAB026379: , HPA006344: AB_1078118, HPA056230: AB_2683073"	"unprognostic (6.66e-2)"	"unprognostic (1.51e-1)"	"unprognostic (9.90e-3)"	"prognostic unfavorable (7.08e-4)"	"unprognostic (2.61e-2)"	"unprognostic (8.88e-2)"	"unprognostic (5.05e-2)"	"prognostic unfavorable (6.34e-5)"	"unprognostic (1.34e-1)"	"unprognostic (8.26e-3)"	"unprognostic (2.59e-1)"	"unprognostic (4.72e-2)"	"unprognostic (4.51e-3)"	"unprognostic (1.10e-3)"	"unprognostic (3.51e-1)"	"unprognostic (7.03e-3)"	"unprognostic (2.34e-2)"	86.9	16.2	21.8	17.3	18.2	2.2	60.2	101.3	58.6	19.4	6.8	48.7	8.6	31.4	9.4	18.8	31.5	31.7	35.6	15.4	54.6	32.2	30.8	44.7	7.0	59.4	33.9	14.3	88.6	10.9	1.7	23.5	38.6	64.3	23.3	13.3	110.3	6.6	21.0	12.0	8.7	25.1	43.3	11.2	14.5	25.8	100.9	57.4	6.0	22.3	14.6	3.4	33.3	21.4	70.9	7.8	37.8	53.2	0.1	98.2	145.9	18.8	43.9	23.7	19.3	19.4	0.9	141.6	0.0	17.1	33.2	160.4	1.0	102.2	32.5	17.2	50.2	37.6	0.6	40.8	35.6	10.9	0.0	9.6	104.0	0.0	81.9	4.3	25.4	127.8	0.6	9.8	0.9	70.7	0.5	0.3	0.1	33.3	0.1	43.9	193.0	2.3	0.2	110.2	6.3	37.9	22.0	14.1	0.5	24.9	74.6	2.8	0.5	188.2	2.6	34.0	110.4	202.9	0.4	0.1	0.2	63.2	0.1	37.4	37.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.8	18.2	101.3	58.6	15.4	54.6	59.4	33.9	14.3	64.3	11.2	57.4	70.9	352.6	12.8	16.2	34.3	6.8	19.6	19.6	63.2	1.2	14.5	1.2	3.9	12.1	5.7	31.1	51.5	2.1	2.4	0.9	1.2	1.9	107.0	101.4	14.2	195.4	278.4	1.8	3.2	75.8	6.7	10.1	270.0	3.6	31.6	64.2	14.7	194.5	4.8	26.9	0.0	33.3	0.7	4.1	15.7	45.4	116.3	39.7	13.9	58.7	37.5	0.6	583.0	1.0	59.8	5.1	322.1	1.1	110.6	6.7	49.5	0.0	89.4	6.0	31.0	98.6	208.3	243.0	325.4	33.0	1.6	11.4	10.0	5.1	9.3	2.5	105.3
ALPG	"ALPPL2, GCAP"	ENSG00000163286	"Alkaline phosphatase, germ cell"	P10696	2	232406844-232410714	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"endometrial cancer: 49.1;testis cancer: 64.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"CAPAN-2: 33.9;HaCaT: 24.9;SuSa: 38.3"									"CAB020698, HPA038764, HPA038765, HPA051699"	Approved		Approved	"Plasma membrane"	"Intracellular and membrane"	NA	NA			"Plasma membrane"		"CAB020698: , HPA038764: AB_2676194, HPA038765: AB_2676195, HPA051699: AB_2681577"		"unprognostic (1.39e-1)"	"unprognostic (6.63e-3)"	"unprognostic (1.27e-2)"		"unprognostic (2.89e-1)"		"unprognostic (1.46e-1)"		"unprognostic (1.26e-1)"	"unprognostic (1.69e-3)"			"unprognostic (1.65e-1)"	"unprognostic (2.67e-1)"		"unprognostic (6.72e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.1	0.0	0.3	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.7	33.9	0.0	0.0	0.0	0.0	24.9	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	3.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.3	0.0	38.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
ALPL	"HOPS, TNALP, TNAP, TNSALP"	ENSG00000162551	"Alkaline phosphatase, biomineralization associated"	P05186	1	21509397-21578410	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Biomineralization	Hydrolase	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 61.2"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 92.0;Breast myoepithelial cells: 32.4;Glandular and luminal cells: 43.3;Hepatic stellate cells: 40.7;Hepatocytes: 30.1;Proximal tubular cells: 43.9;Rod photoreceptor cells: 34.2"	"Cancer enhanced"	"Detected in all"		"testis cancer: 199.6"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	90	"neutrophil: 379.1"	"Lineage enriched"	"Detected in many"	139	"granulocytes: 379.1"	"Cell line enhanced"	"Detected in many"		"HSkMC: 176.9;hTEC/SVTERT24-B: 141.2;LHCN-M2: 103.7;NTERA-2: 41.2;SCLC-21H: 88.2;SuSa: 48.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007105, HPA008765, CAB020829"	Enhanced		Approved	Cytosol	"Intracellular and membrane"	NA	NA		13000000	Cytosol		"CAB020829: , HPA007105: AB_1078137, HPA008765: AB_1078138"	"unprognostic (3.89e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (7.57e-4)"	"unprognostic (3.05e-3)"	"unprognostic (6.50e-3)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (7.08e-4)"	"unprognostic (1.17e-2)"	"unprognostic (2.48e-3)"	"unprognostic (1.74e-1)"	"unprognostic (7.28e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.27e-1)"	"unprognostic (9.70e-3)"	"unprognostic (2.58e-1)"	23.7	61.2	19.8	28.1	14.6	4.3	23.1	16.2	26.0	2.9	23.6	3.7	2.6	5.9	1.3	4.2	10.4	3.9	16.0	15.7	16.5	46.1	56.7	55.3	6.4	20.7	16.0	14.1	2.8	3.9	3.3	9.4	3.1	19.9	7.1	1.6	18.9	6.5	9.3	1.1	4.1	7.6	3.5	16.1	45.8	4.7	4.2	19.8	1.6	8.7	5.7	5.9	9.8	3.4	18.4	0.0	0.2	5.2	0.2	0.8	6.6	11.4	0.4	2.4	0.9	1.5	1.0	0.0	2.4	7.7	0.0	0.1	0.1	31.3	0.2	0.6	0.0	2.1	0.0	3.5	3.9	1.8	0.0	0.7	176.9	0.0	141.2	0.5	0.0	0.0	0.0	0.2	0.0	103.7	0.0	0.1	0.0	41.2	0.2	0.0	0.0	3.8	0.2	0.1	0.0	88.2	1.2	0.0	0.1	0.3	48.1	0.2	0.0	0.0	5.2	4.3	0.1	0.0	0.3	0.0	0.1	0.9	0.0	0.8	0.0	0.0	4.2	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.5	0.0	0.0	379.1	0.0	0.0	0.0	0.0	0.1	19.8	14.6	16.2	26.0	15.7	16.5	20.7	16.0	14.1	19.9	16.1	19.8	18.4	25.9	3.2	92.0	0.3	3.8	0.1	0.6	8.2	0.6	2.5	6.6	32.4	2.1	2.8	17.6	0.0	0.0	0.1	0.1	0.0	7.9	0.0	1.4	15.0	2.2	26.5	0.0	5.7	0.9	0.0	0.3	6.8	0.0	43.3	7.6	10.6	40.7	30.1	0.1	1.7	0.3	0.0	12.2	1.6	0.3	8.5	0.3	1.0	0.0	18.7	0.0	6.0	0.0	6.0	0.2	0.0	0.0	0.0	0.3	1.7	0.0	43.9	3.6	34.2	0.0	0.3	5.1	0.4	14.0	0.2	0.4	1.5	1.0	8.0	0.0	0.3
ALX4	"FPP, KIAA1788, PFM, PFM2"	ENSG00000052850	"ALX homeobox 4"	Q9H161	11	44260440-44310139	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Craniosynostosis, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"breast: 1.9;choroid plexus: 1.9"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 20.4;Fibroblasts: 4.3;Leydig cells: 4.7;Microglial cells: 6.5;Skeletal myocytes: 5.5"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 4.0;BJ: 3.4;HAP1: 4.7;HEK 293: 4.8;HEL: 6.8;K-562: 3.2;SiHa: 7.0"	"Region enriched"	"Detected in some"	8	"olfactory bulb: 9.0"	"Region enriched"	"Detected in single"	31	"olfactory bulb: 9.0"	HPA001903			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA001903: AB_2666495"	"unprognostic (7.56e-5)"	"unprognostic (1.69e-1)"	"unprognostic (5.40e-2)"	"unprognostic (2.74e-1)"	"unprognostic (7.24e-3)"	"unprognostic (2.63e-4)"	"unprognostic (1.95e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.33e-4)"	"unprognostic (5.13e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.34e-6)"	"unprognostic (3.62e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.02e-3)"	"unprognostic (2.03e-1)"	0.4	0.0	0.4	0.0	0.1	0.0	1.9	0.1	0.5	0.5	1.9	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.5	0.0	0.0	0.7	0.0	1.0	0.8	0.0	0.3	0.1	0.0	0.0	0.5	0.1	0.0	0.1	0.6	0.0	0.0	0.0	0.2	0.0	0.5	0.0	4.0	0.0	0.0	0.0	3.4	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	4.7	0.0	0.0	1.0	4.8	6.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.5	0.2	0.0	0.2	0.5	0.0	0.1	0.1	0.1	0.2	0.4	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	1.1	1.3	20.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.3	0.6	4.7	0.1	0.0	6.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1
AMHR2	"MISR2, MISRII"	ENSG00000135409	"Anti-Mullerian hormone receptor type 2"	Q16671	12	53423855-53431672	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Disease variant, Pseudohermaphroditism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 41.8;ovary: 33.4"	"Group enriched"	"Detected in some"	4	"granulocytes: 26.0;Granulosa cells: 36.1;Theca cells: 94.9"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	19	"HEL: 40.1;K-562: 22.2"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in single"	11	"hippocampal formation: 9.4"	"HPA060228, HPA069636"			Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			Vesicles	"Nucleoplasm, Cytosol"	"HPA060228: AB_2684227, HPA069636: AB_2686163"	"unprognostic (5.79e-2)"	"unprognostic (3.65e-1)"	"unprognostic (3.98e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.61e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.91e-1)"	"unprognostic (4.98e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.15e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.97e-1)"	0.3	41.8	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.3	0.4	0.1	0.5	0.0	0.2	0.0	0.9	0.4	0.0	0.0	0.0	0.0	33.4	12.6	0.4	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	4.2	0.1	0.1	0.0	0.0	5.8	0.7	9.2	0.3	0.0	0.0	1.8	0.0	0.2	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.6	40.1	0.0	0.8	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	22.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.9	3.5	2.6	0.0	0.1	1.5	0.0	4.2	0.1	2.1	0.1	2.7	0.0	0.1	26.0	36.1	11.4	0.3	0.1	0.0	0.0	0.0	0.0	1.2	0.0	2.5	5.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	4.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.1	0.3	0.0	0.0	0.3	0.8	94.9	0.1	0.0
ANGPTL6	"AGF, ARP5"	ENSG00000130812	"Angiopoietin like 6"	Q8NI99	19	10092338-10102796	"Plasma proteins, Predicted secreted proteins"	"Angiogenesis, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"liver: 30.4"	"Cell type enhanced"	"Detected in some"		"B-cells: 4.1;Hepatic stellate cells: 5.7;Hepatocytes: 8.2;Smooth muscle cells: 15.8;Spermatogonia: 6.3"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"HMC-1: 58.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"								"Secreted to blood"	NA	NA	450000	23000000				"unprognostic (1.28e-1)"	"unprognostic (2.18e-6)"	"unprognostic (1.42e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.02e-2)"	"unprognostic (8.77e-2)"	"unprognostic (5.25e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.26e-10)"	"unprognostic (8.96e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.32e-1)"	0.3	0.3	1.7	2.1	0.9	2.9	0.3	1.0	1.1	0.2	0.4	0.5	0.7	0.1	0.2	0.3	0.7	0.4	0.1	0.8	1.2	0.3	30.4	0.5	3.4	1.7	1.0	0.7	0.3	1.1	0.1	0.4	2.2	1.4	0.2	0.4	0.1	0.2	0.0	0.0	0.3	3.6	0.2	1.5	3.4	1.6	1.6	1.3	0.8	0.3	0.0	3.3	0.5	0.2	3.1	0.3	0.0	0.0	0.1	0.1	0.0	0.4	0.2	0.1	0.0	0.2	0.0	0.1	7.8	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	2.0	0.2	0.2	0.0	0.5	58.9	0.0	0.2	0.1	0.1	0.3	0.0	0.6	0.4	0.3	0.0	0.0	1.3	4.7	0.2	0.4	1.1	0.2	0.0	0.2	0.0	0.0	0.1	0.2	0.3	0.0	0.5	0.0	0.0	5.0	0.0	0.1	0.1	0.0	0.0	5.1	1.4	2.9	0.2	0.7	0.7	0.0	0.3	0.0	0.6	0.4	0.4	0.7	0.4	0.4	0.1	0.9	0.2	0.4	0.0	0.4	0.2	0.1	0.5	0.2	1.7	0.9	1.0	1.1	0.8	1.2	1.7	1.0	0.7	1.4	1.5	1.3	3.1	0.3	0.0	0.0	0.0	4.1	0.3	0.1	0.4	0.0	0.1	0.4	0.3	0.4	2.8	0.3	0.0	0.0	0.2	1.7	0.1	1.9	0.3	0.3	0.0	0.3	0.2	0.0	0.4	0.9	0.0	0.2	2.5	0.5	0.1	0.0	0.1	5.7	8.2	2.3	0.0	0.6	0.0	0.0	0.0	0.3	0.4	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.0	0.0	2.1	0.0	0.2	0.5	0.2	0.2	0.0	0.1	15.8	0.5	6.3	0.0	0.0	0.3	1.0	0.9	0.1	0.1
ANKRD2	ARPP	ENSG00000165887	"Ankyrin repeat domain 2"	Q9GZV1	10	97572499-97583884	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 238.3;skeletal muscle: 989.2;tongue: 831.1"	"Cell type enriched"	"Detected in some"	6	"Cardiomyocytes: 218.3"	"Cancer enhanced"	"Detected in many"		"renal cancer: 4.9;testis cancer: 5.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 17.6;BJ hTERT+ SV40 Large T+: 7.3;HaCaT: 13.0;RPTEC TERT1: 17.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA040842, HPA040884"	Enhanced		Enhanced	Vesicles		NA	NA		110000	Vesicles		"HPA040842: AB_10963794, HPA040884: AB_10969453"	"unprognostic (1.27e-2)"	"unprognostic (9.99e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.53e-1)"	"unprognostic (5.60e-3)"	"unprognostic (2.17e-1)"	"unprognostic (3.12e-1)"	"unprognostic (4.91e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.05e-2)"	"unprognostic (3.69e-3)"	"unprognostic (4.56e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.13e-1)"	0.4	0.8	2.6	0.1	2.4	0.0	0.5	2.6	3.8	0.2	2.0	0.2	0.0	0.3	0.3	1.0	0.1	0.3	238.3	2.5	2.7	5.6	0.3	0.8	0.2	2.6	2.5	2.4	0.1	0.9	0.0	0.6	0.0	2.6	2.9	0.0	0.3	3.4	1.0	989.2	1.9	0.2	0.2	2.2	0.1	0.2	0.5	2.9	0.0	0.5	831.1	0.1	0.1	0.4	3.1	17.6	5.4	0.0	0.0	0.2	0.0	0.4	0.9	0.0	7.3	4.7	0.3	5.3	0.0	0.6	0.2	0.4	13.0	0.0	4.7	5.0	0.2	0.2	0.0	0.3	0.0	0.5	0.0	0.0	0.8	2.1	4.3	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	17.4	0.8	0.0	0.0	0.0	4.4	0.0	0.4	2.1	0.3	0.0	0.1	1.5	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.6	2.4	2.6	3.8	2.5	2.7	2.6	2.5	2.4	2.6	2.2	2.9	3.1	0.1	0.0	0.0	1.3	0.0	0.1	0.7	1.7	1.2	0.0	0.2	0.4	218.3	2.8	0.2	3.7	0.0	0.2	0.0	0.0	31.3	1.2	0.6	0.1	0.3	1.6	0.0	0.0	1.3	0.2	0.4	1.0	0.0	0.1	0.0	0.7	0.4	0.2	0.1	0.0	1.5	0.0	0.0	0.0	0.4	0.2	0.0	0.3	0.0	0.0	1.6	0.0	0.0	0.5	0.4	0.9	0.0	1.9	0.0	0.1	0.0	19.1	0.0	0.1	0.0	13.6	1.1	2.5	3.5	0.6	0.3	0.3	0.2	0.1	0.0	0.5
ANKRD7	TSA806	ENSG00000106013	"Ankyrin repeat domain 7"	Q92527	7	118214669-118496171	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	431	"testis: 867.8"	"Group enriched"	"Detected in some"	61	"Early spermatids: 3367.0;Late spermatids: 861.1;Spermatocytes: 3073.6"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.9"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 4.3;JURKAT: 4.6;SCLC-21H: 7.8;U-266/70: 9.8;WM-115: 3.1"									"HPA043489, HPA052941"			Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA043489: AB_10959304, HPA052941: "	"unprognostic (1.29e-1)"	"unprognostic (7.22e-4)"		"unprognostic (3.13e-3)"	"unprognostic (6.16e-2)"	"unprognostic (8.49e-2)"		"unprognostic (1.69e-1)"	"unprognostic (5.51e-1)"	"unprognostic (9.46e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.63e-3)"	"unprognostic (1.45e-2)"	"unprognostic (1.55e-2)"	"unprognostic (3.35e-2)"	"unprognostic (3.57e-4)"	"unprognostic (3.32e-2)"	0.1	0.5	0.2	0.1	0.4	0.0	0.5	0.0	0.7	0.3	0.1	0.2	0.5	0.1	2.0	0.1	0.4	0.1	0.3	0.4	1.4	0.7	0.2	0.1	0.2	0.7	0.6	0.4	0.3	0.7	0.1	0.7	0.0	1.0	0.6	0.1	0.3	0.1	0.1	0.3	0.1	0.2	0.2	0.0	0.2	0.1	867.8	0.7	0.1	0.9	0.1	0.2	0.1	0.1	0.9	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	4.3	1.2	0.0	2.3	0.0	0.0	0.2	0.1	1.2	0.8	0.0	0.0	0.0	1.4	0.0	0.0	1.7	0.3	0.5	0.0	0.3	0.0	4.6	0.0	1.7	1.1	0.0	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	2.0	0.0	0.0	1.5	0.0	0.0	1.0	0.3	0.0	0.8	0.2	0.0	9.8	0.5	0.4	1.4	0.0	3.1	0.0	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.4	0.0	0.7	0.4	1.4	0.7	0.6	0.4	1.0	0.0	0.7	0.9	0.3	0.0	0.0	0.3	0.3	0.0	0.3	0.4	0.0	0.9	0.1	0.3	0.5	1.5	0.1	0.0	0.0	0.1	0.0	0.1	5.9	0.2	3367.0	0.5	0.3	1.6	0.0	0.4	2.8	0.2	0.1	0.2	0.0	0.0	0.0	1.2	0.4	0.0	0.1	3.3	2.8	0.0	0.0	0.0	0.0	861.1	39.4	2.7	1.8	1.0	0.0	1.8	0.0	0.0	1.0	0.1	0.0	29.3	0.1	0.1	0.0	2.0	0.2	0.0	26.3	0.2	0.2	3073.6	29.9	0.0	0.1	0.0	0.1	2.5	0.0	0.1
ANO2	"C12orf3, TMEM16B"	ENSG00000047617	"Anoctamin 2"	Q9NQ90	12	5531869-5946232	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	22	"retina: 228.0"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 81.3;Early spermatids: 57.3;Late spermatids: 283.2;Microglial cells: 143.4;Rod photoreceptor cells: 179.9"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.4"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	5	"basophil: 1.8"	"Lineage enriched"	"Detected in single"	19	"granulocytes: 1.8"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 9.6;HUVEC TERT2: 9.5;U-2 OS: 24.1"	"Region enriched"	"Detected in many"	4	"basal ganglia: 19.6"					"HPA036276, HPA057499"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA036276: AB_10670713, HPA057499: AB_2732613"	"unprognostic (6.32e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.77e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.05e-3)"	"unprognostic (2.86e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.84e-3)"	"unprognostic (3.78e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.10e-2)"	"unprognostic (9.93e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.17e-1)"	7.2	0.4	4.0	0.4	3.8	0.0	6.6	2.3	3.7	4.2	5.8	1.9	0.7	1.8	1.5	1.7	3.2	1.1	6.9	2.5	2.6	1.1	0.2	7.2	0.1	3.2	4.6	1.5	1.5	0.9	1.3	0.7	4.1	3.5	2.5	0.6	228.0	1.3	1.0	2.0	1.1	1.8	1.5	2.8	3.4	2.2	10.2	3.8	0.3	2.4	4.4	0.2	2.4	3.6	4.2	2.5	0.0	4.4	0.0	0.0	0.2	2.0	0.0	9.6	0.5	1.0	0.0	0.2	0.2	0.3	0.0	0.1	0.3	0.0	0.1	0.7	0.3	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	9.5	0.0	0.0	1.9	0.0	1.0	0.0	0.0	4.6	2.3	0.0	1.9	0.0	1.0	0.1	0.1	0.0	0.0	2.3	1.6	0.0	3.9	1.3	0.0	0.2	0.0	24.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	4.0	3.8	2.3	3.7	2.5	2.6	3.2	4.6	1.5	3.5	2.8	3.8	4.2	9.7	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.6	11.5	0.3	0.1	1.9	0.0	0.0	0.0	81.3	1.4	0.0	0.0	0.0	0.0	57.3	0.4	0.4	9.1	0.0	0.0	1.7	0.0	2.0	0.3	0.0	0.5	0.0	0.0	4.6	0.0	0.2	10.1	2.0	0.0	0.0	0.0	0.0	283.2	0.3	0.1	0.0	143.4	0.0	13.0	0.0	31.2	9.9	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.0	179.9	0.0	1.3	0.6	1.4	1.8	0.0	0.1	2.5	0.0	0.2	0.2	0.0
AOC2	"DAO2, RAO"	ENSG00000131480	"Amine oxidase copper containing 2"	O75106	17	42844580-42850707	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Catecholamine metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	5	"Early spermatids: 29.5"	"Cancer enhanced"	"Detected in some"		"testis cancer: 3.8"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	5	"neutrophil: 1.1"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 1.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 11.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA057779	Uncertain				"Intracellular and membrane"	NA	NA					"HPA057779: "	"unprognostic (3.79e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.10e-4)"	"unprognostic (1.90e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.42e-1)"	"unprognostic (4.63e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.64e-2)"	"unprognostic (2.16e-2)"	"unprognostic (8.27e-3)"	"unprognostic (4.55e-5)"	"unprognostic (3.55e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.63e-2)"	"prognostic favorable (2.47e-4)"	5.9	1.1	2.0	0.6	2.2	0.9	2.6	2.1	2.9	1.3	1.0	1.1	0.3	1.0	0.5	0.7	1.6	0.7	0.6	2.6	1.9	1.2	3.4	2.3	0.5	2.3	1.8	2.3	1.1	0.7	0.2	2.0	0.4	2.8	1.5	0.2	1.5	0.6	0.5	1.6	1.3	0.8	0.6	1.4	1.7	0.8	4.9	2.1	0.3	0.9	0.6	0.6	1.8	1.2	2.8	0.2	2.3	0.5	2.5	11.2	1.1	6.0	0.8	0.7	1.6	2.2	1.8	0.2	0.9	1.1	0.2	0.7	1.0	2.2	0.6	3.2	2.0	6.0	0.3	1.3	1.9	0.7	0.3	2.2	1.7	2.0	1.5	2.3	0.4	0.4	3.1	0.6	2.1	0.4	0.3	0.5	0.9	0.8	0.2	0.7	1.1	2.3	1.9	0.3	3.6	0.8	0.5	0.1	0.8	3.4	4.6	0.4	0.2	0.4	1.5	3.2	2.0	1.0	4.6	4.9	0.9	0.4	2.2	0.8	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	2.0	2.2	2.1	2.9	2.6	1.9	2.3	1.8	2.3	2.8	1.4	2.1	2.8	1.1	0.0	0.5	1.6	0.3	1.0	0.5	0.1	0.0	0.5	0.9	0.9	0.4	0.0	0.7	0.0	2.1	0.1	0.4	0.0	0.0	0.3	29.5	1.4	0.7	1.4	0.0	0.0	1.8	0.4	0.1	0.2	0.0	2.8	0.0	0.5	0.4	0.7	0.1	0.0	1.2	0.2	0.0	0.3	0.6	5.0	0.3	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.2	0.1	0.0	0.0	1.2	0.1	0.2	0.4	0.8	0.0	0.5	1.0	2.3	2.1	0.4	1.6	0.0	0.2	0.4	0.2	0.6
ARID3B	"BDP, DRIL2"	ENSG00000179361	"AT-rich interaction domain 3B"	Q8IVW6	15	74541206-74598131	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 24.8"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 43.8;Early spermatids: 45.4;Glandular and luminal cells: 45.6;Late spermatids: 65.8;Rod photoreceptor cells: 50.8;Syncytiotrophoblasts: 64.0"	"Cancer enhanced"	"Detected in all"		"testis cancer: 10.9"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 87.8;SuSa: 95.4;U-266/70: 53.0"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 28.8"	HPA050320	Enhanced		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA050320: AB_2681085"	"unprognostic (2.97e-1)"	"unprognostic (5.91e-2)"	"unprognostic (6.41e-2)"	"unprognostic (8.15e-2)"	"unprognostic (8.42e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.33e-3)"	"unprognostic (3.95e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.42e-2)"	"unprognostic (4.71e-2)"	"unprognostic (3.52e-2)"	"unprognostic (9.45e-3)"	"unprognostic (2.20e-1)"	2.6	2.4	2.8	6.2	2.2	24.8	2.6	4.5	2.9	2.9	5.5	4.1	4.5	2.3	1.9	6.2	2.6	2.4	2.3	3.0	2.8	3.6	4.1	7.3	7.3	2.8	2.5	1.6	1.5	5.7	1.7	6.3	15.8	3.1	4.7	4.0	18.9	3.8	1.7	3.4	3.1	7.0	1.7	2.0	9.6	7.1	22.3	3.2	6.1	3.9	2.2	6.4	3.2	3.9	2.5	7.6	3.1	40.7	8.9	1.5	0.8	43.8	1.8	2.0	2.5	2.7	49.9	3.6	0.7	2.0	1.9	14.3	9.0	49.8	6.8	2.2	47.7	11.6	29.5	6.0	13.7	1.0	4.7	18.5	1.0	3.0	4.2	4.3	2.0	4.3	11.7	26.1	16.8	0.7	1.8	12.9	15.7	87.8	3.2	2.7	5.7	1.6	12.1	2.4	7.9	10.4	18.4	2.2	4.5	8.8	95.4	5.8	8.5	2.7	3.4	4.3	2.7	5.6	53.0	36.1	5.3	1.8	7.3	1.3	2.6	1.9	7.0	5.0	1.5	3.0	3.1	2.9	3.8	1.4	1.4	2.2	2.9	13.0	4.0	2.0	1.9	4.4	3.4	2.8	2.2	4.5	2.9	3.0	2.8	2.8	2.5	1.6	3.1	2.0	3.2	2.5	3.5	3.2	5.6	10.7	11.8	5.2	5.2	3.5	3.4	23.9	4.4	2.3	1.2	4.3	1.9	0.0	43.8	36.0	10.2	10.2	0.0	2.5	45.4	20.5	4.4	4.8	5.4	9.7	7.3	3.5	20.6	2.3	8.6	45.6	2.5	4.2	4.2	2.5	8.3	11.8	7.8	6.0	0.0	8.7	9.1	65.8	2.8	9.5	3.6	5.6	6.4	5.9	18.6	5.5	7.8	7.6	8.4	3.0	19.2	7.8	7.0	1.7	3.8	50.8	0.0	1.5	1.8	17.2	19.4	10.4	3.3	64.0	12.8	5.5	4.0	8.0
ATG9B	"APG9L2, FLJ14885, NOS3AS, SONE"	ENSG00000181652	"Autophagy related 9B"	Q674R7	7	151012209-151024499	"Metabolic proteins, Predicted membrane proteins, Transporters"	Autophagy			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 8.3;skin 1: 11.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 50.7;Endometrial ciliated cells: 28.6;Late spermatids: 30.3;Respiratory ciliated cells: 25.9;Syncytiotrophoblasts: 115.5"	"Cancer enhanced"	"Detected in many"		"testis cancer: 6.2"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"naive CD4 T-cell: 8.9"	"Lineage enriched"	"Detected in many"	5	"T-cells: 8.9"	"Group enriched"	"Detected in some"	5	"BEWO: 13.0;CAPAN-2: 4.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (1.59e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.03e-2)"	"unprognostic (1.53e-3)"	"unprognostic (1.05e-3)"	"unprognostic (2.79e-3)"	"unprognostic (6.66e-2)"	"unprognostic (2.38e-3)"	"unprognostic (6.76e-2)"	"unprognostic (2.02e-1)"	"unprognostic (5.06e-2)"	"unprognostic (2.08e-6)"	"unprognostic (2.82e-2)"	"unprognostic (2.70e-2)"	"unprognostic (6.34e-2)"	"unprognostic (2.63e-1)"	0.0	0.5	1.7	0.4	1.6	0.2	0.2	0.7	1.0	0.8	0.3	0.0	0.0	0.4	1.1	8.3	1.0	0.2	0.0	0.6	1.7	0.0	0.0	0.2	0.8	1.2	1.4	0.7	0.1	0.0	0.0	1.6	4.1	1.5	0.2	0.0	0.8	0.5	0.0	0.2	11.5	0.0	0.0	1.2	0.1	0.1	2.0	1.5	0.3	0.1	0.0	0.8	0.1	1.6	1.5	0.6	0.0	0.7	0.1	0.0	0.0	13.0	0.0	0.0	0.0	0.0	0.1	4.2	0.3	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.6	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.2	0.0	0.0	0.0	0.6	0.2	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.3	1.5	0.4	0.6	0.0	1.1	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.2	1.1	0.0	1.0	0.9	5.0	1.3	0.0	1.6	8.9	3.4	0.0	0.4	0.1	0.7	5.4	1.4	1.7	1.6	0.7	1.0	0.6	1.7	1.2	1.4	0.7	1.5	1.2	1.5	1.5	0.4	0.0	0.0	0.0	2.8	0.0	0.2	1.9	0.6	4.0	0.7	0.9	1.4	1.5	1.6	0.0	0.0	10.2	1.5	0.3	0.0	0.3	50.7	28.6	3.3	1.1	0.0	0.0	2.7	0.2	2.5	0.5	0.0	15.4	14.7	7.8	2.2	0.0	1.9	0.0	7.7	0.0	4.1	0.3	0.4	30.3	0.6	0.8	0.0	0.0	0.3	0.5	1.0	0.5	0.6	3.8	0.0	0.7	0.4	0.3	0.0	0.1	25.9	0.6	0.0	0.0	0.9	19.8	12.7	0.8	0.3	115.5	4.7	0.1	0.2	1.9
ATP11C	"ATPIG, ATPIQ"	ENSG00000101974	"ATPase phospholipid transporting 11C"	Q8NB49	X	139726346-139945276	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	Translocase	"Disease variant, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 50.2"	"Cell type enhanced"	"Detected in many"		"Spermatocytes: 67.9"	"Cancer enhanced"	"Detected in all"		"testis cancer: 15.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030830	Approved					NA	NA					"HPA030830: AB_10601336"	"unprognostic (8.94e-2)"	"unprognostic (1.00e-2)"	"unprognostic (3.06e-2)"	"unprognostic (3.42e-3)"	"unprognostic (3.08e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.41e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.37e-1)"	"unprognostic (4.80e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.65e-2)"	"unprognostic (9.75e-2)"	"unprognostic (2.73e-1)"	"unprognostic (5.18e-2)"	12.2	7.4	3.8	9.1	4.6	6.1	10.5	3.9	4.7	11.8	9.8	9.0	5.6	12.0	9.4	5.2	10.8	8.5	4.9	3.3	4.9	11.9	50.2	7.3	14.9	5.0	4.9	2.8	12.8	4.9	5.7	3.8	5.4	5.6	9.9	7.2	2.8	6.1	14.7	3.5	5.8	8.7	10.7	4.3	12.3	7.7	9.7	4.7	11.2	6.2	4.4	8.9	13.8	9.4	4.9	16.9	7.1	14.2	23.3	20.7	27.9	18.0	19.7	26.4	15.6	21.5	6.3	13.4	24.0	43.3	28.2	10.3	13.7	34.6	9.0	24.4	22.1	20.2	12.1	15.2	12.3	23.0	21.4	7.4	18.6	5.9	16.9	14.4	17.3	27.3	18.3	14.0	17.9	20.8	9.1	19.7	14.5	24.1	0.1	13.3	19.5	15.3	20.1	13.1	27.6	11.0	18.3	7.8	0.8	10.6	13.3	5.8	11.7	31.0	21.2	6.9	25.9	27.1	5.1	5.4	18.7	9.7	26.3	10.8	2.4	0.4	0.1	0.4	0.3	0.8	0.9	0.4	0.3	0.4	0.9	0.4	0.7	0.9	1.2	0.6	0.7	0.3	0.2	3.8	4.6	3.9	4.7	3.3	4.9	5.0	4.9	2.8	5.6	4.3	4.7	4.9	27.4	16.0	8.4	22.5	14.6	14.5	16.7	6.5	5.7	1.9	8.0	8.9	4.4	2.8	9.2	11.0	0.0	2.3	11.6	7.0	1.9	4.8	13.6	11.5	22.7	32.4	9.1	15.3	1.3	10.1	12.6	17.2	10.7	13.7	9.5	23.6	34.6	46.6	9.4	0.0	26.1	6.4	8.2	37.2	14.4	11.9	14.3	15.3	10.6	45.9	33.9	3.1	7.2	29.1	27.8	7.8	7.2	15.4	13.2	15.8	4.7	7.7	6.8	3.1	0.0	19.3	19.2	67.9	53.1	5.9	13.5	6.7	12.7	11.5	5.2	14.6
ATP12A	"ATP1AL1, H-K-ATPase, HK"	ENSG00000075673	"ATPase H+/K+ transporting non-gastric alpha2 subunit"	P54707	13	24680408-24712472	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Hydrogen ion transport, Ion transport, Potassium transport, Sodium transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"esophagus: 11.3;kidney: 5.5;lymphoid tissue: 14.9;placenta: 5.6;skin 1: 5.8"	"Group enriched"	"Detected in some"	4	"Basal respiratory cells: 75.6;Club cells: 49.2"	"Cancer enhanced"	"Detected in many"		"testis cancer: 12.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	7	"SuSa: 4.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA039526	Approved		Approved	"Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Plasma membrane, Actin filaments"	Cytosol	"HPA039526: AB_10673534"	"unprognostic (8.33e-3)"	"unprognostic (3.58e-2)"	"unprognostic (2.93e-1)"	"unprognostic (5.21e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.21e-2)"		"unprognostic (8.03e-3)"	"unprognostic (2.64e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.39e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.67e-1)"	"unprognostic (6.80e-2)"	"unprognostic (8.22e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	11.3	0.0	0.0	0.0	0.1	0.0	5.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	5.6	0.0	0.2	2.0	0.0	0.1	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.0	14.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.0	0.0	0.0	0.0	75.6	0.0	0.0	0.2	0.3	0.4	0.0	49.2	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.1	0.3	0.5	0.0	0.0	0.0	0.9	0.0	0.0	0.4	0.0	2.2	1.3	0.0	0.0	0.0	0.0	0.0	0.7	0.2	8.2	0.0	0.0	0.1	0.3	0.1	0.0	1.0	0.0	0.0	0.0	1.0	0.6	0.1	1.2	0.0	0.0	0.2	0.0	0.1	13.6	0.0	0.0	0.0	1.8	1.0	1.1	0.0	0.0	0.0	0.1	0.0	0.1	1.3
BHLHA9	BHLHF42	ENSG00000205899	"Basic helix-loop-helix family member a9"	Q7RTU4	17	1270444-1271815	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	13	"brain: 1.6"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"testis cancer: 0.6"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"									NA	NA								"unprognostic (9.27e-2)"							"unprognostic (2.63e-1)"				"unprognostic (2.99e-1)"	"unprognostic (7.74e-2)"			0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.1	0.0	0.0	1.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	1.6	0.5	0.2	1.0	0.3	0.1	1.4	0.0	0.6	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
BRWD3	"FLJ38568, MRX93"	ENSG00000165288	"Bromodomain and WD repeat domain containing 3"	Q6RI45	X	80669503-80809877	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 69.4"	"Cancer enhanced"	"Detected in all"		"testis cancer: 8.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012802	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA012802: AB_2066662"	"unprognostic (1.13e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.85e-1)"	"unprognostic (3.17e-3)"	"unprognostic (7.04e-3)"	"unprognostic (2.00e-1)"	"unprognostic (1.50e-1)"	"unprognostic (7.18e-2)"	"unprognostic (7.44e-2)"	"unprognostic (2.75e-1)"	"unprognostic (7.18e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.41e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.35e-1)"	2.9	2.2	1.7	4.1	2.3	5.2	3.1	5.9	1.9	2.8	1.7	3.0	3.6	3.1	2.5	4.4	3.3	2.4	1.8	1.8	2.2	2.2	3.2	3.4	4.3	1.8	2.6	1.1	4.5	3.1	2.1	3.1	3.6	2.9	2.4	3.3	5.9	3.3	1.9	1.5	6.2	4.1	1.9	2.0	4.0	3.1	4.0	2.2	5.2	3.5	1.7	3.9	2.8	3.5	2.1	4.4	4.6	7.1	4.6	2.8	3.4	5.0	2.5	2.1	3.1	4.2	2.2	5.9	4.7	5.7	2.3	3.8	7.7	10.7	4.2	4.2	4.0	4.5	9.6	7.8	3.3	2.1	5.5	6.2	2.3	2.9	3.5	4.9	4.6	4.8	4.1	7.1	11.5	3.7	0.8	3.3	5.6	10.6	4.8	1.9	2.8	12.2	2.9	3.8	3.7	1.6	4.0	6.1	3.3	2.7	12.9	1.5	5.5	4.4	3.7	4.5	3.4	2.7	5.1	5.7	5.4	3.0	11.0	2.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.4	0.0	0.1	0.1	0.1	0.0	1.7	2.3	5.9	1.9	1.8	2.2	1.8	2.6	1.1	2.9	2.0	2.2	2.1	16.1	12.8	13.4	48.3	14.5	17.5	8.0	8.6	13.6	27.7	9.7	6.2	8.2	15.7	15.4	5.5	16.7	5.7	13.1	13.8	0.0	6.5	2.8	11.5	15.6	13.3	7.2	12.0	47.0	6.0	7.7	10.5	21.9	16.6	11.4	22.4	8.2	5.6	5.5	62.2	54.2	10.8	2.0	13.2	17.7	3.7	9.9	19.7	1.8	45.9	17.5	8.1	6.2	69.4	53.5	8.8	22.4	10.1	13.5	13.0	17.1	4.0	12.7	20.8	6.6	14.3	11.9	6.7	9.6	16.8	20.9	7.7	15.1	12.7	12.1	19.2
BTLA	"BTLA1, CD272"	ENSG00000186265	"B and T lymphocyte associated"	Q7Z6A9	3	112463966-112499472	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"lymphoid tissue: 28.9"	"Cell type enriched"	"Detected in some"	4	"B-cells: 66.2"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"memory B-cell: 65.0;naive B-cell: 96.5;plasmacytoid DC: 24.9"	"Group enriched"	"Detected in many"	4	"B-cells: 96.5;dendritic cells: 24.9"	"Cell line enhanced"	"Detected in single"		"U-698: 2.0"	"Not detected"	"Not detected"							"HPA047211, HPA062029"	Enhanced					NA	NA					"HPA047211: AB_2679983, HPA062029: AB_2684665"	"unprognostic (1.13e-3)"	"unprognostic (2.13e-3)"	"unprognostic (5.79e-4)"	"unprognostic (1.01e-4)"	"unprognostic (7.08e-2)"	"unprognostic (7.74e-6)"	"unprognostic (6.20e-3)"	"unprognostic (7.59e-3)"	"unprognostic (5.98e-2)"	"unprognostic (1.53e-5)"	"unprognostic (2.33e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.57e-5)"	"unprognostic (2.57e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.42e-2)"	0.4	0.3	0.0	11.3	0.0	2.1	2.0	0.1	0.4	0.5	0.1	1.7	1.6	0.3	0.1	0.6	0.3	1.1	0.3	0.1	0.0	0.3	0.6	0.9	26.6	0.1	0.0	0.0	0.1	0.4	0.0	0.0	0.1	0.1	0.4	1.7	0.2	1.4	0.1	0.1	0.1	3.1	0.4	0.0	10.9	3.0	0.1	0.1	7.8	0.3	0.1	28.9	2.0	0.1	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.2	0.1	0.0	11.2	0.0	8.3	65.0	13.6	6.5	4.6	96.5	12.7	12.6	0.5	0.3	0.1	24.9	3.4	6.5	0.0	0.0	0.1	0.4	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.5	0.0	66.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.0	2.3	0.8	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.1	0.0	1.5	1.3	0.0	0.4	0.2	0.1	0.0	0.4	0.0	0.0	1.3	4.7	3.6	0.0	1.6	7.2	0.0	1.9	0.0	0.0	1.0	0.3	0.0	0.0	0.0	15.9	0.0	0.0	0.2	0.7	0.0	0.0	0.3	0.1	0.2	0.3	0.0	0.3	0.1	8.6	0.0	0.0	0.1
C14orf39	SIX6OS1	ENSG00000179008	"Chromosome 14 open reading frame 39"	Q8N1H7	14	60396469-60515543	"Plasma proteins, Predicted intracellular proteins"	"DNA recombination, Meiosis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"pituitary gland: 4.9;salivary gland: 4.7;testis: 10.9"	"Cell type enriched"	"Detected in some"	4	"Spermatocytes: 92.5"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"	"Group enriched"	"Detected in some"	11	"hypothalamus: 2.3;thalamus: 1.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 6.2;JURKAT: 28.3;MOLT-4: 23.9;RH-30: 6.2;U-2 OS: 12.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA059518	Uncertain		Approved	Nucleoplasm,Nucleoli		Yes	No			"Nucleoplasm, Nucleoli"		"HPA059518: AB_2684049"	"unprognostic (6.17e-2)"	"unprognostic (1.73e-3)"		"unprognostic (3.00e-6)"	"unprognostic (2.78e-1)"	"unprognostic (6.97e-2)"		"unprognostic (7.55e-4)"	"unprognostic (2.12e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.78e-1)"		"unprognostic (7.46e-2)"	"unprognostic (4.35e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.09e-1)"	0.2	1.9	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.7	0.4	0.2	0.5	0.0	0.1	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.2	0.0	0.5	4.9	0.0	0.1	1.1	0.0	2.7	4.7	0.1	3.0	0.0	0.1	0.1	0.0	0.0	0.3	10.9	1.7	0.1	0.2	3.7	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.8	6.2	0.0	0.0	0.0	0.0	0.3	4.5	0.0	0.7	0.0	0.1	0.0	28.3	0.0	0.0	2.0	0.0	23.9	0.3	3.0	0.0	1.4	0.0	6.2	0.0	0.4	1.7	0.1	2.6	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	12.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	2.3	0.1	0.0	0.0	0.1	0.0	1.7	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.6	0.5	0.0	0.9	0.0	0.1	0.7	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.2	0.0	0.0	2.8	0.0	0.0	0.3	0.0	0.0	1.3	0.0	0.0	0.0	0.0	3.3	0.9	0.0	0.0	0.0	0.0	6.8	0.3	0.0	0.0	1.0	0.0	12.3	0.0	1.0	0.7	0.0	0.0	0.7	0.0	0.8	0.0	0.0	1.2	1.1	0.0	10.0	0.2	92.5	19.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2
C2CD4C	"FAM148C, KIAA1957, NLF3"	ENSG00000183186	"C2 calcium dependent domain containing 4C"	Q8TF44	19	405445-409147	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 17.5"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 13.2;Excitatory neurons: 3.6;Granulosa cells: 3.7;Hepatic stellate cells: 3.6;Rod photoreceptor cells: 7.6"	"Cancer enhanced"	"Detected in many"		"testis cancer: 7.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 6.4;MCF7: 4.4;NTERA-2: 6.2;SCLC-21H: 11.1;U-2 OS: 6.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA055915	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA055915: AB_2682968"	"unprognostic (1.29e-1)"	"unprognostic (9.43e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.64e-1)"	"unprognostic (9.39e-3)"	"unprognostic (2.14e-1)"	"unprognostic (1.67e-1)"	"unprognostic (9.81e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.43e-2)"	"unprognostic (5.04e-2)"	"unprognostic (5.09e-2)"	"unprognostic (1.74e-1)"	2.9	1.0	8.8	0.3	10.7	0.0	3.1	2.7	17.5	2.8	1.7	1.3	0.4	2.3	0.0	0.7	2.0	2.8	3.0	9.4	13.1	2.4	0.7	1.8	0.1	6.6	6.6	12.7	0.3	1.0	0.1	2.6	0.4	6.4	1.0	0.0	0.8	0.3	0.0	0.9	0.7	1.4	0.1	5.4	1.1	0.8	2.1	10.4	0.1	3.9	0.5	0.0	0.6	1.0	6.7	0.0	0.5	1.5	1.3	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.1	2.0	0.0	0.5	0.0	0.7	2.4	2.4	0.2	0.1	6.4	1.3	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.2	0.0	0.4	0.2	0.0	0.0	4.4	0.0	0.0	6.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	11.1	3.2	1.0	0.0	0.0	0.5	0.2	0.0	0.0	0.1	6.5	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	10.7	2.7	17.5	9.4	13.1	6.6	6.6	12.7	6.4	5.4	10.4	6.7	13.2	0.0	0.0	0.3	0.1	0.3	0.3	0.3	0.0	0.5	0.3	0.1	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.2	1.9	3.0	0.0	3.6	0.4	0.0	0.1	0.0	0.2	0.0	3.7	3.6	0.1	0.0	0.0	3.1	0.0	2.0	0.0	0.4	0.3	0.0	0.0	0.0	1.9	0.0	2.0	0.0	3.0	0.6	0.1	0.0	0.0	0.0	0.6	0.0	0.1	0.0	7.6	0.0	0.4	0.4	0.7	2.2	0.0	0.3	0.0	0.1	0.0	0.0	0.1
C2CD6	"ALS2CR11, FLJ25351"	ENSG00000155754	"C2 calcium dependent domain containing 6"	Q53TS8	2	201487421-201619178	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"testis: 40.2"	"Cell type enriched"	"Detected in some"	21	"Theca cells: 41.0"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 1.9;HSkMC: 2.0;hTEC/SVTERT24-B: 2.0;SCLC-21H: 2.3;THP-1: 2.0;U-2197: 7.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (2.64e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.77e-3)"	"unprognostic (7.13e-6)"	"unprognostic (1.33e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.16e-1)"	"unprognostic (4.81e-2)"	"unprognostic (3.15e-2)"	"unprognostic (6.53e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.10e-1)"	"unprognostic (5.13e-10)"	"unprognostic (1.95e-1)"	"unprognostic (6.35e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.18e-1)"	0.6	0.7	2.3	0.0	2.1	0.0	0.3	2.2	1.0	0.1	0.7	0.1	0.1	0.2	0.1	0.2	0.1	0.4	1.2	0.6	2.0	0.1	0.1	0.3	0.2	4.6	2.5	0.1	0.7	0.0	0.0	0.7	0.1	4.1	0.3	0.0	0.9	0.1	0.1	0.1	0.1	0.1	0.2	5.2	0.1	0.0	40.2	2.9	0.0	0.1	0.0	0.0	0.1	0.1	6.5	0.0	0.0	0.0	0.0	0.2	1.9	0.3	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	2.0	0.0	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.1	0.2	0.1	0.0	2.0	0.0	0.0	0.5	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.3	2.1	2.2	1.0	0.6	2.0	4.6	2.5	0.1	4.1	5.2	2.9	6.5	0.3	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.6	0.0	0.0	0.1	0.1	0.0	1.9	0.0	0.0	0.3	1.4	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	41.0	0.0	0.0
C5orf58		ENSG00000234511	"Chromosome 5 open reading frame 58"	C9J3I9	5	170232447-170252575	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	35	"testis: 218.3"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"testis cancer: 1.3"	"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	12	"U-266/84: 85.6"					"Not detected"	"Not detected"									NA	NA						"unprognostic (9.24e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.61e-2)"	"unprognostic (5.55e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.35e-1)"	"unprognostic (5.33e-6)"	"unprognostic (1.01e-1)"	"unprognostic (5.61e-2)"	"unprognostic (8.48e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.78e-1)"	"unprognostic (3.29e-10)"	"unprognostic (4.83e-3)"	"unprognostic (5.45e-2)"	"unprognostic (3.94e-2)"	"unprognostic (8.27e-2)"	2.6	0.8	0.3	2.7	0.4	6.3	2.5	0.3	2.0	1.2	0.8	0.7	0.6	0.5	0.0	0.4	0.7	1.1	0.8	0.2	0.4	0.5	1.0	5.0	2.2	0.7	0.5	0.0	0.4	0.3	0.0	0.6	1.2	1.2	1.0	0.0	0.0	1.9	0.0	0.5	0.8	1.4	0.0	0.9	3.6	0.6	218.3	0.7	0.0	0.9	0.0	0.1	0.9	1.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	3.5	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	2.9	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	6.9	0.8	0.0	0.0	0.0	0.0	0.0	2.6	85.6	0.0	0.0	1.0	0.0	0.0	0.2	0.5	0.6	0.3	0.4	0.0	0.4	0.6	0.0	0.0	0.3	0.9	1.0	0.6	0.3	0.0	0.0	0.0	0.3	0.4	0.3	2.0	0.2	0.4	0.7	0.5	0.0	1.2	0.9	0.7	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
C6orf163		ENSG00000203872	"Chromosome 6 open reading frame 163"	Q5TEZ5	6	87344813-87365463	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 7.8"	"Group enriched"	"Detected in some"	7	"Early spermatids: 180.7;Late spermatids: 267.1"	"Cancer enhanced"	"Detected in single"		"testis cancer: 1.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in some"			"Region enriched"	"Detected in single"	4	"basal ganglia: 1.5"	"Low region specificity"	"Detected in all"			"HPA044797, HPA052927"	Uncertain		Uncertain	Nucleoplasm		NA	NA			Nucleoplasm		"HPA044797: AB_10962365, HPA052927: AB_2681990"	"unprognostic (4.98e-2)"	"unprognostic (6.42e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.33e-2)"	"unprognostic (4.18e-2)"	"unprognostic (3.49e-2)"	"unprognostic (7.55e-3)"	"unprognostic (3.96e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.95e-2)"	"unprognostic (5.60e-4)"	"unprognostic (6.66e-2)"	"unprognostic (3.77e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.93e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.42e-2)"	0.5	0.6	1.2	0.3	0.9	2.3	0.9	0.6	1.7	0.9	1.2	0.6	0.2	0.9	1.4	0.4	1.5	0.4	0.8	1.3	0.5	0.5	0.7	0.4	0.7	1.0	0.9	0.6	1.2	0.8	0.7	1.2	0.4	1.5	0.9	0.8	1.2	0.9	0.3	1.3	1.6	0.8	0.4	0.0	1.2	0.6	7.8	0.5	0.5	0.8	0.6	0.6	0.5	0.5	1.5	0.0	0.2	1.0	1.6	0.1	1.1	1.3	0.0	0.0	0.2	0.3	0.4	0.3	0.6	0.1	0.1	0.6	0.3	0.4	0.9	0.0	0.6	0.7	0.8	0.4	0.3	0.0	0.4	0.2	0.5	0.5	0.3	0.3	0.4	0.2	0.6	1.3	0.5	0.1	0.2	0.1	0.5	0.2	0.0	0.0	1.4	0.3	0.0	0.7	1.0	0.8	0.4	0.1	0.2	0.5	1.0	0.2	0.4	0.3	0.6	0.5	0.3	0.5	0.2	0.3	0.1	0.0	0.8	0.4	0.2	0.1	0.0	0.4	0.1	0.2	0.2	0.3	0.2	0.1	0.2	0.3	0.3	0.8	0.2	0.2	0.0	0.2	0.1	1.2	0.9	0.6	1.7	1.3	0.5	1.0	0.9	0.6	1.5	0.0	0.5	1.5	0.7	0.0	0.5	28.4	0.4	0.4	0.5	0.5	0.0	0.6	0.5	0.3	2.5	1.5	0.2	0.0	0.0	0.6	0.3	0.6	0.0	0.3	180.7	1.8	1.2	1.3	0.0	1.3	31.4	0.0	0.4	0.5	1.5	0.4	0.0	1.6	0.4	0.5	0.2	0.0	25.1	0.4	0.0	0.8	0.0	267.1	2.5	0.4	1.8	12.2	0.2	0.2	0.0	14.1	16.0	0.1	0.2	1.9	0.5	0.4	0.4	0.5	1.1	0.5	6.6	1.4	0.9	2.3	1.8	0.2	0.1	0.8	0.7	1.6	0.2	0.4
CABYR	"CBP86, CT88, FSP-2"	ENSG00000154040	"Calcium binding tyrosine phosphorylation regulated"	O75952	18	24138987-24161600	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	28	"testis: 305.9"	"Group enriched"	"Detected in many"	18	"Early spermatids: 2505.6;Late spermatids: 3543.7"	"Cancer enhanced"	"Detected in many"		"testis cancer: 8.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"basophil: 4.8;memory B-cell: 4.7;naive B-cell: 5.0;neutrophil: 1.9"	"Group enriched"	"Detected in many"	6	"B-cells: 5.0;granulocytes: 4.8"	"Cell line enhanced"	"Detected in many"		"SiHa: 26.8"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA040703, HPA047801"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA040703: AB_2677087, HPA047801: AB_2680159"	"unprognostic (1.18e-3)"	"unprognostic (4.18e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.65e-1)"	"unprognostic (5.26e-2)"	"unprognostic (9.07e-3)"	"prognostic unfavorable (4.75e-4)"	"unprognostic (1.46e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.37e-2)"	"unprognostic (7.24e-3)"	"unprognostic (1.58e-1)"	"unprognostic (3.21e-4)"	"unprognostic (2.52e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.67e-1)"	1.4	3.4	6.2	1.2	6.7	1.1	5.3	3.8	10.0	6.8	9.4	1.2	1.0	2.9	2.0	1.7	3.7	1.8	0.8	9.8	5.0	0.8	1.1	1.0	1.2	7.1	5.5	6.4	1.8	0.7	0.4	8.3	0.9	8.5	2.4	1.1	5.7	2.1	1.6	1.0	2.1	1.2	3.6	4.8	1.2	1.5	305.9	5.5	1.5	1.0	0.1	1.0	2.4	1.4	11.0	4.9	11.9	3.4	1.7	3.4	9.1	14.7	8.2	5.4	10.2	10.6	2.5	9.2	0.2	6.8	12.6	0.5	4.5	3.4	6.9	10.7	0.6	5.6	0.3	6.9	2.3	4.8	0.4	0.5	11.2	11.1	12.7	3.3	4.8	2.9	0.6	0.0	0.3	2.6	1.4	0.1	0.4	11.3	0.5	7.4	0.7	0.4	0.2	4.2	5.5	7.2	8.3	26.8	5.2	0.5	2.0	11.3	1.2	1.7	0.8	2.3	3.4	0.2	0.3	0.3	0.1	4.7	0.9	0.5	4.8	0.3	0.6	0.2	0.2	0.1	4.7	0.3	0.3	0.1	5.0	0.3	0.6	1.9	0.8	0.4	0.4	0.2	0.4	6.2	6.7	3.8	10.0	9.8	5.0	7.1	5.5	6.4	8.5	4.8	5.5	11.0	1.1	0.0	0.0	1.6	1.0	0.3	0.9	7.2	1.2	2.0	3.1	7.1	0.8	0.0	1.9	0.0	2.1	0.2	0.3	2.2	0.0	0.8	2505.6	76.2	3.3	2.0	0.0	0.4	10.7	0.2	0.5	0.9	0.0	5.1	0.0	0.9	0.4	0.0	0.6	0.0	9.9	1.9	6.1	0.0	0.7	3543.7	23.3	2.4	1.8	2.8	0.0	0.0	1.0	7.5	12.6	0.4	1.3	21.8	0.0	0.1	0.2	0.1	2.8	2.1	19.7	0.7	2.0	166.3	19.1	0.5	0.0	0.0	0.5	0.9	0.4	0.3
CACNA1B	"CACNL1A5, CACNN, Cav2.2"	ENSG00000148408	"Calcium voltage-gated channel subunit alpha1 B"	Q00975	9	137877782-138124624	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Disease variant, Epilepsy, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 12.8;pituitary gland: 6.9;testis: 5.1"	"Group enriched"	"Detected in some"	8	"Excitatory neurons: 388.8;Inhibitory neurons: 330.9"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"SCLC-21H: 19.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022919, HPA044347"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA022919: , HPA044347: AB_10960837"	"unprognostic (1.34e-3)"	"unprognostic (2.70e-2)"	"unprognostic (8.08e-2)"	"unprognostic (2.51e-7)"	"unprognostic (8.10e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.10e-1)"	"unprognostic (2.50e-1)"	"unprognostic (2.36e-2)"	"unprognostic (9.73e-4)"	"unprognostic (5.98e-2)"	"unprognostic (6.63e-6)"	"unprognostic (4.25e-2)"	"unprognostic (4.72e-1)"	"unprognostic (7.77e-3)"	"unprognostic (8.69e-2)"	0.0	2.8	7.9	0.1	9.2	0.0	0.0	1.2	12.8	0.3	0.0	0.3	0.0	0.0	0.6	0.0	3.1	0.4	0.3	5.7	4.0	0.0	0.3	0.0	0.0	1.8	3.6	11.8	0.0	0.4	0.8	6.9	0.0	1.5	0.5	0.1	3.5	0.0	0.4	0.0	0.2	0.2	0.1	0.0	0.0	0.3	5.1	1.7	1.2	0.2	0.0	0.0	0.0	0.1	3.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.5	3.7	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	9.2	1.2	12.8	5.7	4.0	1.8	3.6	11.8	1.5	0.0	1.7	3.1	0.0	0.0	0.0	43.4	0.0	0.0	0.1	0.0	0.0	11.7	0.2	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	3.4	0.0	0.2	0.1	0.0	0.0	388.8	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	6.7	330.9	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	17.8	0.6	1.7	0.0	16.1	10.1	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.2	8.2	9.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0
CACNA1G	"Cav3.1, NBR13"	ENSG00000006283	"Calcium voltage-gated channel subunit alpha1 G"	O43497	17	50560715-50627474	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Disease variant, FDA approved drug targets, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"brain: 38.3"	"Cell type enriched"	"Detected in some"	7	"Bipolar cells: 176.7"	"Cancer enhanced"	"Detected in some"		"glioma: 1.6;testis cancer: 1.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 9.2;GAMG: 3.2;HeLa: 3.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004714	Uncertain					NA	NA					"HPA004714: AB_1078368"	"unprognostic (1.90e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.00e-1)"	"unprognostic (9.89e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.02e-4)"	"unprognostic (1.47e-2)"	"unprognostic (2.16e-2)"	"unprognostic (9.76e-2)"	"unprognostic (4.87e-12)"	"unprognostic (3.34e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.56e-3)"	"unprognostic (6.63e-2)"	0.8	0.2	7.2	0.2	5.6	0.3	1.0	18.9	8.9	9.3	0.0	0.3	0.2	2.9	0.1	0.4	3.5	0.2	1.9	2.8	8.2	0.0	0.0	0.3	0.3	4.4	19.3	2.7	5.4	0.1	0.0	0.2	0.4	6.2	1.1	0.1	8.9	0.3	0.4	0.1	1.4	0.1	0.7	6.1	0.1	0.2	0.6	38.3	0.1	0.3	0.1	0.2	0.1	3.8	6.6	0.0	9.2	2.1	2.4	0.6	0.1	0.1	0.1	0.0	0.0	0.1	1.8	0.2	0.0	0.6	0.1	3.2	0.3	1.1	0.0	0.2	1.1	0.4	0.6	3.2	0.3	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.7	0.5	0.4	1.0	0.8	0.0	0.0	0.1	2.7	1.1	1.8	0.1	0.0	1.5	0.0	0.1	0.2	0.8	2.5	0.3	0.1	0.6	0.0	0.0	0.4	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	7.2	5.6	18.9	8.9	2.8	8.2	4.4	19.3	2.7	6.2	6.1	38.3	6.6	0.2	0.0	0.0	0.3	0.0	1.9	0.2	0.0	0.6	176.7	0.3	0.5	4.5	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	1.6	0.6	11.2	0.6	0.0	0.0	16.0	0.0	0.6	4.5	0.0	0.6	0.0	0.1	0.0	0.0	0.4	5.0	21.5	0.0	0.0	0.0	5.7	0.2	0.0	0.9	3.6	1.0	0.0	2.3	0.0	22.6	0.8	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	5.9	0.0	0.3	3.7	0.7	0.9	0.8	2.8	0.1	0.3	0.0	0.1	0.1
CACNA2D2	KIAA0558	ENSG00000007402	"Calcium voltage-gated channel auxiliary subunit alpha2delta 2"	Q9NY47	3	50362613-50504244	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lung: 49.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 76.9;Alveolar cells type 2: 182.3;Inhibitory neurons: 36.0"	"Cancer enhanced"	"Detected in many"		"testis cancer: 20.4"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	8	"SH-SY5Y: 192.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034771, HPA071829"	Enhanced		Approved	Vesicles		NA	NA		9700000	Vesicles		"HPA034771: AB_10603555, HPA071829: AB_2686454"	"unprognostic (2.06e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.72e-2)"	"prognostic unfavorable (7.62e-5)"	"unprognostic (6.59e-2)"	"unprognostic (6.37e-2)"	"unprognostic (6.91e-2)"	"unprognostic (6.57e-3)"	"unprognostic (4.39e-2)"	"unprognostic (1.17e-1)"	"prognostic favorable (1.21e-4)"	"unprognostic (2.71e-2)"	"unprognostic (1.57e-4)"	"unprognostic (3.03e-1)"	"unprognostic (4.14e-2)"	"unprognostic (3.55e-1)"	"unprognostic (4.22e-2)"	0.9	0.6	5.5	1.3	5.1	1.2	1.2	10.0	5.9	1.3	0.2	1.6	1.2	1.6	0.9	0.6	1.1	0.7	5.7	0.9	11.7	2.3	0.3	49.5	1.3	8.4	8.8	1.5	2.1	4.3	2.5	7.1	1.9	9.8	3.0	1.9	8.7	1.4	1.1	1.9	2.6	1.6	1.2	3.2	1.4	4.1	6.6	9.7	1.0	2.3	1.6	0.5	0.5	0.7	10.2	0.0	0.1	3.0	6.6	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.6	0.0	0.6	0.2	24.8	0.0	0.1	0.1	1.8	0.2	0.2	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.2	0.4	0.0	1.1	0.1	0.2	7.9	0.2	0.5	0.2	0.0	0.7	0.0	0.0	18.6	192.7	0.6	0.4	0.0	5.5	1.5	0.0	0.0	0.1	1.8	0.2	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.7	0.0	0.9	0.7	0.9	0.7	0.0	0.5	1.2	0.7	0.0	0.9	0.0	0.1	1.2	0.4	5.5	5.1	10.0	5.9	0.9	11.7	8.4	8.8	1.5	9.8	3.2	9.7	10.2	0.4	76.9	182.3	4.2	0.4	1.5	0.4	0.0	1.8	21.5	2.5	1.7	4.6	0.0	2.5	1.8	20.9	0.0	6.8	0.8	0.0	0.2	0.7	0.1	0.4	0.6	1.2	2.7	7.8	0.0	0.0	1.5	3.1	0.2	20.3	0.3	0.4	0.0	0.1	0.0	36.0	11.0	0.0	0.0	0.4	4.0	0.3	0.4	0.0	1.9	0.1	4.3	15.5	6.0	0.9	0.4	0.3	1.9	2.9	0.7	0.2	0.7	2.2	9.8	13.1	2.4	2.4	2.6	11.2	0.2	0.6	0.3	2.9	3.4	0.6	0.3
CASTOR2	"GATSL1, GATSL2"	ENSG00000274070	"Cytosolic arginine sensor for mTORC1 subunit 2"	A6NHX0	7	74964705-75031528	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 28.6;skeletal muscle: 49.0;tongue: 26.5"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 1.3;Endometrial ciliated cells: 7.4;Endometrial stromal cells: 2.1;Glandular and luminal cells: 5.1"	"Cancer enhanced"	"Detected in all"		"testis cancer: 11.6"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"A549: 18.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057229	Approved					NA	NA					"HPA057229: AB_2683374"	"unprognostic (1.07e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.03e-1)"	"unprognostic (3.23e-1)"	"unprognostic (1.31e-1)"	"unprognostic (8.28e-2)"	"unprognostic (2.78e-5)"	"unprognostic (1.28e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.35e-2)"	"unprognostic (6.27e-2)"	"unprognostic (9.72e-3)"	"unprognostic (1.11e-1)"	"unprognostic (3.30e-1)"	"unprognostic (2.50e-1)"	"unprognostic (9.20e-3)"	1.5	1.9	19.2	0.7	17.1	4.8	1.2	11.2	23.2	1.2	0.0	1.1	1.7	2.1	1.6	1.4	1.8	1.6	2.8	22.3	12.7	1.2	0.8	1.2	0.6	23.8	18.6	15.8	4.0	3.2	1.7	1.9	2.0	28.6	2.0	0.6	5.3	2.0	2.4	49.0	2.7	1.5	1.8	10.4	0.8	1.0	2.1	18.4	2.1	0.7	26.5	1.1	0.9	1.4	14.6	2.6	18.9	3.5	12.1	6.7	2.1	7.3	2.4	1.5	0.9	1.2	8.8	1.0	0.7	2.0	4.9	2.4	1.2	4.7	1.7	1.2	2.0	3.1	1.5	8.0	15.5	2.6	0.7	2.5	5.8	0.9	2.8	0.3	1.2	3.1	5.8	2.8	1.0	1.1	8.5	3.6	4.1	6.3	7.1	1.7	7.5	3.0	2.5	8.5	4.2	8.8	5.9	3.2	5.4	0.8	4.9	3.9	0.8	3.9	2.0	4.1	5.5	0.9	1.7	3.7	3.3	1.7	2.8	1.1	1.7	0.2	0.8	0.4	0.2	0.3	0.1	0.2	0.3	0.0	0.2	0.2	0.3	1.8	0.3	0.2	0.2	0.7	0.2	19.2	17.1	11.2	23.2	22.3	12.7	23.8	18.6	15.8	28.6	10.4	18.4	14.6	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.8	0.0	0.0	0.0	0.0	0.0	0.2	1.3	0.0	0.0	0.0	0.0	7.4	2.1	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	5.1	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.3	0.3	0.4	0.0	0.0
CBX2	"CDCA6, MGC10561"	ENSG00000173894	"Chromobox 2"	Q14781	17	79778148-79787983	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Differentiation, Sexual differentiation, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Repressor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 7.4;testis: 12.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 32.5;Granulosa cells: 10.4;Late spermatids: 39.1;Spermatogonia: 14.3"	"Cancer enhanced"	"Detected in many"		"testis cancer: 20.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"REH: 96.4;SK-BR-3: 134.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA023083	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA023083: AB_2671063"	"unprognostic (1.37e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.80e-2)"	"unprognostic (1.49e-1)"	"unprognostic (9.72e-2)"	"unprognostic (2.25e-11)"	"unprognostic (1.05e-1)"	"unprognostic (7.77e-2)"	"unprognostic (6.34e-3)"	"unprognostic (1.86e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.25e-8)"	"unprognostic (1.34e-1)"	"unprognostic (3.33e-2)"	"unprognostic (2.37e-3)"	"unprognostic (2.07e-1)"	1.3	0.3	1.1	0.8	0.9	2.2	1.2	0.7	0.9	1.1	0.6	0.5	0.4	1.2	1.8	4.2	1.0	0.6	1.6	0.7	0.7	0.7	0.4	1.2	1.3	1.0	0.8	0.6	2.1	1.4	0.5	0.2	2.2	1.0	0.6	0.2	0.5	0.9	0.5	0.7	2.0	0.7	0.7	0.7	1.6	0.5	12.9	1.0	7.4	0.5	1.1	1.4	1.0	1.6	1.0	7.5	20.5	37.0	67.4	0.4	0.5	13.2	2.7	1.2	1.3	2.4	21.2	1.7	29.7	5.8	0.3	4.7	3.8	43.0	1.2	0.9	4.3	23.3	1.5	24.0	14.2	1.4	9.0	6.1	0.7	2.6	0.7	1.7	1.6	7.5	31.3	20.8	2.3	1.4	31.3	47.3	22.1	36.8	10.3	23.4	96.4	27.7	18.0	1.5	10.5	45.1	69.8	11.7	134.7	8.0	17.6	24.5	13.4	5.4	13.1	38.4	4.0	5.3	8.7	4.8	18.3	0.5	24.1	15.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.9	0.7	0.9	0.7	0.7	1.0	0.8	0.6	1.0	0.7	1.0	1.0	5.3	0.0	0.0	0.3	0.1	1.0	0.3	0.4	0.0	1.0	0.6	1.8	2.5	0.0	0.3	1.8	2.1	0.4	2.9	0.4	1.9	3.6	32.5	0.9	1.8	8.6	0.0	5.9	0.1	0.9	1.4	0.8	1.1	1.8	0.0	10.4	3.6	1.1	1.2	0.0	0.0	0.8	0.0	0.6	0.9	39.1	0.6	0.5	3.6	0.0	0.8	4.3	0.0	0.0	0.3	1.1	0.0	0.7	0.5	0.7	0.0	0.8	0.1	0.4	0.0	0.3	1.0	1.6	14.3	4.1	1.4	0.3	1.2	0.9	0.5	0.9
CCDC81	"FLJ16339, FLJ23514"	ENSG00000149201	"Coiled-coil domain containing 81"	Q6ZN84	11	86374736-86423109	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"choroid plexus: 8.5;fallopian tube: 27.6"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 37.5;Endometrial ciliated cells: 72.7;Extravillous trophoblasts: 35.8;Respiratory ciliated cells: 38.4"	"Cancer enhanced"	"Detected in single"		"testis cancer: 1.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 3.4;BJ hTERT+: 1.8;HBF TERT88: 1.9;SuSa: 2.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.02e-1)"	"unprognostic (6.06e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.53e-1)"	"unprognostic (6.76e-2)"	"unprognostic (7.00e-3)"	"unprognostic (8.54e-3)"	"unprognostic (1.46e-3)"	"unprognostic (2.82e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.57e-1)"	"unprognostic (8.14e-4)"	"unprognostic (1.61e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.27e-1)"	"unprognostic (6.62e-2)"	0.6	0.3	2.8	0.2	1.6	0.2	0.4	2.2	1.7	1.5	8.5	0.4	0.0	1.6	0.5	0.2	27.6	0.4	0.3	1.7	4.0	0.4	0.3	1.4	0.4	3.5	4.3	0.7	0.8	0.2	0.1	1.8	0.6	3.6	0.7	0.2	1.0	0.2	0.7	0.8	0.4	0.3	1.1	3.8	0.4	0.4	5.9	2.3	0.8	0.7	0.1	0.3	0.6	0.6	2.4	0.0	0.1	1.1	0.0	0.3	0.1	0.4	3.4	1.8	0.5	0.4	0.4	0.3	0.2	1.3	0.6	0.1	0.2	0.6	0.1	1.9	0.2	0.2	0.3	0.1	0.3	0.1	0.2	0.3	0.0	0.6	0.9	0.3	0.6	0.6	0.2	0.2	0.0	0.4	0.5	0.4	1.0	0.1	0.5	0.0	0.2	0.1	0.3	0.2	0.0	0.1	0.2	0.1	0.2	0.0	2.1	0.2	0.4	0.1	0.8	0.4	0.8	0.1	0.0	0.4	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	1.6	2.2	1.7	1.7	4.0	3.5	4.3	0.7	3.6	3.8	2.3	2.4	0.1	3.2	0.5	4.6	0.0	0.3	0.2	1.0	0.0	1.8	0.7	0.6	1.1	0.0	5.2	0.0	0.0	4.0	0.2	0.1	0.0	0.1	37.5	72.7	1.0	0.4	0.0	0.0	2.3	0.0	35.8	1.0	0.0	1.3	0.0	0.3	1.8	0.0	2.1	0.0	3.8	0.0	2.0	0.6	0.7	5.1	1.5	0.5	0.0	1.0	0.6	0.4	0.0	2.5	3.5	0.0	0.1	0.7	0.0	0.6	0.1	0.1	38.4	1.0	13.1	0.7	0.9	5.8	0.3	0.0	0.6	2.7	0.2	1.0	0.1	0.2
CCL19	"CKb11, ELC, exodus-3, MIP-3b, SCYA19"	ENSG00000172724	"C-C motif chemokine ligand 19"	Q99731	9	34689570-34691276	"Cancer-related genes, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 637.6"	"Group enriched"	"Detected in some"	12	"Basal keratinocytes: 74.7;Basal respiratory cells: 56.9;Fibroblasts: 59.6;Langerhans cells: 111.9;Melanocytes: 92.5;monocytes: 107.1;Smooth muscle cells: 150.9;Suprabasal keratinocytes: 54.0"	"Cancer enhanced"	"Detected in all"		"testis cancer: 118.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 1.0;HDLM-2: 3.2;TIME: 1.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA067758	Enhanced				"Secreted to blood"	NA	NA	195000	63000			"HPA067758: AB_2685897"	"prognostic favorable (2.88e-5)"	"prognostic favorable (9.91e-6)"	"unprognostic (8.25e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.17e-2)"	"unprognostic (8.36e-3)"	"unprognostic (8.31e-2)"	"unprognostic (2.43e-1)"	"prognostic unfavorable (8.63e-7)"	"unprognostic (7.98e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.87e-1)"	134.4	3.4	2.8	615.1	3.1	0.0	44.0	2.6	8.3	20.0	7.0	34.6	7.9	5.5	3.8	56.0	14.2	70.0	23.5	2.4	5.0	28.5	49.5	49.1	637.6	4.8	3.5	2.3	2.4	4.9	0.3	8.0	0.0	4.6	34.6	70.9	0.1	50.0	2.0	0.4	43.2	147.6	32.8	2.9	60.2	69.4	4.1	3.3	531.3	52.1	2.2	608.0	109.4	9.2	6.5	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.2	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	3.1	2.6	8.3	2.4	5.0	4.8	3.5	2.3	4.6	2.9	3.3	6.5	3.3	0.0	0.0	0.0	0.8	74.7	0.0	56.9	0.0	0.0	0.4	1.0	0.1	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	7.3	0.0	0.0	0.0	0.2	0.0	59.6	0.0	0.1	0.0	0.0	0.4	0.1	0.2	0.0	0.0	0.0	0.0	1.3	111.9	0.2	0.0	3.7	92.5	1.0	107.1	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.1	150.9	0.7	0.6	0.9	54.0	0.0	6.6	0.0	0.0	0.5
CCL26	"eotaxin-3, IMAC, MIP-4a, MIP-4alpha, SCYA26, TSC-1"	ENSG00000006606	"C-C motif chemokine ligand 26"	Q9Y258	7	75769533-75789896	"Human disease related genes, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 20.6;pituitary gland: 16.5"	"Cell type enhanced"	"Detected in some"		"Fibroblasts: 7.1;Intestinal goblet cells: 7.7;Leydig cells: 16.8;Sertoli cells: 13.1;Smooth muscle cells: 20.2"	"Cancer enhanced"	"Detected in many"		"testis cancer: 14.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 11.2;hTEC/SVTERT24-B: 14.8;PC-3: 51.1;U-2 OS: 13.7"					"Region enriched"	"Detected in single"	16	"spinal cord: 1.7"						"Secreted to blood"	NA	NA	117000					"unprognostic (1.14e-1)"	"unprognostic (4.17e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.52e-2)"	"unprognostic (2.18e-2)"	"unprognostic (6.17e-2)"	"unprognostic (3.02e-1)"	"unprognostic (8.71e-2)"	"unprognostic (7.93e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.05e-11)"	"unprognostic (2.46e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.73e-1)"	"unprognostic (6.29e-3)"	2.6	3.1	1.7	0.6	1.7	0.1	1.9	1.7	4.1	2.4	11.0	0.8	0.3	1.2	1.9	1.9	2.7	1.4	2.5	1.6	1.7	1.7	0.4	1.9	3.4	1.8	1.7	1.9	20.6	0.4	3.2	16.5	0.4	1.7	1.0	7.3	2.5	0.7	0.3	0.4	1.8	1.0	1.4	1.8	0.4	0.9	1.2	1.9	0.3	0.6	0.1	0.2	3.6	4.3	1.8	0.2	11.2	0.0	0.0	1.3	1.7	0.0	0.6	5.2	4.3	7.3	0.3	3.2	0.0	7.2	3.5	0.3	2.1	0.0	0.0	5.8	0.0	0.5	0.0	0.0	1.1	0.5	0.0	0.0	0.0	0.6	14.8	0.1	2.3	0.0	0.0	5.2	0.0	2.2	0.7	0.0	0.0	8.4	0.5	51.1	0.0	0.8	0.0	0.0	0.0	1.0	0.0	0.6	0.1	0.0	2.2	0.0	0.0	0.3	8.2	13.7	4.2	2.7	0.0	0.0	0.0	2.5	0.0	0.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.7	1.7	4.1	1.6	1.7	1.8	1.7	1.9	1.7	1.8	1.9	1.8	0.5	0.0	0.0	0.0	0.0	1.1	3.5	1.8	0.0	0.5	0.1	0.1	0.4	0.0	0.7	0.0	4.2	0.0	0.0	2.3	0.0	0.0	0.5	0.1	1.1	0.6	0.0	0.0	0.1	0.0	0.0	7.1	0.5	0.1	0.0	0.1	1.1	0.0	0.0	0.0	0.1	7.7	0.0	3.2	1.4	0.9	16.8	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.2	0.1	4.9	0.0	0.6	0.1	0.0	0.2	2.2	13.1	0.9	20.2	0.1	0.4	0.6	1.8	0.0	0.2	2.5	1.6	2.6
CDC25A		ENSG00000164045	"Cell division cycle 25A"	P30304	3	48157146-48188417	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Hydrolase, Protein phosphatase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 15.5;lymphoid tissue: 8.9;testis: 13.4"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 111.2;Early spermatids: 18.3;Late spermatids: 31.8;Spermatogonia: 16.3"	"Cancer enhanced"	"Detected in many"		"testis cancer: 19.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005855, HPA008803"			Approved	"Nucleoplasm,Golgi apparatus"		NA	Yes			Nucleoplasm	"Golgi apparatus"	"HPA005855: AB_1846364, HPA008803: "	"unprognostic (1.49e-1)"	"unprognostic (8.13e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.43e-3)"	"unprognostic (2.14e-1)"	"unprognostic (9.51e-2)"	"unprognostic (7.05e-7)"	"unprognostic (1.35e-2)"	"unprognostic (4.32e-3)"	"unprognostic (8.92e-3)"	"unprognostic (4.41e-2)"	"unprognostic (9.09e-2)"	"unprognostic (4.41e-3)"	"unprognostic (1.57e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.72e-1)"	0.7	0.9	0.8	3.3	0.7	15.5	1.1	0.6	1.0	0.6	0.6	3.6	2.0	0.6	0.9	2.4	0.2	0.3	0.4	0.7	1.6	0.6	0.8	0.3	4.5	1.1	1.6	0.7	2.2	0.7	0.8	0.8	2.6	1.4	0.6	3.9	2.0	0.8	0.7	0.4	0.6	1.8	1.1	0.7	2.0	0.9	13.4	1.8	8.9	1.8	0.3	5.7	0.9	0.9	1.1	22.2	10.7	50.0	27.2	1.7	3.2	34.2	29.9	11.3	36.7	29.6	46.8	11.2	64.9	11.4	8.0	23.4	16.3	86.6	20.6	38.6	21.4	45.1	83.8	19.0	23.1	1.7	59.4	23.4	1.7	3.1	45.8	19.6	4.6	14.1	47.8	67.6	33.6	20.1	11.8	74.8	46.6	73.4	20.2	24.2	33.2	32.9	35.1	9.5	20.7	23.5	28.8	18.6	21.6	9.5	31.7	11.3	41.9	7.2	18.0	27.7	20.3	41.4	16.7	54.2	101.5	13.5	65.2	15.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.7	0.6	1.0	0.7	1.6	1.1	1.6	0.7	1.4	0.7	1.8	1.1	0.3	0.0	0.0	1.0	1.1	0.4	0.4	0.8	1.8	0.5	1.2	1.0	111.2	0.0	0.1	0.0	2.1	4.2	0.2	2.4	0.0	0.4	18.3	0.5	0.9	2.7	1.2	8.0	0.2	0.9	7.4	1.5	1.5	1.3	0.0	4.6	1.4	0.3	3.1	0.0	0.5	2.0	0.0	0.6	0.9	31.8	1.5	0.5	0.0	0.0	0.1	1.1	0.0	0.5	0.0	1.1	0.8	1.9	13.0	0.7	0.4	0.4	0.2	0.4	0.0	0.1	2.2	14.5	16.3	4.3	0.0	0.3	0.6	2.4	4.1	0.5
CDH8		ENSG00000150394	"Cadherin 8"	P55286	16	61647242-62037035	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 23.1"	"Group enriched"	"Detected in some"	13	"Excitatory neurons: 220.8;Inhibitory neurons: 236.4;Oligodendrocytes: 145.7"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"AF22: 7.0;fHDF/TERT166: 6.3;HaCaT: 14.4;LHCN-M2: 17.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014908, HPA076441"	Approved		Approved	"Plasma membrane"		NA	NA		870000	"Plasma membrane"		"HPA014908: AB_1845908, HPA076441: "	"unprognostic (1.91e-1)"	"unprognostic (2.41e-1)"	"unprognostic (4.02e-2)"	"unprognostic (7.70e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.83e-1)"	"unprognostic (8.71e-2)"	"unprognostic (3.66e-2)"	"unprognostic (5.41e-2)"	"unprognostic (2.85e-1)"	"unprognostic (6.59e-2)"	"unprognostic (2.91e-4)"	"unprognostic (6.02e-2)"	"unprognostic (4.06e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.06e-1)"	0.1	0.1	5.2	0.0	10.4	0.0	0.3	0.0	23.1	0.4	0.0	0.1	0.3	0.1	0.2	0.1	0.0	0.2	0.2	17.3	9.9	0.0	0.0	0.1	0.0	6.5	8.9	7.2	1.8	0.0	0.1	0.7	0.3	13.1	0.4	0.1	2.2	0.4	5.1	0.4	0.1	0.2	0.4	2.4	0.0	0.1	0.3	7.0	0.5	0.1	0.9	0.0	0.4	0.1	13.3	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	6.3	0.0	14.4	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.4	0.0	17.3	0.0	0.0	0.0	1.3	0.0	1.3	0.0	0.0	1.1	0.0	1.9	0.1	0.1	0.0	0.0	0.0	2.2	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	10.4	0.0	23.1	17.3	9.9	6.5	8.9	7.2	13.1	2.4	7.0	13.3	0.4	0.0	0.5	3.9	0.0	0.1	0.8	1.3	1.2	15.1	0.1	0.9	1.0	0.0	0.8	0.0	0.0	1.3	0.0	0.0	0.0	0.0	4.9	0.1	0.1	0.5	0.0	0.0	220.8	0.0	0.2	0.8	0.0	0.0	0.0	1.6	0.0	0.0	0.3	0.0	236.4	0.0	2.0	0.0	0.0	1.3	0.0	0.1	0.0	8.4	0.0	0.7	0.0	7.5	145.7	0.0	0.0	0.4	0.0	0.3	0.0	0.2	2.7	0.7	0.0	0.7	4.7	1.3	2.5	0.5	0.1	0.3	0.1	0.1	0.0	0.8
CELA1	ELA1	ENSG00000139610	"Chymotrypsin like elastase 1"	Q9UNI1	12	51328442-51346679	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"adrenal gland: 2.2;pancreas: 6.6"	"Cell type enhanced"	"Detected in some"		"Exocrine glandular cells: 16.6;Extravillous trophoblasts: 2.9;Kupffer cells: 7.9;NK-cells: 3.1"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"basophil: 12.4;naive CD4 T-cell: 12.3"	"Group enriched"	"Detected in many"	8	"granulocytes: 12.4;T-cells: 12.3"	"Cell line enriched"	"Detected in some"	4	"BEWO: 5.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"								"Secreted - unknown location"	NA	NA						"unprognostic (3.54e-2)"	"unprognostic (1.64e-1)"		"unprognostic (4.73e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.70e-1)"		"unprognostic (1.52e-1)"		"unprognostic (1.13e-1)"	"unprognostic (3.59e-2)"		"unprognostic (3.83e-3)"	"unprognostic (2.52e-1)"	"unprognostic (1.46e-1)"			0.0	2.2	0.1	0.2	0.1	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.8	0.1	0.1	0.0	0.0	6.6	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.2	0.1	0.5	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	12.4	1.6	0.1	1.0	0.8	0.4	0.3	2.7	0.8	1.0	0.0	12.3	5.9	0.2	0.2	1.0	0.0	0.3	1.2	0.1	0.1	0.1	0.2	0.1	0.3	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	16.6	2.9	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.8	0.0	0.1	0.0	0.0	7.9	0.0	0.0	0.0	1.4	0.0	0.0	1.8	0.0	3.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.9	0.0	0.0	0.5	1.4	0.2	0.0	0.0
CENPA	"CenH3, CENP-A"	ENSG00000115163	"Centromere protein A"	P49450	2	26764289-26801067	"Predicted intracellular proteins"	"Cell cycle, Cell division, Host-virus interaction, Mitosis"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 13.4"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 45.0;Extravillous trophoblasts: 33.2;Granulosa cells: 24.2;Plasma cells: 17.8;Spermatogonia: 28.6"	"Cancer enhanced"	"Detected in many"		"testis cancer: 24.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"CAB008371, HPA073086"	Enhanced		Supported	Nucleoplasm		NA	Yes			Nucleoplasm		"CAB008371: AB_591074, HPA073086: AB_2686569"	"unprognostic (3.94e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.29e-2)"	"prognostic unfavorable (2.38e-4)"	"unprognostic (1.13e-1)"	"unprognostic (2.89e-2)"	"prognostic unfavorable (2.88e-8)"	"prognostic unfavorable (3.70e-4)"	"unprognostic (1.69e-3)"	"unprognostic (7.80e-2)"	"prognostic unfavorable (1.30e-4)"	"unprognostic (4.21e-3)"	"unprognostic (0.00e+0)"	"unprognostic (5.74e-2)"	"unprognostic (1.33e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.07e-1)"	0.3	0.3	0.0	4.0	0.0	3.8	0.4	0.1	0.1	0.3	0.0	3.0	4.1	0.7	0.0	3.7	0.1	0.1	0.2	0.0	0.1	0.1	0.2	0.4	7.4	0.0	0.1	0.0	0.1	0.1	0.0	0.0	1.6	0.0	0.1	2.7	0.0	0.6	0.0	0.0	3.6	2.9	0.9	0.0	2.1	1.6	2.2	0.1	13.4	0.1	0.0	8.5	0.7	1.1	0.2	86.4	21.0	34.9	19.3	2.4	4.5	24.3	26.2	22.2	37.3	31.5	15.4	30.0	25.7	16.2	10.4	45.7	25.6	28.9	15.3	37.7	77.3	25.6	44.0	11.0	28.6	0.8	26.7	49.0	0.4	1.6	16.1	24.4	6.7	22.1	33.7	36.7	58.5	32.5	30.1	39.0	42.2	26.6	35.3	34.3	45.4	53.6	30.8	17.5	5.5	27.5	26.7	25.7	32.7	23.6	12.9	18.2	27.2	12.6	23.9	54.2	27.9	46.4	51.5	53.5	107.3	11.1	54.7	46.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.2	1.0	0.0	0.0	0.0	5.2	6.2	0.7	1.9	1.8	0.0	2.0	2.5	2.7	0.0	0.5	0.0	0.0	15.3	1.0	2.3	0.0	0.5	0.6	1.6	1.6	1.5	4.2	45.0	0.1	0.2	33.2	4.9	2.6	3.0	0.0	24.2	3.9	0.6	15.7	0.0	0.1	6.6	0.0	2.9	2.8	0.1	0.9	4.4	1.8	0.0	0.0	0.0	1.0	0.0	0.0	0.1	1.4	0.0	17.8	2.1	0.8	0.2	0.1	0.0	0.0	0.6	3.9	16.1	28.6	12.5	5.3	3.4	3.4	1.5	11.1	2.0
CEP85L	"bA57K17.2, C6orf204, NY-BR-15"	ENSG00000111860	"Centrosomal protein 85 like"	Q5SZL2	6	118460772-118710075	"Disease related genes, Predicted intracellular proteins"			"Disease variant, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 30.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 266.1;Early spermatids: 445.2;Late spermatids: 742.5;Oligodendrocyte precursor cells: 251.9;Oligodendrocytes: 189.4"	"Cancer enhanced"	"Detected in many"		"testis cancer: 3.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 25.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029137, HPA029138, HPA029139"	Uncertain					NA	NA					"HPA029137: AB_10600657, HPA029138: AB_10600874, HPA029139: AB_10601220"	"unprognostic (3.25e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.34e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.01e-2)"	"unprognostic (8.37e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.39e-3)"	"unprognostic (8.45e-2)"	"unprognostic (2.87e-5)"	"unprognostic (2.72e-3)"	"unprognostic (2.44e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.85e-2)"	3.2	5.2	4.0	7.2	5.5	11.6	2.5	12.0	5.6	3.9	0.2	2.4	1.8	4.2	2.1	3.0	3.8	3.3	3.7	3.9	5.9	1.4	2.2	3.3	13.6	5.5	7.3	2.3	7.6	2.6	3.5	5.1	4.2	6.8	2.2	2.4	3.4	4.6	2.0	8.6	1.3	4.1	3.1	4.5	7.7	8.1	30.2	7.3	19.2	2.2	11.9	9.8	5.3	2.6	5.8	1.3	1.1	6.5	3.7	3.5	6.5	25.7	3.4	5.1	3.0	3.4	0.2	0.3	6.6	1.0	5.0	2.5	1.7	2.9	4.9	5.5	3.6	3.4	8.8	2.0	0.8	2.8	0.6	2.5	3.8	2.6	3.7	4.0	6.0	4.4	9.5	8.7	6.1	5.0	1.0	16.0	4.0	2.0	0.2	1.8	3.8	5.1	1.5	3.6	2.9	4.0	2.3	2.6	0.1	5.0	5.2	0.8	3.3	3.6	4.8	2.7	4.2	5.6	7.8	6.1	6.0	4.0	2.9	5.0	1.5	10.7	9.0	6.6	11.6	6.7	3.4	5.4	5.4	5.5	4.6	7.1	5.9	15.7	6.9	11.2	2.6	4.7	4.0	4.0	5.5	12.0	5.6	3.9	5.9	5.5	7.3	2.3	6.8	4.5	7.3	5.8	24.1	6.4	4.6	266.1	26.3	6.9	10.7	10.6	9.6	31.6	4.5	7.1	33.9	0.0	3.5	3.7	10.4	26.7	35.5	0.2	1.9	3.7	445.2	7.5	43.2	25.8	3.0	2.5	156.1	4.3	5.9	23.4	33.1	16.6	8.8	12.5	14.6	6.5	8.4	33.7	147.1	0.6	2.0	25.7	16.7	742.5	32.0	24.0	23.2	80.6	22.9	4.7	19.6	251.9	189.4	9.4	1.2	29.0	28.7	7.1	0.0	2.1	5.2	9.8	19.7	53.4	32.2	38.2	49.7	3.5	4.8	22.2	48.3	48.3	0.6	8.1
CGA	"FSHA, GPA1, GPHa, GPHA1, HCG, LHA, TSHA"	ENSG00000135346	"Glycoprotein hormones, alpha polypeptide"	P01215	6	87085498-87095106	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"		Hormone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"pituitary gland: 4423.7"	"Cell type enriched"	"Detected in some"	15	"Syncytiotrophoblasts: 85317.2"	"Cancer enhanced"	"Detected in many"		"breast cancer: 10.9;testis cancer: 13.0"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	28	"BEWO: 776.1;SuSa: 1437.9"	"Region enriched"	"Detected in many"	6	"hypothalamus: 22.2"	"Region enriched"	"Detected in many"	40	"hypothalamus: 82.2"	"CAB023350, HPA029698"	Enhanced				"Secreted to blood"	NA	NA					"CAB023350: AB_617281, HPA029698: AB_2673153"	"unprognostic (1.66e-1)"	"unprognostic (2.10e-1)"		"unprognostic (3.22e-5)"	"unprognostic (1.46e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.69e-2)"	"unprognostic (3.17e-1)"			"unprognostic (7.04e-3)"	"unprognostic (1.51e-1)"		"unprognostic (2.85e-1)"	"unprognostic (4.32e-2)"	"unprognostic (8.32e-2)"	"unprognostic (9.15e-3)"	0.5	4.1	0.2	0.1	0.5	2.0	0.1	0.5	0.6	0.0	0.3	0.3	0.5	1.0	1.2	1.2	0.1	0.2	1.2	0.2	0.6	2.7	2.0	0.7	0.3	1.6	1.0	0.3	0.5	1.3	19.0	4423.7	732.2	1.0	2.7	0.3	0.3	0.5	1.1	3.3	1.9	0.3	3.4	0.2	1.1	38.4	0.5	0.6	0.8	0.5	0.0	0.3	0.4	0.2	1.3	0.0	1.0	0.0	0.1	0.0	0.0	776.1	0.7	0.6	0.5	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.9	4.2	1.8	0.3	40.2	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.9	0.0	0.3	0.2	0.1	0.0	0.3	0.0	0.1	1.0	0.6	0.1	22.6	0.0	1437.9	0.1	0.0	0.0	0.9	0.2	0.4	0.3	3.1	0.4	0.5	0.2	0.0	0.1	0.7	0.2	0.1	0.3	0.0	0.1	0.2	0.1	0.3	0.1	0.4	0.2	0.4	0.6	0.2	0.3	0.4	0.1	0.0	0.2	0.5	0.5	0.6	0.2	0.6	1.6	1.0	0.3	1.0	0.2	0.6	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.9	1.9	0.0	0.0	7.3	0.0	1414.2	0.1	0.0	0.0	0.0	0.2	20.2	1.1	22.9	1.8	0.0	0.2	0.0	5400.7	65.5	0.0	28.4	0.0	0.0	0.0	0.0	625.7	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.4	0.0	0.0	85317.2	6.0	0.0	0.2	9.9
CGB5	HCG	ENSG00000189052	"Chorionic gonadotropin subunit beta 5"	P0DN86	19	49043848-49045311	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"pituitary gland: 8.7;placenta: 25.8"	"Cell type enriched"	"Detected in some"	4	"Syncytiotrophoblasts: 19.7"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 10.0;testis cancer: 5.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	25	"BEWO: 120.1;U-251 MG: 53.2"									"HPA038925, HPA038934"	Supported		Approved	Cytosol	"Secreted to blood"	NA	NA			Cytosol		"HPA038925: AB_2676272, HPA038934: AB_2676277"		"unprognostic (1.38e-1)"				"unprognostic (1.68e-1)"					"unprognostic (1.51e-3)"			"prognostic unfavorable (1.18e-5)"	"unprognostic (1.07e-1)"		"prognostic unfavorable (9.47e-4)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.8	0.1	8.7	25.8	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.1	0.0	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.8	0.4	0.0	0.0	0.0	0.0	120.1	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	3.5	0.0	0.0	0.0	0.1	2.2	0.0	53.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	4.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.7	0.0	0.0	0.0	0.0
CHIT1	"CHI3, CHIT"	ENSG00000133063	"Chitinase 1"	Q13231	1	203212827-203273641	"Candidate cardiovascular disease genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"	"Carbohydrate metabolism, Chitin degradation, Polysaccharide degradation"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 50.3;lung: 36.7;lymphoid tissue: 21.9"	"Cell type enriched"	"Detected in some"	10	"Hofbauer cells: 40.6"	"Cancer enhanced"	"Detected in many"		"testis cancer: 31.9"	"Region enriched"	"Detected in some"	5	"cerebral cortex: 12.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA010575, HPA074844"	Enhanced				"Secreted to blood"	NA	NA	26400000	57000000			"HPA010575: AB_1078512, HPA074844: "	"unprognostic (5.80e-3)"	"prognostic favorable (2.02e-4)"	"unprognostic (2.58e-2)"	"unprognostic (2.19e-1)"	"unprognostic (7.87e-2)"	"unprognostic (2.28e-2)"	"unprognostic (7.55e-2)"	"unprognostic (6.36e-3)"	"unprognostic (1.17e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.56e-3)"	"unprognostic (3.37e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.95e-1)"	8.7	0.3	0.4	0.4	0.5	50.3	8.3	0.2	12.5	8.2	0.4	1.2	0.0	3.6	0.1	0.0	0.1	0.4	0.2	0.4	0.2	0.1	0.8	36.7	21.9	0.5	0.4	0.3	0.5	2.1	0.0	0.0	0.7	1.4	1.0	1.0	0.0	0.4	0.0	0.2	0.3	0.8	0.0	0.6	5.7	0.5	0.0	0.4	3.5	1.3	0.0	1.1	0.1	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.4	0.4	0.5	0.2	12.5	0.4	0.2	0.5	0.4	0.3	1.4	0.6	0.4	2.3	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.2	0.0	0.0	0.2	0.3	0.8	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.5	0.4	0.0	0.1	0.0	0.0	0.0	0.0	40.6	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	3.9	0.0	0.0	0.6	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0
CHRNA3		ENSG00000080644	"Cholinergic receptor nicotinic alpha 3 subunit"	P32297	15	78593052-78621295	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"adrenal gland: 39.6;lymphoid tissue: 66.4;retina: 53.9"	"Cell type enriched"	"Detected in some"	19	"Cone photoreceptor cells: 164.7"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"SH-SY5Y: 356.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA029430	Enhanced		Supported	"Nuclear speckles,Plasma membrane"		NA	NA			"Plasma membrane"	"Nuclear speckles"	"HPA029430: AB_10603785"	"unprognostic (2.28e-1)"	"unprognostic (3.45e-1)"	"unprognostic (2.58e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.12e-1)"	"unprognostic (9.16e-3)"	"unprognostic (1.97e-1)"	"unprognostic (4.28e-2)"	"unprognostic (7.20e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.86e-4)"	"unprognostic (2.65e-3)"	"unprognostic (2.76e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.48e-1)"	0.4	39.6	3.9	5.2	2.0	0.0	0.1	6.2	2.3	0.6	0.7	6.5	1.5	0.5	0.0	0.1	0.0	0.3	0.3	0.8	2.0	0.0	0.0	0.2	0.3	3.0	6.7	0.5	0.1	0.2	0.0	1.2	0.1	6.6	0.2	4.1	53.9	0.1	0.0	0.1	0.5	3.0	3.8	0.3	0.1	2.8	1.0	9.1	66.4	0.2	0.0	0.9	0.2	0.7	1.1	0.1	0.3	0.7	0.6	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.1	0.2	0.1	0.2	0.0	1.5	0.0	8.8	0.0	0.0	0.3	1.4	0.5	0.4	0.1	0.0	0.1	4.0	0.0	0.3	0.0	0.0	0.0	0.0	22.6	0.2	0.0	0.0	0.3	7.1	0.0	1.6	0.1	0.2	0.4	0.3	0.1	0.0	0.4	67.7	356.1	0.3	0.1	0.1	0.5	0.4	0.0	0.0	0.1	1.7	0.1	0.4	0.2	0.7	0.1	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	2.0	6.2	2.3	0.8	2.0	3.0	6.7	0.5	6.6	0.3	9.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.8	0.0	0.0	0.0	164.7	0.0	0.0	0.2	1.9	0.0	3.7	0.1	1.2	0.4	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.2	1.7	0.4	3.6	0.0	0.0	0.0	3.5	0.0	0.2	0.0	0.0	0.0	3.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.1	0.1	0.3	2.1	0.0	0.0	0.0	0.0	2.6	0.1	0.1
CHRNB4		ENSG00000117971	"Cholinergic receptor nicotinic beta 4 subunit"	P30926	15	78624111-78727754	"FDA approved drug targets, Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 3.0;retina: 2.7;testis: 5.9"	"Group enriched"	"Detected in some"	11	"Early spermatids: 44.1;Late spermatids: 54.9"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.0"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	16	"SCLC-21H: 30.9;SH-SY5Y: 40.7"	"Group enriched"	"Detected in some"	5	"olfactory bulb: 5.3;pons and medulla: 1.4;thalamus: 4.2"					HPA059484			Approved	"Endoplasmic reticulum,Cell Junctions"		NA	NA			"Endoplasmic reticulum"	"Cell Junctions"	"HPA059484: "	"unprognostic (4.74e-2)"	"unprognostic (4.54e-1)"	"unprognostic (1.26e-2)"	"unprognostic (8.77e-5)"	"unprognostic (8.15e-2)"	"unprognostic (6.43e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.19e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.45e-4)"	"unprognostic (7.00e-3)"	"unprognostic (2.58e-1)"	"unprognostic (8.50e-2)"	"unprognostic (7.76e-2)"	0.0	2.5	0.2	0.6	0.2	0.3	0.0	0.1	0.3	0.2	0.2	0.8	0.0	0.3	0.3	0.6	0.0	0.0	0.0	0.2	0.4	0.2	0.0	0.0	0.5	0.7	1.9	0.2	0.1	0.0	0.2	0.4	0.0	0.9	0.0	0.4	2.7	0.1	0.0	0.3	0.1	0.3	0.4	0.0	0.4	0.3	5.9	0.3	3.0	0.1	0.0	0.4	0.0	0.2	0.3	0.3	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.7	0.1	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.0	0.6	0.4	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	30.9	40.7	0.2	0.5	0.1	0.3	0.1	0.1	0.0	0.2	0.5	0.0	0.0	2.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.3	0.2	0.4	0.7	1.9	0.2	0.9	0.0	0.3	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	2.1	0.1	0.0	0.0	0.0	0.0	44.1	0.3	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	54.9	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.5	0.1	0.2	0.0	0.4	0.0	0.0	0.3	0.4	0.1	0.1	0.0	0.0	0.0	1.6	2.0	0.0	0.0	0.0	0.0	4.5	0.0	0.1
CLDN19		ENSG00000164007	"Claudin 19"	Q8N6F1	1	42733093-42740254	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Sensory transduction, Vision"		"Disease variant, Primary hypomagnesemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"choroid plexus: 15.7;kidney: 16.8;placenta: 9.8"	"Cell type enriched"	"Detected in some"	6	"Extravillous trophoblasts: 221.6"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.6"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"CACO-2: 3.0;Hep G2: 6.3;SuSa: 3.5"	"Region enhanced"	"Detected in many"		"olfactory bulb: 5.4"	"Region enriched"	"Detected in many"	6	"spinal cord: 41.8"							NA	NA						"unprognostic (6.23e-4)"	"unprognostic (1.80e-1)"		"unprognostic (1.85e-6)"	"unprognostic (5.30e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.21e-2)"	"unprognostic (3.22e-1)"	"unprognostic (9.45e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.68e-1)"	"unprognostic (7.22e-2)"	"unprognostic (8.76e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.12e-1)"		"unprognostic (3.29e-3)"	0.4	0.1	0.1	0.0	0.1	0.1	1.2	0.5	0.5	0.0	15.7	0.0	0.0	0.0	0.6	0.1	0.1	0.0	0.1	1.3	0.1	16.8	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	9.8	0.5	0.3	0.0	0.0	0.8	0.8	0.2	0.4	0.1	0.0	0.1	0.0	0.3	0.0	0.1	1.6	0.0	0.9	0.0	0.4	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.5	1.3	0.1	0.1	0.2	0.1	0.5	0.1	0.1	0.2	0.4	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.3	0.2	8.3	0.3	0.0	0.6	12.9	0.0	12.5	0.0	0.0	33.2	0.0	0.0	0.2	0.2	0.2	0.0	0.0	0.0	0.0	221.6	0.7	0.0	0.2	0.0	0.0	0.7	0.0	5.0	0.0	0.0	0.0	0.0	0.8	0.4	0.0	0.0	0.3	0.0	1.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	3.7	0.0	0.2	0.0	0.3	0.1	0.1	0.1	0.0	0.0	12.4	0.1	0.2	0.1	0.0
CLDN6		ENSG00000184697	"Claudin 6"	P56747	16	3014712-3020071	"Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 1.3;pancreas: 1.0"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 35.8;Ductal cells: 23.7;Extravillous trophoblasts: 144.2;Syncytiotrophoblasts: 44.1"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 73.6;testis cancer: 112.4"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"BEWO: 477.8;CACO-2: 134.6;NTERA-2: 443.1;SuSa: 328.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (2.59e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (2.42e-6)"	"unprognostic (1.16e-1)"	"unprognostic (1.58e-1)"	"unprognostic (6.08e-2)"	"unprognostic (1.92e-1)"	"unprognostic (5.50e-4)"	"unprognostic (1.02e-2)"	"unprognostic (5.88e-1)"	"unprognostic (1.98e-2)"	"unprognostic (7.66e-4)"	"unprognostic (1.79e-3)"	"unprognostic (1.02e-1)"	"unprognostic (4.99e-2)"	"prognostic unfavorable (1.78e-4)"	0.0	0.2	0.8	0.0	1.0	0.1	0.0	1.2	0.7	0.0	0.6	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.7	0.5	0.1	0.0	0.2	0.0	0.5	0.4	0.8	0.0	1.0	0.0	0.3	0.7	0.8	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.0	0.1	0.9	0.5	0.1	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.9	0.3	0.7	0.0	477.8	0.1	0.0	0.0	0.0	134.6	0.7	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.7	0.0	0.0	0.2	0.1	60.2	0.0	0.1	0.1	0.1	0.6	0.1	0.0	0.2	0.0	0.0	0.4	0.2	0.1	1.0	0.0	0.3	443.1	0.5	0.1	0.1	0.0	0.1	0.0	0.0	0.4	0.4	0.6	0.6	0.0	328.9	0.2	0.1	0.5	0.2	0.4	0.2	0.1	0.1	0.1	0.0	0.1	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	1.0	1.2	0.7	0.7	0.5	0.5	0.4	0.8	0.8	0.2	0.5	1.3	0.2	3.2	0.0	0.0	0.0	0.9	1.2	0.0	0.0	0.0	0.8	1.3	0.3	0.0	0.1	0.0	0.0	35.8	0.0	0.0	0.0	23.7	0.2	1.4	0.1	0.2	0.0	0.0	0.1	0.0	144.2	0.6	0.0	1.6	0.0	0.0	0.0	0.0	4.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.5	0.0	0.1	0.1	0.0	0.0	1.8	0.4	0.6	5.4	0.0	0.4	44.1	0.2	0.0	0.1	0.2
CLEC2L	FLJ32986	ENSG00000236279	"C-type lectin domain family 2 member L"	P0C7M8	7	139523685-139544985	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 38.4;parathyroid gland: 14.4"	"Group enriched"	"Detected in some"	8	"Excitatory neurons: 51.7;Inhibitory neurons: 49.5;Theca cells: 72.8"	"Cancer enhanced"	"Detected in many"		"testis cancer: 3.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"OE19: 12.0;U-266/84: 10.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045050	Enhanced					NA	NA					"HPA045050: AB_10965839"	"unprognostic (1.18e-2)"	"unprognostic (2.42e-1)"	"unprognostic (7.20e-4)"	"unprognostic (1.24e-2)"	"unprognostic (1.33e-2)"	"unprognostic (6.17e-2)"	"unprognostic (2.29e-6)"	"unprognostic (1.45e-1)"	"unprognostic (1.59e-1)"	"unprognostic (6.73e-2)"	"unprognostic (2.68e-1)"	"unprognostic (8.31e-2)"	"unprognostic (7.94e-4)"	"unprognostic (3.57e-3)"	"unprognostic (4.03e-2)"	"unprognostic (8.42e-3)"	"unprognostic (3.02e-2)"	0.3	0.1	15.3	0.2	13.6	0.4	0.1	29.8	34.2	0.8	4.7	0.3	0.1	1.5	0.0	0.6	0.1	0.8	0.2	18.0	16.6	0.0	0.0	0.1	0.1	32.5	16.5	13.2	0.2	0.1	14.4	0.5	0.0	37.4	0.0	0.1	10.4	0.1	0.0	3.1	0.2	0.3	0.8	12.0	0.2	0.1	0.6	34.6	8.1	0.2	6.6	0.1	0.1	0.1	38.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.5	0.0	1.2	12.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	15.3	13.6	29.8	34.2	18.0	16.6	32.5	16.5	13.2	37.4	12.0	34.6	38.4	0.2	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.1	1.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	51.7	0.0	2.8	1.7	0.0	0.1	0.0	2.7	0.0	0.0	0.2	5.0	49.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	1.8	0.0	5.5	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.3	0.8	1.9	0.0	0.0	0.4	0.0	72.8	0.0	0.1
CLEC4E	"CLECSF9, mincle"	ENSG00000166523	"C-type lectin domain family 4 member E"	Q9ULY5	12	8533305-8540905	"Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 76.4;lymphoid tissue: 52.7"	"Cell type enhanced"	"Detected in some"		"Glandular and luminal cells: 31.9;Kupffer cells: 158.0;Macrophages: 115.2;monocytes: 109.5"	"Cancer enhanced"	"Detected in many"		"testis cancer: 6.0"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	16	"classical monocyte: 128.8;neutrophil: 448.8"	"Group enriched"	"Detected in many"	17	"granulocytes: 448.8;monocytes: 128.8"	"Group enriched"	"Detected in some"	4	"NB-4: 4.3;RPTEC TERT1: 12.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA004935	Uncertain		Uncertain	Cytosol		NA	NA			Cytosol		"HPA004935: AB_2667299"	"unprognostic (3.05e-2)"	"unprognostic (2.01e-2)"	"unprognostic (8.91e-2)"	"unprognostic (3.76e-1)"	"unprognostic (1.76e-1)"	"unprognostic (9.71e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.24e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.11e-2)"	"unprognostic (7.65e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.51e-1)"	"unprognostic (8.44e-2)"	"unprognostic (2.29e-1)"	13.4	5.4	2.5	37.8	2.7	76.4	4.5	2.6	4.5	5.9	2.3	2.1	0.4	2.3	0.4	3.2	5.6	11.9	2.3	3.1	1.8	3.6	6.6	22.6	7.7	2.2	1.8	2.5	1.8	6.2	1.7	1.9	2.1	2.5	2.3	1.0	1.3	1.4	1.2	0.7	0.8	3.1	5.7	0.8	52.7	2.5	1.1	2.3	2.2	10.5	5.0	2.4	9.6	1.7	3.7	0.1	0.4	0.4	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.1	1.5	0.1	0.1	2.0	0.0	0.1	0.1	0.2	0.2	0.1	0.3	0.2	0.2	0.1	0.5	0.1	0.0	1.5	0.0	0.5	0.2	0.2	0.2	0.2	0.0	0.1	0.0	4.3	0.3	0.0	0.0	0.0	0.2	0.1	12.4	0.1	0.0	0.2	0.0	0.0	0.1	0.4	0.0	0.4	1.0	0.5	0.1	1.0	0.1	0.2	0.1	0.1	1.3	0.4	0.1	0.2	128.8	0.5	0.1	18.1	0.3	0.1	0.1	0.1	16.9	0.1	0.0	0.1	448.8	0.0	0.7	0.7	0.0	30.3	2.5	2.7	2.6	4.5	3.1	1.8	2.2	1.8	2.5	2.5	0.8	2.3	3.7	6.2	0.0	4.7	0.0	1.5	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	5.7	1.8	1.8	0.0	0.0	0.3	0.0	0.0	9.0	0.3	2.1	4.4	3.5	0.0	0.0	0.0	0.0	0.1	1.4	0.0	31.9	0.0	0.0	7.1	2.1	5.6	0.0	0.0	0.0	0.0	158.0	9.0	2.9	0.9	115.2	0.0	0.0	109.5	0.0	4.1	0.0	0.0	0.4	0.0	0.4	1.3	0.0	0.0	0.2	0.7	0.0	13.1	0.2	0.4	0.2	0.5	0.1	0.0	0.1	1.1	0.0	0.0	0.1
COL22A1		ENSG00000169436	"Collagen type XXII alpha 1 chain"	Q8NFW1	8	138588235-138914041	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"pituitary gland: 44.4"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 39.6;Excitatory neurons: 13.0;Late spermatids: 33.7;Muller glia cells: 25.5"	"Cancer enhanced"	"Detected in many"		"testis cancer: 9.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 29.5;RT4: 12.2;SCLC-21H: 8.1;U-2 OS: 6.8"					"Low region specificity"	"Detected in many"			HPA024830	Enhanced		Supported	"Endoplasmic reticulum,Vesicles"	"Secreted to extracellular matrix"	NA	NA			Vesicles	"Endoplasmic reticulum"	"HPA024830: AB_1847102"	"unprognostic (1.06e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.88e-2)"	"unprognostic (4.19e-6)"	"prognostic unfavorable (4.15e-4)"	"unprognostic (1.05e-2)"	"unprognostic (5.57e-3)"	"prognostic unfavorable (2.13e-6)"	"unprognostic (2.01e-1)"	"unprognostic (9.24e-2)"	"unprognostic (5.74e-2)"	"unprognostic (3.62e-2)"	"unprognostic (3.66e-15)"	"unprognostic (2.38e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.09e-1)"	0.1	7.7	1.0	0.6	0.7	0.0	0.0	2.8	0.5	0.6	0.3	0.7	0.3	1.9	0.2	0.1	0.4	0.3	0.2	0.2	4.4	1.9	0.0	0.0	0.5	2.9	1.3	0.2	0.2	0.1	1.4	44.4	0.0	0.7	3.0	0.1	5.2	0.9	2.4	0.7	0.0	0.5	1.6	4.4	0.2	2.2	1.1	1.5	2.1	0.2	1.1	1.2	0.9	0.4	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	12.2	8.1	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.7	2.8	0.5	0.2	4.4	2.9	1.3	0.2	0.7	4.4	1.5	2.5	0.0	0.0	0.0	0.3	0.0	0.0	3.7	2.5	0.0	0.3	0.2	0.3	1.7	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	39.6	0.1	0.2	0.8	0.0	0.0	13.0	0.2	0.0	0.2	0.0	0.6	0.0	0.6	0.0	0.0	5.9	0.0	0.8	0.0	8.2	0.0	0.0	33.7	0.3	0.3	0.0	1.0	0.6	25.5	0.0	0.5	0.3	3.0	0.0	0.0	0.0	4.8	0.0	0.1	0.2	1.6	0.0	0.1	0.3	2.1	1.7	0.0	0.0	0.0	0.0	0.0	0.1	1.9
COL6A6		ENSG00000206384	"Collagen type VI alpha 6 chain"	A6NMZ7	3	130560334-130678155	"Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"parathyroid gland: 98.7"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 4.6;Fibroblasts: 20.6;Inhibitory neurons: 5.3;Oligodendrocytes: 4.6;Skeletal myocytes: 3.3"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"SuSa: 1.2"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	15	"spinal cord: 10.0"	HPA045239	Uncertain				"Secreted to extracellular matrix"	NA	NA		700000			"HPA045239: AB_2679268"	"unprognostic (4.86e-3)"	"unprognostic (2.16e-2)"	"unprognostic (9.91e-2)"	"unprognostic (2.08e-4)"	"unprognostic (2.79e-1)"	"unprognostic (1.11e-5)"	"unprognostic (3.74e-3)"	"unprognostic (5.59e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.50e-2)"	"unprognostic (8.90e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.96e-4)"	"unprognostic (5.82e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.07e-1)"	1.8	0.0	0.0	0.0	0.2	0.2	2.5	0.2	0.3	0.0	0.0	0.0	0.0	0.6	0.3	0.9	0.3	0.1	2.9	0.0	0.0	0.0	0.8	7.4	0.0	0.1	0.0	0.0	0.2	0.0	98.7	3.6	0.7	0.1	0.0	0.0	0.3	1.5	0.0	0.1	0.4	0.0	0.5	0.0	1.2	0.1	0.4	0.1	1.3	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.2	1.1	0.0	1.1	1.3	0.0	0.9	0.0	0.0	0.0	1.1	0.2	0.4	2.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	2.9	0.1	0.0	0.0	4.6	0.0	0.0	20.6	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	5.3	0.0	0.0	0.0	1.5	0.1	0.3	0.2	0.0	0.0	0.0	0.1	0.0	3.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	3.3	0.8	0.0	0.4	0.0	0.9	0.1	0.2	0.0	0.0	0.0
CR1L		ENSG00000197721	"Complement C3b/C4b receptor 1 like"	Q2VPA4	1	207645113-207738416	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	9	"bone marrow: 1.5"	"Cell type enriched"	"Detected in some"	18	"Erythroid cells: 128.6"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"HEL: 1.3;HMC-1: 2.9;K-562: 1.6"									HPA049348	Approved				"Secreted in other tissues"	NA	NA					"HPA049348: AB_2680723"	"unprognostic (2.35e-2)"	"unprognostic (8.27e-2)"	"unprognostic (1.99e-1)"	"unprognostic (8.89e-2)"	"unprognostic (1.31e-2)"	"unprognostic (5.50e-2)"	"unprognostic (2.01e-1)"	"unprognostic (7.45e-2)"	"unprognostic (5.27e-2)"	"unprognostic (8.21e-3)"	"unprognostic (7.94e-2)"	"unprognostic (3.02e-1)"	"unprognostic (6.33e-2)"	"unprognostic (2.02e-1)"	"unprognostic (8.90e-2)"	"unprognostic (1.31e-2)"	"unprognostic (9.68e-2)"	0.0	0.0	0.0	0.1	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.2	0.4	0.0	0.0	0.1	0.5	0.5	0.0	0.3	1.8	0.0	0.1	0.0	0.0	5.9	0.4	0.2	6.9	0.2	1.8	0.0	128.6	0.4	0.0	0.1	0.2	0.0	1.0	0.0	0.0	3.6	0.2	1.2	0.0	0.4	0.0	2.0	0.3	0.3	0.4	0.0	0.5	0.0	1.0	1.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.4	0.0	0.2	3.3	0.0	0.0	0.6	0.1	0.0	0.0	0.1	0.3	0.3	0.1	0.1	0.0	0.2
CRHBP	"CRF-BP, CRFBP"	ENSG00000145708	"Corticotropin releasing hormone binding protein"	P24387	5	76953045-76981158	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"liver: 167.9"	"Group enriched"	"Detected in some"	6	"Granulosa cells: 480.8;Hepatic stellate cells: 1319.7"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 4.4;BJ hTERT+ SV40 Large T+ RasG12V: 4.4;HBF TERT88: 7.7;hTEC/SVTERT24-B: 2.6;RPMI-8226: 2.5;U-698: 7.6;U-87 MG: 4.3;WM-115: 3.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA036234, HPA046120"	Approved	Supported			"Secreted to blood"	NA	NA		69000000			"HPA036234: , HPA046120: AB_10959760"	"unprognostic (1.41e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.78e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.36e-3)"	"unprognostic (4.44e-5)"	"unprognostic (2.16e-1)"	"unprognostic (7.08e-2)"	"unprognostic (4.98e-4)"	"unprognostic (1.09e-1)"	"unprognostic (6.63e-5)"	"unprognostic (2.76e-2)"	"unprognostic (4.64e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.95e-2)"	22.4	13.8	8.0	0.7	5.6	3.2	6.3	3.0	7.5	3.7	2.1	0.4	0.6	2.6	0.9	0.2	1.8	0.9	7.4	5.6	15.9	36.9	167.9	0.5	0.9	7.1	7.2	4.6	1.3	0.1	0.6	0.1	10.3	11.7	1.2	0.4	0.1	1.1	4.2	0.9	0.4	0.7	1.5	3.4	37.6	0.3	0.8	20.9	0.5	4.1	1.3	0.6	0.9	0.8	7.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.1	4.4	4.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	7.7	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.5	0.0	0.0	2.6	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	2.0	0.0	0.0	0.0	7.6	4.3	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	8.0	5.6	3.0	7.5	5.6	15.9	7.1	7.2	4.6	11.7	3.4	20.9	7.0	134.9	0.0	0.0	1.3	8.8	0.4	0.0	0.0	0.0	0.0	0.4	1.1	0.7	17.2	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.3	0.0	0.0	45.9	0.0	39.4	0.8	0.2	0.2	0.3	0.0	0.0	0.0	480.8	1319.7	9.9	1.8	0.0	32.4	0.0	0.0	75.0	2.1	1.0	0.3	3.8	0.0	4.7	0.3	0.0	0.0	0.5	11.1	0.0	0.0	0.0	0.9	0.0	0.0	3.6	0.0	0.0	0.0	0.1	2.3	0.5	1.9	0.1	0.0	0.0	1.7	0.0	0.0	0.1
CRYBA4		ENSG00000196431	"Crystallin beta A4"	P53673	22	26621963-26630669	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Eye lens protein"	"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 1.5;testis: 1.1"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 3.3;NK-cells: 1.0;Spermatogonia: 3.2"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 2.0;testis cancer: 2.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"HEL: 7.3"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"cerebral cortex: 4.3;hippocampal formation: 4.0"	HPA071178	Supported					NA	NA					"HPA071178: AB_2686354"	"unprognostic (6.69e-2)"	"unprognostic (3.94e-3)"	"unprognostic (5.61e-5)"	"unprognostic (1.74e-2)"	"unprognostic (5.57e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.71e-1)"	"unprognostic (7.92e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.85e-1)"	"unprognostic (9.05e-6)"	"unprognostic (2.86e-1)"	"unprognostic (1.20e-6)"	"unprognostic (1.87e-2)"	"unprognostic (7.23e-2)"	"unprognostic (7.71e-2)"	"unprognostic (3.70e-1)"	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.2	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.4	0.0	0.0	3.3	0.0	0.0	0.1	0.0	0.4	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.8	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.9	3.2	0.0	0.0	0.3	0.1	0.0	0.5	0.1
CRYGD	CRYG4	ENSG00000118231	"Crystallin gamma D"	P07320	2	208121607-208124524	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Sensory transduction, Vision"	"Eye lens protein"	"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"ovary: 8.1"	"Cell type enriched"	"Detected in some"	4	"Granulosa cells: 140.2"	"Cancer enhanced"	"Detected in some"		"testis cancer: 3.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	20	"HEL: 10.0"					"Not detected"	"Not detected"			"HPA041269, HPA043386"	Supported		Approved	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"HPA041269: AB_2732491, HPA043386: "					"unprognostic (4.49e-2)"						"unprognostic (2.64e-1)"				"unprognostic (3.62e-1)"			0.0	0.0	0.5	0.0	0.4	1.3	0.0	0.2	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.4	0.6	0.0	0.0	0.0	0.0	0.5	0.7	0.4	8.1	0.0	0.0	0.4	0.0	0.6	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	1.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.0	10.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.2	0.8	0.4	0.6	0.5	0.7	0.4	0.6	0.3	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	12.2	0.0	0.0	0.1	0.0	4.6	0.3	0.0	0.1	0.9	0.0	0.0	0.0	140.2	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	4.2	0.0	0.4	0.0	0.0	0.0	34.5	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.9	0.1	1.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0
CSMD1	"KIAA1890, PPP1R24"	ENSG00000183117	"CUB and Sushi multiple domains 1"	Q96PZ7	8	2935353-4994972	"Plasma proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 8.4;testis: 2.6"	"Group enriched"	"Detected in some"	20	"Excitatory neurons: 4868.4;Inhibitory neurons: 3913.1;Oligodendrocyte precursor cells: 4521.8"	"Cancer enhanced"	"Detected in some"		"testis cancer: 0.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"K-562: 4.9;U-2 OS: 2.2;U-266/70: 2.2;U-266/84: 2.1;U-698: 1.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA074707			Approved	Vesicles		NA	NA			Vesicles		"HPA074707: AB_2686707"	"unprognostic (6.32e-2)"	"unprognostic (4.23e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.67e-3)"	"unprognostic (5.72e-2)"	"unprognostic (4.26e-2)"	"unprognostic (1.02e-2)"	"unprognostic (4.66e-2)"	"unprognostic (7.69e-2)"	"unprognostic (3.30e-2)"	"unprognostic (1.36e-1)"	"unprognostic (7.90e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.74e-2)"	"unprognostic (5.09e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.11e-1)"	0.0	0.0	3.9	0.0	6.1	0.0	0.2	0.0	8.4	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	6.2	1.5	0.5	0.0	0.1	0.0	0.4	0.2	6.9	0.0	0.0	0.1	0.1	0.6	1.4	0.1	0.0	1.6	0.0	0.2	0.2	0.0	0.0	0.2	0.0	0.6	0.0	2.6	0.3	0.0	0.1	0.2	0.0	0.0	0.0	3.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	2.2	0.0	0.0	2.2	2.1	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	6.1	0.0	8.4	6.2	1.5	0.4	0.2	6.9	1.4	0.0	0.3	3.0	0.6	0.0	0.5	108.4	0.0	0.3	0.0	0.0	2.2	15.0	1.0	0.9	2.2	0.0	0.6	1.8	0.0	3.4	0.0	0.1	0.0	0.0	52.5	1.5	0.3	2.2	0.0	0.0	4868.4	0.0	1.3	0.7	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	3913.1	0.1	0.0	0.0	0.7	15.0	0.3	0.2	0.0	220.2	0.7	0.5	0.0	4521.8	135.2	0.0	0.1	0.4	0.0	0.0	0.0	1.2	9.7	0.6	0.0	0.2	0.5	10.2	5.3	1.0	0.1	3.6	0.1	2.8	0.0	0.1
CST9L	"bA218C14.1, CTES7B"	ENSG00000101435	"Cystatin 9 like"	Q9H4G1	20	23564732-23568484	"Predicted secreted proteins"		"Protease inhibitor, Thiol protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	337	"epididymis: 26.6;testis: 88.7"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 4.0;Late spermatids: 13.2;Leydig cells: 2.5;Peritubular cells: 1.5;Spermatocytes: 1.6"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	20	"HEL: 2.1"					"Not detected"	"Not detected"								"Secreted in male reproductive system"	NA	NA						"unprognostic (2.10e-2)"																	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	26.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	88.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.2	2.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CYP26A1	"CP26, CYP26, P450RAI, P450RAI1"	ENSG00000095596	"Cytochrome P450 family 26 subfamily A member 1"	O43174	10	93073475-93077885	"Metabolic proteins, Predicted intracellular proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	26	"liver: 18.1"	"Group enriched"	"Detected in some"	4	"Basal respiratory cells: 48.0;Endometrial ciliated cells: 46.3;Glandular and luminal cells: 86.7;Muller glia cells: 62.1"	"Cancer enhanced"	"Detected in many"		"testis cancer: 5.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"AF22: 62.1"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"cerebral cortex: 6.9"							NA	NA						"unprognostic (2.80e-1)"	"unprognostic (4.21e-3)"	"unprognostic (5.65e-2)"	"unprognostic (2.94e-1)"	"unprognostic (2.16e-1)"	"unprognostic (4.90e-1)"	"unprognostic (4.17e-2)"	"unprognostic (6.22e-2)"	"unprognostic (3.35e-1)"	"unprognostic (4.89e-1)"	"unprognostic (1.11e-2)"	"unprognostic (6.24e-2)"	"unprognostic (2.04e-11)"	"unprognostic (1.84e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.11e-1)"	0.0	0.1	0.3	0.0	0.5	0.0	0.2	0.1	0.6	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.5	0.4	0.0	18.1	0.0	0.0	0.3	0.2	0.3	0.0	0.0	0.0	0.1	0.5	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.8	62.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.3	0.2	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.6	0.0	0.0	0.0	0.1	0.0	5.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.1	0.6	0.5	0.4	0.3	0.2	0.3	0.2	0.1	0.4	0.3	0.2	0.0	0.0	0.0	0.1	0.0	0.0	48.0	0.0	1.1	0.4	8.1	0.3	0.0	13.1	0.0	2.1	0.3	0.1	0.0	0.0	0.2	0.2	46.3	10.6	1.0	0.0	0.0	0.9	0.0	1.1	0.2	0.0	86.7	0.0	0.0	0.0	8.2	0.1	0.0	4.9	0.0	6.1	0.0	0.0	0.2	0.0	0.2	0.0	1.0	0.0	62.1	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.4	2.7	0.0	0.0	0.4	2.1	2.6	0.0	0.0	7.7	0.6	1.9	0.0	0.0
CYP2F1	CYP2F	ENSG00000197446	"Cytochrome P450 family 2 subfamily F member 1"	P24903	19	41114432-41128381	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lung: 1.4;salivary gland: 1.0;testis: 2.1"	"Cell type enriched"	"Detected in some"	4	"Club cells: 67.4"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	7	"HMC-1: 2.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"	NA	NA						"unprognostic (2.04e-1)"	"unprognostic (8.79e-2)"	"unprognostic (4.63e-1)"	"unprognostic (4.60e-2)"	"unprognostic (2.54e-1)"	"unprognostic (7.29e-3)"		"unprognostic (6.23e-3)"		"unprognostic (2.87e-2)"	"unprognostic (3.91e-2)"		"unprognostic (1.58e-6)"	"unprognostic (1.59e-1)"	"unprognostic (1.29e-1)"	"unprognostic (9.90e-2)"	"unprognostic (1.50e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.5	0.0	67.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.1	0.4	0.2	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	16.5	0.0	0.0	0.0	1.6	8.0	5.3	1.5	0.0	0.0	0.6	0.0	0.0	0.1
DDIT4L	"REDD2, Rtp801L"	ENSG00000145358	"DNA damage inducible transcript 4 like"	Q96D03	4	100185870-100190782	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"skeletal muscle: 326.6;tongue: 107.9"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 22.0;Distal tubular cells: 21.5;Extravillous trophoblasts: 18.5;Granulosa cells: 23.5;Sertoli cells: 19.7"	"Cancer enhanced"	"Detected in many"		"testis cancer: 19.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 19.3;BJ: 29.6;fHDF/TERT166: 16.2;HSkMC: 14.7;hTERT-RPE1: 32.8;RPTEC TERT1: 20.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050903			Uncertain	"Nucleoplasm,Plasma membrane,Actin filaments"		NA	NA			"Plasma membrane"	"Nucleoplasm, Actin filaments"	"HPA050903: "	"unprognostic (2.21e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.34e-1)"	"prognostic favorable (5.77e-4)"	"unprognostic (1.66e-3)"	"unprognostic (5.92e-2)"	"unprognostic (2.72e-2)"	"unprognostic (3.12e-1)"	"unprognostic (3.21e-1)"	"unprognostic (7.18e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.47e-2)"	"unprognostic (4.82e-3)"	"unprognostic (2.09e-2)"	"unprognostic (7.53e-5)"	"unprognostic (4.99e-3)"	2.8	1.0	6.7	0.6	17.9	0.4	2.2	8.2	11.1	23.1	7.0	1.7	0.3	1.5	1.8	7.7	2.2	0.6	2.3	9.9	8.1	13.0	0.4	0.8	0.5	11.1	8.5	6.5	7.8	0.4	0.6	2.0	3.7	11.7	11.3	0.9	1.2	17.5	7.0	326.6	0.9	0.7	1.6	8.9	1.2	0.5	3.1	8.3	1.2	1.1	107.9	0.4	1.2	2.6	8.5	0.0	2.2	8.5	0.0	3.7	19.3	1.2	29.6	2.5	0.5	0.1	0.1	0.9	0.0	0.7	16.2	0.7	0.0	6.2	0.5	0.5	0.0	0.2	0.0	0.5	0.0	0.2	0.0	0.0	14.7	0.1	0.3	1.5	32.8	0.2	0.0	0.0	0.2	0.2	0.0	0.0	0.0	9.7	0.0	0.0	0.6	0.0	0.0	20.5	0.1	0.1	0.1	0.6	1.2	4.0	2.0	0.0	0.1	0.1	0.0	0.0	0.0	2.3	3.9	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	6.7	17.9	8.2	11.1	9.9	8.1	11.1	8.5	6.5	11.7	8.9	8.3	8.5	3.8	0.0	0.0	6.2	0.0	2.7	0.2	4.2	1.8	0.1	1.0	0.9	7.3	0.0	1.3	22.0	0.0	1.9	0.4	0.2	21.5	0.1	0.8	0.5	0.3	3.6	0.0	0.0	0.0	0.0	18.5	5.1	1.5	0.9	0.0	23.5	0.0	0.0	12.0	0.0	0.5	0.3	0.0	0.0	3.0	0.4	0.9	0.3	7.2	0.0	0.0	8.6	0.0	0.5	0.0	0.5	0.0	2.2	0.2	1.1	0.0	2.2	0.1	0.2	19.7	7.3	11.9	4.7	0.8	0.9	1.4	4.0	0.6	8.3	0.4	0.3
DKKL1	"CT34, SGY-1"	ENSG00000104901	"Dickkopf like acrosomal protein 1"	Q9UK85	19	49361783-49375116	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	277	"testis: 347.5"	"Group enriched"	"Detected in some"	4	"Early spermatids: 2188.8;Late spermatids: 2340.4"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.5"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	6	"memory B-cell: 1.7"	"Lineage enriched"	"Detected in single"	17	"B-cells: 1.7"	"Cell line enhanced"	"Detected in some"		"AF22: 5.1;AN3-CA: 9.8;HeLa: 2.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB025410, HPA047194"	Enhanced		Approved	Vesicles	"Secreted in male reproductive system"	NA	NA			Vesicles		"CAB025410: , HPA047194: AB_2679979"	"unprognostic (1.64e-1)"	"unprognostic (5.30e-1)"	"unprognostic (5.39e-4)"	"unprognostic (1.85e-4)"	"unprognostic (3.79e-2)"	"unprognostic (4.30e-2)"	"unprognostic (5.52e-4)"	"unprognostic (1.00e-1)"	"unprognostic (6.76e-2)"	"unprognostic (4.08e-1)"	"unprognostic (1.90e-1)"	"unprognostic (5.65e-2)"	"unprognostic (2.56e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.18e-1)"	"unprognostic (5.57e-2)"	0.7	0.5	0.3	0.5	0.3	0.0	0.5	0.2	0.5	0.6	0.4	0.4	0.3	1.1	0.3	0.2	1.2	0.7	0.4	0.2	0.4	0.3	0.3	0.3	0.5	0.4	0.3	0.1	0.9	1.0	0.2	0.1	0.3	0.2	0.6	0.1	0.3	0.9	0.6	0.2	0.2	0.3	0.4	0.3	0.4	0.3	347.5	0.1	0.0	0.2	0.4	0.2	0.4	0.4	0.3	0.0	1.2	5.1	9.8	0.0	0.3	0.4	0.9	0.0	0.1	0.3	0.0	0.5	0.0	0.7	0.1	0.4	0.0	0.1	0.0	0.0	0.0	1.7	0.0	2.9	0.2	0.0	0.0	0.9	0.7	0.3	0.2	0.3	0.9	0.8	0.0	1.2	0.3	0.1	0.4	0.0	0.0	2.0	0.5	1.1	0.0	0.1	0.0	0.0	0.0	0.0	2.1	0.9	0.0	0.5	1.0	1.0	2.0	1.2	1.0	0.6	0.6	0.0	0.4	0.6	0.2	0.0	0.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.2	0.5	0.2	0.4	0.4	0.3	0.1	0.2	0.3	0.1	0.3	1.3	0.0	0.0	0.0	0.4	0.1	0.1	0.1	0.6	0.6	1.2	2.2	0.4	0.0	0.1	0.0	2.1	0.0	0.0	0.1	0.0	0.4	2188.8	0.5	1.0	1.9	0.0	0.0	0.2	0.5	0.2	0.7	0.0	0.2	0.0	0.5	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.0	2340.4	16.8	1.4	1.8	0.0	0.0	2.1	0.0	0.0	0.0	0.3	0.0	12.0	0.0	0.2	0.0	0.0	0.0	0.4	6.6	0.7	0.9	491.0	15.2	0.2	0.0	0.0	0.1	0.5	0.2	0.2
DLGAP3	"DAP3, SAPAP3"	ENSG00000116544	"DLG associated protein 3"	O95886	1	34865436-34929650	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"brain: 63.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 18.9;Excitatory neurons: 39.1;Horizontal cells: 21.9;Inhibitory neurons: 27.9;Late spermatids: 19.3"	"Cancer enhanced"	"Detected in some"		"testis cancer: 5.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 8.0;NTERA-2: 4.2;SCLC-21H: 12.5;SH-SY5Y: 2.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026445, HPA027304"	Enhanced		Approved	"Endoplasmic reticulum,Plasma membrane,Midbody"		Yes	NA			"Endoplasmic reticulum"	"Plasma membrane, Midbody"	"HPA026445: AB_1847733, HPA027304: "	"unprognostic (8.63e-2)"	"unprognostic (8.58e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.77e-7)"	"unprognostic (4.01e-2)"	"unprognostic (5.51e-2)"	"unprognostic (2.95e-2)"	"unprognostic (8.78e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.27e-4)"	"unprognostic (2.13e-1)"	"unprognostic (1.97e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.21e-1)"	0.2	0.4	49.5	0.5	32.7	1.1	0.2	0.0	53.3	0.2	0.0	0.3	0.2	0.3	0.0	0.1	0.3	0.1	0.1	37.1	17.5	0.6	0.1	0.2	0.3	18.2	21.9	21.0	0.1	1.2	0.2	4.9	0.0	27.2	0.2	0.0	1.8	0.2	0.2	0.1	0.2	0.5	0.0	0.0	2.0	0.3	7.5	63.8	0.3	0.4	0.0	0.1	0.2	0.2	8.1	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	8.0	0.1	0.0	1.0	0.0	1.3	0.0	0.0	0.1	0.1	0.6	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.2	0.0	1.3	0.0	0.0	4.2	0.0	0.0	0.4	0.0	0.1	0.0	0.4	12.5	2.4	0.1	0.1	0.0	0.2	0.3	0.0	0.1	0.0	1.3	0.0	0.0	0.1	0.2	1.6	0.1	0.1	0.1	0.1	0.6	0.0	0.0	0.3	0.2	0.0	0.1	0.1	0.8	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.2	0.2	49.5	32.7	0.0	53.3	37.1	17.5	18.2	21.9	21.0	27.2	0.0	63.8	8.1	0.2	0.0	0.0	1.0	1.8	0.3	0.9	0.8	1.8	4.1	0.7	0.8	1.0	0.0	0.1	1.8	4.2	0.1	0.9	0.8	3.9	0.4	18.9	0.2	0.1	0.4	1.2	0.0	39.1	0.6	0.2	0.4	0.0	0.1	0.0	0.3	0.4	0.1	10.1	21.9	27.9	0.4	0.0	7.1	0.6	19.3	0.9	4.1	0.0	1.9	0.7	1.5	1.0	8.0	0.7	0.2	0.0	0.0	0.8	0.2	1.3	0.8	0.0	2.2	0.0	0.7	0.4	3.4	4.9	1.1	0.3	0.0	1.3	0.1	0.9	0.6
DLK1	"Delta1, FA1, pG2, Pref-1, ZOG"	ENSG00000185559	"Delta like non-canonical Notch ligand 1"	P80370	14	100725705-100738224	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adrenal gland: 1341.7;pituitary gland: 778.9;placenta: 1644.9"	"Cell type enhanced"	"Detected in some"		"Exocrine glandular cells: 576.5;Fibroblasts: 699.3;Leydig cells: 1357.0;Skeletal myocytes: 2360.1"	"Cancer enhanced"	"Detected in many"		"liver cancer: 28.1;testis cancer: 25.4"	"Region enhanced"	"Detected in many"		"hypothalamus: 119.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"AF22: 120.0;Hep G2: 419.1;SH-SY5Y: 473.8"	"Region enhanced"	"Detected in many"		"hypothalamus: 111.7"	"Group enriched"	"Detected in many"	5	"hypothalamus: 41.2;midbrain: 156.8"	"CAB005872, HPA062262"	Enhanced		Approved	"Golgi apparatus"		NA	NA		2600000	"Golgi apparatus"		"CAB005872: AB_731965, HPA062262: AB_2684729"	"unprognostic (2.16e-2)"			"prognostic unfavorable (2.31e-4)"	"unprognostic (1.49e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.89e-3)"	"unprognostic (5.75e-2)"		"unprognostic (1.87e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.24e-1)"		"unprognostic (3.11e-2)"	"unprognostic (6.57e-2)"			3.2	1341.7	7.4	6.1	2.0	0.1	7.1	0.1	12.4	6.2	0.2	0.2	1.8	0.7	0.2	2.6	3.1	2.3	23.5	0.5	119.2	0.6	1.8	0.9	0.5	16.0	38.8	0.2	279.6	21.4	0.0	778.9	1644.9	52.4	1.4	0.0	0.0	27.1	0.0	17.7	1.0	1.3	0.2	2.2	1.1	1.0	41.2	15.4	1.7	0.2	83.8	0.0	1.1	1.5	36.9	0.0	0.0	120.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	12.6	0.3	419.1	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	60.6	0.0	0.0	0.0	0.0	0.3	3.4	0.0	0.0	0.0	1.4	0.1	0.0	0.5	33.7	473.8	0.0	0.1	0.0	2.9	0.0	0.0	0.2	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	35.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	7.4	2.0	0.1	12.4	0.5	119.2	16.0	38.8	0.2	52.4	2.2	15.4	36.9	0.4	0.0	0.0	0.0	0.0	0.6	0.9	0.0	0.0	0.0	1.3	1.0	2.6	0.0	0.0	0.0	0.0	55.2	0.2	0.0	0.0	4.8	7.1	0.0	0.0	6.7	0.0	0.0	0.0	576.5	45.3	699.3	0.0	0.0	0.0	0.8	0.0	0.0	84.3	0.0	0.0	0.0	0.0	0.0	0.3	35.0	1357.0	4.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	5.0	0.0	172.6	0.0	1.3	0.0	0.2	0.0	0.0	59.2	2360.1	3.0	13.5	69.9	0.0	0.4	105.8	0.8	63.2	0.0	0.2
DMC1	LIM15	ENSG00000100206	"DNA meiotic recombinase 1"	Q14565	22	38518948-38570204	"Predicted intracellular proteins"	"Cell cycle, Meiosis"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 12.4"	"Group enriched"	"Detected in many"	5	"Spermatocytes: 109.3;Spermatogonia: 36.0"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.7"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 25.5;hTEC/SVTERT24-B: 17.4;U-266/84: 21.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA001232, CAB015397"	Enhanced		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"CAB015397: AB_629406, HPA001232: AB_1078683"	"unprognostic (1.29e-2)"	"unprognostic (3.11e-3)"	"unprognostic (4.48e-3)"	"unprognostic (5.71e-2)"	"unprognostic (6.43e-2)"	"unprognostic (2.22e-1)"	"unprognostic (8.22e-2)"	"unprognostic (2.61e-2)"	"unprognostic (4.23e-2)"	"unprognostic (3.99e-3)"	"unprognostic (7.40e-3)"	"unprognostic (1.00e-2)"	"unprognostic (2.16e-4)"	"unprognostic (3.94e-1)"	"unprognostic (2.79e-1)"	"unprognostic (7.27e-2)"	"unprognostic (2.99e-1)"	0.6	0.2	0.4	1.4	0.4	2.3	0.9	1.2	0.7	0.9	0.3	0.9	0.2	2.5	0.9	0.9	0.8	0.4	2.3	0.4	0.4	0.5	0.3	0.4	2.8	0.4	0.2	0.4	1.2	0.5	0.3	0.4	0.7	0.6	1.2	1.1	0.8	0.3	0.7	1.3	1.6	0.7	0.7	0.1	0.5	0.6	12.4	0.2	3.4	0.3	0.6	3.1	0.6	0.7	0.6	7.1	2.6	5.0	0.1	0.4	2.1	0.2	7.4	1.0	11.7	8.1	0.2	0.8	3.5	0.3	2.0	0.0	1.2	2.0	0.3	13.1	25.5	0.5	13.6	2.0	0.2	0.2	1.2	2.7	0.5	0.0	17.4	0.0	0.1	0.9	11.2	10.5	3.5	4.1	3.9	2.8	10.3	9.0	3.5	0.2	6.2	0.0	5.2	1.5	0.9	9.7	0.5	12.5	1.1	0.1	1.1	2.1	2.9	0.3	0.1	0.8	0.1	0.1	9.8	21.4	6.4	2.0	2.8	0.9	0.4	0.1	0.1	0.3	0.0	0.0	0.1	0.2	0.1	0.2	0.2	0.2	0.1	0.4	0.5	0.1	0.1	0.1	0.1	0.4	0.4	1.2	0.7	0.4	0.4	0.4	0.2	0.4	0.6	0.1	0.2	0.6	0.6	0.0	2.3	3.6	0.7	2.3	1.0	0.4	1.8	0.7	2.7	2.4	2.5	0.0	2.7	3.7	0.0	1.9	0.4	1.3	1.9	0.2	2.9	0.9	0.8	0.8	0.0	11.8	1.1	0.0	1.7	1.4	0.0	1.3	1.3	1.1	0.4	0.1	1.0	0.0	1.4	1.6	0.0	0.0	1.2	3.0	1.5	1.1	0.0	1.9	0.1	4.8	1.0	2.5	0.6	0.1	0.5	1.5	3.8	0.2	0.1	0.4	0.9	0.2	13.1	1.3	0.9	109.3	36.0	0.3	0.6	0.8	0.9	0.3	2.5	0.5
DMD	"BMD, DXS142, DXS164, DXS206, DXS230, DXS239, DXS268, DXS269, DXS270, DXS272, MRX85"	ENSG00000198947	Dystrophin	P11532	X	31097677-33339609	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transporters"		Actin-binding	"Cancer-related genes, Cardiomyopathy, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 452.8;Excitatory neurons: 1275.8;Inhibitory neurons: 719.8;Oligodendrocyte precursor cells: 1161.6;Oligodendrocytes: 610.2;Rod photoreceptor cells: 375.9"	"Cancer enhanced"	"Detected in many"		"testis cancer: 8.0"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 4.3"	"Group enriched"	"Detected in many"	7	"B-cells: 1.1;granulocytes: 4.3"	"Cell line enhanced"	"Detected in many"		"AF22: 27.9;Hep G2: 30.3;RH-30: 25.0;SuSa: 27.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000119, HPA002725, HPA023885"	Enhanced					NA	NA					"CAB000119: , HPA002725: AB_1078714, HPA023885: AB_1847931"	"unprognostic (3.91e-3)"	"unprognostic (2.29e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.17e-1)"	"unprognostic (7.58e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.60e-4)"	"unprognostic (6.98e-2)"	"unprognostic (1.25e-1)"	"unprognostic (5.84e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.15e-2)"	"unprognostic (8.76e-3)"	"unprognostic (1.82e-1)"	"unprognostic (9.83e-2)"	"unprognostic (1.51e-2)"	15.2	14.9	13.3	5.3	13.6	0.6	17.0	0.8	16.0	6.8	8.1	27.8	5.5	18.2	11.3	9.2	17.0	21.7	38.2	16.8	3.2	5.5	50.4	7.2	4.8	3.8	2.3	10.7	14.0	53.3	4.4	4.4	15.3	3.7	13.6	8.4	80.7	30.5	31.0	74.0	11.6	9.5	22.2	0.1	2.3	15.6	8.3	3.4	3.3	7.3	68.0	6.4	21.2	7.2	11.1	0.3	0.2	27.9	0.3	0.3	0.3	7.6	6.1	0.6	2.8	3.1	13.3	0.6	0.4	0.2	12.5	2.3	8.5	10.5	15.0	4.2	7.4	8.6	3.3	10.5	30.3	14.7	1.2	3.7	3.3	9.5	4.6	17.1	15.3	6.1	2.0	2.9	0.4	8.3	0.5	4.4	0.6	13.3	0.1	9.8	0.3	25.0	0.1	0.3	3.3	0.5	8.5	0.1	2.3	2.8	27.7	2.2	0.1	1.6	0.3	0.5	1.1	4.6	0.4	23.8	0.6	1.0	2.3	14.4	0.8	0.1	2.0	0.1	0.1	0.1	1.1	0.1	0.1	0.3	0.9	0.1	0.1	4.3	0.1	0.1	0.4	0.2	0.1	13.3	13.6	0.8	16.0	16.8	3.2	3.8	2.3	10.7	3.7	0.1	3.4	11.1	8.5	28.9	25.3	164.9	6.7	20.1	7.0	6.3	3.4	78.0	26.5	50.0	452.8	7.2	15.0	3.7	308.6	33.7	0.7	0.8	3.9	3.8	22.4	22.5	1.4	9.9	8.4	0.0	1275.8	12.3	9.5	26.1	3.6	5.6	1.3	37.9	6.1	49.8	4.2	11.8	719.8	1.3	6.1	4.8	5.4	20.5	89.2	3.5	19.6	94.6	6.7	54.9	0.0	1161.6	610.2	6.0	0.1	118.8	0.2	3.6	3.6	2.1	60.4	375.9	118.3	95.2	50.3	4.0	8.8	1.8	11.5	5.1	1.0	33.1	4.2	4.8
DNAH10	FLJ43808	ENSG00000197653	"Dynein axonemal heavy chain 10"	Q8IVF4	12	123762188-123935720	"Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 4.3;fallopian tube: 4.1;testis: 3.0"	"Group enriched"	"Detected in many"	5	"Early spermatids: 35.5;Endometrial ciliated cells: 88.5;Late spermatids: 68.9;Respiratory ciliated cells: 88.0"	"Cancer enhanced"	"Detected in single"		"testis cancer: 1.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA039066	Enhanced					NA	NA					"HPA039066: AB_10673237"	"unprognostic (1.37e-1)"	"unprognostic (1.78e-1)"	"unprognostic (6.08e-3)"	"unprognostic (9.90e-3)"	"unprognostic (2.16e-1)"	"unprognostic (8.91e-2)"	"unprognostic (3.39e-2)"	"unprognostic (1.86e-1)"	"unprognostic (5.59e-2)"	"unprognostic (1.08e-2)"	"unprognostic (7.28e-3)"	"unprognostic (5.25e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.33e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.22e-2)"	"unprognostic (9.11e-3)"	0.1	0.0	3.9	0.0	1.0	1.2	0.0	1.3	0.5	0.5	2.1	0.0	0.1	0.1	0.0	0.0	4.1	0.0	0.1	0.7	1.5	0.1	0.0	1.2	0.0	3.7	3.6	0.0	0.0	0.0	0.0	0.1	0.1	2.5	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.3	0.0	4.3	0.1	0.0	3.0	1.9	0.0	0.1	0.0	0.0	0.1	0.1	1.2	0.0	0.0	0.0	0.5	0.9	0.4	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.9	1.0	1.3	0.5	0.7	1.5	3.7	3.6	0.0	2.5	4.3	1.9	1.2	0.0	0.0	5.5	2.0	0.7	0.0	0.0	1.6	0.0	1.2	0.1	0.3	2.3	0.0	12.9	0.0	0.0	0.0	0.6	0.0	1.9	0.0	35.5	88.5	1.2	0.3	0.0	0.4	7.2	0.0	0.0	0.8	0.0	2.1	0.0	0.1	0.4	0.0	0.1	0.0	6.1	0.2	0.0	0.0	0.0	68.9	0.0	0.3	0.0	0.0	0.4	1.0	1.0	2.0	5.0	0.1	0.0	0.0	0.0	0.0	1.2	2.9	88.0	1.4	13.1	0.6	1.0	9.9	2.1	0.0	0.0	0.0	0.4	0.9	0.4	0.1
EGFLAM	"AGRINL, AGRNL, FLJ39155, PIKA"	ENSG00000164318	"EGF like, fibronectin type III and laminin G domains"	Q63HQ2	5	38258409-38465480	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"tongue: 122.2"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 120.9;Early spermatids: 50.7;Late spermatids: 49.1;Leydig cells: 155.4;Sertoli cells: 85.5;Smooth muscle cells: 70.9"	"Cancer enhanced"	"Detected in all"		"testis cancer: 6.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 10.2;HBEC3-KT: 12.6;hTERT-HME1: 16.4;HUVEC TERT2: 16.1;LHCN-M2: 37.0;U-2 OS: 15.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA066577	Approved				"Secreted - unknown location"	NA	NA					"HPA066577: "	"unprognostic (2.05e-1)"	"unprognostic (4.81e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.38e-3)"	"unprognostic (1.08e-2)"	"unprognostic (3.63e-3)"	"unprognostic (6.31e-2)"	"unprognostic (2.83e-1)"	"unprognostic (2.08e-2)"	"unprognostic (1.71e-3)"	"unprognostic (1.12e-1)"	"unprognostic (5.80e-2)"	"prognostic unfavorable (4.47e-5)"	"unprognostic (7.02e-6)"	"unprognostic (2.60e-1)"	"unprognostic (9.90e-2)"	"unprognostic (1.04e-2)"	39.6	20.0	2.0	2.8	2.3	0.2	47.5	1.9	2.3	15.0	3.2	5.3	1.9	5.7	6.9	4.0	8.3	4.9	16.4	1.4	5.8	6.9	4.7	2.9	14.3	2.8	4.2	1.6	23.9	3.2	4.0	5.8	52.1	3.5	14.3	3.2	67.3	6.9	20.8	72.7	5.9	4.7	6.7	1.4	9.9	3.4	15.2	3.0	20.6	9.1	122.2	9.1	7.7	13.1	2.4	3.2	0.0	6.5	0.2	0.8	0.2	0.0	2.9	0.0	0.5	0.1	0.0	0.0	0.1	10.2	0.1	0.1	0.0	0.0	12.6	0.0	0.0	1.6	0.0	6.1	0.0	2.8	0.0	0.1	5.4	0.0	0.1	16.4	0.0	16.1	0.0	0.0	0.0	37.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.3	3.9	0.0	3.7	0.1	1.3	0.0	0.2	0.0	0.1	15.6	0.6	0.2	0.0	0.2	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	2.3	1.9	2.3	1.4	5.8	2.8	4.2	1.6	3.5	1.4	3.0	2.4	11.4	0.0	0.0	0.3	0.0	2.7	0.3	0.0	0.0	1.3	2.4	9.8	2.6	0.0	0.0	0.0	120.9	0.3	0.4	0.0	3.9	0.5	50.7	0.2	3.2	5.4	0.0	0.0	0.6	1.0	0.5	17.8	0.0	0.3	0.0	1.6	1.4	0.0	0.7	0.0	0.9	0.0	0.0	0.0	4.2	49.1	155.4	0.6	5.4	1.9	0.0	3.4	0.0	1.0	0.1	1.3	0.0	30.9	0.0	0.2	0.0	6.5	0.0	33.1	85.5	22.0	70.9	9.8	3.3	0.3	2.0	0.5	0.4	23.5	0.0	0.3
EID3	"FLJ25832, NSE4B, NSMCE4B"	ENSG00000255150	"EP300 interacting inhibitor of differentiation 3"	Q8N140	12	104303739-104305205	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"testis: 61.8"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 78.5;Early spermatids: 72.8;Spermatocytes: 306.8"	"Cancer enhanced"	"Detected in many"		"testis cancer: 5.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 9.1;BJ: 8.5;BJ hTERT+: 6.9;BJ hTERT+ SV40 Large T+ RasG12V: 6.8;HeLa: 8.9"	"Not detected"	"Not detected"							HPA059367	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA059367: AB_2683992"	"unprognostic (1.25e-1)"	"unprognostic (5.41e-3)"	"unprognostic (5.82e-2)"	"unprognostic (8.21e-2)"	"prognostic unfavorable (1.14e-4)"	"unprognostic (8.02e-2)"	"unprognostic (5.88e-5)"	"unprognostic (1.06e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.66e-2)"	"unprognostic (5.38e-3)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (5.96e-5)"	"unprognostic (8.70e-2)"	"unprognostic (3.54e-1)"	"unprognostic (2.04e-3)"	"unprognostic (2.87e-2)"	2.8	3.1	1.9	3.6	1.9	5.3	2.4	2.2	2.4	3.0	2.8	2.5	0.8	2.8	2.7	1.8	3.1	2.7	1.9	2.1	10.6	1.8	1.4	3.0	6.2	7.0	2.6	1.8	4.1	2.5	1.2	3.7	1.7	2.3	3.3	0.9	6.7	1.4	5.6	0.6	2.4	2.7	2.3	2.6	3.0	2.2	61.8	2.4	3.8	1.5	1.0	3.9	2.4	2.1	3.8	0.3	9.1	0.3	0.9	2.0	2.0	1.7	8.5	6.9	4.0	6.8	0.2	0.5	0.1	0.0	1.9	1.8	0.2	0.3	0.7	5.9	0.5	0.1	1.7	8.9	1.4	2.9	0.1	0.5	2.7	0.0	2.5	0.5	0.4	0.6	0.4	0.1	0.5	2.5	0.1	3.1	1.3	0.4	0.1	1.8	0.2	0.0	0.1	2.2	0.3	0.1	0.0	5.6	0.4	0.2	0.2	0.0	0.0	1.3	0.1	0.3	2.0	0.4	0.4	0.2	0.1	0.2	0.0	0.9	0.0	0.3	0.5	4.4	1.4	4.6	2.3	5.6	5.4	0.2	2.3	7.9	5.0	0.7	6.2	0.9	0.5	7.3	2.2	1.9	1.9	2.2	2.4	2.1	10.6	7.0	2.6	1.8	2.3	2.6	2.4	3.8	4.7	0.0	6.0	0.0	5.9	13.4	78.5	5.9	1.8	4.9	2.4	3.9	1.4	2.8	2.7	1.8	27.1	2.4	11.1	2.4	0.0	3.5	72.8	13.8	9.6	14.0	0.0	6.6	0.0	1.3	1.6	12.7	5.1	21.1	1.3	6.1	5.3	3.0	1.9	11.8	0.0	1.2	4.1	4.7	26.8	23.5	8.7	6.8	1.8	0.0	4.0	7.5	6.2	0.0	0.0	4.9	4.5	4.5	4.3	47.6	1.2	1.7	7.5	18.6	6.6	7.6	8.4	306.8	44.3	1.4	7.7	2.5	11.1	15.6	1.0	46.9
ELOVL3	CIG-30	ENSG00000119915	"ELOVL fatty acid elongase 3"	Q9HB03	10	102226299-102229589	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"skin 1: 18.2"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 2.5;Breast myoepithelial cells: 3.2;Skeletal myocytes: 5.0;Spermatogonia: 3.4;Theca cells: 2.2"	"Cancer enhanced"	"Detected in many"		"testis cancer: 10.6"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	10	"classical monocyte: 7.1;intermediate monocyte: 2.4;myeloid DC: 2.0;non-classical monocyte: 5.9"	"Group enriched"	"Detected in many"	10	"dendritic cells: 2.0;monocytes: 7.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 9.5;ASC TERT1: 9.4;HSkMC: 13.9;NB-4: 11.6;SiHa: 22.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA036236	Enhanced		Approved	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"HPA036236: AB_10601550"	"unprognostic (1.52e-2)"	"unprognostic (6.76e-2)"	"unprognostic (1.84e-2)"	"prognostic unfavorable (6.25e-5)"	"unprognostic (8.23e-3)"	"unprognostic (9.82e-2)"	"unprognostic (2.17e-4)"	"unprognostic (4.27e-2)"	"unprognostic (2.28e-1)"	"unprognostic (5.56e-2)"	"unprognostic (1.84e-2)"	"unprognostic (5.36e-3)"	"unprognostic (2.66e-9)"	"unprognostic (1.04e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.79e-1)"	3.3	0.7	1.0	0.4	0.7	1.8	3.6	0.4	1.3	0.1	0.3	0.1	0.0	0.1	0.2	0.2	0.2	0.2	0.2	0.9	0.4	0.3	0.0	1.0	0.1	0.4	0.8	0.9	0.1	0.0	0.1	0.0	0.9	0.5	0.2	0.1	0.1	0.3	0.1	0.2	18.2	0.2	0.0	0.4	0.8	0.1	1.2	0.4	0.0	0.0	0.3	0.0	0.2	0.3	0.7	3.2	0.2	0.2	7.8	9.5	9.4	2.8	0.1	0.3	0.4	0.5	0.5	3.0	0.0	0.3	0.0	0.0	0.1	5.9	0.1	0.5	0.0	0.0	0.2	0.4	0.8	0.3	0.0	0.1	13.9	1.6	3.6	0.0	0.0	0.0	0.9	0.1	3.5	0.8	0.0	0.0	11.6	0.1	1.1	1.0	0.0	5.1	0.0	2.0	0.1	0.0	0.4	22.6	0.9	0.7	0.6	8.1	2.7	0.0	1.5	0.0	0.3	0.3	0.5	7.2	0.0	3.4	6.5	0.0	0.0	7.1	0.0	0.0	2.4	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.4	0.0	5.9	0.0	0.0	1.7	1.0	0.7	0.4	1.3	0.9	0.4	0.4	0.8	0.9	0.5	0.4	0.4	0.7	2.5	0.0	1.1	0.0	0.2	0.4	0.5	0.6	0.6	0.0	1.1	3.2	0.3	0.0	0.5	0.0	0.0	0.0	1.1	0.2	0.0	0.1	0.0	0.0	1.3	1.9	0.0	0.0	0.3	0.0	0.7	1.3	0.0	0.2	0.0	0.0	1.4	0.4	0.2	0.0	0.0	0.2	0.0	1.5	0.8	0.0	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	5.0	1.2	0.1	3.4	0.6	0.1	0.3	0.3	2.2	0.2	0.1
EOMES	TBR2	ENSG00000163508	Eomesodermin	O95936	3	27715949-27722711	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Adaptive immunity, Differentiation, Gastrulation, Immunity, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 8.0;lymphoid tissue: 15.1"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 43.6;Erythroid cells: 16.8;NK-cells: 93.7;T-cells: 31.5"	"Cancer enhanced"	"Detected in many"		"testis cancer: 5.8"	"Region enriched"	"Detected in some"	5	"cerebellum: 8.0"	"Group enriched"	"Detected in many"	7	"gdT-cell: 16.5;MAIT T-cell: 26.2;memory CD8 T-cell: 19.5;naive CD8 T-cell: 11.9;NK-cell: 33.0"	"Group enriched"	"Detected in many"	107	"NK-cells: 33.0;T-cells: 26.2"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 7.4;JURKAT: 8.3;SCLC-21H: 3.9"	"Region enriched"	"Detected in many"	8	"olfactory bulb: 77.5"	"Group enriched"	"Detected in some"	27	"cerebellum: 30.2;olfactory bulb: 12.7"	HPA028896	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA028896: AB_10601370"	"unprognostic (1.53e-4)"	"unprognostic (5.95e-3)"	"unprognostic (3.01e-2)"	"unprognostic (1.60e-4)"	"unprognostic (4.13e-2)"	"unprognostic (9.63e-4)"	"unprognostic (4.29e-4)"	"unprognostic (3.14e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.82e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (9.45e-6)"	"unprognostic (1.61e-1)"	"unprognostic (5.09e-1)"	"unprognostic (6.32e-3)"	"unprognostic (1.49e-2)"	0.7	0.6	0.2	3.2	0.2	1.8	0.6	8.0	0.4	0.4	0.5	0.7	0.4	0.8	0.8	0.3	0.4	1.6	0.3	0.2	0.4	0.4	2.4	2.2	15.1	0.2	0.7	0.2	0.5	0.3	0.1	0.2	0.4	1.5	0.5	0.8	1.6	0.9	0.1	0.1	0.3	1.4	0.4	0.3	12.9	1.3	0.4	0.3	1.5	0.5	0.1	5.5	1.3	0.4	0.4	0.0	0.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	1.6	1.3	0.0	7.4	1.1	0.0	0.0	0.5	0.0	0.9	0.0	0.0	0.8	0.0	0.9	0.3	0.0	8.3	0.2	0.0	0.0	2.0	2.0	0.0	0.2	0.2	0.9	1.3	0.0	0.0	0.6	0.0	3.9	0.0	0.0	0.0	0.9	0.3	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	16.5	0.0	26.2	0.0	3.0	19.5	0.0	0.0	0.2	11.9	0.2	33.0	0.1	0.1	0.0	2.9	0.2	0.2	8.0	0.4	0.2	0.4	0.2	0.7	0.2	1.5	0.3	0.3	0.4	0.3	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.4	0.2	0.3	0.8	1.5	0.0	0.0	0.0	0.0	43.6	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.0	16.8	0.0	0.0	0.0	0.3	0.5	0.1	0.0	0.0	2.2	1.6	0.2	0.0	0.0	0.0	0.0	3.1	0.7	0.0	0.3	1.3	1.8	1.0	1.1	0.1	93.7	0.0	0.0	0.0	0.0	0.4	9.8	0.1	0.0	0.1	0.0	0.5	0.0	0.0	0.7	0.0	2.0	0.0	0.1	0.0	31.5	0.0	0.0	0.0
EPHA8	"EEK, Hek3"	ENSG00000070886	"EPH receptor A8"	P29322	1	22563489-22603595	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Neurogenesis"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"choroid plexus: 23.3"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 4.2;Cone photoreceptor cells: 2.1;Early spermatids: 2.8;Horizontal cells: 3.3;Late spermatids: 5.8;Rod photoreceptor cells: 8.8"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	12	"SCLC-21H: 59.6"	"Region enhanced"	"Detected in many"		"cerebellum: 13.0"	"Region enriched"	"Detected in many"	4	"cerebellum: 11.7"	"CAB009660, HPA031433"	Uncertain				"Intracellular and membrane"	NA	NA					"CAB009660: AB_2099696, HPA031433: AB_10601371"	"unprognostic (8.58e-2)"	"unprognostic (8.59e-2)"	"unprognostic (3.72e-1)"	"unprognostic (1.15e-2)"	"unprognostic (4.69e-4)"	"unprognostic (3.58e-1)"		"unprognostic (7.14e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.75e-2)"	"unprognostic (9.80e-2)"	"unprognostic (2.10e-1)"	"unprognostic (9.84e-14)"	"unprognostic (2.14e-3)"	"unprognostic (1.69e-1)"	"unprognostic (2.76e-1)"	"unprognostic (8.68e-2)"	0.0	3.6	1.8	0.0	2.4	0.0	0.0	1.4	1.8	0.0	23.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	5.0	4.8	0.0	0.0	0.0	0.0	1.7	2.9	2.2	0.0	3.3	0.0	1.5	0.0	1.6	0.0	0.0	2.2	0.0	0.0	0.0	0.1	0.0	0.0	1.0	4.6	0.0	2.2	3.9	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	59.6	4.8	0.0	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	2.4	1.4	1.8	5.0	4.8	1.7	2.9	2.2	1.6	1.0	3.9	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.1	0.0	1.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.1	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	3.3	1.3	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.1	0.0	0.4	0.0	0.1	0.0	0.0	0.0	8.8	0.0	0.0	0.1	1.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ERCC6L	"FLJ20105, PICH, RAD26L"	ENSG00000186871	"ERCC excision repair 6 like, spindle assembly checkpoint helicase"	Q2NKX8	X	72204657-72239027	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 3.3;lymphoid tissue: 3.6"	"Cell type enhanced"	"Detected in some"		"Erythroid cells: 3.4;Granulosa cells: 2.5;Spermatocytes: 2.1;Spermatogonia: 2.4;Squamous epithelial cells: 2.4"	"Cancer enhanced"	"Detected in many"		"testis cancer: 11.0"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	4	"NK-cell: 1.7"	"Lineage enriched"	"Detected in single"	4	"NK-cells: 1.7"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA050492	Approved		Uncertain	Nucleoplasm,Centrosome,Cytosol		No	Yes			Centrosome	"Nucleoplasm, Cytosol"	"HPA050492: AB_2681145"	"prognostic unfavorable (1.80e-4)"	"unprognostic (2.93e-1)"	"unprognostic (1.95e-2)"	"unprognostic (5.76e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.36e-1)"	"unprognostic (9.23e-6)"	"unprognostic (8.63e-3)"	"unprognostic (1.57e-2)"	"unprognostic (1.99e-2)"	"unprognostic (3.68e-5)"	"unprognostic (4.61e-2)"	"unprognostic (0.00e+0)"	"unprognostic (2.97e-3)"	"unprognostic (9.56e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.41e-2)"	0.2	0.1	0.1	1.3	0.2	3.3	0.4	0.7	0.2	0.4	0.0	0.9	0.7	0.2	0.2	1.2	0.2	0.2	0.1	0.1	0.0	0.1	0.1	0.1	2.3	0.1	0.1	0.0	0.3	0.1	0.0	0.1	0.5	0.3	0.1	1.2	0.5	0.3	0.0	0.1	0.6	0.6	0.3	0.0	0.5	0.8	0.8	0.2	3.6	0.1	0.0	2.7	0.2	0.4	0.5	19.0	16.3	14.6	9.3	1.0	1.7	8.0	19.8	9.1	17.0	17.7	13.3	11.6	30.5	7.3	7.2	23.0	15.2	27.8	14.8	30.1	17.5	20.2	10.5	5.5	7.9	0.0	20.7	14.2	0.2	0.9	23.7	4.4	2.8	9.6	15.1	14.1	7.3	17.6	14.8	19.8	12.1	26.6	18.3	24.8	16.4	26.2	5.4	4.4	11.5	12.0	8.6	14.7	9.8	3.6	11.8	7.5	4.6	6.0	11.4	18.3	21.8	13.1	5.7	9.4	25.9	8.1	14.1	11.7	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.4	0.1	1.7	0.1	0.1	0.4	0.1	0.1	0.2	0.7	0.2	0.1	0.0	0.1	0.1	0.0	0.3	0.0	0.2	0.5	0.1	0.0	0.0	0.0	0.9	0.3	0.2	0.5	0.0	0.0	0.3	0.6	0.5	1.5	0.2	0.0	0.0	1.1	0.9	0.6	0.0	0.0	0.3	0.9	0.8	0.3	0.0	3.4	0.9	0.0	1.7	0.5	0.0	0.5	0.0	2.5	0.0	0.0	1.0	0.0	0.7	0.4	0.0	0.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.5	1.7	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.4	2.1	2.4	2.4	0.1	0.4	0.3	0.2	0.9	0.1
ESRRB	"DFNB35, ERR2, ERRb, ERRbeta, ESRL2, NR3B2"	ENSG00000119715	"Estrogen related receptor beta"	O95718	14	76310712-76501837	"Disease related genes, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"retina: 36.8"	"Cell type enhanced"	"Detected in some"		"Distal tubular cells: 13.7;Early spermatids: 14.1;Horizontal cells: 55.5;Late spermatids: 37.6;Rod photoreceptor cells: 40.3"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.6"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 1.3;K-562: 5.0;U-266/70: 2.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA074772			Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA074772: "	"unprognostic (1.12e-1)"	"unprognostic (1.34e-2)"	"unprognostic (6.28e-2)"	"unprognostic (3.92e-5)"	"unprognostic (5.18e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.24e-2)"	"unprognostic (2.16e-2)"	"unprognostic (4.11e-2)"	"unprognostic (2.68e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.12e-4)"	"unprognostic (4.40e-2)"	0.0	0.0	0.3	0.0	0.4	0.0	0.3	0.4	0.4	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.1	0.0	4.9	0.3	0.5	6.2	0.0	0.0	0.0	1.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	36.8	0.0	0.0	6.6	0.0	0.0	0.0	0.6	0.2	2.4	1.2	0.8	0.1	0.0	1.6	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.2	0.0	0.0	0.0	0.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	5.0	0.2	0.0	0.6	0.0	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.5	0.0	0.4	0.0	0.2	2.3	0.7	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.4	0.4	0.3	0.5	1.1	0.8	0.0	0.8	0.6	0.8	0.7	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	2.4	1.0	0.4	5.8	0.0	0.0	0.0	2.1	0.0	0.0	0.0	13.7	0.0	14.1	0.0	0.0	0.8	0.0	0.0	1.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	55.5	2.0	0.0	0.0	0.0	0.0	37.6	0.0	0.1	0.0	3.7	0.0	4.6	0.0	1.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	40.3	0.0	0.1	0.8	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ETV4	"E1A-F, E1AF, PEA3"	ENSG00000175832	"ETS variant transcription factor 4"	P43268	17	43527844-43579620	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 23.3;Cholangiocytes: 17.2;Distal tubular cells: 17.6;Enteroendocrine cells: 14.9;Extravillous trophoblasts: 19.8;Syncytiotrophoblasts: 14.9"	"Cancer enhanced"	"Detected in all"		"testis cancer: 80.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 177.7;Hep G2: 173.0;SK-MEL-30: 197.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA005768	Approved		Supported	"Nucleoli rim,Mitotic chromosome"		Yes	No			"Nucleoli rim"	"Mitotic chromosome"	"HPA005768: AB_1848294"	"unprognostic (2.32e-1)"	"unprognostic (7.33e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.97e-2)"	"unprognostic (3.14e-3)"	"prognostic unfavorable (2.48e-4)"	"unprognostic (1.58e-2)"	"unprognostic (5.34e-2)"	"unprognostic (8.13e-2)"	"unprognostic (7.05e-2)"	"unprognostic (3.01e-1)"	"unprognostic (7.79e-2)"	"unprognostic (2.03e-1)"	"unprognostic (7.08e-2)"	"prognostic favorable (7.60e-4)"	"unprognostic (1.69e-1)"	0.5	2.5	1.3	1.0	1.6	0.0	7.1	0.9	2.2	3.0	0.0	2.0	6.1	2.5	1.0	9.2	2.5	6.4	3.1	1.4	1.4	5.4	1.2	2.3	0.6	1.1	0.9	0.8	0.4	7.9	7.9	14.9	5.3	1.1	4.6	1.8	3.0	4.7	3.6	1.3	6.4	4.2	1.4	0.3	0.4	3.8	1.2	0.7	0.3	7.0	2.5	4.8	2.2	5.3	0.9	24.5	67.0	80.4	177.7	3.1	20.1	17.9	7.9	21.1	14.9	15.2	38.1	33.9	0.1	4.3	4.1	36.6	43.6	2.7	40.2	13.2	0.8	0.5	2.3	10.7	173.0	4.3	47.0	20.9	3.6	1.4	56.8	35.0	16.8	32.1	0.3	48.9	0.1	31.0	9.8	0.2	82.9	116.9	123.1	110.9	99.8	9.8	58.9	33.0	17.3	0.1	71.4	2.1	4.5	197.0	43.8	0.8	13.9	15.1	10.6	52.0	15.7	22.1	7.3	47.8	0.1	18.9	8.9	63.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.3	1.6	0.9	2.2	1.4	1.4	1.1	0.9	0.8	1.1	0.3	0.7	0.9	0.2	0.0	0.0	1.3	0.0	1.9	2.5	3.6	23.3	3.2	10.4	12.3	1.1	17.2	2.4	0.0	0.0	2.3	0.1	1.1	17.6	6.5	3.1	0.7	0.3	1.5	14.9	0.0	1.6	1.0	19.8	1.9	3.1	1.6	0.0	0.2	0.7	0.0	0.8	0.0	1.0	4.0	2.0	0.3	0.3	6.0	0.3	0.2	3.6	1.0	0.0	10.9	0.0	1.0	0.0	3.7	3.3	0.4	0.0	0.9	1.9	0.1	1.0	0.3	0.0	2.1	1.7	0.0	1.3	3.6	1.1	14.9	0.3	0.1	7.7	4.3
FBN3	KIAA1776	ENSG00000142449	"Fibrillin 3"	Q75N90	19	8065402-8149592	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 2.4;salivary gland: 4.0"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 6.4;Cardiomyocytes: 2.4;Inhibitory neurons: 3.4;Oligodendrocyte precursor cells: 17.1"	"Cancer enhanced"	"Detected in many"		"testis cancer: 8.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.8;CACO-2: 3.7;NTERA-2: 12.3;REH: 18.6;SuSa: 4.5"					"Not detected"	"Not detected"			HPA049482	Uncertain				"Secreted to extracellular matrix"	NA	NA		2400000			"HPA049482: AB_2680786"	"unprognostic (9.66e-3)"	"unprognostic (5.15e-3)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (5.15e-4)"	"unprognostic (4.14e-2)"	"unprognostic (5.14e-3)"	"unprognostic (6.26e-2)"	"unprognostic (4.10e-3)"	"unprognostic (3.17e-2)"	"unprognostic (8.94e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.76e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.17e-2)"	"unprognostic (3.17e-1)"	0.1	0.0	0.4	0.0	0.3	0.0	0.3	0.3	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.5	0.0	0.0	0.2	0.5	2.4	0.1	1.4	0.0	0.5	0.5	0.2	0.1	0.0	0.0	0.8	0.0	0.6	0.9	0.1	0.0	4.0	0.0	0.4	0.2	0.1	0.1	0.5	0.0	0.1	0.5	0.4	0.5	1.9	0.9	0.0	0.0	0.0	0.7	0.0	0.0	0.9	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	3.7	0.4	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	12.3	0.0	0.0	18.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.3	0.4	0.2	0.5	0.5	0.5	0.2	0.6	0.5	0.4	0.7	0.0	6.4	1.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	2.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.2	0.0	0.8	0.0	0.0	0.2	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	17.1	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.4	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1
FBXO36	"Fbx36, FLJ37592"	ENSG00000153832	"F-box protein 36"	Q8NEA4	2	229922302-230013119	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 35.5;Early spermatids: 61.7;Endometrial ciliated cells: 40.8;Respiratory ciliated cells: 53.0;Spermatocytes: 55.8"	"Cancer enhanced"	"Detected in all"		"testis cancer: 9.6"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053865			Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA053865: AB_2682282"	"unprognostic (4.39e-3)"	"unprognostic (6.51e-2)"	"unprognostic (2.38e-2)"	"prognostic favorable (2.28e-4)"	"unprognostic (2.43e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.28e-2)"	"unprognostic (8.04e-2)"	"unprognostic (7.79e-3)"	"unprognostic (3.72e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.68e-1)"	1.7	3.7	5.3	0.7	4.1	0.8	3.5	4.6	4.5	3.0	3.5	1.2	1.4	2.5	2.8	1.7	11.1	1.7	1.2	3.6	5.7	5.1	1.6	2.3	0.9	5.7	5.3	3.3	2.4	1.6	4.3	2.7	1.6	4.9	2.9	1.2	9.1	2.3	2.5	0.8	3.0	1.4	1.7	5.8	0.8	1.7	6.1	4.3	1.5	7.5	0.8	1.0	1.3	1.5	5.1	1.0	1.9	2.3	0.9	1.1	6.8	4.6	1.2	3.2	1.7	2.9	0.7	3.1	0.1	0.6	2.2	2.1	0.8	1.1	0.6	2.9	0.3	0.7	0.4	0.6	1.2	4.4	0.8	0.3	7.2	5.2	3.2	2.4	2.2	1.8	3.4	1.4	0.6	2.0	4.2	1.7	1.9	6.1	2.2	2.2	2.0	0.6	0.5	3.0	0.8	2.2	2.8	2.0	1.6	0.8	2.6	3.4	1.4	1.3	2.8	1.0	4.6	0.5	2.1	1.8	0.7	3.4	0.4	2.1	0.0	0.5	0.0	0.8	0.4	0.6	1.1	0.6	0.6	1.3	0.7	1.4	0.8	0.2	1.0	0.3	0.6	1.2	0.5	5.3	4.1	4.6	4.5	3.6	5.7	5.7	5.3	3.3	4.9	5.8	4.3	5.1	3.1	9.6	1.1	11.4	1.1	3.8	2.9	8.3	1.2	8.3	4.3	4.3	3.7	0.0	9.9	11.0	35.5	1.9	0.6	2.3	15.6	6.2	61.7	40.8	4.9	2.3	0.0	2.5	19.5	6.6	2.0	3.7	3.1	4.7	0.0	4.2	1.4	2.7	1.1	10.1	22.1	1.6	14.2	1.6	3.0	10.5	3.4	1.2	3.6	5.6	2.9	7.5	4.1	12.5	12.5	6.2	0.5	4.1	0.7	3.0	2.2	12.2	53.0	28.8	6.6	2.8	4.2	55.8	8.6	3.2	4.5	2.2	1.5	9.1	1.4	1.9
FGD1	"FGDY, ZFYVE3"	ENSG00000102302	"FYVE, RhoGEF and PH domain containing 1"	P98174	X	54445454-54496234	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 16.1;Granulosa cells: 12.6;Inhibitory neurons: 15.2"	"Cancer enhanced"	"Detected in all"		"testis cancer: 28.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000911, HPA076516"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA000911: AB_1078853, HPA076516: "	"unprognostic (2.49e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.64e-2)"	"prognostic unfavorable (2.10e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.36e-2)"	"unprognostic (8.74e-2)"	"unprognostic (1.57e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.77e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.40e-3)"	"unprognostic (1.70e-2)"	"unprognostic (4.92e-2)"	"unprognostic (3.41e-2)"	"unprognostic (9.40e-3)"	3.9	5.1	8.0	1.6	6.0	0.0	3.6	4.9	7.7	6.9	2.2	4.7	1.0	7.2	1.6	5.9	5.1	2.2	4.9	7.5	4.3	3.5	1.2	2.8	0.5	3.6	4.0	6.2	7.4	3.2	3.6	3.6	3.5	4.6	4.3	1.6	1.6	3.5	3.3	1.3	5.2	2.8	5.5	2.8	2.4	3.6	2.4	4.1	0.4	3.4	1.0	1.0	4.8	5.4	4.4	18.5	6.9	13.2	19.3	7.8	13.8	6.2	10.4	12.8	10.6	8.5	0.6	0.4	0.0	8.2	19.9	9.6	5.3	14.6	9.0	5.8	1.0	8.9	0.0	5.0	2.2	8.3	0.0	0.0	11.3	5.6	16.1	7.6	9.4	9.7	2.3	2.0	0.0	8.4	2.4	0.7	0.0	12.6	0.0	10.2	9.4	6.7	0.0	9.1	0.3	13.1	11.9	10.3	0.2	16.6	21.0	10.3	0.4	6.9	10.5	8.7	23.0	9.4	0.1	0.2	0.1	11.0	0.6	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	6.0	4.9	7.7	7.5	4.3	3.6	4.0	6.2	4.6	2.8	4.1	4.4	3.2	0.0	0.0	4.6	0.0	2.9	1.2	2.0	5.2	2.5	3.2	3.9	3.4	0.0	0.7	0.0	0.0	0.5	0.1	0.2	0.0	1.6	0.4	1.3	7.0	4.2	1.2	0.0	16.1	1.1	1.0	5.1	1.5	2.1	0.0	12.6	2.9	0.3	0.4	1.7	15.2	1.0	0.0	0.0	1.0	0.6	2.8	0.1	7.2	5.6	0.0	2.3	0.0	7.1	1.8	0.5	0.5	4.1	0.1	1.6	0.1	1.4	0.3	3.5	0.0	2.3	4.0	0.3	2.2	5.5	4.1	0.3	0.1	2.9	2.8	1.0
FGD4	"CMT4H, frabin, FRABP, ZFYVE6"	ENSG00000139132	"FYVE, RhoGEF and PH domain containing 4"	Q96M96	12	32399558-32646050	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Actin-binding, Guanine-nucleotide releasing factor"	"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 232.5;Early spermatids: 196.3;Late spermatids: 250.1;Microglial cells: 203.3"	"Cancer enhanced"	"Detected in all"		"testis cancer: 14.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"dendritic cells: 3.6;granulocytes: 8.4;monocytes: 5.7"	"Cell line enhanced"	"Detected in many"		"ASC diff: 24.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039235	Approved		Approved	"Actin filaments"		No	No			"Actin filaments"		"HPA039235: AB_10673420"	"unprognostic (6.73e-2)"	"unprognostic (2.55e-2)"	"unprognostic (5.99e-2)"	"unprognostic (2.64e-2)"	"unprognostic (2.37e-1)"	"unprognostic (5.45e-2)"	"unprognostic (8.61e-3)"	"unprognostic (3.91e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.13e-3)"	"unprognostic (2.79e-1)"	"prognostic favorable (7.16e-5)"	"unprognostic (9.50e-2)"	"unprognostic (7.52e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.41e-3)"	12.7	4.3	7.5	5.7	10.1	12.2	8.1	11.7	6.9	6.1	13.6	9.5	8.9	2.3	2.9	7.4	5.0	10.4	5.4	7.4	9.4	10.9	17.9	8.1	1.8	11.6	9.1	2.8	24.8	9.5	14.9	3.1	10.4	12.1	4.7	10.2	23.8	6.7	4.1	10.8	7.2	8.3	3.5	10.5	5.2	29.2	12.2	10.0	1.7	6.4	10.9	2.7	4.1	5.9	13.8	5.4	2.6	6.6	2.0	24.1	14.8	8.1	4.5	22.5	1.2	0.4	8.1	8.3	0.8	2.5	0.3	2.8	5.1	5.3	7.5	0.7	0.7	2.6	4.7	2.7	2.5	4.3	0.9	0.0	8.8	10.3	6.0	12.9	3.3	11.6	1.1	0.5	5.4	15.6	1.9	0.0	1.7	17.4	5.3	0.2	0.4	6.9	16.2	8.0	5.3	7.2	8.5	4.7	4.4	6.6	11.8	7.0	0.3	13.1	0.1	1.5	18.8	0.7	1.9	4.6	2.9	0.0	2.8	5.2	3.6	3.8	8.4	0.2	5.7	0.2	0.6	0.3	0.2	3.6	1.4	0.2	0.3	5.5	0.7	5.1	0.4	0.2	1.3	7.5	10.1	11.7	6.9	7.4	9.4	11.6	9.1	2.8	12.1	10.5	10.0	13.8	84.3	48.1	31.4	232.5	5.6	8.4	11.3	12.1	8.6	23.8	10.7	7.5	19.2	54.3	18.3	22.0	118.9	1.3	0.5	57.8	13.7	16.8	196.3	36.0	8.1	24.8	19.2	4.4	40.5	20.7	16.8	19.9	78.5	65.7	2.5	34.1	9.3	37.7	11.8	70.7	55.1	31.2	26.4	71.7	22.3	250.1	4.7	92.9	14.2	203.3	39.9	79.3	1.0	25.1	95.1	33.5	29.3	1.5	16.4	16.4	54.8	15.0	15.3	114.5	52.6	16.5	41.3	10.4	7.4	25.0	12.6	1.4	3.1	25.6	30.5	20.2
FGF17	FGF-13	ENSG00000158815	"Fibroblast growth factor 17"	O60258	8	22042398-22048809	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted secreted proteins, RAS pathway related proteins"		"Developmental protein, Growth factor"	"Cancer-related genes, Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.9;choroid plexus: 9.1"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 9.3;Cone photoreceptor cells: 14.6;Excitatory neurons: 10.6;Inhibitory neurons: 13.1"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 2.6;testis cancer: 3.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 1.1;RPMI-8226: 1.8"	"Region enriched"	"Detected in single"	4	"basal ganglia: 2.1"	"Region enhanced"	"Detected in single"		"cerebellum: 2.1"	HPA052600	Uncertain				"Secreted in brain"	NA	NA					"HPA052600: AB_2681881"	"unprognostic (3.45e-2)"	"unprognostic (1.64e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.33e-2)"	"unprognostic (3.51e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.78e-2)"	"unprognostic (5.65e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.92e-5)"	"unprognostic (6.85e-2)"	"unprognostic (2.58e-4)"	"unprognostic (6.55e-3)"	"unprognostic (7.18e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.95e-3)"	0.3	3.9	11.8	0.0	13.5	0.1	0.4	19.7	25.9	3.0	9.1	0.3	0.0	1.1	0.1	0.2	1.5	0.2	0.4	13.0	11.9	1.4	0.4	0.7	0.0	10.8	11.0	12.9	1.5	1.2	0.8	5.1	0.1	15.9	2.8	0.0	1.2	0.7	0.1	0.1	0.4	0.4	0.3	9.0	3.6	0.5	0.7	11.6	0.4	4.9	0.0	0.0	0.6	1.3	13.2	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.8	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.2	0.9	0.3	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.8	13.5	19.7	25.9	13.0	11.9	10.8	11.0	12.9	15.9	9.0	11.6	13.2	0.2	0.0	0.0	2.3	0.0	0.0	0.3	0.1	0.0	9.3	0.2	0.4	1.1	0.0	0.2	0.0	14.6	0.1	0.0	0.1	0.0	0.1	1.8	0.0	0.1	0.1	0.0	0.0	10.6	0.2	0.0	0.1	0.0	0.1	0.0	0.5	0.0	0.0	0.1	1.7	13.1	0.0	0.0	0.0	0.0	0.3	0.3	0.0	1.8	1.0	0.0	0.6	0.0	2.0	2.4	0.1	0.0	1.2	0.1	0.2	0.0	0.0	0.2	1.3	0.0	0.3	0.2	0.2	0.5	0.0	0.0	0.3	0.1	0.4	0.0	0.1
FGF8	AIGF	ENSG00000107831	"Fibroblast growth factor 8"	P55075	10	101770130-101780369	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"	Differentiation	"Developmental protein, Growth factor, Mitogen"	"Cancer-related genes, Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	40	"skeletal muscle: 49.2"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"endometrial cancer: 2.1;testis cancer: 3.3"	"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	17	"RH-30: 37.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted in other tissues"	NA	NA						"unprognostic (1.56e-1)"	"unprognostic (3.90e-3)"	"unprognostic (1.12e-2)"	"unprognostic (4.88e-1)"	"unprognostic (2.47e-2)"	"unprognostic (9.09e-2)"		"unprognostic (8.75e-3)"	"unprognostic (8.12e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.35e-9)"	"unprognostic (6.17e-3)"	"unprognostic (9.01e-2)"		"unprognostic (1.97e-1)"	0.5	0.0	0.7	0.0	0.6	0.2	0.2	0.5	1.2	0.1	0.8	0.2	0.3	0.2	0.2	0.9	0.1	0.3	0.3	0.9	0.8	0.1	0.1	0.3	0.3	0.6	0.7	0.7	0.0	0.0	0.0	0.0	0.3	0.6	0.1	0.1	0.5	0.0	0.1	49.2	0.2	0.0	0.0	0.4	0.6	0.1	1.1	0.6	0.0	0.2	0.0	0.0	0.2	0.0	1.0	0.6	0.1	0.3	1.4	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.6	0.7	0.4	0.6	0.0	0.0	0.5	0.3	0.0	0.0	1.1	1.0	0.4	0.3	0.5	0.0	0.0	0.4	0.1	0.2	0.0	0.0	0.1	0.0	1.0	0.3	0.9	0.0	0.4	0.6	2.2	0.2	0.0	0.1	0.6	37.8	0.8	0.0	0.2	0.9	0.9	0.0	0.6	0.5	0.0	0.6	0.1	0.6	0.6	1.1	0.8	0.2	0.2	0.8	1.3	0.8	0.7	0.8	1.9	0.4	0.5	0.3	0.5	0.6	0.4	0.4	0.4	0.4	0.5	0.6	0.5	1.1	0.7	0.9	0.4	0.5	0.3	0.7	0.6	0.5	1.2	0.9	0.8	0.6	0.7	0.7	0.6	0.4	0.6	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.2	0.1	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0
FMR1NB	"CT37, FLJ25736, NY-SAR-35"	ENSG00000176988	"FMR1 neighbor"	Q8N0W7	X	147981337-148026665	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	333	"testis: 58.6"	"Group enriched"	"Detected in some"	10	"Spermatocytes: 502.2;Spermatogonia: 296.7"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	24	"U-266/70: 67.5;U-266/84: 57.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA011284, CAB026403"	Enhanced					NA	NA					"CAB026403: , HPA011284: AB_1078898"				"unprognostic (2.22e-3)"			"unprognostic (1.05e-1)"			"unprognostic (1.83e-1)"					"unprognostic (4.38e-2)"	"unprognostic (4.11e-3)"	"unprognostic (2.85e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	58.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	67.5	57.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	18.1	0.1	0.0	0.5	0.0	0.0	0.4	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	18.4	5.6	0.4	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.1	39.5	0.0	0.0	502.2	296.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0
FOXR2	"FOXN6, MGC21658"	ENSG00000189299	"Forkhead box R2"	Q6PJQ5	X	55623400-55626192	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	11	"testis: 1.3"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	110	"NTERA-2: 10.8;SH-SY5Y: 9.9;U-266/70: 6.2;U-266/84: 16.8"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA034487, HPA057358"	Uncertain		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA034487: AB_10795354, HPA057358: AB_2683418"															"unprognostic (3.81e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	16.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FTHL17	CT38	ENSG00000132446	"Ferritin heavy chain like 17"	Q9BXU8	X	31071233-31072041	"Predicted intracellular proteins"	"Iron storage"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	19	"testis: 4.0"	"Cell type enriched"	"Detected in some"	6	"Spermatocytes: 18.3"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"									NA	NA																				"unprognostic (5.67e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.3	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GABRQ		ENSG00000268089	"Gamma-aminobutyric acid type A receptor subunit theta"	Q9UN88	X	152637895-152657542	"FDA approved drug targets, Predicted membrane proteins"	"Ion transport, Transport"	"Chloride channel, Ion channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 52.8"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 4.0;Glandular and luminal cells: 2.8;Spermatogonia: 1.4;Squamous epithelial cells: 2.5;Suprabasal keratinocytes: 1.8"	"Cancer enhanced"	"Detected in many"		"testis cancer: 6.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 11.4;SiHa: 11.6;SuSa: 5.0;U-87 MG: 37.2"	"Region enriched"	"Detected in many"	5	"hypothalamus: 52.6"	"Group enriched"	"Detected in some"	4	"hypothalamus: 7.7;midbrain: 20.8;pons: 6.3"							NA	NA						"unprognostic (3.68e-3)"	"unprognostic (7.78e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.17e-4)"	"unprognostic (3.38e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.45e-4)"	"unprognostic (1.31e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.73e-1)"	"unprognostic (3.76e-2)"	"unprognostic (3.10e-5)"	"unprognostic (3.43e-3)"	"unprognostic (1.84e-1)"	"unprognostic (6.42e-2)"	"unprognostic (7.70e-2)"	0.0	2.2	18.0	0.0	26.1	0.0	0.0	0.1	28.7	7.8	0.1	0.0	0.0	1.2	0.1	0.6	0.1	0.0	0.0	15.7	52.8	0.0	0.0	0.0	0.0	10.0	18.7	9.1	0.0	0.0	0.0	0.1	0.1	12.4	0.4	0.0	0.2	0.0	0.5	0.0	0.3	0.2	0.8	2.2	0.0	0.0	1.2	30.9	0.0	0.0	0.0	0.1	0.0	0.7	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.3	0.2	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	1.0	0.0	2.9	0.0	0.0	0.0	0.0	1.6	11.6	2.1	0.0	5.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.0	26.1	0.1	28.7	15.7	52.8	10.0	18.7	9.1	12.4	2.2	30.9	4.1	0.0	0.0	0.0	0.0	0.0	4.0	0.1	0.0	0.6	1.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.2	0.0	0.0	0.2	0.0	0.0	0.3	0.0	2.8	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	1.0	1.4	2.5	1.8	0.8	0.0	0.0	0.0	0.5
GAL	"GAL-GMAP, GALN, GLNN, GMAP"	ENSG00000069482	"Galanin and GMAP prepropeptide"	P22466	11	68683779-68691175	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"		"Hormone, Neuropeptide"	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	32	"brain: 423.8;pituitary gland: 892.7"	"Group enriched"	"Detected in many"	4	"Basal prostatic cells: 22.2;Ductal cells: 38.9;Endometrial ciliated cells: 64.2;Endometrial stromal cells: 50.8;Exocrine glandular cells: 52.1;Extravillous trophoblasts: 48.7;Glandular and luminal cells: 26.4;Pancreatic endocrine cells: 39.5;Prostatic glandular cells: 82.5;Urothelial cells: 24.3"	"Cancer enhanced"	"Detected in many"		"testis cancer: 22.2"	"Region enriched"	"Detected in many"	10	"hypothalamus: 423.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 267.2;HEK 293: 119.3;K-562: 139.5;NB-4: 493.5;SH-SY5Y: 189.6"	"Region enhanced"	"Detected in many"		"hypothalamus: 82.6"	"Low region specificity"	"Detected in all"			"HPA049864, CAB079779"	Enhanced	Supported	Supported	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA	60000	200000	"Golgi apparatus"	Vesicles	"CAB079779: , HPA049864: AB_2680922"	"unprognostic (8.56e-2)"	"unprognostic (1.45e-2)"	"unprognostic (7.50e-2)"	"prognostic unfavorable (1.22e-4)"	"unprognostic (2.70e-1)"	"unprognostic (2.27e-2)"	"unprognostic (8.07e-3)"	"prognostic unfavorable (8.17e-4)"	"unprognostic (5.98e-2)"	"unprognostic (1.07e-2)"	"unprognostic (8.84e-2)"	"unprognostic (7.42e-2)"	"unprognostic (1.20e-1)"	"unprognostic (8.85e-2)"	"unprognostic (7.88e-2)"	"unprognostic (5.38e-2)"	"unprognostic (3.24e-2)"	3.0	0.9	3.2	15.0	12.0	0.7	4.4	1.1	5.2	0.6	0.9	14.5	1.8	0.2	0.0	0.8	1.0	0.2	0.6	2.8	423.8	1.5	0.3	0.5	0.1	42.5	5.2	1.3	0.2	2.1	0.1	892.7	0.3	9.6	4.4	4.0	0.0	0.9	0.2	0.4	20.3	4.2	10.0	0.6	0.3	9.8	1.0	12.4	0.7	0.4	0.0	0.0	0.7	3.0	3.0	0.0	11.0	1.1	0.3	0.0	0.0	24.0	36.7	0.0	0.7	0.0	267.2	9.9	0.0	12.7	1.3	0.4	0.1	0.0	0.2	0.0	0.0	119.3	6.4	74.6	0.0	1.3	3.7	0.0	1.7	4.0	0.0	0.1	0.0	6.3	0.0	139.5	0.0	0.2	77.2	0.0	493.5	60.3	2.9	23.7	0.0	0.1	51.1	0.6	0.0	49.8	189.6	25.8	1.5	0.0	26.8	1.5	57.6	0.0	0.0	0.0	0.3	2.9	0.0	0.0	0.1	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	12.0	1.1	5.2	2.8	423.8	42.5	5.2	1.3	9.6	0.6	12.4	3.0	0.6	0.0	0.0	0.0	0.2	2.0	22.2	0.1	0.0	0.0	3.2	5.8	1.4	0.0	0.0	0.0	0.0	0.6	0.1	0.7	0.0	38.9	0.1	64.2	50.8	3.4	1.8	4.2	2.1	52.1	48.7	6.6	2.0	26.4	4.5	0.4	0.0	0.0	2.0	0.0	0.2	1.1	4.1	0.0	1.2	0.2	0.0	0.7	1.8	0.0	0.6	0.0	0.0	0.0	0.3	39.5	0.1	0.0	1.0	82.5	0.0	0.4	0.0	0.0	0.0	1.6	6.7	2.2	10.9	1.1	3.4	1.9	0.8	0.0	1.3	24.3
GATA4		ENSG00000136574	"GATA binding protein 4"	P43694	8	11676959-11760002	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Atrial septal defect, Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 85.8;ovary: 96.2;pancreas: 53.9"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 41.4;Exocrine glandular cells: 33.7;Gastric mucus-secreting cells: 61.2;Granulosa cells: 158.4;Hepatic stellate cells: 57.8;Late spermatids: 37.0;Leydig cells: 41.3;Peritubular cells: 41.3;Theca cells: 80.1"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 21.8;testis cancer: 12.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 19.7;HHSteC: 20.9;OE19: 6.2;SH-SY5Y: 20.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB013125, HPA073899"	Uncertain		Supported	"Nuclear bodies"		NA	NA			"Nuclear bodies"		"CAB013125: AB_2533804, HPA073899: AB_2686641"	"unprognostic (2.99e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.36e-1)"	"unprognostic (8.68e-4)"	"unprognostic (2.66e-3)"	"unprognostic (1.71e-1)"	"unprognostic (8.55e-3)"	"unprognostic (1.02e-2)"	"unprognostic (5.47e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.78e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.67e-8)"	"unprognostic (1.09e-1)"	"unprognostic (1.61e-1)"		"unprognostic (1.29e-2)"	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	20.4	0.2	0.0	0.0	2.3	4.0	85.8	0.0	0.0	0.0	36.9	0.2	0.0	0.0	0.0	0.0	96.2	53.9	0.0	0.1	7.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	9.9	0.0	0.0	0.1	35.5	32.6	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	1.2	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.9	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	19.7	20.9	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.2	0.0	0.0	0.2	1.3	0.0	0.0	1.5	20.5	0.0	0.0	0.1	3.9	1.2	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.4	1.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.2	16.1	0.0	0.1	6.1	0.0	0.0	0.1	33.7	0.2	12.0	61.2	0.0	0.0	158.4	57.8	12.1	0.6	0.0	0.1	0.8	0.0	2.8	0.0	37.0	41.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	14.5	0.0	41.3	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	5.3	2.4	2.2	0.0	0.0	0.8	0.1	80.1	0.9	0.0
GFY	Goofy	ENSG00000261949	"Golgi associated olfactory signaling regulator"	I3L273	19	49423749-49428987	"Predicted membrane proteins"	"Olfaction, Sensory transduction"			"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 1.1;testis: 1.3"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"testis cancer: 1.0"	"Region enhanced"	"Detected in single"		"cerebellum: 1.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"HEK 293: 1.8;SCLC-21H: 4.0;T-47d: 1.1;U-266/84: 2.7"	"Region enriched"	"Detected in single"	13	"olfactory bulb: 1.4"	"Region enriched"	"Detected in some"	6	"cerebellum: 6.6"							NA	NA						"unprognostic (8.04e-2)"	"unprognostic (8.21e-2)"		"unprognostic (1.16e-1)"	"unprognostic (2.43e-1)"	"unprognostic (4.50e-2)"		"unprognostic (8.99e-2)"		"unprognostic (8.85e-2)"				"unprognostic (1.42e-1)"	"unprognostic (1.82e-1)"		"unprognostic (9.62e-3)"	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.3	0.0	0.0	1.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.1	0.5	0.2	0.0	0.3	0.1	0.1	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GLDC	"GCSP, NKH"	ENSG00000178445	"Glycine decarboxylase"	P23378	9	6532467-6645729	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 174.9"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 31.3;Cytotrophoblasts: 79.0;Extravillous trophoblasts: 41.6;Hepatocytes: 120.5;Oligodendrocyte precursor cells: 52.3;Proximal tubular cells: 31.6;Syncytiotrophoblasts: 46.0"	"Cancer enhanced"	"Detected in many"		"testis cancer: 41.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 235.7;CACO-2: 58.2;HMC-1: 45.6;RPTEC TERT1: 95.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002318, HPA052887"	Enhanced		Supported	Nucleoplasm,Mitochondria		NA	NA		740000	Mitochondria	Nucleoplasm	"HPA002318: AB_1849700, HPA052887: AB_2681980"	"unprognostic (6.73e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.50e-2)"	"prognostic unfavorable (5.24e-5)"	"unprognostic (1.50e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.47e-2)"	"unprognostic (2.69e-1)"	"prognostic favorable (3.50e-4)"	"unprognostic (1.65e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.62e-3)"	"unprognostic (1.17e-2)"	0.3	0.3	13.8	1.4	14.8	0.5	0.8	13.9	23.9	0.2	12.0	1.0	0.9	0.4	5.2	3.2	0.7	0.8	0.1	14.0	13.8	37.7	174.9	1.0	1.7	13.2	12.6	14.0	0.3	0.1	0.0	5.0	15.3	13.5	0.5	0.4	1.6	1.1	1.0	1.3	2.7	0.8	0.0	12.4	1.2	1.0	3.5	14.0	0.0	5.1	0.1	1.2	1.1	0.1	14.6	0.6	4.9	2.1	25.6	0.2	0.4	235.7	0.1	0.0	0.0	0.1	58.2	0.5	0.3	5.6	0.1	0.7	0.4	0.0	0.7	0.2	1.2	13.4	0.2	0.3	38.3	0.0	0.1	45.6	0.0	0.1	1.8	0.3	1.0	9.0	4.3	0.0	0.5	1.2	1.5	0.9	0.2	27.5	4.6	3.8	1.3	0.0	0.5	95.4	1.0	22.6	11.7	0.0	21.4	0.3	13.9	5.3	0.1	3.0	0.6	0.6	2.6	1.3	1.1	34.4	0.1	0.8	2.4	5.1	0.4	0.1	0.1	0.1	0.0	0.1	0.8	0.1	0.0	0.0	0.1	0.0	0.1	0.4	0.1	0.1	0.1	0.0	0.3	13.8	14.8	13.9	23.9	14.0	13.8	13.2	12.6	14.0	13.5	12.4	14.0	14.6	0.2	0.0	0.0	17.6	1.9	0.0	0.0	0.2	1.2	0.4	1.5	0.6	0.7	11.5	0.1	31.3	0.0	79.0	0.2	0.0	5.9	0.0	12.6	5.4	0.5	0.6	0.0	0.0	21.6	0.2	41.6	0.3	0.0	10.7	0.0	1.1	2.2	120.5	7.0	0.0	15.9	0.0	0.0	2.8	0.3	10.8	0.3	0.4	0.0	1.9	0.0	9.6	0.0	52.3	1.8	0.1	0.0	0.0	15.1	0.0	0.0	31.6	0.0	0.4	0.0	1.7	0.8	4.5	5.1	0.4	0.0	46.0	0.8	0.0	0.0	0.1
GLI1	GLI	ENSG00000111087	"GLI family zinc finger 1"	P08151	12	57459785-57472268	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 11.2"	"Cell type enhanced"	"Detected in some"		"Fibroblasts: 6.5;Leydig cells: 29.5;Peritubular cells: 42.9;Sertoli cells: 13.1;Theca cells: 7.8"	"Cancer enhanced"	"Detected in many"		"testis cancer: 7.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.9"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 1.9"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 24.2;BJ hTERT+: 16.9;NTERA-2: 14.0;RH-30: 60.6;U-266/70: 16.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB009460, HPA065172, HPA068903"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"CAB009460: AB_2111764, HPA065172: AB_2685427, HPA068903: AB_2732122"	"unprognostic (4.97e-4)"	"unprognostic (5.53e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.58e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.80e-2)"	"unprognostic (9.00e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.43e-1)"	"unprognostic (8.52e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.53e-8)"	"unprognostic (4.59e-3)"	"unprognostic (2.98e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.04e-2)"	1.5	1.2	1.4	1.7	1.6	0.5	1.5	3.8	2.0	11.2	0.8	3.0	2.6	9.6	6.7	0.6	3.8	5.5	1.6	1.2	2.0	1.4	0.8	1.6	0.7	2.0	2.2	1.2	1.5	0.8	0.0	1.0	0.5	3.8	4.2	4.1	0.0	1.6	2.9	0.6	1.5	3.3	2.4	1.8	0.9	1.9	4.8	3.3	0.3	2.3	1.8	1.0	4.5	3.2	1.3	0.1	9.8	3.2	24.2	0.7	0.1	0.3	0.9	16.9	2.1	2.3	0.3	0.7	3.1	0.0	0.5	2.3	1.7	1.8	1.1	0.4	2.7	0.3	0.1	1.2	0.2	2.7	0.7	1.4	0.8	0.4	3.1	1.0	4.2	0.3	2.2	0.4	7.8	1.0	0.0	0.7	0.5	14.0	0.8	0.9	1.2	60.6	1.7	2.7	0.0	0.1	0.1	0.2	0.1	0.4	2.4	0.0	0.3	0.1	2.2	7.7	0.6	0.3	16.7	1.0	5.7	2.0	1.3	3.8	0.8	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.1	1.9	0.0	0.0	0.1	0.2	0.0	1.4	1.6	3.8	2.0	1.2	2.0	2.0	2.2	1.2	3.8	1.8	3.3	1.3	0.4	0.0	0.0	2.0	0.7	0.1	0.4	0.3	0.0	0.0	0.1	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.6	0.1	3.5	0.5	0.0	0.0	0.1	0.0	0.1	6.5	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	1.4	2.5	29.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	42.9	0.1	0.2	0.0	1.3	0.0	0.0	13.1	1.9	1.6	0.3	1.1	0.2	0.6	0.1	0.5	7.8	0.1	0.1
GNB3		ENSG00000111664	"G protein subunit beta 3"	P16520	12	6839954-6847393	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		Transducer	"Congenital stationary night blindness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"retina: 430.2"	"Group enriched"	"Detected in many"	7	"Bipolar cells: 471.3;Cone photoreceptor cells: 932.0;Rod photoreceptor cells: 462.8"	"Cancer enhanced"	"Detected in some"		"testis cancer: 3.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Daudi: 14.1;NTERA-2: 17.0;U-698: 40.9"	"Low region specificity"	"Detected in some"			"Region enhanced"	"Detected in some"		"cerebellum: 5.1"	HPA040736	Uncertain		Approved	"Golgi apparatus,Plasma membrane"		NA	NA			"Plasma membrane"	"Golgi apparatus"	"HPA040736: AB_2677106"	"unprognostic (3.86e-2)"	"unprognostic (1.58e-1)"	"unprognostic (4.96e-2)"	"unprognostic (8.75e-2)"	"unprognostic (2.53e-2)"	"unprognostic (5.74e-3)"	"unprognostic (5.98e-2)"	"unprognostic (4.43e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.25e-5)"	"unprognostic (3.21e-2)"	"unprognostic (4.77e-11)"	"unprognostic (2.43e-1)"	"unprognostic (6.48e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.07e-2)"	0.9	1.4	5.6	1.6	5.7	1.0	0.6	6.3	9.6	2.1	6.2	1.2	1.7	2.2	0.7	0.4	1.6	1.1	4.4	5.7	6.1	0.8	0.2	0.7	1.6	5.4	14.2	5.6	2.8	0.7	1.5	36.4	0.4	5.5	2.1	0.6	430.2	2.1	1.4	1.3	0.8	1.5	3.3	4.6	0.9	1.0	0.6	5.2	0.3	1.6	0.3	1.6	1.6	1.1	6.1	0.4	1.2	9.4	3.1	1.3	2.0	0.9	4.8	0.8	2.5	2.1	1.9	0.5	14.1	0.1	5.1	0.1	0.5	9.2	0.3	2.3	1.2	2.1	3.4	6.8	1.5	0.9	1.1	2.3	2.4	0.5	2.4	2.7	9.6	2.5	1.8	1.5	1.3	1.2	0.7	0.7	0.8	17.0	0.1	0.5	0.7	2.8	0.9	0.5	0.4	1.1	2.2	0.4	0.1	1.0	2.5	0.1	0.6	4.0	3.2	3.8	4.8	6.7	1.4	1.0	40.9	1.3	0.7	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	5.7	6.3	9.6	5.7	6.1	5.4	14.2	5.6	5.5	4.6	5.2	6.1	0.3	0.0	0.0	5.2	1.3	0.4	0.4	0.2	1.2	471.3	0.8	1.3	6.1	0.0	0.1	0.0	932.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	2.0	3.3	0.0	1.3	12.3	0.0	0.0	2.3	2.0	0.1	0.0	0.1	1.1	0.0	0.1	74.0	12.4	0.0	4.1	0.3	0.4	0.0	3.7	0.1	1.8	3.7	0.1	86.7	0.0	6.0	1.2	0.1	0.0	3.4	3.2	0.8	0.0	0.1	0.6	462.8	0.0	0.3	1.4	0.1	0.5	0.0	0.0	0.0	0.4	0.2	0.1	0.2
GNRH2		ENSG00000125787	"Gonadotropin releasing hormone 2"	O43555	20	3043622-3045747	"Predicted secreted proteins"		Hormone		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 4.1"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 1.0;Early spermatids: 1.2;Excitatory neurons: 2.0;Inhibitory neurons: 2.0;Late spermatids: 1.8;Oligodendrocytes: 1.3;Sertoli cells: 6.6"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"U-266/84: 3.8"					"Low region specificity"	"Detected in many"			HPA004338	Uncertain				"Secreted to blood"	NA	NA					"HPA004338: AB_1079012"	"unprognostic (1.29e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.20e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.26e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.36e-2)"	"unprognostic (4.04e-3)"	"unprognostic (7.00e-2)"	"unprognostic (1.93e-2)"	"unprognostic (2.47e-4)"	"unprognostic (2.69e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.29e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.21e-2)"	0.4	0.5	2.0	0.6	1.6	0.3	0.3	4.1	2.1	0.4	0.6	0.2	0.2	0.5	0.6	0.3	0.9	0.5	0.4	2.4	1.0	0.7	2.0	0.3	0.4	1.2	1.1	1.6	2.2	0.1	0.2	0.9	0.2	1.7	1.9	0.1	0.3	0.8	0.8	0.1	0.1	0.2	0.0	0.2	0.3	1.0	1.4	1.1	0.1	1.1	0.0	0.0	0.3	0.3	1.7	0.5	0.5	1.4	1.8	0.8	0.2	0.2	0.3	0.0	0.2	0.3	0.9	0.3	0.7	0.0	0.1	0.5	1.5	0.5	0.5	0.4	0.5	1.6	0.6	0.6	1.1	0.0	0.0	0.9	1.1	1.1	1.1	0.0	0.2	0.4	1.2	0.7	0.2	0.6	0.5	0.3	1.2	0.6	0.0	0.0	0.4	0.2	0.4	0.2	1.3	2.1	0.9	0.1	1.2	0.7	0.6	1.3	0.6	0.0	0.8	0.3	0.7	0.8	0.5	3.8	0.4	0.7	0.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	1.6	4.1	2.1	2.4	1.0	1.2	1.1	1.6	1.7	0.2	1.1	1.7	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.1	0.1	0.0	0.0	0.0	2.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.3	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
GP1BA	"CD42b, GP1B, GPIbalpha"	ENSG00000185245	"Glycoprotein Ib platelet subunit alpha"	P07359	17	4932277-4935023	"CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins"	"Blood coagulation, Cell adhesion, Hemostasis"		"Bernard Soulier syndrome, Disease variant, von Willebrand disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 5.0;lymphoid tissue: 14.8"	"Cell type enhanced"	"Detected in some"		"Distal tubular cells: 3.9;Macrophages: 14.2"	"Cancer enhanced"	"Detected in many"		"testis cancer: 2.8"	"Region enhanced"	"Detected in single"		"cerebellum: 2.2"	"Immune cell enriched"	"Detected in single"	13	"basophil: 7.0"	"Lineage enriched"	"Detected in single"	43	"granulocytes: 7.0"	"Cell line enriched"	"Detected in some"	24	"HEL: 71.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB002496, HPA013316"	Supported					NA	NA		1600000000			"CAB002496: AB_563748, HPA013316: AB_1855459"	"unprognostic (4.87e-4)"	"unprognostic (8.21e-2)"	"unprognostic (2.81e-2)"	"unprognostic (6.11e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.59e-3)"	"unprognostic (7.30e-3)"	"unprognostic (5.58e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.64e-1)"	"unprognostic (6.54e-4)"	"unprognostic (1.27e-1)"	"unprognostic (4.85e-3)"	"unprognostic (4.58e-3)"	"unprognostic (2.56e-1)"	"unprognostic (3.53e-4)"	"unprognostic (8.35e-2)"	0.5	0.1	0.2	3.8	0.4	5.0	0.4	2.2	0.2	0.4	0.1	0.6	1.3	0.3	0.0	0.5	0.4	0.3	0.5	0.1	0.0	0.5	0.9	1.6	14.8	0.3	0.1	0.0	0.4	0.3	0.0	0.2	0.3	0.8	0.4	0.5	2.4	0.9	0.0	2.7	2.4	1.8	0.0	0.0	3.7	0.8	0.4	0.2	0.6	0.4	0.0	7.7	0.4	0.5	0.0	0.1	2.3	0.5	0.3	0.0	0.0	1.1	0.3	0.0	0.0	0.0	2.2	0.3	2.3	0.7	0.0	0.0	2.3	0.0	0.0	0.0	0.8	1.8	71.6	1.2	0.0	0.0	0.4	2.5	0.0	0.0	0.0	0.0	0.7	0.0	1.3	0.7	0.7	0.0	0.8	0.6	0.3	0.3	0.2	0.4	1.2	0.5	0.3	0.0	1.4	0.1	0.3	0.9	0.0	0.3	0.6	2.9	1.3	0.3	0.4	0.4	1.5	0.2	1.2	0.5	1.7	1.0	1.1	0.7	7.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	2.2	0.2	0.4	2.2	0.2	0.1	0.0	0.3	0.1	0.0	0.8	0.0	0.2	0.0	0.2	0.0	0.0	0.0	1.3	1.5	0.6	0.4	0.0	1.8	0.2	0.5	1.1	0.0	0.2	0.0	2.1	0.3	0.4	0.1	3.9	0.2	0.3	0.8	1.8	0.5	0.0	1.7	0.2	0.0	0.2	0.7	0.0	2.4	0.0	0.1	2.5	0.9	0.1	0.0	0.2	0.0	0.0	0.9	3.3	0.6	0.3	14.2	0.0	0.0	2.6	0.3	1.0	0.0	0.1	0.0	0.0	1.9	0.3	0.4	0.3	0.9	0.0	2.7	0.0	1.4	0.5	1.0	0.6	0.0	1.8	0.3	1.0	0.1	0.1	0.3
GPR19		ENSG00000183150	"G protein-coupled receptor 19"	Q15760	12	12660890-12696207	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 10.4;pituitary gland: 7.8"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 7.8;Excitatory neurons: 15.2;Inhibitory neurons: 15.6;Oligodendrocyte precursor cells: 15.6;Oligodendrocytes: 5.9"	"Cancer enhanced"	"Detected in many"		"testis cancer: 5.8"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"T-reg: 6.5"	"Group enriched"	"Detected in many"	15	"granulocytes: 2.9;T-cells: 6.5"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 39.9;NTERA-2: 39.7;SuSa: 28.5;WM-115: 20.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013955	Uncertain					NA	NA					"HPA013955: AB_1849287"	"unprognostic (1.92e-1)"	"unprognostic (3.38e-2)"	"unprognostic (1.72e-1)"	"unprognostic (8.62e-5)"	"unprognostic (1.60e-1)"	"unprognostic (3.21e-1)"	"unprognostic (8.25e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.73e-1)"	"unprognostic (6.90e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.67e-12)"	"unprognostic (5.19e-2)"	"unprognostic (1.38e-1)"	"unprognostic (7.60e-2)"	"unprognostic (1.60e-1)"	0.3	0.8	7.3	2.0	7.3	0.9	0.3	9.2	10.4	0.1	3.8	0.5	0.3	0.1	0.1	0.5	0.2	0.3	0.1	6.9	8.9	0.1	0.2	0.2	1.8	6.7	6.7	7.0	0.0	0.3	0.1	7.8	0.3	6.8	0.1	0.6	2.0	0.1	0.1	0.0	0.8	0.5	0.3	6.4	0.7	0.4	4.3	7.3	2.8	0.1	0.0	2.4	0.3	0.1	6.8	1.6	0.6	16.6	0.4	0.0	0.0	7.0	1.6	1.7	2.9	2.5	6.6	10.1	6.8	2.5	1.2	2.3	1.3	2.7	0.3	4.8	39.9	0.3	1.6	0.7	1.1	0.0	1.7	0.6	0.1	0.0	3.1	1.9	1.2	0.5	0.7	0.3	13.8	0.6	2.4	0.6	1.0	39.7	1.7	3.0	4.4	2.5	0.2	0.2	1.4	5.4	5.0	0.7	1.4	13.4	28.5	0.9	1.7	0.0	0.8	7.2	1.3	3.9	7.6	7.2	13.3	3.1	4.7	20.4	0.0	0.0	0.0	1.2	0.0	0.8	0.2	2.4	1.4	0.0	0.1	0.4	0.9	2.9	0.3	0.0	0.0	6.5	0.3	7.3	7.3	9.2	10.4	6.9	8.9	6.7	6.7	7.0	6.8	6.4	7.3	6.8	0.2	0.0	0.0	7.8	0.4	0.1	0.1	0.0	0.0	1.8	0.4	0.5	0.3	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	4.7	0.1	0.2	0.1	0.0	2.7	15.2	0.0	0.3	0.1	0.0	0.1	0.0	0.2	0.4	0.2	0.1	0.0	15.6	0.1	0.0	0.3	0.3	1.6	0.3	0.2	0.0	2.8	0.0	1.7	0.0	15.6	5.9	0.2	0.0	0.0	2.0	0.1	0.0	0.0	0.0	0.4	0.0	0.5	0.8	3.6	0.6	0.0	0.0	0.1	1.2	0.0	0.3	0.1
GRIP2	KIAA1719	ENSG00000144596	"Glutamate receptor interacting protein 2"	Q9C0E4	3	14489107-14556075	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 13.4;skeletal muscle: 36.1;tongue: 12.6"	"Cell type enriched"	"Detected in many"	4	"Inhibitory neurons: 89.0"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 3.1;BJ hTERT+ SV40 Large T+ RasG12V: 1.9;NTERA-2: 2.1;PC-3: 6.1;SCLC-21H: 3.4;U-2 OS: 2.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA035673			Approved	Cytosol		NA	NA			Cytosol		"HPA035673: AB_10669776"	"unprognostic (1.48e-1)"	"unprognostic (6.26e-3)"	"unprognostic (2.43e-2)"	"unprognostic (3.13e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.14e-3)"	"unprognostic (1.87e-1)"	"unprognostic (8.19e-2)"	"unprognostic (9.14e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.90e-1)"	"unprognostic (5.82e-1)"	"unprognostic (4.01e-1)"	1.0	1.1	3.1	0.7	2.8	0.0	1.0	0.0	6.7	0.9	0.0	0.8	0.4	1.1	0.4	2.2	0.8	1.2	13.4	0.3	3.0	2.2	0.3	0.4	0.4	3.0	3.8	0.9	3.4	0.5	0.3	1.0	3.9	1.3	0.9	1.0	0.3	0.9	0.4	36.1	2.0	1.0	1.0	0.5	1.6	4.6	0.7	7.4	0.3	0.8	12.6	0.7	1.1	1.2	2.1	0.1	0.9	0.0	0.0	0.3	0.2	0.0	0.3	3.1	0.3	1.9	1.2	0.0	0.0	0.7	0.2	0.5	0.2	0.7	0.0	0.0	0.0	0.2	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.1	1.5	6.1	0.0	0.0	0.0	0.0	0.0	3.4	0.6	0.3	0.0	1.0	1.1	0.0	0.0	0.0	0.1	2.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	2.8	0.0	6.7	0.3	3.0	3.0	3.8	0.9	1.3	0.5	7.4	2.1	2.3	0.0	0.5	2.3	0.1	0.0	0.1	0.0	1.2	14.9	0.1	1.3	8.5	0.0	0.6	0.0	14.6	0.0	0.7	0.1	0.0	0.0	3.0	2.1	1.4	0.8	4.2	0.0	3.0	0.2	0.0	2.0	2.0	4.9	0.0	0.0	1.1	0.0	0.1	0.0	89.0	0.1	0.0	0.0	0.0	5.2	4.1	0.7	0.0	2.8	0.0	0.5	0.0	0.5	0.9	0.0	0.0	2.2	0.3	0.1	0.0	0.2	0.0	21.9	19.7	4.3	14.7	0.1	0.8	0.2	0.0	0.1	0.3	1.1	0.0	0.0
GRM4	"GPRC1D, mGlu4, MGLUR4"	ENSG00000124493	"Glutamate metabotropic receptor 4"	Q14833	6	34018643-34155622	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	84	"brain: 73.2"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 5.3;Early spermatids: 3.7;Enteroendocrine cells: 3.0;Excitatory neurons: 9.5;Inhibitory neurons: 10.8;Spermatogonia: 5.0"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.7"	"Group enriched"	"Detected in all"	6	"cerebellum: 73.2;pons: 21.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"BEWO: 7.6;SCLC-21H: 18.2"	"Region enhanced"	"Detected in all"		"cerebellum: 79.1"	"Region enriched"	"Detected in many"	5	"cerebellum: 138.8"	CAB022096	Enhanced					NA	NA					"CAB022096: "	"unprognostic (1.29e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.03e-1)"	"unprognostic (7.00e-2)"	"unprognostic (4.03e-2)"	"unprognostic (8.36e-2)"	"unprognostic (9.05e-3)"	"unprognostic (3.56e-1)"	"unprognostic (9.45e-2)"	"unprognostic (2.08e-2)"	"unprognostic (6.21e-3)"	"unprognostic (2.44e-1)"	"unprognostic (2.15e-11)"	"unprognostic (5.32e-2)"	"unprognostic (9.16e-2)"	"unprognostic (6.57e-2)"	"unprognostic (3.07e-1)"	0.0	0.2	3.1	0.0	8.1	0.0	0.0	73.2	4.5	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.3	2.0	0.0	0.0	0.0	0.0	4.4	7.9	2.4	0.1	0.7	0.0	0.5	0.0	21.2	0.1	0.0	0.8	0.0	0.0	0.0	0.1	0.2	0.1	1.0	0.0	0.0	0.8	6.6	0.0	0.0	0.0	0.1	0.0	0.1	3.2	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	18.2	0.1	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	8.1	73.2	4.5	2.3	2.0	4.4	7.9	2.4	21.2	1.0	6.6	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	5.3	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	3.7	0.4	0.1	0.2	3.0	0.0	9.5	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	10.8	1.1	0.0	0.3	0.3	2.4	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.5	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.1	0.7	0.0	0.0	0.1	0.9	5.0	0.0	0.0	0.1	0.4	0.0	0.3	0.1
GSG1	MGC3146	ENSG00000111305	"Germ cell associated 1"	Q2KHT4	12	13083532-13103683	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"testis: 433.3"	"Cell type enriched"	"Detected in many"	4	"Late spermatids: 10812.1"	"Cancer enhanced"	"Detected in single"		"testis cancer: 1.9"	"Region enhanced"	"Detected in some"		"midbrain: 6.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 8.8;LHCN-M2: 9.8;RPTEC TERT1: 12.3;U-2 OS: 5.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"								"Intracellular and membrane"	NA	NA						"unprognostic (1.50e-1)"	"unprognostic (2.21e-2)"		"unprognostic (6.33e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.01e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.52e-1)"	"unprognostic (6.85e-2)"	"unprognostic (8.23e-2)"	"unprognostic (5.91e-2)"	"unprognostic (3.20e-3)"	"unprognostic (1.48e-1)"	"unprognostic (3.65e-2)"	"unprognostic (1.79e-1)"	"unprognostic (6.32e-3)"	0.1	0.1	0.4	0.2	0.9	0.8	0.4	1.8	1.4	0.0	1.1	0.1	1.4	0.1	0.6	0.1	0.0	0.2	0.1	0.6	0.4	0.5	0.1	0.1	0.3	0.1	6.8	0.5	0.1	4.8	0.0	0.2	0.2	0.6	0.4	0.2	30.7	0.1	0.0	0.3	0.2	0.7	0.0	0.0	0.2	0.1	433.3	0.1	0.1	0.1	0.0	0.1	0.0	0.1	1.4	0.1	0.4	0.3	0.1	2.0	1.2	0.4	0.2	0.4	0.3	0.4	0.2	0.1	0.2	0.1	8.8	0.6	0.1	0.1	0.0	0.8	0.2	0.0	0.2	0.6	0.3	0.0	0.2	0.1	0.8	0.0	1.6	0.1	0.1	0.0	0.1	0.1	1.6	9.8	0.2	0.1	1.0	2.1	0.1	0.2	0.1	3.5	0.1	12.3	0.2	0.6	0.2	0.3	0.0	0.1	0.3	0.0	1.4	0.1	0.5	5.9	0.3	0.3	0.5	0.3	0.1	2.5	0.2	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.4	0.9	1.8	1.4	0.6	0.4	0.1	6.8	0.5	0.6	0.0	0.1	1.4	0.1	3.2	1.1	0.3	0.0	0.1	0.1	0.0	0.0	134.9	0.1	0.0	0.3	1.5	0.0	0.0	6.2	0.1	0.0	0.0	1.9	0.6	2248.2	0.1	0.2	2.8	27.5	2.7	1.8	0.0	0.1	0.7	0.0	0.1	0.0	0.0	1.4	0.0	0.6	1.7	0.8	2.0	2.0	0.3	0.0	10812.1	53.4	2.9	0.0	1.0	0.1	6.7	0.0	0.0	0.1	0.0	1.2	39.9	0.0	0.1	0.1	0.0	0.0	16.1	6.6	0.4	0.1	57.0	27.1	0.0	0.0	0.0	0.1	0.1	0.1	0.1
GSTA3		ENSG00000174156	"Glutathione S-transferase alpha 3"	Q16772	6	52896639-52909698	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"adrenal gland: 67.8;fallopian tube: 65.9;placenta: 22.9;skin 1: 26.2"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 194.9;Syncytiotrophoblasts: 515.3;Theca cells: 91.3"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.5;testis cancer: 1.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SuSa: 1.4"									"HPA004342, HPA048934, HPA053817"	Approved		Supported	Cytosol		NA	NA			Cytosol		"HPA004342: AB_1078987, HPA048934: AB_2680563, HPA053817: AB_2630367"	"unprognostic (7.51e-2)"			"unprognostic (7.06e-3)"		"unprognostic (3.10e-1)"	"unprognostic (5.53e-2)"	"unprognostic (4.38e-3)"	"unprognostic (2.86e-3)"	"unprognostic (1.81e-1)"		"unprognostic (1.41e-1)"		"unprognostic (1.93e-1)"	"unprognostic (9.35e-2)"			0.0	67.8	0.2	0.1	0.1	0.0	1.8	0.1	0.0	0.7	0.4	0.0	0.3	0.8	0.9	0.0	65.9	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.0	0.0	0.3	0.0	0.9	0.1	3.0	0.0	22.9	0.1	0.1	0.0	0.0	0.3	0.2	0.0	26.2	0.4	0.1	0.0	0.0	2.4	11.1	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.3	0.1	0.0	0.0	1.1	0.0	0.0	1.0	0.0	0.9	0.0	0.0	0.4	0.0	0.0	0.0	6.2	0.0	0.0	194.9	0.0	0.0	0.0	0.0	1.3	47.0	0.5	0.5	0.0	0.0	0.0	0.0	7.5	1.1	0.0	0.7	1.3	7.4	0.0	0.4	15.7	0.0	0.0	0.0	2.0	0.0	0.4	2.1	1.5	0.0	24.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.4	24.8	0.0	0.0	0.0	0.8	0.5	0.5	0.0	9.8	515.3	0.1	91.3	0.0	0.0
H3Y1	"H3.Y, H3.Y.1"	ENSG00000269466	"H3.Y histone 1"	P0DPK2	5	17654868-17655849	"Predicted intracellular proteins"				"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"testis cancer: 2.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	14	"U-2 OS: 1.7"									HPA042570	Uncertain					NA	NA					"HPA042570: AB_2678056"															"unprognostic (1.50e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HDC		ENSG00000140287	"Histidine decarboxylase"	P19113	15	50241947-50265965	"Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Catecholamine biosynthesis"	"Decarboxylase, Lyase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 87.6;epididymis: 46.5"	"Cell type enriched"	"Detected in some"	12	"granulocytes: 596.0"	"Cancer enhanced"	"Detected in some"		"breast cancer: 2.9;testis cancer: 2.7"	"Group enriched"	"Detected in many"	5	"hypothalamus: 87.6;pons: 36.0"	"Immune cell enriched"	"Detected in single"	2140	"basophil: 686.2"	"Lineage enriched"	"Detected in single"	2140	"granulocytes: 686.2"	"Group enriched"	"Detected in some"	4	"HEL: 460.8;HMC-1: 1051.3"	"Region enriched"	"Detected in many"	5	"hypothalamus: 43.9"	"Group enriched"	"Detected in some"	10	"hypothalamus: 16.5;midbrain: 4.2"	HPA038891	Enhanced		Approved	"Nuclear bodies"		NA	NA			"Nuclear bodies"		"HPA038891: AB_10673231"	"unprognostic (4.97e-2)"	"unprognostic (7.42e-2)"	"unprognostic (1.43e-4)"	"unprognostic (1.08e-1)"	"unprognostic (6.16e-2)"	"unprognostic (3.93e-7)"	"unprognostic (4.18e-5)"	"unprognostic (8.79e-3)"	"unprognostic (1.48e-1)"	"unprognostic (8.46e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.53e-1)"	"unprognostic (7.20e-2)"	"unprognostic (9.78e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.50e-1)"	2.0	0.4	0.2	3.5	3.6	4.7	1.4	0.0	0.2	2.3	0.6	3.8	4.1	2.6	46.5	4.9	0.8	11.3	0.7	0.2	87.6	0.4	0.5	7.0	0.9	0.0	8.1	0.0	0.1	1.2	0.5	0.4	0.4	36.0	1.8	3.6	0.8	1.3	1.0	0.3	2.0	4.6	2.5	0.0	0.5	13.0	1.3	12.9	0.9	0.1	0.8	1.0	3.8	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	460.8	0.2	0.0	0.0	1.2	1051.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.5	181.8	0.3	0.0	0.0	0.2	0.4	0.4	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.5	0.2	0.4	686.2	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.0	0.0	1.6	0.2	3.6	0.0	0.2	0.2	87.6	0.0	8.1	0.0	36.0	0.0	12.9	0.1	0.0	12.8	47.5	0.3	0.0	0.8	0.0	0.0	0.0	2.6	0.0	0.0	0.5	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.2	0.0	10.9	0.3	0.0	0.0	2.3	9.2	0.0	596.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	1.8	0.4	0.0	1.2	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	3.8	0.0	0.0	0.0	4.5	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.9	0.0	3.5	0.0	0.1	0.1
HELLS	"LSH, Nbla10143, PASG, SMARCA6"	ENSG00000119969	"Helicase, lymphoid specific"	Q9NRZ9	10	94501434-94613905	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation"	"Developmental protein, Helicase, Hydrolase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 16.5;lymphoid tissue: 16.0"	"Cell type enhanced"	"Detected in many"		"Spermatocytes: 182.0;Spermatogonia: 173.9"	"Cancer enhanced"	"Detected in all"		"testis cancer: 16.1"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 36.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB004491, HPA063242"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		No	Yes			Nucleoplasm	"Golgi apparatus, Vesicles"	"CAB004491: AB_627895, HPA063242: AB_2684968"	"unprognostic (1.94e-1)"	"prognostic favorable (1.36e-4)"	"unprognostic (9.85e-2)"	"unprognostic (3.38e-2)"	"unprognostic (8.65e-2)"	"unprognostic (4.85e-3)"	"unprognostic (1.76e-5)"	"unprognostic (7.59e-3)"	"unprognostic (7.03e-3)"	"unprognostic (6.49e-2)"	"unprognostic (2.05e-2)"	"unprognostic (9.45e-5)"	"unprognostic (9.93e-13)"	"unprognostic (2.25e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.24e-2)"	"unprognostic (3.03e-2)"	1.1	1.3	0.6	6.5	0.6	16.5	3.1	5.7	1.3	2.7	1.3	4.3	2.9	2.9	1.4	6.0	1.7	2.0	0.6	0.5	1.4	1.9	1.8	1.7	12.5	1.1	1.0	0.3	2.6	1.2	1.4	3.1	4.2	2.8	2.1	5.1	1.1	1.9	1.0	0.3	5.3	3.9	2.2	1.2	4.3	3.8	12.9	1.1	16.0	1.1	0.2	12.7	3.7	3.2	1.8	57.7	55.4	70.6	90.1	2.9	6.4	37.4	42.9	27.8	34.4	54.6	70.3	45.5	70.0	16.7	15.5	29.1	56.3	40.9	34.9	50.7	68.5	45.5	37.3	56.3	58.0	1.7	71.2	31.6	3.6	2.0	42.1	20.0	9.4	24.0	46.0	20.7	43.5	43.1	54.9	75.2	35.6	73.4	42.3	24.1	70.3	62.1	16.3	24.2	72.2	28.4	22.8	50.3	14.5	7.8	59.0	60.9	23.1	17.2	38.4	19.4	35.4	52.4	22.3	47.6	74.5	19.0	42.8	17.9	0.3	0.7	0.0	7.0	1.5	2.4	18.8	11.4	9.4	2.3	23.2	5.2	7.7	1.0	10.2	1.0	36.8	19.7	2.3	0.6	0.6	5.7	1.3	0.5	1.4	1.1	1.0	0.3	2.8	1.2	1.1	1.8	4.7	9.6	3.9	0.0	19.7	21.5	11.5	12.6	13.1	16.4	10.0	15.0	1.0	12.8	12.6	22.0	0.0	46.3	13.2	26.2	3.9	9.0	2.0	9.3	16.4	8.1	10.8	50.5	3.3	6.2	43.4	13.0	17.9	16.3	5.7	60.6	5.7	3.6	15.1	6.7	5.4	17.8	8.2	2.2	10.3	5.3	9.0	7.3	1.8	9.4	5.7	4.3	1.0	4.5	6.6	4.7	1.8	5.7	37.5	3.7	1.7	1.6	6.3	11.4	19.7	10.5	16.4	182.0	173.9	22.9	9.9	11.1	15.7	16.5	30.9	11.7
HFM1	"FLJ36760, FLJ39011, MER3, SEC63D1"	ENSG00000162669	"Helicase for meiosis 1"	A2PYH4	1	91260766-91404856	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	Meiosis	"Helicase, Hydrolase"	"Disease variant, Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"pituitary gland: 9.3;testis: 13.9"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 50.9;Inhibitory neurons: 38.4;Oligodendrocyte precursor cells: 90.5;Spermatocytes: 58.9"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 5.2;AN3-CA: 2.8;K-562: 3.0;SH-SY5Y: 2.1;U-266/70: 2.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA035036, HPA035557"			Supported	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"		"HPA035036: AB_2797224, HPA035557: AB_10696507"	"unprognostic (1.35e-2)"	"unprognostic (9.39e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.83e-4)"	"unprognostic (2.05e-2)"	"unprognostic (1.52e-1)"	"unprognostic (7.43e-3)"	"unprognostic (1.79e-1)"	"unprognostic (7.75e-2)"	"unprognostic (7.97e-2)"	"unprognostic (1.76e-4)"	"unprognostic (2.81e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.89e-3)"	"unprognostic (2.78e-2)"	"unprognostic (1.77e-4)"	"unprognostic (9.59e-2)"	0.4	0.4	1.3	0.1	0.9	0.2	0.4	4.9	1.1	0.9	0.0	0.4	0.3	2.4	1.1	0.1	0.8	0.2	0.6	0.6	1.8	0.7	0.1	0.2	0.1	1.7	1.4	0.4	3.9	0.7	0.1	9.3	0.5	2.5	0.6	0.3	4.6	0.5	1.2	1.5	0.1	0.2	0.9	1.0	0.4	0.2	13.9	1.1	0.1	1.7	1.1	0.2	0.4	0.3	1.3	0.0	0.1	5.2	2.8	0.0	0.1	0.0	0.3	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.0	0.6	0.0	0.0	0.1	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	3.0	0.0	0.0	0.0	0.3	0.1	1.6	0.0	0.0	0.2	1.0	0.0	0.0	0.0	1.7	2.1	0.0	0.0	0.7	1.4	0.0	0.5	0.0	0.0	0.5	0.5	0.1	2.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.9	4.9	1.1	0.6	1.8	1.7	1.4	0.4	2.5	1.0	1.1	1.3	0.2	0.0	1.1	50.9	0.0	0.0	0.0	0.0	0.6	3.9	0.1	0.3	3.1	0.0	0.0	0.0	6.2	0.5	0.0	0.0	0.0	0.4	17.8	0.2	1.9	0.4	0.0	2.5	17.6	0.2	0.2	0.6	0.0	0.0	0.0	5.9	0.0	0.0	0.1	0.0	38.4	0.0	0.0	0.0	0.0	5.0	4.1	0.0	0.0	10.3	0.0	2.4	0.0	90.5	9.5	0.1	0.0	2.2	0.0	0.1	0.0	0.0	0.0	6.2	0.0	2.0	1.4	58.9	15.6	0.0	0.0	0.0	0.0	1.8	0.0	0.0
HORMAD1	"CT46, DKFZP434A1315"	ENSG00000143452	"HORMA domain containing 1"	Q86X24	1	150698060-150720895	"Predicted intracellular proteins"	"Differentiation, Meiosis, Oogenesis, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"testis: 118.8"	"Cell type enriched"	"Detected in some"	4	"Spermatocytes: 727.7"	"Cancer enhanced"	"Detected in many"		"testis cancer: 6.9"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A549: 5.6;HeLa: 4.9;hTCEpi: 19.4;SiHa: 6.1;SuSa: 6.5;THP-1: 11.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA028346, HPA037850"	Enhanced		Approved	Nucleoplasm,Nucleoli		Yes	No			Nucleoplasm	Nucleoli	"HPA028346: AB_2672564, HPA037850: AB_10696358"	"unprognostic (7.21e-2)"	"unprognostic (7.88e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.15e-2)"	"unprognostic (9.06e-2)"	"unprognostic (3.91e-3)"	"unprognostic (4.08e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.56e-2)"	"unprognostic (5.17e-3)"	"unprognostic (3.79e-9)"	"unprognostic (3.32e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.49e-2)"	0.1	0.0	0.1	0.5	0.1	0.5	0.1	0.0	0.3	0.0	0.1	0.2	0.0	0.0	0.0	3.7	0.0	0.2	0.0	0.1	0.1	0.0	0.1	0.2	0.4	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.5	0.1	0.1	0.4	0.1	0.4	0.0	0.0	6.8	0.2	0.1	0.2	0.9	0.1	118.8	0.2	0.0	0.0	0.0	0.8	0.0	0.2	0.2	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	2.6	0.0	0.0	0.0	0.1	0.0	0.1	4.9	0.0	0.0	0.1	0.1	0.0	19.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	6.1	0.0	0.1	6.5	0.0	11.3	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.5	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.2	0.2	0.1	0.0	0.0	0.0	0.2	5.4	0.0	1.4	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.0	3.4	0.0	0.3	0.0	0.1	88.3	0.5	0.1	0.5	0.0	0.0	2.7	0.0	2.1	0.4	0.0	0.1	0.0	0.1	0.4	0.0	0.8	0.0	2.0	0.0	0.0	1.3	0.9	35.1	5.3	0.8	0.0	1.0	1.5	0.0	0.0	1.0	0.1	0.0	0.1	4.9	0.0	0.0	0.0	0.0	0.5	0.0	32.9	0.0	0.4	727.7	163.5	0.0	9.2	2.2	0.0	0.3	0.2	0.1
HSD3B2	SDR11E2	ENSG00000203859	"Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2"	P26439	1	119414931-119423035	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	Steroidogenesis	"Isomerase, Multifunctional enzyme, Oxidoreductase"	"Congenital adrenal hyperplasia, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	56	"adrenal gland: 2192.7"	"Group enriched"	"Detected in some"	4	"Granulosa cells: 40.6;Proximal enterocytes: 38.8;Theca cells: 68.9"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SK-MEL-30: 1.4"									"HPA043261, HPA043264, HPA044028"	Supported		Uncertain	"Nucleoli,Endoplasmic reticulum,Cytokinetic bridge"		Yes	NA			"Nucleoli, Endoplasmic reticulum"	"Cytokinetic bridge"	"HPA043261: AB_2630368, HPA043264: AB_2678398, HPA044028: AB_2678781"	"unprognostic (3.56e-1)"		"unprognostic (1.85e-1)"		"unprognostic (2.80e-1)"		"unprognostic (2.72e-2)"		"unprognostic (8.87e-2)"	"unprognostic (3.91e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.94e-1)"	"unprognostic (6.51e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.55e-1)"			0.2	2192.7	0.4	2.1	0.8	0.0	0.1	0.0	0.8	0.2	0.0	4.2	0.0	0.2	0.0	0.2	0.4	0.0	0.2	0.3	0.2	0.9	1.0	0.5	0.0	0.3	0.0	0.7	0.9	0.5	0.0	0.1	3.6	0.2	0.4	1.0	0.0	1.0	0.0	0.1	0.2	39.0	0.1	0.0	0.2	0.3	3.0	0.1	0.5	0.2	0.0	0.0	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	1.4	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.8	0.0	0.8	0.3	0.2	0.3	0.0	0.7	0.2	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	11.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.1	3.5	0.0	0.0	0.0	40.6	0.0	0.0	0.1	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.6	0.0	0.0	38.8	0.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	68.9	1.7	0.0
HTR2C	"5-HT2C, 5HTR2C, HTR1C"	ENSG00000147246	"5-hydroxytryptamine receptor 2C"	P28335	X	114584078-114910061	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"	Behavior	"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"choroid plexus: 226.1"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 24.2;Inhibitory neurons: 55.3;Oligodendrocyte precursor cells: 10.1"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"EFO-21: 2.7;RPMI-8226: 1.4;U-266/70: 4.8;U-266/84: 4.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA										"unprognostic (2.14e-1)"	"unprognostic (6.09e-3)"		"unprognostic (9.54e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.89e-2)"		"unprognostic (3.42e-2)"		"unprognostic (9.22e-4)"	"unprognostic (1.37e-1)"		"unprognostic (6.84e-2)"	0.0	0.0	11.2	0.0	22.5	0.0	0.0	1.3	7.2	0.3	226.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.6	15.5	0.0	0.0	0.0	0.0	13.9	8.8	5.4	0.0	0.0	0.0	0.4	0.1	10.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.3	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.2	0.6	0.0	0.0	0.0	1.4	0.0	0.7	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	4.8	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.2	22.5	1.3	7.2	13.6	15.5	13.9	8.8	5.4	10.0	4.5	10.4	10.2	0.0	0.0	0.0	1.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	24.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	55.3	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	2.8	0.0	0.0	0.0	10.1	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HTRA4	FLJ90724	ENSG00000169495	"HtrA serine peptidase 4"	P83105	8	38974228-38988663	"Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"placenta: 67.5"	"Cell type enriched"	"Detected in some"	10	"Extravillous trophoblasts: 444.0"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	24	"BEWO: 233.6"	"Region enhanced"	"Detected in single"		"hippocampal formation: 2.1"	"Low region specificity"	"Detected in all"			HPA045402	Enhanced				"Secreted in female reproductive system"	NA	NA		23000			"HPA045402: AB_2679316"	"unprognostic (1.20e-1)"	"unprognostic (5.83e-4)"	"unprognostic (8.02e-2)"	"unprognostic (2.13e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.80e-1)"	"unprognostic (7.40e-3)"	"unprognostic (1.40e-1)"	"unprognostic (5.14e-4)"	"unprognostic (1.01e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.58e-1)"	"unprognostic (5.19e-3)"	"unprognostic (2.39e-3)"	"unprognostic (1.19e-3)"	0.6	0.5	1.1	0.9	1.2	7.3	1.2	3.3	5.0	0.9	0.0	0.5	0.3	0.9	0.9	0.1	0.3	0.5	0.3	1.3	0.5	0.4	0.6	2.0	2.6	0.8	0.5	0.6	0.6	0.8	0.5	0.1	67.5	1.2	0.6	0.7	1.9	0.3	1.1	1.0	0.8	0.4	0.7	0.2	1.2	0.4	0.9	0.7	0.5	0.5	0.1	1.7	0.4	0.1	2.3	0.4	0.3	0.2	0.4	0.8	0.4	233.6	0.6	0.4	0.3	0.4	0.4	0.5	0.5	0.2	0.2	0.4	0.4	0.2	0.2	0.1	0.2	0.4	0.4	0.7	0.3	0.2	0.6	0.6	0.7	0.2	0.2	0.5	0.3	0.2	0.2	0.4	1.3	0.2	0.5	0.4	0.3	0.3	0.1	0.2	0.2	0.2	0.4	0.2	0.7	0.4	0.6	0.5	0.3	0.1	9.6	0.5	0.7	0.0	0.7	0.5	0.3	0.3	0.5	0.2	0.2	0.2	0.7	0.2	0.3	0.1	0.4	0.2	0.1	0.3	0.2	0.2	0.2	0.1	0.5	0.2	0.2	0.5	0.2	0.2	0.5	0.3	0.0	1.1	1.2	3.3	5.0	1.3	0.5	0.8	0.5	0.6	1.2	0.2	0.7	2.3	0.1	0.0	0.0	0.0	1.0	0.1	1.7	0.1	1.2	0.5	0.1	0.3	0.7	0.0	0.0	0.0	2.1	2.8	1.1	0.1	0.0	0.0	0.1	0.2	0.7	0.3	0.0	0.0	0.4	0.0	444.0	1.2	0.0	0.5	0.0	0.7	1.4	0.0	11.6	1.7	0.2	0.0	0.0	0.6	0.3	0.0	0.0	3.8	1.8	1.0	0.0	0.4	1.0	1.5	0.2	0.3	0.0	0.0	0.5	1.5	0.0	0.2	0.1	0.2	0.0	3.5	0.2	0.0	0.1	0.0	0.1	40.4	0.7	0.2	0.2	1.1
IGSF5	JAM4	ENSG00000183067	"Immunoglobulin superfamily member 5"	Q9NSI5	21	39745407-39802096	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in some"			"Cell type enriched"	"Detected in some"	8	"Syncytiotrophoblasts: 114.1"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"T-47d: 5.8"									HPA057282	Uncertain		Approved	"Focal adhesion sites"		NA	NA			"Focal adhesion sites"		"HPA057282: AB_2683395"	"unprognostic (1.06e-1)"	"unprognostic (2.53e-1)"	"unprognostic (7.06e-2)"	"unprognostic (9.73e-5)"	"unprognostic (1.56e-2)"	"unprognostic (3.15e-1)"		"unprognostic (1.41e-1)"	"unprognostic (2.18e-2)"	"unprognostic (2.09e-1)"	"unprognostic (8.35e-2)"	"unprognostic (9.61e-2)"	"unprognostic (4.01e-1)"	"unprognostic (4.18e-1)"	"unprognostic (3.75e-2)"	"unprognostic (6.89e-2)"	"unprognostic (1.07e-2)"	0.3	1.3	2.2	0.2	2.4	0.4	0.9	0.4	1.5	0.7	1.8	0.4	0.3	0.7	1.9	0.2	0.7	0.4	3.4	1.3	1.8	0.4	0.4	0.3	0.4	1.3	1.2	0.8	1.0	1.5	0.2	0.6	2.6	1.7	1.4	0.7	1.2	0.5	0.4	0.2	0.6	0.3	0.4	0.6	0.4	0.5	1.1	2.4	0.6	0.7	0.1	0.4	0.4	0.1	1.2	0.7	0.4	2.4	0.6	2.3	1.8	0.6	0.4	0.6	0.6	1.0	0.4	0.7	0.8	0.6	0.9	0.9	0.6	0.8	1.6	1.3	1.3	1.1	0.7	1.9	0.3	1.4	1.0	0.3	1.7	2.9	1.5	1.7	1.2	0.3	0.3	1.4	0.5	0.9	0.9	0.2	0.3	1.3	0.6	0.4	0.4	1.1	0.4	1.0	1.0	1.1	0.3	0.6	1.6	1.0	1.0	5.8	0.6	0.2	1.0	1.2	0.5	1.0	0.5	0.4	0.5	0.6	0.8	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	2.2	2.4	0.4	1.5	1.3	1.8	1.3	1.2	0.8	1.7	0.6	2.4	1.2	0.0	0.0	0.0	8.5	0.0	0.0	0.2	0.0	0.0	1.2	1.0	0.8	9.7	0.0	0.1	1.8	0.0	1.6	0.0	0.6	5.9	0.6	12.8	0.0	0.4	0.2	0.0	0.0	2.9	0.2	1.7	0.4	0.0	0.0	0.0	0.7	0.0	0.0	0.4	0.0	4.1	0.4	0.0	0.0	0.0	4.8	0.3	0.1	0.0	0.0	0.0	1.0	0.0	5.0	1.0	0.2	0.2	0.4	0.0	1.4	0.0	6.8	0.1	0.2	0.0	0.0	0.2	0.5	0.2	0.0	0.0	114.1	0.1	1.1	0.4	2.0
INPP5F	"hSac2, KIAA0966, SAC2"	ENSG00000198825	"Inositol polyphosphate-5-phosphatase F"	Q9Y2H2	10	119726042-119829147	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 132.8"	"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 79.5;Inhibitory neurons: 130.5;Late spermatids: 88.6;Oligodendrocytes: 70.5"	"Cancer enhanced"	"Detected in all"		"testis cancer: 27.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"AF22: 91.4;SK-MEL-30: 149.0;SuSa: 181.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042605			Supported	Vesicles		NA	NA			Vesicles		"HPA042605: AB_10793886"	"unprognostic (2.65e-2)"	"unprognostic (3.23e-1)"	"unprognostic (3.42e-2)"	"unprognostic (5.84e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.57e-3)"	"unprognostic (2.46e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.09e-2)"	"unprognostic (2.09e-1)"	"unprognostic (6.46e-2)"	"unprognostic (7.78e-2)"	"unprognostic (1.02e-1)"	"unprognostic (9.91e-2)"	"unprognostic (2.96e-2)"	"unprognostic (6.21e-2)"	9.2	17.0	55.3	10.0	55.6	4.8	7.7	51.6	65.9	15.4	18.4	13.1	4.6	15.5	23.0	9.3	8.4	6.9	5.9	52.7	113.6	10.6	3.2	9.2	10.8	73.7	68.9	47.5	12.4	6.7	7.4	57.6	11.0	82.1	11.0	8.1	33.2	10.9	10.1	11.1	13.8	9.6	13.3	57.8	7.6	8.6	14.9	73.3	7.0	10.6	3.8	13.1	9.3	12.6	132.8	13.5	8.2	91.4	14.3	6.9	10.6	8.5	18.4	9.3	8.4	8.4	12.0	15.2	8.3	7.6	19.7	10.6	14.4	7.9	9.8	11.9	6.0	10.3	6.5	3.9	11.0	13.5	4.4	19.0	9.7	8.6	14.2	13.5	15.7	23.2	6.1	5.7	13.8	20.8	7.0	5.5	15.7	9.2	9.9	12.0	7.0	18.8	2.3	12.5	5.3	6.5	70.2	19.8	7.2	149.0	181.5	4.3	3.4	19.6	9.9	12.2	11.0	17.5	15.2	7.7	4.5	11.0	12.8	32.3	0.9	3.4	1.3	1.0	3.0	1.3	6.7	2.2	1.3	6.2	9.1	2.2	1.1	0.8	3.4	3.6	1.4	5.3	1.9	55.3	55.6	51.6	65.9	52.7	113.6	73.7	68.9	47.5	82.1	57.8	73.3	132.8	7.8	6.4	4.8	52.5	21.5	9.1	11.7	7.5	10.2	24.2	6.9	9.5	5.4	1.5	7.8	12.9	16.7	9.3	7.9	15.1	11.7	3.6	58.7	4.3	18.3	8.6	1.2	5.2	79.5	4.5	10.6	7.9	5.1	6.9	2.5	9.7	4.2	3.5	9.9	42.1	130.5	5.6	10.2	6.0	27.8	88.6	5.3	13.1	19.6	34.7	16.3	21.7	6.2	52.8	70.5	6.8	6.6	3.8	4.7	8.2	6.5	24.7	4.0	21.6	6.6	7.8	13.8	22.4	41.0	13.1	10.4	13.3	7.7	19.3	6.5	13.1
ISM2	"FLJ32147, TAIL1, THSD3"	ENSG00000100593	"Isthmin 2"	Q6H9L7	14	77474394-77498816	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	58	"placenta: 215.2"	"Group enriched"	"Detected in some"	10	"Cytotrophoblasts: 291.0;Extravillous trophoblasts: 617.2;Syncytiotrophoblasts: 177.5"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.4"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	15	"BEWO: 386.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA039314, HPA039742"	Supported		Supported	Nucleoplasm	"Secreted in female reproductive system"	NA	NA		1100000	Nucleoplasm		"HPA039314: AB_10673239, HPA039742: AB_10673427"	"unprognostic (5.69e-2)"	"unprognostic (9.17e-3)"	"unprognostic (2.58e-2)"	"unprognostic (1.41e-3)"	"unprognostic (3.73e-2)"	"unprognostic (2.34e-1)"		"unprognostic (2.16e-2)"	"unprognostic (3.09e-3)"	"unprognostic (2.11e-1)"	"unprognostic (4.13e-1)"	"unprognostic (8.10e-2)"	"unprognostic (1.42e-2)"	"unprognostic (9.36e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.67e-2)"	"unprognostic (3.95e-1)"	0.3	0.0	0.3	0.1	1.2	0.0	0.0	0.0	0.6	0.7	0.7	0.2	0.1	1.2	3.7	0.2	0.4	0.1	0.0	0.3	0.6	0.6	0.0	0.0	0.0	0.4	0.4	0.3	0.1	0.6	0.4	0.5	215.2	0.3	1.9	0.0	0.1	0.1	1.4	0.0	0.0	0.0	0.3	0.1	0.0	0.0	1.6	0.6	0.0	0.2	0.0	0.0	0.3	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	386.3	0.0	0.0	0.1	0.0	6.1	0.0	0.0	0.1	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.4	0.0	0.0	25.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.4	0.3	0.5	0.8	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.2	0.0	0.6	0.3	0.6	0.4	0.4	0.3	0.3	0.1	0.6	0.2	0.2	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	291.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.4	0.0	617.2	2.1	0.0	0.0	0.0	0.1	0.0	0.0	33.4	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.7	1.7	0.0	0.0	177.5	0.0	0.0	0.0	0.0
ITGA2B	"CD41, CD41B, GP2B, PPP1R93"	ENSG00000005961	"Integrin subunit alpha 2b"	P08514	17	44372180-44389649	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Integrin, Receptor"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 16.7;epididymis: 10.8;lymphoid tissue: 11.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 16.1;Erythroid cells: 43.5;granulocytes: 17.8;Late spermatids: 24.8;Macrophages: 23.0"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.1"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	14	"basophil: 64.5"	"Lineage enriched"	"Detected in single"	75	"granulocytes: 64.5"	"Group enriched"	"Detected in some"	14	"HEL: 404.6;HMC-1: 631.7"	"Not detected"	"Not detected"							"CAB018611, HPA031168, HPA031169, HPA031170, HPA031171"	Enhanced		Approved	"Plasma membrane"		NA	NA		90000000	"Plasma membrane"		"CAB018611: AB_2265153, HPA031168: AB_10664706, HPA031169: AB_10669671, HPA031170: AB_10696214, HPA031171: AB_10669773"	"unprognostic (6.11e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.85e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.98e-3)"	"unprognostic (4.23e-5)"	"unprognostic (1.25e-1)"	"unprognostic (1.33e-2)"	"unprognostic (7.22e-2)"	"unprognostic (2.97e-3)"	"unprognostic (1.30e-1)"	"unprognostic (8.83e-9)"	"unprognostic (7.82e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.25e-1)"	0.6	0.2	3.2	0.2	3.1	16.7	0.4	3.6	4.8	1.4	3.2	0.3	0.0	0.9	10.8	0.3	1.5	0.8	0.9	3.1	3.1	0.7	0.6	5.1	0.2	3.2	3.0	3.0	1.5	0.1	1.3	1.9	1.1	3.2	0.6	0.2	1.6	0.1	0.8	0.6	0.1	0.3	0.2	2.8	11.3	0.3	2.9	3.0	0.1	3.1	1.1	0.1	0.2	0.7	3.3	0.5	0.7	2.2	0.3	0.1	0.3	18.4	0.3	0.1	0.8	0.6	0.0	0.2	0.0	0.3	0.0	0.2	0.6	1.8	0.0	0.4	0.4	1.1	404.6	0.3	1.3	0.0	0.2	631.7	0.4	0.0	0.2	0.0	0.0	0.0	0.3	0.7	1.1	0.0	0.7	0.5	36.4	0.8	0.0	0.7	0.7	0.2	0.0	0.0	0.1	0.4	1.0	0.5	0.5	0.1	1.5	4.5	0.9	0.3	0.2	0.7	0.0	0.0	0.4	0.2	0.3	0.4	0.3	0.8	64.5	0.3	4.0	0.1	0.0	0.3	0.0	0.0	0.0	0.5	0.1	0.0	0.0	4.5	0.0	0.0	0.8	0.0	19.3	3.2	3.1	3.6	4.8	3.1	3.1	3.2	3.0	3.0	3.2	2.8	3.0	3.3	0.3	0.0	1.5	1.0	0.4	0.3	0.4	0.1	1.8	5.1	0.2	1.1	1.5	1.5	1.3	5.5	8.4	1.3	0.1	0.6	0.0	0.0	16.1	1.0	0.7	2.1	0.0	43.5	4.1	0.0	1.4	1.1	0.0	3.2	17.8	0.1	3.6	0.0	0.2	3.3	2.8	0.0	0.0	3.1	0.7	24.8	1.8	23.0	0.0	1.0	2.9	1.3	0.0	9.5	4.6	0.1	0.0	1.9	0.1	0.3	0.0	0.0	0.0	3.0	0.0	1.8	0.7	3.4	7.4	0.5	0.0	0.7	0.6	0.1	0.3	0.3
JARID2	JMJ	ENSG00000008083	"Jumonji and AT-rich interaction domain containing 2"	Q92833	6	15246069-15522042	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Chromatin regulator, Developmental protein, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 58.3"	"Cell type enhanced"	"Detected in all"		"Langerhans cells: 195.0"	"Cancer enhanced"	"Detected in all"		"testis cancer: 34.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"JURKAT: 73.8;SuSa: 78.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063889, CAB069890"	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"CAB069890: AB_10000529, HPA063889: AB_2685143"	"unprognostic (5.06e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.43e-1)"	"unprognostic (4.87e-3)"	"unprognostic (6.35e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.60e-2)"	"unprognostic (3.26e-3)"	"unprognostic (7.04e-2)"	"unprognostic (4.48e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.99e-1)"	7.4	4.7	6.5	9.3	7.3	58.3	6.1	20.9	8.9	4.6	4.4	4.9	5.8	5.0	6.7	13.8	3.9	4.4	5.6	7.4	6.6	3.4	3.7	7.3	9.1	7.6	7.5	5.6	5.8	3.5	3.6	4.4	7.2	10.2	4.6	4.6	20.2	6.4	3.4	11.9	13.5	6.9	4.1	5.5	10.7	7.1	16.2	7.9	20.2	3.9	4.3	9.9	5.8	6.8	8.2	12.4	8.5	34.0	19.6	4.1	4.0	33.5	3.5	8.3	4.5	5.5	8.8	9.4	6.5	12.3	7.1	6.8	6.3	8.0	20.1	4.1	13.0	12.4	23.3	10.6	11.6	4.6	23.9	26.3	5.7	12.3	6.6	26.2	13.4	4.7	73.8	30.5	10.8	2.7	12.6	47.6	44.6	36.4	6.1	3.8	20.9	10.4	18.6	4.2	13.0	26.2	15.0	7.3	24.9	32.1	78.1	8.7	25.0	8.5	20.6	11.4	11.5	12.3	6.9	17.8	11.7	7.0	21.9	26.6	10.1	3.8	3.2	3.4	2.4	2.9	2.5	1.6	2.1	3.1	3.4	2.1	2.9	13.2	4.9	2.7	4.4	1.4	2.1	6.5	7.3	20.9	8.9	7.4	6.6	7.6	7.5	5.6	10.2	5.5	7.9	8.2	30.1	6.4	12.8	175.3	40.7	80.4	10.7	23.0	31.9	74.2	28.3	23.1	10.5	15.7	17.1	5.5	87.6	27.0	62.9	10.0	1.9	8.2	89.2	30.7	18.0	27.1	26.8	50.9	125.9	4.4	25.0	17.6	19.9	77.5	25.3	14.8	15.7	13.8	24.0	154.8	124.4	16.4	16.2	61.3	195.0	40.8	8.7	89.5	26.6	97.4	49.1	134.0	54.6	136.7	136.6	15.6	9.3	8.6	34.9	6.8	16.6	3.8	8.7	89.7	6.6	18.1	23.6	9.4	71.1	43.4	151.6	25.2	43.2	17.4	14.7	15.4
KANK3	"ANKRD47, FLJ46061"	ENSG00000186994	"KN motif and ankyrin repeat domains 3"	Q6NY19	19	8322584-8343262	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Adipocytes: 196.2;Endothelial cells: 83.8;Hepatic stellate cells: 55.3"	"Cancer enhanced"	"Detected in all"		"testis cancer: 7.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Group enriched"	"Detected in many"	4	"NK-cells: 1.2;T-cells: 1.0"	"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 8.1;TIME: 14.8;U-266/70: 5.9"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"olfactory bulb: 16.2"	HPA051153	Approved		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA051153: AB_2681365"	"unprognostic (1.56e-1)"	"unprognostic (1.63e-4)"	"unprognostic (1.54e-2)"	"unprognostic (8.95e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.84e-3)"	"unprognostic (1.82e-3)"	"unprognostic (3.26e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.34e-2)"	"unprognostic (4.77e-1)"	"prognostic favorable (1.69e-5)"	"unprognostic (5.03e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.86e-1)"	"unprognostic (3.24e-1)"	25.7	7.6	11.6	2.3	8.9	0.6	26.3	8.5	12.3	8.0	5.0	6.2	2.9	10.3	0.7	5.1	11.3	2.5	22.3	7.6	7.9	17.9	4.2	33.6	2.9	11.6	10.5	6.3	3.7	3.9	1.5	7.0	14.7	10.9	7.7	0.5	0.3	4.2	1.8	13.8	6.2	7.3	2.4	8.3	35.7	6.3	2.4	11.4	0.7	15.7	6.1	0.8	8.0	6.9	9.8	0.1	0.6	0.2	0.5	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.7	0.2	0.0	2.3	0.0	0.0	0.1	0.5	2.6	0.0	0.7	1.4	0.3	0.3	0.4	0.1	0.2	1.3	0.0	0.8	0.0	0.0	0.0	8.1	0.6	0.0	0.3	0.0	0.4	0.0	0.4	0.5	0.5	0.2	1.4	0.0	0.7	0.1	0.1	0.0	0.1	0.0	0.7	0.1	0.0	0.5	0.0	14.8	0.0	1.3	0.3	0.1	5.9	0.2	0.3	0.1	0.1	0.2	0.2	0.1	0.0	1.0	0.0	0.5	0.1	0.5	0.1	0.0	0.1	0.2	0.4	0.2	1.2	0.0	0.0	0.4	0.2	11.6	8.9	8.5	12.3	7.6	7.9	11.6	10.5	6.3	10.9	8.3	11.4	9.8	196.2	6.4	3.2	2.0	0.3	2.5	0.4	0.6	0.6	0.3	1.5	2.5	2.2	0.0	0.8	0.0	4.2	0.4	3.8	0.1	5.9	0.1	6.6	0.5	0.7	83.8	0.0	2.7	0.6	1.8	0.3	6.4	1.5	0.8	0.0	0.2	55.3	1.0	0.5	0.0	0.9	0.0	0.0	1.3	2.1	8.1	0.6	0.9	5.4	18.7	0.0	0.4	12.3	0.5	1.6	0.6	0.1	0.4	0.4	1.0	0.0	0.4	0.7	0.7	19.7	8.3	12.9	6.5	3.6	1.1	1.3	0.3	2.8	4.0	0.1	0.8
KASH5	"CCDC155, FLJ32658"	ENSG00000161609	"KASH domain containing 5"	Q8N6L0	19	49388219-49417990	"Predicted intracellular proteins, Predicted membrane proteins"	Meiosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"testis: 54.9"	"Cell type enriched"	"Detected in single"	18	"Cardiomyocytes: 1.9"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"	"Group enriched"	"Detected in some"	7	"cerebellum: 3.8;pons: 1.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SCLC-21H: 1.3;U-266/70: 3.6;U-698: 1.0"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA019937, HPA019940"	Enhanced					NA	NA					"HPA019937: AB_1848877, HPA019940: AB_1848879"	"unprognostic (1.31e-1)"	"unprognostic (4.23e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.99e-1)"	"unprognostic (1.79e-1)"	"unprognostic (6.41e-2)"	"unprognostic (5.31e-2)"	"unprognostic (8.96e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.57e-1)"	"unprognostic (7.11e-9)"	"unprognostic (6.50e-2)"	"unprognostic (4.18e-1)"	"unprognostic (3.08e-3)"	"unprognostic (1.20e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	2.0	0.0	0.0	0.0	1.5	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.7	0.0	0.3	0.2	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.6	0.6	1.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.1	0.0	0.1	0.0	0.3	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KCNA2	"HK4, Kv1.2"	ENSG00000177301	"Potassium voltage-gated channel subfamily A member 2"	P16389	1	110519837-110631474	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"brain: 77.2"	"Group enriched"	"Detected in some"	4	"Astrocytes: 49.9;Excitatory neurons: 36.7;Inhibitory neurons: 37.1;Muller glia cells: 19.8;Oligodendrocyte precursor cells: 36.2"	"Cancer enhanced"	"Detected in some"		"glioma: 1.2;testis cancer: 1.0"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"T-reg: 1.3"	"Lineage enriched"	"Detected in single"	8	"T-cells: 1.3"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 4.8;SCLC-21H: 1.4;U-2 OS: 1.2;U-266/70: 1.9;U-266/84: 3.1;WM-115: 1.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB001976	Enhanced					NA	NA					"CAB001976: "	"unprognostic (1.84e-2)"	"unprognostic (9.70e-3)"	"unprognostic (1.97e-1)"	"unprognostic (2.98e-1)"	"unprognostic (7.17e-3)"	"unprognostic (6.68e-3)"		"unprognostic (5.05e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.29e-1)"	"unprognostic (4.50e-3)"	"unprognostic (3.08e-3)"	"unprognostic (2.93e-4)"	"unprognostic (2.15e-1)"	"unprognostic (3.55e-1)"	"unprognostic (6.41e-2)"	"unprognostic (2.83e-1)"	1.3	0.3	6.8	0.7	5.9	0.0	0.6	10.6	77.2	0.2	0.0	1.2	0.4	0.1	0.3	0.4	0.1	0.4	0.6	10.2	9.7	0.1	0.0	0.2	0.6	24.8	8.0	2.8	0.1	0.8	0.0	2.2	0.0	32.0	0.5	0.5	9.7	0.5	0.8	1.0	0.5	0.6	0.4	0.0	0.3	0.7	0.9	27.0	3.0	2.3	2.1	1.5	0.3	0.3	41.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.8	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.7	0.0	0.0	1.4	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	1.2	0.0	0.0	1.9	3.1	0.1	0.0	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.5	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.3	0.0	6.8	5.9	10.6	77.2	10.2	9.7	24.8	8.0	2.8	32.0	0.0	27.0	41.3	0.1	0.0	0.0	49.9	0.2	0.0	0.0	0.0	0.0	7.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.5	0.2	0.0	0.0	36.7	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	37.1	0.0	0.0	0.0	0.0	1.1	0.0	0.9	0.0	8.4	0.0	19.8	0.0	36.2	6.8	0.0	0.0	5.3	1.6	0.0	0.0	0.0	0.0	4.2	0.0	0.4	1.0	0.0	2.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0
KCNK13	"K2p13.1, THIK-1, THIK1"	ENSG00000152315	"Potassium two pore domain channel subfamily K member 13"	Q9HB14	14	90061994-90185853	"Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"choroid plexus: 4.6;parathyroid gland: 6.1;testis: 9.3"	"Cell type enriched"	"Detected in some"	4	"Microglial cells: 41.2"	"Cancer enhanced"	"Detected in many"		"testis cancer: 5.3"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"myeloid DC: 1.2"	"Lineage enhanced"	"Detected in single"		"dendritic cells: 1.2"	"Cell line enhanced"	"Detected in some"		"GAMG: 1.0;RT4: 1.9;SuSa: 2.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA003514	Approved		Approved	"Nuclear speckles,Cell Junctions"		NA	NA			"Nuclear speckles, Cell Junctions"		"HPA003514: AB_2666978"	"unprognostic (1.40e-1)"	"unprognostic (1.73e-1)"	"unprognostic (6.17e-2)"	"unprognostic (6.31e-2)"	"unprognostic (2.56e-1)"	"unprognostic (5.55e-2)"	"unprognostic (3.56e-2)"	"unprognostic (3.98e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.45e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.04e-2)"	"unprognostic (6.32e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.65e-2)"	0.3	0.8	1.7	1.7	1.5	0.0	0.2	1.0	1.9	0.1	4.6	0.4	0.5	0.2	1.0	0.2	0.3	0.4	1.3	1.7	1.7	3.2	0.5	0.4	0.6	1.3	2.1	1.8	0.1	0.3	6.1	0.3	0.2	1.4	0.1	0.5	0.0	0.2	0.4	0.0	0.1	0.5	0.3	2.4	0.6	0.4	9.3	2.0	1.1	1.9	0.0	0.5	0.5	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.4	0.0	0.0	0.3	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.1	1.9	0.7	0.2	0.0	0.7	0.5	2.9	0.0	0.7	0.0	0.0	0.8	0.0	0.3	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	1.7	1.5	1.0	1.9	1.7	1.7	1.3	2.1	1.8	1.4	2.4	2.0	2.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	2.8	0.4	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	6.3	0.0	0.4	0.0	0.0	6.0	0.0	4.4	0.0	0.0	4.0	8.1	0.6	0.0	3.2	0.0	41.2	9.0	0.0	0.0	3.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.6	0.0	0.3	0.1	0.1	0.4	0.0	0.1
KCNN1	"hSK1, KCa2.1"	ENSG00000105642	"Potassium calcium-activated channel subfamily N member 1"	Q92952	19	17951293-18000080	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Transport"	"Calmodulin-binding, Ion channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	37	"brain: 83.2"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 12.8;Langerhans cells: 19.8;Skeletal myocytes: 6.8"	"Cancer enhanced"	"Detected in some"		"testis cancer: 3.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	12	"REH: 155.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065938			Approved	"Actin filaments,Cytosol"		Yes	No			"Actin filaments, Cytosol"		"HPA065938: AB_2685582"	"unprognostic (7.55e-2)"	"unprognostic (4.03e-2)"	"unprognostic (1.82e-1)"	"unprognostic (7.80e-2)"	"unprognostic (1.90e-1)"	"unprognostic (8.94e-5)"	"unprognostic (3.92e-3)"	"unprognostic (1.01e-1)"	"unprognostic (8.42e-2)"	"unprognostic (3.59e-1)"	"unprognostic (2.71e-3)"	"unprognostic (3.38e-1)"	"unprognostic (5.21e-3)"	"unprognostic (2.70e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.24e-3)"	"unprognostic (3.24e-1)"	0.1	0.2	33.9	0.4	22.7	0.1	0.2	0.0	66.1	0.7	0.0	0.3	0.1	0.6	0.1	0.2	0.1	0.1	0.6	83.2	0.6	0.2	0.0	0.1	0.1	14.7	2.6	16.0	1.8	0.1	1.6	1.0	0.0	15.5	0.6	0.0	0.8	0.4	0.2	0.1	0.1	0.2	0.0	0.0	0.1	0.2	2.2	3.0	0.2	0.1	0.0	0.1	0.1	0.3	30.2	0.1	0.6	0.2	6.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.6	0.0	0.5	0.2	5.3	0.0	0.2	0.2	2.5	5.0	0.3	0.1	0.0	0.0	12.8	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.3	0.2	0.0	0.4	0.0	0.0	1.8	0.0	0.1	155.3	0.0	0.2	0.0	0.0	0.2	8.6	0.0	0.0	0.1	0.4	0.3	0.2	0.1	0.0	4.7	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.9	22.7	0.0	66.1	83.2	0.6	14.7	2.6	16.0	15.5	0.0	3.0	30.2	0.4	0.0	0.0	3.6	1.1	2.5	3.7	0.0	0.0	2.3	0.2	0.3	0.8	0.0	0.7	0.0	2.1	0.1	1.5	0.2	0.0	0.0	0.2	1.3	1.5	1.9	0.0	0.0	12.8	0.0	0.2	2.6	0.0	1.9	0.0	3.6	0.4	0.2	0.1	0.0	4.4	0.0	0.0	0.3	19.8	0.4	0.9	2.1	5.4	1.9	2.2	1.4	1.0	3.0	0.7	0.2	0.0	1.9	0.7	2.8	0.0	0.2	0.0	1.0	0.0	6.8	1.8	0.6	4.0	0.0	3.8	0.1	1.5	2.2	0.0	1.8
KEL	"CD238, ECE3"	ENSG00000197993	"Kell metallo-endopeptidase (Kell blood group)"	P23276	7	142941114-142962363	"Blood group antigen proteins, Cancer-related genes, CD markers, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Blood group antigen, Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"bone marrow: 56.7;testis: 32.6"	"Cell type enhanced"	"Detected in some"		"Erythroid cells: 79.7;Oligodendrocytes: 30.1;Squamous epithelial cells: 16.8"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	20	"HEL: 31.7;K-562: 26.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA064442			Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Golgi apparatus, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA064442: "	"unprognostic (5.78e-3)"	"unprognostic (1.08e-5)"	"unprognostic (5.29e-3)"	"unprognostic (4.85e-3)"	"unprognostic (9.68e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.54e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.08e-2)"	"unprognostic (3.71e-2)"	"unprognostic (3.57e-2)"	"unprognostic (2.29e-3)"	"unprognostic (9.24e-2)"	"unprognostic (7.05e-2)"	"unprognostic (3.32e-2)"	"unprognostic (3.25e-3)"	0.1	0.0	1.6	0.8	2.3	56.7	0.3	1.5	2.2	0.8	1.2	0.1	0.0	0.2	0.0	0.8	0.5	0.0	0.3	1.8	1.7	0.6	0.3	0.5	10.7	2.3	2.0	1.3	0.2	0.2	0.0	0.2	0.4	2.7	0.3	0.0	0.1	0.6	0.1	0.2	0.1	0.9	0.0	1.7	4.9	0.2	32.6	1.8	1.3	0.3	0.0	6.7	0.1	0.4	2.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	31.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.2	0.0	0.0	0.1	0.5	0.1	0.6	0.0	0.0	0.1	0.0	0.2	0.0	1.4	0.0	0.2	0.0	0.0	0.3	0.4	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	2.3	1.5	2.2	1.8	1.7	2.3	2.0	1.3	2.7	1.7	1.8	2.7	0.2	0.0	0.0	0.3	0.0	0.0	1.3	0.2	4.0	0.0	0.3	0.1	0.4	0.0	1.4	3.7	0.0	0.1	0.1	0.0	1.9	0.3	2.4	0.2	0.1	0.1	0.0	79.7	3.0	0.0	0.2	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.9	0.0	0.5	0.0	0.0	0.0	0.0	0.8	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	30.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	3.1	0.0	1.4	0.2	16.8	0.0	0.1	0.0	0.0	0.0	0.9
KERA	"CNA2, SLRR2B"	ENSG00000139330	Keratocan	O60938	12	91050491-91058024	"Disease related genes, Human disease related genes, Predicted secreted proteins"	"Sensory transduction, Vision"		"Disease variant"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"Fibroblasts: 2.0"	"Cancer enhanced"	"Detected in some"		"testis cancer: 0.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"amygdala: 4.1;basal ganglia: 5.6;cerebral cortex: 6.2;hippocampal formation: 5.6"	HPA039321	Uncertain				"Secreted to extracellular matrix"	NA	NA					"HPA039321: AB_10795248"	"unprognostic (2.77e-1)"	"unprognostic (2.39e-1)"	"unprognostic (3.47e-1)"	"unprognostic (3.70e-1)"	"unprognostic (4.76e-3)"	"unprognostic (3.65e-1)"		"unprognostic (6.08e-2)"		"unprognostic (1.19e-1)"	"unprognostic (3.68e-2)"	"unprognostic (5.96e-2)"		"unprognostic (4.93e-3)"	"unprognostic (2.06e-2)"		"unprognostic (2.53e-1)"	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.3	0.0	0.2	0.1	0.1	0.5	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0
KIF17	"KIAA1405, KIF17B, KIF3X, KLP-2, OSM-3"	ENSG00000117245	"Kinesin family member 17"	Q9P2E2	1	20664014-20718017	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"testis: 23.4"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 18.9;Early spermatids: 44.0;Hepatic stellate cells: 15.4;Late spermatids: 88.7;Sertoli cells: 19.7"	"Cancer enhanced"	"Detected in many"		"testis cancer: 3.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 1.6;hTERT-HME1: 3.7;U-2 OS: 2.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA032085	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			Nucleoplasm	"Plasma membrane"	"HPA032085: AB_10669917"	"unprognostic (4.15e-3)"	"unprognostic (8.60e-3)"	"unprognostic (6.43e-2)"	"unprognostic (1.12e-2)"	"unprognostic (7.68e-2)"	"unprognostic (3.70e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.11e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.34e-3)"	"unprognostic (8.73e-2)"	"unprognostic (3.63e-3)"	"unprognostic (1.08e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.20e-2)"	0.0	0.2	2.8	0.0	2.6	0.0	0.0	0.2	1.7	0.3	1.7	0.1	0.1	0.4	0.0	0.0	1.8	0.0	0.0	2.2	3.8	0.3	0.1	0.2	0.0	0.8	1.1	3.4	0.2	0.0	0.0	0.6	0.0	0.5	0.2	0.0	0.2	0.0	0.4	0.0	0.0	0.1	0.5	0.3	0.0	0.0	23.4	2.2	0.0	0.4	0.0	0.0	0.1	0.1	0.7	0.8	0.7	0.4	0.0	0.0	0.0	0.1	1.2	1.6	0.6	0.4	0.2	0.4	0.0	0.5	0.9	0.3	0.0	0.6	0.4	0.4	0.0	0.1	0.0	0.0	0.2	0.7	0.0	0.0	0.1	0.3	0.5	3.7	0.4	0.0	0.0	0.3	0.0	0.8	0.0	0.0	0.0	1.1	0.0	0.8	0.0	0.0	0.0	0.3	0.0	0.3	0.6	0.2	0.0	0.1	0.7	0.0	0.0	0.0	0.2	2.3	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	2.6	0.2	1.7	2.2	3.8	0.8	1.1	3.4	0.5	0.3	2.2	0.7	18.9	0.0	0.0	0.7	0.2	1.7	0.0	0.1	0.6	0.0	0.2	0.3	2.8	0.0	0.2	1.8	4.2	0.1	2.8	0.1	0.0	0.0	44.0	2.8	0.3	15.2	0.0	0.0	11.0	0.0	0.1	0.9	0.0	0.2	0.0	0.0	15.4	0.5	5.1	0.0	2.8	0.0	0.0	1.6	9.8	88.7	1.2	3.2	1.8	1.9	0.2	0.0	0.0	0.0	0.7	0.0	0.0	3.8	0.1	0.1	0.1	0.3	3.5	0.3	19.7	0.5	2.7	3.2	4.3	0.1	1.3	1.6	0.2	5.2	0.1	0.2
KIF25	KNSL3	ENSG00000125337	"Kinesin family member 25"	Q9UIL4	6	167996241-168045095	"Predicted intracellular proteins"		"Motor protein"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 4.5;retina: 2.6"	"Cell type enriched"	"Detected in some"	4	"Adipocytes: 165.2"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HDLM-2: 2.0"					"Not detected"	"Not detected"			HPA046153	Uncertain					NA	NA					"HPA046153: AB_10960550"	"unprognostic (1.11e-1)"	"unprognostic (9.32e-3)"	"unprognostic (1.39e-1)"	"unprognostic (6.65e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.46e-3)"	"unprognostic (1.66e-3)"	"unprognostic (2.27e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.07e-3)"	"unprognostic (2.45e-1)"	"unprognostic (7.08e-5)"	"unprognostic (1.55e-2)"	"unprognostic (5.09e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.77e-3)"	2.1	0.1	1.6	0.2	1.8	0.1	1.3	4.5	3.8	0.3	0.5	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.4	1.4	1.8	0.2	0.6	0.4	0.5	2.7	2.0	1.6	0.5	0.0	0.1	0.0	0.4	4.4	0.3	0.1	2.6	0.2	0.0	1.3	0.4	0.3	0.0	1.6	0.2	0.3	0.5	2.1	0.1	0.1	0.0	0.1	0.2	0.1	2.6	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.5	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	1.8	4.5	3.8	1.4	1.8	2.7	2.0	1.6	4.4	1.6	2.1	2.6	165.2	0.0	0.0	0.7	0.0	0.4	0.1	0.0	0.0	4.2	1.3	1.1	1.0	0.0	0.0	3.7	0.0	1.1	0.3	0.1	0.0	0.2	0.0	0.1	0.4	9.3	0.0	0.0	6.0	0.0	0.3	0.6	0.0	0.3	4.5	0.1	0.7	0.1	0.1	3.3	4.7	0.3	0.0	0.0	0.0	0.5	0.0	0.1	1.8	1.0	0.0	0.7	0.0	3.5	34.4	0.0	0.1	0.4	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.3	1.0	0.3	3.2	0.0	0.4	0.0	0.1	0.1	0.0	0.2
KIT	"C-Kit, CD117, PBT, SCFR"	ENSG00000157404	"KIT proto-oncogene, receptor tyrosine kinase"	P10721	4	54657918-54740715	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, RAS pathway related proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 116.1"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 83.1;granulocytes: 529.3;Inhibitory neurons: 111.2;Ionocytes: 101.7;Melanocytes: 211.7"	"Cancer enhanced"	"Detected in many"		"testis cancer: 28.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"basophil: 20.3;eosinophil: 12.8;NK-cell: 13.1"	"Group enriched"	"Detected in many"	7	"granulocytes: 20.3;NK-cells: 13.1"	"Group enriched"	"Detected in many"	13	"HEL: 247.2;HMC-1: 496.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003288, HPA004471, CAB068253, CAB072867, HPA073252"	Enhanced	Supported	Supported	"Plasma membrane"		NA	NA		49000000	"Plasma membrane"		"CAB003288: AB_2335702, CAB068253: AB_2665717, CAB072867: AB_2665718, HPA004471: AB_1078431, HPA073252: AB_2686589"	"unprognostic (1.55e-2)"	"unprognostic (1.91e-1)"	"unprognostic (4.04e-2)"	"unprognostic (8.19e-2)"	"unprognostic (3.96e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.97e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.92e-2)"	"prognostic favorable (5.63e-4)"	"unprognostic (1.34e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.30e-1)"	5.8	1.9	7.7	5.4	4.9	6.5	116.1	21.5	6.4	17.7	4.3	13.7	9.3	9.7	6.0	13.1	2.9	20.5	3.4	20.0	5.7	12.5	0.8	22.0	3.4	5.9	13.8	3.7	45.4	2.6	1.7	1.9	10.1	8.6	5.7	16.1	3.2	21.5	8.8	1.1	24.7	13.5	10.2	4.2	5.0	17.5	6.3	15.8	3.1	47.6	7.0	6.3	14.6	4.9	4.9	0.0	0.0	3.9	0.0	0.7	0.3	0.0	3.3	4.6	12.6	15.8	0.0	0.0	0.0	0.0	7.3	0.6	0.3	2.6	0.0	10.8	0.0	5.9	247.2	0.0	0.0	0.0	0.0	496.2	0.0	0.0	0.0	0.0	0.0	28.4	4.3	3.5	0.5	0.0	0.0	1.4	2.5	6.9	0.0	0.0	0.8	0.0	0.0	0.0	24.2	6.0	2.1	0.0	0.0	0.0	14.1	0.0	2.6	0.3	0.5	0.0	4.9	0.1	0.4	0.0	0.0	0.5	0.9	0.6	20.3	0.0	12.8	0.1	0.0	2.3	0.0	0.4	0.9	2.3	0.0	0.0	0.0	1.0	13.1	1.4	0.1	0.0	0.2	7.7	4.9	21.5	6.4	20.0	5.7	5.9	13.8	3.7	8.6	4.2	15.8	4.9	7.3	6.4	21.9	9.8	1.0	14.3	0.9	0.4	2.2	4.5	83.1	59.2	0.7	4.3	3.6	3.7	0.0	0.1	5.2	0.4	3.9	1.0	0.0	0.2	0.7	9.2	5.4	15.5	0.9	0.0	0.1	2.8	8.6	0.7	529.3	0.5	1.8	0.0	0.3	0.0	111.2	0.5	101.7	0.3	4.2	0.4	1.2	1.6	211.7	14.0	0.2	2.4	0.0	16.1	3.7	0.0	0.1	0.0	3.2	0.5	0.0	0.8	0.1	0.2	0.0	0.7	0.8	0.1	12.3	2.2	3.8	0.3	8.8	63.7	0.6	0.3
KRT77	KRT1B	ENSG00000189182	"Keratin 77"	Q7Z794	12	52689626-52703524	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"skin 1: 257.0"	"Cell type enriched"	"Detected in some"	8	"Suprabasal keratinocytes: 20.2"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	36	"HaCaT: 3.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA045934	Enhanced		Approved	"Nuclear membrane,Plasma membrane"		NA	NA		1200000000	"Nuclear membrane, Plasma membrane"		"HPA045934: AB_10960065"	"unprognostic (3.52e-2)"	"unprognostic (1.54e-1)"				"unprognostic (1.41e-1)"		"unprognostic (3.79e-1)"	"unprognostic (2.61e-1)"						"unprognostic (2.11e-1)"		"unprognostic (2.06e-1)"	0.3	0.0	0.0	0.0	0.0	0.1	19.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	257.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.9	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	20.2	0.0	0.0	0.0	0.0	0.0
LMNTD1	"FLJ36004, IFLTD1, Pas1c1"	ENSG00000152936	"Lamin tail domain containing 1"	Q8N9Z9	12	25409307-25648579	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 13.9;fallopian tube: 17.1;testis: 14.9"	"Group enriched"	"Detected in some"	4	"Astrocytes: 15.0;Early spermatids: 49.0;Endometrial ciliated cells: 17.6;Late spermatids: 40.6;Respiratory ciliated cells: 14.6"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 6.2;RT4: 7.7;SH-SY5Y: 7.6;U-2197: 26.8"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA038640			Approved	Nucleoplasm,Centrosome		NA	NA			"Nucleoplasm, Centrosome"		"HPA038640: AB_2676127"				"unprognostic (8.92e-3)"	"unprognostic (3.21e-1)"			"unprognostic (2.41e-1)"		"unprognostic (1.19e-2)"	"unprognostic (9.57e-2)"	"unprognostic (1.68e-1)"		"unprognostic (6.18e-2)"	"unprognostic (2.42e-1)"	"unprognostic (7.80e-2)"	"unprognostic (3.89e-2)"	0.4	0.1	13.8	0.7	5.9	0.3	1.0	6.3	3.8	0.5	2.9	3.6	1.4	0.7	0.6	0.3	17.1	0.8	0.2	4.8	13.9	0.7	0.2	1.3	0.3	11.7	10.8	2.7	0.2	0.6	0.0	0.7	0.2	7.4	0.2	3.4	1.2	0.0	0.2	0.2	0.4	0.6	1.1	10.0	0.6	0.6	14.9	5.7	0.2	0.9	0.0	0.2	0.3	0.0	10.0	0.4	0.3	0.0	0.2	0.2	1.6	2.7	3.3	6.2	1.4	0.2	0.0	0.4	0.2	0.1	0.0	3.9	0.1	0.3	0.1	0.3	1.1	0.1	1.1	0.9	2.3	0.3	0.1	0.1	0.5	0.2	1.8	0.5	0.1	0.1	0.0	2.3	0.4	0.0	0.5	0.0	0.4	1.8	0.1	0.6	0.5	0.2	0.2	0.2	7.7	0.2	7.6	0.1	0.4	4.3	0.9	0.3	1.8	0.3	0.2	1.0	26.8	0.3	0.8	1.6	1.8	0.3	1.8	2.9	0.5	0.1	0.1	0.2	0.0	0.1	0.4	0.2	0.2	0.1	0.5	0.2	0.3	0.5	0.1	0.0	0.5	0.1	0.1	13.8	5.9	6.3	3.8	4.8	13.9	11.7	10.8	2.7	7.4	10.0	5.7	10.0	0.1	0.0	0.0	15.0	0.1	0.0	2.4	0.0	0.0	0.0	0.2	0.3	0.6	0.0	1.3	0.0	0.0	0.3	0.0	0.0	1.9	0.0	49.0	17.6	0.1	0.1	0.0	0.0	1.5	0.0	0.3	0.3	0.0	0.2	0.0	0.7	0.0	0.4	0.1	0.0	1.0	0.0	0.0	0.3	0.0	40.6	0.0	0.3	0.0	5.6	0.0	0.0	0.0	1.5	0.7	0.0	0.0	0.0	0.0	1.0	0.0	0.1	14.6	0.0	0.0	0.7	0.1	1.1	0.4	0.0	0.0	0.3	0.1	0.0	0.0	0.9
LOXHD1	"DFNB77, FLJ32670, LH2D1"	ENSG00000167210	"Lipoxygenase homology domains 1"	Q8IVV2	18	46476972-46657220	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Hearing		"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"epididymis: 7.3;testis: 23.2"	"Group enriched"	"Detected in some"	70	"Early spermatids: 199.3;Late spermatids: 439.4"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"	"Region enhanced"	"Detected in some"		"basal ganglia: 2.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA077128			Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA077128: "	"unprognostic (6.95e-2)"	"unprognostic (1.88e-2)"	"unprognostic (4.81e-3)"	"unprognostic (2.65e-1)"	"unprognostic (1.30e-2)"	"unprognostic (7.75e-4)"	"unprognostic (9.53e-2)"	"unprognostic (7.91e-2)"	"unprognostic (7.61e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.93e-2)"	"unprognostic (7.43e-3)"	"unprognostic (6.48e-5)"	"unprognostic (2.30e-1)"	"unprognostic (8.10e-3)"	"unprognostic (1.66e-3)"	1.9	0.0	0.5	0.0	2.7	2.8	0.6	0.0	2.2	0.0	0.0	0.1	0.0	0.1	7.3	0.0	1.7	0.2	0.6	0.3	0.1	0.8	0.0	1.0	0.0	0.4	0.1	0.1	0.1	0.2	0.2	1.9	0.7	1.0	0.0	0.0	0.0	0.0	0.2	0.7	0.1	0.1	0.1	0.0	0.8	0.1	23.2	0.4	0.1	0.2	0.3	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	2.7	0.0	2.2	0.3	0.1	0.4	0.1	0.1	1.0	0.0	0.4	0.3	1.2	3.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	199.3	0.0	0.1	0.9	0.0	0.0	4.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.6	0.0	0.0	0.0	0.0	439.4	1.8	0.3	0.0	0.0	0.3	0.0	0.0	1.5	0.6	0.0	0.0	2.2	0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.1	4.5	1.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0
LRFN5	"C14orf146, FIGLER8, SALM5"	ENSG00000165379	"Leucine rich repeat and fibronectin type III domain containing 5"	Q96NI6	14	41606876-41904549	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 17.1;parathyroid gland: 11.2"	"Group enriched"	"Detected in some"	19	"Excitatory neurons: 873.9;Inhibitory neurons: 581.5;Oligodendrocyte precursor cells: 296.1"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 16.4;HSkMC: 3.1;RPTEC TERT1: 5.2;SCLC-21H: 8.8;U-138 MG: 10.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001177	Uncertain				"Intracellular and membrane"	NA	NA					"HPA001177: AB_1079274"	"unprognostic (5.23e-3)"	"unprognostic (1.37e-1)"	"unprognostic (5.10e-1)"	"unprognostic (6.24e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.54e-1)"	"unprognostic (1.31e-1)"	"unprognostic (6.38e-3)"	"unprognostic (2.61e-2)"	"unprognostic (5.78e-2)"	"unprognostic (2.70e-2)"	"unprognostic (9.27e-2)"	"unprognostic (6.02e-3)"	"unprognostic (3.79e-3)"	"unprognostic (1.98e-1)"	"unprognostic (6.07e-3)"	"unprognostic (2.92e-3)"	0.9	2.2	3.3	1.0	7.9	0.0	1.4	0.0	17.1	9.6	0.0	1.5	0.2	2.6	0.6	0.5	3.4	1.1	0.5	7.2	6.9	0.2	0.3	0.8	0.0	1.2	3.0	8.3	1.6	0.3	11.2	0.8	1.1	3.4	2.4	1.0	2.6	0.3	6.4	0.2	0.5	0.4	1.5	0.3	0.6	0.7	0.9	2.3	0.3	0.5	0.5	0.2	6.1	5.2	8.3	0.0	0.0	1.7	16.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	3.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	8.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	10.7	0.1	0.0	0.1	0.0	0.0	0.0	1.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	7.9	0.0	17.1	7.2	6.9	1.2	3.0	8.3	3.4	0.3	2.3	8.3	0.5	0.0	0.0	29.7	0.0	0.3	0.0	0.0	0.0	8.2	0.1	0.6	1.0	2.8	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	3.2	0.3	7.8	0.9	0.0	0.0	873.9	0.0	0.1	7.9	0.0	0.6	0.0	0.2	0.0	0.5	0.1	0.0	581.5	0.0	0.0	0.0	0.8	1.7	8.4	0.1	1.8	24.4	0.0	0.4	0.0	296.1	11.8	0.1	0.0	4.1	0.0	0.0	0.0	0.0	0.0	1.5	0.0	1.4	1.5	0.0	2.1	0.0	0.3	0.1	0.2	2.1	0.0	0.1
MAEL	"CT128, FLJ14904, SPATA35"	ENSG00000143194	"Maelstrom spermatogenic transposon silencer"	Q96JY0	1	166975582-167022214	"Predicted intracellular proteins"	"Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	24	"testis: 160.6"	"Group enriched"	"Detected in some"	4	"Early spermatids: 1324.3;Late spermatids: 406.1;Spermatocytes: 573.7"	"Cancer enhanced"	"Detected in many"		"testis cancer: 3.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	8	"NTERA-2: 3.4"	"Region enriched"	"Detected in single"	5	"thalamus: 1.1"	"Low region specificity"	"Detected in all"			HPA078602	Approved					NA	NA					"HPA078602: AB_2732386"	"unprognostic (1.36e-1)"	"unprognostic (7.01e-2)"	"unprognostic (5.81e-2)"	"unprognostic (3.15e-1)"	"unprognostic (9.78e-2)"	"unprognostic (3.08e-1)"	"unprognostic (2.68e-3)"	"unprognostic (4.99e-2)"	"unprognostic (1.42e-1)"	"unprognostic (9.00e-3)"	"unprognostic (3.04e-1)"	"unprognostic (8.88e-2)"	"unprognostic (5.49e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.32e-1)"	"unprognostic (8.67e-2)"	"unprognostic (1.85e-1)"	0.1	0.2	1.7	0.0	2.0	0.0	0.1	1.3	2.2	0.1	1.0	0.9	0.0	0.0	1.4	0.2	0.1	0.3	5.7	2.1	1.9	1.6	0.3	0.2	0.1	1.5	1.6	1.8	0.1	0.2	0.0	0.8	6.6	1.6	0.7	0.0	4.4	0.3	1.0	0.3	0.0	0.1	0.4	1.3	0.0	0.1	160.6	1.6	0.1	0.1	0.3	0.1	0.4	0.1	1.8	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	3.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.7	2.0	1.3	2.2	2.1	1.9	1.5	1.6	1.8	1.6	1.3	1.6	1.8	0.2	0.0	0.0	8.8	0.1	0.1	0.5	0.0	0.0	1.4	0.1	0.1	4.8	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	1324.3	0.0	0.0	1.3	0.0	0.0	11.5	0.2	0.4	4.8	0.0	0.0	0.0	0.2	0.0	0.1	0.4	0.0	3.9	0.0	0.0	0.0	0.3	406.1	10.8	0.8	0.0	1.0	0.0	45.3	0.0	8.0	3.3	0.0	0.0	10.1	0.0	0.2	0.0	5.6	0.0	1.5	0.0	3.4	0.4	573.7	156.3	0.0	0.0	0.3	0.2	0.2	0.0	0.2
MAGEB16		ENSG00000189023	"MAGE family member B16"	A2A368	X	35798342-35803735	"Predicted intracellular proteins"		"Tumor antigen"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	33	"testis: 3.3"	"Group enriched"	"Detected in some"	35	"Spermatocytes: 7.4;Spermatogonia: 13.8"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"U-266/70: 59.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA055743, HPA076456"	Uncertain		Approved	Nucleoplasm,Centrosome		NA	NA			Nucleoplasm	Centrosome	"HPA055743: AB_2682902, HPA076456: "															"unprognostic (2.12e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	59.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	7.4	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MAGEB6	"CT3.4, FLJ40242, MAGE-B6, MAGEB6A"	ENSG00000176746	"MAGE family member B6"	Q8N7X4	X	26192440-26195646	"Cancer-related genes, Predicted intracellular proteins"		"Tumor antigen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	32	"testis: 3.2"	"Group enriched"	"Detected in some"	6	"Spermatocytes: 23.5;Spermatogonia: 16.3"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	10	"K-562: 4.6"									"HPA041853, HPA076711"	Enhanced					NA	NA					"HPA041853: AB_10796785, HPA076711: "									"unprognostic (2.05e-1)"						"unprognostic (1.31e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.5	16.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MAP3K15	"ASK3, bA723P2.3, FLJ16518"	ENSG00000180815	"Mitogen-activated protein kinase kinase kinase 15"	Q6ZN16	X	19360056-19515261	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"adrenal gland: 10.9;choroid plexus: 10.6"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 5.5;Cone photoreceptor cells: 4.2;Granulosa cells: 7.5;Theca cells: 29.8"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 2.0;HAP1: 4.9;HEK 293: 4.1;JURKAT: 2.5;REH: 2.6;SuSa: 4.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA004006			Approved	Vesicles		NA	NA			Vesicles		"HPA004006: AB_1079358"	"unprognostic (2.87e-1)"	"unprognostic (7.09e-2)"	"unprognostic (3.21e-2)"	"unprognostic (6.56e-8)"	"unprognostic (3.47e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.19e-3)"	"unprognostic (2.35e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.87e-2)"	"unprognostic (1.30e-2)"	"unprognostic (8.95e-2)"	"unprognostic (2.77e-3)"	"unprognostic (4.00e-1)"	"unprognostic (2.37e-1)"	"unprognostic (3.98e-2)"	"unprognostic (8.20e-2)"	0.0	10.9	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	10.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.4	1.2	0.0	0.3	0.0	0.0	0.2	0.0	0.4	0.5	0.7	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.3	0.0	4.9	0.0	0.0	0.8	4.1	1.7	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.3	0.0	0.0	0.1	0.0	1.1	1.3	0.0	0.5	2.6	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.8	0.4	0.0	0.2	0.0	0.3	0.0	0.1	0.0	0.2	0.0	3.1	0.3	0.0	0.1	0.5	0.0	0.0	1.0	0.2	0.6	2.9	0.0	0.0	5.5	4.2	0.0	0.1	0.2	3.9	0.0	0.4	0.3	0.3	0.1	0.0	0.4	2.6	0.0	0.3	0.4	0.0	0.3	0.0	7.5	0.4	0.0	0.1	0.0	2.5	0.0	0.0	0.0	0.0	0.2	0.3	0.2	0.0	1.0	0.0	0.3	0.0	0.5	1.1	0.1	0.0	1.2	0.0	0.2	0.0	0.1	0.0	0.6	0.0	0.3	0.2	0.6	1.4	0.0	0.0	0.1	0.2	29.8	0.1	0.0
MAP4K1	HPK1	ENSG00000104814	"Mitogen-activated protein kinase kinase kinase kinase 1"	Q92918	19	38587641-38618882	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 30.3;lymphoid tissue: 57.3"	"Cell type enhanced"	"Detected in many"		"B-cells: 42.6;dendritic cells: 42.6;Langerhans cells: 27.8;Plasma cells: 30.4;Rod photoreceptor cells: 77.9;T-cells: 43.6"	"Cancer enhanced"	"Detected in all"		"testis cancer: 15.2"	"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 45.2;HDLM-2: 46.4;Karpas-707: 46.9;REH: 25.5;RPMI-8226: 29.8;U-266/70: 36.0;U-266/84: 38.2;U-698: 57.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA007419, CAB007754"	Enhanced		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"CAB007754: AB_562299, HPA007419: AB_1853778"	"unprognostic (1.99e-3)"	"prognostic favorable (6.17e-5)"	"unprognostic (9.50e-3)"	"unprognostic (3.27e-1)"	"unprognostic (6.03e-2)"	"prognostic favorable (3.26e-4)"	"unprognostic (4.88e-3)"	"unprognostic (5.32e-3)"	"unprognostic (2.79e-1)"	"unprognostic (2.51e-1)"	"unprognostic (3.92e-2)"	"unprognostic (2.55e-1)"	"prognostic unfavorable (7.99e-10)"	"unprognostic (1.72e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.50e-2)"	2.6	1.5	0.6	14.7	0.7	9.3	1.7	0.7	1.2	1.6	0.7	3.3	2.7	1.3	0.8	2.8	1.9	2.3	1.4	0.7	0.7	2.7	3.0	6.2	32.5	0.8	0.7	0.5	0.9	1.2	0.2	1.8	1.8	0.8	2.5	2.3	16.2	2.8	0.5	0.8	1.9	30.3	0.9	0.8	57.3	3.1	1.5	0.8	13.3	3.2	0.2	29.5	2.9	2.2	0.9	0.2	0.3	0.2	0.6	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	45.2	0.7	0.0	0.0	0.1	0.1	0.0	0.0	46.4	0.3	9.8	0.1	0.1	0.0	3.1	0.5	0.1	0.0	0.0	0.0	0.0	0.0	21.3	0.2	46.9	0.1	0.3	11.0	12.0	1.4	0.3	0.1	25.5	0.1	29.8	0.0	0.0	0.4	0.1	0.1	0.2	0.1	0.3	0.2	10.8	0.1	0.1	0.3	0.1	0.1	36.0	38.2	57.8	0.0	13.5	0.1	2.9	4.9	2.0	18.9	9.4	17.4	22.7	15.8	20.1	23.9	15.5	8.6	12.1	0.5	6.1	5.7	22.2	22.2	12.1	0.6	0.7	0.7	1.2	0.7	0.7	0.8	0.7	0.5	0.8	0.8	0.8	0.9	0.7	3.2	4.9	0.3	42.6	2.3	0.2	0.4	1.2	6.7	0.7	1.0	0.9	0.0	0.6	0.0	12.5	0.2	42.6	0.1	0.0	0.0	0.0	0.3	0.2	1.6	0.0	5.5	0.7	0.2	0.3	1.5	2.0	0.3	15.8	0.4	1.1	1.1	2.6	1.7	1.0	0.1	0.0	8.8	27.8	0.2	0.0	11.6	3.6	1.9	10.3	11.5	15.5	1.0	0.5	0.0	0.0	0.0	30.4	0.3	0.0	0.2	0.0	77.9	0.0	1.0	0.4	0.7	6.4	0.6	1.0	0.1	43.6	0.3	0.3	0.1
MAP7D2	FLJ14503	ENSG00000184368	"MAP7 domain containing 2"	Q96T17	X	20006713-20116907	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 68.1;epididymis: 36.7"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 93.0;Excitatory neurons: 45.5;Inhibitory neurons: 55.2;Spermatocytes: 57.8;Spermatogonia: 134.9"	"Cancer enhanced"	"Detected in many"		"testis cancer: 7.7"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	9	"basophil: 3.0"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 3.0"	"Cell line enhanced"	"Detected in some"		"A549: 13.3;CACO-2: 19.3;HEK 293: 25.0;HeLa: 21.4;Hep G2: 11.4;SCLC-21H: 29.1;SiHa: 12.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051508, HPA059537"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA051508: AB_2681513, HPA059537: AB_2684054"	"unprognostic (1.51e-1)"	"unprognostic (9.19e-2)"	"unprognostic (3.76e-1)"	"unprognostic (1.45e-5)"	"unprognostic (5.65e-2)"	"unprognostic (9.77e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.50e-1)"	"unprognostic (5.95e-2)"	"unprognostic (7.77e-3)"	"unprognostic (3.58e-4)"	"unprognostic (2.21e-2)"	"prognostic unfavorable (7.27e-5)"	"unprognostic (9.12e-3)"	"unprognostic (3.60e-2)"	"unprognostic (2.54e-3)"	"unprognostic (3.19e-1)"	0.1	2.9	10.5	0.3	17.4	0.7	0.4	14.1	68.1	0.3	0.0	0.7	0.7	0.6	36.7	0.2	2.4	0.5	0.3	13.9	14.6	3.5	0.1	0.2	0.2	34.0	11.2	15.6	0.3	1.1	0.0	3.9	7.7	32.4	0.8	0.8	14.7	0.2	2.0	0.5	0.9	1.2	0.4	3.7	0.1	8.8	9.6	25.8	2.3	0.1	0.1	0.3	0.1	0.3	59.3	0.0	13.3	1.1	0.1	0.1	0.3	0.0	1.4	0.0	0.2	0.1	19.3	0.5	2.3	2.0	0.0	0.2	0.0	0.0	0.0	0.1	1.0	25.0	0.0	21.4	11.4	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.2	0.0	0.2	0.1	0.1	0.0	0.1	0.0	0.2	5.0	1.0	0.0	0.3	0.0	0.0	1.5	0.0	29.1	5.0	12.8	4.4	0.0	2.8	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.5	1.4	0.1	1.4	3.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	10.5	17.4	14.1	68.1	13.9	14.6	34.0	11.2	15.6	32.4	3.7	25.8	59.3	0.2	3.2	0.0	4.6	0.6	1.8	0.3	7.2	0.6	29.1	0.9	1.1	1.2	0.0	2.5	0.0	2.1	93.0	0.8	2.2	3.9	1.3	16.4	0.6	0.2	0.7	9.6	0.0	45.5	0.9	9.2	1.1	28.1	0.7	0.0	12.3	0.0	0.2	6.1	18.5	55.2	0.6	2.0	0.0	0.7	17.8	0.6	0.7	0.0	6.5	0.0	2.8	0.0	11.1	3.6	0.8	4.8	1.9	0.9	1.0	3.5	18.8	6.9	8.1	0.0	0.6	0.8	57.8	134.9	0.9	1.6	30.6	0.4	0.9	1.3	0.5
MEI4		ENSG00000269964	"Meiotic double-stranded break formation protein 4"	A8MW99	6	77650274-77927028	"Predicted intracellular proteins"	"DNA recombination, Meiosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 4.0;testis: 3.7;thyroid gland: 2.2"	"Cell type enriched"	"Detected in some"	4	"Early spermatids: 86.1"	"Cancer enhanced"	"Detected in some"		"renal cancer: 0.9;testis cancer: 1.3"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (3.47e-1)"				"unprognostic (9.76e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.88e-1)"	"unprognostic (4.62e-2)"	"unprognostic (9.70e-4)"	"unprognostic (3.16e-1)"	"unprognostic (2.86e-4)"	"unprognostic (3.35e-2)"	"unprognostic (4.17e-2)"	"unprognostic (4.85e-2)"	0.1	0.7	0.4	0.0	0.4	0.0	0.0	0.3	0.3	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.5	0.2	0.7	4.0	0.9	0.0	0.0	0.9	0.5	0.1	0.0	2.0	0.1	1.0	0.0	1.2	0.0	0.0	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.1	3.7	0.5	0.0	2.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.3	0.3	0.2	0.7	0.9	0.5	0.1	1.2	0.5	0.5	0.7	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	86.1	0.0	0.0	0.1	0.0	0.0	4.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	3.0	0.0	0.0	0.0	0.0	21.3	0.3	0.0	0.0	9.4	0.0	0.6	0.0	2.0	2.5	0.1	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.1	0.0	0.0	0.0	3.6	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MMP24	MT5-MMP	ENSG00000125966	"Matrix metallopeptidase 24"	Q9Y5R2	20	35226690-35276998	"Enzymes, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion"	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 37.8"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 16.0;Excitatory neurons: 24.6;Horizontal cells: 15.2;Inhibitory neurons: 38.4;Oligodendrocyte precursor cells: 12.5;Oligodendrocytes: 12.0;Proximal tubular cells: 11.4"	"Cancer enhanced"	"Detected in many"		"renal cancer: 11.4;testis cancer: 10.8"	"Region enhanced"	"Detected in all"		"cerebellum: 37.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 36.3;CACO-2: 56.0;EFO-21: 15.8;RPTEC TERT1: 24.6;U-2 OS: 17.7"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 51.5"	"HPA049280, HPA078816"	Approved		Approved	"Nucleoli,Plasma membrane"	"Secreted to extracellular matrix"	Yes	No			"Nucleoli, Plasma membrane"		"HPA049280: , HPA078816: "	"unprognostic (1.52e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.51e-4)"	"unprognostic (2.47e-2)"	"unprognostic (7.61e-3)"	"unprognostic (1.22e-1)"	"unprognostic (4.59e-2)"	"unprognostic (2.32e-2)"	"unprognostic (8.82e-2)"	"unprognostic (9.20e-3)"	"unprognostic (7.12e-2)"	"prognostic favorable (8.17e-11)"	"unprognostic (3.32e-2)"	"unprognostic (5.63e-2)"	"unprognostic (1.69e-2)"	"unprognostic (9.90e-4)"	1.7	1.0	6.5	0.5	5.8	0.7	0.6	37.8	8.5	0.7	3.5	0.6	2.2	1.3	0.1	0.3	2.2	0.6	0.6	6.5	6.1	7.6	0.5	4.7	0.4	4.8	8.0	6.4	0.4	5.9	0.3	3.8	0.2	15.5	1.7	0.2	2.5	0.6	4.3	0.3	1.2	1.4	2.0	3.1	0.4	0.6	0.4	7.8	0.0	0.7	0.1	0.0	0.4	0.3	5.6	0.6	36.3	0.1	0.2	0.2	0.0	1.0	1.9	2.3	3.8	2.0	56.0	9.7	0.0	15.8	2.5	1.2	0.6	8.5	0.0	1.6	0.2	0.3	1.9	1.2	0.6	0.0	0.1	0.4	0.2	0.2	0.1	0.1	1.0	0.1	0.1	0.1	0.5	0.4	0.5	0.1	0.2	13.6	0.1	2.4	0.1	0.2	0.0	24.6	0.1	14.1	9.7	2.5	0.7	0.3	2.9	0.5	0.3	0.6	7.4	17.7	1.8	0.7	0.3	0.2	0.1	1.6	0.2	1.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	6.5	5.8	37.8	8.5	6.5	6.1	4.8	8.0	6.4	15.5	3.1	7.8	5.6	0.3	16.0	1.5	5.2	0.0	0.1	0.2	0.0	0.0	3.9	0.2	0.8	0.5	8.6	1.3	1.8	0.0	0.1	0.1	0.7	5.9	8.5	0.6	0.8	0.3	1.4	0.0	0.0	24.6	0.9	0.1	0.6	0.0	0.5	0.0	0.1	0.4	0.4	0.0	15.2	38.4	0.1	0.0	0.6	0.0	0.0	0.3	0.1	1.8	10.3	0.0	0.2	0.0	12.5	12.0	1.9	0.1	0.0	0.0	0.4	2.3	11.4	0.0	0.4	0.0	0.2	0.2	0.1	0.3	0.0	0.3	0.0	0.2	0.0	0.1	0.1
MSH2	"COCA1, HNPCC, HNPCC1"	ENSG00000095002	"MutS homolog 2"	P43246	2	47403067-47663146	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"	DNA-binding	"Cancer-related genes, Disease variant, Hereditary nonpolyposis colorectal cancer, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Cancer enhanced"	"Detected in all"		"testis cancer: 46.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009572, HPA066845, CAB070867"	Approved		Supported	Nucleoplasm,Vesicles		NA	Yes		28000	Nucleoplasm	Vesicles	"CAB009572: AB_2144828, CAB070867: , HPA066845: AB_2732752"	"unprognostic (2.35e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.89e-3)"	"prognostic unfavorable (4.44e-4)"	"unprognostic (2.23e-1)"	"unprognostic (6.31e-3)"	"prognostic unfavorable (1.72e-9)"	"unprognostic (1.77e-1)"	"unprognostic (7.09e-3)"	"unprognostic (8.57e-2)"	"prognostic unfavorable (4.63e-4)"	"unprognostic (5.38e-2)"	"unprognostic (3.29e-3)"	"unprognostic (1.20e-3)"	"unprognostic (5.74e-1)"	"unprognostic (8.46e-2)"	"unprognostic (1.48e-1)"	8.2	7.6	9.0	12.9	10.8	15.8	15.9	15.7	11.4	9.8	11.7	12.0	7.9	11.8	14.1	9.5	12.5	5.8	10.2	10.0	11.0	8.3	6.8	8.2	23.9	9.7	9.5	8.7	8.8	6.6	14.9	6.2	11.7	10.4	8.7	15.1	35.2	8.6	7.8	7.1	11.2	9.4	8.9	9.3	10.9	8.2	16.4	9.5	32.9	16.0	7.2	25.2	8.0	6.5	10.3	114.3	35.3	103.3	57.9	7.3	21.2	64.3	62.9	33.3	80.9	76.9	72.3	50.1	141.2	84.6	23.8	56.6	49.8	78.6	37.4	122.3	68.1	55.8	99.3	42.3	65.6	7.7	97.7	34.9	12.3	11.2	68.1	19.0	19.1	45.2	3.9	165.1	34.0	63.1	44.2	119.6	75.4	195.7	69.3	45.1	151.1	182.2	84.4	35.8	57.3	85.9	91.6	58.4	49.2	48.0	83.6	46.9	38.8	18.7	55.5	70.9	57.1	74.6	20.8	63.4	180.1	33.1	72.5	35.4	3.0	1.3	4.9	8.0	4.4	9.3	6.7	7.7	10.3	2.5	7.9	12.6	13.1	1.0	14.2	3.9	3.4	11.8	6.5	9.0	10.8	15.7	11.4	10.0	11.0	9.7	9.5	8.7	10.4	9.3	9.5	10.3	14.7	9.6	11.5	18.6	13.0	8.3	7.9	14.4	8.6	17.4	7.5	7.1	15.6	5.7	12.6	9.2	45.9	19.9	14.2	6.6	3.9	11.5	17.8	21.0	11.3	13.4	3.5	54.1	59.9	8.4	20.7	12.2	7.1	18.8	12.0	28.2	5.0	1.6	11.4	11.8	58.0	12.1	14.2	4.1	4.6	22.8	5.3	5.1	8.8	16.9	5.5	22.6	17.5	35.7	54.7	7.3	5.0	6.4	12.4	2.8	5.4	4.5	23.3	41.1	0.0	9.8	9.0	56.5	50.8	9.3	6.5	5.1	12.8	24.3	13.5	3.8
MSH6	GTBP	ENSG00000116062	"MutS homolog 6"	P52701	2	47695530-47810063	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction"	DNA-binding	"Cancer-related genes, Disease variant, Hereditary nonpolyposis colorectal cancer"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Granulosa cells: 119.6;Theca cells: 114.9"	"Cancer enhanced"	"Detected in all"		"testis cancer: 31.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009091, HPA028376, HPA028446, CAB070870"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	Yes		15000	Nucleoplasm	"Golgi apparatus, Vesicles"	"CAB009091: AB_670083, CAB070870: AB_2144959, HPA028376: AB_10598909, HPA028446: AB_10602182"	"unprognostic (5.10e-2)"	"unprognostic (5.87e-3)"	"unprognostic (3.29e-2)"	"prognostic unfavorable (1.34e-4)"	"unprognostic (1.98e-1)"	"unprognostic (3.09e-2)"	"prognostic unfavorable (7.86e-4)"	"unprognostic (1.79e-1)"	"unprognostic (2.35e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.74e-3)"	"unprognostic (8.99e-2)"	"prognostic unfavorable (1.06e-7)"	"unprognostic (1.22e-1)"	"unprognostic (2.31e-1)"	"unprognostic (9.68e-2)"	"unprognostic (3.48e-2)"	11.8	23.0	9.9	17.9	14.1	24.2	16.4	16.2	12.8	15.7	12.6	11.6	9.1	28.0	10.3	11.8	17.9	11.0	9.4	9.7	11.1	12.2	20.0	11.7	28.6	13.5	12.7	9.1	53.4	31.5	17.1	9.9	20.5	14.6	15.2	12.6	21.8	10.9	15.8	10.6	13.2	9.9	27.5	12.0	12.8	11.0	35.7	12.2	36.6	17.3	11.3	31.3	12.9	12.3	20.9	116.5	77.6	128.4	37.5	42.3	46.3	67.9	63.6	51.1	60.2	59.8	67.2	41.4	158.1	84.5	59.5	82.0	46.0	130.3	74.3	82.1	80.7	69.0	117.0	60.8	71.1	28.8	131.5	37.8	38.6	28.3	60.7	41.6	53.8	40.8	5.3	115.9	69.8	61.8	85.5	144.2	80.1	130.7	81.3	37.7	219.6	204.3	84.7	44.5	76.2	92.8	100.3	79.1	40.4	42.7	124.3	54.6	42.6	33.4	72.2	92.3	54.6	80.6	63.8	79.3	276.2	61.9	77.9	42.4	7.7	3.7	3.8	4.8	6.2	5.5	4.3	5.5	5.0	5.5	4.2	8.4	4.5	2.5	5.9	6.4	2.7	5.3	3.6	9.9	14.1	16.2	12.8	9.7	11.1	13.5	12.7	9.1	14.6	12.0	12.2	20.9	19.8	28.9	21.4	5.9	19.2	25.2	22.0	12.3	31.9	25.4	14.4	15.1	8.6	2.8	21.8	7.3	35.5	35.6	20.7	7.4	3.9	15.7	46.4	27.1	31.1	18.4	4.8	47.1	8.5	9.6	21.8	24.0	8.6	31.7	17.7	119.6	13.6	10.2	13.0	15.2	12.1	9.7	20.3	5.6	13.2	17.5	25.4	16.8	3.6	7.5	10.0	22.7	8.2	9.5	27.4	9.1	3.7	22.6	31.1	16.1	2.6	6.7	22.1	31.4	6.6	27.4	33.0	54.3	48.8	22.0	17.5	9.6	19.8	114.9	12.1	11.7
MT1H	MT1	ENSG00000205358	"Metallothionein 1H"	P80294	16	56669814-56671129	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 845.9;liver: 1146.3"	"Cell type enriched"	"Detected in many"	5	"Proximal tubular cells: 18797.6"	"Cancer enhanced"	"Detected in many"		"testis cancer: 173.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"EFO-21: 3.6;SuSa: 8.9"															NA	NA						"unprognostic (1.32e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.51e-1)"	"unprognostic (8.65e-2)"	"prognostic unfavorable (2.37e-7)"	"unprognostic (8.48e-3)"	"unprognostic (6.26e-2)"	"unprognostic (7.44e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (5.44e-5)"	"unprognostic (5.77e-2)"	"unprognostic (3.50e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.34e-1)"	3.9	0.2	30.6	6.8	43.0	0.0	0.8	32.7	98.9	1.9	27.5	120.3	51.6	1.7	0.7	29.4	2.1	1.1	0.6	31.2	31.3	845.9	1146.3	1.9	0.8	39.9	32.6	35.8	0.1	206.2	0.0	0.4	0.9	35.7	22.2	61.8	5.6	4.1	0.0	0.2	6.5	300.5	8.1	28.7	0.4	76.9	0.3	31.1	0.1	328.3	0.0	0.6	3.5	2.6	31.5	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	1.3	0.1	0.0	0.0	0.1	0.0	0.7	0.1	0.0	0.9	0.6	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	30.6	43.0	32.7	98.9	31.2	31.3	39.9	32.6	35.8	35.7	28.7	31.1	31.5	0.1	0.0	0.0	1.0	73.2	12.2	1.4	0.9	1.2	0.0	0.4	0.5	2.2	42.9	0.7	535.2	0.0	3.1	0.0	1181.8	1668.9	1.8	0.0	668.1	153.9	9.3	43.6	133.7	0.0	47.9	543.9	2.7	28.5	1793.8	4.5	0.4	54.7	3439.8	19.3	0.0	0.0	767.4	0.0	55.1	0.8	0.0	0.3	195.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	43.3	3282.6	0.0	0.1	27.8	3229.9	18797.6	0.0	0.0	0.0	1.6	5.5	0.1	0.4	5.5	18.9	66.9	55.5	0.0	851.8	1.3
MYMX	MINION	ENSG00000262179	"Myomixer, myoblast fusion factor"	A0A1B0GTQ4	6	44216926-44218234	"Predicted intracellular proteins"	Myogenesis			"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	5	"adipose tissue: 7.6;breast: 6.9;pancreas: 5.6;stomach 1: 2.3"	"Group enriched"	"Detected in some"	4	"Adipocytes: 5.5;Distal tubular cells: 3.9;Exocrine glandular cells: 2.2;Extravillous trophoblasts: 1.6"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.5"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	106	"plasmacytoid DC: 10.6"	"Lineage enriched"	"Detected in single"	106	"dendritic cells: 10.6"	"Cell line enriched"	"Detected in some"	31	"RH-30: 134.6"	"Not detected"	"Not detected"							HPA051451	Supported		Approved	Vesicles,Mitochondria,Cytosol		NA	NA			Vesicles	"Mitochondria, Cytosol"	"HPA051451: "	"unprognostic (1.24e-1)"	"unprognostic (8.55e-2)"	"unprognostic (6.86e-2)"	"unprognostic (6.51e-3)"	"unprognostic (2.78e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.27e-2)"	"unprognostic (2.10e-3)"	"unprognostic (4.32e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.71e-2)"	"unprognostic (2.70e-2)"	"unprognostic (2.01e-4)"	"unprognostic (1.63e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.67e-1)"	7.6	0.1	0.0	0.2	0.0	0.0	6.9	0.1	0.1	0.2	0.0	0.3	0.0	0.1	0.2	0.2	0.1	0.5	0.8	0.0	0.0	0.7	0.1	0.4	0.6	0.1	0.0	0.0	0.1	5.6	0.0	0.0	0.0	0.1	0.1	0.1	0.0	1.1	0.0	0.4	0.9	0.5	0.1	0.0	0.8	2.3	0.4	0.0	0.8	0.4	0.2	0.4	0.5	0.2	0.1	0.0	0.0	0.2	0.0	0.1	0.0	4.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	3.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.0	1.0	0.0	0.0	0.0	134.6	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.0	1.7	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.9	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	2.2	1.6	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
NAALAD2	"GCPIII, NAALADASE2"	ENSG00000077616	"N-acetylated alpha-linked acidic dipeptidase 2"	Q9Y3Q0	11	90131515-90192894	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Carboxypeptidase, Dipeptidase, Hydrolase, Metalloprotease, Multifunctional enzyme, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 20.0;testis: 14.0"	"Group enriched"	"Detected in many"	4	"Early spermatids: 39.7;Excitatory neurons: 109.3;Horizontal cells: 70.7;Inhibitory neurons: 110.2;Oligodendrocyte precursor cells: 153.8;Oligodendrocytes: 83.7"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 19.2;SH-SY5Y: 6.1;SuSa: 4.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA060820, HPA065419"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA060820: AB_2684373, HPA065419: AB_2685487"	"unprognostic (1.68e-1)"	"unprognostic (2.66e-3)"	"unprognostic (1.49e-1)"	"unprognostic (4.52e-3)"	"unprognostic (4.73e-3)"	"unprognostic (2.97e-1)"	"unprognostic (3.82e-3)"	"unprognostic (1.77e-2)"	"unprognostic (2.44e-1)"	"unprognostic (2.30e-1)"	"unprognostic (3.30e-2)"	"unprognostic (8.00e-2)"	"unprognostic (9.97e-4)"	"unprognostic (1.52e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.63e-2)"	"unprognostic (2.93e-1)"	3.3	10.1	2.9	0.4	3.4	0.1	3.3	1.8	5.2	10.1	0.9	1.7	0.2	4.2	1.9	0.8	3.4	1.2	1.9	3.2	3.1	1.5	0.9	2.1	0.4	4.0	3.6	2.6	7.5	0.7	0.1	20.0	3.6	4.4	3.2	0.6	3.5	1.1	1.2	1.1	0.7	1.3	1.1	2.1	2.7	1.2	14.0	3.2	0.1	1.4	0.7	0.2	2.2	4.0	4.4	0.1	0.2	1.8	0.1	0.5	0.1	2.2	0.1	0.1	0.1	0.0	19.2	0.7	0.3	0.2	0.0	0.3	0.3	1.3	0.0	0.0	0.0	0.3	1.9	0.4	1.7	0.2	0.1	0.1	1.9	0.0	0.0	0.0	0.5	0.4	0.2	0.1	0.0	0.0	0.0	0.3	0.3	1.8	0.5	0.2	0.3	0.0	0.2	0.0	0.0	0.2	6.1	0.0	0.2	0.0	4.3	0.2	0.4	2.4	0.1	1.4	0.3	0.3	1.0	0.3	0.3	0.6	0.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.9	3.4	1.8	5.2	3.2	3.1	4.0	3.6	2.6	4.4	2.1	3.2	4.4	2.6	0.0	0.0	3.3	0.1	0.3	0.1	0.0	0.0	17.3	0.0	0.0	2.4	1.5	0.6	0.0	0.0	1.2	0.1	0.0	0.0	0.1	39.7	0.8	13.7	1.2	0.0	0.0	109.3	0.0	0.6	7.5	1.1	0.6	0.0	1.7	0.7	0.2	0.3	70.7	110.2	0.0	0.0	7.2	0.4	17.7	11.1	0.5	0.0	12.2	0.0	8.4	0.0	153.8	83.7	0.0	0.0	14.7	0.4	0.4	0.0	0.1	0.0	2.4	0.0	6.4	4.6	0.6	11.3	0.4	0.0	0.8	0.2	19.4	0.2	0.1
NCR1	"CD335, LY94, NK-p46, NKP46"	ENSG00000189430	"Natural cytotoxicity triggering receptor 1"	O76036	19	54906148-54916140	"CD markers, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"lymphoid tissue: 3.6"	"Group enriched"	"Detected in some"	7	"dendritic cells: 30.2;NK-cells: 110.2"	"Cancer enhanced"	"Detected in single"		"testis cancer: 1.2"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	4	"NK-cell: 1.1"	"Lineage enriched"	"Detected in single"	4	"NK-cells: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA049311			Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA049311: AB_2680707"	"unprognostic (3.92e-2)"	"unprognostic (2.21e-3)"	"unprognostic (1.67e-1)"	"unprognostic (2.87e-4)"	"unprognostic (2.89e-1)"	"unprognostic (6.32e-4)"	"unprognostic (2.22e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.15e-5)"	"unprognostic (1.82e-2)"	"unprognostic (5.92e-2)"	"unprognostic (3.81e-3)"	"unprognostic (6.05e-3)"	0.2	0.0	0.0	0.2	0.0	0.7	0.1	0.0	0.9	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.5	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.6	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	1.5	0.0	0.0	0.0	0.0	30.2	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	6.6	0.4	0.0	0.0	0.1	1.1	0.1	0.0	0.1	0.7	0.1	0.1	0.0	0.3	0.0	0.0	0.6	0.3	0.0	0.0	1.8	0.0	1.9	0.1	0.0	110.2	0.5	0.4	0.0	0.0	0.0	4.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.1
NCR3	"1C7, CD337, LY117, NKp30"	ENSG00000204475	"Natural cytotoxicity triggering receptor 3"	O14931	6	31588895-31593006	"CD markers, Predicted membrane proteins"	Immunity	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"bone marrow: 4.1;intestine: 5.7;lymphoid tissue: 16.3"	"Group enriched"	"Detected in some"	10	"B-cells: 43.6;dendritic cells: 110.4;NK-cells: 166.9;T-cells: 55.5"	"Cancer enhanced"	"Detected in many"		"testis cancer: 2.6"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 274.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Daudi: 2.0;HEL: 2.7;NB-4: 10.9;U-698: 1.7"					"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (3.99e-3)"	"unprognostic (9.23e-4)"	"unprognostic (1.23e-3)"	"unprognostic (2.49e-4)"	"unprognostic (2.15e-1)"	"unprognostic (2.57e-4)"	"unprognostic (5.99e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.40e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.21e-4)"	"unprognostic (1.72e-1)"	"unprognostic (1.83e-1)"	"unprognostic (8.17e-2)"	"unprognostic (1.43e-1)"	0.4	0.0	0.0	2.9	0.0	4.1	0.2	0.0	0.1	0.1	0.0	0.3	0.3	0.2	0.0	0.2	0.2	0.0	0.2	0.0	0.0	0.3	1.1	1.9	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.4	0.0	0.1	0.1	5.7	0.0	0.0	16.3	0.4	0.7	0.1	2.0	0.3	0.0	5.0	0.5	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.1	0.0	0.2	0.5	0.0	98.8	0.1	274.3	65.2	12.1	53.9	0.3	51.8	5.7	30.1	0.9	76.6	0.6	0.6	20.3	31.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.7	0.0	1.9	0.0	43.6	3.4	0.0	0.0	0.6	0.0	0.3	0.4	0.1	0.0	1.3	0.0	0.0	0.1	110.4	0.1	0.0	0.0	0.5	0.1	0.2	0.5	0.0	2.7	0.0	0.0	0.2	0.3	0.5	0.1	8.9	0.0	1.4	0.4	0.4	0.0	0.0	0.0	0.0	2.5	2.9	0.2	0.3	1.2	3.6	0.0	1.6	0.0	166.9	0.0	0.1	0.0	0.1	0.0	2.9	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.6	0.7	0.1	1.7	0.1	55.5	0.0	0.1	0.0
NGEF	ARHGEF27	ENSG00000066248	"Neuronal guanine nucleotide exchange factor"	Q8N5V2	2	232878701-233013256	"Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein, Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adrenal gland: 56.7;brain: 101.2;intestine: 43.1;liver: 35.8;skin 1: 30.5"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 38.0;Excitatory neurons: 105.9;Proximal enterocytes: 66.7"	"Cancer enhanced"	"Detected in many"		"testis cancer: 22.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 53.9;HDLM-2: 45.3;HeLa: 21.6;PC-3: 57.0;T-47d: 32.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basal ganglia: 167.6;cerebral cortex: 133.8;hippocampal formation: 73.0"	HPA008160	Approved		Approved	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA			"Plasma membrane, Cytosol"		"HPA008160: AB_1854450"	"unprognostic (3.92e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.12e-3)"	"unprognostic (1.66e-1)"	"unprognostic (5.25e-2)"	"unprognostic (5.46e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.39e-3)"	"unprognostic (5.41e-3)"	"unprognostic (2.58e-1)"	"unprognostic (6.94e-3)"	"unprognostic (1.24e-1)"	"unprognostic (6.16e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.80e-2)"	"unprognostic (2.74e-1)"	1.1	56.7	12.1	2.2	101.2	0.1	1.9	0.0	59.6	3.3	0.0	14.3	43.1	5.1	4.1	10.4	4.9	3.1	1.3	25.5	16.7	7.1	35.8	0.7	0.2	18.9	3.9	23.2	2.1	6.1	12.0	2.8	0.3	38.7	1.8	10.6	1.4	2.1	0.7	0.9	30.5	31.6	6.7	0.0	0.4	10.8	3.8	11.4	0.0	0.9	0.7	0.3	1.8	5.3	35.5	53.9	15.4	0.6	0.2	0.2	8.2	0.9	0.9	0.1	0.4	0.0	0.7	5.2	0.0	15.2	10.9	5.5	6.9	11.6	3.0	0.4	45.3	3.8	0.1	21.6	16.7	0.2	0.0	0.3	0.0	0.2	3.5	0.6	0.2	1.9	0.2	0.2	0.2	0.5	4.0	0.0	0.1	1.3	0.2	57.0	0.0	0.0	0.1	1.0	1.4	1.9	0.4	6.6	3.3	0.1	2.0	32.2	0.4	0.0	0.5	4.5	0.3	1.0	0.5	0.2	0.0	3.8	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.1	101.2	0.0	59.6	25.5	16.7	18.9	3.9	23.2	38.7	0.0	11.4	35.5	0.0	0.0	0.0	10.4	0.0	9.9	1.2	1.2	2.8	0.3	2.1	1.4	2.4	4.3	0.5	0.0	0.0	0.1	0.0	38.0	0.0	3.9	0.7	9.1	0.9	0.4	4.9	0.0	105.9	10.5	0.3	0.7	17.3	2.0	0.0	0.3	0.4	20.4	0.1	1.7	12.8	14.6	0.0	0.3	0.6	2.0	0.0	0.3	1.8	6.5	0.0	5.5	0.0	4.5	6.0	12.1	23.5	1.2	0.1	0.5	66.7	9.8	2.5	0.2	0.0	0.2	0.3	1.1	0.8	3.8	7.5	0.0	0.2	0.5	20.2	1.1
NKX1-2	"bB238F13.2, C10orf121"	ENSG00000229544	"NK1 homeobox 2"	Q9UD57	10	124445243-124450035	"Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"Basal squamous epithelial cells: 2.2"	"Cancer enhanced"	"Detected in some"		"testis cancer: 3.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 5.7;hTCEpi: 5.4;NTERA-2: 10.8;SCLC-21H: 4.7;SuSa: 12.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA029367	Uncertain		Approved	"Nucleoli fibrillar center,Cytosol"		NA	NA			Cytosol	"Nucleoli fibrillar center"	"HPA029367: AB_2673011"	"unprognostic (2.43e-1)"	"unprognostic (7.85e-3)"		"unprognostic (6.81e-5)"	"unprognostic (1.55e-2)"	"unprognostic (3.61e-2)"		"unprognostic (5.40e-2)"	"unprognostic (7.28e-2)"	"unprognostic (2.20e-1)"		"unprognostic (3.73e-2)"		"unprognostic (2.69e-1)"	"unprognostic (1.71e-1)"		"unprognostic (8.68e-2)"	0.0	0.0	0.1	0.0	0.5	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.3	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.1	5.7	0.5	0.8	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	10.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.1	0.0	0.1	12.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.4	0.1	0.2	0.2	0.1	0.1	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.2	0.0	0.4	0.3	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0
NMRK2	"ITGB1BP3, MIBP, NRK2"	ENSG00000077009	"Nicotinamide riboside kinase 2"	Q9NPI5	19	3933103-3942416	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Pyridine nucleotide biosynthesis"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	111	"heart muscle: 1317.2;skeletal muscle: 640.8;tongue: 728.5"	"Cell type enriched"	"Detected in some"	36	"Cardiomyocytes: 995.1"	"Cancer enhanced"	"Detected in some"		"renal cancer: 32.8;testis cancer: 13.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"BEWO: 29.2;NTERA-2: 24.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA049909, HPA054792, HPA072450"	Approved		Enhanced	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA049909: , HPA054792: AB_2682601, HPA072450: AB_2686522"				"unprognostic (3.61e-1)"	"unprognostic (5.92e-2)"	"unprognostic (1.18e-2)"		"unprognostic (2.54e-1)"	"unprognostic (1.03e-1)"	"unprognostic (7.61e-2)"		"unprognostic (3.30e-2)"	"prognostic favorable (1.19e-4)"	"unprognostic (1.72e-1)"	"unprognostic (3.29e-2)"	"unprognostic (5.38e-1)"		0.6	1.7	0.4	0.0	0.2	0.0	0.8	0.3	0.9	0.1	0.1	0.4	0.0	0.4	0.1	5.8	0.6	0.0	1317.2	0.6	0.3	1.8	0.3	2.1	0.0	0.5	0.3	0.0	0.5	0.6	0.0	1.7	0.1	0.5	2.6	0.1	0.0	8.0	0.9	640.8	0.5	0.5	0.0	0.3	0.1	0.6	0.5	0.2	0.0	0.6	728.5	0.0	0.4	0.8	0.7	0.0	0.0	0.0	0.0	0.0	0.0	29.2	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	24.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.7	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.3	0.9	0.6	0.3	0.5	0.3	0.0	0.5	0.3	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	995.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	12.4	0.0	0.0	0.2	0.0	0.6	26.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	24.6	0.0	0.7	0.0	0.0	0.1	0.1	0.0	0.0	0.0
NPAS1	"bHLHe11, MOP5, PASD5"	ENSG00000130751	"Neuronal PAS domain protein 1"	Q99742	19	47019837-47045775	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 6.0;skin 1: 7.7"	"Group enriched"	"Detected in many"	4	"Cone photoreceptor cells: 16.7;Gastric mucus-secreting cells: 27.0;Inhibitory neurons: 28.3"	"Cancer enhanced"	"Detected in many"		"testis cancer: 5.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 9.9;Daudi: 10.2;HEK 293: 11.1;HMC-1: 9.0;NB-4: 18.1;U-266/84: 11.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA043364, HPA072259"		Approved	Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA043364: , HPA072259: AB_2686500"	"unprognostic (2.34e-3)"	"unprognostic (6.25e-2)"	"unprognostic (7.32e-4)"	"unprognostic (1.38e-1)"	"unprognostic (6.24e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.76e-3)"	"unprognostic (2.21e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.75e-1)"	"unprognostic (5.91e-2)"	"unprognostic (2.64e-1)"	"unprognostic (2.14e-8)"	"unprognostic (8.82e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.20e-2)"	0.5	0.4	2.5	0.3	1.2	0.2	0.7	0.1	6.0	0.3	0.9	0.3	0.0	0.1	0.0	1.0	0.6	0.0	0.7	4.8	1.6	1.4	0.6	0.4	0.5	2.5	1.7	1.8	0.2	0.6	0.0	1.3	0.1	3.7	0.4	0.0	0.6	0.4	0.0	0.1	7.7	0.5	0.1	0.4	2.8	2.7	0.6	1.1	0.1	0.5	0.0	0.3	0.4	0.7	2.4	0.2	2.4	0.3	0.5	0.2	0.2	0.0	9.9	0.3	0.1	0.4	0.7	0.5	10.2	2.2	8.1	0.4	0.2	2.1	0.2	0.1	0.7	11.1	0.8	1.2	2.5	0.0	5.5	9.0	0.9	0.4	0.0	0.1	0.6	0.2	1.3	3.5	0.8	1.3	0.9	0.4	18.1	2.4	0.4	1.7	0.9	0.4	0.8	0.6	0.6	0.7	0.6	0.8	0.3	2.4	0.8	2.1	1.7	0.1	0.2	0.9	0.1	0.2	5.4	11.5	2.2	1.2	1.1	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	1.2	0.1	6.0	4.8	1.6	2.5	1.7	1.8	3.7	0.4	1.1	2.4	0.1	0.0	0.6	1.6	1.1	0.8	1.4	1.1	1.8	0.7	2.2	2.5	1.1	0.0	1.1	0.0	16.7	0.0	0.1	0.3	0.0	0.6	0.1	0.4	0.2	0.2	1.2	2.7	5.7	0.4	0.1	0.5	27.0	0.4	0.0	0.7	0.0	0.1	0.3	0.0	28.3	1.4	2.0	0.0	0.0	0.0	0.0	0.4	0.0	1.0	0.0	5.4	0.0	2.0	1.2	1.0	0.2	0.0	2.6	1.5	0.0	0.9	2.0	5.4	0.0	0.1	1.1	0.4	2.1	2.2	2.3	0.0	1.2	0.1	0.6	1.2
NPPB		ENSG00000120937	"Natriuretic peptide B"	P16860	1	11857464-11858945	"Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"		"Hormone, Vasoactive, Vasodilator"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	768	"heart muscle: 5206.4"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 351.7;Ductal cells: 266.6;Pancreatic endocrine cells: 86.2"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.2"	"Region enhanced"	"Detected in some"		"basal ganglia: 3.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 135.5;CACO-2: 362.2;SuSa: 67.7"	"Region enhanced"	"Detected in single"		"pons and medulla: 1.4"					HPA077324			Approved	Vesicles,Cytosol	"Secreted to blood"	NA	NA	9680		Vesicles	Cytosol	"HPA077324: "				"unprognostic (3.87e-1)"	"unprognostic (1.29e-2)"					"unprognostic (2.49e-1)"	"unprognostic (4.23e-1)"				"unprognostic (3.28e-2)"			0.9	0.3	0.3	0.1	3.4	0.0	0.7	0.4	1.4	0.1	0.1	0.3	0.0	0.3	0.3	0.2	0.0	0.6	5206.4	0.3	1.3	0.3	0.5	6.7	0.9	0.4	0.4	0.4	0.8	4.1	0.1	0.5	0.8	0.3	0.5	0.0	0.1	1.2	0.0	0.8	0.5	0.4	0.0	0.5	0.1	0.7	0.8	0.4	0.1	0.5	0.0	0.0	0.2	0.3	0.4	0.0	0.1	0.0	0.0	0.0	0.0	135.5	0.3	0.0	2.1	1.1	362.2	0.0	0.0	0.1	0.1	0.3	3.8	0.1	0.0	2.5	0.0	0.0	0.0	0.0	1.0	0.2	0.1	0.0	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.2	0.1	0.4	0.2	0.0	67.7	0.0	0.0	0.0	0.0	32.0	0.2	0.2	0.0	0.1	0.0	0.1	0.2	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.4	0.4	1.4	0.3	1.3	0.4	0.4	0.4	0.3	0.5	0.4	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	351.7	0.0	0.0	0.0	0.0	11.6	0.0	0.0	0.0	266.6	0.1	0.8	0.1	4.9	0.0	0.0	0.2	8.3	2.2	11.7	0.0	1.4	0.0	0.2	0.0	0.0	1.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	2.0	0.2	0.0	0.0	0.0	86.2	0.0	0.4	0.0	0.0	0.0	0.0	0.7	0.6	0.0	0.0	17.6	5.8	0.1	0.0	0.0	3.4	0.0	0.0	0.0	0.1
NT5DC4		ENSG00000144130	"5'-nucleotidase domain containing 4"	Q86YG4	2	112721486-112742879	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"testis: 2.2"	"Group enriched"	"Detected in some"	11	"Early spermatids: 20.0;Late spermatids: 6.4"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"K-562: 16.1"					"Not detected"	"Not detected"			HPA046856	Uncertain					NA	NA					"HPA046856: AB_2679841"	"unprognostic (2.49e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.20e-4)"	"unprognostic (2.26e-1)"	"unprognostic (3.66e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.38e-4)"	"unprognostic (1.38e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.60e-4)"	"unprognostic (9.02e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.78e-4)"	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	2.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.2	0.1	0.1	0.0	1.0	0.3	0.0	0.0	0.0	0.2	0.0	0.4	0.2	0.6	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.1	1.2	0.0	0.0	0.1	2.2	0.0	1.2	0.1	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.3	0.1	0.1	0.0	0.2	0.5	0.0	0.2	0.1	0.1	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	20.0	0.3	0.1	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	1.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.1
OR3A2	"OLFRA04, OR17-228, OR228"	ENSG00000221882	"Olfactory receptor family 3 subfamily A member 2"	P47893	17	3276942-3386317	"G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	6	"brain: 3.3;retina: 1.1;testis: 3.2"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 3.9;granulocytes: 1.3"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"HDLM-2: 11.3;JURKAT: 11.8"					"Low region specificity"	"Detected in single"									NA	NA						"unprognostic (7.58e-2)"				"unprognostic (5.10e-2)"						"unprognostic (6.89e-2)"		"unprognostic (1.12e-1)"		"unprognostic (1.32e-1)"			0.1	0.0	1.0	0.1	0.9	0.0	0.1	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	1.3	0.0	0.0	0.2	0.3	0.6	1.1	0.3	0.2	0.0	0.0	0.2	0.2	1.6	0.1	0.0	1.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.0	3.2	2.4	0.3	0.0	0.0	0.1	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.1	0.2	0.0	0.4	0.9	0.3	0.0	0.2	0.1	0.3	0.4	0.2	0.1	0.0	1.0	0.1	0.2	1.0	0.9	0.0	1.2	0.4	1.3	0.6	1.1	0.3	1.6	0.1	2.4	3.3	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
ORC1	"HSORC1, ORC1L, PARC1"	ENSG00000085840	"Origin recognition complex subunit 1"	Q13415	1	52372829-52404423	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA replication"	DNA-binding	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 29.3;lymphoid tissue: 11.7"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 5.5;Early spermatids: 5.6;Erythroid cells: 14.1;Extravillous trophoblasts: 9.9;Plasma cells: 6.3;Spermatogonia: 6.5"	"Cancer enhanced"	"Detected in many"		"testis cancer: 15.7"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"NK-cell: 3.4"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA027439, HPA027450"	Approved		Supported	Nucleoplasm		NA	Yes			Nucleoplasm		"HPA027439: , HPA027450: AB_10602041"	"unprognostic (3.28e-1)"	"unprognostic (4.42e-3)"	"prognostic favorable (1.74e-5)"	"unprognostic (1.29e-2)"	"unprognostic (7.29e-2)"	"unprognostic (2.34e-3)"	"prognostic unfavorable (3.22e-5)"	"unprognostic (3.77e-3)"	"prognostic unfavorable (3.69e-4)"	"unprognostic (3.86e-2)"	"unprognostic (2.70e-3)"	"unprognostic (8.39e-2)"	"unprognostic (1.25e-10)"	"unprognostic (4.56e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.57e-2)"	0.4	0.7	0.1	3.6	0.1	29.3	1.1	0.5	0.2	0.5	0.0	3.4	1.7	0.6	0.1	2.8	0.3	0.4	0.2	0.1	0.1	0.5	0.6	0.6	6.7	0.2	0.1	0.1	0.5	0.3	0.3	0.3	1.9	0.2	0.4	4.1	1.0	0.6	0.1	0.5	2.0	2.4	0.9	0.0	2.0	1.0	5.2	0.2	11.7	0.3	0.1	7.7	0.9	1.0	0.2	19.3	20.8	33.0	21.7	0.8	2.7	31.8	13.5	12.2	38.9	40.0	25.8	10.7	44.2	11.6	8.5	17.8	25.9	48.9	16.9	33.8	19.0	28.1	53.2	30.2	25.8	0.2	71.9	29.2	1.4	0.8	38.1	4.3	2.7	11.7	27.6	63.0	20.9	12.8	14.4	56.9	34.0	73.1	11.7	29.5	60.2	51.3	43.1	6.8	25.0	18.5	15.6	31.0	18.8	10.3	30.5	10.2	28.7	5.4	15.8	22.5	24.9	34.0	10.9	31.1	54.4	15.6	52.6	19.5	0.0	0.1	0.0	0.2	0.1	0.2	0.2	0.4	0.4	0.6	0.8	0.1	0.3	0.4	3.4	0.2	0.0	1.2	0.3	0.1	0.1	0.5	0.2	0.1	0.1	0.2	0.1	0.1	0.2	0.0	0.2	0.2	0.6	0.0	0.0	0.3	1.7	0.9	0.3	0.4	1.2	0.7	0.7	1.1	0.5	0.0	0.1	0.0	0.0	5.5	0.7	1.2	0.0	0.3	5.6	0.5	0.6	0.5	0.0	14.1	0.7	0.2	9.9	0.7	0.5	0.6	0.0	2.8	0.0	0.2	2.9	0.0	0.7	1.3	0.0	0.3	0.4	3.8	0.6	0.6	0.0	1.0	0.3	0.2	0.0	0.5	0.5	0.2	0.8	0.4	6.3	0.2	0.2	3.9	0.1	0.9	0.0	0.6	0.7	4.1	6.5	2.5	1.1	1.8	1.1	0.9	3.7	0.4
OTOGL	"C12orf64, FLJ90579"	ENSG00000165899	"Otogelin like"	Q3ZCN5	12	80099537-80380880	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"			"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 1.6;kidney: 5.2"	"Group enriched"	"Detected in some"	5	"Excitatory neurons: 51.2;Oligodendrocyte precursor cells: 42.3"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SCLC-21H: 1.3;U-87 MG: 2.4"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	6	"basal ganglia: 4.2"	"HPA040364, HPA053392"	Uncertain		Approved	Cytosol	"Secreted in other tissues"	NA	NA			Cytosol		"HPA040364: AB_10795365, HPA053392: AB_2682135"	"unprognostic (2.43e-1)"	"unprognostic (2.78e-2)"	"unprognostic (2.55e-2)"	"unprognostic (1.50e-1)"	"unprognostic (5.99e-2)"	"unprognostic (3.10e-1)"	"unprognostic (3.34e-3)"	"unprognostic (4.76e-2)"	"unprognostic (2.72e-2)"	"unprognostic (4.52e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.95e-5)"	"unprognostic (1.41e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.79e-2)"	"unprognostic (2.04e-2)"	0.1	0.0	0.3	0.0	0.8	0.0	0.1	0.0	1.0	0.1	0.0	0.3	0.0	0.1	0.1	0.1	0.1	0.1	1.6	0.4	0.4	5.2	0.0	0.0	0.2	0.1	0.0	0.6	0.0	0.2	0.0	0.3	0.5	0.2	0.1	0.1	0.5	0.0	0.1	0.5	0.0	0.1	0.2	0.0	0.1	0.1	0.3	0.0	0.1	0.0	0.1	0.1	0.2	0.1	0.6	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	1.3	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.9	0.0	0.0	0.3	0.0	0.0	2.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.0	1.0	0.4	0.4	0.1	0.0	0.6	0.2	0.0	0.0	0.6	0.1	0.0	0.0	8.8	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	1.4	0.1	0.1	0.2	0.0	0.0	51.2	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.9	0.0	0.0	0.0	42.3	1.6	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1
P2RX2	"DFNA41, P2X2"	ENSG00000187848	"Purinergic receptor P2X 2"	Q9UBL9	12	132618776-132622388	"Disease related genes, Human disease related genes, Predicted membrane proteins"	"Hearing, Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 11.8;epididymis: 22.0;prostate: 14.3"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 1.6;Endometrial ciliated cells: 2.6;Fibroblasts: 8.3;Gastric mucus-secreting cells: 1.1;Peritubular cells: 3.0"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.3"	"Group enriched"	"Detected in many"	5	"amygdala: 9.5;cerebral cortex: 11.8;hippocampal formation: 10.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"MCF7: 5.1;T-47d: 11.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"									NA	NA						"unprognostic (1.12e-1)"	"unprognostic (1.49e-2)"	"unprognostic (5.92e-2)"	"unprognostic (5.94e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.12e-1)"	"unprognostic (5.79e-3)"	"unprognostic (6.75e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.11e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.88e-2)"	"unprognostic (6.21e-2)"	"unprognostic (3.05e-1)"		"unprognostic (9.12e-2)"	0.5	0.1	9.5	0.7	0.5	0.1	0.2	0.4	11.8	0.6	0.0	2.0	1.1	0.2	22.0	7.3	9.4	0.1	0.0	10.3	1.2	0.9	0.4	5.0	1.9	0.2	0.2	1.8	0.3	0.5	0.7	1.3	0.4	0.4	14.3	0.3	0.0	0.1	9.1	0.0	0.2	4.3	0.1	0.1	3.2	1.7	1.6	2.2	0.4	0.2	0.0	0.8	1.0	1.9	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.0	5.1	0.1	0.3	0.5	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.1	0.0	0.0	1.9	0.0	0.6	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	9.5	0.5	0.4	11.8	10.3	1.2	0.2	0.2	1.8	0.4	0.1	2.2	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.6	0.1	0.1	0.0	0.0	0.1	0.0	0.1	8.3	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	3.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.1
PASD1	CT63	ENSG00000166049	"PAS domain containing repressor 1"	Q8IV76	X	151563675-151676739	"Predicted intracellular proteins"	"Biological rhythms"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	163	"testis: 16.2"	"Group enriched"	"Detected in some"	5	"Spermatocytes: 19.3;Spermatogonia: 57.5"	"Cancer enhanced"	"Detected in some"		"melanoma: 0.7;testis cancer: 0.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"BEWO: 34.8;HMC-1: 55.3;U-266/84: 27.8"	"Not detected"	"Not detected"							"HPA011122, HPA011152"	Enhanced		Enhanced	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA011122: AB_1854990, HPA011152: AB_1854991"										"unprognostic (3.34e-1)"					"unprognostic (1.02e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	55.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	1.3	27.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	6.6	0.0	0.0	19.3	57.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PDCL2	GCPHLP	ENSG00000163440	"Phosducin like 2"	Q8N4E4	4	55556519-55592245	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	197	"testis: 65.6"	"Group enriched"	"Detected in some"	19	"Early spermatids: 1285.9;Late spermatids: 634.7"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 2.0;testis cancer: 3.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 1.1;HaCaT: 1.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA048260, HPA072384"	Enhanced		Approved	Microtubules,Centrosome		NA	NA			Microtubules	Centrosome	"HPA048260: AB_2680333, HPA072384: "		"unprognostic (5.93e-3)"		"unprognostic (1.19e-7)"		"unprognostic (1.04e-1)"				"unprognostic (3.01e-3)"				"unprognostic (1.16e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.41e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	65.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1285.9	0.0	0.0	0.6	0.0	0.0	0.4	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	634.7	7.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.2	0.0	13.1	0.0	0.1	40.4	50.4	0.0	0.3	0.1	0.0	0.0	0.0	0.0
PDE6G	"PDEG, RP57"	ENSG00000185527	"Phosphodiesterase 6G"	P18545	17	81650459-81663112	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Sensory transduction, Vision"	Hydrolase	"Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	99	"retina: 2068.0"	"Cell type enriched"	"Detected in many"	6	"Rod photoreceptor cells: 4448.6"	"Cancer enhanced"	"Detected in many"		"testis cancer: 10.6"	"Region enhanced"	"Detected in single"		"midbrain: 2.1"	"Group enriched"	"Detected in many"	6	"basophil: 127.0;NK-cell: 220.2"	"Group enriched"	"Detected in all"	6	"granulocytes: 127.0;NK-cells: 220.2"	"Cell line enhanced"	"Detected in some"		"Hep G2: 5.2;NB-4: 5.8;NTERA-2: 8.9;REH: 11.9;SuSa: 6.2"	"Region enhanced"	"Detected in some"		"hippocampal formation: 4.7"	"Not detected"	"Not detected"			HPA045118	Supported		Uncertain	Vesicles		NA	NA			Vesicles		"HPA045118: AB_2732517"	"unprognostic (6.16e-2)"	"unprognostic (1.95e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.51e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.46e-2)"	"unprognostic (6.33e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.85e-2)"	"unprognostic (5.01e-2)"	"unprognostic (1.94e-2)"	"unprognostic (5.71e-2)"	"unprognostic (5.44e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.14e-1)"	1.5	0.3	0.1	4.7	0.1	7.9	1.0	0.2	0.5	1.0	0.2	1.6	0.6	0.2	0.1	0.8	0.7	2.5	0.5	0.1	0.5	1.7	4.3	3.0	20.8	0.2	2.1	0.0	0.0	0.0	0.1	0.1	12.1	0.2	0.2	1.0	2068.0	0.5	0.4	1.2	0.3	1.6	1.0	0.2	20.0	1.7	0.9	0.3	8.4	0.4	0.3	7.2	3.0	0.1	0.7	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.3	0.1	0.2	0.0	0.9	0.0	0.0	0.0	0.0	5.2	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.4	2.8	0.2	0.1	0.2	0.4	0.3	0.0	5.8	8.9	0.0	0.0	11.9	0.0	1.9	0.0	0.0	0.0	0.2	0.0	0.1	0.1	6.2	0.1	0.8	1.2	0.2	0.0	0.0	0.1	0.1	0.6	0.9	0.4	3.1	0.1	127.0	18.1	30.5	4.1	26.2	1.3	2.7	0.8	2.3	28.9	5.1	2.1	7.4	2.4	220.2	15.5	2.9	0.1	13.5	0.1	0.1	0.2	0.5	0.1	0.5	0.2	2.1	0.0	0.2	0.2	0.3	0.7	0.3	0.0	0.6	0.3	1.1	0.9	0.0	0.0	0.6	422.5	0.3	0.4	0.2	0.0	0.0	5.5	517.1	0.2	4.3	0.1	1.9	0.4	0.8	1.5	0.3	27.2	0.0	1.7	0.2	0.2	0.4	0.2	0.0	0.5	23.6	0.1	2.9	0.2	22.6	262.5	0.1	0.2	0.0	4.8	8.0	2.3	0.0	4.4	3.6	0.0	13.3	709.0	11.3	0.0	0.1	0.2	0.0	0.0	0.8	0.1	0.1	1.0	0.0	4448.6	0.0	0.1	0.1	1.1	0.2	0.3	1.4	0.3	1.7	2.1	0.0	0.1
PEG3	"KIAA0287, ZKSCAN22, ZNF904, ZSCAN24"	ENSG00000198300	"Paternally expressed 3"	Q9GZU2	19	56810077-56840728	"Predicted intracellular proteins, Transcription factors"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adrenal gland: 77.6;brain: 171.0;choroid plexus: 144.9;ovary: 262.4;placenta: 136.2"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 345.8;Granulosa cells: 224.1;Horizontal cells: 148.0;Syncytiotrophoblasts: 477.1;Theca cells: 395.9"	"Cancer enhanced"	"Detected in many"		"testis cancer: 9.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"BEWO: 103.6;Hep G2: 218.1;RH-30: 71.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026070	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA026070: AB_10603328"	"unprognostic (1.38e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.12e-2)"	"unprognostic (1.58e-1)"	"unprognostic (4.84e-2)"	"unprognostic (4.84e-2)"	"unprognostic (4.44e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.82e-3)"	"unprognostic (9.92e-2)"	"unprognostic (2.48e-5)"	"unprognostic (6.92e-3)"	"unprognostic (2.19e-1)"	"prognostic unfavorable (1.56e-4)"	"unprognostic (6.68e-3)"	2.4	77.6	73.4	1.5	55.8	0.1	11.0	4.9	44.2	8.7	144.9	3.8	0.6	23.0	5.9	2.2	13.0	1.9	3.5	27.3	171.0	3.4	4.6	1.8	0.5	54.5	72.9	32.2	262.4	2.6	10.0	29.0	136.2	70.4	3.0	1.7	18.1	5.4	5.0	0.7	1.5	1.4	9.2	12.8	0.8	2.1	33.9	110.0	1.0	5.7	1.8	6.3	3.5	3.3	89.5	0.0	0.0	4.0	0.0	0.0	0.0	103.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	218.1	0.0	0.0	2.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.6	0.0	0.6	0.0	71.7	0.1	0.1	0.1	0.2	6.0	0.0	0.0	0.0	20.7	0.0	0.0	0.0	0.0	11.8	0.0	0.0	0.0	7.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	73.4	55.8	4.9	44.2	27.3	171.0	54.5	72.9	32.2	70.4	12.8	110.0	89.5	4.1	0.0	4.6	0.0	0.2	4.8	1.9	0.0	4.0	31.0	10.9	17.8	17.2	1.5	1.8	1.8	8.4	345.8	1.6	0.0	1.9	0.9	32.0	1.3	35.0	3.5	0.0	0.0	0.0	0.0	45.4	56.9	0.0	1.6	0.0	224.1	4.6	4.3	34.3	148.0	0.0	0.0	0.0	0.6	1.7	19.4	58.7	1.2	14.2	0.0	0.0	17.0	0.0	0.0	0.0	0.3	0.0	109.9	0.0	2.0	0.0	1.1	2.2	13.7	13.1	29.5	17.0	53.0	36.2	2.0	2.6	477.1	0.2	395.9	0.0	0.7
PHF24	KIAA1045	ENSG00000122733	"PHD finger protein 24"	Q9UPV7	9	34957608-34982544	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 44.8;testis: 16.2"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 3.7;Cone photoreceptor cells: 8.4;Early spermatids: 3.9;Late spermatids: 7.9;Muller glia cells: 14.2;Spermatocytes: 4.9;Spermatogonia: 4.8"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.8"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	20	"neutrophil: 2.0"	"Lineage enriched"	"Detected in single"	20	"granulocytes: 2.0"	"Cell line enhanced"	"Detected in single"		"WM-115: 1.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020974	Approved					NA	NA					"HPA020974: AB_1852364"	"unprognostic (5.54e-3)"	"unprognostic (1.21e-1)"	"unprognostic (9.00e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.00e-2)"	"unprognostic (6.30e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.78e-2)"	"unprognostic (7.06e-2)"	"unprognostic (2.97e-1)"	"unprognostic (4.80e-4)"	"unprognostic (1.24e-1)"	"unprognostic (4.58e-6)"	"unprognostic (1.87e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.23e-2)"	"unprognostic (2.30e-1)"	0.5	0.2	12.2	0.4	27.9	0.0	0.6	0.2	44.8	0.3	0.0	0.4	0.1	0.5	0.2	0.3	0.4	0.2	0.1	22.4	12.6	0.1	0.1	0.2	1.0	10.7	8.6	26.1	0.1	0.0	0.0	0.4	0.0	15.9	0.1	0.2	6.8	0.1	0.0	0.1	1.0	0.5	0.4	0.0	0.2	0.3	16.2	12.7	0.7	0.4	0.0	0.8	0.1	0.3	23.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	12.2	27.9	0.2	44.8	22.4	12.6	10.7	8.6	26.1	15.9	0.0	12.7	23.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.1	0.0	1.1	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	0.0	3.9	0.7	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	1.2	0.0	0.0	0.0	0.0	14.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.1	0.0	0.1	0.4	4.9	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1
PHTF2	DKFZp434D166	ENSG00000006576	"Putative homeodomain transcription factor 2"	Q8N3S3	7	77798792-77957503	"Predicted membrane proteins, Transcription factors"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 113.8;tongue: 58.2"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 109.1;Inhibitory neurons: 94.6;Oligodendrocyte precursor cells: 91.5;Oligodendrocytes: 144.4"	"Cancer enhanced"	"Detected in all"		"testis cancer: 16.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"non-classical monocyte: 25.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012312	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA012312: AB_2668649"	"unprognostic (1.96e-1)"	"unprognostic (2.60e-3)"	"unprognostic (4.04e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.70e-2)"	"unprognostic (1.99e-3)"	"unprognostic (5.36e-3)"	"unprognostic (2.81e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.82e-1)"	"prognostic unfavorable (3.09e-7)"	"unprognostic (8.28e-3)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (2.78e-4)"	"unprognostic (5.53e-2)"	8.0	4.8	4.4	13.2	5.3	12.4	7.1	5.7	6.3	8.8	3.6	6.0	4.0	8.8	5.2	8.7	5.4	10.8	13.1	5.2	4.6	5.7	6.3	7.7	18.2	4.6	4.2	5.1	8.3	4.6	26.5	4.7	11.0	5.0	6.8	6.6	7.2	5.0	8.0	113.8	6.9	8.0	12.0	4.1	12.9	4.5	10.1	4.2	9.2	6.6	58.2	17.8	11.8	5.9	7.9	34.6	15.5	20.9	42.6	17.8	19.5	17.3	59.6	54.1	34.9	39.3	26.6	27.3	31.0	4.8	46.4	37.8	27.9	30.1	15.5	49.3	20.9	24.0	12.7	16.7	7.8	19.3	16.9	33.5	11.6	14.5	20.4	30.4	22.4	12.6	17.1	21.0	53.1	37.7	21.7	14.0	10.9	18.9	9.6	18.2	13.8	42.3	25.4	9.6	45.9	20.0	27.9	33.4	37.5	21.9	30.5	39.7	13.0	12.9	59.7	31.9	34.0	35.5	24.9	31.1	38.3	18.9	26.7	52.5	14.1	2.7	4.6	1.8	11.7	3.7	8.2	5.6	1.7	2.8	5.3	1.7	1.8	1.6	5.1	25.4	1.2	8.2	2.7	4.4	5.3	5.7	6.3	5.2	4.6	4.6	4.2	5.1	5.0	4.1	4.2	7.9	12.8	6.4	15.2	31.6	54.0	15.9	20.9	9.0	21.1	8.7	13.2	10.0	23.8	14.3	10.8	7.3	12.5	13.7	18.4	8.9	0.0	4.4	27.4	8.1	20.9	9.6	5.4	8.4	109.1	6.7	8.6	18.3	7.7	12.5	39.2	26.7	18.9	5.7	11.7	3.3	94.6	6.6	22.4	32.7	32.6	4.5	12.2	39.7	10.6	47.8	11.1	4.7	10.3	91.5	144.4	5.7	5.6	13.5	34.8	9.0	2.3	2.2	9.7	9.0	13.1	15.1	15.3	47.6	39.2	14.4	17.8	14.8	54.2	14.7	4.8	21.5
PIF1	"C15orf20, FLJ22692"	ENSG00000140451	"PIF1 5'-to-3' DNA helicase"	Q9H611	15	64815632-64825668	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 4.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 21.3;Erythroid cells: 17.7;Granulosa cells: 15.1;NK-cells: 15.5;Theca cells: 18.3"	"Cancer enhanced"	"Detected in many"		"testis cancer: 10.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB018701	Supported		Supported	Nucleoplasm		NA	Yes			Nucleoplasm		"CAB018701: AB_2164654"	"unprognostic (1.99e-1)"	"unprognostic (6.11e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.12e-2)"	"unprognostic (1.62e-1)"	"unprognostic (8.33e-3)"	"unprognostic (8.66e-4)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (5.22e-4)"	"unprognostic (6.68e-2)"	"unprognostic (2.38e-2)"	"unprognostic (3.27e-2)"	"unprognostic (0.00e+0)"	"unprognostic (2.96e-3)"	"unprognostic (1.78e-1)"	"unprognostic (9.61e-2)"	"unprognostic (5.95e-2)"	0.6	1.0	0.9	2.6	0.9	3.8	0.4	0.8	1.3	0.8	0.8	2.2	1.9	0.8	0.1	3.1	0.7	0.8	0.9	0.9	1.2	0.6	0.6	1.0	4.6	1.4	1.0	0.8	0.4	0.2	0.2	0.5	0.9	1.1	1.7	1.1	0.1	0.7	0.7	0.3	1.0	2.6	1.2	1.0	4.9	1.8	2.5	1.2	3.6	0.5	0.2	3.3	1.5	1.4	1.0	7.7	8.7	21.1	8.6	3.7	4.3	7.8	7.4	3.9	7.3	5.6	14.0	12.6	9.3	3.0	3.6	6.8	20.9	21.8	6.2	2.7	14.8	8.0	10.8	28.5	10.2	1.9	4.3	8.4	2.5	0.0	3.2	2.6	1.8	7.5	13.6	7.2	18.0	7.0	6.7	4.7	17.9	17.2	9.7	6.0	9.7	7.0	13.0	4.1	4.3	8.7	5.6	5.7	6.3	3.3	9.2	7.0	4.7	5.2	4.4	22.6	7.0	14.0	14.3	14.3	9.0	4.2	18.8	6.4	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.1	0.9	0.9	0.8	1.3	0.9	1.2	1.4	1.0	0.8	1.1	1.0	1.2	1.0	1.2	0.0	1.1	3.6	6.5	1.9	0.8	0.6	0.0	0.5	0.6	0.6	1.9	0.0	0.1	0.0	0.0	5.1	7.5	3.2	0.0	0.0	21.3	0.4	4.4	2.3	0.0	17.7	2.6	0.0	6.5	5.6	3.6	0.7	0.0	15.1	5.3	0.5	5.8	0.0	1.0	2.4	0.0	5.1	2.0	2.3	1.5	4.5	0.0	1.9	0.1	0.8	15.5	3.5	0.1	0.2	0.1	2.2	9.7	1.1	0.2	0.1	0.1	1.2	6.6	4.2	3.5	0.8	2.0	1.6	1.0	1.1	7.5	18.3	6.2	1.3
PIWIL1	"CT80.1, HIWI, PIWI"	ENSG00000125207	"Piwi like RNA-mediated gene silencing 1"	Q96J94	12	130337887-130372637	"Disease related genes, Predicted intracellular proteins"	"Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis, Translation regulation"	"Developmental protein, Endonuclease, Hydrolase, Nuclease, RNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	36	"testis: 43.0"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 123.0;Early spermatids: 48.6;Rod photoreceptor cells: 177.9;Spermatocytes: 125.6"	"Cancer enhanced"	"Detected in some"		"testis cancer: 6.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 2.6;OE19: 4.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA066880	Enhanced					NA	NA					"HPA066880: "	"unprognostic (1.00e-2)"	"unprognostic (1.46e-2)"	"unprognostic (8.28e-2)"	"unprognostic (2.22e-1)"		"unprognostic (1.48e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.14e-1)"	"unprognostic (8.81e-2)"	"unprognostic (3.95e-1)"	"unprognostic (1.86e-1)"	"unprognostic (9.36e-2)"	"unprognostic (9.85e-6)"	"unprognostic (3.83e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.43e-2)"	"unprognostic (3.60e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	43.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	1.0	1.3	0.3	0.7	0.0	8.1	0.7	0.1	1.0	1.5	0.1	1.8	123.0	0.5	0.1	0.7	0.0	0.3	48.6	0.4	0.3	1.4	1.2	0.0	4.4	0.0	0.3	0.6	0.0	0.6	0.0	0.1	1.1	0.0	0.4	1.7	5.8	0.6	0.0	1.9	3.1	30.6	2.8	0.5	0.0	0.0	0.8	12.2	4.1	1.0	0.4	0.6	0.3	2.2	0.1	0.4	0.4	0.9	0.1	177.9	0.0	0.0	0.2	125.6	5.3	0.0	1.3	1.0	0.6	0.5	0.5	0.2
PKD1L1	PRO19563	ENSG00000158683	"Polycystin 1 like 1, transient receptor potential channel interacting"	Q8TDX9	7	47740202-47948466	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"	Heterotaxy	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"tongue: 3.3"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 9.1;Astrocytes: 13.4;Early spermatids: 11.8;Excitatory neurons: 25.7;Inhibitory neurons: 37.9;Microglial cells: 15.0;Oligodendrocyte precursor cells: 11.6;Oligodendrocytes: 17.1"	"Cancer enhanced"	"Detected in single"		"testis cancer: 1.7"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"T-47d: 5.9;U-266/70: 14.7;U-266/84: 5.7"	"Not detected"	"Not detected"							"HPA020422, HPA022424"	Uncertain					NA	NA					"HPA020422: AB_1855434, HPA022424: AB_1855435"	"unprognostic (5.47e-2)"	"unprognostic (5.33e-3)"	"unprognostic (1.49e-2)"	"unprognostic (9.74e-2)"	"unprognostic (4.03e-2)"	"unprognostic (6.31e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.11e-1)"	"unprognostic (9.63e-3)"	"unprognostic (7.96e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.88e-4)"	"unprognostic (1.88e-3)"	"unprognostic (2.56e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.90e-1)"	1.8	0.1	0.7	0.4	0.9	1.1	0.5	2.1	1.9	0.1	0.0	0.4	0.9	0.3	0.6	0.4	0.3	0.4	1.8	0.3	0.8	0.2	0.8	0.4	0.9	0.6	0.6	0.5	0.3	0.3	0.1	0.4	0.6	1.1	0.3	0.5	1.8	0.4	0.1	2.8	0.5	0.4	0.4	0.0	0.3	0.4	1.5	0.6	1.5	0.4	3.3	0.6	0.6	0.1	1.2	0.4	0.7	0.6	0.8	0.1	0.0	1.2	0.3	0.2	0.2	0.4	0.8	0.4	0.3	0.3	0.4	0.4	0.8	0.5	0.6	0.6	0.2	0.4	0.3	0.3	0.8	0.0	0.5	0.3	0.2	0.1	0.3	0.2	0.2	1.1	0.4	0.4	1.1	0.5	0.2	0.3	0.3	0.4	0.0	0.2	0.2	0.3	0.3	0.1	0.7	0.5	0.4	0.5	0.3	0.4	0.5	5.9	0.1	0.1	0.5	1.1	0.2	0.3	14.7	5.7	0.5	0.2	0.2	0.3	0.9	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.4	0.2	0.1	0.2	0.1	0.1	0.7	0.9	2.1	1.9	0.3	0.8	0.6	0.6	0.5	1.1	0.0	0.6	1.2	9.1	0.0	0.0	13.4	0.3	0.1	0.0	0.0	0.0	3.1	0.1	0.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	11.8	0.5	0.1	3.7	0.0	0.0	25.7	0.2	0.2	1.7	0.0	0.3	0.0	0.2	2.2	0.1	1.4	1.7	37.9	0.7	0.0	0.3	0.0	5.3	0.3	0.2	0.0	15.0	0.0	0.5	0.0	11.6	17.1	0.0	0.0	0.0	0.4	0.1	0.3	0.0	0.0	1.5	0.0	0.4	0.2	1.4	0.6	0.0	0.0	0.0	0.1	0.3	0.8	0.0
PLBD1	FLJ22662	ENSG00000121316	"Phospholipase B domain containing 1"	Q6P4A8	12	14503661-14567883	"Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 288.7"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 187.7;Hofbauer cells: 105.6;Kupffer cells: 109.4;Macrophages: 116.3;monocytes: 192.8;Paneth cells: 105.9"	"Cancer enhanced"	"Detected in all"		"testis cancer: 113.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"classical monocyte: 662.9;intermediate monocyte: 204.4;myeloid DC: 357.3;neutrophil: 443.8"	"Group enriched"	"Detected in all"	135	"dendritic cells: 357.3;granulocytes: 443.8;monocytes: 662.9"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 48.6;BEWO: 98.4;CAPAN-2: 245.6;MCF7: 46.3"	"Not detected"	"Not detected"							HPA040303	Enhanced				"Intracellular and membrane"	NA	NA		3400000			"HPA040303: AB_2676922"	"unprognostic (9.13e-3)"	"unprognostic (5.77e-2)"	"unprognostic (2.29e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.30e-2)"	"prognostic unfavorable (2.81e-5)"	"unprognostic (4.80e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (1.66e-4)"	"unprognostic (1.12e-1)"	"unprognostic (3.03e-3)"	"unprognostic (3.47e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.99e-2)"	"unprognostic (5.44e-2)"	29.7	5.7	1.9	34.0	2.4	288.7	28.1	2.4	3.7	22.6	22.7	59.3	28.4	13.6	10.7	56.8	16.7	33.4	32.9	2.0	4.4	26.5	10.6	64.6	9.3	3.5	2.6	1.4	4.4	30.2	3.2	3.4	36.2	2.8	10.3	80.0	0.8	12.0	15.5	10.0	25.0	43.0	28.4	3.0	25.4	36.9	10.1	2.8	7.8	6.2	17.3	33.0	59.0	29.8	5.8	7.1	5.0	0.5	48.6	0.3	0.0	98.4	0.2	0.0	3.0	2.4	14.1	245.6	0.0	1.4	1.0	0.4	9.4	0.0	0.0	0.5	0.0	0.1	0.0	6.4	0.0	3.8	0.0	0.0	7.7	0.1	0.0	0.0	0.0	0.0	0.0	21.2	0.0	1.1	46.3	0.1	0.2	16.5	0.7	0.3	0.1	0.1	0.5	0.7	28.9	0.0	0.4	30.2	14.8	1.9	26.5	9.0	9.6	0.0	0.5	0.4	0.0	0.6	8.7	23.7	0.2	0.0	0.1	0.4	0.4	662.9	5.8	1.0	204.4	0.6	3.6	0.5	0.4	357.3	0.8	0.7	0.7	443.8	1.7	73.5	4.1	0.9	423.2	1.9	2.4	2.4	3.7	2.0	4.4	3.5	2.6	1.4	2.8	3.0	2.8	5.8	15.5	9.6	8.6	0.3	2.9	6.8	8.8	4.9	6.8	0.0	11.9	6.6	16.5	30.0	20.4	33.1	0.0	94.5	1.5	67.8	11.7	13.1	51.8	2.5	9.1	7.2	9.1	1.7	1.6	46.5	187.7	59.6	13.3	0.9	5.1	5.9	4.6	2.9	105.6	0.0	0.9	31.3	6.1	109.4	68.6	5.8	26.1	116.3	5.4	7.5	192.8	1.6	1.0	1.5	0.2	28.6	105.9	27.8	3.6	3.8	52.8	15.7	19.0	0.2	0.0	12.0	10.4	17.4	12.0	17.8	19.9	70.3	1.6	6.1	75.2	30.1
PLK5	"PLK5P, SgK384ps"	ENSG00000185988	"Polo like kinase 5 (inactive)"	Q496M5	19	1508023-1536046	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 14.5;cervix: 8.7;testis: 7.2"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 14.7;Leydig cells: 36.4;Muller glia cells: 9.4;Peritubular cells: 67.7"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.6"	"Region enhanced"	"Detected in many"		"cerebellum: 14.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"Daudi: 1.1"	"Region enhanced"	"Detected in all"		"cerebellum: 42.0"	"Group enriched"	"Detected in many"	5	"cerebellum: 36.9;cerebral cortex: 10.6;hippocampal formation: 13.9"	HPA035024	Enhanced					NA	NA					"HPA035024: AB_2674418"	"unprognostic (4.32e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.35e-1)"	"unprognostic (7.69e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.69e-1)"	"unprognostic (8.38e-2)"	"unprognostic (4.06e-2)"	"unprognostic (1.74e-1)"	"unprognostic (3.36e-2)"	"unprognostic (9.94e-3)"	"unprognostic (2.18e-3)"	"unprognostic (3.21e-1)"	"unprognostic (7.49e-2)"	"unprognostic (3.54e-2)"	"unprognostic (4.01e-4)"	0.1	0.2	4.4	0.0	1.7	0.4	0.5	14.5	4.1	8.7	1.6	0.3	0.1	3.0	2.1	0.6	2.5	0.0	0.1	6.5	0.5	0.1	0.1	0.0	0.1	1.5	1.9	1.8	0.5	0.1	0.1	0.8	0.0	7.3	0.9	0.0	0.6	0.2	1.0	0.2	0.3	0.2	1.0	0.2	0.0	0.1	7.2	1.1	0.0	0.1	0.0	0.0	0.1	3.7	0.8	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.1	0.3	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.4	0.0	0.2	0.1	0.2	0.0	0.1	0.0	0.1	0.3	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.1	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.6	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.9	0.2	0.1	0.2	0.1	0.0	4.4	1.7	14.5	4.1	6.5	0.5	1.5	1.9	1.8	7.3	0.2	1.1	0.8	0.3	0.0	0.0	14.7	0.0	0.1	0.1	0.0	0.6	2.7	0.9	0.8	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.6	0.1	0.0	0.0	2.4	0.0	0.0	1.3	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	4.0	36.4	0.4	1.8	0.0	0.0	9.4	0.0	1.0	0.3	0.0	0.0	67.7	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.4	0.1	1.9	0.4	0.1	0.1	0.0	0.1	0.0	0.1
PLPPR3	"FLJ11535, LPPR3, PRG-2, PRG2"	ENSG00000129951	"Phospholipid phosphatase related 3"	Q6T4P5	19	812488-821955	"Enzymes, Metabolic proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"bone marrow: 9.9;brain: 23.5;fallopian tube: 11.2"	"Cell type enriched"	"Detected in some"	7	"Endometrial ciliated cells: 37.2"	"Cancer enhanced"	"Detected in many"		"testis cancer: 4.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"NB-4: 61.8;THP-1: 128.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052293, HPA057034"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA052293: AB_2681787, HPA057034: AB_2683316"	"unprognostic (7.65e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.33e-2)"	"unprognostic (3.66e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.59e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.32e-1)"	"unprognostic (4.51e-4)"	"unprognostic (8.06e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.72e-12)"	"unprognostic (1.21e-2)"	"unprognostic (6.82e-2)"	"unprognostic (8.50e-2)"	"unprognostic (2.91e-1)"	0.0	0.0	19.2	0.2	16.7	9.9	2.2	0.0	21.3	0.3	0.0	0.1	0.0	0.2	0.0	0.0	11.2	0.1	0.0	15.7	8.4	0.0	0.0	2.3	0.1	5.9	7.4	23.5	0.3	0.0	0.2	0.4	0.0	6.0	0.3	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.7	0.2	0.1	3.2	9.5	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.3	1.5	12.2	0.0	0.0	0.0	6.9	0.2	0.1	0.0	0.0	0.7	0.1	0.1	8.4	0.1	0.1	0.3	2.3	0.0	0.0	0.0	5.2	0.0	1.6	0.0	0.5	4.4	0.2	1.5	0.0	0.0	0.0	0.0	0.0	0.1	12.0	0.3	0.0	1.1	0.0	61.8	9.5	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.3	15.5	0.3	0.0	0.0	6.3	5.4	128.9	0.1	0.2	0.2	0.3	0.1	0.2	0.5	0.2	0.0	10.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.2	16.7	0.0	21.3	15.7	8.4	5.9	7.4	23.5	6.0	0.7	9.5	7.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	3.7	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	37.2	0.6	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.4	0.0	1.2	0.0	0.0	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.9	0.1	5.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0
PNLDC1	"dJ195P10.2, FLJ40240"	ENSG00000146453	"PARN like, ribonuclease domain containing 1"	Q8NA58	6	159800249-159820704	"Enzymes, Predicted membrane proteins"	"Nonsense-mediated mRNA decay"	"Exonuclease, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 9.4;testis: 8.1"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 19.9;Late spermatids: 13.6;Spermatocytes: 14.3;Spermatogonia: 13.3"	"Cancer enhanced"	"Detected in many"		"testis cancer: 4.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA052026	Uncertain					NA	NA					"HPA052026: AB_2681699"	"unprognostic (1.58e-1)"	"unprognostic (3.88e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.39e-3)"	"unprognostic (8.47e-3)"	"unprognostic (3.55e-2)"	"unprognostic (2.04e-1)"	"unprognostic (4.24e-1)"	"unprognostic (1.01e-1)"	"unprognostic (5.37e-2)"	"unprognostic (4.19e-1)"	"unprognostic (9.98e-2)"	"unprognostic (2.69e-9)"	"unprognostic (1.14e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.24e-1)"	0.2	0.2	2.0	0.1	3.0	0.1	0.5	2.3	9.4	0.1	1.9	0.2	0.0	0.1	0.0	0.2	1.9	0.0	0.2	3.4	1.8	0.2	0.5	0.2	0.4	1.8	1.7	1.6	0.4	1.7	0.0	0.3	0.0	2.8	0.3	0.0	0.1	0.1	0.0	0.1	0.7	0.1	0.0	2.0	0.4	0.2	8.1	2.1	0.2	0.2	0.0	0.2	0.2	0.2	2.7	0.0	0.1	0.0	0.4	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.2	0.0	0.2	0.0	0.2	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.0	3.0	2.3	9.4	3.4	1.8	1.8	1.7	1.6	2.8	2.0	2.1	2.7	0.1	0.0	0.0	0.3	0.2	0.3	0.0	0.3	0.0	0.0	0.3	0.5	0.3	4.3	0.2	0.0	0.0	0.0	0.1	0.1	0.0	3.8	19.9	2.1	0.1	0.1	0.0	0.0	1.5	0.9	0.0	0.2	0.0	0.1	4.5	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.8	13.6	0.3	0.1	0.0	3.7	0.0	0.0	0.0	0.5	1.3	1.3	0.0	0.0	0.0	0.1	0.0	0.9	2.7	0.0	0.0	0.5	0.2	14.3	13.3	0.0	0.0	0.0	0.1	0.0	0.0	0.2
PPM1N	FLJ40125	ENSG00000213889	"Protein phosphatase, Mg2+/Mn2+ dependent 1N (putative)"	Q8N819	19	45488777-45502510	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in many"	8	"skeletal muscle: 215.3"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 123.1;Rod photoreceptor cells: 74.3"	"Cancer enhanced"	"Detected in many"		"testis cancer: 11.3"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	6	"non-classical monocyte: 142.4"	"Lineage enriched"	"Detected in all"	11	"monocytes: 142.4"	"Cell line enhanced"	"Detected in many"		"OE19: 24.1;RT4: 29.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA043577			Supported	Vesicles		NA	NA			Vesicles		"HPA043577: "	"unprognostic (2.38e-2)"	"unprognostic (1.11e-2)"	"unprognostic (8.53e-2)"	"unprognostic (6.59e-2)"	"unprognostic (4.71e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.98e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.45e-2)"	"unprognostic (9.27e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.11e-16)"	"unprognostic (3.42e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.86e-3)"	2.0	0.8	14.0	2.0	13.2	2.6	3.3	13.0	20.0	2.0	13.1	2.6	0.6	0.7	1.3	2.6	0.9	1.4	1.3	13.8	13.3	0.8	2.7	2.6	3.1	13.2	13.0	13.1	0.6	0.5	2.2	1.2	4.7	13.8	1.2	1.3	26.0	0.9	2.0	215.3	3.1	1.6	1.2	12.6	9.3	2.9	5.3	12.8	2.4	1.1	0.2	3.5	2.4	1.7	14.7	2.6	7.1	1.2	5.1	5.9	7.8	14.7	1.9	3.0	0.6	2.3	1.7	15.8	11.1	3.2	1.8	4.1	7.6	3.0	2.2	0.9	10.9	4.5	9.0	2.7	1.9	1.4	0.8	18.1	3.2	3.6	3.1	1.9	4.0	1.0	4.4	10.3	9.6	1.0	1.9	3.1	4.6	4.0	24.1	1.4	2.0	1.5	3.0	3.4	29.9	5.8	6.8	1.0	11.1	9.2	8.8	3.8	2.7	1.5	8.2	4.7	4.3	1.4	1.7	4.5	2.3	6.1	2.3	7.2	6.7	4.4	3.2	6.4	22.5	5.5	6.3	3.9	6.2	12.8	3.6	4.3	7.9	6.5	3.1	142.4	2.4	4.5	5.7	14.0	13.2	13.0	20.0	13.8	13.3	13.2	13.0	13.1	13.8	12.6	12.8	14.7	6.4	0.0	2.7	1.0	7.5	3.4	14.7	6.2	17.6	14.1	5.9	32.5	2.3	17.2	2.5	3.7	31.3	3.2	6.0	5.5	0.0	2.9	12.5	2.0	3.9	3.5	3.0	0.8	1.1	1.8	123.1	6.5	3.1	7.4	7.0	1.0	5.3	1.3	20.1	1.7	1.4	4.2	0.0	15.5	15.7	4.9	0.9	15.2	1.8	1.0	6.1	7.3	20.6	0.0	0.3	3.1	4.7	0.7	1.7	6.7	6.9	0.6	0.8	74.3	0.0	25.6	5.5	2.9	9.1	3.4	4.1	8.5	7.5	0.3	3.1	8.4
PPP1R17	"C7orf16, GSBS"	ENSG00000106341	"Protein phosphatase 1 regulatory subunit 17"	O96001	7	31687215-31708455	"Predicted intracellular proteins"		"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"brain: 19.1"	"Group enriched"	"Detected in some"	35	"Early spermatids: 42.9;Late spermatids: 112.7"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	4	"non-classical monocyte: 51.9"	"Lineage enriched"	"Detected in many"	21	"monocytes: 51.9"	"Group enriched"	"Detected in some"	180	"NTERA-2: 40.4;SCLC-21H: 124.1"	"Region enriched"	"Detected in many"	32	"cerebellum: 430.8"					"HPA047819, HPA073123"	Enhanced					NA	NA					"HPA047819: AB_2680166, HPA073123: AB_2732219"					"unprognostic (1.50e-1)"			"unprognostic (1.33e-1)"					"unprognostic (6.56e-2)"	"unprognostic (5.55e-2)"	"unprognostic (2.33e-1)"			0.2	4.6	7.9	0.2	1.8	0.3	0.0	18.0	1.6	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.1	0.2	6.8	0.0	0.0	0.5	0.0	1.1	10.1	0.6	0.0	0.0	0.0	2.6	0.0	7.3	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.8	19.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	40.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	124.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	11.7	0.0	0.0	0.0	0.0	2.4	0.3	0.0	0.0	0.1	0.0	51.9	0.0	0.0	0.8	7.9	1.8	18.0	1.6	0.2	6.8	1.1	10.1	0.6	7.3	0.2	19.1	0.8	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.9	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	112.7	0.3	2.2	0.0	0.0	0.9	0.0	1.0	0.5	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRND	"dJ1068H6.4, DOPPEL, DPL, PrPLP"	ENSG00000171864	"Prion like protein doppel"	Q9UKY0	20	4721909-4728460	"Predicted membrane proteins, Transporters"	Fertilization	Prion		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	12	"choroid plexus: 25.3;testis: 71.5"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 5.3;Endothelial cells: 17.7;Late spermatids: 11.2;Spermatocytes: 4.7"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.6"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA043373	Enhanced					NA	NA					"HPA043373: AB_2678450"	"unprognostic (1.69e-1)"	"unprognostic (3.66e-2)"	"unprognostic (2.24e-2)"	"unprognostic (8.46e-2)"	"unprognostic (3.40e-2)"	"unprognostic (3.47e-3)"	"unprognostic (3.01e-1)"	"unprognostic (6.41e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.10e-1)"	"unprognostic (5.85e-2)"	"unprognostic (2.02e-3)"	"unprognostic (6.11e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.63e-3)"	0.2	0.0	0.1	0.1	0.2	0.1	0.2	0.8	0.2	0.1	25.3	1.0	0.1	4.1	0.0	0.1	0.0	1.2	0.2	1.0	0.1	0.0	0.0	0.1	0.3	0.3	0.4	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.2	0.5	0.1	0.0	0.0	0.1	0.2	0.0	1.3	0.0	0.1	0.1	71.5	0.6	0.1	0.1	0.1	0.3	0.3	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.8	0.2	1.0	0.1	0.3	0.4	0.1	0.2	0.0	0.6	0.2	5.3	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.5	0.1	0.2	17.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	11.2	2.1	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.3	4.7	1.9	0.0	0.0	0.0	0.1	1.3	0.0	0.2
PRODH	"HSPOX2, PIG6, PRODH1, PRODH2, TP53I6"	ENSG00000100033	"Proline dehydrogenase 1"	O43272	22	18912777-18936553	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Proline metabolism"	Oxidoreductase	"Disease variant, Schizophrenia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 49.6;skin 1: 39.0"	"Cell type enriched"	"Detected in some"	7	"Astrocytes: 183.1"	"Cancer enhanced"	"Detected in many"		"testis cancer: 11.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"OE19: 91.3;RPTEC TERT1: 35.9"									HPA020361	Approved		Approved	Nucleoplasm,Vesicles,Mitochondria		NA	NA			Mitochondria	"Nucleoplasm, Vesicles"	"HPA020361: AB_10963116"	"unprognostic (2.46e-2)"	"prognostic favorable (1.54e-4)"	"unprognostic (1.40e-1)"	"unprognostic (3.70e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.49e-2)"	"unprognostic (6.56e-2)"	"unprognostic (3.12e-2)"	"unprognostic (1.61e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.34e-2)"	"unprognostic (3.94e-2)"	7.1	0.7	5.4	0.4	4.4	0.0	8.6	3.0	9.8	3.8	29.9	3.0	5.7	1.5	0.1	11.7	5.8	0.1	11.4	6.1	3.4	14.3	15.8	20.7	0.2	6.4	3.2	2.8	0.5	1.5	0.0	5.4	0.2	9.8	3.2	0.3	0.6	4.2	0.2	49.6	39.0	32.8	0.0	2.0	0.5	3.5	1.7	4.9	0.3	7.4	6.3	0.9	4.2	8.6	5.0	0.0	0.8	0.0	0.3	0.9	0.0	0.2	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.3	0.0	0.0	2.9	3.9	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	2.9	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.6	4.5	91.3	0.0	0.0	0.0	0.4	35.9	0.9	0.1	0.2	0.8	1.4	0.3	5.2	1.4	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.4	4.4	3.0	9.8	6.1	3.4	6.4	3.2	2.8	9.8	2.0	4.9	5.0	0.1	16.0	25.6	183.1	0.0	5.1	0.3	13.1	0.0	0.0	0.2	0.1	1.8	0.0	11.5	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.6	1.2	0.2	0.4	3.5	0.0	0.5	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	1.1	0.0	2.0	0.0	1.5	0.1	0.0	0.1	21.4	17.8	0.0	0.6	0.0	14.1	2.1	0.0	2.3	0.0	0.0	0.0	8.0	0.1	21.0	0.1	0.0	1.1	0.6	0.2	0.4	1.0	15.2	0.0	0.3	0.0	1.6	0.2
PROK1	"EGVEGF, PK1, PRK1"	ENSG00000143125	"Prokineticin 1"	P58294	1	110451149-110457358	"Predicted secreted proteins"	Angiogenesis	"Growth factor, Mitogen"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"ovary: 198.7;placenta: 50.6;testis: 59.6"	"Group enriched"	"Detected in some"	8	"Leydig cells: 173.1;Peritubular cells: 668.0"	"Cancer enhanced"	"Detected in many"		"testis cancer: 4.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	11	"ASC diff: 22.6"	"Region enriched"	"Detected in single"	11	"pons and medulla: 1.4"	"Low region specificity"	"Detected in many"								"Secreted to blood"	NA	NA						"unprognostic (2.66e-1)"	"unprognostic (2.71e-2)"		"unprognostic (1.30e-1)"	"unprognostic (1.42e-1)"		"unprognostic (1.37e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.86e-1)"	"unprognostic (6.80e-2)"	"unprognostic (1.24e-2)"	"unprognostic (3.74e-2)"	"unprognostic (7.39e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.38e-1)"	3.2	9.8	0.5	0.4	0.7	0.0	5.2	0.4	0.8	11.1	0.3	0.2	0.1	0.3	0.1	1.2	3.5	0.4	2.1	1.2	0.5	0.1	0.2	0.3	0.0	5.0	1.0	0.4	198.7	0.3	0.0	0.7	50.6	1.2	12.9	0.0	0.1	0.5	10.0	1.3	2.2	0.2	0.0	1.8	1.5	0.4	59.6	0.8	0.1	0.2	0.0	0.0	4.6	25.3	1.5	0.0	0.0	0.0	0.1	22.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.7	0.4	0.8	1.2	0.5	5.0	1.0	0.4	1.2	1.8	0.8	1.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	6.7	0.6	16.4	0.1	0.0	0.0	0.0	0.0	0.1	5.9	0.0	0.3	0.0	1.4	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	23.4	173.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	668.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	3.7	1.1	0.0	0.0	1.0	0.1	52.3	0.0	0.1
PRR20G		ENSG00000239620	"Proline rich 20G"	P0DPQ3	3	127283783-127288046	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	41	"testis: 4.1"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"testis cancer: 2.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA											"unprognostic (4.60e-3)"		"unprognostic (2.41e-3)"		"unprognostic (1.45e-1)"				"unprognostic (5.78e-2)"	"unprognostic (4.97e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRSS41	TESSP1	ENSG00000215148	"Serine protease 41"	Q7RTY9	16	2798470-2805304	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"testis: 1.3"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"testis cancer: 1.8"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	105	"eosinophil: 10.5"	"Lineage enriched"	"Detected in single"	105	"granulocytes: 10.5"	"Cell line enriched"	"Detected in single"	10	"BEWO: 1.8"					"Not detected"	"Not detected"									NA	NA								"unprognostic (1.58e-1)"	"unprognostic (3.65e-1)"		"unprognostic (3.04e-3)"				"unprognostic (1.03e-1)"	"unprognostic (1.71e-2)"			"unprognostic (1.69e-1)"	"unprognostic (1.98e-1)"		"unprognostic (1.24e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0
PRTG	"FLJ25756, IGDCC5"	ENSG00000166450	Protogenin	Q2VWP7	15	55611544-55743152	"Predicted intracellular proteins, Predicted membrane proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 10.5;thyroid gland: 10.8"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 191.8;Oligodendrocyte precursor cells: 51.8;Rod photoreceptor cells: 62.3"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	6	"AF22: 148.6;SuSa: 172.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA032138			Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA			Cytosol	"Vesicles, Plasma membrane"	"HPA032138: AB_10669675"	"unprognostic (2.80e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.32e-1)"	"unprognostic (4.64e-2)"	"unprognostic (2.07e-2)"	"unprognostic (4.96e-4)"	"unprognostic (1.82e-4)"	"unprognostic (1.31e-1)"	"unprognostic (3.19e-1)"	"unprognostic (4.76e-3)"	"unprognostic (1.37e-1)"	"unprognostic (5.32e-2)"	"unprognostic (5.67e-2)"	"unprognostic (2.42e-6)"	"unprognostic (8.81e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.70e-1)"	0.5	1.0	2.1	0.4	2.1	0.1	1.1	2.5	1.6	1.0	1.3	0.5	0.1	3.6	0.5	0.1	1.1	0.3	0.6	1.5	5.4	0.9	0.1	1.7	0.2	3.7	2.5	0.6	1.9	0.1	1.9	0.9	2.8	3.5	0.4	0.3	10.5	0.2	0.5	0.7	0.1	0.3	1.3	3.3	0.1	0.5	3.6	3.3	0.0	10.8	0.4	0.2	0.4	0.5	5.5	1.2	3.4	148.6	3.2	0.0	0.1	13.2	1.2	4.5	3.9	5.4	25.8	0.8	0.0	5.4	0.2	5.8	0.0	0.6	0.3	5.2	0.0	6.4	1.0	1.1	9.8	1.1	1.0	0.0	0.5	0.2	1.7	2.7	3.0	2.8	0.3	2.7	0.0	2.3	2.2	0.0	0.0	5.9	0.0	3.0	0.0	22.3	0.0	3.1	0.4	1.8	7.6	1.2	1.9	8.3	172.9	0.7	0.5	0.2	2.1	1.6	0.0	4.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.1	2.1	2.5	1.6	1.5	5.4	3.7	2.5	0.6	3.5	3.3	3.3	5.5	3.2	9.6	20.2	17.6	0.0	0.3	0.0	0.0	0.0	12.4	5.0	4.4	6.0	0.0	2.5	16.5	191.8	19.9	0.1	0.1	0.0	0.0	21.8	2.8	25.5	9.7	0.0	0.0	0.7	0.2	4.1	4.0	3.6	3.1	0.0	2.9	3.6	0.0	1.7	0.0	11.1	0.0	0.0	0.0	0.0	25.3	5.3	0.2	0.0	28.1	0.0	4.4	0.0	51.8	13.6	0.4	0.0	2.6	0.1	0.1	0.0	1.4	0.0	62.3	0.0	5.8	2.4	8.9	12.1	0.0	0.0	6.0	0.1	9.5	0.5	0.1
PSORS1C2	"C6orf17, SPR1"	ENSG00000204538	"Psoriasis susceptibility 1 candidate 2"	Q9UIG4	6	31137534-31139066	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	47	"skin 1: 166.8"	"Group enriched"	"Detected in some"	8	"Endometrial ciliated cells: 3.3;Glandular and luminal cells: 9.0;Melanocytes: 8.8;Suprabasal keratinocytes: 7.0"	"Cancer enhanced"	"Detected in many"		"testis cancer: 14.6;urothelial cancer: 20.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA061228	Enhanced				"Secreted in other tissues"	NA	NA					"HPA061228: AB_2684455"	"unprognostic (8.86e-2)"	"unprognostic (7.73e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.67e-2)"	"unprognostic (5.20e-3)"	"unprognostic (1.67e-1)"		"unprognostic (1.75e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.78e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.06e-1)"	"unprognostic (9.40e-5)"	"unprognostic (2.09e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.66e-1)"	1.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.3	0.0	0.2	0.0	3.5	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.1	166.8	0.4	0.0	0.0	0.0	0.4	1.8	0.0	0.0	0.3	0.0	0.2	0.2	2.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.8	0.0	0.0	0.8	0.4	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	7.0	0.0	0.0	0.1	0.0	0.5
PTCH2		ENSG00000117425	"Patched 2"	Q9Y6C5	1	44819844-44843253	"Cancer-related genes, Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Receptor	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"ovary: 24.8;parathyroid gland: 59.5;salivary gland: 75.8;testis: 25.8"	"Cell type enhanced"	"Detected in many"		"Leydig cells: 107.8;Peritubular cells: 68.1;Plasma cells: 67.1;Theca cells: 138.7"	"Cancer enhanced"	"Detected in many"		"testis cancer: 9.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/84: 11.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA046839			Supported	"Nucleoli,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoli	"HPA046839: "	"unprognostic (6.54e-5)"	"unprognostic (1.05e-1)"	"unprognostic (7.29e-3)"	"unprognostic (3.65e-3)"	"unprognostic (3.89e-1)"	"unprognostic (7.42e-3)"	"unprognostic (3.01e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.51e-1)"	"unprognostic (8.67e-2)"	"prognostic favorable (5.74e-5)"	"unprognostic (2.92e-1)"	"unprognostic (5.74e-6)"	"unprognostic (1.55e-2)"	"unprognostic (4.86e-2)"	"unprognostic (6.31e-2)"	"unprognostic (6.81e-2)"	3.0	3.2	6.2	0.9	3.9	9.5	3.5	6.2	6.9	4.8	3.1	2.9	1.0	6.5	1.7	0.9	4.4	2.5	1.3	3.6	3.5	1.3	1.3	1.0	2.3	3.2	4.5	4.4	24.8	1.0	59.5	9.9	0.3	5.3	3.0	0.9	3.6	75.8	1.3	2.0	3.2	1.8	1.2	1.8	2.5	2.0	25.8	4.5	0.8	4.7	0.8	0.7	3.1	3.4	5.2	0.2	0.3	1.0	2.5	0.8	0.9	1.0	0.8	1.6	0.5	0.4	0.2	0.4	1.1	0.4	0.4	0.5	0.0	1.1	0.0	0.2	2.1	1.9	0.6	1.0	0.8	0.3	0.7	1.1	0.3	0.4	1.0	0.1	1.7	0.1	1.0	0.7	1.1	0.0	0.5	1.4	2.1	0.3	0.1	0.4	1.0	0.2	0.5	0.2	0.0	1.5	0.6	0.3	0.4	0.8	0.5	0.2	1.2	0.1	0.2	0.5	1.3	0.5	1.9	11.6	3.2	0.6	3.0	0.4	2.5	1.9	0.1	0.5	0.9	1.0	1.0	0.6	0.6	1.2	1.4	0.7	0.6	0.6	0.9	0.9	3.6	0.3	0.2	6.2	3.9	6.2	6.9	3.6	3.5	3.2	4.5	4.4	5.3	1.8	4.5	5.2	2.8	0.0	1.1	14.0	13.4	0.5	0.7	1.0	0.6	0.8	4.8	8.0	1.0	7.2	1.0	1.8	2.1	2.4	6.8	7.8	0.0	5.5	2.3	9.3	13.5	2.7	11.5	1.3	23.7	1.8	1.6	14.3	28.1	8.5	0.0	4.4	0.7	7.9	6.7	8.4	27.3	4.9	2.0	24.5	2.2	8.0	107.8	17.3	0.0	5.6	3.9	2.4	2.1	9.5	2.6	2.1	2.5	68.1	67.1	0.8	13.6	0.2	1.7	1.2	13.1	5.4	5.6	5.0	3.6	0.6	1.6	2.3	7.5	138.7	5.5	0.2
RAB15		ENSG00000139998	"RAB15, member RAS oncogene family"	P59190	14	64945814-64973226	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 51.3;Inhibitory neurons: 28.0;Intestinal goblet cells: 35.2"	"Cancer enhanced"	"Detected in all"		"testis cancer: 83.1"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	5	"plasmacytoid DC: 1.9"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 1.9"	"Cell line enhanced"	"Detected in many"		"HAP1: 128.1;RH-30: 151.2;RT4: 116.1;SK-BR-3: 116.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041177	Uncertain		Approved	"Vesicles,Centriolar satellite"		NA	NA			"Vesicles, Centriolar satellite"		"HPA041177: AB_10794547"	"unprognostic (9.80e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.53e-1)"	"unprognostic (4.94e-2)"	"unprognostic (6.29e-2)"	"unprognostic (3.45e-1)"	"prognostic unfavorable (4.68e-4)"	"unprognostic (7.14e-2)"	"unprognostic (3.12e-1)"	"unprognostic (4.25e-2)"	"unprognostic (2.79e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.86e-2)"	"unprognostic (2.82e-2)"	2.8	5.0	31.1	6.3	36.1	0.8	8.5	30.0	45.1	7.3	15.4	13.7	12.8	4.2	5.6	4.3	4.7	6.2	32.1	39.9	28.6	19.2	21.4	10.0	3.8	23.2	23.3	36.7	2.2	12.7	39.7	9.6	16.3	26.3	11.0	20.4	5.9	36.8	4.6	10.1	6.1	13.2	11.9	18.1	2.8	11.0	1.7	29.7	7.8	6.8	1.2	3.0	18.1	5.1	34.4	10.9	57.0	20.3	20.3	4.5	6.4	57.6	6.7	9.3	13.5	11.8	26.8	28.4	0.6	3.9	16.5	6.2	10.9	128.1	1.3	9.5	3.6	6.2	12.3	1.1	23.5	0.6	0.6	7.5	4.4	2.5	5.9	1.2	3.5	42.6	29.2	0.4	2.0	23.9	61.8	15.2	11.3	45.8	65.6	8.2	18.5	151.2	1.0	15.8	116.1	65.4	12.7	3.4	116.7	15.0	23.6	33.2	11.8	11.2	11.5	49.0	5.5	8.7	0.6	0.4	5.8	2.4	0.3	8.6	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	1.9	0.1	0.0	31.1	36.1	30.0	45.1	39.9	28.6	23.2	23.3	36.7	26.3	18.1	29.7	34.4	1.7	6.4	3.9	5.9	0.8	2.5	3.2	1.3	0.6	2.9	12.4	7.4	22.2	4.3	4.2	16.5	0.0	24.7	5.0	5.5	3.9	7.9	0.5	6.6	2.8	3.7	1.2	0.0	51.3	12.2	16.0	2.0	2.6	13.6	1.3	4.1	4.6	8.7	2.7	11.8	28.0	35.2	0.0	0.3	1.3	1.1	0.3	0.9	0.0	4.7	1.0	2.0	1.0	10.6	4.9	13.0	5.5	1.5	0.2	5.6	2.9	5.9	1.3	2.9	0.0	2.4	5.2	0.9	0.4	1.6	1.1	17.9	1.5	1.5	12.0	14.1
RAB39A	RAB39	ENSG00000179331	"RAB39A, member RAS oncogene family"	Q14964	11	107928448-107963482	"Predicted intracellular proteins"	"Autophagy, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 6.5;lymphoid tissue: 3.0"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 4.2;Excitatory neurons: 5.2;Inhibitory neurons: 8.8;Microglial cells: 20.6;Spermatocytes: 6.4"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.8"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 2.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"GAMG: 11.6;NTERA-2: 8.6;RPMI-8226: 15.5;SCLC-21H: 27.8;SH-SY5Y: 17.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA042505	Uncertain					NA	NA					"HPA042505: AB_2678030"	"unprognostic (1.45e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.40e-2)"	"unprognostic (4.99e-1)"	"unprognostic (4.30e-2)"	"unprognostic (4.26e-3)"	"unprognostic (1.20e-1)"	"unprognostic (5.55e-2)"	"unprognostic (7.36e-2)"	"unprognostic (4.22e-3)"	"unprognostic (2.24e-2)"	"unprognostic (1.41e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.36e-1)"	"unprognostic (5.02e-2)"	"unprognostic (2.43e-1)"	0.7	0.9	3.0	3.0	1.7	0.6	0.3	3.2	3.7	0.2	0.2	0.5	0.5	0.2	0.0	0.3	0.2	0.8	0.2	5.0	3.5	0.6	0.6	0.9	2.1	3.4	1.9	1.1	0.2	0.3	0.2	0.4	1.2	3.7	0.2	0.8	1.1	0.2	0.1	0.0	0.3	0.7	0.7	3.0	3.0	0.6	0.8	3.9	2.6	0.3	0.1	1.4	0.9	0.0	6.5	0.0	1.8	7.3	0.1	0.0	0.0	0.9	0.1	0.0	0.8	0.6	0.0	0.0	0.4	0.1	0.0	11.6	0.0	7.4	0.0	0.1	0.0	0.9	0.1	0.1	0.0	0.0	0.5	6.7	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	8.6	0.0	0.2	0.0	4.0	15.5	0.1	0.0	27.8	17.1	0.0	0.0	0.4	1.6	0.4	3.0	0.0	0.1	1.9	0.0	1.3	0.1	4.3	0.0	0.4	1.7	4.1	0.1	1.4	0.0	0.0	2.2	0.0	0.8	0.0	0.0	1.0	0.5	0.0	0.0	0.1	0.0	1.6	0.1	0.0	0.4	3.0	1.7	3.2	3.7	5.0	3.5	3.4	1.9	1.1	3.7	3.0	3.9	6.5	0.0	0.0	1.1	0.7	0.8	0.0	0.0	0.0	0.0	0.7	0.1	0.1	0.1	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.2	1.8	0.0	5.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	8.8	0.0	0.0	4.1	3.7	0.8	0.0	4.1	0.0	20.6	1.8	0.0	0.0	4.0	0.5	0.1	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.1	6.4	2.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0
RAD51	"BRCC5, FANCR, HsRad51, HsT16930, RAD51A, RECA"	ENSG00000051180	"RAD51 recombinase"	Q06609	15	40694774-40732340	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"	DNA-binding	"Cancer-related genes, Disease variant, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 15.8;testis: 24.5"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 35.3;Extravillous trophoblasts: 67.2;Spermatocytes: 53.6;Spermatogonia: 24.8;Syncytiotrophoblasts: 25.3"	"Cancer enhanced"	"Detected in all"		"testis cancer: 19.9"	"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB010381, HPA039310"	Enhanced		Supported	"Nucleoli rim,Cytosol"		NA	Yes			"Nucleoli rim"	Cytosol	"CAB010381: AB_2253533, HPA039310: AB_2676434"	"prognostic unfavorable (7.94e-4)"	"unprognostic (7.20e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.72e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (9.33e-4)"	"unprognostic (3.40e-3)"	"unprognostic (2.53e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.41e-3)"	"unprognostic (2.53e-3)"	"unprognostic (0.00e+0)"	"unprognostic (2.26e-2)"	"unprognostic (2.34e-1)"	"unprognostic (9.59e-2)"	"unprognostic (1.94e-2)"	0.9	0.6	0.4	5.6	0.5	10.6	2.0	1.6	0.8	0.8	0.5	8.4	3.3	1.2	0.4	4.2	0.7	1.3	0.6	0.4	0.3	0.5	1.3	1.2	11.1	0.4	0.4	0.5	0.6	1.4	0.5	0.2	6.9	0.7	0.8	9.1	0.3	1.0	0.3	1.0	3.1	4.1	2.4	0.2	2.4	1.8	24.5	0.3	15.8	0.6	0.5	13.4	1.8	1.5	0.5	33.8	16.1	33.4	16.3	4.4	7.8	31.1	54.9	16.5	43.3	43.8	35.4	22.1	20.4	26.8	20.9	18.9	67.7	56.6	22.1	42.3	39.0	22.2	47.7	28.2	30.4	0.4	37.9	28.5	1.7	2.9	30.0	13.5	6.4	22.5	48.5	59.6	55.8	36.6	28.5	54.4	43.6	35.2	69.2	19.0	61.0	49.0	30.7	15.4	45.3	15.4	27.0	23.6	41.4	8.5	39.2	27.0	39.4	9.9	32.8	22.2	48.7	27.2	12.0	65.1	59.8	16.3	78.0	33.5	1.3	0.6	1.7	2.4	1.3	0.6	1.7	2.5	3.2	1.0	1.1	0.6	1.2	1.2	1.8	1.4	0.9	5.9	1.2	0.4	0.5	1.6	0.8	0.4	0.3	0.4	0.4	0.5	0.7	0.2	0.3	0.5	0.0	0.0	0.0	0.3	1.9	3.6	1.5	2.0	0.0	0.8	0.1	0.0	0.9	0.0	1.0	0.0	0.0	35.3	1.4	3.0	0.0	0.0	5.7	0.2	0.2	1.0	0.0	16.0	1.6	0.0	67.2	1.3	2.0	0.2	0.0	0.6	2.2	0.2	12.7	0.0	1.2	5.3	2.0	1.6	1.7	5.3	0.6	0.5	0.0	1.0	0.3	0.3	2.1	0.5	0.6	0.1	5.0	0.7	8.2	0.9	1.0	0.0	0.1	0.0	0.0	0.5	0.9	53.6	24.8	3.9	1.6	25.3	1.2	0.1	8.0	2.1
RASGRP2	CALDAG-GEFI	ENSG00000068831	"RAS guanyl releasing protein 2"	Q7LDG7	11	64726911-64745456	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"Guanine-nucleotide releasing factor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 148.5;lymphoid tissue: 141.6"	"Cell type enhanced"	"Detected in many"		"B-cells: 125.5;dendritic cells: 86.1;Kupffer cells: 77.3;Macrophages: 72.2;NK-cells: 98.9;Sertoli cells: 131.5"	"Cancer enhanced"	"Detected in many"		"testis cancer: 5.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 103.4;HL-60: 192.8;NB-4: 347.1;REH: 105.0;THP-1: 108.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015635, HPA015667"	Approved		Supported	"Plasma membrane"		NA	NA		1900000	"Plasma membrane"		"HPA015635: , HPA015667: AB_1856090"	"unprognostic (5.96e-2)"	"unprognostic (3.24e-3)"	"unprognostic (5.55e-2)"	"unprognostic (1.50e-2)"	"unprognostic (3.52e-2)"	"unprognostic (4.74e-5)"	"unprognostic (1.11e-2)"	"unprognostic (7.36e-3)"	"unprognostic (2.02e-1)"	"unprognostic (3.33e-1)"	"unprognostic (4.91e-3)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (1.38e-4)"	"unprognostic (1.08e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.23e-1)"	22.5	10.2	15.2	53.3	29.5	148.5	16.9	9.5	21.5	19.3	7.9	30.8	6.7	28.5	4.6	9.2	29.5	8.8	49.4	12.7	13.5	15.7	10.2	29.7	106.8	13.2	15.4	10.7	9.1	4.1	1.0	5.5	11.0	17.6	23.4	5.4	1.3	4.7	18.8	12.3	5.6	87.1	15.2	8.7	141.6	17.6	12.0	23.0	34.9	10.7	10.3	62.5	26.9	15.6	11.4	0.1	0.1	3.0	0.1	0.0	0.3	8.7	1.3	0.2	1.2	0.8	1.5	0.2	62.8	2.7	0.2	0.8	0.7	5.4	0.9	0.3	0.3	1.7	103.4	0.0	0.4	0.3	192.8	35.9	0.0	0.0	0.5	0.0	0.0	0.1	25.9	4.1	1.1	0.0	1.4	45.4	347.1	2.5	0.4	0.0	105.0	0.2	4.4	0.0	0.0	0.5	2.3	0.1	0.1	0.0	2.2	0.6	108.5	0.6	0.0	2.0	1.5	0.1	0.5	0.1	58.9	0.0	58.2	0.0	64.4	34.1	59.9	70.4	88.0	37.3	170.7	72.9	57.2	34.5	100.2	92.7	83.1	70.9	55.3	105.8	85.9	93.8	67.5	15.2	29.5	9.5	21.5	12.7	13.5	13.2	15.4	10.7	17.6	8.7	23.0	11.4	27.4	3.2	1.8	2.6	125.5	2.3	0.1	0.0	0.0	2.6	1.6	3.7	53.1	2.8	0.0	0.0	0.0	1.7	86.1	0.1	0.0	0.0	6.6	1.9	27.1	13.5	0.0	24.2	6.0	0.0	1.3	6.6	2.6	1.2	3.8	5.7	31.4	1.7	6.1	0.0	12.2	0.1	0.0	77.3	19.7	19.5	18.0	72.2	0.0	6.5	55.8	0.7	98.9	2.5	0.9	0.0	0.0	47.8	28.6	0.1	0.4	0.9	0.7	2.5	131.5	5.4	56.8	18.0	43.9	0.9	1.3	11.8	61.0	0.8	0.3	0.2
RASGRP4		ENSG00000171777	"RAS guanyl releasing protein 4"	Q8TDF6	19	38409051-38426305	"Predicted intracellular proteins, RAS pathway related proteins"	Differentiation	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 21.0;lymphoid tissue: 8.9"	"Group enriched"	"Detected in some"	11	"Cardiomyocytes: 18.1;granulocytes: 26.6;Hofbauer cells: 15.1;Kupffer cells: 32.9;Langerhans cells: 11.6;Macrophages: 19.1;monocytes: 25.7"	"Cancer enhanced"	"Detected in many"		"testis cancer: 3.2"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 39.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEL: 25.7;HMC-1: 24.0;U-937: 6.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA041929			Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA041929: AB_10961405"	"unprognostic (1.22e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.39e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.00e-1)"	"unprognostic (5.23e-4)"	"unprognostic (6.54e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.30e-3)"	"unprognostic (2.19e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.56e-1)"	"unprognostic (2.66e-2)"	3.2	0.8	0.3	6.7	0.5	21.0	0.7	0.3	0.9	1.1	0.7	1.2	1.2	0.5	0.1	1.1	1.0	1.9	0.6	0.3	0.7	0.3	0.7	3.4	1.1	0.7	0.4	0.1	0.4	1.1	0.3	0.2	2.3	0.6	0.5	0.8	0.0	0.4	0.5	0.9	0.5	1.8	2.1	0.6	8.9	0.9	0.2	0.8	1.1	0.2	1.4	0.7	2.5	0.4	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	25.7	0.0	0.0	0.0	0.1	24.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	12.5	13.5	20.1	0.0	15.4	0.0	0.1	0.3	0.0	9.4	0.1	0.0	0.0	39.4	0.0	17.9	0.7	1.4	4.4	0.3	0.5	0.3	0.9	0.3	0.7	0.7	0.4	0.1	0.6	0.6	0.8	0.9	0.2	0.0	0.6	0.0	0.2	0.8	0.0	0.0	0.0	0.1	0.0	0.3	18.1	0.0	1.3	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.8	0.7	0.0	0.2	0.4	0.0	0.0	26.6	0.0	1.4	0.0	15.1	0.0	0.4	0.0	0.0	32.9	11.6	0.0	0.0	19.1	1.8	0.0	25.7	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.7	0.0	0.4	0.4	0.0	0.1	0.0	0.0	0.3	1.5	0.0	0.0	0.1
RASL10B	"RRP17, VTS58635"	ENSG00000270885	"RAS like family 10 member B"	Q96S79	17	35731639-35743521	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.9;skeletal muscle: 31.8"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 13.8;Early spermatids: 10.4;Late spermatids: 34.6;Muller glia cells: 29.0"	"Cancer enhanced"	"Detected in many"		"testis cancer: 14.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HAP1: 24.3;HHSteC: 26.7;NTERA-2: 41.3;REH: 20.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046842, HPA057092"	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"HPA046842: AB_2679835, HPA057092: AB_2683332"	"unprognostic (5.78e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.36e-2)"	"prognostic unfavorable (6.38e-6)"	"unprognostic (8.60e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.69e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.97e-2)"	"unprognostic (7.13e-2)"	"unprognostic (2.61e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.71e-6)"	"unprognostic (2.41e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.32e-2)"	"unprognostic (9.60e-3)"	15.5	1.7	24.7	0.1	26.9	0.0	11.4	9.2	25.8	3.7	6.7	1.5	0.7	2.9	0.6	0.4	3.9	0.7	16.6	26.8	15.9	1.8	2.1	1.2	0.1	19.4	18.7	18.5	3.7	5.0	5.3	6.7	2.9	18.4	3.0	0.1	9.1	9.2	14.8	31.8	0.7	1.2	0.8	11.4	0.3	1.8	3.0	17.3	0.5	1.7	0.9	0.1	1.4	2.3	14.4	0.0	0.3	6.3	0.0	1.1	0.6	1.8	1.2	0.8	4.3	3.6	8.1	0.0	0.0	0.7	0.2	0.0	0.0	24.3	0.0	1.5	0.0	8.0	0.0	4.1	9.3	26.7	0.0	0.0	19.5	1.5	1.5	0.0	3.4	0.0	13.2	5.5	0.0	0.3	0.5	11.6	0.0	41.3	0.0	0.0	20.8	11.1	18.5	0.0	0.0	18.3	17.8	1.2	0.4	1.7	17.8	2.3	1.2	0.0	2.0	14.5	0.1	0.5	0.0	0.0	5.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.7	26.9	9.2	25.8	26.8	15.9	19.4	18.7	18.5	18.4	11.4	17.3	14.4	0.3	0.0	0.5	0.3	0.0	0.1	0.5	0.0	0.0	3.9	2.7	1.4	13.8	4.3	0.0	1.8	2.1	0.0	0.0	0.0	0.0	1.3	10.4	1.0	0.7	0.7	0.0	0.0	2.6	0.0	0.0	1.9	0.0	1.4	0.0	2.8	0.0	6.7	0.2	6.7	4.9	0.2	0.0	0.6	0.0	34.6	2.1	0.1	0.0	1.0	0.0	29.0	0.0	0.5	0.5	0.3	0.0	3.0	0.0	0.6	0.4	0.1	0.0	1.2	0.0	1.5	2.3	4.8	0.9	0.0	0.0	0.3	0.1	7.0	0.4	0.2
RBM24	"dJ259A10.1, FLJ30829, RNPC6"	ENSG00000112183	"RNA binding motif protein 24"	Q9BX46	6	17281361-17293871	"Predicted intracellular proteins"	"Differentiation, mRNA processing, mRNA splicing, Translation regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"heart muscle: 143.4;skeletal muscle: 316.0;tongue: 106.6"	"Cell type enriched"	"Detected in many"	5	"Cardiomyocytes: 193.2"	"Cancer enhanced"	"Detected in many"		"testis cancer: 5.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 58.7;RH-30: 59.7;T-47d: 28.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA066927, HPA067231"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA066927: AB_2685750, HPA067231: AB_2685808"	"unprognostic (9.05e-3)"	"unprognostic (2.57e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.67e-3)"	"unprognostic (1.53e-1)"	"unprognostic (4.54e-4)"	"unprognostic (3.34e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.97e-3)"	"unprognostic (3.38e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.33e-4)"	4.3	0.5	4.4	1.8	5.0	0.1	3.8	0.6	6.1	12.4	2.7	6.8	1.6	31.5	16.9	7.4	24.2	2.7	143.4	4.6	5.0	0.7	1.2	1.3	0.5	3.0	1.7	5.0	2.2	0.2	2.1	5.6	0.6	1.5	10.0	7.5	0.4	4.1	5.8	316.0	1.2	3.7	29.5	1.4	1.2	2.2	4.2	2.8	0.8	2.1	106.6	0.3	8.8	3.6	3.0	1.5	9.3	12.0	0.0	0.0	0.0	0.0	18.7	6.8	12.4	13.0	0.0	1.1	0.0	5.7	13.4	19.5	0.0	11.5	0.4	22.3	0.0	0.4	0.0	1.0	6.4	0.5	0.0	1.1	6.4	0.0	2.4	0.5	15.8	1.6	0.0	0.0	0.0	58.7	2.8	0.0	0.2	4.1	0.0	1.4	0.1	59.7	0.0	0.0	0.0	7.8	0.9	0.2	0.0	0.2	9.3	28.2	0.4	0.0	4.2	10.0	0.0	16.2	0.0	0.0	0.1	0.3	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	5.0	0.6	6.1	4.6	5.0	3.0	1.7	5.0	1.5	1.4	2.8	3.0	1.1	0.0	0.0	0.0	0.0	1.1	0.2	1.1	0.0	2.3	3.2	0.8	193.2	0.0	1.8	0.0	0.0	0.1	0.1	4.3	0.0	0.0	0.6	33.5	13.6	1.5	4.8	0.0	11.6	0.0	13.4	6.4	0.0	9.9	1.3	0.5	0.4	0.0	0.3	1.7	6.6	4.5	0.0	0.0	0.7	1.9	0.0	0.3	1.8	1.9	0.0	0.7	0.0	0.5	0.4	0.3	2.2	0.7	0.0	0.3	0.0	0.6	21.9	0.0	6.6	23.9	19.7	0.4	7.3	0.2	1.0	0.8	0.5	0.0	3.0	0.1
RD3	"C1orf36, LCA12"	ENSG00000198570	"Retinal degeneration 3, GUCY2D regulator"	Q7Z3Z2	1	211476522-211492162	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Sensory transduction, Vision"		"Leber congenital amaurosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	31	"retina: 47.6"	"Group enriched"	"Detected in some"	10	"Bipolar cells: 82.7;Cone photoreceptor cells: 100.1;Rod photoreceptor cells: 66.4"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.7"	"Region enhanced"	"Detected in single"		"midbrain: 1.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 4.6;HMC-1: 14.4;SH-SY5Y: 21.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA029941, HPA029943"	Enhanced					NA	NA					"HPA029941: AB_2732449, HPA029943: AB_2732450"	"unprognostic (1.42e-1)"	"unprognostic (2.75e-2)"		"unprognostic (1.14e-2)"		"unprognostic (6.07e-2)"		"unprognostic (2.96e-2)"		"unprognostic (2.18e-1)"	"unprognostic (9.54e-2)"	"unprognostic (7.87e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.80e-2)"	"unprognostic (4.58e-2)"		"unprognostic (2.86e-2)"	0.0	0.7	0.1	0.0	0.2	0.2	0.0	0.5	0.3	0.2	0.7	0.0	0.1	0.1	0.7	0.1	0.0	0.1	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	1.5	0.2	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	47.6	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.1	14.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.7	21.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.5	0.3	0.2	0.5	0.0	1.5	0.2	0.2	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	82.7	0.0	0.0	0.5	0.0	0.0	0.0	100.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	66.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1
RESF1	"C12orf35, FLJ10652, FLJ20696, GET, KIAA1551, UTA2-1"	ENSG00000174718	"Retroelement silencing factor 1"	Q9HCM1	12	31959370-31993107	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 74.6"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 35.8;B-cells: 43.7;dendritic cells: 88.1;Hofbauer cells: 34.1;Plasma cells: 66.6;T-cells: 21.5"	"Cancer enhanced"	"Detected in all"		"testis cancer: 65.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 212.8"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 212.8"	"Cell line enhanced"	"Detected in all"		"SuSa: 112.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013816, HPA015622"	Approved		Supported	"Nucleoli,Nucleoli rim,Intermediate filaments,Cytosol"		NA	NA			"Nucleoli, Nucleoli rim"	"Intermediate filaments, Cytosol"	"HPA013816: AB_1848661, HPA015622: AB_1848663"	"unprognostic (7.97e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.76e-1)"	"unprognostic (8.49e-2)"	"unprognostic (3.21e-1)"	"unprognostic (3.09e-3)"	"unprognostic (2.24e-1)"	"unprognostic (2.19e-1)"	"unprognostic (8.87e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.90e-2)"	"prognostic unfavorable (5.04e-9)"	"unprognostic (3.83e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.61e-1)"	"unprognostic (7.26e-3)"	14.4	7.1	2.6	51.2	3.2	22.0	14.0	7.5	9.9	29.2	3.5	14.1	24.0	23.4	9.1	10.7	38.4	19.4	8.2	2.0	3.0	9.2	25.1	17.2	70.7	3.5	2.5	1.2	74.6	6.8	9.9	4.0	38.2	5.1	9.3	13.9	7.1	8.3	11.3	4.1	9.2	27.6	16.2	2.9	45.7	20.7	13.3	3.6	61.2	12.7	12.0	63.1	17.9	8.7	5.2	7.6	13.3	22.5	8.6	10.1	12.0	33.6	9.1	9.0	6.0	6.9	50.6	48.9	36.4	21.9	7.6	21.5	9.6	31.3	6.0	8.4	27.1	4.4	51.1	6.7	6.7	19.7	37.0	79.2	6.5	9.0	7.1	11.6	25.4	50.3	24.0	29.5	56.1	6.8	3.7	52.6	15.6	48.3	28.4	5.5	24.1	21.4	16.0	6.3	14.0	9.0	8.1	11.7	6.0	6.0	112.9	20.8	40.5	32.0	6.7	10.4	11.5	9.6	33.9	38.1	44.8	3.6	20.6	7.4	55.5	14.7	15.4	42.2	16.1	40.3	33.6	38.0	40.7	12.3	26.8	44.1	43.8	212.8	30.6	18.1	7.7	38.9	20.4	2.6	3.2	7.5	9.9	2.0	3.0	3.5	2.5	1.2	5.1	2.9	3.6	5.2	35.8	0.0	0.0	0.0	43.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.3	0.0	0.0	0.0	0.0	15.0	88.1	0.0	0.0	0.0	0.0	0.0	0.0	12.8	0.0	0.0	0.0	0.0	2.2	7.4	0.0	0.0	0.0	0.0	0.0	0.0	34.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	66.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	0.0	0.0	5.1	21.5	0.0	0.0	0.0
RHOXF2	"CT107, PEPP-2, PEPP2, THG1"	ENSG00000131721	"Rhox homeobox family member 2"	Q9BQY4	X	120158613-120165630	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"testis: 11.1"	"Group enriched"	"Detected in some"	22	"Spermatocytes: 6.6;Spermatogonia: 7.1"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.8"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"K-562: 100.5;NB-4: 69.9;THP-1: 27.9;U-266/84: 47.2"									"HPA003314, CAB020794"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"CAB020794: , HPA003314: AB_1855193"					"unprognostic (1.60e-1)"										"unprognostic (5.04e-2)"			0.0	0.0	0.5	0.0	0.2	0.0	0.0	2.1	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.3	0.1	0.0	11.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	12.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	100.5	0.0	0.0	0.0	0.0	69.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.9	0.5	0.0	0.0	0.0	0.0	0.0	47.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.5	0.2	2.1	0.5	0.1	0.4	0.6	0.5	0.0	1.1	0.3	0.5	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RIMKLB	"FAM80B, KIAA1238, NAAGS, NAAGS-I"	ENSG00000166532	"Ribosomal modification protein rimK like family member B"	Q9ULI2	12	8681600-8783095	"Enzymes, Predicted intracellular proteins"		Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 184.2;Endometrial ciliated cells: 191.3;Glandular and luminal cells: 1012.9;Late spermatids: 300.3"	"Cancer enhanced"	"Detected in many"		"testis cancer: 17.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-698: 145.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059552			Approved	"Nucleoplasm,Centriolar satellite"		NA	NA			"Nucleoplasm, Centriolar satellite"		"HPA059552: "	"unprognostic (5.29e-3)"	"unprognostic (2.26e-2)"	"unprognostic (1.89e-5)"	"unprognostic (2.40e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.35e-2)"	"unprognostic (6.56e-2)"	"unprognostic (8.52e-2)"	"unprognostic (8.67e-3)"	"unprognostic (1.76e-1)"	"unprognostic (3.25e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.16e-2)"	"unprognostic (3.02e-1)"	"unprognostic (3.74e-1)"	"unprognostic (3.99e-1)"	25.1	11.0	25.4	8.1	21.9	21.2	24.3	23.1	18.7	28.8	19.2	22.4	5.4	40.5	16.1	11.2	29.7	15.0	12.8	20.3	29.6	11.7	3.2	19.6	9.2	26.1	22.6	15.7	30.3	8.2	22.4	12.9	24.7	21.7	14.3	7.1	19.3	11.9	14.2	13.8	12.6	12.9	27.8	26.9	13.6	11.1	32.7	22.0	13.8	20.1	9.5	7.1	15.5	21.9	19.7	3.7	18.1	43.5	44.9	5.7	5.4	63.0	19.6	8.8	16.1	10.5	1.5	20.6	27.9	16.2	11.7	17.9	6.3	21.5	23.9	17.1	0.5	13.9	13.3	52.4	0.2	6.6	4.1	13.3	11.7	10.4	14.4	24.2	10.1	21.0	22.9	18.0	0.0	9.4	11.8	27.0	2.0	53.2	0.0	1.0	42.0	60.5	0.1	22.8	10.2	1.4	28.2	17.5	24.9	19.4	70.9	6.0	13.4	41.2	15.7	51.0	8.6	6.4	0.2	0.0	145.9	13.3	2.9	10.9	2.1	1.2	0.3	0.8	0.3	1.0	0.7	0.8	1.3	0.5	1.3	1.4	0.5	0.1	1.2	0.5	0.4	0.0	1.0	25.4	21.9	23.1	18.7	20.3	29.6	26.1	22.6	15.7	21.7	26.9	22.0	19.7	69.8	28.9	42.9	99.6	13.3	15.2	23.3	16.6	27.9	25.5	10.9	11.4	15.6	7.2	25.7	12.9	0.0	61.0	4.2	1.0	15.6	12.8	184.2	191.3	99.5	38.5	9.0	30.9	33.0	3.0	18.6	27.3	4.1	1012.9	12.0	72.3	22.9	0.0	19.9	13.5	52.7	2.1	16.2	8.8	8.0	300.3	23.3	12.4	33.8	41.2	2.0	34.2	5.2	78.9	9.5	5.8	3.7	30.9	3.8	23.4	6.7	9.1	33.9	3.6	13.1	15.6	29.6	77.1	38.3	17.8	13.4	136.5	11.0	27.7	1.5	21.5
RNF125	FLJ20456	ENSG00000101695	"Ring finger protein 125"	Q96EQ8	18	32018825-32073219	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Adaptive immunity, Immunity, Ubl conjugation pathway"	Transferase	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 18.5"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 169.6;Early spermatids: 90.7;NK-cells: 160.6;Oligodendrocytes: 64.3;T-cells: 114.8"	"Cancer enhanced"	"Detected in all"		"testis cancer: 8.6"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 51.5;SK-MEL-30: 13.2;U-937: 11.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041514	Uncertain		Supported	"Nucleoli,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoli	"HPA041514: AB_10795596"	"unprognostic (2.13e-2)"	"unprognostic (2.05e-2)"	"unprognostic (2.88e-1)"	"unprognostic (3.93e-1)"	"unprognostic (5.03e-1)"	"unprognostic (4.50e-2)"	"unprognostic (2.30e-3)"	"unprognostic (6.15e-2)"	"unprognostic (4.21e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.68e-1)"	"unprognostic (4.35e-2)"	"prognostic unfavorable (4.06e-4)"	"unprognostic (2.99e-1)"	"unprognostic (4.12e-1)"	"unprognostic (1.82e-1)"	"unprognostic (7.07e-3)"	10.3	1.3	2.0	5.3	3.5	18.5	6.3	2.7	2.8	4.0	1.9	5.1	10.6	2.9	0.5	2.5	3.4	3.3	2.0	2.0	2.8	1.0	12.6	4.7	7.0	3.5	3.4	1.7	1.4	3.1	1.7	0.3	3.7	3.6	1.8	6.5	0.3	2.2	1.4	2.3	4.9	11.4	3.4	2.8	5.9	3.5	1.0	2.9	5.4	1.4	3.0	4.1	3.0	1.7	6.4	1.2	0.1	0.2	0.4	0.5	0.8	1.0	0.1	0.0	0.0	0.0	0.1	2.5	0.1	1.2	0.1	0.4	0.9	1.6	1.2	0.2	6.6	2.6	0.3	0.4	0.3	0.1	8.9	51.5	1.6	2.4	0.0	2.8	0.3	0.4	2.7	0.1	1.9	0.1	2.0	2.3	8.2	4.2	8.9	1.5	9.2	0.6	0.2	0.5	0.5	0.9	0.3	0.2	0.1	13.2	1.6	1.3	4.2	0.2	0.1	0.7	0.1	0.1	5.9	0.2	0.1	0.6	11.5	6.9	13.3	4.5	4.5	15.0	2.5	9.9	2.5	12.0	12.8	4.2	2.3	9.5	12.3	1.9	15.5	2.8	4.3	13.7	6.9	2.0	3.5	2.7	2.8	2.0	2.8	3.5	3.4	1.7	3.6	2.8	2.9	6.4	62.2	3.2	5.8	3.3	16.3	9.8	3.1	1.0	14.2	0.8	5.3	3.7	2.1	4.3	3.8	12.9	0.0	0.4	169.6	24.6	1.9	1.0	90.7	4.9	2.1	28.4	1.2	15.8	2.7	1.8	0.1	5.3	8.6	13.4	18.9	0.2	12.5	25.1	10.5	0.0	3.0	8.3	0.0	19.2	12.6	17.4	2.8	18.4	1.8	30.9	23.8	0.7	160.6	3.5	64.3	1.1	4.5	0.0	49.9	2.7	41.4	4.5	1.7	0.9	0.0	3.2	3.2	0.5	1.8	5.8	6.8	0.8	114.8	0.2	14.7	2.4
RPRML	MGC43894	ENSG00000179673	"Reprimo like"	Q8N4K4	17	46978156-46979253	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	7	"brain: 12.0"	"Group enriched"	"Detected in some"	6	"Enteroendocrine cells: 31.8;Excitatory neurons: 17.4"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"Daudi: 12.4;HEK 293: 3.8"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"basal ganglia: 90.0"	HPA062668	Uncertain					NA	NA					"HPA062668: AB_2684827"			"unprognostic (7.79e-4)"		"unprognostic (1.66e-2)"		"unprognostic (8.35e-2)"	"unprognostic (2.42e-2)"		"unprognostic (2.31e-1)"	"unprognostic (8.93e-4)"	"unprognostic (2.78e-2)"		"unprognostic (1.00e-1)"	"unprognostic (1.65e-1)"			0.1	0.0	2.4	0.0	12.0	0.0	0.3	0.1	7.3	0.1	0.0	0.2	0.0	0.0	0.6	0.3	0.2	0.0	0.4	6.6	5.2	0.0	0.0	0.1	0.0	1.8	0.7	6.7	0.0	0.2	0.0	0.4	0.0	2.4	0.1	0.0	0.0	0.2	0.0	1.3	1.6	0.2	0.0	0.0	0.0	0.3	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.2	4.9	0.0	0.1	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.1	0.0	1.8	0.0	0.5	0.7	0.2	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	12.0	0.1	7.3	6.6	5.2	1.8	0.7	6.7	2.4	0.0	1.2	4.9	2.2	0.0	0.0	1.6	0.4	0.4	0.0	0.0	0.0	2.5	0.5	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	1.2	31.8	0.0	17.4	3.9	0.1	0.1	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	1.3	2.3	0.0	0.0	0.5	0.0	0.3	0.0	1.8	1.0	0.0	0.0	0.0	1.0	1.4	0.2	0.1	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.8	0.3	0.0	0.1	0.5	1.1	0.0	0.0	0.0	0.3	0.0
SCML2		ENSG00000102098	"Scm polycomb group protein like 2"	Q9UQR0	X	18239313-18354688	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 11.7"	"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 15.3;Oligodendrocyte precursor cells: 17.1;Spermatocytes: 26.3;Spermatogonia: 27.5"	"Cancer enhanced"	"Detected in many"		"testis cancer: 4.1"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	6	"plasmacytoid DC: 3.8"	"Lineage enriched"	"Detected in single"	6	"dendritic cells: 3.8"	"Cell line enhanced"	"Detected in many"		"NTERA-2: 39.7;REH: 37.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA001662, HPA064713"	Enhanced		Approved	Nucleoli,Cytosol		NA	NA			"Nucleoli, Cytosol"		"HPA001662: AB_1079879, HPA064713: AB_2685333"	"unprognostic (5.15e-2)"	"unprognostic (2.57e-2)"	"unprognostic (7.93e-2)"	"unprognostic (7.26e-5)"	"unprognostic (1.24e-1)"	"unprognostic (2.24e-2)"	"unprognostic (4.95e-5)"	"unprognostic (2.33e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.15e-4)"	"unprognostic (1.83e-1)"	"unprognostic (2.35e-4)"	"unprognostic (3.30e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.97e-2)"	"unprognostic (3.31e-3)"	1.4	4.0	1.2	1.2	1.2	6.4	2.0	1.5	1.5	2.2	1.1	1.6	1.1	2.6	1.1	1.0	1.5	0.7	0.7	1.2	1.1	0.7	1.4	0.5	1.1	1.2	1.1	1.0	6.1	1.3	1.7	1.5	1.9	1.3	1.2	1.3	3.5	8.9	1.1	1.3	2.0	0.9	2.5	1.0	1.2	0.6	11.7	1.1	3.4	2.4	1.4	1.2	1.4	1.7	1.5	1.9	6.8	24.7	5.9	1.9	2.5	7.2	4.0	2.9	7.3	8.3	9.2	1.3	0.0	0.9	1.9	5.7	0.1	32.7	0.6	9.4	0.0	26.0	0.0	5.7	4.0	0.9	21.1	5.0	1.5	1.1	5.7	6.9	1.9	0.4	20.2	16.0	0.0	5.1	3.2	33.3	10.0	39.7	0.7	9.0	37.8	11.9	4.5	0.2	0.4	14.0	16.3	7.7	6.5	0.1	26.0	8.2	8.8	1.0	6.8	4.9	15.2	3.6	0.0	20.4	32.0	2.6	13.8	5.4	0.0	0.1	0.0	0.4	0.1	0.4	0.1	0.1	0.1	0.5	0.6	0.1	0.0	0.0	0.5	0.0	3.8	0.0	0.2	1.2	1.2	1.5	1.5	1.2	1.1	1.2	1.1	1.0	1.3	1.0	1.1	1.5	0.5	0.0	0.5	3.6	1.7	3.6	1.0	0.0	2.8	2.3	0.8	1.3	1.8	0.0	0.6	0.0	0.0	1.8	1.7	0.4	0.0	0.3	1.3	0.9	2.5	1.2	1.2	4.2	7.7	0.2	0.4	2.4	0.0	0.2	0.0	6.1	0.0	0.9	1.9	6.7	15.3	0.7	0.0	0.0	0.5	1.6	1.8	0.6	0.0	0.0	0.2	1.7	0.0	17.1	10.2	0.2	0.0	1.2	0.3	1.2	0.1	0.8	0.0	3.8	0.0	2.6	0.6	26.3	27.5	1.8	4.1	0.4	0.5	9.8	1.2	0.3
SEMA6A	"HT018, KIAA1368, SEMA, SEMA6A1, SEMAQ"	ENSG00000092421	"Semaphorin 6A"	Q9H2E6	5	116443555-116574823	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 60.6;brain: 72.4"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 128.9;Hepatic stellate cells: 145.6;Horizontal cells: 138.0;Oligodendrocyte precursor cells: 138.7;Oligodendrocytes: 311.3;Syncytiotrophoblasts: 348.1"	"Cancer enhanced"	"Detected in all"		"testis cancer: 20.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 44.3;HAP1: 52.0;NTERA-2: 115.2;SuSa: 221.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031264, HPA031265, HPA031267"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Intermediate filaments"		NA	NA		620000	Nucleoplasm	"Nuclear bodies, Intermediate filaments"	"HPA031264: , HPA031265: AB_10610423, HPA031267: "	"unprognostic (3.79e-2)"	"unprognostic (3.91e-1)"	"unprognostic (1.82e-2)"	"unprognostic (6.81e-2)"	"unprognostic (2.69e-2)"	"unprognostic (3.77e-1)"	"prognostic unfavorable (4.39e-4)"	"unprognostic (1.64e-1)"	"unprognostic (4.71e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.62e-3)"	"unprognostic (1.92e-1)"	"unprognostic (6.21e-3)"	"unprognostic (7.32e-3)"	13.5	60.6	21.9	4.9	41.9	3.5	13.2	33.9	34.0	9.0	0.0	20.8	20.1	6.1	2.8	4.5	8.2	13.0	6.3	20.3	30.7	8.6	5.6	18.1	4.6	46.8	39.8	10.8	18.3	11.3	2.0	5.9	32.2	45.9	6.1	17.7	10.5	16.7	2.6	8.3	6.9	25.8	5.8	32.5	11.3	7.1	7.5	38.3	3.6	9.2	6.6	2.2	5.6	8.2	72.4	0.3	0.1	36.9	44.3	0.2	0.0	38.2	0.7	0.4	0.2	0.2	2.2	1.5	1.6	1.7	0.6	0.7	0.4	52.0	0.0	0.1	1.6	7.7	0.7	0.7	13.1	0.5	0.5	2.6	0.7	0.0	0.0	0.0	0.5	0.2	0.3	0.3	0.4	0.2	0.8	0.7	3.9	115.2	0.2	0.3	6.9	24.2	1.8	19.0	33.7	10.3	3.7	0.2	0.7	19.7	221.1	14.4	2.6	0.9	3.6	3.1	0.4	1.5	0.6	0.7	0.8	0.6	1.8	13.8	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	21.9	41.9	33.9	34.0	20.3	30.7	46.8	39.8	10.8	45.9	32.5	38.3	72.4	64.7	0.0	0.6	71.8	1.1	6.5	0.7	13.1	34.7	17.9	17.0	8.3	8.6	61.5	3.1	14.7	2.1	128.9	0.3	73.3	0.0	42.9	13.6	12.2	4.8	60.9	28.1	2.7	26.9	1.3	8.1	15.4	1.1	10.6	0.0	9.7	145.6	0.9	12.5	138.0	62.2	30.7	0.0	14.8	4.6	2.4	6.5	1.1	24.9	54.4	0.1	5.8	0.0	138.7	311.3	2.0	46.7	1.9	2.6	1.5	40.7	4.4	0.6	3.5	0.0	36.1	8.1	0.9	1.5	11.3	4.1	348.1	0.8	3.5	40.3	2.2
SEPTIN12	"FLJ25410, SEPT12"	ENSG00000140623	"Septin 12"	Q8IYM1	16	4777606-4788398	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Spermatogenesis"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	86	"testis: 99.6"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA041128			Uncertain	Microtubules		NA	NA			Microtubules		"HPA041128: AB_10796568"	"unprognostic (2.11e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.29e-2)"	"unprognostic (2.71e-1)"	"unprognostic (5.45e-2)"		"unprognostic (7.40e-2)"		"unprognostic (1.39e-1)"	"unprognostic (3.80e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.49e-8)"	"unprognostic (7.41e-2)"	"unprognostic (9.87e-2)"		"unprognostic (8.36e-3)"	0.0	0.0	0.2	0.0	0.4	0.1	0.1	1.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.1	0.1	0.0	0.0	0.4	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.5	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	99.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	1.1	0.6	0.6	0.1	0.4	0.2	0.1	0.5	0.2	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
SLC13A4	"SUT-1, SUT1"	ENSG00000164707	"Solute carrier family 13 member 4"	Q9UKG4	7	135681237-135729258	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"choroid plexus: 659.0"	"Cell type enriched"	"Detected in some"	4	"Syncytiotrophoblasts: 786.0"	"Cancer enhanced"	"Detected in single"		"testis cancer: 1.3"	"Region enhanced"	"Detected in many"		"hippocampal formation: 49.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"HDLM-2: 30.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048582	Enhanced					NA	NA					"HPA048582: AB_2680450"	"unprognostic (2.40e-1)"	"unprognostic (2.51e-1)"	"unprognostic (9.70e-3)"	"unprognostic (1.78e-1)"	"unprognostic (7.69e-2)"	"unprognostic (3.96e-6)"	"unprognostic (3.33e-2)"	"unprognostic (1.32e-1)"	"unprognostic (8.56e-3)"	"unprognostic (9.23e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.30e-6)"	"unprognostic (1.53e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.73e-2)"	0.0	0.0	2.3	0.0	0.6	0.0	0.0	9.4	14.3	0.3	659.0	0.0	0.0	0.0	0.0	2.4	0.5	0.0	0.1	49.0	0.9	0.0	0.0	0.0	0.0	0.9	8.6	0.2	0.0	0.2	0.0	1.4	54.9	3.1	0.0	0.0	2.4	0.5	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	3.9	10.5	0.0	0.0	0.0	2.0	0.0	1.1	0.7	0.0	0.0	0.0	0.0	0.0	0.4	5.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	30.3	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.1	0.0	2.4	0.1	0.1	2.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.6	9.4	14.3	49.0	0.9	0.9	8.6	0.2	3.1	0.6	10.5	0.7	0.0	0.0	0.0	3.3	0.0	0.0	0.5	0.1	0.0	3.4	0.1	0.1	1.9	0.0	0.1	0.0	4.2	189.9	0.0	0.0	0.0	0.2	0.6	0.5	0.5	1.0	0.0	0.0	2.7	0.0	9.5	1.2	0.0	0.1	0.0	0.1	0.0	0.0	14.9	3.3	3.0	0.0	0.0	0.0	0.3	0.5	0.3	0.4	0.0	1.0	0.0	2.1	0.0	3.5	2.5	0.1	0.0	0.0	0.1	0.5	0.0	0.1	4.3	14.9	0.0	0.6	0.3	0.3	0.5	0.0	0.1	786.0	0.1	0.1	0.0	0.4
SLC5A7	"CHT1, hCHT"	ENSG00000115665	"Solute carrier family 5 member 7"	Q9GZV3	2	107986523-108013994	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Neurotransmitter biosynthesis, Sodium transport, Symport, Transport"		"Congenital myasthenic syndrome, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"brain: 22.2"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;Club cells: 3.1;Respiratory ciliated cells: 1.5"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	20	"RT4: 3.6;SCLC-21H: 1.0"	"Group enriched"	"Detected in many"	4	"basal ganglia: 23.1;hypothalamus: 9.0;midbrain: 9.4;pons and medulla: 14.4;thalamus: 6.2"	"Group enriched"	"Detected in many"	6	"basal ganglia: 20.4;pons: 26.5;spinal cord: 46.7"	HPA046105			Approved	"Nuclear bodies,Cell Junctions,Intermediate filaments"		NA	NA			"Cell Junctions, Intermediate filaments"	"Nuclear bodies"	"HPA046105: "	"unprognostic (2.98e-1)"		"unprognostic (1.01e-1)"					"unprognostic (1.29e-3)"			"unprognostic (7.10e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.39e-4)"	"unprognostic (1.05e-2)"	"unprognostic (9.78e-3)"	"unprognostic (6.42e-2)"	"unprognostic (1.61e-2)"	0.1	0.7	1.1	0.5	2.5	0.0	0.1	0.0	7.0	0.7	0.8	1.9	0.7	0.1	0.1	0.3	0.1	0.1	0.3	0.2	5.8	0.3	0.0	0.2	0.0	15.9	13.5	0.9	0.2	0.1	0.0	0.0	0.0	22.2	0.3	0.7	0.9	0.3	1.1	0.0	0.0	0.8	0.7	4.4	0.0	0.5	0.1	3.3	0.0	1.2	0.1	0.0	1.3	0.6	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	2.5	0.0	7.0	0.2	5.8	15.9	13.5	0.9	22.2	4.4	3.3	7.6	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.3	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3
SLC66A3	"C2orf22, MGC33602, PQLC3"	ENSG00000162976	"Solute carrier family 66 member 3"	Q8N755	2	11155198-11178870	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 15.5;Cytotrophoblasts: 17.5;Extravillous trophoblasts: 82.4;Fibroblasts: 16.1;Hofbauer cells: 56.3"	"Cancer enhanced"	"Detected in all"		"testis cancer: 72.1"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 64.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA061607			Approved	Cytosol		NA	NA			Cytosol		"HPA061607: AB_2797264"	"unprognostic (3.22e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.19e-1)"	"unprognostic (5.55e-2)"	"unprognostic (1.65e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.09e-3)"	"unprognostic (9.11e-2)"	"unprognostic (3.14e-1)"	"unprognostic (2.24e-1)"	"unprognostic (4.93e-3)"	"unprognostic (2.93e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.34e-1)"	"unprognostic (4.00e-2)"	30.4	26.6	10.5	17.5	10.9	10.0	29.5	11.0	14.1	38.8	17.0	17.7	10.9	24.0	47.7	14.5	19.9	28.0	14.4	10.4	13.2	26.1	17.6	27.3	22.7	12.7	11.2	10.0	30.2	29.3	13.3	5.8	14.5	12.2	22.8	19.5	2.5	17.2	20.0	8.6	14.8	15.6	21.6	11.7	40.1	20.2	11.7	10.7	14.4	17.5	17.2	17.0	22.7	17.4	14.8	7.1	23.3	4.3	13.4	64.6	43.9	15.5	14.8	19.3	6.8	8.0	4.3	27.3	2.5	10.5	28.5	29.3	9.1	6.9	7.3	6.8	43.8	3.2	6.5	2.7	3.0	26.1	3.3	19.5	31.7	24.5	4.3	9.7	14.5	15.5	15.3	6.2	14.8	18.8	31.6	4.8	6.6	9.1	25.2	7.6	6.2	7.2	7.7	25.8	11.6	1.6	7.2	12.4	37.9	27.9	19.1	33.9	12.2	22.0	9.6	3.8	10.2	4.1	25.2	19.6	1.2	24.9	15.5	19.4	79.4	153.7	150.3	68.8	194.9	60.7	42.4	65.6	66.7	153.6	31.9	35.9	49.5	9.5	59.9	207.4	28.7	73.2	166.2	10.5	10.9	11.0	14.1	10.4	13.2	12.7	11.2	10.0	12.2	11.7	10.7	14.8	15.5	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	17.5	11.9	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	82.4	16.1	0.0	0.0	0.0	0.0	0.0	0.0	56.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	11.2	2.2	0.0	0.0	0.0
SLCO1A2	"OATP, OATP-A, OATP1A2, SLC21A3"	ENSG00000084453	"Solute carrier organic anion transporter family member 1A2"	P46721	12	21264600-21419594	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 88.2;choroid plexus: 35.1"	"Cell type enriched"	"Detected in some"	4	"Oligodendrocytes: 487.6"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 16.7;RPMI-8226: 12.0;SuSa: 16.1;U-266/70: 23.1;U-266/84: 9.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA071152			Supported	"Plasma membrane"		No	No			"Plasma membrane"		"HPA071152: AB_2686350"	"unprognostic (5.43e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.28e-1)"	"unprognostic (8.59e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.36e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.51e-1)"	"unprognostic (8.82e-2)"	"unprognostic (1.66e-4)"	"unprognostic (2.52e-2)"	"unprognostic (3.20e-1)"		"unprognostic (1.24e-1)"	0.0	0.1	54.4	0.1	69.4	0.1	4.0	49.7	64.5	0.0	35.1	0.1	0.0	0.1	0.2	0.1	0.3	0.2	0.9	46.8	53.0	1.2	11.6	2.8	0.7	66.1	59.7	39.2	0.2	2.4	0.2	0.4	1.2	63.4	0.7	0.0	0.6	15.9	0.0	0.4	0.5	0.1	0.0	52.5	0.5	0.4	1.9	56.8	0.6	0.2	0.0	0.4	0.2	0.0	88.2	2.1	0.6	0.8	0.1	0.0	0.0	3.4	0.0	0.0	0.1	0.0	3.8	1.4	0.1	2.1	0.2	0.0	0.3	0.3	0.2	0.5	0.7	0.9	0.0	0.5	1.5	0.0	0.4	0.3	0.0	1.7	0.2	0.2	1.5	0.1	0.4	4.0	1.2	0.0	2.6	0.4	0.1	16.7	2.0	0.2	0.2	0.2	12.0	0.0	2.2	1.9	2.9	0.0	0.2	0.2	16.1	3.2	0.9	0.0	0.1	1.7	0.8	0.4	23.1	9.8	0.2	0.1	0.3	0.0	0.2	0.1	0.1	0.4	0.1	0.6	0.4	0.6	0.4	0.0	0.2	0.6	0.4	1.3	0.3	0.0	0.2	0.5	0.1	54.4	69.4	49.7	64.5	46.8	53.0	66.1	59.7	39.2	63.4	52.5	56.8	88.2	0.0	35.3	3.1	5.9	0.0	0.0	0.0	0.0	0.0	0.2	3.5	2.8	0.5	0.0	0.0	1.8	0.0	0.2	0.0	0.0	0.0	0.0	5.0	0.0	0.0	2.8	0.0	0.0	0.7	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.8	0.0	0.0	0.0	0.0	4.5	0.0	0.1	0.0	102.1	0.0	0.1	0.0	2.5	487.6	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.1	0.4	1.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0
SMCP	MCSP	ENSG00000163206	"Sperm mitochondria associated cysteine rich protein"	P49901	1	152878322-152885047	"Predicted intracellular proteins"	Fertilization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	957	"testis: 754.0"	"Group enriched"	"Detected in some"	80	"Early spermatids: 3632.3;Late spermatids: 13748.1"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 1.2;hTERT-HME1: 1.1"					"Not detected"	"Not detected"			"HPA035105, HPA077113"	Enhanced					NA	NA					"HPA035105: AB_10601590, HPA077113: "						"unprognostic (5.51e-2)"												0.1	0.1	0.0	0.0	0.0	0.0	0.6	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.1	754.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3632.3	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13748.1	84.5	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	60.9	0.0	0.0	0.0	0.0	0.0	0.0	26.3	0.0	0.0	107.5	47.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SOCS4	SOCS7	ENSG00000180008	"Suppressor of cytokine signaling 4"	Q8WXH5	14	55027230-55049489	"Predicted intracellular proteins"	"Growth regulation, Ubl conjugation pathway"	"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Cancer enhanced"	"Detected in all"		"testis cancer: 17.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013478, HPA057961"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"CAB013478: , HPA057961: AB_2683564"	"unprognostic (7.18e-3)"	"unprognostic (1.49e-1)"	"unprognostic (9.74e-3)"	"unprognostic (4.57e-2)"	"unprognostic (3.36e-3)"	"unprognostic (3.82e-3)"	"unprognostic (3.69e-3)"	"unprognostic (2.70e-1)"	"unprognostic (9.70e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.56e-2)"	"unprognostic (7.61e-2)"	"unprognostic (4.35e-3)"	"unprognostic (1.13e-1)"	6.7	4.9	6.7	7.9	7.3	6.9	5.8	7.9	7.2	4.7	6.3	5.2	5.3	5.9	4.2	5.1	5.2	6.7	5.7	6.6	9.8	6.4	4.9	6.7	9.0	9.0	7.8	5.0	3.9	4.2	5.6	4.5	5.7	8.7	4.8	5.7	10.9	4.5	4.6	4.9	5.1	5.4	6.1	9.5	7.6	7.1	4.3	8.0	8.1	6.9	5.2	7.6	6.6	4.2	10.2	14.2	11.0	16.2	18.9	11.0	12.2	12.0	16.4	12.1	9.9	16.0	9.6	15.2	20.8	11.3	12.4	9.7	19.1	21.4	13.5	23.1	20.8	8.8	12.8	16.3	6.1	11.1	14.3	20.9	9.9	14.4	17.6	13.0	11.5	18.5	22.0	7.4	19.2	19.3	14.6	21.9	11.6	12.7	11.7	12.0	20.3	24.5	8.5	15.2	15.0	21.1	18.5	16.6	9.8	16.8	14.8	14.0	11.2	19.3	25.5	23.9	13.1	14.0	7.4	8.3	19.6	17.2	11.8	20.2	0.9	1.2	1.2	0.8	1.3	1.3	0.8	1.0	0.8	0.9	1.1	0.6	0.6	0.7	1.8	1.8	1.2	1.0	0.5	6.7	7.3	7.9	7.2	6.6	9.8	9.0	7.8	5.0	8.7	9.5	8.0	10.2	30.7	6.4	12.4	9.8	22.3	24.0	10.8	10.7	14.8	13.6	14.7	12.3	20.2	11.5	15.8	14.7	20.9	5.2	27.5	14.7	13.7	9.4	7.4	36.8	22.5	20.9	20.4	16.8	14.3	8.7	6.2	14.8	29.0	20.6	32.9	11.8	15.0	9.4	7.4	37.0	13.6	8.3	8.2	13.3	21.8	2.6	7.2	15.6	3.6	11.2	17.3	21.0	13.4	4.5	20.4	15.6	9.6	10.1	19.4	8.1	6.7	14.6	19.7	17.4	0.0	15.8	21.5	20.7	10.9	14.7	23.2	4.9	21.7	13.7	8.1	11.5
SOX15	"SOX20, SOX26, SOX27"	ENSG00000129194	"SRY-box transcription factor 15"	O60248	17	7588178-7590094	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 88.1;skin 1: 43.0"	"Group enriched"	"Detected in many"	4	"Basal keratinocytes: 209.2;Basal squamous epithelial cells: 447.3;Squamous epithelial cells: 388.1;Suprabasal keratinocytes: 169.9"	"Cancer enhanced"	"Detected in many"		"testis cancer: 67.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 6.7;non-classical monocyte: 10.6"	"Lineage enriched"	"Detected in many"	5	"monocytes: 10.6"	"Group enriched"	"Detected in many"	8	"A-431: 130.6;HaCaT: 142.1;HBEC3-KT: 57.8;hTCEpi: 56.6"	"Not detected"	"Not detected"							"HPA067196, HPA074049"	Enhanced		Supported	"Nucleoplasm,Nucleoli,Golgi apparatus,Vesicles"		Yes	NA			Nucleoplasm	"Nucleoli, Golgi apparatus, Vesicles"	"HPA067196: AB_2685802, HPA074049: AB_2686656"	"unprognostic (5.79e-3)"	"unprognostic (6.65e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.60e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.81e-2)"	"unprognostic (5.00e-2)"	"unprognostic (8.50e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.61e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.95e-2)"	"unprognostic (2.97e-1)"	2.0	0.9	12.6	0.8	12.6	2.8	3.4	15.3	23.5	16.1	9.4	9.1	0.7	8.3	1.7	88.1	11.1	1.0	6.2	12.8	12.0	1.7	1.3	1.5	0.5	12.2	11.9	11.6	15.5	1.0	0.2	8.0	0.3	13.3	12.2	0.5	5.1	14.7	7.2	2.3	43.0	3.5	1.3	12.1	1.1	4.7	2.6	11.8	1.0	2.3	1.8	2.8	10.5	33.0	12.5	130.6	3.2	1.8	1.0	0.1	0.3	9.6	1.4	0.5	1.1	1.7	2.5	0.8	0.4	1.2	0.1	0.4	142.1	0.1	57.8	0.4	3.3	3.9	0.5	1.7	0.5	0.2	0.3	2.6	0.0	56.6	0.7	11.9	3.6	0.0	2.6	2.9	0.8	0.2	0.9	0.6	1.5	3.6	0.3	0.7	1.6	1.8	1.0	2.7	0.7	0.8	2.2	1.5	0.5	0.7	5.5	1.1	1.0	1.6	1.3	2.3	1.6	4.4	0.9	1.5	1.6	4.4	1.7	3.2	0.1	2.1	0.0	0.0	6.7	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	10.6	1.0	0.0	0.4	12.6	12.6	15.3	23.5	12.8	12.0	12.2	11.9	11.6	13.3	12.1	11.8	12.5	0.8	0.0	0.0	2.6	0.1	209.2	51.8	72.7	447.3	13.6	6.3	13.0	4.7	0.0	20.6	1.8	14.6	1.7	0.7	0.5	1.9	0.1	0.2	0.4	4.9	3.1	1.2	0.0	8.1	0.5	2.0	10.4	0.0	0.4	0.0	1.3	1.4	0.0	0.4	10.1	7.7	0.4	10.2	1.2	19.3	1.1	31.4	0.9	26.6	1.0	1.2	50.0	0.0	4.0	2.4	0.5	0.1	36.9	4.9	21.2	0.3	0.2	16.2	9.4	32.9	7.8	7.1	0.7	10.9	388.1	169.9	1.1	1.1	0.6	0.8	73.8
SP8		ENSG00000164651	"Sp8 transcription factor"	Q8IXZ3	7	20782279-20786886	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"brain: 4.0;prostate: 6.6"	"Cell type enhanced"	"Detected in some"		"Basal prostatic cells: 3.5;Inhibitory neurons: 5.3;Paneth cells: 1.2;Prostatic glandular cells: 2.9;Spermatocytes: 1.1;Spermatogonia: 1.5;Urothelial cells: 1.0"	"Cancer enhanced"	"Detected in many"		"testis cancer: 7.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 4.3;HUVEC TERT2: 6.4;NTERA-2: 12.6;PC-3: 21.6"	"Group enriched"	"Detected in many"	11	"basal ganglia: 15.3;olfactory bulb: 54.5"	"Region enriched"	"Detected in some"	11	"olfactory bulb: 29.8"	HPA054006	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA054006: AB_2682340"		"unprognostic (1.56e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.35e-1)"	"unprognostic (7.90e-4)"		"unprognostic (3.46e-1)"	"unprognostic (5.49e-1)"	"unprognostic (1.73e-2)"		"unprognostic (2.42e-2)"		"unprognostic (3.38e-1)"	"unprognostic (7.44e-2)"			0.0	0.0	1.0	0.0	2.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.5	0.0	0.0	0.0	0.0	3.8	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.4	6.6	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.6	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.3	0.0	0.2	0.0	1.2	0.0	0.0	0.0	4.3	0.4	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.1	0.0	0.0	0.0	0.0	0.7	12.6	0.1	21.6	0.0	1.0	0.0	0.0	0.0	0.6	0.0	0.3	0.0	0.4	0.8	0.0	0.0	0.0	0.0	2.7	0.0	1.0	0.1	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	2.0	0.0	4.0	0.8	1.5	3.8	0.0	0.5	0.4	0.6	0.1	0.2	0.0	0.0	0.0	0.3	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	2.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.5	0.0	0.0	0.0	0.0	0.0	0.2	1.0
SPIC	"MGC40611, SPI-C"	ENSG00000166211	"Spi-C transcription factor"	Q8N5J4	12	101475336-101486997	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"lymphoid tissue: 31.0"	"Group enriched"	"Detected in some"	8	"Kupffer cells: 16.7;Macrophages: 11.0"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.9"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"intermediate monocyte: 1.1"	"Lineage enriched"	"Detected in single"	8	"monocytes: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (9.82e-2)"	"unprognostic (2.43e-2)"					"unprognostic (9.03e-3)"	"unprognostic (2.51e-1)"		"unprognostic (4.85e-2)"			"unprognostic (5.78e-2)"	"unprognostic (5.30e-2)"	"unprognostic (1.77e-1)"			0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.1	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	31.0	0.1	0.1	0.0	1.2	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.3	0.0	0.2	0.0	0.0	16.7	0.0	0.0	0.0	11.0	0.0	1.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1
SRY	TDF	ENSG00000184895	"Sex determining region Y"	Q05066	Y	2786855-2787682	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Sexual differentiation, Transcription, Transcription regulation"	"Activator, Calmodulin-binding, DNA-binding, Repressor"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skin 1: 1.8;testis: 2.3"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 1.8;Muller glia cells: 2.4"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"RT4: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA										"unprognostic (1.34e-1)"	"unprognostic (5.53e-4)"									"unprognostic (1.61e-1)"			0.1	0.3	0.3	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	1.8	0.0	0.0	0.3	0.0	0.0	2.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.3	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.3	0.9	0.0	0.0	0.0	0.0	0.0	0.1
SSUH2	"C3orf32, fls485, ssu-2"	ENSG00000125046	"Ssu-2 homolog"	Q9Y2M2	3	8619400-8745040	"Disease related genes, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 3.8;testis: 4.0"	"Group enriched"	"Detected in some"	4	"Early spermatids: 61.7;Late spermatids: 43.6;Proximal enterocytes: 16.1"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	27	"Hep G2: 26.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA049777	Approved					NA	NA					"HPA049777: AB_2680876"	"unprognostic (2.49e-1)"	"unprognostic (7.62e-2)"	"unprognostic (9.65e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.46e-1)"	"unprognostic (8.86e-2)"	"unprognostic (1.46e-3)"	"unprognostic (9.79e-2)"	"unprognostic (1.53e-1)"	"unprognostic (4.09e-1)"	"unprognostic (7.97e-3)"	"unprognostic (1.52e-1)"	"unprognostic (3.15e-3)"	"unprognostic (1.31e-1)"	"unprognostic (3.65e-2)"	"unprognostic (4.96e-2)"	"unprognostic (7.50e-2)"	0.5	0.1	0.1	0.0	0.0	0.0	0.6	0.0	0.3	0.1	0.0	0.4	3.8	0.2	0.0	0.2	0.2	0.4	1.8	0.0	0.0	0.9	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.1	0.2	0.1	0.0	0.3	0.0	0.1	0.1	3.3	0.1	0.0	1.6	0.3	4.0	0.0	0.0	0.8	0.1	0.1	0.2	0.2	0.1	0.0	0.5	0.6	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.3	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	9.9	0.0	0.0	1.3	0.0	0.3	0.1	0.1	0.0	0.0	0.3	0.8	1.8	0.0	0.1	0.0	0.0	0.0	0.1	3.1	0.0	0.0	61.7	1.7	0.1	3.0	0.0	0.0	4.5	0.0	0.0	0.1	0.0	0.2	0.0	0.7	2.2	0.0	0.0	0.0	1.9	1.8	0.0	0.0	0.4	43.6	1.2	0.2	1.8	1.0	0.0	0.0	0.0	2.0	1.4	0.1	1.2	0.4	0.0	0.1	16.1	0.9	4.0	0.0	0.0	0.4	0.7	0.5	1.1	0.3	0.1	0.0	0.1	0.5	0.8	0.2
STK31	"SgK396, TDRD8"	ENSG00000196335	"Serine/threonine kinase 31"	Q9BXU1	7	23710203-23832513	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	60	"testis: 64.6"	"Group enriched"	"Detected in some"	5	"Spermatocytes: 161.5;Spermatogonia: 75.0"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.1"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"CACO-2: 20.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA023194, HPA072896"	Enhanced					NA	NA					"HPA023194: AB_1857590, HPA072896: "	"unprognostic (4.25e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.98e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.42e-3)"	"unprognostic (2.92e-1)"	"unprognostic (1.29e-6)"	"unprognostic (7.83e-2)"	"unprognostic (9.21e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.65e-1)"	0.1	0.1	0.3	0.0	0.4	0.0	0.2	1.0	0.4	0.1	0.1	0.1	0.3	0.1	0.0	0.3	0.2	0.1	0.0	0.2	0.3	0.2	0.3	0.4	0.0	0.5	0.3	0.1	0.2	0.4	0.0	0.1	0.0	0.6	0.2	0.0	0.2	0.2	0.0	0.0	0.2	0.3	0.0	0.2	0.2	0.4	64.6	0.4	0.1	0.2	0.0	0.0	0.1	0.1	0.5	0.2	0.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	20.5	2.3	0.0	2.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	1.0	0.4	0.2	0.3	0.5	0.3	0.1	0.6	0.2	0.4	0.5	0.4	3.2	1.1	2.9	0.3	0.1	0.2	0.5	0.0	2.0	1.0	0.1	0.6	1.5	2.8	0.0	0.0	0.6	0.1	0.3	0.0	0.2	21.1	0.6	0.0	0.4	1.2	0.0	2.9	0.6	0.1	0.6	2.0	0.2	0.0	0.3	0.0	0.5	0.2	0.0	4.6	0.4	2.0	0.0	0.0	19.6	3.4	0.5	0.0	2.8	0.0	1.0	0.0	2.5	12.7	0.4	5.3	3.0	0.5	0.3	0.8	0.1	4.3	1.2	0.0	0.6	0.1	161.5	75.0	0.0	0.1	0.5	0.5	0.1	0.5	0.5
SULT4A1	"hBR-STL-1, SULTX3"	ENSG00000130540	"Sulfotransferase family 4A member 1"	Q9BR01	22	43824509-43862513	"Metabolic proteins, Predicted intracellular proteins"	"Lipid metabolism, Steroid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	31	"brain: 86.9"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 23.0;Early spermatids: 23.7;Excitatory neurons: 53.1;Horizontal cells: 23.5;Inhibitory neurons: 55.2;Late spermatids: 29.4;Rod photoreceptor cells: 19.5"	"Cancer enhanced"	"Detected in many"		"testis cancer: 6.3"	"Region enhanced"	"Detected in many"		"cerebral cortex: 86.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003129	Enhanced					NA	NA					"HPA003129: AB_1080130"	"unprognostic (2.61e-3)"	"unprognostic (1.05e-2)"	"unprognostic (2.62e-1)"	"unprognostic (6.30e-2)"	"unprognostic (6.12e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.63e-1)"	"unprognostic (8.74e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.48e-4)"	"unprognostic (1.91e-2)"	"unprognostic (6.10e-2)"	"unprognostic (7.59e-4)"	"unprognostic (7.89e-2)"	"unprognostic (1.22e-1)"	"unprognostic (8.20e-3)"	"unprognostic (8.34e-3)"	0.0	2.7	10.9	0.3	18.1	0.0	0.0	1.2	86.9	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	20.3	21.4	0.1	0.0	0.0	0.0	9.5	21.0	20.4	0.0	0.2	0.0	2.6	0.0	9.7	0.0	0.2	2.2	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.4	0.8	14.2	0.0	0.0	0.0	0.0	0.0	0.3	44.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	18.1	1.2	86.9	20.3	21.4	9.5	21.0	20.4	9.7	0.0	14.2	44.6	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.3	0.0	23.0	0.2	0.5	1.4	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	0.0	23.7	1.1	1.3	0.4	0.0	0.0	53.1	0.0	0.0	0.4	0.0	3.7	0.0	1.9	0.0	0.0	0.1	23.5	55.2	0.0	0.0	0.0	0.0	29.4	0.0	0.1	0.0	10.3	0.0	4.0	0.0	8.0	6.2	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.2	19.5	0.0	0.0	0.2	3.0	5.7	0.0	0.0	0.0	0.0	3.2	0.0	0.0
SUSD2	"BK65A6.2, FLJ22778, W5C5"	ENSG00000099994	"Sushi domain containing 2"	Q9UGT4	22	24181487-24189106	"Predicted membrane proteins"		Receptor	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 100.7"	"Group enriched"	"Detected in many"	6	"Alveolar cells type 1: 250.0;Alveolar cells type 2: 151.5;Proximal enterocytes: 154.9"	"Cancer enhanced"	"Detected in all"		"testis cancer: 64.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	29	"SK-BR-3: 898.7"	"Low region specificity"	"Detected in all"							HPA004117	Enhanced		Approved	"Plasma membrane"		NA	NA		6800000	"Plasma membrane"		"HPA004117: AB_1857674"	"unprognostic (5.24e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.74e-1)"	"unprognostic (7.30e-2)"	"unprognostic (1.27e-2)"	"unprognostic (5.40e-2)"	"unprognostic (5.20e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.87e-2)"	"unprognostic (1.20e-2)"	"unprognostic (9.74e-3)"	"unprognostic (8.97e-2)"	"prognostic unfavorable (3.29e-5)"	"unprognostic (2.72e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.88e-2)"	"unprognostic (3.33e-3)"	10.7	9.7	4.7	1.9	2.3	0.2	9.6	1.6	5.1	12.2	3.3	4.6	12.9	9.9	0.5	2.8	15.1	1.9	9.4	1.6	17.2	32.9	2.9	100.7	2.2	16.8	6.3	1.5	5.4	4.4	1.5	7.2	3.6	25.2	5.6	1.0	0.1	4.8	5.6	2.2	27.9	34.9	3.5	6.7	3.6	6.3	3.3	14.1	0.8	17.9	1.5	1.3	5.4	11.1	11.0	5.1	10.4	0.1	0.0	18.8	24.3	0.8	2.4	0.1	0.1	0.0	7.8	0.6	1.4	21.5	0.5	0.4	1.4	0.1	0.5	0.0	0.6	0.3	0.0	0.4	30.6	8.0	0.0	0.3	21.5	0.4	0.1	6.2	0.0	0.1	0.0	0.5	0.3	0.0	9.1	0.3	0.4	0.7	2.5	0.3	0.3	0.0	2.5	0.1	0.2	1.7	13.5	0.7	898.7	0.2	3.6	3.0	0.0	0.0	0.1	0.9	0.7	0.1	1.1	1.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	2.3	1.6	5.1	1.6	17.2	16.8	6.3	1.5	25.2	6.7	14.1	11.0	1.7	250.0	151.5	0.3	0.6	0.3	0.3	2.6	0.0	0.0	3.4	3.4	6.8	0.0	20.9	1.8	0.0	13.8	0.3	0.7	5.9	0.1	0.0	1.3	0.7	1.1	1.8	0.0	0.2	0.0	0.7	6.7	0.5	1.3	3.8	0.1	2.9	0.5	1.1	0.0	0.1	5.5	2.0	0.0	0.3	0.4	0.6	0.8	0.0	2.8	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.4	154.9	27.8	3.6	0.0	0.0	0.6	22.1	1.7	1.3	0.7	2.7	26.4	1.1	0.0	1.6	0.6
SYCP2L	"C6orf177, dJ62D2.1, NO145"	ENSG00000153157	"Synaptonemal complex protein 2 like"	Q5T4T6	6	10886831-10979320	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	21	"parathyroid gland: 69.2"	"Group enriched"	"Detected in many"	4	"Astrocytes: 21.5;dendritic cells: 9.5;Early spermatids: 17.1;Excitatory neurons: 28.5;granulocytes: 10.8;Inhibitory neurons: 23.1;Microglial cells: 13.1;Oligodendrocyte precursor cells: 14.1;Oligodendrocytes: 12.4;Spermatogonia: 8.7"	"Cancer enhanced"	"Detected in single"		"testis cancer: 1.4"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	7	"basophil: 1.7;eosinophil: 3.4;plasmacytoid DC: 4.2"	"Group enriched"	"Detected in many"	17	"dendritic cells: 4.2;granulocytes: 3.4"	"Cell line enhanced"	"Detected in some"		"HL-60: 13.4;HMC-1: 38.7;K-562: 10.7;NB-4: 15.3;SuSa: 8.1;THP-1: 11.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA034679			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA034679: AB_10669729"	"unprognostic (3.25e-1)"	"unprognostic (2.58e-2)"	"unprognostic (3.23e-1)"	"unprognostic (3.72e-5)"	"unprognostic (2.20e-1)"	"unprognostic (1.21e-2)"	"unprognostic (5.57e-3)"	"unprognostic (4.23e-1)"	"unprognostic (6.03e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.21e-3)"	"unprognostic (1.07e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.85e-2)"	"unprognostic (2.74e-2)"	0.6	0.3	0.6	0.6	1.0	0.7	0.5	0.9	1.5	0.4	0.0	0.3	0.1	0.4	2.6	0.2	0.4	0.5	0.9	0.9	0.4	1.1	0.1	1.8	0.5	0.3	0.4	0.5	0.8	1.7	69.2	0.4	1.1	0.4	0.6	0.2	0.7	0.3	0.2	0.2	0.5	0.3	0.2	0.0	0.6	0.3	3.3	0.3	0.1	1.2	0.9	0.3	0.3	0.3	1.3	0.0	1.0	1.9	0.1	0.1	0.0	5.6	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	4.5	0.2	0.2	0.1	6.4	0.0	0.0	0.0	0.0	13.4	38.7	0.0	1.0	0.0	0.0	0.3	0.0	0.4	10.7	0.1	0.0	0.1	3.4	15.3	0.7	0.0	0.1	0.2	0.4	0.0	0.2	0.0	0.7	3.5	0.0	3.5	0.0	8.1	0.1	11.4	0.0	0.0	0.7	0.0	0.2	0.3	0.0	0.1	0.1	0.1	1.1	1.7	0.0	3.4	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.6	1.0	0.9	1.5	0.9	0.4	0.3	0.4	0.5	0.4	0.0	0.3	1.3	1.1	0.0	1.3	21.5	0.3	0.1	0.0	0.2	0.0	2.1	0.3	0.0	0.4	0.0	0.1	0.0	0.0	2.9	9.5	0.0	0.0	0.2	17.1	0.1	0.4	1.4	0.0	2.1	28.5	0.2	2.0	2.9	0.0	0.4	10.8	1.5	0.0	0.0	0.5	3.3	23.1	0.0	0.0	0.0	0.5	3.2	1.2	1.0	0.0	13.1	1.0	0.6	0.0	14.1	12.4	0.6	0.0	1.5	0.0	0.5	0.0	0.0	0.7	0.1	0.0	0.6	0.3	3.1	8.7	0.0	0.0	1.4	0.6	0.1	0.0	0.1
SYN3		ENSG00000185666	"Synapsin III"	O14994	22	32507820-33058381	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 21.6"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 54.5;Excitatory neurons: 347.7;Inhibitory neurons: 198.6;Late spermatids: 250.7;Oligodendrocyte precursor cells: 75.9"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.0"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"naive B-cell: 3.2"	"Group enriched"	"Detected in many"	11	"B-cells: 3.2;granulocytes: 1.6"	"Cell line enhanced"	"Detected in many"		"A-431: 15.0;EFO-21: 12.5;NTERA-2: 7.0;PC-3: 9.0;SCLC-21H: 7.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA034566	Uncertain					NA	NA					"HPA034566: AB_10603120"	"unprognostic (1.15e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.03e-2)"	"unprognostic (5.13e-3)"	"unprognostic (2.34e-1)"	"unprognostic (9.39e-2)"	"unprognostic (3.24e-1)"	"unprognostic (7.77e-2)"	"unprognostic (8.91e-2)"	"unprognostic (8.59e-2)"	"unprognostic (7.44e-3)"	"unprognostic (4.35e-3)"	"unprognostic (1.80e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.40e-2)"	"unprognostic (3.52e-1)"	0.7	0.8	13.4	0.6	0.0	2.5	0.6	0.0	21.6	0.3	0.0	0.7	0.6	0.6	0.6	1.5	0.7	1.0	0.6	7.3	1.9	0.6	0.5	0.8	1.2	5.0	0.0	1.5	0.4	1.2	0.4	1.7	2.6	9.4	0.6	0.6	4.1	0.5	0.4	0.5	1.8	1.0	0.6	0.0	1.4	0.9	4.0	0.0	0.7	0.9	0.4	0.6	0.3	0.2	13.4	15.0	0.7	0.4	1.9	0.0	0.4	0.6	0.5	0.1	0.0	0.2	1.4	1.1	0.7	12.5	0.1	6.2	3.6	5.4	0.1	0.0	0.3	1.1	0.7	5.1	3.0	0.0	0.9	0.6	0.2	1.0	0.1	0.0	0.3	0.1	0.3	0.9	0.6	0.0	0.1	0.6	0.5	7.0	0.2	9.0	0.4	0.6	0.6	0.0	1.0	7.4	0.6	1.2	0.1	1.2	3.3	0.2	0.4	0.4	0.7	4.8	1.0	1.0	0.5	0.7	0.6	0.4	0.4	2.8	0.9	0.2	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	3.2	0.0	0.0	1.6	0.1	0.2	0.1	0.0	0.1	13.4	0.0	0.0	21.6	7.3	1.9	5.0	0.0	1.5	9.4	0.0	0.0	13.4	1.6	0.0	0.0	8.5	1.5	0.4	0.1	0.0	0.0	3.1	0.1	0.0	0.8	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	54.5	0.1	0.4	0.9	0.0	0.0	347.7	0.0	0.6	0.2	0.0	0.1	0.0	0.0	0.4	0.1	0.3	5.0	198.6	0.0	0.0	0.0	0.5	250.7	1.5	0.1	0.0	12.2	0.0	0.0	0.0	75.9	8.1	0.0	0.0	1.5	0.0	0.1	0.0	0.0	0.0	0.6	6.6	0.0	0.9	3.7	9.0	0.0	0.1	1.1	0.0	0.7	0.0	0.0
TAFA4	"FAM19A4, TAFA-4"	ENSG00000163377	"TAFA chemokine like family member 4"	Q96LR4	3	68731766-68953297	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"adrenal gland: 15.0;brain: 13.2;retina: 11.2;stomach 1: 4.9"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"testis cancer: 0.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 1.8;NTERA-2: 9.2;SCLC-21H: 1.0;SuSa: 2.5"	"Region enriched"	"Detected in many"	5	"thalamus: 13.5"	"Low region specificity"	"Detected in many"								"Secreted in brain"	NA	NA						"unprognostic (1.92e-1)"			"unprognostic (9.97e-3)"	"unprognostic (2.28e-1)"			"unprognostic (8.19e-3)"		"unprognostic (8.78e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.66e-2)"	"unprognostic (8.06e-2)"	"unprognostic (2.50e-1)"		0.0	15.0	4.6	0.2	4.9	0.0	0.0	3.9	3.1	0.0	0.7	0.3	0.0	0.0	0.0	0.3	0.0	1.2	0.0	1.8	6.8	0.1	0.0	0.1	0.0	4.5	9.8	1.5	0.4	0.0	0.0	0.7	0.3	4.5	0.9	0.0	11.2	0.0	0.1	0.0	0.0	0.2	0.2	3.7	0.0	4.9	1.0	13.2	0.0	0.0	0.0	0.0	0.1	0.0	7.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.4	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	4.9	3.9	3.1	1.8	6.8	4.5	9.8	1.5	4.5	3.7	13.2	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TAS2R19	"T2R19, T2R23, TAS2R23, TAS2R48"	ENSG00000212124	"Taste 2 receptor member 19"	P59542	12	11021619-11022620	"G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Sensory transduction, Taste"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"testis cancer: 1.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA						"unprognostic (1.90e-2)"	"unprognostic (9.54e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.18e-3)"	"unprognostic (1.84e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.50e-2)"	"unprognostic (5.73e-2)"	"unprognostic (2.35e-1)"	"unprognostic (8.76e-2)"	"unprognostic (8.26e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.57e-8)"	"unprognostic (9.08e-2)"	"unprognostic (1.58e-1)"	"unprognostic (7.96e-2)"	"unprognostic (4.32e-1)"	0.3	0.3	0.2	0.0	0.3	0.0	0.3	0.3	0.4	0.7	0.2	0.4	0.0	0.6	0.0	0.2	0.4	0.0	0.3	0.3	0.2	0.2	0.2	0.4	0.0	0.5	0.5	0.1	1.4	0.4	0.0	1.1	0.0	0.6	0.4	0.0	0.2	0.2	0.0	0.5	0.2	0.3	0.0	0.2	0.3	0.3	0.6	0.2	0.1	0.4	0.0	0.0	0.4	0.4	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.3	0.4	0.3	0.2	0.5	0.5	0.1	0.6	0.2	0.2	0.9	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.5	0.4	0.1	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0
TCF15	"bHLHa40, EC2, PARAXIS"	ENSG00000125878	"Transcription factor 15"	Q12870	20	603797-610398	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 17.5;skeletal muscle: 13.3;tongue: 9.2"	"Cell type enriched"	"Detected in some"	6	"Adipocytes: 260.0"	"Cancer enhanced"	"Detected in many"		"testis cancer: 3.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HEL: 10.6;HMC-1: 16.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA050998, HPA060221"	Approved		Supported	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA050998: AB_2681302, HPA060221: AB_2684225"	"unprognostic (2.12e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.58e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.29e-1)"	"unprognostic (4.62e-2)"	"unprognostic (5.57e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.81e-1)"	"prognostic unfavorable (3.25e-4)"	"unprognostic (1.52e-1)"	"unprognostic (9.43e-2)"	"unprognostic (1.27e-3)"	"unprognostic (7.21e-2)"	"unprognostic (8.56e-2)"	"unprognostic (5.11e-1)"	"unprognostic (6.99e-2)"	5.8	0.6	1.5	0.1	1.1	0.0	4.6	1.2	1.4	0.2	0.9	1.2	0.1	0.8	0.0	0.3	0.4	0.1	17.5	1.1	1.2	0.7	0.2	0.6	0.1	1.3	1.3	1.0	0.2	0.3	0.1	0.4	3.3	1.4	0.3	0.0	0.0	0.6	0.0	13.3	0.2	0.5	0.2	1.2	0.0	0.6	2.0	1.5	0.0	0.5	9.2	0.0	0.9	0.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	1.5	0.0	0.0	0.0	2.9	10.6	0.0	0.0	0.0	0.0	16.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.7	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.1	0.0	0.0	1.7	0.0	0.0	0.0	1.5	0.0	1.3	0.0	3.0	0.0	1.4	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.1	1.2	1.4	1.1	1.2	1.3	1.3	1.0	1.4	1.2	1.5	1.3	260.0	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.6	0.5	0.6	1.0	15.6	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.7	0.2	0.2	41.2	0.0	0.0	0.0	0.0	0.1	2.2	0.0	0.6	0.0	0.1	7.1	0.0	0.1	1.7	0.5	0.0	0.0	0.0	0.4	0.2	0.0	0.5	0.0	2.8	0.0	0.1	0.0	1.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	13.1	3.7	23.3	2.3	0.6	0.0	0.0	0.0	0.2	0.5	0.0	0.0
TDRD10	DKFZp434M202	ENSG00000163239	"Tudor domain containing 10"	Q5VZ19	1	154502219-154548147	"Cancer-related genes, Predicted intracellular proteins"		RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"testis: 56.0"	"Group enriched"	"Detected in some"	5	"Early spermatids: 61.8;Late spermatids: 89.0;Spermatocytes: 103.7"	"Cancer enhanced"	"Detected in many"		"testis cancer: 5.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 3.0;TIME: 1.4"					"Not detected"	"Not detected"			HPA054327			Approved	Vesicles		NA	NA			Vesicles		"HPA054327: AB_2682452"	"unprognostic (1.30e-1)"	"unprognostic (6.33e-2)"	"unprognostic (1.78e-1)"	"unprognostic (5.33e-3)"	"unprognostic (9.69e-3)"	"unprognostic (5.80e-3)"	"unprognostic (2.99e-1)"	"unprognostic (5.97e-3)"	"unprognostic (2.44e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.00e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.34e-3)"	"unprognostic (1.15e-2)"	"unprognostic (1.13e-1)"	"prognostic favorable (8.04e-5)"	"unprognostic (1.62e-1)"	9.1	4.5	3.3	0.5	3.2	0.1	6.9	2.7	3.8	4.7	3.5	2.8	0.7	4.2	2.3	2.5	6.6	1.6	7.1	3.0	3.0	3.4	4.5	8.1	0.8	3.0	3.1	2.7	10.2	0.9	0.9	2.6	1.7	2.9	3.9	1.3	0.1	1.8	1.2	1.9	2.3	3.5	1.8	2.7	9.0	1.9	56.0	3.3	0.5	11.1	1.4	0.4	3.9	3.7	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	3.2	2.7	3.8	3.0	3.0	3.0	3.1	2.7	2.9	2.7	3.3	3.0	10.0	3.2	6.7	4.9	0.1	0.6	0.0	0.0	0.0	0.0	0.1	0.5	1.3	1.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	61.8	0.0	0.1	8.2	0.0	0.0	0.3	0.0	0.0	2.1	0.0	0.0	1.3	0.7	6.1	0.4	0.4	0.0	0.5	0.0	0.0	4.0	2.1	89.0	2.5	1.0	0.0	6.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.4	103.7	16.5	0.1	0.3	0.0	0.0	0.1	0.0	0.0
TENT5B	"FAM46B, MGC16491"	ENSG00000158246	"Terminal nucleotidyltransferase 5B"	Q96A09	1	27005020-27012850	"Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 112.7;skin 1: 114.9"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 26.8;Breast myoepithelial cells: 24.8;Distal tubular cells: 23.5;Endometrial ciliated cells: 11.7;Glandular and luminal cells: 10.8"	"Cancer enhanced"	"Detected in many"		"testis cancer: 87.1"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 62.0;hTERT-HME1: 31.6;NTERA-2: 32.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"								"Intracellular and membrane"	NA	NA						"unprognostic (1.67e-2)"	"unprognostic (5.94e-3)"	"unprognostic (1.61e-1)"	"unprognostic (5.28e-3)"	"unprognostic (3.20e-2)"	"unprognostic (2.22e-2)"	"unprognostic (2.44e-4)"	"unprognostic (4.05e-2)"	"unprognostic (1.39e-1)"	"unprognostic (6.02e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.00e-1)"	"unprognostic (5.82e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.46e-2)"	6.8	0.9	0.4	2.6	0.4	0.0	15.8	1.5	0.8	19.0	0.7	32.3	1.1	25.0	0.8	112.7	16.5	1.8	26.0	0.4	0.7	4.9	0.4	12.9	0.2	2.2	1.0	0.4	3.6	1.9	2.0	2.6	3.2	1.1	12.4	1.7	3.0	27.9	15.6	2.2	114.9	10.7	12.3	0.3	0.6	17.5	6.4	0.7	0.6	5.1	1.7	5.5	37.6	47.7	0.5	3.9	0.6	7.6	2.3	0.9	1.2	1.9	5.5	1.8	21.5	8.5	15.3	5.0	0.0	9.1	3.0	4.8	12.4	1.3	20.1	5.8	0.0	1.2	0.2	2.9	2.6	10.6	0.1	0.3	4.8	62.0	6.6	31.6	0.0	0.3	0.0	0.4	0.0	2.8	3.0	0.0	1.2	32.8	2.8	1.5	0.4	0.0	0.2	21.3	0.0	0.9	0.6	10.6	23.4	14.3	15.9	18.6	0.3	0.5	5.2	18.0	0.6	1.1	0.3	0.8	0.0	1.1	0.1	3.3	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	1.5	0.8	0.4	0.7	2.2	1.0	0.4	1.1	0.3	0.7	0.5	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	26.8	24.8	0.0	0.0	0.0	0.0	0.0	3.2	0.4	0.0	23.5	1.8	0.0	11.7	1.8	0.5	0.0	0.0	0.0	1.9	3.1	0.5	0.0	10.8	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	5.3	0.1	0.0	0.0	0.0
TEX11	"MZIP4, Spo22, TGC1, TSGA3, ZIP4"	ENSG00000120498	"Testis expressed 11"	Q8IYF3	X	70528940-70908711	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Meiosis		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"pancreas: 59.3"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 20.1;Early spermatids: 14.7;Exocrine glandular cells: 9.7;Late spermatids: 28.0;Paneth cells: 12.5;Spermatocytes: 46.5;Spermatogonia: 30.0"	"Cancer enhanced"	"Detected in some"		"renal cancer: 1.3;testis cancer: 1.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA002950	Approved					NA	NA					"HPA002950: AB_1080249"	"unprognostic (6.78e-3)"	"unprognostic (3.57e-3)"	"unprognostic (2.87e-3)"	"unprognostic (7.77e-2)"	"unprognostic (7.75e-3)"	"unprognostic (2.14e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.74e-1)"	"unprognostic (8.30e-2)"	"unprognostic (5.74e-3)"	"unprognostic (2.88e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.03e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.56e-2)"	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	3.2	1.4	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	59.3	0.0	0.0	0.2	0.0	0.1	1.5	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.9	0.5	11.7	0.0	0.1	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.5	0.0	0.0	0.0	0.0	0.0	20.1	0.0	0.0	14.7	0.1	0.0	0.2	1.2	0.0	2.6	9.7	0.0	1.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	2.2	0.8	0.0	0.0	0.3	28.0	0.6	0.1	0.0	0.0	0.6	0.0	0.0	2.0	1.9	0.5	12.5	0.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	46.5	30.0	0.0	0.1	0.0	0.0	0.1	1.5	0.0
TFAP2C	"AP2-GAMMA, ERF1, hAP-2g, TFAP2G"	ENSG00000087510	"Transcription factor AP-2 gamma"	Q92754	20	56629306-56639283	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 29.3;skin 1: 53.7"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 132.4;Basal squamous epithelial cells: 120.1;Breast glandular cells: 66.1;Breast myoepithelial cells: 79.6;Cytotrophoblasts: 91.7;Extravillous trophoblasts: 59.7;Squamous epithelial cells: 81.0;Suprabasal keratinocytes: 149.3;Syncytiotrophoblasts: 105.6"	"Cancer enhanced"	"Detected in many"		"testis cancer: 54.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"BEWO: 190.6;MCF7: 169.2;SK-BR-3: 308.9;T-47d: 86.8;WM-115: 114.7"	"Region enriched"	"Detected in single"	13	"olfactory bulb: 2.4"	"Region enhanced"	"Detected in single"		"olfactory bulb: 1.4"	"CAB016061, CAB016079, HPA055179, HPA057076"	Enhanced		Supported	Nucleoplasm		Yes	NA			Nucleoplasm		"CAB016061: AB_667770, CAB016079: AB_2199447, HPA055179: AB_2682729, HPA057076: AB_2683329"	"unprognostic (1.74e-2)"	"prognostic favorable (6.90e-4)"	"unprognostic (2.24e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.52e-2)"	"unprognostic (6.75e-2)"	"unprognostic (2.54e-2)"	"unprognostic (8.26e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.14e-3)"	"unprognostic (2.63e-1)"	"unprognostic (9.04e-5)"	"unprognostic (2.31e-1)"	"unprognostic (1.85e-1)"	"unprognostic (6.71e-2)"	"unprognostic (3.28e-2)"	1.1	0.3	1.3	0.2	0.6	0.1	26.3	0.4	1.5	18.3	0.5	3.2	0.2	6.3	5.3	29.3	2.7	1.0	0.3	1.7	5.1	0.9	0.0	2.7	0.1	0.9	0.8	0.8	0.3	1.0	2.7	0.8	17.1	1.1	7.1	1.2	2.7	20.9	4.5	2.1	53.7	0.3	1.1	0.5	0.1	0.7	1.0	0.6	0.7	2.4	0.1	3.0	4.0	19.4	1.2	12.8	15.8	0.1	0.2	0.0	0.0	190.6	20.1	36.4	25.0	4.5	3.2	0.3	0.0	1.3	13.3	13.3	42.7	27.3	5.5	17.0	0.1	2.8	0.0	1.7	0.0	0.0	0.0	1.7	0.3	21.4	7.4	7.2	0.0	0.0	8.1	0.2	3.2	0.0	169.2	20.8	1.2	9.5	9.9	20.7	0.1	0.0	7.0	0.0	10.1	5.1	0.1	13.6	308.9	21.8	28.3	86.8	4.6	0.2	16.2	0.4	8.6	15.4	0.1	0.0	0.1	4.0	0.1	114.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.6	0.4	1.5	1.7	5.1	0.9	0.8	0.8	1.1	0.5	0.6	1.2	0.7	0.0	9.5	3.9	0.3	132.4	29.9	2.4	120.1	4.1	66.1	79.6	1.0	0.0	5.6	9.2	0.0	91.7	1.5	1.7	0.0	0.3	0.3	7.8	18.7	2.0	3.0	0.0	0.0	0.0	59.7	7.4	1.5	16.0	0.0	0.0	0.7	0.0	7.8	0.0	0.0	1.7	10.2	0.3	8.2	0.0	0.0	1.6	21.4	3.7	0.0	0.3	0.0	0.0	0.0	1.0	0.6	0.0	3.8	18.6	0.0	0.0	5.2	0.0	0.0	0.5	2.1	0.0	1.8	81.0	149.3	105.6	1.3	0.0	1.0	18.5
TFCP2L1	"CRTR1, LBP-9"	ENSG00000115112	"Transcription factor CP2 like 1"	Q9NZI6	2	121216587-121285202	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 49.1;salivary gland: 98.4"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 79.1;Distal enterocytes: 117.9;Glandular and luminal cells: 83.0;Ionocytes: 262.4"	"Cancer enhanced"	"Detected in many"		"testis cancer: 21.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 18.2;HEL: 15.7;hTCEpi: 17.3;RPTEC TERT1: 42.4;RT4: 31.8;SCLC-21H: 13.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA029708	Uncertain		Approved	"Nucleoli fibrillar center,Mitochondria"		Yes	NA			"Nucleoli fibrillar center"	Mitochondria	"HPA029708: AB_10602479"	"unprognostic (8.85e-3)"	"unprognostic (4.19e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.32e-2)"	"unprognostic (3.16e-1)"	"unprognostic (3.25e-2)"	"unprognostic (2.72e-3)"	"unprognostic (1.20e-3)"	"unprognostic (5.76e-2)"	"prognostic favorable (7.72e-6)"	"unprognostic (1.05e-1)"	"unprognostic (2.39e-1)"	"unprognostic (6.67e-3)"	"unprognostic (2.01e-1)"	1.4	0.4	0.7	1.7	1.3	0.2	29.0	1.7	1.1	18.3	15.3	19.2	0.6	0.5	8.4	13.4	3.6	3.0	0.2	1.7	0.8	49.1	0.2	5.6	0.2	1.6	2.0	0.1	0.1	6.5	2.6	0.8	7.5	1.0	13.7	22.8	0.0	98.4	2.0	2.7	30.1	3.2	0.6	0.6	1.8	16.4	1.1	1.9	0.2	37.9	0.1	1.2	1.9	11.0	1.0	0.0	1.6	0.0	0.1	0.0	0.0	18.2	0.0	0.0	0.0	0.0	1.5	1.1	0.0	0.7	0.0	0.7	0.4	4.4	4.5	0.0	0.0	3.2	15.7	0.0	0.0	0.0	0.0	0.6	0.0	17.3	0.0	4.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	7.9	0.1	0.0	0.5	2.1	42.4	31.8	13.3	0.1	1.7	0.1	0.0	6.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.3	1.7	1.1	1.7	0.8	1.6	2.0	0.1	1.0	0.6	1.9	1.0	0.1	6.4	28.8	3.9	0.3	1.7	38.0	10.3	28.5	0.0	22.1	11.6	2.6	17.2	35.4	79.1	0.0	32.2	0.9	117.9	31.3	2.7	0.1	43.5	5.8	1.0	10.2	0.0	0.2	1.5	2.3	0.8	58.6	83.0	0.0	1.2	0.0	0.4	4.9	0.0	0.3	31.2	262.4	4.6	0.8	0.5	0.3	5.5	7.2	9.4	0.2	0.5	0.0	0.0	0.1	7.4	28.0	0.0	2.1	36.3	0.3	27.7	11.9	0.0	0.0	1.9	1.1	0.1	1.5	41.0	3.3	20.2	1.1	9.5	44.3	40.7
TFDP3	"CT30, E2F-like, HCA661"	ENSG00000183434	"Transcription factor Dp family member 3"	Q5H9I0	X	133216662-133218354	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	35	"testis: 4.3"	"Group enriched"	"Detected in some"	17	"Spermatocytes: 23.5;Spermatogonia: 31.1"	"Cancer enhanced"	"Detected in some"		"liver cancer: 0.7;testis cancer: 1.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA077304			Supported	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			"Nucleoplasm, Nuclear membrane"	Cytosol	"HPA077304: "	"unprognostic (1.57e-1)"								"unprognostic (2.17e-1)"					"unprognostic (3.22e-1)"	"unprognostic (2.91e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	23.5	31.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TIAM1		ENSG00000156299	"TIAM Rac1 associated GEF 1"	Q13009	21	31118416-31559977	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 203.5"	"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 327.3;Microglial cells: 133.0;Oligodendrocyte precursor cells: 120.6;Oligodendrocytes: 124.6;Suprabasal keratinocytes: 143.3"	"Cancer enhanced"	"Detected in many"		"testis cancer: 15.1"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 17.4;intermediate monocyte: 15.3;memory CD4 T-cell: 12.5;myeloid DC: 9.6;naive CD4 T-cell: 16.2;NK-cell: 11.3;non-classical monocyte: 22.0;T-reg: 27.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 34.5;HEL: 34.7;HMC-1: 29.1;RT4: 35.5;SCLC-21H: 32.6"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 245.9"	"CAB010416, HPA034853"	Enhanced		Supported	"Nucleoplasm,Nuclear membrane,Cell Junctions,Cytokinetic bridge,Cytosol"		Yes	NA			"Nucleoplasm, Cell Junctions"	"Nuclear membrane, Cytokinetic bridge, Cytosol"	"CAB010416: AB_2240410, HPA034853: "	"unprognostic (9.59e-2)"	"unprognostic (7.44e-3)"	"unprognostic (5.64e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.81e-3)"	"unprognostic (2.84e-2)"	"unprognostic (3.73e-1)"	"unprognostic (8.08e-2)"	"unprognostic (2.70e-3)"	"unprognostic (7.97e-3)"	"unprognostic (9.52e-2)"	"unprognostic (1.20e-3)"	"unprognostic (2.38e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.21e-1)"	6.6	12.8	40.7	6.7	35.9	2.9	5.5	203.5	49.6	15.2	14.8	4.6	1.7	10.0	3.3	40.0	11.1	4.6	3.8	51.8	29.0	5.4	7.9	5.9	11.2	28.0	41.7	33.6	3.4	2.2	0.3	13.0	4.3	76.2	9.1	3.1	8.7	5.7	3.4	0.9	26.6	5.0	11.1	29.5	5.2	2.4	10.5	36.1	18.9	2.0	0.8	11.2	12.2	18.7	30.3	2.9	1.0	21.7	1.3	0.4	4.9	34.5	0.0	0.0	2.7	0.9	0.2	3.9	7.6	1.5	0.5	4.0	5.1	2.5	4.4	4.3	0.6	12.0	34.7	0.7	0.2	0.5	0.0	29.1	2.2	1.5	14.7	5.9	2.6	0.0	11.3	0.0	10.9	11.1	14.7	5.4	0.2	7.1	5.3	9.4	7.0	6.8	0.0	3.3	35.5	32.6	8.1	1.5	11.4	1.3	7.5	4.7	0.1	0.2	3.1	12.5	0.0	1.5	12.3	9.9	6.6	7.2	2.6	24.2	1.5	17.4	0.0	0.5	15.3	3.1	0.1	12.5	2.4	9.6	0.0	16.2	1.0	1.0	11.3	22.0	0.5	27.8	5.9	40.7	35.9	203.5	49.6	51.8	29.0	28.0	41.7	33.6	76.2	29.5	36.1	30.3	3.7	3.2	2.3	21.2	1.7	83.7	65.6	3.0	22.8	8.9	4.9	1.9	1.1	1.5	11.8	0.0	2.1	10.1	8.0	1.3	0.0	1.8	11.7	25.2	2.2	31.4	5.4	2.7	43.9	0.7	29.7	11.4	2.0	28.4	24.1	2.0	35.0	5.5	8.1	74.0	327.3	0.4	10.2	22.9	73.4	11.3	34.5	26.3	10.6	133.0	37.3	35.2	4.1	120.6	124.6	1.8	11.6	58.3	3.2	30.8	0.0	0.5	1.2	4.6	6.6	0.9	2.1	1.3	9.8	60.2	143.3	10.7	16.3	82.6	1.2	106.7
TMEM266	"C15orf27, FLJ38190"	ENSG00000169758	"Transmembrane protein 266"	Q2M3C6	15	76059958-76229121	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 8.5;skeletal muscle: 5.9;tongue: 2.3"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 10.4;Cytotrophoblasts: 16.0;Early spermatids: 7.0;Late spermatids: 19.7;Rod photoreceptor cells: 9.1;Sertoli cells: 6.6;Spermatogonia: 6.3"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.3"	"Region enhanced"	"Detected in many"		"cerebellum: 8.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"NTERA-2: 1.3"	"Region enriched"	"Detected in all"	6	"cerebellum: 58.7"	"Region enriched"	"Detected in many"	5	"cerebellum: 26.8"	"HPA041921, HPA049425"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA041921: AB_10796789, HPA049425: AB_2732552"	"unprognostic (8.63e-3)"	"unprognostic (6.11e-3)"	"unprognostic (3.44e-3)"	"unprognostic (9.17e-5)"	"unprognostic (4.67e-1)"	"unprognostic (2.61e-2)"	"unprognostic (9.34e-3)"	"unprognostic (5.61e-2)"	"unprognostic (8.48e-3)"	"unprognostic (2.89e-2)"	"unprognostic (1.18e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.68e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.13e-2)"	"unprognostic (7.86e-2)"	0.0	0.9	0.9	0.0	1.1	0.0	0.1	8.5	1.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.2	0.5	0.0	0.5	0.1	0.6	1.2	1.0	0.0	1.1	0.0	1.2	0.9	2.9	0.1	0.0	1.1	0.0	0.0	5.9	0.5	0.0	0.0	0.5	0.1	0.0	0.6	1.3	0.3	0.0	2.3	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.6	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.1	8.5	1.7	1.2	1.2	0.6	1.2	1.0	2.9	0.5	1.3	1.0	0.2	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	4.3	0.5	0.5	0.0	0.0	0.0	1.8	10.4	16.0	0.0	0.0	1.9	0.0	7.0	0.2	0.1	0.4	0.0	0.0	0.0	0.2	2.2	0.9	1.5	0.1	0.0	0.2	0.4	0.4	4.5	1.7	0.0	0.0	0.0	0.3	0.0	19.7	0.0	0.4	0.0	0.0	0.0	0.5	1.0	0.0	0.0	0.1	0.0	0.7	0.0	1.0	0.0	0.7	1.5	9.1	6.6	1.3	0.2	0.5	6.3	0.0	0.0	5.9	0.2	0.5	0.0	0.7
TMEM31	MGC39655	ENSG00000179363	"Transmembrane protein 31"	Q5JXX7	X	103710909-103714032	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	32	"testis: 110.9"	"Cell type enriched"	"Detected in some"	5	"Late spermatids: 3288.8"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.8;BEWO: 4.3;MCF7: 6.4;NTERA-2: 1.8;U-937: 2.4"					"Low region specificity"	"Detected in all"			HPA052760			Approved	"Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"		"HPA052760: "	"unprognostic (9.42e-5)"	"unprognostic (1.46e-2)"	"unprognostic (1.18e-1)"	"unprognostic (7.51e-2)"	"unprognostic (7.75e-3)"	"unprognostic (1.22e-2)"	"unprognostic (2.43e-1)"	"unprognostic (4.50e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.39e-2)"	"unprognostic (3.77e-1)"	"unprognostic (5.91e-5)"	"unprognostic (1.75e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.72e-1)"	"unprognostic (4.68e-2)"	0.3	0.2	2.4	0.1	2.6	0.0	0.6	2.4	3.4	1.4	1.8	0.2	0.0	0.7	0.5	0.1	1.0	0.2	0.3	2.3	2.4	0.5	0.3	0.3	0.2	2.5	2.4	2.1	1.8	0.2	1.3	0.9	0.9	2.6	0.6	0.0	0.2	0.2	0.3	1.0	0.4	0.2	0.1	2.3	0.4	0.2	110.9	2.5	0.3	0.3	0.0	0.0	0.4	0.6	2.9	0.0	0.0	1.8	0.1	0.1	0.0	4.3	0.1	0.0	0.2	0.3	0.0	0.2	0.0	0.1	0.0	0.3	0.0	0.7	0.0	0.2	0.0	1.6	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.2	6.4	0.1	1.2	1.8	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.5	0.3	0.4	0.0	0.2	0.8	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.5	0.0	2.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.3	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	2.4	2.6	2.4	3.4	2.3	2.4	2.5	2.4	2.1	2.6	2.3	2.5	2.9	0.3	0.0	0.0	0.0	0.0	0.8	0.7	0.2	0.0	0.0	0.4	1.5	0.2	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.2	641.3	10.1	0.4	1.1	0.0	0.0	0.2	0.7	8.6	0.6	0.0	0.2	0.0	1.1	0.7	0.2	0.4	0.0	0.1	0.1	0.0	0.3	0.3	3288.8	13.4	1.2	0.0	0.0	0.0	0.0	0.0	0.5	0.7	0.1	0.0	7.5	0.0	0.3	0.0	0.2	0.0	0.0	13.1	0.3	0.3	19.6	12.1	0.0	0.3	2.9	0.0	0.2	0.0	0.2
TRAJ49		ENSG00000211840	"T cell receptor alpha joining 49"		14	22489488-22489543	"Predicted intracellular proteins, T-cell receptor genes"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in some"	38	"retina: 410.0"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"testis cancer: 0.7"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	9	"gdT-cell: 257.1;memory CD4 T-cell: 196.1;memory CD8 T-cell: 121.1;naive CD4 T-cell: 200.3;naive CD8 T-cell: 146.4;NK-cell: 104.2;T-reg: 361.0"	"Group enriched"	"Detected in all"	10	"NK-cells: 104.2;T-cells: 361.0"	"Cell line enhanced"	"Detected in some"		"RH-30: 3.2;SH-SY5Y: 5.0;U-266/84: 15.4;U-698: 3.7"															NA	NA																							0.0	0.0	0.4	10.6	0.8	2.8	0.0	1.4	1.3	0.0	1.2	4.5	4.7	0.0	0.0	0.0	0.0	0.0	5.0	0.4	1.6	0.0	0.8	0.8	3.6	2.2	3.8	0.4	0.0	0.0	0.0	0.0	0.0	1.9	0.8	2.9	410.0	0.0	0.0	0.0	0.0	3.5	0.0	0.2	8.2	7.7	0.4	1.0	3.8	0.0	0.0	3.0	0.5	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	3.7	0.0	0.0	0.0	0.7	2.5	0.2	257.1	0.2	1.1	23.2	196.1	121.1	0.3	2.0	200.3	146.4	3.3	104.2	1.8	1.8	361.0	73.9	0.4	0.8	1.4	1.3	0.4	1.6	2.2	3.8	0.4	1.9	0.2	1.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TRBV20OR9-2	"TCRBV20S2, TCRBV2O, TCRBV2S2O, TRBV20/OR9-2"	ENSG00000205274	"T cell receptor beta variable 20/OR9-2 (non-functional)"		9	33617762-33618506	"Predicted intracellular proteins, T-cell receptor genes"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in some"	4	"brain: 12.1"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"testis cancer: 1.0"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"T-reg: 17.0"	"Lineage enriched"	"Detected in single"	31	"T-cells: 17.0"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.2;HEL: 1.4;MOLT-4: 1.0;RH-30: 5.0;SuSa: 1.1"															NA	NA							"unprognostic (1.53e-1)"				"unprognostic (3.70e-2)"						"unprognostic (3.01e-2)"			"unprognostic (1.31e-1)"		"unprognostic (1.51e-1)"	0.0	0.0	0.6	0.1	1.1	0.0	0.0	1.5	2.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.9	0.0	0.0	0.0	0.0	5.8	6.5	0.7	0.0	0.8	0.0	2.9	2.1	12.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.0	0.0	0.8	2.4	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.5	0.0	0.0	0.0	0.0	1.2	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.0	1.0	0.3	0.3	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.2	0.0	5.7	0.0	6.9	4.0	0.0	0.0	6.4	5.3	0.0	0.0	0.0	0.0	17.0	1.9	0.6	1.1	1.5	2.3	0.6	1.9	5.8	6.5	0.7	12.1	1.3	2.4	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TRDV1	hDV101S1	ENSG00000211804	"T cell receptor delta variable 1"	A0A1B0GX56	14	22096032-22096619	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"lymphoid tissue: 76.0"	"Group enriched"	"Detected in some"	8	"Plasma cells: 2.1;T-cells: 7.9"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.0"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in many"	21	"gdT-cell: 1071.6"	"Lineage enriched"	"Detected in many"	198	"T-cells: 1071.6"	"Not detected"	"Not detected"																	NA	NA						"unprognostic (1.59e-4)"	"unprognostic (2.31e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.09e-3)"		"unprognostic (3.18e-3)"	"unprognostic (1.51e-2)"	"unprognostic (4.21e-5)"	"unprognostic (6.57e-2)"	"unprognostic (1.83e-4)"	"unprognostic (3.39e-1)"	"unprognostic (2.21e-1)"	"unprognostic (3.20e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.01e-2)"	"unprognostic (4.69e-2)"	0.3	0.2	0.0	2.1	0.0	1.0	0.3	0.0	0.0	0.5	0.0	4.7	0.5	0.2	0.0	0.1	0.3	2.6	0.0	0.0	0.3	0.0	0.8	3.5	10.4	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.1	0.2	2.6	0.0	0.3	0.6	0.3	0.1	0.7	0.1	0.0	20.1	1.8	1.3	0.0	76.0	1.1	0.0	5.7	0.9	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.6	0.4	1071.6	0.6	3.3	1.4	26.0	27.4	0.0	0.3	23.8	51.7	5.4	0.1	1.1	1.2	43.5	55.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0
TRIM6	RNF89	ENSG00000121236	"Tripartite motif containing 6"	Q9C030	11	5596109-5612958	"Enzymes, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 21.1"	"Cell type enriched"	"Detected in many"	4	"Proximal tubular cells: 74.4"	"Cancer enhanced"	"Detected in many"		"testis cancer: 7.8"	"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 22.2;SuSa: 36.7;TIME: 19.2;U-2 OS: 21.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA060514	Uncertain					NA	NA					"HPA060514: AB_2684300"	"unprognostic (9.00e-2)"	"unprognostic (2.10e-3)"	"unprognostic (9.16e-3)"	"unprognostic (1.82e-1)"	"unprognostic (3.25e-3)"	"unprognostic (3.25e-3)"	"unprognostic (2.35e-2)"	"unprognostic (3.26e-3)"	"unprognostic (8.59e-2)"	"unprognostic (3.40e-2)"	"unprognostic (8.61e-2)"	"unprognostic (3.90e-1)"	"unprognostic (5.68e-2)"	"unprognostic (4.65e-4)"	"unprognostic (4.77e-1)"	"unprognostic (3.33e-2)"	"unprognostic (4.36e-1)"	2.8	3.8	0.4	1.8	0.3	2.0	3.3	0.2	0.4	1.9	0.8	1.7	0.5	3.3	4.9	4.3	3.2	2.3	0.9	0.2	1.1	21.1	0.8	2.1	0.7	0.7	0.5	0.3	4.4	1.3	1.3	0.9	5.4	0.5	2.6	1.7	0.2	10.6	3.6	0.8	1.0	1.1	5.2	0.6	3.8	1.0	9.4	0.5	1.3	3.9	0.6	1.3	2.6	2.8	0.7	0.7	16.2	1.1	0.0	2.0	2.9	18.7	4.4	3.3	4.3	4.2	0.4	3.6	0.0	2.5	4.5	12.1	2.9	7.5	6.7	6.1	0.6	5.0	2.0	1.6	0.1	0.7	6.6	8.7	5.1	6.4	6.2	4.3	6.4	3.8	0.1	8.0	0.2	1.8	0.2	0.0	0.9	22.2	2.6	5.7	7.7	0.0	0.1	0.9	6.6	0.1	0.2	0.0	8.4	0.8	36.7	3.2	1.1	19.2	4.0	21.3	0.1	4.7	0.2	0.1	0.0	3.7	0.0	3.5	0.2	0.2	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	1.1	0.3	0.0	0.2	0.0	0.1	0.4	0.3	0.2	0.4	0.2	1.1	0.7	0.5	0.3	0.5	0.6	0.5	0.7	1.2	0.0	4.8	0.0	0.1	0.5	0.6	0.5	1.8	0.0	3.1	1.8	0.4	0.0	0.8	1.8	0.0	12.5	0.0	0.2	3.9	1.2	1.2	0.7	1.7	1.5	0.0	2.1	0.0	0.2	15.5	2.1	0.0	1.0	0.0	4.1	0.0	0.5	3.1	0.0	0.0	0.3	2.0	3.5	0.3	0.8	0.9	1.1	1.8	0.0	2.2	0.0	0.0	0.0	0.0	0.6	0.1	1.9	0.0	0.4	0.3	74.4	1.1	0.0	0.0	0.5	0.7	10.8	3.3	1.8	0.4	5.7	0.4	4.1	0.2	0.3
TRIM61	RNF35	ENSG00000183439	"Tripartite motif containing 61"	Q5EBN2	4	164954446-164977668	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Early spermatids: 34.5;Late spermatids: 14.0;Spermatocytes: 50.1"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 15.1;SuSa: 10.2;U-266/70: 17.2"	"Not detected"	"Not detected"							HPA049109	Uncertain		Approved	"Nucleoli fibrillar center,Endoplasmic reticulum"		NA	NA			"Nucleoli fibrillar center, Endoplasmic reticulum"		"HPA049109: AB_2680636"	"unprognostic (2.05e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.02e-2)"	"unprognostic (8.24e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.98e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.67e-1)"	"unprognostic (2.92e-1)"	"unprognostic (9.77e-5)"	"unprognostic (4.61e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.32e-2)"	2.1	3.6	1.9	2.2	2.4	3.7	1.3	2.2	2.5	2.9	0.6	1.4	1.9	1.5	2.2	1.0	3.6	2.9	3.0	1.9	2.7	1.0	1.1	2.3	3.2	2.5	2.1	1.9	5.0	1.4	1.2	1.0	1.7	2.3	1.8	1.4	2.8	0.9	2.0	0.9	1.1	1.4	2.2	1.5	2.1	1.3	8.9	2.5	2.6	5.7	1.4	2.9	2.3	0.2	2.8	0.9	0.8	2.0	2.1	1.1	1.1	1.2	4.2	1.3	0.9	0.8	0.7	1.4	0.9	1.1	5.3	1.0	1.0	1.4	1.5	0.9	1.6	0.8	1.6	1.5	0.9	15.1	1.6	1.4	9.0	1.3	3.7	1.4	8.5	0.8	1.3	1.8	3.6	0.8	1.0	1.4	1.0	6.5	1.0	0.7	1.4	1.1	1.2	0.6	2.6	1.7	1.1	1.0	1.5	1.2	10.2	0.5	1.6	0.9	2.7	1.8	0.9	1.7	17.2	8.2	2.3	1.0	0.9	1.9	5.4	1.4	0.1	2.9	1.2	3.3	3.5	1.8	3.3	1.5	5.8	4.4	3.6	0.3	8.0	1.1	4.1	0.8	1.4	1.9	2.4	2.2	2.5	1.9	2.7	2.5	2.1	1.9	2.3	1.5	2.5	2.8	0.2	0.0	3.3	1.0	3.8	0.3	1.2	0.4	0.0	1.1	0.1	0.1	2.3	0.0	0.2	3.7	4.2	0.3	2.3	0.0	0.0	0.3	34.5	0.4	2.1	0.9	0.0	1.3	1.9	0.7	0.0	1.6	0.5	0.1	0.0	4.8	0.0	0.4	1.1	1.7	1.4	0.0	0.0	0.6	0.7	14.0	1.2	0.9	0.0	0.0	1.7	2.7	1.0	3.5	4.3	0.1	0.1	1.5	6.4	0.6	0.0	3.7	0.1	0.4	0.0	1.5	1.3	50.1	3.7	0.2	0.0	0.3	2.2	2.8	0.0	0.6
TRO	"KIAA1114, MAGE-D3, MAGED3"	ENSG00000067445	Trophinin	Q12816	X	54920462-54931431	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 31.4"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 9.4;Excitatory neurons: 14.6;Granulosa cells: 12.3;Inhibitory neurons: 20.0;Oligodendrocyte precursor cells: 17.1;Oligodendrocytes: 9.4"	"Cancer enhanced"	"Detected in many"		"testis cancer: 11.7"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"NK-cell: 2.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AF22: 37.1;SH-SY5Y: 33.8;SuSa: 74.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071449			Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA			Vesicles	"Plasma membrane, Cytosol"	"HPA071449: "	"unprognostic (6.18e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.24e-2)"	"prognostic unfavorable (4.41e-5)"	"unprognostic (9.09e-3)"	"unprognostic (2.72e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.67e-2)"	"unprognostic (3.18e-1)"	"prognostic favorable (1.93e-4)"	"unprognostic (1.17e-1)"	"unprognostic (3.19e-2)"	"unprognostic (1.67e-4)"	"unprognostic (6.33e-2)"	"unprognostic (3.27e-2)"	"unprognostic (6.86e-2)"	3.7	3.0	10.4	1.3	10.9	1.0	3.8	0.7	23.9	9.3	0.7	2.5	0.9	13.5	6.6	1.6	5.4	4.3	1.9	10.8	11.2	3.9	16.9	2.1	1.6	5.5	3.5	9.1	17.7	7.2	5.3	24.5	4.4	10.9	5.5	2.1	6.2	1.5	5.3	31.4	1.2	1.6	8.7	1.7	1.0	2.0	2.6	8.3	4.7	10.2	1.0	1.6	2.6	5.5	13.6	0.0	0.3	37.1	0.1	7.1	9.8	0.0	2.1	13.1	2.0	0.7	0.0	0.0	0.0	5.3	13.8	3.1	0.2	0.3	0.6	1.0	0.1	23.3	18.0	0.0	1.5	2.7	0.0	0.1	22.8	0.0	12.0	0.0	11.8	0.9	9.1	0.0	0.2	14.0	0.0	0.3	0.1	19.6	0.1	0.0	11.3	16.4	0.1	3.5	0.3	25.3	33.8	0.0	0.5	3.1	74.2	0.0	2.2	0.0	15.7	15.9	0.2	2.2	5.8	0.9	0.0	2.3	0.0	13.8	0.0	0.0	0.0	0.4	0.0	0.2	0.2	0.0	0.1	0.0	0.1	0.1	0.2	0.0	2.2	0.1	0.9	0.0	0.1	10.4	10.9	0.7	23.9	10.8	11.2	5.5	3.5	9.1	10.9	1.7	8.3	13.6	0.4	0.0	0.0	9.4	0.3	0.4	1.4	0.8	5.2	4.2	0.5	1.9	1.8	0.0	1.9	3.7	0.0	0.8	0.2	0.0	0.0	1.7	0.4	0.3	7.9	1.9	0.0	0.0	14.6	0.2	0.6	7.0	0.5	0.5	1.3	12.3	0.4	0.0	0.5	8.4	20.0	0.0	0.0	0.0	0.4	0.6	5.9	0.2	0.0	1.0	0.1	2.2	0.0	17.1	9.4	0.2	0.0	3.8	0.1	0.4	0.0	0.4	0.0	0.9	0.0	1.5	3.3	1.2	1.9	0.1	0.1	0.7	0.7	2.9	0.0	0.3
TRPM6	"CHAK2, FLJ22628, HOMG, HSH"	ENSG00000119121	"Transient receptor potential cation channel subfamily M member 6"	Q9BX84	9	74722495-74888094	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant, Primary hypomagnesemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 6.8;intestine: 16.7"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 128.9;Glandular and luminal cells: 36.5;Microglial cells: 39.4;Oligodendrocytes: 81.1;Proximal enterocytes: 23.3"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.8"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 23.1;neutrophil: 7.5"	"Lineage enriched"	"Detected in single"	41	"granulocytes: 23.1"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.8;HeLa: 2.4;Karpas-707: 1.3;RT4: 3.8;U-266/70: 1.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (3.95e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.65e-1)"	"unprognostic (7.80e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.84e-1)"	"unprognostic (5.72e-4)"	"unprognostic (1.58e-1)"	"unprognostic (1.71e-2)"	"unprognostic (8.10e-2)"	"unprognostic (7.54e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.11e-2)"	0.5	0.0	2.1	0.6	3.4	2.7	0.6	2.9	2.4	0.3	0.6	13.3	7.1	0.3	0.2	0.3	0.2	0.3	0.2	1.5	2.7	2.0	0.1	0.3	0.3	3.8	3.6	1.1	0.0	0.1	1.4	0.5	0.3	4.3	0.5	16.7	0.5	0.3	0.1	0.1	0.7	7.9	0.5	3.1	0.5	0.2	1.4	3.1	0.4	0.2	0.1	0.3	0.4	0.3	6.8	0.0	0.8	0.1	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	1.0	0.1	0.3	0.0	0.0	0.1	0.1	0.2	0.2	0.0	0.0	0.1	0.1	2.4	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	1.3	0.0	0.5	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	3.8	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.5	0.1	0.0	1.4	0.0	0.1	0.0	0.1	0.1	23.1	0.1	2.4	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.3	0.1	0.1	7.5	0.5	0.2	0.3	0.0	0.1	2.1	3.4	2.9	2.4	1.5	2.7	3.8	3.6	1.1	4.3	3.1	3.1	6.8	3.3	0.0	1.7	1.0	0.3	0.1	1.9	0.3	2.2	0.3	0.2	0.4	0.9	0.0	1.3	3.7	0.0	0.2	0.2	128.9	0.0	0.0	4.0	11.3	3.4	3.2	3.6	0.0	1.3	0.0	0.1	0.3	0.0	36.5	0.0	0.1	3.3	0.1	0.0	0.0	0.5	3.0	0.0	0.3	0.6	0.9	0.0	0.4	0.0	39.4	0.0	0.3	0.0	0.5	81.1	0.0	13.8	0.4	0.1	1.3	23.3	0.0	0.8	2.7	0.0	0.7	0.4	1.6	2.4	0.5	1.0	0.1	0.5	0.2	7.5	0.8
TSACC	"C1orf182, SIP, SSTK-IP"	ENSG00000163467	"TSSK6 activating cochaperone"	Q96A04	1	156337314-156346995	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	283	"testis: 932.1"	"Group enriched"	"Detected in many"	6	"Early spermatids: 6594.1;Late spermatids: 20555.9"	"Cancer enhanced"	"Detected in many"		"testis cancer: 5.3"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	8	"basophil: 15.2"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 15.2"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			HPA029897			Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nuclear bodies"	Nucleoplasm	"HPA029897: AB_2756315"	"unprognostic (3.95e-1)"	"unprognostic (5.82e-3)"	"unprognostic (8.24e-2)"	"unprognostic (9.34e-2)"	"unprognostic (1.04e-1)"	"unprognostic (8.36e-3)"	"unprognostic (1.18e-2)"	"unprognostic (5.95e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.53e-2)"	"unprognostic (4.85e-2)"	"unprognostic (2.63e-6)"	"unprognostic (1.05e-1)"	"unprognostic (6.78e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.28e-2)"	0.4	1.5	1.6	0.9	1.5	0.6	1.0	2.0	2.1	0.4	1.5	0.4	0.8	0.3	2.4	0.6	0.4	0.6	0.4	2.2	1.3	1.0	1.8	0.2	1.0	1.6	1.6	1.0	0.3	0.6	0.7	0.5	0.5	2.2	1.3	0.4	2.3	0.5	0.9	0.9	0.4	0.8	0.1	1.2	0.4	0.5	932.1	1.8	0.2	1.0	0.4	0.5	0.3	0.3	3.2	2.7	3.7	1.6	1.8	1.1	2.1	2.9	1.3	0.7	1.7	1.9	3.4	1.9	4.0	2.1	0.8	1.9	3.1	3.1	0.3	1.6	2.3	6.7	2.8	6.3	3.7	0.8	2.5	2.3	0.8	5.1	1.7	2.3	1.0	0.5	3.8	7.6	2.5	0.3	4.8	2.5	1.5	5.0	6.7	4.4	2.8	0.6	4.0	4.6	1.7	2.4	1.3	1.8	5.0	2.2	6.9	2.7	2.7	1.3	1.1	1.8	0.9	1.9	4.5	7.8	6.1	0.7	1.4	1.0	15.2	0.4	0.1	1.1	0.3	0.5	1.2	0.8	1.0	0.2	1.4	1.5	1.3	0.1	1.9	0.4	1.7	1.0	0.3	1.6	1.5	2.0	2.1	2.2	1.3	1.6	1.6	1.0	2.2	1.2	1.8	3.2	0.1	0.0	0.0	0.7	1.2	0.3	0.3	1.4	0.6	0.6	1.3	1.9	0.6	0.0	1.8	3.7	0.0	4.8	0.1	0.2	1.9	0.9	6594.1	2.4	0.4	4.7	0.0	0.4	0.5	0.6	1.7	0.2	1.1	0.9	0.0	0.4	0.0	3.7	1.1	0.0	0.4	0.7	0.0	0.8	0.0	20555.9	111.6	7.6	0.0	0.0	0.0	0.4	0.0	0.5	0.9	1.0	0.1	85.7	1.2	0.3	0.6	7.9	4.5	0.8	52.6	0.1	0.3	2124.8	93.8	1.5	0.4	2.7	0.7	0.5	0.5	0.6
TSBP1	"C6orf10, TSBP"	ENSG00000204296	"Testis expressed basic protein 1"	Q5SRN2	6	32288526-32371912	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	74	"testis: 35.3"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"testis cancer: 0.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA047479, HPA057426"	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA047479: , HPA057426: "	"unprognostic (1.00e-1)"	"unprognostic (2.24e-1)"				"unprognostic (1.05e-1)"		"unprognostic (5.63e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.14e-1)"		"unprognostic (1.55e-1)"	"unprognostic (4.32e-4)"	"unprognostic (2.42e-1)"	"unprognostic (8.19e-2)"	"unprognostic (6.56e-2)"		0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.1	0.2	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	35.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.3	0.3	0.4	0.2	0.2	0.3	0.1	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TUBA3C	"bA408E5.3, TUBA2"	ENSG00000198033	"Tubulin alpha 3c"	P0DPH7	13	19173772-19181824	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	714	"testis: 408.0"	"Group enriched"	"Detected in some"	25	"Early spermatids: 703.3;Late spermatids: 250.4;Spermatocytes: 947.8;Spermatogonia: 255.9"	"Cancer enhanced"	"Detected in many"		"liver cancer: 2.7;testis cancer: 2.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	49	"HDLM-2: 107.5;U-2 OS: 256.9;U-266/70: 84.2;U-266/84: 109.7"									"HPA039247, HPA043684, HPA063394"	Uncertain		Supported	Microtubules		NA	Yes			Microtubules		"HPA039247: AB_2676410, HPA043684: AB_2678617, HPA063394: AB_2685003"	"unprognostic (3.76e-3)"				"unprognostic (1.33e-1)"							"unprognostic (3.00e-1)"		"unprognostic (1.04e-1)"	"unprognostic (1.26e-1)"			0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	408.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.4	0.0	0.0	0.0	0.0	107.5	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.5	0.0	0.4	256.9	0.2	0.3	84.2	109.7	0.2	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	703.3	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	250.4	21.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.0	0.6	947.8	255.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0
TUBA3D	H2-ALPHA	ENSG00000075886	"Tubulin alpha 3d"	P0DPH8	2	131476119-131482934	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"testis: 221.9"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 358.9;Late spermatids: 119.6;Spermatocytes: 667.9;Spermatogonia: 326.1"	"Cancer enhanced"	"Detected in many"		"testis cancer: 7.6"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"NB-4: 1.1"	"Not detected"	"Not detected"							"CAB004972, HPA039247, HPA043684, HPA063394"	Uncertain		Supported	Microtubules		NA	NA			Microtubules		"CAB004972: AB_425727, HPA039247: AB_2676410, HPA043684: AB_2678617, HPA063394: AB_2685003"	"prognostic favorable (4.65e-4)"	"unprognostic (6.66e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.96e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.50e-3)"	"unprognostic (2.17e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.05e-1)"	"prognostic unfavorable (4.75e-9)"	"unprognostic (4.60e-2)"	"unprognostic (2.28e-1)"	"unprognostic (9.96e-4)"	"unprognostic (2.28e-1)"	0.1	0.1	0.4	0.2	0.2	0.4	0.6	1.5	0.4	2.0	0.0	0.1	0.1	4.9	6.9	0.2	4.1	0.2	47.7	0.7	0.1	0.1	0.4	0.1	0.4	0.3	0.0	0.2	0.5	0.2	0.0	0.1	0.0	0.7	10.2	0.0	0.3	0.3	0.4	0.1	0.6	0.2	0.3	0.1	0.2	0.2	221.9	0.1	0.0	0.3	0.0	0.0	0.1	0.3	0.2	0.5	0.2	0.2	0.9	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.8	0.3	0.3	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.7	0.1	0.6	0.3	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.3	0.0	0.5	0.5	1.1	0.7	0.0	0.3	0.4	0.0	0.2	0.0	0.2	0.5	0.1	0.2	0.0	0.0	0.2	0.1	0.0	0.2	0.3	0.4	0.5	0.3	0.1	0.2	0.2	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	1.5	0.4	0.7	0.1	0.3	0.0	0.2	0.7	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.3	0.4	36.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	358.9	0.4	1.1	1.2	0.0	0.0	0.4	0.0	0.1	0.6	0.0	1.1	0.0	0.4	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	119.6	12.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	10.1	0.0	4.8	0.0	0.0	0.0	0.0	52.6	0.0	0.1	667.9	326.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1
TUNAR	"HI-LNC78, LINC00617, TUNA"	ENSG00000250366	"TCL1 upstream neural differentiation-associated RNA"		14	95876392-95925663	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"brain: 34.4;fallopian tube: 8.6;retina: 8.6"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 4.1;Endometrial ciliated cells: 11.5;Endometrial stromal cells: 8.9;Excitatory neurons: 4.6;Glandular and luminal cells: 16.8;Spermatogonia: 3.5"	"Cancer enhanced"	"Detected in many"		"testis cancer: 3.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"AF22: 16.3;HAP1: 7.0;NTERA-2: 11.8;SCLC-21H: 16.1;SuSa: 4.6"															NA	NA						"unprognostic (1.28e-3)"			"unprognostic (3.94e-1)"	"unprognostic (4.10e-2)"					"unprognostic (1.69e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.34e-1)"	"prognostic favorable (1.55e-4)"	"unprognostic (5.33e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.18e-1)"		0.0	0.1	7.3	0.1	34.4	0.3	0.4	6.3	11.3	0.3	0.1	0.0	0.1	6.6	0.1	0.0	8.6	0.1	0.0	10.5	9.9	0.2	0.0	0.0	0.3	28.4	13.9	7.3	0.1	2.7	0.0	1.3	0.0	32.4	0.0	0.0	8.6	0.0	3.6	0.0	0.1	0.0	0.0	6.2	0.1	0.5	1.3	27.1	0.1	1.1	0.0	0.2	0.0	0.0	33.9	0.0	0.1	16.3	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.1	7.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.0	11.8	0.0	0.1	0.7	0.0	0.0	0.4	0.1	16.1	1.3	0.0	0.1	0.0	4.6	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	34.4	6.3	11.3	10.5	9.9	28.4	13.9	7.3	32.4	6.2	27.1	33.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.3	0.0	0.0	0.0	2.1	0.0	1.3	0.0	0.0	0.0	2.8	11.5	8.9	0.1	0.0	0.0	4.6	0.0	0.0	0.0	0.0	16.8	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.7	0.0	0.0	0.1	0.1	3.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0
UPP1	"UDRPASE, UP, UPASE, UPP"	ENSG00000183696	"Uridine phosphorylase 1"	Q16831	7	48088628-48108736	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 67.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 250.1;Extravillous trophoblasts: 260.3;Macrophages: 199.5;Paneth cells: 260.8"	"Cancer enhanced"	"Detected in all"		"testis cancer: 62.8"	"Region enhanced"	"Detected in all"		"hypothalamus: 20.2"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in many"	4	"hTERT-HME1: 362.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA054040, HPA055394"	Enhanced		Enhanced	Nucleoplasm		No	No			Nucleoplasm		"HPA054040: AB_2682352, HPA055394: AB_2682805"	"unprognostic (1.16e-1)"	"prognostic unfavorable (1.02e-4)"	"unprognostic (5.96e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.21e-3)"	"unprognostic (6.36e-2)"	"unprognostic (1.78e-3)"	"prognostic unfavorable (1.97e-4)"	"unprognostic (3.81e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.52e-3)"	"unprognostic (2.95e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.39e-1)"	14.5	9.5	2.5	7.6	3.5	12.6	10.1	2.6	5.5	10.7	1.9	7.2	4.3	4.0	0.8	67.4	5.7	5.9	8.6	2.7	20.2	22.4	12.0	19.0	3.7	3.7	2.5	3.2	1.9	4.6	5.0	7.5	3.9	3.8	4.9	5.3	0.6	14.3	1.2	3.7	2.9	6.5	3.5	1.0	20.5	4.1	2.2	4.6	1.2	8.0	0.9	6.6	9.2	31.4	4.2	19.5	26.0	2.4	5.2	8.9	4.0	29.7	7.9	15.5	14.5	17.5	10.8	9.9	0.0	2.5	9.7	89.9	13.9	5.2	46.1	9.4	4.1	4.5	0.8	4.8	4.6	7.4	0.9	1.3	5.0	21.8	6.4	362.8	5.9	9.1	0.4	1.5	13.5	7.6	2.3	0.0	2.9	9.4	4.2	20.7	0.0	4.8	6.0	33.7	11.5	2.3	1.6	10.2	3.0	63.4	29.3	2.4	0.9	12.4	29.6	22.9	7.3	22.6	21.4	34.7	3.7	29.6	3.0	77.8	11.5	16.0	12.2	11.8	12.1	8.9	0.2	7.8	8.7	6.5	0.6	8.1	8.1	6.2	5.4	14.8	0.5	8.4	10.9	2.5	3.5	2.6	5.5	2.7	20.2	3.7	2.5	3.2	3.8	1.0	4.6	4.2	107.4	19.2	58.5	5.2	19.1	46.8	26.3	104.4	19.4	27.6	9.0	16.1	11.6	24.3	51.0	11.0	33.3	15.1	122.9	250.1	70.5	50.5	1.0	42.1	22.4	108.1	13.1	4.4	16.5	40.5	260.3	34.1	5.1	91.1	25.9	3.8	72.5	17.5	110.0	16.8	29.4	35.0	85.5	130.5	118.1	2.4	5.3	199.5	87.2	1.0	61.4	13.3	71.1	4.0	3.6	117.9	260.8	2.2	30.3	30.4	42.8	23.3	11.9	29.2	6.6	21.1	32.2	0.3	9.5	42.9	29.8	78.7	71.0	1.5	29.1	34.9
USP44	FLJ14528	ENSG00000136014	"Ubiquitin specific peptidase 44"	Q9H0E7	12	95516560-95551476	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 24.4"	"Cell type enriched"	"Detected in many"	4	"Early spermatids: 482.2"	"Cancer enhanced"	"Detected in some"		"testis cancer: 3.0"	"Group enriched"	"Detected in some"	4	"cerebellum: 7.0;pons: 2.5"	"Immune cell enhanced"	"Detected in many"		"naive CD4 T-cell: 6.1"	"Group enriched"	"Detected in many"	41	"B-cells: 4.6;T-cells: 6.1"	"Cell line enhanced"	"Detected in some"		"HEL: 26.4;JURKAT: 58.4;NTERA-2: 138.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA026543			Approved	"Nucleoli fibrillar center,Microtubules"		NA	NA			"Nucleoli fibrillar center, Microtubules"		"HPA026543: AB_1858692"	"unprognostic (2.12e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.01e-3)"	"unprognostic (1.83e-4)"	"unprognostic (7.18e-4)"	"unprognostic (5.55e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.73e-2)"	"unprognostic (6.88e-2)"	"unprognostic (2.97e-2)"	"unprognostic (8.12e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.41e-2)"	"unprognostic (7.07e-2)"	0.7	0.6	0.6	1.0	0.7	0.3	0.9	7.0	0.9	0.8	0.1	0.9	0.3	1.3	0.7	0.4	1.2	0.8	0.5	0.5	0.8	1.4	0.1	3.9	1.1	0.7	1.1	0.4	0.9	2.4	1.7	1.3	0.1	2.5	0.7	0.4	1.7	1.1	1.6	0.2	0.3	0.9	0.9	0.5	1.6	0.6	24.4	0.5	3.7	1.3	0.3	1.2	0.5	0.5	1.0	0.2	0.4	11.4	0.0	0.1	0.1	0.4	1.1	3.3	1.4	0.5	0.0	0.1	0.1	3.4	0.0	0.0	0.1	0.0	0.0	1.9	0.0	5.8	26.4	0.0	0.0	5.8	10.8	0.5	0.1	0.0	0.8	0.0	0.6	0.6	58.4	4.3	0.0	0.0	0.0	13.9	0.1	138.3	0.0	0.0	0.0	0.0	0.0	2.4	0.8	8.8	5.9	0.0	0.0	0.1	13.2	0.1	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.3	4.6	0.0	1.0	0.3	0.0	0.0	0.0	1.1	0.0	2.4	4.6	1.7	1.5	0.0	3.7	6.1	4.0	0.1	0.1	0.0	0.0	0.2	1.0	0.6	0.7	7.0	0.9	0.5	0.8	0.7	1.1	0.4	2.5	0.5	0.5	1.0	1.9	12.8	31.0	1.3	5.7	1.0	3.4	0.3	4.6	8.6	1.5	3.2	1.8	0.0	3.8	7.3	6.2	2.8	0.6	0.1	0.0	4.4	482.2	0.9	2.2	2.5	0.0	0.4	5.1	3.1	0.5	3.5	1.1	1.8	0.0	10.6	1.8	0.0	0.1	0.0	16.2	0.0	0.0	0.3	1.0	116.6	5.6	0.8	3.6	1.9	0.6	2.4	1.0	15.6	4.0	0.9	0.1	3.4	1.1	5.0	0.1	1.0	0.3	9.5	6.6	2.9	3.7	77.6	6.7	0.6	0.9	1.1	3.2	2.5	0.1	1.9
VASH2	FLJ12505	ENSG00000143494	"Vasohibin 2"	Q86V25	1	212950520-212992037	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 8.0"	"Group enriched"	"Detected in many"	6	"Early spermatids: 92.8;Late spermatids: 80.8"	"Cancer enhanced"	"Detected in many"		"testis cancer: 3.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 24.2;AN3-CA: 29.6;NTERA-2: 46.2;RH-30: 135.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA045820			Approved	Cytosol	"Secreted to blood"	NA	NA			Cytosol		"HPA045820: "	"unprognostic (2.22e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.25e-2)"	"unprognostic (4.04e-2)"	"unprognostic (2.59e-3)"	"unprognostic (3.50e-2)"	"unprognostic (2.45e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.84e-5)"	"unprognostic (1.95e-3)"	"unprognostic (2.74e-1)"	"unprognostic (6.85e-2)"	"unprognostic (6.81e-4)"	1.7	0.1	1.1	3.4	0.8	0.9	2.0	0.3	1.3	1.5	0.0	0.5	0.7	1.9	0.4	4.1	0.7	2.6	0.9	0.9	0.6	0.4	0.2	1.1	2.3	1.6	1.1	0.9	0.6	0.2	0.9	2.6	0.8	1.8	2.8	0.6	0.5	0.9	0.8	0.5	0.5	0.9	1.9	0.3	1.2	0.8	8.0	1.8	4.3	0.3	0.8	2.1	1.5	0.5	1.6	0.3	1.7	24.2	29.6	0.2	0.1	4.0	0.1	0.0	1.0	1.3	0.1	0.6	0.1	0.4	0.1	0.6	0.1	9.9	0.0	1.2	20.3	3.7	2.0	1.4	1.5	0.1	0.2	0.4	3.8	0.0	1.3	0.0	0.6	0.3	11.4	0.1	5.9	2.0	0.5	13.1	1.5	46.2	0.0	3.6	7.6	135.5	1.3	0.2	1.9	5.6	8.6	3.1	0.2	0.3	12.4	4.5	0.9	0.0	1.0	2.7	0.6	1.3	3.4	6.2	0.9	0.1	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	1.1	0.8	0.3	1.3	0.9	0.6	1.6	1.1	0.9	1.8	0.3	1.8	1.6	0.9	0.0	1.1	0.0	0.6	1.5	0.8	0.2	5.7	3.0	4.1	6.0	1.2	0.0	0.0	0.0	2.1	0.1	12.6	0.2	0.0	0.7	92.8	0.9	1.4	1.1	1.2	0.8	5.4	0.2	0.3	10.9	2.0	1.0	0.0	11.2	0.0	0.1	0.2	1.7	4.3	0.2	2.0	0.3	3.2	80.8	0.3	1.5	0.0	0.0	0.7	0.4	0.0	0.5	0.6	0.1	0.0	0.7	1.0	1.5	0.0	0.4	0.9	2.0	0.0	8.4	4.0	3.2	1.1	0.4	1.6	0.0	0.5	0.1	0.3	0.4
VCX2	VCX-2r	ENSG00000177504	"Variable charge X-linked 2"	Q9H322	X	8169944-8171267	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	283	"testis: 28.2"	"Group enriched"	"Detected in some"	5	"Spermatocytes: 306.0;Spermatogonia: 414.0"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 0.8;testis cancer: 0.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA044642, HPA044996, HPA049357"	Enhanced					NA	NA					"HPA044642: AB_2679033, HPA044996: AB_2679174, HPA049357: AB_2680727"															"unprognostic (1.34e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	63.0	4.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	59.2	0.0	0.0	306.0	414.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
VCX3B	VCX-C	ENSG00000205642	"Variable charge X-linked 3B"	Q9H321	X	8464830-8466510	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	64	"testis: 33.1"	"Group enriched"	"Detected in some"	8	"Spermatocytes: 902.7;Spermatogonia: 1055.5"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	19	"U-138 MG: 18.6"									"HPA044996, HPA049357"	Supported					NA	NA					"HPA044996: AB_2679174, HPA049357: AB_2680727"		"unprognostic (1.60e-1)"		"unprognostic (1.25e-1)"	"unprognostic (1.67e-1)"			"unprognostic (7.51e-2)"		"unprognostic (2.07e-1)"		"unprognostic (4.19e-3)"	"unprognostic (4.41e-2)"		"unprognostic (3.06e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.58e-2)"	0.0	0.2	0.3	0.0	0.3	0.0	0.2	0.2	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.3	0.3	0.3	0.2	0.0	0.0	0.3	0.3	0.2	0.1	0.1	0.0	0.2	0.0	0.3	0.3	0.0	0.5	0.1	0.0	0.1	0.2	0.0	0.0	0.2	0.1	0.1	33.1	0.2	0.0	0.4	0.0	0.0	0.1	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.3	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	18.6	0.0	0.6	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.2	0.4	0.3	0.3	0.3	0.3	0.2	0.3	0.2	0.2	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.3	0.2	0.0	0.0	1.8	0.0	0.1	0.0	0.0	0.0	0.0	75.7	0.1	0.1	0.9	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.1	1.7	0.2	0.0	0.0	0.0	0.0	54.4	8.1	1.0	1.8	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	1.9	0.0	0.0	0.0	0.0	0.1	0.1	111.7	0.0	0.1	902.7	1055.5	0.0	0.3	0.1	0.0	0.1	0.0	0.0
WDHD1	"AND-1, CHTF4, CTF4"	ENSG00000198554	"WD repeat and HMG-box DNA binding protein 1"	O75717	14	54938949-55027105	"Predicted intracellular proteins, Predicted membrane proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 8.1"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 15.5;Spermatocytes: 15.0;Spermatogonia: 19.3"	"Cancer enhanced"	"Detected in all"		"testis cancer: 23.5"	"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000632, HPA001122"	Enhanced		Enhanced	Nucleoplasm		NA	Yes			Nucleoplasm		"HPA000632: , HPA001122: AB_1080589"	"unprognostic (1.88e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.98e-2)"	"unprognostic (2.25e-3)"	"unprognostic (1.20e-1)"	"unprognostic (6.85e-3)"	"unprognostic (2.33e-4)"	"unprognostic (5.52e-3)"	"unprognostic (7.28e-3)"	"unprognostic (8.05e-3)"	"prognostic unfavorable (9.24e-4)"	"unprognostic (5.11e-2)"	"unprognostic (2.67e-4)"	"unprognostic (8.31e-3)"	"unprognostic (1.50e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.36e-2)"	1.3	0.8	0.5	3.8	1.0	7.2	2.2	1.0	0.8	1.2	0.1	2.9	1.9	2.1	0.6	2.5	1.6	1.3	0.9	0.8	0.4	1.1	1.2	1.3	5.5	0.3	0.3	0.6	1.4	0.9	1.5	0.3	2.8	0.6	1.0	4.1	1.8	0.7	0.9	0.6	2.1	1.7	2.6	0.3	1.7	1.6	5.3	0.3	8.1	0.9	0.9	6.7	1.7	1.1	0.6	39.6	24.7	48.4	21.4	4.6	11.2	28.1	37.5	16.1	29.6	36.0	16.6	25.9	44.9	18.6	10.8	21.4	32.8	72.9	21.5	61.7	30.0	12.7	29.8	23.7	16.2	1.9	56.7	21.8	5.9	3.8	36.6	14.3	7.1	19.6	28.8	37.8	22.0	28.7	21.7	53.5	11.1	38.6	21.1	25.7	49.5	69.7	17.3	8.4	26.0	28.1	19.8	39.8	10.0	12.8	35.1	26.8	11.3	12.8	37.3	43.9	27.5	32.1	6.5	14.4	58.8	17.1	27.4	30.0	1.7	0.3	0.6	0.9	0.2	1.2	1.2	1.0	1.3	0.5	1.8	1.3	1.8	0.4	2.0	0.4	0.7	1.6	0.6	0.5	1.0	1.0	0.8	0.8	0.4	0.3	0.3	0.6	0.6	0.3	0.3	0.6	2.3	0.0	2.0	3.9	5.1	3.8	2.2	3.5	3.4	2.9	1.8	1.9	1.7	0.0	4.0	3.7	0.0	8.7	3.6	1.8	0.0	1.8	0.8	1.9	3.1	2.0	0.0	15.5	10.3	1.0	8.4	3.4	2.6	2.5	0.0	12.4	0.7	0.9	4.1	3.3	6.5	2.4	6.1	2.1	1.2	1.1	0.0	2.4	1.8	5.6	1.4	1.4	2.1	4.5	10.1	1.1	0.3	3.0	7.8	0.6	0.5	6.2	3.5	3.1	0.0	2.4	3.0	15.0	19.3	6.1	2.4	2.6	3.6	2.8	5.2	1.7
WDR62	"C19orf14, DKFZP434J046, FLJ33298, MCPH2"	ENSG00000075702	"WD repeat domain 62"	O43379	19	36054649-36105108	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Neurogenesis		"Disease variant, Mental retardation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 111.3;testis: 64.2;tongue: 63.6"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 43.4;Cone photoreceptor cells: 85.5;Early spermatids: 42.5;Late spermatids: 46.2;Rod photoreceptor cells: 41.7;Spermatocytes: 67.6"	"Cancer enhanced"	"Detected in many"		"testis cancer: 10.1"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"non-classical monocyte: 2.7"	"Lineage enriched"	"Detected in single"	4	"monocytes: 2.7"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA043255, HPA043639"	Enhanced		Enhanced	"Centriolar satellite,Cytosol"		NA	NA			Cytosol	"Centriolar satellite"	"HPA043255: AB_2678393, HPA043639: AB_2678593"	"unprognostic (1.77e-1)"	"unprognostic (2.79e-3)"	"unprognostic (3.16e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.77e-1)"	"unprognostic (4.22e-3)"	"unprognostic (1.78e-4)"	"unprognostic (2.00e-1)"	"unprognostic (4.00e-2)"	"unprognostic (5.82e-3)"	"unprognostic (4.72e-2)"	"unprognostic (4.69e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.73e-3)"	"unprognostic (2.72e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.67e-1)"	0.4	0.4	0.3	2.1	0.4	5.4	0.4	0.8	0.7	0.7	0.1	0.6	1.1	0.6	0.2	3.7	0.7	0.3	22.4	0.4	0.3	0.4	0.7	0.7	2.9	0.5	0.3	0.2	0.4	0.2	0.1	0.4	0.5	0.4	0.7	0.5	6.8	1.3	0.2	111.3	2.7	1.2	0.7	0.1	2.0	0.9	64.2	0.3	5.0	0.4	63.6	1.8	0.3	1.4	0.8	19.9	37.8	12.3	12.6	1.1	0.3	7.8	18.0	7.6	24.1	20.8	20.0	6.7	24.7	10.9	9.3	11.3	6.1	18.6	6.8	13.5	16.1	8.8	16.9	20.5	13.5	0.8	16.8	19.6	0.3	0.7	17.7	5.2	1.7	6.0	17.3	21.7	26.8	11.3	20.6	33.1	9.0	7.3	16.0	7.4	23.3	12.5	11.7	3.3	7.5	15.3	8.6	12.1	16.7	2.8	7.6	9.6	14.3	4.1	20.8	19.9	16.7	29.6	14.0	22.1	32.0	9.1	13.0	24.6	0.5	0.1	0.1	0.1	0.7	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.6	0.2	2.7	0.1	0.5	0.1	0.3	0.4	0.8	0.7	0.4	0.3	0.5	0.3	0.2	0.4	0.1	0.3	0.8	1.8	0.0	5.5	0.3	1.0	2.2	1.3	0.5	0.6	1.6	0.9	0.6	43.4	0.0	0.8	0.0	85.5	1.9	1.2	2.5	1.9	0.4	42.5	0.8	0.8	2.0	0.0	11.0	1.4	0.9	1.9	1.8	5.6	0.8	0.0	4.3	1.1	0.8	2.2	3.3	1.0	2.2	2.0	1.3	1.6	46.2	1.2	1.9	1.8	1.0	0.8	2.1	0.0	1.0	1.0	0.5	0.2	0.4	7.1	0.8	0.3	0.3	0.2	41.7	6.6	2.8	1.9	67.6	15.4	2.0	3.7	0.3	2.2	1.2	3.0	0.7
WFDC6	"C20orf171, dJ461P17.11, WAP6"	ENSG00000243543	"WAP four-disulfide core domain 6"	Q9BQY6	20	45534196-45539482	"Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"epididymis: 253.1"	"Cell type enriched"	"Detected in some"	4	"Respiratory ciliated cells: 34.2"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 0.9;testis cancer: 0.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"U-87 MG: 2.6"														"Secreted in male reproductive system"	NA	NA						"unprognostic (3.68e-3)"			"unprognostic (2.21e-3)"				"unprognostic (1.26e-2)"		"unprognostic (8.74e-2)"					"unprognostic (2.91e-2)"			0.1	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.3	0.7	0.0	0.0	0.0	0.2	253.1	0.1	7.8	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	1.9	0.0	0.3	0.1	0.0	0.0	0.0	0.0	37.8	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	6.8	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	34.2	0.0	0.0	0.0	0.2	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1
WNT2B	"WNT13, XWNT2"	ENSG00000134245	"Wnt family member 2B"	Q93097	1	112466541-112530165	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Leydig cells: 80.2;Peritubular cells: 197.5"	"Cancer enhanced"	"Detected in many"		"testis cancer: 4.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 4.4;HSkMC: 8.0;SuSa: 3.4;TIME: 3.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA047274, HPA066368"			Approved	Nucleoplasm,Vesicles	"Secreted to extracellular matrix"	NA	NA			Vesicles	Nucleoplasm	"HPA047274: AB_2732539, HPA066368: AB_2685664"	"unprognostic (2.08e-3)"	"unprognostic (2.06e-3)"	"unprognostic (2.94e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.49e-1)"	"unprognostic (9.42e-2)"	"unprognostic (4.90e-3)"	"unprognostic (1.15e-1)"	"unprognostic (2.37e-1)"	"unprognostic (5.94e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.65e-4)"	"unprognostic (5.41e-2)"	"unprognostic (7.64e-2)"	"unprognostic (4.80e-2)"	"unprognostic (2.49e-2)"	4.0	1.9	2.1	1.5	4.5	0.1	2.8	2.2	2.7	6.5	2.2	4.6	3.1	4.9	2.8	5.9	4.8	2.8	3.8	2.0	1.8	2.4	1.0	6.3	0.8	2.5	2.0	1.9	11.0	1.9	0.6	2.3	4.9	2.4	6.1	5.3	5.5	2.2	14.0	1.6	11.2	5.3	2.2	1.7	1.7	3.8	3.8	2.0	0.2	1.9	0.8	0.7	5.6	9.2	2.4	0.4	0.3	2.2	0.5	2.2	4.4	0.4	1.0	1.0	0.2	0.4	0.2	0.5	1.1	0.2	1.1	0.2	1.4	0.7	0.3	0.2	0.0	0.4	0.1	0.8	0.3	1.8	0.2	0.5	8.0	0.8	0.4	0.1	1.3	1.2	0.3	0.1	0.2	0.2	0.3	0.1	0.1	0.3	0.0	0.3	0.1	0.3	0.0	1.5	0.3	0.3	0.3	0.7	0.1	0.7	3.4	0.0	0.2	3.5	0.3	1.4	0.8	0.3	0.1	0.1	0.0	0.9	0.1	0.9	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	2.1	4.5	2.2	2.7	2.0	1.8	2.5	2.0	1.9	2.4	1.7	2.0	2.4	7.6	12.8	3.3	2.0	2.0	10.1	1.8	6.1	5.2	14.1	2.1	0.9	6.5	1.5	3.9	1.8	27.1	2.1	2.4	3.5	0.0	0.8	5.6	2.6	3.6	10.2	8.4	2.1	5.5	1.4	0.8	17.7	1.1	6.8	2.5	2.8	6.1	0.2	1.1	5.0	6.2	2.2	4.1	2.1	8.2	3.4	80.2	4.0	3.6	30.9	2.2	9.8	0.0	11.6	7.1	2.0	4.8	197.5	2.5	4.4	2.9	0.9	4.6	27.6	0.0	9.7	2.7	5.9	5.5	26.4	13.9	1.9	1.9	2.0	1.5	2.6
WNT5B		ENSG00000111186	"Wnt family member 5B"	Q9H1J7	12	1529891-1647212	"Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 32.6"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 25.6;Microglial cells: 19.7;Muller glia cells: 40.4;Urothelial cells: 16.2"	"Cancer enhanced"	"Detected in all"		"testis cancer: 15.8"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 1.8;eosinophil: 1.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 231.4;BJ hTERT+: 143.5;BJ hTERT+ SV40 Large T+: 165.4;BJ hTERT+ SV40 Large T+ RasG12V: 136.4;fHDF/TERT166: 162.6;HBF TERT88: 144.1;hTEC/SVTERT24-B: 144.8;U-138 MG: 142.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA061991			Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA			Vesicles		"HPA061991: "	"unprognostic (7.44e-2)"	"unprognostic (5.59e-2)"	"unprognostic (8.14e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.45e-1)"	"unprognostic (5.53e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.02e-2)"	"unprognostic (4.08e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.49e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.93e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.71e-2)"	3.0	2.4	3.7	4.2	3.8	0.5	3.0	2.8	3.7	5.4	2.0	17.7	4.3	7.2	5.1	15.1	6.3	2.8	3.6	2.9	4.6	1.7	4.6	3.0	2.6	4.7	3.9	3.2	8.3	1.5	9.1	11.3	3.9	3.9	32.6	5.8	5.4	15.8	20.1	1.4	5.1	5.1	5.5	3.6	5.3	6.5	1.8	4.8	3.7	2.1	6.7	3.1	14.0	9.8	4.0	0.3	0.1	1.4	0.2	34.6	61.2	0.0	231.4	143.5	165.4	136.4	8.7	0.9	2.9	0.4	162.6	111.1	3.5	3.3	0.0	144.1	55.0	7.9	12.8	0.0	0.0	8.5	0.2	0.1	51.3	3.3	144.8	41.3	66.6	0.0	0.1	9.5	51.9	39.4	0.1	0.0	0.3	5.7	0.2	0.5	0.0	2.3	4.0	2.0	0.0	1.0	3.2	4.9	0.5	0.2	17.7	0.2	0.9	0.0	142.4	5.9	56.7	119.7	13.9	2.2	0.7	13.9	0.0	1.5	0.0	1.8	1.5	0.0	0.8	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.5	3.7	3.8	2.8	3.7	2.9	4.6	4.7	3.9	3.2	3.9	3.6	4.8	4.0	0.9	0.0	0.6	7.5	1.5	0.9	11.0	1.9	25.6	1.8	0.7	6.5	2.2	0.0	3.3	0.0	0.0	1.0	0.2	2.4	0.0	1.1	0.2	1.7	10.4	1.4	0.0	0.0	6.9	0.7	1.1	8.0	0.5	2.7	0.0	0.3	0.4	1.7	5.3	0.0	7.9	1.9	2.0	2.1	2.9	0.5	2.1	2.7	3.6	19.7	4.1	40.4	0.0	4.0	5.6	2.8	5.0	2.6	4.5	8.8	1.0	0.2	4.3	2.7	6.6	7.9	4.3	0.7	5.7	7.7	1.3	0.7	0.2	0.0	1.7	16.2
ZBTB8B	"DKFZp547H154, RP1-27O5.1, ZNF916B"	ENSG00000273274	"Zinc finger and BTB domain containing 8B"	Q8NAP8	1	32465072-32496686	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"brain: 1.6"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 6.2;Langerhans cells: 4.7;Oligodendrocyte precursor cells: 9.0"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in single"		"RT4: 1.0"									"HPA055553, HPA071427"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA055553: AB_2682848, HPA071427: "	"unprognostic (8.32e-4)"	"unprognostic (1.23e-1)"	"unprognostic (3.83e-1)"	"unprognostic (3.83e-5)"	"unprognostic (1.86e-2)"	"unprognostic (5.65e-2)"	"unprognostic (1.67e-4)"	"unprognostic (1.57e-2)"	"unprognostic (5.94e-2)"	"unprognostic (3.43e-3)"	"unprognostic (9.08e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.93e-2)"	"unprognostic (3.44e-2)"	"unprognostic (6.11e-2)"	"unprognostic (3.26e-3)"	"unprognostic (5.88e-3)"	0.0	0.1	1.6	0.1	1.1	0.4	0.1	0.8	1.2	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.1	0.1	0.0	1.0	1.4	0.0	0.1	0.0	0.1	1.2	0.9	1.1	0.1	0.1	0.1	0.6	0.1	1.1	0.1	0.0	0.5	0.1	0.0	0.6	0.2	0.0	0.0	0.6	0.1	0.0	0.2	1.4	0.0	0.1	0.0	0.1	0.1	0.0	1.3	0.0	0.0	0.5	0.4	0.0	0.1	0.1	0.0	0.0	0.2	0.1	0.0	0.1	0.1	0.2	0.0	0.3	0.2	0.6	0.0	0.1	0.1	0.6	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.5	0.0	0.2	0.0	0.0	0.0	0.1	1.0	0.9	0.5	0.3	0.1	0.0	0.7	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.2	0.2	0.1	0.1	0.1	0.1	1.0	0.1	0.2	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.2	0.1	0.1	0.5	0.2	0.1	0.2	0.1	0.0	1.6	1.1	0.8	1.2	1.0	1.4	1.2	0.9	1.1	1.1	0.6	1.4	1.3	0.4	0.0	1.8	0.3	0.2	1.7	1.1	0.1	0.0	2.6	0.3	0.5	0.8	0.0	0.7	0.0	6.2	1.9	1.4	0.3	0.0	0.0	2.1	0.5	1.6	0.7	0.0	0.0	0.8	0.0	1.3	0.8	0.0	0.5	3.8	2.8	0.7	0.2	0.4	3.3	2.2	0.0	0.0	0.3	4.7	2.1	0.6	0.7	1.8	1.9	0.0	1.4	1.0	9.0	0.4	0.0	0.0	0.0	0.3	0.9	0.0	0.1	1.5	2.4	0.0	1.6	0.7	2.2	1.5	0.0	0.6	0.3	0.7	0.9	0.0	0.9
ZIK1	ZNF762	ENSG00000171649	"Zinc finger protein interacting with K protein 1"	Q3SY52	19	57578456-57593890	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Cancer enhanced"	"Detected in many"		"testis cancer: 5.6"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 28.8;NTERA-2: 34.3;REH: 25.6;U-266/84: 34.8"	"Low region specificity"	"Detected in all"							HPA059975	Uncertain		Approved	"Intermediate filaments"		NA	NA			"Intermediate filaments"		"HPA059975: AB_2684184"	"unprognostic (2.14e-2)"	"unprognostic (9.03e-3)"	"unprognostic (9.42e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.34e-4)"	"unprognostic (2.22e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.13e-1)"	"unprognostic (8.16e-3)"	"unprognostic (1.02e-1)"	"unprognostic (4.18e-6)"	"unprognostic (6.21e-2)"	"unprognostic (5.15e-1)"	"unprognostic (5.21e-2)"	"unprognostic (3.50e-1)"	1.9	2.0	2.2	2.7	2.2	4.6	3.2	5.7	2.2	2.9	1.8	1.7	0.6	2.4	4.3	1.3	4.9	1.9	3.1	1.9	2.1	2.2	0.8	2.5	5.9	1.5	1.8	2.0	6.1	1.1	6.7	2.6	3.4	2.6	3.3	1.4	7.0	1.7	4.1	1.8	2.1	2.2	2.7	1.6	4.7	1.6	5.3	2.3	7.2	5.7	2.4	6.4	2.0	1.1	2.3	0.1	0.0	22.5	0.1	0.9	0.9	0.0	7.9	7.4	11.3	10.2	0.1	0.2	0.0	5.6	4.0	8.9	0.6	0.0	12.6	16.0	0.0	28.8	4.6	0.1	2.5	2.6	0.1	8.5	4.6	0.0	8.7	0.0	1.0	0.8	1.8	0.2	0.0	3.7	0.0	17.8	2.4	34.3	0.0	2.8	25.6	0.1	5.6	3.2	0.0	16.4	16.5	0.1	0.0	0.7	17.4	0.1	0.3	0.1	10.2	5.2	0.0	9.3	0.2	34.8	8.8	0.1	0.0	10.1	1.8	1.6	8.1	1.8	1.9	3.5	6.8	3.5	2.2	2.6	9.4	6.5	3.2	0.3	4.1	1.7	2.8	4.4	2.6	2.2	2.2	5.7	2.2	1.9	2.1	1.5	1.8	2.0	2.6	1.6	2.3	2.3	1.4	0.0	0.0	3.3	4.5	1.0	1.4	1.8	1.2	3.7	1.7	1.4	3.0	5.7	1.9	5.5	0.0	2.0	1.1	0.0	3.9	3.0	2.9	0.3	1.5	1.8	0.0	4.2	2.3	0.2	1.0	1.7	2.0	0.3	3.8	5.4	2.9	0.3	1.9	3.3	1.9	0.1	4.1	0.8	1.8	3.4	2.1	1.2	0.0	1.0	1.0	4.8	0.0	4.0	0.7	0.2	0.1	2.2	2.6	0.7	0.0	0.5	0.9	5.0	6.6	1.5	1.9	1.0	5.6	0.7	0.9	1.2	2.3	1.7	0.1	1.1
ZNF157	HZF22	ENSG00000147117	"Zinc finger protein 157"	P51786	X	47370578-47414498	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 2.8"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 1.6;Inhibitory neurons: 2.8;Oligodendrocyte precursor cells: 3.5;Oligodendrocytes: 2.5;Spermatogonia: 1.0"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.7"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 1.2;U-266/84: 2.3"					"Not detected"	"Not detected"			HPA003319	Uncertain					NA	NA					"HPA003319: AB_1080677"	"unprognostic (1.85e-1)"	"unprognostic (3.99e-1)"		"unprognostic (7.24e-4)"	"unprognostic (1.17e-2)"	"unprognostic (1.02e-2)"		"unprognostic (7.38e-4)"	"unprognostic (2.99e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.59e-4)"	"unprognostic (5.36e-2)"	"unprognostic (6.51e-2)"	"unprognostic (1.80e-2)"	"unprognostic (3.51e-2)"	"unprognostic (7.15e-2)"	"unprognostic (4.92e-2)"	0.1	0.2	0.5	0.1	0.5	0.2	0.1	2.8	0.6	0.3	0.0	0.1	0.0	0.3	1.4	0.1	1.2	0.1	0.0	0.4	0.5	0.3	0.0	0.1	0.5	0.3	0.6	0.4	0.4	0.0	0.7	0.9	0.0	1.1	0.2	0.1	1.1	0.1	0.3	0.1	0.2	0.1	0.2	0.2	0.2	0.1	0.3	0.5	0.5	0.5	0.1	0.3	0.1	0.1	0.6	0.0	0.1	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.2	0.1	0.3	0.0	0.8	0.4	0.0	0.0	0.3	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.5	0.0	0.0	0.0	0.8	0.0	1.2	0.1	0.0	0.4	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.9	1.0	0.0	0.1	0.1	0.8	0.5	0.1	0.0	0.3	0.4	0.0	0.0	0.6	2.3	0.6	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.1	0.5	0.3	0.2	0.1	0.0	0.1	0.1	0.1	0.5	0.5	2.8	0.6	0.4	0.5	0.3	0.6	0.4	1.1	0.2	0.5	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.5	2.5	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.3	0.1	0.6	1.0	0.0	0.1	0.0	0.2	0.0	0.0	0.2
ZNF257	BMZF-4	ENSG00000197134	"Zinc finger protein 257"	Q9Y2Q1	19	22052430-22091480	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 9.8;Spermatocytes: 19.9;Spermatogonia: 13.5"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.5"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"GAMG: 5.1;NB-4: 4.4;NTERA-2: 12.1;RH-30: 5.2;U-698: 4.4"															NA	NA						"unprognostic (8.23e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.45e-2)"	"unprognostic (3.29e-3)"	"unprognostic (1.99e-3)"	"unprognostic (9.40e-3)"	"unprognostic (7.00e-2)"	"unprognostic (1.16e-1)"	"prognostic favorable (2.05e-4)"	"unprognostic (1.70e-1)"	"unprognostic (2.84e-2)"	"unprognostic (7.13e-2)"	"unprognostic (2.34e-3)"	"unprognostic (2.21e-1)"	"unprognostic (2.15e-1)"	"unprognostic (6.62e-4)"	0.6	0.5	0.5	1.0	0.9	4.1	1.2	1.2	1.2	1.5	0.3	0.7	0.5	1.4	1.6	0.3	0.9	0.5	0.6	0.5	0.9	0.6	0.4	0.8	2.6	1.0	1.3	0.2	2.4	2.1	1.1	0.2	2.0	1.1	1.4	0.6	0.7	0.3	0.9	0.2	0.8	0.4	0.8	0.8	1.6	1.4	2.7	0.7	1.6	2.3	0.0	1.3	1.1	0.4	1.2	0.0	0.0	0.0	0.1	0.0	0.0	1.1	2.3	0.6	3.6	2.9	0.0	0.5	0.0	1.4	0.1	5.1	0.0	0.0	0.0	3.7	0.0	0.1	3.6	0.4	0.0	0.1	0.0	0.9	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.8	0.5	0.0	0.0	3.8	4.4	12.1	0.0	1.0	0.0	5.2	3.0	0.5	0.8	0.0	1.4	0.0	0.0	0.9	1.7	0.0	2.5	0.0	0.0	0.1	0.4	0.0	0.1	2.6	4.4	0.1	0.0	0.2	2.7	0.3	1.4	0.6	0.5	0.8	2.6	1.2	0.9	0.3	2.1	1.4	0.7	1.8	1.3	0.5	0.7	0.6	0.3	0.5	0.9	1.2	1.2	0.5	0.9	1.0	1.3	0.2	1.1	0.8	0.7	1.2	1.7	0.0	0.0	1.0	3.9	1.3	1.4	0.0	1.2	1.4	2.1	1.5	1.9	0.0	1.3	7.3	0.0	4.1	1.3	0.4	9.8	1.8	4.6	1.0	1.5	2.3	0.0	0.4	2.0	2.0	5.5	1.7	1.5	1.1	2.5	9.2	3.9	0.0	1.2	5.0	1.1	0.5	2.0	0.3	1.9	2.6	1.5	1.1	0.0	5.6	0.6	1.1	3.1	8.0	4.6	0.8	0.2	1.5	0.7	1.0	0.0	3.5	1.5	0.4	0.0	1.1	1.3	19.9	13.5	0.4	1.7	3.4	2.4	2.4	0.4	1.3
ZNF273	HZF9	ENSG00000198039	"Zinc finger protein 273"	Q14593	7	64870172-64930966	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skin 1: 3.4"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 44.0;Inhibitory neurons: 51.2;Respiratory ciliated cells: 82.0"	"Cancer enhanced"	"Detected in many"		"testis cancer: 4.9"	"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											HPA077549			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA077549: AB_2732352"	"unprognostic (7.01e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.80e-2)"	"unprognostic (5.87e-4)"	"unprognostic (1.83e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.97e-2)"	"unprognostic (1.65e-2)"	"unprognostic (2.02e-5)"	"unprognostic (2.54e-1)"	"unprognostic (5.76e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.43e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.14e-1)"	"unprognostic (9.48e-2)"	"unprognostic (1.85e-2)"	0.3	0.1	0.2	0.2	0.2	2.4	1.2	1.1	0.7	0.8	0.1	0.2	0.3	0.6	0.1	0.5	0.8	0.1	0.1	0.2	0.2	0.2	0.1	0.4	1.1	0.5	0.3	0.2	0.9	0.3	0.2	0.0	0.5	0.4	0.4	0.4	0.4	0.4	0.3	0.3	3.4	0.1	0.2	0.3	0.4	0.2	2.1	0.2	1.2	1.6	0.4	1.0	0.4	0.6	0.3	1.8	1.3	2.8	4.1	0.4	0.9	2.3	0.8	0.5	1.2	2.2	2.0	1.6	4.7	2.4	0.4	2.2	0.6	5.6	1.1	1.0	2.3	2.1	2.5	0.6	0.7	0.2	2.4	1.7	0.7	0.7	2.0	1.8	0.8	1.1	6.9	6.7	1.8	1.4	1.6	5.3	2.7	5.7	1.0	2.0	5.5	4.2	2.8	0.6	1.1	2.6	2.7	2.2	1.1	1.3	5.4	2.1	3.5	0.5	1.4	1.5	1.0	1.7	1.7	2.4	6.8	0.3	2.4	1.0	2.0	0.2	1.2	0.3	0.3	0.6	1.2	0.7	0.5	0.6	1.0	0.5	0.9	0.4	0.2	0.2	0.6	0.8	0.3	0.2	0.2	1.1	0.7	0.2	0.2	0.5	0.3	0.2	0.4	0.3	0.2	0.3	8.2	3.2	2.3	22.5	12.9	25.0	6.2	8.8	6.8	5.5	7.6	4.7	4.3	1.5	11.1	1.8	0.0	6.8	4.9	0.5	7.9	3.4	25.0	27.1	4.7	7.1	0.0	30.7	44.0	2.9	13.1	7.8	3.6	4.4	3.8	13.4	6.4	1.1	3.6	5.0	51.2	2.0	8.2	3.1	3.5	13.5	6.2	4.1	5.4	15.0	3.9	3.6	7.2	20.1	11.6	2.6	6.1	3.4	2.8	3.6	0.6	1.6	82.0	3.2	0.0	4.8	4.4	21.6	11.4	9.7	18.9	2.9	7.2	5.2	3.5	3.1
ZNF280A	"3'OY11.1, SUHW1, ZNF280, ZNF636"	ENSG00000169548	"Zinc finger protein 280A"	P59817	22	22513736-22520270	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	6	"adrenal gland: 1.4"	"Cell type enhanced"	"Detected in some"		"Melanocytes: 1.8;Spermatogonia: 1.2;Syncytiotrophoblasts: 5.1;Theca cells: 1.9"	"Cancer enhanced"	"Detected in some"		"melanoma: 1.7;testis cancer: 1.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.8;K-562: 8.2;SK-MEL-30: 2.1"									HPA044475			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA044475: AB_10960420"			"unprognostic (7.53e-2)"	"unprognostic (3.76e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.56e-2)"		"unprognostic (3.14e-1)"	"unprognostic (1.78e-2)"	"unprognostic (3.29e-1)"	"unprognostic (4.65e-3)"			"unprognostic (1.58e-1)"	"unprognostic (1.29e-1)"			0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.1	0.0	0.6	0.0	0.0	1.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	8.2	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.3	0.2	0.3	0.1	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	1.2	0.0	0.0	5.1	0.0	1.9	0.0	0.0
ZNF296	ZNF342	ENSG00000170684	"Zinc finger protein 296"	Q8WUU4	19	45071500-45076587	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 9.3"	"Cell type enhanced"	"Detected in many"		"B-cells: 53.3;Basal squamous epithelial cells: 94.4;Plasma cells: 48.2;Squamous epithelial cells: 107.3"	"Cancer enhanced"	"Detected in all"		"testis cancer: 19.5"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 24.0;SK-BR-3: 15.6;U-698: 28.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"HPA046940, HPA049576"	Uncertain		Approved	Nucleoplasm,Centrosome		NA	NA			Nucleoplasm	Centrosome	"HPA046940: AB_2679871, HPA049576: AB_2680821"	"unprognostic (1.32e-1)"	"unprognostic (5.37e-3)"	"unprognostic (1.18e-1)"	"unprognostic (7.71e-2)"	"unprognostic (1.46e-1)"	"prognostic favorable (5.24e-4)"	"unprognostic (3.83e-3)"	"unprognostic (1.67e-2)"	"unprognostic (9.70e-2)"	"unprognostic (9.55e-2)"	"unprognostic (3.20e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.67e-5)"	"unprognostic (7.14e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.39e-3)"	0.6	1.1	1.1	2.2	0.9	5.4	1.7	3.1	2.0	1.1	0.2	1.6	3.0	0.5	0.1	9.3	1.4	0.2	0.4	1.1	0.8	1.5	0.7	1.3	2.8	1.0	0.8	0.7	0.7	0.7	0.1	3.3	0.1	1.5	2.5	0.3	0.5	5.1	0.4	0.5	5.8	4.2	0.1	1.0	6.0	2.7	2.3	0.7	0.4	1.2	0.1	1.4	1.5	3.2	0.8	4.6	2.9	0.1	0.6	0.0	0.2	2.5	0.6	0.0	0.3	0.2	4.7	1.6	24.0	2.7	0.1	0.0	8.3	1.2	1.8	0.0	5.2	6.3	7.2	1.4	4.8	1.2	3.9	7.2	0.9	0.9	0.9	0.0	0.1	0.7	0.4	5.2	8.0	0.0	6.5	0.3	6.8	2.7	2.8	6.3	13.5	0.0	14.8	0.5	1.6	4.4	0.4	3.0	15.6	0.1	0.4	3.4	8.1	1.5	0.0	2.4	0.1	0.0	8.6	9.3	28.7	0.2	5.0	0.1	59.7	10.7	17.2	8.3	18.3	9.7	82.6	4.3	9.3	26.0	62.8	1.8	4.7	5.1	45.9	18.5	78.5	4.4	8.7	1.1	0.9	3.1	2.0	1.1	0.8	1.0	0.8	0.7	1.5	1.0	0.7	0.8	2.4	0.0	0.6	2.3	53.3	12.1	13.9	1.5	94.4	1.4	20.5	13.3	1.2	0.0	2.6	3.7	4.2	0.4	31.9	18.5	0.0	1.8	0.5	6.1	1.0	2.0	5.3	3.0	0.4	0.9	3.6	1.3	21.9	4.5	8.9	0.5	1.4	0.2	3.5	0.0	0.3	32.1	6.1	2.9	19.1	0.5	0.0	7.6	3.6	0.0	24.9	0.4	12.3	0.0	0.5	1.2	36.1	1.2	48.2	6.4	23.4	0.2	3.9	1.6	0.0	0.8	3.2	1.1	14.2	107.3	10.1	0.8	18.5	0.2	28.9	6.2
ZNF483	"KIAA1962, ZKSCAN16, ZSCAN48"	ENSG00000173258	"Zinc finger protein 483"	Q8TF39	9	111525159-111577844	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 45.4"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 46.5;Excitatory neurons: 118.2;Inhibitory neurons: 122.4;Oligodendrocyte precursor cells: 54.3;Oligodendrocytes: 86.8"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 9.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055041			Approved	Nucleoli		NA	NA			Nucleoli		"HPA055041: AB_2682681"	"unprognostic (4.33e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.34e-1)"	"unprognostic (4.11e-2)"	"unprognostic (5.95e-3)"	"unprognostic (9.18e-5)"	"unprognostic (2.02e-1)"	"unprognostic (9.50e-2)"	"unprognostic (4.44e-3)"	"unprognostic (5.49e-2)"	"unprognostic (5.19e-4)"	"unprognostic (7.19e-3)"	"unprognostic (1.74e-1)"	"unprognostic (4.30e-2)"	"unprognostic (6.17e-2)"	1.1	6.1	17.7	0.7	25.8	3.6	2.7	45.4	20.4	2.3	1.3	1.2	0.9	5.1	8.3	0.9	3.0	2.2	2.1	19.3	30.8	2.2	0.8	1.7	1.5	5.5	15.4	18.2	5.7	1.8	4.0	6.0	0.5	12.8	3.7	0.8	11.8	1.5	3.8	1.4	1.8	1.2	2.3	2.0	2.3	1.4	5.3	27.0	1.0	6.1	0.7	1.1	1.4	1.7	19.9	0.2	2.0	2.1	3.4	0.5	0.5	0.6	0.4	1.0	2.0	1.7	0.2	0.9	0.3	0.3	0.8	1.5	0.7	1.1	0.9	1.2	0.1	1.3	1.0	3.2	2.3	0.6	0.4	0.2	0.8	0.5	1.1	0.5	1.7	1.8	1.4	0.8	0.5	0.5	2.2	0.1	0.4	9.7	1.3	0.7	0.2	2.9	0.3	1.1	0.8	4.8	2.2	1.0	0.5	0.4	2.1	1.2	0.3	0.5	0.6	1.0	1.1	1.5	0.4	1.3	0.2	0.8	0.3	0.3	3.1	0.4	0.3	2.7	0.2	1.6	0.8	1.7	1.3	0.1	1.2	3.3	3.6	1.5	1.1	0.4	0.5	1.1	0.8	17.7	25.8	45.4	20.4	19.3	30.8	5.5	15.4	18.2	12.8	2.0	27.0	19.9	1.6	0.0	6.3	33.0	1.4	0.8	6.3	1.5	2.2	46.5	2.0	7.6	4.0	1.5	4.0	7.3	20.9	1.1	3.0	0.2	5.9	1.0	20.3	2.6	1.9	2.0	3.0	0.0	118.2	2.0	0.5	6.1	1.5	3.5	0.0	4.9	1.4	2.1	0.3	35.3	122.4	0.1	0.0	0.9	1.9	8.6	4.7	0.6	1.8	13.1	0.4	19.1	5.2	54.3	86.8	1.0	1.1	10.1	0.2	4.2	0.8	0.2	1.6	26.8	6.6	5.5	3.5	11.0	4.1	0.6	1.4	0.7	2.6	6.3	0.2	3.7
ZNF490	KIAA1198	ENSG00000188033	"Zinc finger protein 490"	Q9ULM2	19	12576100-12640098	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 10.2;Gastric mucus-secreting cells: 13.7;Inhibitory neurons: 9.3;Oligodendrocytes: 10.0;Plasma cells: 14.8"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.5"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA005576	Uncertain					NA	NA					"HPA005576: AB_10602689"	"unprognostic (1.81e-2)"	"unprognostic (1.32e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.94e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.39e-1)"	"unprognostic (5.77e-2)"	"unprognostic (9.53e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.38e-3)"	"unprognostic (2.80e-1)"	"unprognostic (7.59e-2)"	"unprognostic (5.79e-2)"	0.7	1.0	1.7	1.3	2.1	1.7	1.4	2.4	2.7	1.3	0.4	1.2	1.2	1.0	2.1	0.8	1.5	1.1	0.9	1.9	1.9	1.3	1.8	1.4	2.0	1.4	1.0	2.3	1.9	1.5	1.9	0.5	1.1	1.8	1.4	1.3	2.1	1.1	1.3	0.9	1.8	0.9	0.9	0.7	2.4	1.2	1.4	1.5	2.2	2.3	1.0	2.5	1.0	0.5	3.3	0.7	0.6	1.2	3.3	3.5	2.3	1.0	0.9	1.6	1.2	1.5	1.1	1.0	1.2	2.0	1.2	0.8	0.9	1.7	1.4	1.6	1.6	1.0	1.5	1.4	1.4	1.9	2.9	3.6	1.8	1.6	1.0	2.2	1.7	1.1	1.4	1.1	1.4	1.6	1.5	2.0	2.2	1.8	0.6	1.8	1.5	1.8	2.1	1.4	1.8	2.2	1.5	1.9	1.2	1.5	1.8	1.7	1.7	1.6	3.0	0.8	2.2	1.0	4.3	3.3	1.5	1.6	1.9	2.0	5.0	1.5	2.3	2.7	2.1	2.5	2.2	1.7	2.6	1.3	2.8	1.5	2.6	1.4	3.8	2.6	3.8	2.3	1.0	1.7	2.1	2.4	2.7	1.9	1.9	1.4	1.0	2.3	1.8	0.7	1.5	3.3	1.7	0.0	1.1	7.2	7.4	0.5	0.3	1.2	2.8	1.4	1.8	1.8	1.2	1.5	1.7	0.0	0.0	0.3	2.7	0.9	1.9	0.2	3.9	1.6	3.0	1.5	0.0	3.8	10.2	0.2	0.2	2.4	13.7	2.3	5.7	1.5	0.0	1.0	0.4	0.0	9.3	0.1	0.0	1.6	1.8	1.6	0.6	2.4	3.6	6.5	0.3	0.5	1.0	4.0	10.0	0.2	0.1	0.0	14.8	0.3	0.9	0.3	0.8	0.8	6.6	0.8	2.2	0.9	1.0	4.9	0.3	0.8	6.0	1.1	0.5	0.2
ZNF589	SZF1	ENSG00000164048	"Zinc finger protein 589"	Q86UQ0	3	48241100-48299253	"Predicted intracellular proteins, Transcription factors"		"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 20.9"	"Cancer enhanced"	"Detected in all"		"testis cancer: 15.6"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HAP1: 44.1;NTERA-2: 71.1"									HPA003145	Uncertain		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA003145: AB_1080738"	"unprognostic (2.49e-3)"	"prognostic favorable (2.50e-4)"	"unprognostic (9.14e-2)"	"unprognostic (7.34e-3)"	"unprognostic (1.18e-1)"	"prognostic favorable (1.71e-4)"	"unprognostic (3.01e-5)"	"prognostic favorable (6.45e-5)"	"unprognostic (2.64e-2)"	"unprognostic (9.67e-2)"	"prognostic favorable (1.21e-4)"	"unprognostic (8.02e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.32e-2)"	"unprognostic (3.45e-2)"	"unprognostic (9.57e-3)"	"unprognostic (2.19e-2)"	6.2	8.6	9.0	6.8	9.4	5.9	6.9	14.6	10.9	10.6	2.7	8.0	3.9	7.6	20.3	10.3	8.8	4.6	5.4	10.8	8.3	6.0	3.7	10.1	12.4	9.3	7.7	10.6	13.7	6.6	5.9	7.8	3.0	9.5	18.5	6.7	15.0	6.7	15.8	6.2	9.9	16.3	6.1	7.4	24.3	8.0	6.6	8.5	8.2	16.7	4.2	12.3	8.5	10.8	11.4	4.5	3.2	12.7	10.8	15.8	8.7	16.1	4.6	3.5	5.2	6.9	6.8	6.0	17.8	3.3	4.7	4.0	3.9	44.1	11.2	4.2	11.5	10.5	22.5	14.9	5.4	2.9	5.4	5.6	2.8	7.5	6.4	4.3	5.7	9.0	13.7	15.4	4.5	2.8	4.5	6.8	4.1	71.1	4.3	6.6	3.3	4.6	6.8	4.0	4.4	4.9	9.1	3.4	3.7	13.7	18.8	6.0	8.0	14.0	3.0	5.8	7.2	3.5	8.9	12.0	14.6	4.0	12.6	9.3	1.2	2.2	1.6	2.8	2.0	3.5	3.1	3.4	3.8	2.3	1.9	3.8	3.8	1.2	1.2	2.8	10.9	3.1	1.9	9.0	9.4	14.6	10.9	10.8	8.3	9.3	7.7	10.6	9.5	7.4	8.5	11.4	2.0	0.0	5.4	4.2	5.5	1.1	1.4	0.9	3.4	15.3	2.4	1.5	4.1	0.0	2.8	9.2	20.9	2.2	13.7	1.3	3.9	1.4	1.5	7.3	3.5	2.7	1.8	2.1	9.8	1.0	1.2	4.3	1.5	11.7	0.0	3.9	2.5	1.0	3.3	1.7	11.5	2.5	0.0	5.5	3.0	2.0	2.1	7.3	1.8	3.7	3.7	5.3	1.0	9.5	11.0	1.0	1.7	4.5	5.3	1.5	1.4	1.6	2.4	13.1	6.6	4.1	3.0	1.4	3.1	2.9	1.3	0.0	4.4	7.0	2.5	0.9
ZNF682	BC39498_3	ENSG00000197124	"Zinc finger protein 682"	O95780	19	19997058-20039505	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 22.2"	"Cancer enhanced"	"Detected in many"		"testis cancer: 7.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 14.4;AN3-CA: 21.8"									HPA055998	Uncertain		Uncertain	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA055998: AB_2683002"	"unprognostic (8.96e-2)"	"unprognostic (3.93e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.16e-2)"	"unprognostic (6.95e-3)"	"unprognostic (1.69e-2)"	"unprognostic (1.71e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.24e-3)"	"unprognostic (7.70e-4)"	"unprognostic (1.77e-3)"	"unprognostic (4.06e-7)"	"unprognostic (2.07e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.19e-1)"	"prognostic favorable (3.51e-4)"	2.0	2.5	4.6	2.5	5.0	2.1	3.4	5.0	7.1	2.5	2.7	2.4	1.5	2.5	3.5	3.3	3.0	2.2	4.6	5.1	5.2	3.1	4.2	3.7	4.0	4.9	5.0	4.1	2.0	3.0	3.0	4.1	3.0	5.0	4.9	2.5	3.2	1.9	4.1	3.4	6.6	2.9	1.3	4.1	4.1	3.1	3.3	4.7	3.1	8.0	1.6	4.5	3.6	3.1	6.4	0.0	0.0	14.4	21.8	1.1	1.5	0.6	3.1	1.4	5.1	8.1	2.5	3.1	0.1	5.2	4.4	1.5	2.6	5.9	0.5	5.7	0.0	6.3	0.0	0.1	1.6	2.0	0.0	5.1	2.1	1.7	2.8	0.0	0.8	0.0	5.7	0.0	0.1	3.9	4.3	8.7	1.3	7.9	0.0	1.9	5.3	7.5	0.1	2.7	9.7	7.9	8.5	0.0	2.8	0.0	7.8	5.4	2.9	0.0	7.5	1.2	12.7	5.4	0.0	9.0	1.4	0.0	0.0	2.4	7.1	0.4	0.9	2.5	0.5	1.8	4.1	3.7	2.0	1.5	2.7	4.0	4.1	1.5	1.4	0.7	1.3	4.2	1.3	4.6	5.0	5.0	7.1	5.1	5.2	4.9	5.0	4.1	5.0	4.1	4.7	6.4	5.2	9.6	15.1	7.2	7.0	3.4	2.1	0.6	5.2	5.4	4.6	5.2	10.3	4.3	4.6	3.7	0.0	6.8	8.2	2.7	5.9	4.0	1.8	1.8	2.9	4.4	1.2	4.4	9.8	7.5	6.8	3.5	2.6	3.0	2.5	5.9	5.0	3.0	2.9	3.3	10.1	2.8	0.0	3.5	2.7	0.9	1.8	2.3	1.8	6.5	0.6	4.0	5.2	6.6	22.2	4.8	1.2	4.5	3.1	1.5	1.7	3.8	1.5	2.3	0.0	3.1	3.4	4.3	4.2	3.7	3.4	2.5	6.9	9.2	2.1	2.5
ZNF695	SBZF3	ENSG00000197472	"Zinc finger protein 695"	Q8IW36	1	246945547-247008093	"Predicted intracellular proteins, Transcription factors"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 3.2;Extravillous trophoblasts: 4.7;Spermatocytes: 3.5;Spermatogonia: 2.8"	"Cancer enhanced"	"Detected in many"		"testis cancer: 2.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"											HPA024743	Uncertain		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA024743: AB_1859419"	"unprognostic (8.46e-3)"	"unprognostic (6.28e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.57e-4)"	"unprognostic (4.51e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.71e-5)"	"unprognostic (7.42e-4)"	"unprognostic (2.81e-3)"	"unprognostic (2.21e-2)"	"unprognostic (1.05e-9)"	"unprognostic (2.22e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.72e-1)"	"unprognostic (3.87e-1)"	0.0	0.0	0.2	0.1	0.1	0.8	0.3	0.1	0.4	0.1	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.1	0.1	0.4	0.0	0.0	0.4	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.5	0.3	0.0	0.0	0.1	0.6	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.5	7.1	0.8	4.2	10.7	0.1	0.1	11.1	2.4	0.1	3.2	4.3	7.3	0.4	5.6	4.4	1.2	2.8	2.2	12.2	0.6	3.7	0.0	4.0	3.8	1.5	4.5	0.0	0.0	1.4	0.2	0.0	3.6	2.9	0.9	1.3	7.3	5.2	0.0	3.4	2.7	8.2	4.1	7.8	6.8	4.3	4.5	9.7	0.0	0.8	3.8	3.7	6.5	3.4	2.8	1.2	4.0	3.0	5.2	0.6	0.5	6.0	3.2	0.0	0.7	2.2	0.1	0.0	0.0	2.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.4	0.4	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.1	0.1	0.2	0.3	0.6	0.0	0.8	1.1	0.5	0.0	0.0	0.0	0.0	3.2	0.0	0.4	0.0	0.3	0.9	0.9	0.5	0.3	0.0	2.1	0.0	0.0	4.7	0.4	1.5	1.4	0.0	2.0	0.4	0.2	1.4	0.0	0.0	2.1	0.0	0.8	0.3	0.1	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.5	3.5	2.8	2.0	0.1	1.1	0.0	0.3	1.7	0.2
ZNF724	ZNF724P	ENSG00000196081	"Zinc finger protein 724"	A8MTY0	19	23221599-23250394	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 2.5;esophagus: 2.6"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 2.1;Extravillous trophoblasts: 5.0;Glandular and luminal cells: 3.0;granulocytes: 2.5;Granulosa cells: 3.4;Syncytiotrophoblasts: 2.7;Theca cells: 3.1"	"Cancer enhanced"	"Detected in many"		"testis cancer: 2.5"	"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 13.6"															NA	NA						"unprognostic (2.02e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.78e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.27e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.94e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.32e-2)"	"unprognostic (5.34e-2)"	"unprognostic (3.07e-2)"	"unprognostic (2.73e-2)"	"unprognostic (3.20e-1)"	"unprognostic (3.76e-1)"	"unprognostic (3.30e-2)"	0.3	0.2	0.6	0.6	0.4	2.5	0.4	1.9	0.8	0.3	0.4	0.5	0.1	0.5	0.4	2.6	0.3	0.3	0.1	0.6	0.9	0.3	0.4	0.2	0.6	0.6	0.6	0.5	0.4	0.3	0.2	0.0	0.6	0.9	0.3	0.6	0.8	0.5	0.1	0.6	0.6	0.4	0.3	0.4	0.7	1.7	1.0	0.7	0.8	0.5	0.1	0.8	0.1	0.2	0.9	3.4	1.6	5.7	7.1	0.5	0.6	6.6	1.6	1.4	4.2	5.1	3.7	1.1	3.4	3.8	1.7	1.5	2.2	6.2	2.4	7.8	0.4	5.5	3.4	1.2	1.4	0.1	0.1	3.2	0.4	0.3	5.1	3.6	0.5	0.2	4.8	5.4	0.3	2.6	5.1	8.5	2.1	13.6	0.1	4.5	4.8	7.4	2.6	0.6	3.6	3.2	2.8	0.0	0.1	0.8	4.5	2.0	2.2	0.1	1.6	0.2	4.8	4.6	0.0	1.5	7.4	0.0	1.0	1.4	2.2	0.6	0.3	1.0	0.6	0.5	1.6	0.6	0.7	0.5	1.9	0.8	1.0	2.6	2.0	0.5	1.4	0.4	0.2	0.6	0.4	1.9	0.8	0.6	0.9	0.6	0.6	0.5	0.9	0.4	0.7	0.9	1.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	1.0	0.0	0.0	0.6	0.0	0.0	2.1	0.8	0.0	0.0	0.8	0.0	1.2	1.9	0.7	0.0	0.0	0.0	0.2	5.0	0.6	0.0	3.0	2.5	3.4	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	2.7	0.4	3.1	0.0	0.0
ZNF727	ZNF727P	ENSG00000214652	"Zinc finger protein 727"	A8MUV8	7	64045434-64085339	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Astrocytes: 7.2;Excitatory neurons: 13.3;Inhibitory neurons: 7.7;Microglial cells: 9.4;Oligodendrocyte precursor cells: 34.2;Oligodendrocytes: 27.0"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"T-47d: 7.2"									"HPA051027, HPA061215"	Uncertain		Uncertain	Nucleoplasm		NA	NA			Nucleoplasm		"HPA051027: , HPA061215: AB_2684452"	"unprognostic (5.87e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.75e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.16e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.54e-1)"	"unprognostic (4.04e-2)"	"unprognostic (5.73e-4)"	"unprognostic (8.70e-2)"	"unprognostic (6.36e-2)"	"unprognostic (8.61e-2)"	1.2	0.7	1.9	0.3	2.4	0.1	2.4	3.1	2.1	1.5	0.1	0.6	0.3	1.9	2.7	0.6	1.7	0.6	0.7	2.5	2.2	1.1	0.1	0.8	0.5	2.4	2.4	1.5	3.3	0.9	1.2	1.1	0.0	2.6	2.0	0.6	3.6	1.0	1.1	0.6	1.4	0.3	1.3	1.3	0.7	0.6	1.9	3.1	0.4	3.1	0.9	0.3	0.7	0.9	3.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.9	7.2	0.0	0.0	0.1	0.8	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.9	2.4	3.1	2.1	2.5	2.2	2.4	2.4	1.5	2.6	1.3	3.1	3.1	1.3	0.0	0.0	7.2	0.1	0.0	0.3	0.0	0.6	2.2	0.5	1.0	1.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.9	0.2	2.1	0.4	2.1	0.6	0.0	0.0	13.3	0.0	0.0	0.9	0.0	0.2	0.0	1.5	0.0	0.1	0.0	1.7	7.7	0.0	0.0	0.0	0.0	2.8	0.0	0.1	0.0	9.4	0.0	0.4	0.0	34.2	27.0	0.2	0.0	0.4	0.0	0.1	0.0	0.3	0.0	0.5	0.0	1.3	0.9	0.6	1.7	0.7	0.0	0.0	0.0	1.6	0.0	0.0
ZNF730		ENSG00000183850	"Zinc finger protein 730"	Q6ZMV8	19	23075210-23147221	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 4.5;testis: 5.1"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 9.1;Early spermatids: 29.8;Granulosa cells: 7.3;Late spermatids: 20.1;Oligodendrocyte precursor cells: 12.1"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 23.3;REH: 21.3;U-698: 19.4"															NA	NA						"unprognostic (6.75e-3)"	"unprognostic (2.49e-2)"	"unprognostic (3.64e-1)"	"unprognostic (1.60e-3)"	"unprognostic (3.33e-2)"	"unprognostic (1.78e-2)"	"unprognostic (4.24e-4)"	"unprognostic (9.34e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.92e-2)"	"unprognostic (3.10e-2)"	"unprognostic (5.98e-2)"	"unprognostic (1.37e-3)"	"unprognostic (5.53e-2)"	"unprognostic (1.90e-1)"	"unprognostic (6.67e-2)"	"unprognostic (1.43e-2)"	0.2	0.2	2.4	0.3	1.2	1.6	1.1	1.5	1.4	0.6	0.0	0.4	0.1	1.2	1.4	0.6	1.0	0.8	0.4	0.7	3.2	0.2	0.2	0.6	1.8	3.4	3.8	0.3	2.6	0.4	0.7	0.1	1.8	4.5	1.7	0.8	0.9	0.2	0.4	0.3	0.4	0.0	1.0	1.6	0.4	0.2	5.1	3.9	2.6	1.1	0.2	2.0	0.4	0.2	3.0	0.0	0.0	17.1	12.3	0.7	1.3	3.7	5.2	0.1	10.3	17.4	0.0	0.0	0.0	6.3	3.2	5.0	0.0	1.8	0.6	15.4	0.0	0.0	0.0	0.1	0.0	0.6	0.0	2.3	2.0	0.0	4.7	1.5	1.1	0.0	13.7	6.3	0.0	9.4	2.4	16.2	5.0	23.3	0.0	2.9	21.3	10.3	1.1	1.4	11.6	0.0	9.8	0.1	0.0	0.0	11.8	8.1	5.6	0.2	0.1	0.9	3.5	5.2	0.0	4.0	19.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.4	1.2	1.5	1.4	0.7	3.2	3.4	3.8	0.3	4.5	1.6	3.9	3.0	0.3	0.0	1.8	9.1	0.4	0.0	0.4	0.0	0.0	3.6	0.3	0.3	0.5	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.3	29.8	0.7	1.3	0.9	0.0	3.8	0.6	0.2	1.8	1.3	0.0	0.4	0.0	7.3	0.0	0.0	0.2	0.0	2.9	0.3	0.0	0.0	0.0	20.1	0.0	0.2	0.0	2.8	0.7	0.2	0.0	12.1	2.5	0.1	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.5	1.3	3.2	3.2	0.3	0.0	1.4	0.3	5.2	0.2	0.2
ZNF732	FLJ59067	ENSG00000186777	"Zinc finger protein 732"	B4DXR9	4	270675-305474	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in single"		"testis: 1.5"	"Cell type enhanced"	"Detected in some"		"Granulosa cells: 2.7;Inhibitory neurons: 1.9;Spermatocytes: 5.0;Spermatogonia: 8.4"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"NTERA-2: 7.7"															NA	NA						"unprognostic (7.83e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.54e-2)"	"unprognostic (8.99e-4)"	"unprognostic (7.60e-3)"	"unprognostic (8.13e-2)"	"unprognostic (3.83e-2)"	"unprognostic (4.89e-3)"	"unprognostic (1.44e-3)"	"unprognostic (3.60e-3)"	"unprognostic (5.45e-3)"	"unprognostic (8.40e-4)"	"unprognostic (3.85e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.53e-1)"	0.1	0.1	0.2	0.2	0.6	0.0	0.4	0.4	0.5	0.6	0.0	0.3	0.0	0.4	0.0	0.3	0.5	0.1	0.2	0.2	0.1	0.2	0.1	0.2	0.5	0.1	0.0	0.2	0.7	0.3	0.1	0.8	0.2	0.3	0.5	0.0	0.9	0.2	0.0	0.0	0.6	0.2	0.1	0.0	0.4	0.2	1.5	0.1	0.0	0.4	0.0	0.7	0.4	0.4	0.2	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.7	1.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	7.7	0.0	1.8	0.0	0.0	0.0	0.6	0.9	0.0	1.8	0.0	0.0	0.0	1.8	1.7	0.0	0.0	0.0	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.4	0.5	0.2	0.1	0.1	0.0	0.2	0.3	0.0	0.1	0.2	0.2	0.0	0.0	0.3	0.0	0.4	0.2	0.0	0.0	0.0	0.3	0.3	0.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.8	0.0	0.4	0.2	0.0	0.0	1.6	0.0	0.6	0.3	0.0	0.1	0.0	2.7	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.0	1.0	0.0	0.0	0.0	1.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	5.0	8.4	0.6	0.3	0.0	0.0	0.3	0.0	0.1
ZNF781	FLJ37549	ENSG00000196381	"Zinc finger protein 781"	Q8N8C0	19	37667751-37692315	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 71.1;Late spermatids: 65.7;Oligodendrocyte precursor cells: 42.3"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 2.3;ASC diff: 2.3;HSkMC: 2.1;SH-SY5Y: 2.2;U-266/84: 2.8"	"Low region specificity"	"Detected in all"							HPA062512	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA062512: AB_2684788"	"unprognostic (3.01e-1)"	"unprognostic (8.26e-2)"	"unprognostic (3.03e-1)"	"unprognostic (2.86e-2)"	"unprognostic (1.90e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.76e-3)"	"unprognostic (2.68e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.84e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.23e-2)"	"unprognostic (2.11e-2)"	"unprognostic (8.12e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.04e-1)"	1.5	1.7	3.1	0.5	3.2	0.0	1.0	5.5	3.2	2.2	2.3	2.0	0.3	2.2	1.3	0.5	2.0	0.7	1.8	2.8	2.9	1.2	0.3	1.0	1.0	3.1	3.0	2.9	3.1	0.5	1.1	4.0	1.4	3.3	1.6	0.8	3.9	0.5	1.4	0.3	0.5	1.2	2.5	1.9	2.1	1.0	1.3	2.8	0.5	2.0	0.5	0.7	1.8	1.2	3.5	0.0	0.0	0.9	2.3	2.3	0.5	0.5	0.8	0.0	0.8	0.5	0.1	0.0	0.1	0.0	0.5	1.5	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	1.0	1.1	0.0	0.0	2.1	0.0	0.6	0.0	0.3	0.2	0.1	0.4	0.0	0.0	0.0	0.6	0.5	0.2	0.0	0.0	0.0	1.6	0.0	0.3	0.6	0.0	2.2	0.0	0.0	0.0	1.1	1.0	0.0	0.0	0.1	0.0	0.0	0.5	0.7	2.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.1	0.5	0.7	0.0	0.2	0.7	0.9	0.0	0.0	0.0	0.0	0.2	0.2	3.1	3.2	5.5	3.2	2.8	2.9	3.1	3.0	2.9	3.3	1.9	2.8	3.5	10.4	0.0	0.6	13.7	2.8	0.5	0.5	0.5	1.2	6.3	2.0	1.0	14.9	2.8	0.1	0.0	20.9	7.5	2.5	0.0	0.0	0.8	71.1	0.4	2.6	5.5	7.8	0.8	18.0	0.0	3.1	4.7	0.5	0.1	3.8	5.3	10.4	0.1	3.9	3.3	22.2	0.0	2.0	1.6	0.4	65.7	4.7	0.5	1.8	3.7	0.1	5.3	11.3	42.3	19.9	0.1	0.0	6.8	0.5	0.2	0.0	0.5	0.5	8.5	13.1	1.5	6.4	17.4	5.1	0.1	0.0	1.4	2.2	2.4	0.0	0.2
